TRH	NNP	B-Gene
of	IN	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
induce	VBP	B-PosReg
growth	NN	B-CPA
behavioral	JJ	B-CPA
defects	NNS	I-CPA

CRISPR	NNP	O
-	:	O
Cas9	NNP	O
technology	NN	O
was	VBD	O
used	VBN	O
to	TO	O
generate	VB	O
seven	CD	O
indel	NNS	O
TRH	NNP	O
mutants	NNS	O
in	IN	O
Daphnia	NNP	O
magna	NN	O
.	.	O

Mono	NNP	O
-	:	O
allelic	JJ	O
indel	NN	O
TRH	NNP	O
-	:	O
clones	NNS	O
showed	VBD	O
normal	JJ	O
levels	NNS	O
of	IN	O
serotonin	NN	O
,	,	O
measured	VBN	O
by	IN	O
both	DT	O
immunohistochemistry	NN	O
and	CC	O
mass	NN	O
spectrometry	NN	O
(	(	O
LC	NNP	O
-	:	O
MS	NNP	O
MS	NNP	O
)	)	O
,	,	O
whereas	JJ	O
bi	SYM	O
-	:	O
allelic	JJ	O
indel	NN	O
TRH	NNP	O
-	:	O
-	:	O
clones	NNS	O
showed	VBD	O
no	DT	O
detectable	JJ	O
levels	NNS	O
of	IN	O
serotonin	NN	O
.	.	O

Life	NNP	O
history	NN	O
and	CC	O
behavioral	JJ	O
responses	NNS	O
of	IN	O
TRH	NNP	O
-	:	O
-	:	O
clones	NNS	O
showed	VBD	O
the	DT	O
anti	JJ	O
-	:	O
phenotype	NN	O
of	IN	O
those	DT	O
exposed	VBN	O
to	TO	O
selective	VB	O
serotonin	JJ	O
reuptake	NN	O
inhibitors	NNS	O
(	(	O
SSRI	NNP	O
)	)	O
.	.	O

Mutants	NNS	B-Var
lacking	VBG	B-NegReg
serotonin	NN	B-MPA
grew	VBD	B-CPA
less	JJR	B-NegReg
and	CC	O
hence	RB	O
reproduced	VBD	B-CPA
latter	JJ	O
,	,	O
produced	VBD	O
smaller	JJR	B-NegReg
clutches	NNS	B-CPA
of	IN	O
smaller	JJR	B-NegReg
offspring	NN	B-CPA
and	CC	O
responded	VBD	O
to	TO	O
a	DT	O
greater	JJR	O
extent	NN	O
to	TO	O
light	NN	O
than	IN	O
wild	JJ	O
type	JJ	O
individuals	NNS	O
.	.	O
Mono	NNP	O
-	:	O
allelic	JJ	O
indel	NN	O
TRH	NNP	O
-	:	O
individuals	NNS	O
showed	VBD	O
the	DT	O
intermediate	JJ	O
phenotype	NN	O
.	.	O

The	DT	O
SSRI	NNP	O
fluoxetine	NN	O
enhanced	VBD	O
offspring	VBG	O
production	NN	O
in	IN	O
all	DT	O
clones	NNS	O
and	CC	O
decreased	VBD	O
the	DT	O
response	NN	O
to	TO	O
light	NN	O
only	RB	O
in	IN	O
those	DT	O
clones	NNS	O
having	VBG	O
serotonin	NN	O
,	,	O
thus	RB	O
indication	NN	O
that	IN	O
behavioral	JJ	O
effects	NNS	O
of	IN	O
this	DT	O
drug	NN	O
in	IN	O
D.	NNP	O
magna	NN	O
are	VBP	O
associated	VBN	O
to	TO	O
serotonin	VB	O
.	.	O

Results	NNS	O
obtained	VBD	O
with	IN	O
the	DT	O
TRH	NNP	O
mutants	NNS	O
are	VBP	O
in	IN	O
line	NN	O
with	IN	O
reported	JJ	O
ones	NNS	O
in	IN	O
TRH	NNP	O
knockouts	NNS	O
of	IN	O
Caenorhabditis	NNP	O
elegans	NNS	O
,	,	O
Drosophila	NNP	O
and	CC	O
mice	NN	O
,	,	O
indicating	VBG	O
that	IN	O
there	EX	O
is	VBZ	O
one	CD	O
gene	NN	O
encoding	VBG	O
TRH	NNP	O
,	,	O
which	WDT	O
is	VBZ	O
the	DT	O
serotonin	NN	O
limiting	VBG	O
enzyme	NN	O
in	IN	O
both	CC	O
the	DT	O
central	JJ	O
and	CC	O
the	DT	O
periphery	NN	O
nervous	JJ	O
system	NN	O
in	IN	O
Daphnia	NNP	O
and	CC	O
that	DT	O
deprivation	NN	O
of	IN	O
serotonin	NN	O
increases	NNS	O
anxiety	VBP	O
-	:	O
like	IN	O
behavior	NN	O


BACKGROUND	NN	O
:	:	O
Filaggrin	NNP	O
is	VBZ	O
an	DT	O
epidermal	JJ	O
protein	NN	O
that	WDT	O
is	VBZ	O
important	JJ	O
for	IN	O
normal	JJ	O
skin	JJ	O
barrier	NN	O
functions	NNS	O
.	.	O

Up	RB	O
to	TO	O
10%	CD	O
of	IN	O
Europeans	NNPS	O
and	CC	O
Asians	NNPS	O
carry	VBP	O
filaggrin	JJ	O
gene	NN	O
(	(	O
FLG	NNP	B-Gene
)	)	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
that	WDT	O
appear	VBP	O
to	TO	O
facilitate	VB	B-PosReg
trans	NNS	B-CPA
-	:	I-CPA
epidermal	JJ	I-CPA
penetration	NN	I-CPA
of	IN	I-CPA
certain	JJ	I-CPA
chemicals	NNS	I-CPA
.	.	O
We	PRP	O
previously	RB	O
showed	VBD	O
that	IN	O
mutation	NN	O
carriers	NNS	O
have	VBP	O
higher	JJR	O
internal	JJ	O
exposure	NN	O
to	TO	O
certain	JJ	O
phthalates	NNS	O
,	,	O
compared	VBN	O
to	TO	O
controls	NNS	O
,	,	O
and	CC	O
hypothesized	VBD	O
that	IN	O
they	PRP	O
could	MD	O
have	VB	O
increased	VBN	O
trans	NNS	O
-	:	O
epidermal	JJ	O
penetration	NN	O
of	IN	O
other	JJ	O
chemicals	NNS	O
.	.	O

OBJECTIVES	NN	O
:	:	O
We	PRP	O
investigated	VBD	O
exposure	NN	O
to	TO	O
non	VB	O
-	:	O
persistent	NN	O
chemicals	NNS	O
in	IN	O
young	JJ	O
Danish	JJ	O
men	NNS	O
with	IN	O
and	CC	O
without	IN	O
FLG	NNP	O
mutations	NNS	O
.	.	O

METHODS	NN	O
:	:	O
Concentrations	NNS	O
of	IN	O
eight	CD	O
simple	NN	O
phenols	NNS	O
,	,	O
six	CD	O
parabens	NNS	O
and	CC	O
nine	CD	O
UV	NNP	O
filters	NNS	O
were	VBD	O
analysed	VBN	O
in	IN	O
urine	NN	O
from	IN	O
65	CD	O
FLG	NNP	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
mutation	NN	O
carriers	NNS	O
and	CC	O
130	CD	O
non	JJ	O
-	:	O
carriers	NNS	O
(	(	O
controls	NNS	O
)	)	O
.	.	O

Regression	NN	O
analyses	NNS	O
,	,	O
controlling	VBG	O
for	IN	O
urinary	JJ	O
dilution	NN	O
and	CC	O
confounders	NNS	O
,	,	O
were	VBD	O
performed	VBN	O
to	TO	O
estimate	VB	O
associations	NNS	O
between	IN	O
FLG	NNP	O
mutation	NN	O
status	NN	O
and	CC	O
chemical	NN	O
concentrations	NNS	O
in	IN	O
urine	NN	O
.	.	O

RESULTS	NN	O
:	:	O
FLG	NNP	O
mutation	NN	O
carriers	NNS	O
had	VBD	O
80%	CD	O
(	(	O
13	CD	O
-	:	O
180%	CD	O
)	)	O
higher	JJR	O
urinary	JJ	O
concentrations	NNS	O
of	IN	O
methyl	NN	O
paraben	NN	O
(	(	O
MeP	NNP	O
)	)	O
and	CC	O
91%	CD	O
(	(	O
13	CD	O
-	:	O
219%	CD	O
)	)	O
higher	JJR	O
concentrations	NNS	O
of	IN	O
n	JJ	O
-	:	O
propyl	NN	O
paraben	NN	O
(	(	O
n	JJ	O
-	:	O
PrP	NN	O
)	)	O
than	IN	O
controls	NNS	O
.	.	O

For	IN	O
13	CD	O
compounds	NNS	O
,	,	O
levels	NNS	O
were	VBD	O
higher	JJR	O
in	IN	O
FLG	NNP	O
mutation	NN	O
carriers	NNS	O
,	,	O
although	IN	O
differences	NNS	O
were	VBD	O
only	RB	O
statistically	RB	O
significant	JJ	O
for	IN	O
MeP	NNP	O
and	CC	O
n	SYM	O
-	:	O
PrP	NN	O
.	.	O

Combined	JJ	O
statistical	JJ	O
analysis	NN	O
of	IN	O
concentrations	NNS	O
of	IN	O
all	PDT	O
the	DT	O
18	CD	O
compounds	NNS	O
that	WDT	O
were	VBD	O
detectable	JJ	O
in	IN	O
10%	CD	O
of	IN	O
subjects	NNS	O
,	,	O
suggested	VBD	O
that	IN	O
concentrations	NNS	O
were	VBD	O
generally	RB	O
higher	JJR	O
in	IN	O
mutation	NN	O
carriers	NNS	O
(	(	O
p	VB	O
0.03	CD	O
)	)	O
.	.	O

CONCLUSION	NN	O
:	:	O
FLG	NNP	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
mutation	NN	O
carriers	NNS	O
have	VBP	O
a	DT	O
higher	JJR	O
internal	JJ	O
exposure	NN	O
to	TO	O
some	DT	O
non	JJ	O
-	:	O
persistent	JJ	O
chemicals	NNS	O
,	,	O
independently	RB	O
of	IN	O
atopic	NN	O
dermatitis	NN	O
.	.	O

This	DT	O
may	MD	O
be	VB	O
due	JJ	O
to	TO	O
increased	VBN	O
trans	NNS	O
-	:	O
epidermal	JJ	O
absorption	NN	O
and	CC	O
or	CC	O
higher	JJR	O
exposure	NN	O
,	,	O
and	CC	O
mutation	NN	O
carriers	NNS	O
may	MD	O
constitute	VB	O
a	DT	O
group	NN	O
susceptible	JJ	O
to	TO	O
increased	VBN	O
absorption	NN	O
of	IN	O
chemicals	NNS	O
and	CC	O
topical	JJ	O
medication	NN	O


Glycine	JJ	O
receptors	NNS	O
(	(	O
GlyRs	NNP	O
)	)	O
are	VBP	O
Cys	NNP	O
-	:	O
loop	NN	O
receptors	NNS	O
that	WDT	O
mediate	VBP	O
fast	RB	O
synaptic	JJ	O
inhibition	NN	O
in	IN	O
the	DT	O
brain	NN	O
stem	NN	O
and	CC	O
spinal	JJ	O
cord	NN	O
.	.	O

They	PRP	O
are	VBP	O
involved	VBN	O
in	IN	O
the	DT	O
generation	NN	O
of	IN	O
motor	NN	O
rhythm	NN	O
,	,	O
reflex	JJ	O
circuit	NN	O
coordination	NN	O
,	,	O
and	CC	O
sensory	JJ	O
signal	NN	O
processing	NN	O
and	CC	O
therefore	RB	O
represent	JJ	O
targets	NNS	O
for	IN	O
therapeutic	JJ	O
interventions	NNS	O
.	.	O

The	DT	O
extracellular	JJ	O
domains	NNS	O
(	(	O
ECDs	NNP	O
)	)	O
of	IN	O
Cys	NNP	O
-	:	O
loop	NN	O
receptors	NNS	O
typically	RB	O
contain	VBP	O
many	JJ	O
aromatic	JJ	O
amino	NN	O
acids	NNS	O
,	,	O
but	CC	O
only	RB	O
those	DT	O
in	IN	O
the	DT	O
receptor	NN	O
binding	VBG	O
pocket	NN	O
have	VBP	O
been	VBN	O
extensively	RB	O
studied	VBN	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
show	VBP	O
that	IN	O
many	JJ	O
Phe	NNP	O
residues	NNS	O
in	IN	O
the	DT	O
ECD	NNP	O
that	WDT	O
are	VBP	O
not	RB	O
located	VBN	O
in	IN	O
the	DT	O
binding	NN	O
pocket	NN	O
are	VBP	O
also	RB	O
involved	VBN	O
in	IN	O
GlyR	NNP	O
function	NN	O
.	.	O

We	PRP	O
examined	VBD	O
these	DT	O
Phe	NNP	O
residues	NNS	O
by	IN	O
creating	VBG	O
several	JJ	O
GlyR	NNP	O
variants	NNS	O
,	,	O
characterizing	VBG	O
these	DT	O
variants	NNS	O
with	IN	O
the	DT	O
two	CD	O
-	:	O
electrode	NN	O
voltage	NN	O
clamp	NN	O
technique	NN	O
in	IN	O
Xenopus	NNP	O
oocytes	NNS	O
,	,	O
and	CC	O
interpreting	VBG	O
changes	NNS	O
in	IN	O
receptor	NN	O
parameters	NNS	O
by	IN	O
using	VBG	O
currently	RB	O
available	JJ	O
structural	JJ	O
information	NN	O
on	IN	O
the	DT	O
open	JJ	O
and	CC	O
closed	JJ	O
states	NNS	O
of	IN	O
the	DT	O
GlyR	NNP	O
.	.	O

Substitution	NN	B-Var
of	IN	I-Var
six	CD	I-Var
of	IN	I-Var
the	DT	I-Var
eight	CD	I-Var
Phe	NNP	I-Var
residues	NNS	I-Var
in	IN	I-Var
the	DT	I-Var
ECD	NNP	I-Var
with	IN	I-Var
Ala	NNP	I-Var
resulted	VBD	O
in	IN	O
loss	NN	B-NegReg
of	IN	O
function	NN	B-MPA
or	CC	O
significantly	RB	O
increased	VBD	B-PosReg
the	DT	O
EC50	NNP	B-MPA
and	CC	O
also	RB	O
altered	VBD	B-Reg
the	DT	O
maximal	JJ	B-MPA
response	NN	I-MPA
to	TO	I-MPA
the	DT	I-MPA
partial	JJ	I-MPA
GlyR	NNP	I-MPA
agonist	NN	I-MPA
taurine	NN	I-MPA
compared	VBN	O
with	IN	O
glycine	NN	O
in	IN	O
those	DT	O
receptor	NN	O
variants	NNS	O
that	WDT	O
were	VBD	O
functional	JJ	O
.	.	O
Substitutions	NNS	O
with	IN	O
other	JJ	O
amino	JJ	O
acids	NNS	O
,	,	O
combined	VBN	O
with	IN	O
examination	NN	O
of	IN	O
nearby	JJ	O
residues	NNS	O
that	WDT	O
could	MD	O
potentially	RB	O
interact	VB	O
with	IN	O
these	DT	O
Phe	NNP	O
residues	NNS	O
,	,	O
suggested	VBD	O
interactions	NNS	O
that	WDT	O
could	MD	O
be	VB	O
important	JJ	O
for	IN	O
GlyR	NNP	O
function	NN	O
,	,	O
and	CC	O
possibly	RB	O
similar	JJ	O
interactions	NNS	O
could	MD	O
contribute	VB	O
to	TO	O
the	DT	O
function	NN	O
of	IN	O
other	JJ	O
members	NNS	O
of	IN	O
the	DT	O
Cys	NNP	O
-	:	O
loop	NN	O
receptor	NN	O
family	NN	O
.	.	O

Overall	JJ	O
,	,	O
our	PRP$	O
results	NNS	O
suggest	VBP	O
that	IN	O
many	JJ	O
ECD	NNP	O
regions	NNS	O
are	VBP	O
important	JJ	O
for	IN	O
GlyR	NNP	O
function	NN	O
and	CC	O
that	IN	O
these	DT	O
regions	NNS	O
could	MD	O
inform	VB	O
the	DT	O
design	NN	O
of	IN	O
therapeutic	JJ	O
agents	NNS	O
targeting	VBG	O
GlyR	NNP	O
activity	NN	O


Calcium	NN	O
(	(	O
Ca2	NNP	O
)	)	O
homeostasis	NN	O
is	VBZ	O
essential	JJ	O
for	IN	O
neuronal	JJ	O
function	NN	O
and	CC	O
survival	NN	O
.	.	O

Altered	NNP	O
Ca2	NNP	O
homeostasis	NN	O
has	VBZ	O
been	VBN	O
consistently	RB	O
observed	VBN	O
in	IN	O
neurological	JJ	O
diseases	NNS	O
.	.	O

How	WRB	O
Ca2	JJ	O
homeostasis	NN	O
is	VBZ	O
achieved	VBN	O
in	IN	O
various	JJ	O
cellular	JJ	O
compartments	NNS	O
of	IN	O
disease	NN	O
-	:	O
relevant	NN	O
cell	NN	O
types	NNS	O
is	VBZ	O
not	RB	O
well	RB	O
understood	RB	O
.	.	O

Here	RB	O
we	PRP	O
show	VBP	O
in	IN	O
Drosophila	NNP	O
Parkinson	NNP	O
's	POS	O
disease	NN	O
(	(	O
PD	NNP	O
)	)	O
models	NNS	O
that	IN	O
Ca2	NNP	O
transport	NN	O
from	IN	O
the	DT	O
endoplasmic	JJ	O
reticulum	NN	O
(	(	O
ER	NNP	O
)	)	O
to	TO	O
mitochondria	VB	O
through	IN	O
the	DT	O
ER	NNP	O
-	:	O
mitochondria	NN	O
contact	NN	O
site	NN	O
(	(	O
ERMCS	NNP	O
)	)	O
critically	RB	O
regulates	VBZ	O
mitochondrial	JJ	O
Ca2	NNP	O
(	(	O
mito	SYM	O
-	:	O
Ca2	NN	O
)	)	O
homeostasis	NN	O
in	IN	O
dopaminergic	NN	O
(	(	O
DA	NNP	O
)	)	O
neurons	NNS	O
,	,	O
and	CC	O
that	IN	O
the	DT	O
PD	NNP	O
-	:	O
associated	VBN	O
PINK1	NNP	O
protein	NN	O
modulates	VBZ	O
this	DT	O
process	NN	O
.	.	O

In	IN	O
PINK1	NNP	B-Gene
mutant	JJ	B-Var
DA	NNP	O
neurons	NNS	O
,	,	O
the	DT	O
ERMCS	NNP	B-MPA
is	VBZ	O
strengthened	VBN	B-PosReg
and	CC	O
mito	SYM	B-MPA
-	:	I-MPA
Ca2	NNP	I-MPA
level	NN	I-MPA
is	VBZ	O
elevated	VBN	B-PosReg
,	,	O
resulting	VBG	O
in	IN	O
mitochondrial	JJ	B-MPA
enlargement	NN	B-PosReg
and	CC	O
neuronal	JJ	B-CPA
death	NN	B-NegReg
.	.	O
Miro	NNP	O
,	,	O
a	DT	O
well	RB	O
-	:	O
characterized	VBN	O
component	NN	O
of	IN	O
the	DT	O
mitochondrial	JJ	O
trafficking	NN	O
machinery	NN	O
,	,	O
mediates	VBZ	O
the	DT	O
effects	NNS	O
of	IN	O
PINK1	NNP	O
on	IN	O
mito	SYM	O
-	:	O
Ca2	NN	O
and	CC	O
mitochondrial	JJ	O
morphology	NN	O
,	,	O
apparently	RB	O
in	IN	O
a	DT	O
transport	NN	O
-	:	O
independent	JJ	O
manner	NN	O
.	.	O

Miro	NNP	O
overexpression	NN	O
mimics	NNS	O
PINK1	NNP	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
effect	NN	O
,	,	O
whereas	JJ	O
inhibition	NN	O
of	IN	O
Miro	NNP	O
or	CC	O
components	NNS	O
of	IN	O
the	DT	O
ERMCS	NNP	O
,	,	O
or	CC	O
pharmacological	JJ	O
modulation	NN	O
of	IN	O
ERMCS	NNP	O
function	NN	O
,	,	O
rescued	VBN	O
PINK1	NNP	O
mutant	JJ	O
phenotypes	NNS	O
.	.	O

Mito	NNP	O
-	:	O
Ca2	NNP	O
homeostasis	NN	O
is	VBZ	O
also	RB	O
altered	VBN	O
in	IN	O
the	DT	O
LRRK2	NNP	O
-	:	O
G2019S	NNP	O
model	NN	O
of	IN	O
PD	NNP	O
and	CC	O
the	DT	O
PAR	NNP	O
-	:	O
1	CD	O
MARK	NNP	O
model	NN	O
of	IN	O
neurodegeneration	NN	O
,	,	O
and	CC	O
genetic	JJ	O
or	CC	O
pharmacological	JJ	O
restoration	NN	O
of	IN	O
mito	JJ	O
-	:	O
Ca2	NNP	O
level	NN	O
is	VBZ	O
beneficial	JJ	O
in	IN	O
these	DT	O
models	NNS	O
.	.	O

Our	PRP$	O
results	NNS	O
highlight	VBD	O
the	DT	O
importance	NN	O
of	IN	O
mito	NN	O
-	:	O
Ca2	NNP	O
homeostasis	NN	O
maintained	VBN	O
by	IN	O
Miro	NNP	O
and	CC	O
the	DT	O
ERMCS	NNP	O
to	TO	O
mitochondrial	VB	O
physiology	NN	O
and	CC	O
neuronal	JJ	O
integrity	NN	O
.	.	O

Targeting	VBG	O
this	DT	O
mito	NN	O
-	:	O
Ca2	NNP	O
homeostasis	NN	O
pathway	NN	O
holds	VBZ	O
promise	NN	O
for	IN	O
a	DT	O
therapeutic	JJ	O
strategy	NN	O
for	IN	O
neurodegenerative	JJ	O
diseases	NNS	O



The	DT	O
filaggrin	NN	O
(	(	O
FLG	NNP	B-Gene
)	)	O
gene	NN	O
is	VBZ	O
widely	RB	O
studied	VBN	O
for	IN	O
its	PRP$	O
skin	NN	O
-	:	O
barrier	NN	O
function	NN	O
in	IN	O
humans	NNS	O
.	.	O
The	DT	O
extensive	JJ	B-Var
genetic	JJ	I-Var
variation	NN	I-Var
in	IN	O
this	DT	O
gene	NN	O
,	,	O
especially	RB	O
common	JJ	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
(	(	O
LoF	NNP	O
)	)	O
mutations	NNS	B-Var
,	,	O
has	VBZ	O
been	VBN	O
established	VBN	O
as	IN	O
primary	JJ	O
risk	NN	O
factors	NNS	O
for	IN	O
atopic	NN	B-Disease
dermatitis	NN	I-Disease
.	.	O
To	TO	O
investigate	VB	O
the	DT	O
evolution	NN	O
of	IN	O
this	DT	O
gene	NN	O
,	,	O
we	PRP	O
analyzed	VBD	O
2	CD	O
,	,	O
504	CD	O
human	JJ	O
genomes	NNS	O
and	CC	O
genotyped	VBD	O
the	DT	O
copy	NN	O
number	NN	O
variation	NN	O
of	IN	O
filaggrin	NN	O
repeats	NNS	O
within	IN	O
FLG	NNP	O
in	IN	O
126	CD	O
individuals	NNS	O
from	IN	O
diverse	JJ	O
ancestral	JJ	O
backgrounds	NNS	O
.	.	O

We	PRP	O
were	VBD	O
unable	JJ	O
to	TO	O
replicate	VB	O
a	DT	O
recent	JJ	O
study	NN	O
claiming	VBG	O
that	IN	O
LoF	NNP	O
of	IN	O
FLG	NNP	O
is	VBZ	O
adaptive	JJ	O
in	IN	O
northern	JJ	O
latitudes	NNS	O
with	IN	O
lower	JJR	O
ultraviolet	NN	O
light	JJ	O
exposure	NN	O
.	.	O

Instead	RB	O
,	,	O
we	PRP	O
present	VBP	O
multiple	JJ	O
lines	NNS	O
of	IN	O
evidence	NN	O
suggesting	VBG	O
that	IN	O
FLG	NNP	O
genetic	JJ	O
variation	NN	O
,	,	O
including	VBG	O
LoF	NNP	O
variants	NNS	O
,	,	O
have	VBP	O
little	JJ	O
or	CC	O
no	DT	O
effect	NN	O
on	IN	O
fitness	NN	O
in	IN	O
modern	JJ	O
humans	NNS	O
.	.	O

Haplotype	NNP	O
-	:	O
level	NN	O
scrutinization	NN	O
of	IN	O
the	DT	O
locus	NN	O
revealed	VBD	O
signatures	NNS	O
of	IN	O
a	DT	O
recent	JJ	O
selective	JJ	O
sweep	NN	O
in	IN	O
Asia	NNP	O
,	,	O
which	WDT	O
increased	VBD	O
the	DT	O
allele	JJ	O
frequency	NN	O
of	IN	O
a	DT	O
haplotype	NN	O
group	NN	O
(	(	O
Huxian	NNP	O
haplogroup	NN	O
)	)	O
in	IN	O
Asian	JJ	O
populations	NNS	O
.	.	O

Functionally	RB	O
,	,	O
we	PRP	O
found	VBD	O
that	IN	O
the	DT	O
Huxian	NNP	O
haplogroup	NN	O
carries	VBZ	O
dozens	NNS	O
of	IN	O
functional	JJ	O
variants	NNS	O
in	IN	O
FLG	NNP	O
and	CC	O
hornerin	NN	O
(	(	O
HRNR	NNP	O
)	)	O
genes	NNS	O
,	,	O
including	VBG	O
those	DT	O
that	WDT	O
are	VBP	O
associated	VBN	O
with	IN	O
atopic	NN	O
dermatitis	NN	O
susceptibility	NN	O
,	,	O
HRNR	NNP	O
expression	NN	O
levels	NNS	O
and	CC	O
microbiome	JJ	O
diversity	NN	O
on	IN	O
the	DT	O
skin	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
target	NN	O
of	IN	O
the	DT	O
adaptive	JJ	O
sweep	NN	O
is	VBZ	O
HRNR	NNP	O
gene	NN	O
function	NN	O
,	,	O
and	CC	O
the	DT	O
functional	JJ	O
FLG	NNP	O
variants	NNS	O
that	WDT	O
involve	VBP	O
susceptibility	NN	O
to	TO	O
atopic	VB	O
dermatitis	NN	O
,	,	O
seem	VBP	O
to	TO	O
hitchhike	VB	O
the	DT	O
selective	JJ	O
sweep	NN	O
on	IN	O
HRNR	NNP	O
.	.	O

Our	PRP$	O
study	NN	O
presents	VBZ	O
a	DT	O
novel	JJ	O
case	NN	O
of	IN	O
a	DT	O
locus	NN	O
that	WDT	O
harbors	VBZ	O
clinically	RB	O
relevant	JJ	O
common	JJ	O
genetic	JJ	O
variation	NN	O
with	IN	O
complex	JJ	O
evolutionary	JJ	O
trajectories	NNS	O

Braf	NNP	B-Gene
mutant	NN	B-Var
lung	VBP	I-Reg
adenocarcinoma	NN	I-Disease


Inactivating	VBG	O
BRAF	NNP	O
mutants	NNS	O
in	IN	O
lung	NN	O
predominate	NN	O
over	IN	O
the	DT	O
activating	VBG	O
V600E	NNP	O
mutant	NN	O
that	WDT	O
is	VBZ	O
frequently	RB	O
observed	VBN	O
in	IN	O
other	JJ	O
tumour	JJ	O
types	NNS	O
.	.	O

Here	RB	O
we	PRP	O
demonstrate	VBP	O
that	IN	O
the	DT	O
expression	NN	O
of	IN	O
an	DT	O
endogenous	JJ	O
Braf	NNP	O
(	(	O
D631A	NNP	O
)	)	O
kinase	VBD	O
-	:	O
inactive	JJ	O
isoform	NN	O
in	IN	O
mice	NN	O
(	(	O
corresponding	VBG	O
to	TO	O
the	DT	O
human	JJ	O
BRAF	NNP	O
(	(	O
D594A	NNP	O
)	)	O
mutation	NN	O
)	)	O
triggers	NNS	O
lung	VBP	O
adenocarcinoma	NN	O
in	IN	O
vivo	NN	O
,	,	O
indicating	VBG	O
that	IN	O
BRAF	NNP	O
-	:	O
inactivating	NN	O
mutations	NNS	O
are	VBP	O
initiating	VBG	O
events	NNS	O
in	IN	O
lung	NN	O
oncogenesis	NN	O
.	.	O

Moreover	RB	O
,	,	O
inactivating	VBG	O
BRAF	NNP	O
mutations	NNS	O
have	VBP	O
also	RB	O
been	VBN	O
identified	VBN	O
in	IN	O
a	DT	O
subset	NN	O
of	IN	O
KRAS	NNP	O
-	:	O
driven	NN	O
human	JJ	O
lung	NN	O
tumours	NNS	O
.	.	O

Co	NNP	O
-	:	O
expression	NN	O
of	IN	O
Kras	NNP	B-Gene
(	(	O
G12V	NNP	B-Var
)	)	O
and	CC	O
Braf	NNP	B-Gene
(	(	O
D631A	NNP	B-Var
)	)	O
in	IN	O
mouse	NN	O
lung	NN	O
cells	NNS	O
markedly	RB	O
enhances	VBZ	B-PosReg
tumour	JJ	B-MPA
initiation	NN	I-MPA
,	,	O
a	DT	O
phenomenon	NN	O
mediated	VBN	O
by	IN	O
Craf	NNP	O
kinase	NN	O
activity	NN	O
,	,	O
and	CC	O
effectively	RB	O
accelerates	VBZ	O
tumour	JJ	O
progression	NN	O
when	WRB	O
activated	VBN	O
in	IN	O
advanced	JJ	O
lung	NN	O
adenocarcinomas	NN	O
.	.	O
We	PRP	O
also	RB	O
report	VBP	O
a	DT	O
key	JJ	O
role	NN	O
for	IN	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
Braf	NNP	O
kinase	NN	O
in	IN	O
sustaining	VBG	O
Kras	NNP	O
(	(	O
G12V	NNP	O
)	)	O
Braf	NNP	O
(	(	O
D631A	NNP	O
)-	NNP	O
driven	NN	O
tumours	NNS	O
.	.	O

Ablation	NN	O
of	IN	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
Braf	NNP	O
allele	NN	O
prevents	VBZ	O
the	DT	O
development	NN	O
of	IN	O
lung	NN	O
adenocarcinoma	NN	O
by	IN	O
inducing	VBG	O
a	DT	O
further	JJ	O
increase	NN	O
in	IN	O
MAPK	NNP	O
signalling	VBG	O
that	IN	O
results	NNS	O
in	IN	O
oncogenic	JJ	O
toxicity	NN	O
;	:	O
this	DT	O
effect	NN	O
can	MD	O
be	VB	O
abolished	VBN	O
by	IN	O
pharmacological	JJ	O
inhibition	NN	O
of	IN	O
Mek	NNP	O
to	TO	O
restore	VB	O
tumour	JJ	O
growth	NN	O
.	.	O

However	RB	O
,	,	O
the	DT	O
loss	NN	B-Var
of	IN	O
wild	JJ	O
-	:	O
type	NN	O
Braf	NNP	B-Gene
also	RB	O
induces	VBZ	B-Reg
transdifferentiation	NN	B-CPA
of	IN	O
club	NN	O
cells	NNS	O
,	,	O
which	WDT	O
leads	VBZ	B-Reg
to	TO	I-Reg
the	DT	O
rapid	JJ	B-MPA
development	NN	I-MPA
of	IN	I-MPA
lethal	JJ	I-MPA
intrabronchiolar	JJ	I-MPA
lesions	NNS	I-MPA
.	.	O
These	DT	O
observations	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
signal	JJ	O
intensity	NN	O
of	IN	O
the	DT	O
MAPK	NNP	O
pathway	NN	O
is	VBZ	O
a	DT	O
critical	JJ	O
determinant	NN	O
not	RB	O
only	RB	O
in	IN	O
tumour	NN	O
development	NN	O
,	,	O
but	CC	O
also	RB	O
in	IN	O
dictating	VBG	O
the	DT	O
nature	NN	O
of	IN	O
the	DT	O
cancer	NN	O
-	:	O
initiating	NN	O
cell	NN	O
and	CC	O
ultimately	RB	O
the	DT	O
resulting	VBG	O
tumour	JJ	O
phenotype	NN	O

Loss	NNP	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
Function	NN	I-NegReg
Variants	NNS	B-Var
TLK2	NNP	B-Gene
Distinct	NNP	B-Disease
Neurodevelopmental	NNP	I-Disease
Disorder	NNP	I-Disease
Next	JJ	O
-	:	O
generation	NN	O
sequencing	NN	O
is	VBZ	O
a	DT	O
powerful	JJ	O
tool	NN	O
for	IN	O
the	DT	O
discovery	NN	O
of	IN	O
genes	NNS	O
related	VBN	O
to	TO	O
neurodevelopmental	JJ	O
disorders	NNS	O
(	(	O
NDDs	NNP	O
)	)	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
report	VBP	O
the	DT	O
identification	NN	O
of	IN	O
a	DT	O
distinct	JJ	O
syndrome	NN	O
due	JJ	O
to	TO	O
de	VB	O
novo	FW	O
or	CC	O
inherited	VBN	O
heterozygous	JJ	O
mutations	NNS	O
in	IN	O
Tousled	NNP	O
-	:	O
like	IN	O
kinase	NN	O
2	CD	O
(	(	O
TLK2	NNP	O
)	)	O
in	IN	O
38	CD	O
unrelated	JJ	O
individuals	NNS	O
and	CC	O
two	CD	O
affected	JJ	O
mothers	NNS	O
,	,	O
using	VBG	O
whole	JJ	O
-	:	O
exome	NN	O
and	CC	O
whole	JJ	O
-	:	O
genome	NN	O
sequencing	NN	O
technologies	NNS	O
,	,	O
matchmaker	NN	O
databases	NNS	O
,	,	O
and	CC	O
international	JJ	O
collaborations	NNS	O
.	.	O

Affected	JJ	O
individuals	NNS	O
had	VBD	O
a	DT	O
consistent	JJ	O
phenotype	NN	O
,	,	O
characterized	VBN	O
by	IN	O
mild	JJ	O
-	:	O
borderline	NN	O
neurodevelopmental	JJ	O
delay	NN	O
(	(	O
86%	CD	O
)	)	O
,	,	O
behavioral	JJ	O
disorders	NNS	O
(	(	O
68%	CD	O
)	)	O
,	,	O
severe	JJ	O
gastro	SYM	O
-	:	O
intestinal	JJ	O
problems	NNS	O
(	(	O
63%	CD	O
)	)	O
,	,	O
and	CC	O
facial	JJ	O
dysmorphism	NN	O
including	VBG	O
blepharophimosis	NN	O
(	(	O
82%	CD	O
)	)	O
,	,	O
telecanthus	RB	O
(	(	O
74%	CD	O
)	)	O
,	,	O
prominent	JJ	O
nasal	NN	O
bridge	NN	O
(	(	O
68%	CD	O
)	)	O
,	,	O
broad	JJ	O
nasal	NN	O
tip	NN	O
(	(	O
66%	CD	O
)	)	O
,	,	O
thin	JJ	O
vermilion	NN	O
of	IN	O
the	DT	O
upper	JJ	O
lip	NN	O
(	(	O
62%	CD	O
)	)	O
,	,	O
and	CC	O
upslanting	JJ	O
palpebral	JJ	O
fissures	NNS	O
(	(	O
55%	CD	O
)	)	O
.	.	O

Analysis	NN	O
of	IN	O
cell	NN	O
lines	NNS	O
from	IN	O
three	CD	O
affected	JJ	O
individuals	NNS	O
showed	VBD	O
that	IN	O
mutations	NNS	O
act	VBP	O
through	IN	O
a	DT	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
mechanism	NN	O
in	IN	O
at	IN	O
least	JJS	O
two	CD	O
case	NN	O
subjects	NNS	O
.	.	O

Genotype	NNP	O
-	:	O
phenotype	NN	O
analysis	NN	O
and	CC	O
comparison	NN	O
of	IN	O
computationally	RB	O
modeled	VBN	O
faces	VBZ	O
showed	VBD	O
that	IN	O
phenotypes	NNS	O
of	IN	O
these	DT	O
and	CC	O
other	JJ	O
individuals	NNS	O
with	IN	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
variants	NNS	O
significantly	RB	O
overlapped	VBD	O
with	IN	O
phenotypes	NNS	O
of	IN	O
individuals	NNS	O
with	IN	O
other	JJ	O
variant	JJ	O
types	NNS	O
(	(	O
missense	NN	O
and	CC	O
C	NNP	O
-	:	O
terminal	JJ	O
truncating	NN	O
)	)	O
.	.	O

This	DT	O
suggests	VBZ	O
that	IN	O
haploinsufficiency	NN	O
of	IN	O
TLK2	NNP	O
is	VBZ	O
the	DT	O
most	RBS	O
likely	JJ	O
underlying	JJ	O
disease	NN	O
mechanism	NN	O
,	,	O
leading	VBG	O
to	TO	O
a	DT	O
consistent	JJ	O
neurodevelopmental	JJ	O
phenotype	NN	O
.	.	O

This	DT	O
work	NN	O
illustrates	VBZ	O
the	DT	O
power	NN	O
of	IN	O
international	JJ	O
data	NNS	O
sharing	NN	O
,	,	O
by	IN	O
the	DT	O
identification	NN	O
of	IN	O
40	CD	O
individuals	NNS	O
from	IN	O
26	CD	O
different	JJ	O
centers	NNS	O
in	IN	O
7	CD	O
different	JJ	O
countries	NNS	O
,	,	O
allowing	VBG	O
the	DT	O
identification	NN	O
,	,	O
clinical	JJ	O
delineation	NN	O
,	,	O
and	CC	O
genotype	SYM	O
-	:	O
phenotype	JJ	O
evaluation	NN	O
of	IN	O
a	DT	O
distinct	JJ	O
NDD	NNP	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
TLK2	NNP	O


p53	NN	I-Var
proteins	NNS	I-Gene
impart	JJ	I-Protein
changes	NNS	B-Reg
cellular	JJ	B-MPA
behavior	NN	I-MPA
function	NN	B-MPA
interactions	NNS	B-Interaction
proteins	NNS	B-Protein

Varying	VBG	O
conformations	NNS	O
of	IN	O
mutant	JJ	B-Var
p53	NN	B-Gene
largely	RB	O
dictate	JJ	B-Reg
protein	NN	B-MPA
-	:	I-MPA
protein	NN	I-MPA
interactions	NNS	I-MPA
as	IN	O
different	JJ	O
point	NN	O
mutations	NNS	O
within	IN	O
protein	JJ	O
-	:	O
coding	NN	O
regions	NNS	O
greatly	RB	O
alter	VBP	O
the	DT	O
extent	NN	O
and	CC	O
array	NN	O
of	IN	O
gain	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
(	(	O
GOF	NNP	O
)	)	O
activities	NNS	O
.	.	O
Given	VBN	O
such	JJ	O
variables	NNS	O
,	,	O
how	WRB	O
can	MD	O
knowledge	VB	O
regarding	VBG	O
p53	NN	O
missense	NN	O
mutations	NNS	O
be	VB	O
translated	VBN	O
into	IN	O
predicting	VBG	O
or	CC	O
altering	VBG	O
biologic	JJ	O
activity	NN	O
for	IN	O
therapy	NN	O
?	.	O

How	WRB	O
may	MD	O
knowledge	VB	O
regarding	VBG	O
mutant	JJ	O
p53	NN	O
functions	NNS	O
within	IN	O
certain	JJ	O
disease	NN	O
contexts	NN	O
be	VB	O
harnessed	VBN	O
to	TO	O
blunt	VB	O
or	CC	O
ablate	VB	O
mutant	JJ	O
p53	NN	O
GOF	NNP	O
for	IN	O
therapy	NN	O
?	.	O

In	IN	O
this	DT	O
article	NN	O
,	,	O
we	PRP	O
review	VBP	O
known	JJ	O
proteins	NNS	O
that	WDT	O
interact	VBP	O
with	IN	O
mutant	JJ	B-Var
p53	NN	B-Gene
and	CC	O
result	NN	O
in	IN	O
the	DT	O
activation	NN	B-PosReg
of	IN	O
genes	NNS	B-Gene
that	WDT	O
contribute	VBP	O
to	TO	O
p53	VB	O
GOF	NNP	O
with	IN	O
particular	JJ	O
emphasis	NN	O
on	IN	O
context	NN	O
dependency	NN	O
and	CC	O
an	DT	O
evolving	VBG	O
appreciation	NN	O
of	IN	O
GOF	NNP	O
mechanisms	NNS	O


DDK	NNP	O
,	,	O
a	DT	O
conserved	JJ	O
serine	NN	O
-	:	O
threonine	NN	O
protein	NN	O
kinase	NN	O
composed	VBN	O
of	IN	O
a	DT	O
regulatory	JJ	O
subunit	NN	O
,	,	O
Dbf4	NNP	O
,	,	O
and	CC	O
a	DT	O
catalytic	JJ	O
subunit	NN	O
,	,	O
Cdc7	NNP	O
,	,	O
is	VBZ	O
essential	JJ	O
for	IN	O
DNA	NNP	O
replication	NN	O
initiation	NN	O
during	IN	O
S	NNP	O
phase	NN	O
of	IN	O
the	DT	O
cell	NN	O
cycle	NN	O
through	IN	O
MCM2	NNP	O
-	:	O
7	CD	O
helicase	NN	O
phosphorylation	NN	O
.	.	O

The	DT	O
biological	JJ	O
significance	NN	O
of	IN	O
DDK	NNP	O
is	VBZ	O
well	RB	O
characterized	VBN	O
,	,	O
but	CC	O
the	DT	O
full	JJ	O
mechanism	NN	O
of	IN	O
how	WRB	O
DDK	NNP	O
associates	VBZ	O
with	IN	O
substrates	NNS	O
remains	NNS	O
unclear	JJ	O
.	.	O

Cdc7	NNP	O
is	VBZ	O
bound	VBN	O
to	TO	O
chromatin	VB	O
in	IN	O
the	DT	O
Saccharomyces	NNP	O
cerevisiae	NN	O
genome	NN	O
throughout	IN	O
the	DT	O
cell	NN	O
cycle	NN	O
,	,	O
but	CC	O
there	EX	O
is	VBZ	O
little	JJ	O
empirical	JJ	O
evidence	NN	O
as	IN	O
to	TO	O
specific	JJ	O
Cdc7	NNP	O
binding	NN	O
locations	NNS	O
.	.	O

Using	VBG	O
biochemical	JJ	O
and	CC	O
genetic	JJ	O
techniques	NNS	O
,	,	O
this	DT	O
study	NN	O
investigated	VBD	O
the	DT	O
specific	JJ	O
localization	NN	O
of	IN	O
Cdc7	NNP	O
on	IN	O
chromatin	NN	O
.	.	O

The	DT	O
Calling	NNP	O
Cards	NNP	O
method	NN	O
,	,	O
using	VBG	O
Ty5	NNP	O
retrotransposons	NNS	O
as	IN	O
a	DT	O
marker	NN	O
for	IN	O
DNA	NNP	O
-	:	O
protein	NN	O
binding	NN	O
,	,	O
suggests	VBZ	O
Cdc7	NNP	O
kinase	NN	O
is	VBZ	O
preferentially	RB	O
bound	VBN	O
to	TO	O
genomic	VB	O
DNA	NNP	O
known	VBN	O
to	TO	O
replicate	VB	O
early	JJ	O
in	IN	O
S	NNP	O
phase	NN	O
,	,	O
including	VBG	O
centromeres	NNS	O
and	CC	O
origins	NNS	O
of	IN	O
replication	NN	O
.	.	O

We	PRP	O
also	RB	O
discovered	VBD	O
Cdc7	NNP	O
binding	VBG	O
throughout	IN	O
the	DT	O
genome	NN	O
,	,	O
which	WDT	O
may	MD	O
be	VB	O
necessary	JJ	O
to	TO	O
initiate	VB	O
other	JJ	O
cellular	JJ	O
processes	NNS	O
,	,	O
including	VBG	O
meiotic	JJ	O
recombination	NN	O
and	CC	O
translesion	NN	O
synthesis	NN	O
.	.	O

A	DT	O
kinase	NN	O
dead	JJ	O
Cdc7	NNP	B-Gene
point	NN	B-Var
mutation	NN	I-Var
increases	VBZ	B-PosReg
the	DT	O
Ty5	NNP	B-MPA
retrotransposon	NN	I-MPA
integration	NN	I-MPA
efficiency	NN	I-MPA
and	CC	O
a	DT	O
55	CD	B-MPA
-	:	I-MPA
amino	NN	I-MPA
acid	NN	I-MPA
C	NNP	I-MPA
-	:	I-MPA
terminal	JJ	I-MPA
truncation	NN	I-MPA
of	IN	O
Cdc7	NNP	B-Gene
,	,	O
unable	JJ	B-NegReg
to	TO	O
bind	VB	B-Interaction
Dbf4	NNP	B-Gene
,	,	O
reduces	VBZ	B-NegReg
Cdc7	NNP	B-Gene
binding	VBG	B-Interaction
suggesting	VBG	O
a	DT	O
requirement	NN	O
for	IN	O
Dbf4	NNP	O
to	TO	O
stabilize	VB	O
Cdc7	NNP	O
on	IN	O
chromatin	NN	O
during	IN	O
S	NNP	O
phase	NN	O
.	.	O
Chromatin	NNP	O
immunoprecipitation	NN	O
demonstrates	VBZ	O
that	IN	O
Cdc7	NNP	O
binding	VBG	O
near	IN	O
specific	JJ	O
origins	NNS	O
changes	NNS	O
during	IN	O
S	NNP	O
phase	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
suggest	VBP	O
a	DT	O
model	NN	O
where	WRB	O
Cdc7	NNP	O
is	VBZ	O
loosely	RB	O
bound	VBN	O
to	TO	O
chromatin	VB	O
during	IN	O
G1	NNP	O
At	IN	O
the	DT	O
G1	NNP	O
S	NNP	O
transition	NN	O
,	,	O
Cdc7	NNP	O
binding	VBG	O
to	TO	O
chromatin	VB	O
is	VBZ	O
increased	VBN	O
and	CC	O
stabilized	VBN	O
,	,	O
preferentially	RB	O
at	IN	O
sites	NNS	O
that	WDT	O
may	MD	O
become	VB	O
origins	NNS	O
,	,	O
in	IN	O
order	NN	O
to	TO	O
carry	VB	O
out	RP	O
a	DT	O
variety	NN	O
of	IN	O
cellular	JJ	O
processes	NNS	O

gain	NN	B-PosReg
of	IN	I-PosReg
mutations	NNS	I-PosReg
p53	NN	I-Var
in	IN	I-Gene
high	JJ	B-Disease
-	:	I-Disease
grade	NN	I-Disease
serous	JJ	I-Disease
ovarian	JJ	I-Disease
carcinoma	NN	I-Disease

gain	VBP	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutations	NNS	B-Var
p53	NN	B-Gene
oncogenic	JJ	B-CPA
activity	NN	I-CPA

p53	NN	B-Protein
protein	NN	I-Protein
mutation	NN	B-Var
higher	JJR	B-PosReg
p53	NN	B-MPA
mRNA	NNS	I-MPA
and	CC	I-MPA
protein	JJ	I-MPA
expression	NN	I-MPA
levels	NNS	I-MPA

Clinically	RB	O
,	,	O
patients	NNS	O
with	IN	O
GOF	NNP	O
mutations	NNS	B-Var
showed	VBD	O
a	DT	O
higher	JJR	B-PosReg
frequency	NN	O
of	IN	O
platinum	NN	B-CPA
resistance	NN	I-CPA
(	(	O
22	CD	O
58	CD	O
,	,	O
37.9%	CD	O
)	)	O
than	IN	O
patients	NNS	O
with	IN	O
NE	NNP	O
-	:	O
GOF	NNP	O
mutations	NNS	O
(	(	O
12	CD	O
56	CD	O
,	,	O
21.4%	CD	O
)	)	O
(	(	O
p	$	O
0.054	CD	O
)	)	O
.	.	O
Furthermore	RB	O
,	,	O
patients	NNS	O
with	IN	O
GOF	NNP	O
mutations	NNS	B-Var
were	VBD	O
more	RBR	O
likely	JJ	O
to	TO	O
develop	VB	B-PosReg
distant	JJ	B-CPA
metastasis	NN	I-CPA
(	(	O
36	CD	O
55	CD	O
,	,	O
65.5%	CD	O
)	)	O
than	IN	O
local	JJ	O
recurrence	NN	O
(	(	O
19	CD	O
55	CD	O
,	,	O
34.5%	CD	O
)	)	O
,	,	O
whereas	JJ	O
patients	NNS	O
with	IN	O
NE	NNP	O
-	:	O
GOF	NNP	O
mutations	NNS	O
showed	VBD	O
a	DT	O
higher	JJR	O
frequency	NN	O
of	IN	O
locoregional	JJ	O
recurrence	NN	O
(	(	O
26	CD	O
47	CD	O
,	,	O
55.3%	CD	O
)	)	O
than	IN	O
distant	JJ	O
metastasis	NN	O
(	(	O
21	CD	O
47	CD	O
,	,	O
44.7%	CD	O
)	)	O
(	(	O
p	$	O
0.035	CD	O
)	)	O
.	.	O
There	EX	O
were	VBD	O
no	DT	O
differences	NNS	O
in	IN	O
overall	JJ	O
or	CC	O
progression	NN	O
-	:	O
free	JJ	O
survival	NN	O
between	IN	O
patients	NNS	O
with	IN	O
GOF	NNP	O
or	CC	O
NE	NNP	O
-	:	O
GOF	NNP	O
mutp53	NN	O
.	.	O

CONCLUSION	NN	O
:	:	O
This	DT	O
study	NN	O
demonstrates	VBZ	O
that	IN	O
patient	NN	O
with	IN	O
GOF	NNP	B-PosReg
mutp53	NN	B-Var
is	VBZ	O
characterized	VBN	O
by	IN	O
a	DT	O
greater	JJR	B-PosReg
likelihood	NN	O
of	IN	O
platinum	NN	B-CPA
treatment	NN	I-CPA
resistance	NN	I-CPA
and	CC	O
distant	JJ	B-CPA
metastatic	JJ	I-CPA
properties	NNS	I-CPA
in	IN	O
HGS	NNP	B-Disease
-	:	I-Disease
OvCa	NN	I-Disease


BACKGROUND	NN	O
:	:	O
Alstr	NNP	O
m	VBZ	O
syndrome	NN	O
(	(	O
AS	IN	O
)	)	O
,	,	O
featuring	VBG	O
retinal	JJ	O
dystrophy	NN	O
,	,	O
neuronal	JJ	O
deafness	NN	O
,	,	O
cardiomyopathy	NN	O
,	,	O
metabolic	JJ	O
syndrome	NN	O
,	,	O
and	CC	O
diffuse	NN	O
fibrosis	NN	O
,	,	O
is	VBZ	O
caused	VBN	O
by	IN	O
biallelic	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
centrosomal	JJ	O
protein	NN	O
ALMS1	NNP	O
.	.	O

Genotype	NNP	O
-	:	O
phenotype	NN	O
correlation	NN	O
has	VBZ	O
been	VBN	O
suggested	VBN	O
without	IN	O
assessment	NN	O
of	IN	O
ALMS1	NNP	O
expression	NN	O
.	.	O

METHODS	NN	O
:	:	O
ALMS1	NNP	O
expression	NN	O
(	(	O
real	JJ	O
-	:	O
time	NN	O
PCR	NNP	O
and	CC	O
immunocytochemistry	NN	O
)	)	O
and	CC	O
cilia	JJ	O
formation	NN	O
(	(	O
immunocytochemistry	NN	O
)	)	O
were	VBD	O
assessed	VBN	O
in	IN	O
fibroblasts	NNS	O
from	IN	O
deeply	NN	O
phenotyped	VBD	O
volunteers	NNS	O
diagnosed	VBN	O
with	IN	O
AS	NNP	O
recruited	VBD	O
from	IN	O
a	DT	O
dedicated	VBN	O
AS	IN	O
Service	NNP	O
.	.	O

Exome	NNP	O
sequencing	NN	O
was	VBD	O
used	VBN	O
in	IN	O
two	CD	O
participants	NNS	O
without	IN	O
convincing	VBG	O
biallelic	JJ	O
ALMS1	NNP	O
mutations	NNS	O
,	,	O
and	CC	O
BBS2	NNP	O
(	(	O
Bardet	NNP	O
-	:	O
Biedl	NNP	O
syndrome	VBP	O
2	CD	O
)	)	O
protein	NN	O
expression	NN	O
was	VBD	O
assessed	VBN	O
in	IN	O
one	CD	O
patient	NN	O
with	IN	O
biallelic	JJ	O
BBS2	NNP	O
mutations	NNS	O
.	.	O

Hedgehog	NNP	O
-	:	O
induced	VBD	O
GLI1	NNP	O
expression	NN	O
and	CC	O
PDGFA	NNP	O
signaling	NN	O
was	VBD	O
assessed	VBN	O
using	VBG	O
quantitative	JJ	O
real	JJ	O
-	:	O
time	NN	O
PCR	NNP	O
,	,	O
immunoblotting	NN	O
,	,	O
or	CC	O
immunostaining	NN	O
of	IN	O
fixed	JJ	O
cells	NNS	O
after	IN	O
stimulation	NN	O
.	.	O

RESULTS	NN	O
:	:	O
In	IN	O
16	CD	O
of	IN	O
the	DT	O
patient	NN	O
cell	NN	O
lines	NNS	O
examined	VBD	O
,	,	O
ALMS1	NNP	B-Gene
protein	NN	B-Protein
was	VBD	O
undetectable	JJ	B-NegReg
(	(	O
14	CD	O
with	IN	O
biallelic	JJ	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
(	(	O
LoF	NNP	O
)	)	O
mutations	NNS	B-Var
)	)	O
,	,	O
and	CC	O
in	IN	O
two	CD	O
,	,	O
ALMS1	NNP	O
staining	NN	O
was	VBD	O
equivocal	JJ	O
(	(	O
one	CD	O
with	IN	O
biallelic	JJ	O
LoF	NNP	O
mutations	NNS	O
)	)	O
.	.	O
In	IN	O
five	CD	O
lines	NNS	O
,	,	O
ALMS1	NNP	O
expression	NN	O
was	VBD	O
normal	JJ	O
using	VBG	O
at	IN	O
least	JJS	O
one	CD	O
fixation	NN	O
method	NN	O
(	(	O
one	CD	O
with	IN	O
biallelic	JJ	O
LoF	NNP	O
mutations	NNS	O
)	)	O
.	.	O

These	DT	O
differences	NNS	O
were	VBD	O
not	RB	O
accounted	VBN	O
for	IN	O
by	IN	O
major	JJ	O
differences	NNS	O
in	IN	O
ALMS1	NNP	O
mRNA	NN	O
expression	NN	O
.	.	O

Exome	NNP	O
sequencing	NN	O
of	IN	O
two	CD	O
participants	NNS	O
with	IN	O
normal	JJ	O
ALMS1	NNP	O
expression	NN	O
identified	VBD	O
biallelic	JJ	O
LoF	NNP	O
BBS2	NNP	O
mutations	NNS	O
in	IN	O
one	CD	O
.	.	O

No	DT	O
second	JJ	O
,	,	O
known	VBN	O
ciliopathy	JJ	O
mutation	NN	O
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
other	JJ	O
patient	NN	O
,	,	O
who	WP	O
had	VBD	O
one	CD	O
LoF	NNP	O
ALMS1	NNP	O
mutation	NN	O
.	.	O

Phenotypes	NNS	O
were	VBD	O
milder	JJR	O
or	CC	O
atypical	JJ	O
in	IN	O
participants	NNS	O
with	IN	O
preserved	JJ	O
ALMS1	NNP	O
immunostaining	NN	O
,	,	O
even	RB	O
when	WRB	O
two	CD	O
with	IN	O
likely	JJ	O
alternative	JJ	O
genetic	JJ	O
diagnoses	NNS	O
were	VBD	O
excluded	VBN	O
.	.	O

All	DT	O
cells	NNS	O
studied	VBN	O
developed	VBD	O
normal	JJ	O
cilia	NNS	O
,	,	O
ALMS1	NNP	O
and	CC	O
BBS2	NNP	O
mutant	NN	O
cells	NNS	O
showed	VBD	O
normal	JJ	O
Hedgehog	NNP	O
-	:	O
induced	JJ	O
upregulation	NN	O
of	IN	O
GLI1	NNP	O
expression	NN	O
,	,	O
and	CC	O
PDGFA	NNP	O
signaling	NN	O
was	VBD	O
normal	JJ	O
in	IN	O
ALMS1	NNP	O
-	:	O
deficient	NN	O
cells	NNS	O
.	.	O

CONCLUSION	NN	O
:	:	O
Milder	NN	O
or	CC	O
atypical	JJ	O
presentations	NNS	O
of	IN	O
AS	NNP	O
should	MD	O
prompt	VB	O
genetic	JJ	O
evaluation	NN	O
for	IN	O
alternative	JJ	O
,	,	O
clinically	RB	O
overlapping	VBG	O
ciliopathies	NNS	O
.	.	O

A	DT	O
subgroup	NN	O
of	IN	O
patients	NNS	O
with	IN	O
bona	JJ	O
fide	NN	O
ALMS1	NNP	O
defects	NNS	O
have	VBP	O
milder	VBN	O
phenotypes	NNS	O
due	JJ	O
to	TO	O
residual	JJ	O
ALMS1	NNP	O
expression	NN	O
,	,	O
which	WDT	O
may	MD	O
be	VB	O
more	RBR	O
important	JJ	O
than	IN	O
mutation	NN	O
site	NN	O


Werner	NNP	B-Disease
syndrome	NN	I-Disease
(	(	O
WS	NNP	O
)	)	O
is	VBZ	O
a	DT	O
premature	NN	O
aging	VBG	O
disorder	NN	O
caused	VBN	B-Reg
by	IN	I-Reg
mutations	NNS	B-Var
in	IN	O
a	DT	O
RecQ	NNP	B-Protein
-	:	I-Protein
family	NN	I-Protein
DNA	NNP	I-Protein
helicase	NN	I-Protein
(	(	O
WRN	NNP	O
)	)	O
.	.	O
Mice	NNP	O
lacking	VBG	O
part	NN	O
of	IN	O
the	DT	O
helicase	NN	O
domain	NN	O
of	IN	O
the	DT	O
WRN	NNP	O
ortholog	MD	O
exhibit	VB	O
several	JJ	O
phenotypic	NN	O
features	NNS	O
of	IN	O
WS	NNP	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
generated	VBD	O
a	DT	O
Wrn	NNP	O
mutant	JJ	O
line	NN	O
that	IN	O
,	,	O
like	IN	O
humans	NNS	O
,	,	O
relies	NNS	O
entirely	RB	O
on	IN	O
dietary	JJ	O
sources	NNS	O
of	IN	O
vitamin	NN	O
C	NNP	O
(	(	O
ascorbate	NN	O
)	)	O
to	TO	O
survive	VB	O
,	,	O
by	IN	O
crossing	VBG	O
them	PRP	O
to	TO	O
mice	VB	O
that	DT	O
lack	VBP	O
the	DT	O
gulonolactone	NN	O
oxidase	NN	O
enzyme	NN	O
required	VBN	O
for	IN	O
ascorbate	JJ	O
synthesis	NN	O
.	.	O

In	IN	O
the	DT	O
presence	NN	O
of	IN	O
0.01%	CD	O
ascorbate	NN	O
(	(	O
w	JJ	O
v	NN	O
)	)	O
in	IN	O
drinking	NN	O
water	NN	O
,	,	O
double	JJ	O
-	:	O
mutant	JJ	O
mice	NN	O
exhibited	VBD	O
a	DT	O
severe	JJ	O
reduction	NN	O
in	IN	O
lifespan	NN	O
,	,	O
small	JJ	O
size	NN	O
,	,	O
sterility	NN	O
,	,	O
osteopenia	NN	O
,	,	O
and	CC	O
metabolic	JJ	O
profiles	NNS	O
different	JJ	O
from	IN	O
wild	JJ	O
-	:	O
type	NN	O
(	(	O
WT	NNP	O
)	)	O
mice	NN	O
.	.	O

Although	IN	O
increasing	VBG	O
the	DT	O
dose	NN	O
of	IN	O
ascorbate	NN	O
to	TO	O
0.4%	CD	O
improved	VBN	O
dramatically	RB	O
the	DT	O
phenotypes	NNS	O
of	IN	O
double	JJ	O
-	:	O
mutant	JJ	O
mice	NN	O
,	,	O
the	DT	O
metabolic	NN	O
and	CC	O
cytokine	NN	O
profiles	NNS	O
were	VBD	O
different	JJ	O
from	IN	O
age	NN	O
-	:	O
matched	VBN	O
WT	NNP	O
mice	NN	O
.	.	O

Finally	RB	O
,	,	O
double	JJ	O
-	:	O
mutant	JJ	O
mice	NN	O
treated	VBD	O
with	IN	O
0.01%	CD	O
ascorbate	NN	O
revealed	VBD	O
a	DT	O
permanent	JJ	O
activation	NN	O
of	IN	O
all	PDT	O
the	DT	O
3	CD	O
branches	NNS	O
of	IN	O
the	DT	O
ER	NNP	O
stress	NN	O
response	NN	O
pathways	NNS	O
due	JJ	O
to	TO	O
a	DT	O
severe	JJ	O
chronic	JJ	O
oxidative	JJ	O
stress	NN	O
in	IN	O
the	DT	O
ER	NNP	O
compartment	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
markers	NNS	O
associated	VBD	O
with	IN	O
the	DT	O
ubiquitin	JJ	O
-	:	O
proteasome	NN	O
-	:	O
dependent	NN	O
ER	NNP	O
-	:	O
associated	VBN	O
degradation	NN	O
pathway	NN	O
were	VBD	O
increased	VBN	O
.	.	O

Augmenting	VBG	O
the	DT	O
dose	NN	O
of	IN	O
ascorbate	NN	O
reversed	VBD	O
the	DT	O
activation	NN	O
of	IN	O
this	DT	O
pathway	NN	O
to	TO	O
WT	NNP	O
levels	NNS	O
rendering	VBG	O
this	DT	O
pathway	NN	O
a	DT	O
potential	JJ	O
therapeutic	JJ	O
target	NN	O
in	IN	O
WS	NNP	O
.	.	O
-	:	O
Aumailley	NNP	O
,	,	O
L.	NNP	O
,	,	O
Dubois	NNP	O
,	,	O
M.	NNP	O
J.	NNP	O
,	,	O
Brennan	NNP	O
,	,	O
T.	NNP	O
A.	NN	O
,	,	O
Garand	NNP	O
,	,	O
C.	NNP	O
,	,	O
Paquet	NNP	O
,	,	O
E.	NNP	O
R.	NNP	O
,	,	O
Pignolo	NNP	O
,	,	O
R.	NNP	O
J.	NNP	O
,	,	O
Marette	NNP	O
,	,	O
A.	NNP	O
,	,	O
Lebel	NNP	O
,	,	O
M.	NNP	O
Serum	NNP	O
vitamin	NNP	O
C	NNP	O
levels	NNS	O
modulate	VBP	O
the	DT	O
lifespan	NN	O
and	CC	O
endoplasmic	JJ	O
reticulum	NN	O
stress	NN	O
response	NN	O
pathways	NNS	O
in	IN	O
mice	NN	O
synthesizing	VBG	O
a	DT	O
nonfunctional	JJ	O
mutant	NN	O
WRN	NNP	O
protein	NN	O


Fragile	NNP	B-Disease
X	NNP	I-Disease
-	:	I-Disease
associated	VBN	I-Disease
tremor	NN	I-Disease
ataxia	NN	I-Disease
syndrome	NN	I-Disease
(	(	O
FXTAS	NNP	O
)	)	O
is	VBZ	O
an	DT	O
inherited	JJ	O
neurodegenerative	JJ	O
disease	NN	O
caused	VBN	B-Reg
by	IN	I-Reg
an	DT	O
expansion	NN	B-Var
of	IN	I-Var
55	CD	I-Var
-	:	I-Var
200	CD	I-Var
CGG	NNP	I-Var
repeats	NNS	I-Var
located	VBN	O
in	IN	O
the	DT	O
FMR1	NNP	B-Gene
gene	NN	O
.	.	O
The	DT	O
main	JJ	O
clinical	JJ	O
and	CC	O
neuropathological	JJ	O
features	NNS	O
of	IN	O
FXTAS	NNP	O
are	VBP	O
progressive	JJ	O
intention	NN	O
tremor	NN	O
and	CC	O
gait	NN	O
ataxia	NN	O
associated	VBN	O
with	IN	O
brain	NN	O
atrophy	NN	O
,	,	O
neuronal	JJ	O
cell	NN	O
loss	NN	O
and	CC	O
presence	NN	O
of	IN	O
ubiquitin	JJ	O
-	:	O
positive	JJ	O
intranuclear	JJ	O
inclusions	NNS	O
in	IN	O
both	DT	O
neurons	NNS	O
and	CC	O
astrocytes	NNS	O
.	.	O

At	IN	O
the	DT	O
molecular	JJ	O
level	NN	O
,	,	O
FXTAS	NNP	O
is	VBZ	O
characterized	VBN	O
by	IN	O
increased	JJ	O
expression	NN	O
of	IN	O
FMR1	NNP	O
sense	NN	O
and	CC	O
antisense	NN	O
RNA	NNP	O
containing	NN	O
expanded	VBD	O
CGG	NNP	O
or	CC	O
GGC	NNP	O
repeats	NNS	O
,	,	O
respectively	RB	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
discuss	VBP	O
the	DT	O
putative	JJ	O
molecular	JJ	O
mechanisms	NNS	O
underlying	VBG	O
FXTAS	NNP	O
and	CC	O
notably	RB	O
recent	JJ	O
reports	NNS	O
that	IN	O
expanded	VBD	O
CGG	NNP	O
and	CC	O
GGC	NNP	O
repeats	NNS	O
may	MD	O
be	VB	O
pathogenic	JJ	O
through	IN	O
RAN	NNP	O
translation	NN	O
into	IN	O
toxic	JJ	O
proteins	NNS	O


Cell	NNP	O
division	NN	O
patterning	NN	O
is	VBZ	O
important	JJ	O
to	TO	O
determine	VB	O
body	NN	O
shape	NN	O
in	IN	O
plants	NNS	O
.	.	O

Nuclear	JJ	O
auxin	NN	O
signaling	VBG	O
mediated	VBN	O
by	IN	O
AUXIN	NNP	O
RESPONSE	NNP	O
FACTOR	NNP	O
(	(	O
ARF	NNP	O
)	)	O
transcription	NN	O
factors	NNS	O
affects	VBZ	O
plant	NN	O
growth	NN	O
and	CC	O
development	NN	O
through	IN	O
regulation	NN	O
of	IN	O
cell	NN	O
division	NN	O
,	,	O
elongation	NN	O
and	CC	O
differentiation	NN	O
.	.	O

The	DT	O
evolutionary	JJ	O
origin	NN	O
of	IN	O
the	DT	O
ARF	NNP	O
-	:	O
mediated	VBD	O
pathway	NN	O
dates	NNS	O
back	RB	O
to	TO	O
at	IN	O
least	JJS	O
the	DT	O
common	JJ	O
ancestor	NN	O
of	IN	O
bryophytes	NNS	O
and	CC	O
other	JJ	O
land	NN	O
plants	NNS	O
.	.	O

The	DT	O
liverwort	NN	O
Marchantia	NNP	O
polymorpha	NN	O
has	VBZ	O
three	CD	O
phylogenetically	RB	O
distinct	JJ	O
ARFs	NNP	O
:	:	O
MpARF1	NNP	O
,	,	O
the	DT	O
sole	JJ	O
activator	NN	O
ARF	NNP	O
;	:	O
and	CC	O
MpARF2	NNP	O
and	CC	O
MpARF3	NNP	O
,	,	O
two	CD	O
repressor	NN	O
ARFs	NNP	O
.	.	O

Genetic	JJ	O
screens	NNS	O
for	IN	O
auxin	NN	O
-	:	O
resistant	JJ	O
mutants	NNS	O
revealed	VBD	O
that	IN	O
loss	NN	O
of	IN	O
MpARF1	NNP	O
function	NN	O
conferred	VBD	O
auxin	JJ	O
insensitivity	NN	O
.	.	O

Mparf1	NNP	B-Gene
mutants	NNS	B-Var
showed	VBD	O
reduced	VBN	B-NegReg
auxin	IN	B-Gene
-	:	I-Gene
inducible	JJ	I-Gene
gene	NN	I-Gene
expression	NN	B-MPA
and	CC	O
various	JJ	O
developmental	JJ	B-CPA
defects	NNS	I-CPA
,	,	O
including	VBG	O
thallus	JJ	O
twisting	NN	O
and	CC	O
gemma	JJ	O
malformation	NN	O
.	.	O
We	PRP	O
further	RB	O
investigated	VBD	O
the	DT	O
role	NN	O
of	IN	O
MpARF1	NNP	O
in	IN	O
gemma	NN	O
development	NN	O
,	,	O
which	WDT	O
is	VBZ	O
traceable	JJ	O
at	IN	O
the	DT	O
cellular	JJ	O
level	NN	O
.	.	O

In	IN	O
wild	JJ	O
-	:	O
type	NN	O
plants	NNS	O
,	,	O
a	DT	O
gemma	NN	O
initial	JJ	O
first	RB	O
undergoes	JJ	O
several	JJ	O
transverse	NN	O
divisions	NNS	O
to	TO	O
generate	VB	O
a	DT	O
single	JJ	O
-	:	O
celled	VBN	O
stalk	NN	O
and	CC	O
a	DT	O
gemma	NN	O
proper	NN	O
,	,	O
followed	VBN	O
by	IN	O
rather	RB	O
synchronous	JJ	O
longitudinal	JJ	O
divisions	NNS	O
in	IN	O
the	DT	O
latter	NN	O
.	.	O

Mparf1	NNP	O
mutants	NNS	O
often	RB	O
contained	VBD	O
multicelled	JJ	O
stalks	NNS	O
and	CC	O
showed	VBD	O
defects	NNS	O
in	IN	O
the	DT	O
execution	NN	O
and	CC	O
timing	NN	O
of	IN	O
the	DT	O
longitudinal	JJ	O
divisions	NNS	O
.	.	O

While	IN	O
wild	JJ	O
-	:	O
type	NN	O
gemmae	NN	O
finally	RB	O
generate	VB	O
two	CD	O
meristem	NN	O
notches	NNS	O
,	,	O
Mparf1	NNP	O
gemmae	VBZ	O
displayed	VBN	O
various	JJ	O
numbers	NNS	O
of	IN	O
ectopic	NN	O
meristems	NNS	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
MpARF1	NNP	O
regulates	VBZ	O
formative	JJ	O
cell	NN	O
divisions	NNS	O
and	CC	O
axis	JJ	O
formation	NN	O
through	IN	O
auxin	NN	O
responses	NNS	O
.	.	O

The	DT	O
mechanism	NN	O
for	IN	O
activator	NN	O
ARF	NNP	O
regulation	NN	O
of	IN	O
pattern	JJ	O
formation	NN	O
may	MD	O
be	VB	O
shared	VBN	O
in	IN	O
land	NN	O
plants	NNS	O
and	CC	O
therefore	RB	O
important	JJ	O
for	IN	O
the	DT	O
general	JJ	O
acquisition	NN	O
of	IN	O
three	CD	O
-	:	O
dimensional	JJ	O
body	NN	O
plans	NNS	O

-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
a	DT	I-Var
candidate	NN	I-Gene
familial	JJ	B-Disease
or	CC	I-Disease
sporadic	JJ	I-Disease
immune	JJ	I-Disease
thrombocytopenia	NN	I-Disease
immune	JJ	B-Disease
thrombocytopenia	NN	I-Disease




RESULTS	NN	O
:	:	O
Whole	JJ	O
-	:	O
exome	NN	O
sequencing	NN	O
identified	VBD	O
a	DT	O
potential	JJ	O
pathologic	NN	B-Reg
p	NN	B-Var
.	.	I-Var
G76S	NNP	I-Var
heterozygous	JJ	O
mutation	NN	O
on	IN	O
the	DT	O
TNFRSF13B	NNP	B-Gene
gene	NN	O
in	IN	O
familial	JJ	B-Disease
ITP	NNP	I-Disease
patients	NNS	O
.	.	O
ITP	NNP	O
patients	NNS	O
harboring	VBG	O
G76S	NNP	B-Var
mutation	NN	O
displayed	VBD	O
upregulated	JJ	B-PosReg
"	NNP	B-MPA
cytokine	NN	I-MPA
-	:	I-MPA
cytokine	NN	I-MPA
receptor	NN	I-MPA
interaction	NN	I-MPA
"	NNP	I-MPA
signal	NN	I-MPA
,	,	O
increased	VBD	B-PosReg
serum	NN	B-MPA
TNF	NNP	I-MPA
,	,	I-MPA
IL	NNP	I-MPA
-	:	I-MPA
17	CD	I-MPA
,	,	I-MPA
IFN	NNP	I-MPA
and	CC	I-MPA
BAFF	NNP	I-MPA
levels	NNS	I-MPA
,	,	O
and	CC	O
enhanced	VBD	B-PosReg
binding	VBG	B-Interaction
capacity	NN	I-Interaction
of	IN	I-Interaction
APRIL	NNP	I-Interaction
ligand	NN	I-Interaction
to	TO	I-Interaction
B	NNP	I-Interaction
cells	NNS	I-Interaction
.	.	O
Additionally	RB	O
,	,	O
EBV	NNP	O
-	:	O
transformed	VBD	O
B	NNP	O
cells	NNS	O
with	IN	O
the	DT	O
G76S	NNP	B-Var
mutation	NN	O
could	MD	O
induce	VB	B-PosReg
human	JJ	B-CPA
megakaryocyte	NN	I-CPA
line	NN	I-CPA
(	(	I-CPA
Meg	NNP	I-CPA
-	:	I-CPA
01	CD	I-CPA
)	)	I-CPA
apoptosis	NN	I-CPA
significantly	RB	O
.	.	O
CONCLUSION	NN	O
:	:	O
p	NN	B-Var
.	.	I-Var
G76S	NNP	I-Var
mutation	NN	O
on	IN	O
TNFRSF13B	NNP	B-Gene
gene	NN	O
is	VBZ	O
responsible	JJ	B-Reg
for	IN	O
ITP	NNP	B-Disease
,	,	O
and	CC	O
is	VBZ	O
a	DT	O
genetic	JJ	O
predisposing	NN	O
factor	NN	O
for	IN	O
familial	JJ	O
or	CC	O
sporadic	JJ	O
ITP	NNP	O
.	.	O
This	DT	O
article	NN	O
is	VBZ	O
protected	VBN	O
by	IN	O
copyright	NN	O
.	.	O

All	DT	O
rights	NNS	O
reserved	VBN	O


Familial	JJ	B-Disease
hypercholesterolemia	NN	I-Disease

Lacking	VBG	O
knowledge	NN	O
of	IN	O
which	WDT	O
and	CC	O
how	WRB	O
these	DT	O
alterations	NNS	O
are	VBP	O
actually	RB	O
impacting	VBG	O
lipid	JJ	O
metabolism	NN	O
is	VBZ	O
one	CD	O
of	IN	O
the	DT	O
main	JJ	O
reasons	NNS	O
why	WRB	O
FH	NNP	O
is	VBZ	O
insufficiently	RB	O
diagnosed	VBN	O
in	IN	O
the	DT	O
region	NN	O
.	.	O

The	DT	O
aim	NN	O
of	IN	O
this	DT	O
study	NN	O
was	VBD	O
to	TO	O
develop	VB	O
a	DT	O
fast	JJ	O
prediction	NN	O
approach	NN	O
using	VBG	O
an	DT	O
integrated	VBN	O
bioinformatics	NNS	O
method	NN	O
for	IN	O
future	JJ	O
screening	NN	O
of	IN	O
the	DT	O
potential	JJ	O
causative	JJ	O
variants	NNS	O
from	IN	O
national	JJ	O
registries	NNS	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
21	CD	O
variants	NNS	O
were	VBD	O
detected	VBN	O
with	IN	O
majority	NN	O
rate	NN	O
in	IN	O
LDLR	NNP	O
(	(	O
81%	CD	O
)	)	O
.	.	O

Variants	NNS	O
were	VBD	O
classified	VBN	O
based	VBN	O
on	IN	O
the	DT	O
type	NN	O
of	IN	O
mutation	NN	O
.	.	O

Missense	NN	O
variants	NNS	O
resulting	VBG	O
in	IN	O
amino	NN	O
acid	NN	O
changes	NNS	O
,	,	O
c	NN	B-Var
.	.	I-Var
1429	CD	I-Var
G	NNP	I-Var
A	NNP	I-Var
(	(	O
p	NN	O
.	.	O
D477N	NNP	O
)	)	O
,	,	O
c	RB	B-Var
.	.	I-Var
1474	CD	I-Var
G	NNP	I-Var
A	NNP	I-Var
(	(	O
p	NN	O
.	.	O
D492N	NNP	O
)	)	O
,	,	O
c	RB	B-Var
.	.	I-Var
1731	CD	I-Var
G	NNP	I-Var
T	NNP	I-Var
(	(	O
p	NN	O
.	.	O
W577C	NNP	O
)	)	O
,	,	O
and	CC	O
c	NN	B-Var
.	.	I-Var
1783	CD	I-Var
C	NNP	I-Var
T	NNP	I-Var
(	(	O
p	NN	O
.	.	O
R595W	NNP	O
)	)	O
in	IN	O
LDLR	NNP	B-Gene
gene	NN	O
,	,	O
in	IN	O
addition	NN	O
to	TO	O
c	VB	B-Var
.	.	I-Var
9835	CD	I-Var
A	NNP	I-Var
G	NNP	I-Var
(	(	O
p	NN	O
.	.	O
S3279G	NNP	O
)	)	O
in	IN	O
APOB	NNP	B-Gene
,	,	O
were	VBD	O
shown	VBN	O
to	TO	O
be	VB	O
deleterious	JJ	O
by	IN	O
concordant	JJ	O
analysis	NN	O
.	.	O
Furthermore	RB	O
,	,	O
functional	JJ	B-Interaction
interaction	NN	I-Interaction
deformities	NNS	B-Reg
showed	VBD	O
a	DT	O
significant	JJ	O
loss	NN	B-NegReg
and	CC	O
gain	NN	B-PosReg
of	IN	O
energies	NNS	B-MPA
in	IN	I-MPA
the	DT	I-MPA
mutated	JJ	I-MPA
proteins	NNS	I-MPA
.	.	O
These	DT	O
findings	NNS	O
will	MD	O
help	VB	O
in	IN	O
distinguishing	VBG	O
the	DT	O
most	RBS	O
harmful	JJ	O
mutations	NNS	O
needed	VBN	O
to	TO	O
be	VB	O
screened	VBN	O
for	IN	O
clinically	RB	O
diagnosed	VBN	O
FH	NNP	O
patients	NNS	O
in	IN	O
SA	NNP	O
.	.	O

Such	JJ	O
computational	JJ	O
research	NN	O
is	VBZ	O
necessary	JJ	O
to	TO	O
avoid	VB	O
time	NN	O
consumption	NN	O
and	CC	O
the	DT	O
usage	NN	O
of	IN	O
expensive	JJ	O
biological	JJ	O
experiments	NNS	O
.	.	O

This	DT	O
can	MD	O
be	VB	O
a	DT	O
fast	JJ	O
track	NN	O
to	TO	O
facilitate	VB	O
the	DT	O
future	NN	O
filtering	NN	O
and	CC	O
screening	NN	O
of	IN	O
causative	JJ	O
mutations	NNS	O
from	IN	O
national	JJ	O
registries	NNS	O

p53	NN	I-Var
gain	NN	I-Gene
of	IN	I-PosReg
function	NN	I-PosReg
human	JJ	B-Disease
osteosarcoma	NN	I-Disease


TP53	NNP	O
is	VBZ	O
the	DT	O
most	RBS	O
frequently	RB	O
mutated	VBN	O
tumor	NN	O
suppressor	NN	O
gene	NN	O
in	IN	O
cancers	NNS	O
and	CC	O
mutant	JJ	O
p53	NN	O
protein	NN	O
(	(	O
mutp53	NN	O
)	)	O
can	MD	O
acquire	VB	O
gain	NN	O
of	IN	O
function	NN	O
(	(	O
GOF	NNP	O
)	)	O
strongly	RB	O
contributing	VBG	O
to	TO	O
malignancy	NN	O
.	.	O

Studies	NNS	O
thus	RB	O
far	RB	O
have	VBP	O
not	RB	O
shown	VBN	O
p53	NN	O
-	:	O
GOF	NN	O
in	IN	O
osteosarcoma	NN	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
investigated	VBD	O
TP53	NNP	O
gene	NN	O
status	NN	O
role	NN	O
in	IN	O
3	CD	O
AB	NNP	O
-	:	O
OS	NNP	O
cells	NNS	O
-	:	O
a	DT	O
highly	RB	O
aggressive	JJ	O
CSC	NNP	O
line	NN	O
previously	RB	O
selected	VBN	O
from	IN	O
human	JJ	O
osteosarcoma	NN	O
MG63	NNP	O
cells	NNS	O
-	:	O
to	TO	O
evaluate	VB	O
its	PRP$	O
involvement	NN	O
in	IN	O
promoting	VBG	O
proliferation	NN	O
,	,	O
invasiveness	NN	O
,	,	O
resistance	NN	O
to	TO	O
apoptosis	NN	O
and	CC	O
stemness	NN	O
.	.	O

By	IN	O
RT	NNP	O
-	:	O
PCR	NN	O
,	,	O
methylation	NN	O
-	:	O
specific	JJ	O
PCR	NNP	O
,	,	O
fluorescent	NN	O
in	IN	O
situ	JJ	O
hybridization	NN	O
,	,	O
DNA	NNP	O
sequence	NN	O
,	,	O
western	JJ	O
blot	NN	O
and	CC	O
immunofluorescence	NN	O
analyses	NNS	O
,	,	O
we	PRP	O
have	VBP	O
shown	VBN	O
that	IN	O
-	:	O
in	IN	O
comparison	NN	O
with	IN	O
parental	JJ	O
MG63	NNP	O
cells	NNS	O
where	WRB	O
TP53	NNP	O
gene	NN	O
is	VBZ	O
hypermethylated	VBN	O
,	,	O
rearranged	VBN	O
and	CC	O
in	IN	O
single	JJ	O
copy	NN	O
-	:	O
in	IN	O
3	CD	O
AB	NNP	O
-	:	O
OS	NNP	O
cells	NNS	O
,	,	O
TP53	NNP	O
is	VBZ	O
unmethylated	JJ	O
,	,	O
rearranged	VBD	O
and	CC	O
in	IN	O
multiple	JJ	O
copies	NNS	O
,	,	O
and	CC	O
mutp53	NN	O
(	(	O
p53	JJ	O
-	:	O
R248W	NNP	O
P72R	NNP	O
)	)	O
is	VBZ	O
post	JJ	O
-	:	O
translationally	RB	O
modified	VBN	O
and	CC	O
with	IN	O
nuclear	JJ	O
localization	NN	O
.	.	O

p53	NN	O
-	:	O
R248W	NNP	O
P72R	NNP	O
-	:	O
knockdown	VBN	O
by	IN	O
short	JJ	O
-	:	O
interfering	VBG	O
RNA	NNP	O
reduced	VBD	O
the	DT	O
growth	NN	O
and	CC	O
replication	NN	O
rate	NN	O
of	IN	O
3	CD	O
AB	NNP	O
-	:	O
OS	NNP	O
cells	NNS	O
,	,	O
markedly	RB	O
increasing	VBG	O
cell	NN	O
cycle	NN	O
inhibitor	NN	O
levels	NNS	O
and	CC	O
sensitized	VBD	O
3	CD	O
AB	NNP	O
-	:	O
OS	NNP	O
cells	NNS	O
to	TO	O
TRAIL	NNP	O
-	:	O
induced	VBN	O
apoptosis	NN	O
by	IN	O
DR5	NNP	O
up	RP	O
-	:	O
regulation	NN	O
;	:	O
moreover	RB	O
,	,	O
it	PRP	O
strongly	RB	O
decreased	VBD	O
the	DT	O
levels	NNS	O
of	IN	O
stemness	NN	O
and	CC	O
invasiveness	NN	O
genes	NNS	O
.	.	O

We	PRP	O
have	VBP	O
also	RB	O
found	VBN	O
that	IN	O
the	DT	O
ectopic	JJ	O
expression	NN	O
of	IN	O
p53	NN	B-Var
-	:	I-Var
R248W	NNP	I-Var
P72R	NNP	I-Var
in	IN	O
MG63	NNP	O
cells	NNS	O
promoted	VBD	B-PosReg
cancer	NN	B-CPA
stem	NN	I-CPA
-	:	I-CPA
like	IN	I-CPA
features	NNS	I-CPA
,	,	O
as	IN	O
high	JJ	B-CPA
proliferation	NN	I-CPA
rate	NN	I-CPA
,	,	O
sphere	EX	B-CPA
formation	NN	I-CPA
,	,	O
clonogenic	JJ	B-CPA
growth	NN	I-CPA
,	,	O
high	JJ	B-CPA
migration	NN	I-CPA
and	CC	O
invasive	JJ	B-CPA
ability	NN	I-CPA
;	:	O
furthermore	RB	O
,	,	O
it	PRP	O
strongly	RB	O
increased	VBD	B-PosReg
the	DT	O
levels	NNS	B-MPA
of	IN	I-MPA
stemness	NN	I-MPA
proteins	NNS	I-MPA
.	.	O
Overall	JJ	O
,	,	O
the	DT	O
findings	NNS	O
suggest	VBP	O
the	DT	O
involvement	NN	B-Reg
of	IN	O
p53	NN	B-Var
-	:	I-Var
R248W	NNP	I-Var
P72R	NNP	I-Var
at	IN	O
the	DT	O
origin	NN	B-CPA
of	IN	I-CPA
the	DT	I-CPA
aberrant	JJ	I-CPA
characters	NNS	I-CPA
of	IN	I-CPA
the	DT	I-CPA
3	CD	I-CPA
AB	NNP	I-CPA
-	:	I-CPA
OS	NNP	I-CPA
cells	NNS	I-CPA
with	IN	O
the	DT	O
hypothesis	NN	O
that	IN	O
its	PRP$	O
GOF	NNP	O
can	MD	O
be	VB	O
at	IN	O
the	DT	O
root	NN	O
of	IN	O
the	DT	O
dedifferentiation	NN	O
of	IN	O
MG63	NNP	O
cells	NNS	O
into	IN	O
CSCs	NNP	O



Nance	NNP	B-Disease
-	:	I-Disease
Horan	NNP	I-Disease
syndrome	NN	I-Disease
caused	VBN	B-Reg
by	IN	I-Reg
nonsense	NN	B-Var
NHS	NNP	B-Gene
In	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	NN	O
presented	VBD	O
congenital	JJ	B-Disease
diaphragmatic	JJ	I-Disease
hernia	NN	I-Disease
.	.	O
NHS	NNP	O
gene	NN	O
expression	NN	O
in	IN	O
murine	JJ	O
fetal	JJ	O
diaphragm	NN	O
was	VBD	O
demonstrated	VBN	O
,	,	O
suggesting	VBG	O
a	DT	O
possible	JJ	O
involvement	NN	O
of	IN	O
NHS	NNP	O
in	IN	O
diaphragm	NN	O
development	NN	O
.	.	O

Congenital	NNP	B-Disease
diaphragmatic	JJ	I-Disease
hernia	NN	I-Disease
could	MD	O
result	VB	B-Reg
from	IN	I-Reg
NHS	NNP	B-Gene
loss	NN	B-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
in	IN	O
pleuroperitoneal	JJ	O
fold	NN	O
or	CC	O
in	IN	O
somites	NNS	O
-	:	O
derived	VBN	O
muscle	NN	O
progenitor	NN	O
cells	NNS	O
leading	VBG	O
to	TO	O
an	DT	O
impairment	NN	O
of	IN	O
their	PRP$	O
cells	NNS	B-CPA
migration	NN	I-CPA

Ovarian	JJ	I-Disease
Insufficiency	NNP	I-Disease
Azoospermia	NNP	B-Disease
Carriers	NNP	B-Reg
PSMC3IP	NNP	B-Gene
.	.	I-Var


Design	NN	O
:	:	O
The	DT	O
study	NN	O
was	VBD	O
a	DT	O
familial	JJ	O
genetic	JJ	O
study	NN	O
.	.	O

Setting	VBG	O
:	:	O
The	DT	O
study	NN	O
was	VBD	O
performed	VBN	O
at	IN	O
two	CD	O
academic	JJ	O
institutions	NNS	O
.	.	O

Patients	NNS	O
:	:	O
We	PRP	O
identified	VBD	O
a	DT	O
consanguineous	JJ	O
Yemeni	NNP	O
family	NN	O
in	IN	O
which	WDT	O
four	CD	O
daughters	NNS	O
had	VBD	O
POI	NNP	O
.	.	O

A	DT	O
brother	NN	O
had	VBD	O
azoospermia	NN	O
.	.	O

Intervention	NN	O
:	:	O
DNA	NN	O
was	VBD	O
subjected	VBN	O
to	TO	O
whole	VB	O
genome	JJ	O
sequencing	NN	O
.	.	O

Shared	VBN	O
regions	NNS	O
of	IN	O
homozygosity	NN	O
were	VBD	O
identified	VBN	O
using	VBG	O
Truploidy	NNP	O
and	CC	O
prioritized	VBN	O
using	VBG	O
the	DT	O
Variant	NNP	O
Annotation	NNP	O
,	,	O
Analysis	NNP	O
,	,	O
and	CC	O
Search	NNP	O
Tool	NNP	O
with	IN	O
control	NN	O
data	NNS	O
from	IN	O
387	CD	O
healthy	JJ	O
subjects	NNS	O
.	.	O

Imaging	VBG	O
and	CC	O
quantification	NN	O
of	IN	O
protein	JJ	O
localization	NN	O
and	CC	O
mitochondrial	JJ	O
function	NN	O
were	VBD	O
examined	VBN	O
in	IN	O
cell	NN	O
lines	NNS	O
.	.	O

Main	NNP	O
Outcome	NNP	O
:	:	O
Homozygous	JJ	O
recessive	JJ	O
gene	NN	O
variants	NNS	O
shared	VBN	O
by	IN	O
the	DT	O
four	CD	O
sisters	NNS	O
.	.	O

Results	NNS	O
:	:	O
The	DT	O
sisters	NNS	O
shared	VBD	O
a	DT	O
homozygous	JJ	O
stop	NN	O
gain	NN	O
mutation	NN	O
in	IN	O
exon	JJ	O
6	CD	O
of	IN	O
PSMC3IP	NNP	O
(	(	O
c	NN	O
.	.	O
489	CD	O
C	NNP	O
G	NNP	O
,	,	O
p	NN	O
.	.	O
Tyr163Ter	NNP	O
)	)	O
and	CC	O
a	DT	O
missense	NN	O
variant	NN	O
in	IN	O
exon	JJ	O
1	CD	O
of	IN	O
CLPP	NNP	O
(	(	O
c	NN	B-Var
.	.	I-Var
100	CD	I-Var
C	NNP	I-Var
T	NNP	I-Var
,	,	O
p	NN	O
.	.	O
Pro34Ser	NNP	O
)	)	O
.	.	O
The	DT	O
affected	JJ	O
brother	NN	O
also	RB	O
carried	VBD	O
the	DT	O
homozygous	JJ	O
PSMC3IP	NNP	O
mutation	NN	O
.	.	O

Functional	JJ	O
studies	NNS	O
demonstrated	VBD	B-Reg
mitochondrial	JJ	B-CPA
fragmentation	NN	I-CPA
in	IN	O
cells	NNS	O
infected	VBN	O
with	IN	O
the	DT	O
CLPP	NNP	B-Gene
mutation	NN	B-Var
.	.	O
However	RB	O
,	,	O
no	DT	O
abnormality	NN	O
was	VBD	O
found	VBN	O
in	IN	O
mitochondrial	JJ	O
targeting	NN	O
or	CC	O
respiration	NN	O
.	.	O

Conclusions	NNS	O
:	:	O
The	DT	O
PSMC3IP	NNP	O
mutation	NN	O
provides	VBZ	O
additional	JJ	O
evidence	NN	O
that	IN	O
mutations	NNS	O
in	IN	O
meiotic	JJ	O
homologous	JJ	O
recombination	NN	O
and	CC	O
DNA	NNP	O
repair	NN	O
genes	NNS	O
result	VBP	O
in	IN	O
distinct	JJ	O
female	NN	O
and	CC	O
male	JJ	O
reproductive	JJ	O
phenotypes	NNS	O
,	,	O
including	VBG	O
delayed	VBN	O
puberty	NN	O
and	CC	O
primary	JJ	O
amenorrhea	NNS	O
caused	VBN	O
by	IN	O
POI	NNP	O
(	(	O
XX	NNP	O
gonadal	VBP	O
dysgenesis	NN	O
)	)	O
in	IN	O
females	NNS	O
but	CC	O
isolated	JJ	O
azoospermia	NN	O
with	IN	O
normal	JJ	O
pubertal	JJ	O
development	NN	O
in	IN	O
males	NNS	O
.	.	O

The	DT	O
findings	NNS	O
also	RB	O
suggest	VBP	O
that	IN	O
the	DT	O
N	NNP	O
-	:	O
terminal	JJ	O
missense	NN	O
mutation	NN	O
in	IN	O
CLPP	NNP	O
does	VBZ	O
not	RB	O
cause	VB	O
substantial	JJ	O
mitochondrial	JJ	O
dysfunction	NN	O
or	CC	O
contribute	NN	O
to	TO	O
ovarian	JJ	O
insufficiency	NN	O
in	IN	O
an	DT	O
oligogenic	JJ	O
manner	NN	O




BON1	NNP	O
is	VBZ	O
a	DT	O
plasma	JJ	O
membrane	NN	O
localized	VBD	O
protein	NN	O
that	IN	O
negatively	RB	O
regulates	VBZ	O
the	DT	O
expression	NN	O
of	IN	O
immune	JJ	O
receptor	NN	O
genes	NNS	O
and	CC	O
positively	RB	O
regulates	VBZ	O
stomatal	JJ	O
closure	NN	O
.	.	O

We	PRP	O
found	VBD	O
that	IN	O
BON1	NNP	O
interacts	VBZ	O
with	IN	O
the	DT	O
autoinhibitory	NN	O
domains	NNS	O
of	IN	O
ACA10	NNP	O
and	CC	O
ACA8	NNP	O
,	,	O
and	CC	O
the	DT	O
aca10	JJ	B-Gene
loss	NN	B-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
(	(	O
LOF	NNP	O
)	)	O
mutants	NNS	B-Var
have	VBP	O
an	DT	O
autoimmune	NN	O
phenotype	NN	O
similar	JJ	O
to	TO	O
that	DT	O
of	IN	O
the	DT	O
bon1	NN	B-Gene
LOF	NNP	B-NegReg
mutants	NNS	B-Var
.	.	O
Genetic	JJ	O
evidences	NNS	O
indicate	VBP	O
that	IN	O
BON1	NNP	O
positively	RB	O
regulates	VBZ	O
the	DT	O
activities	NNS	O
of	IN	O
ACA10	NNP	O
and	CC	O
ACA8	NNP	O
.	.	O

Consistent	JJ	O
with	IN	O
this	DT	O
idea	NN	O
,	,	O
the	DT	O
steady	JJ	B-MPA
level	NN	I-MPA
of	IN	I-MPA
calcium	NN	I-MPA
concentration	NN	I-MPA
is	VBZ	O
increased	VBN	B-PosReg
in	IN	O
both	DT	O
aca10	NN	B-Gene
and	CC	O
bon1	NN	B-Gene
mutants	NNS	B-Var
.	.	O
Most	JJS	O
strikingly	RB	O
,	,	O
cytosolic	JJ	O
calcium	NN	O
oscillation	NN	O
imposed	VBN	O
by	IN	O
external	JJ	O
calcium	NN	O
treatment	NN	O
was	VBD	O
altered	VBN	O
in	IN	O
aca10	NN	O
,	,	O
aca8	NN	O
,	,	O
and	CC	O
bon1	NN	O
mutants	NNS	O
in	IN	O
guard	NN	O
cells	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
calcium	NN	B-CPA
and	CC	I-CPA
pathogen	NN	I-CPA
induced	JJ	I-CPA
stomatal	JJ	I-CPA
closure	NN	I-CPA
was	VBD	O
compromised	VBN	B-NegReg
in	IN	O
the	DT	O
aca10	NN	B-Gene
and	CC	O
bon1	NN	B-Gene
mutants	NNS	B-Var
.	.	O
Taken	VBN	O
together	RB	O
,	,	O
this	DT	O
study	NN	O
indicates	VBZ	O
that	IN	O
ACA10	NNP	O
8	CD	O
and	CC	O
BON1	NNP	O
physically	RB	O
interact	VB	O
on	IN	O
plasma	NN	O
membrane	NN	O
and	CC	O
function	NN	O
in	IN	O
the	DT	O
generation	NN	O
of	IN	O
cytosol	JJ	O
calcium	NN	O
signatures	NNS	O
that	WDT	O
are	VBP	O
critical	JJ	O
for	IN	O
stomatal	JJ	O
movement	NN	O
and	CC	O
impact	NN	O
plant	NN	O
immunity	NN	O

variant	NN	B-Var
MLKL	NNP	B-Gene
susceptibility	NN	B-Reg
Alzheimer	NNP	B-Disease
's	POS	I-Disease
disease	NN	I-Disease


LOAD	NN	O
patients	NNS	O
showed	VBD	O
a	DT	O
significantly	RB	O
higher	JJR	O
burden	NN	O
of	IN	O
rare	JJ	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
variants	NNS	O
in	IN	O
genes	NNS	O
related	VBN	O
to	TO	O
immune	VB	O
function	NN	O
than	IN	O
healthy	JJ	O
controls	NNS	O
.	.	O

Among	IN	O
the	DT	O
genes	NNS	O
involved	VBN	O
in	IN	O
immune	JJ	O
function	NN	O
,	,	O
we	PRP	O
identified	VBD	O
a	DT	O
rare	JJ	O
stop	NN	O
-	:	O
gain	NN	O
variant	NN	O
(	(	O
p	NN	O
.	.	O
Q48X	NNP	O
)	)	O
in	IN	O
mixed	JJ	O
lineage	NN	O
kinase	VBD	O
domain	NN	O
like	IN	O
pseudokinase	NN	O
(	(	O
MLKL	NNP	O
)	)	O
gene	NN	O
present	JJ	O
exclusively	RB	O
in	IN	O
6	CD	O
LOAD	NNP	O
cases	NNS	O
.	.	O

MLKL	NNP	B-Gene
is	VBZ	O
expressed	VBN	O
in	IN	O
neurons	NNS	O
,	,	O
and	CC	O
the	DT	O
its	PRP$	O
expression	NN	B-MPA
levels	NNS	I-MPA
in	IN	O
the	DT	O
p	NN	B-Var
.	.	I-Var
Q48X	JJ	I-Var
carriers	NNS	O
were	VBD	O
significantly	RB	O
lower	JJR	B-NegReg
than	IN	O
that	DT	O
in	IN	O
age	NN	O
-	:	O
matched	VBN	O
wild	JJ	O
-	:	O
type	NN	O
controls	NNS	O
.	.	O
The	DT	O
ratio	NN	O
of	IN	O
A	$	O
42	CD	O
to	TO	O
A	DT	O
40	CD	O
significantly	RB	O
increased	VBN	O
in	IN	O
MLKL	NNP	O
knockdown	NNP	O
cells	NNS	O
compared	VBN	O
to	TO	O
scramble	VB	O
controls	NNS	O
.	.	O

MLKL	NNP	B-Gene
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutation	NN	B-Var
might	MD	O
contribute	VB	O
to	TO	O
late	VB	O
-	:	O
onset	NN	O
ApoE	NNP	O
4	CD	O
-	:	O
negative	JJ	O
AD	NNP	B-Disease
in	IN	O
the	DT	O
Hong	NNP	O
Kong	NNP	O
Chinese	JJ	O
population	NN	O


Renal	JJ	B-Disease
agenesis	NN	I-Disease

Genetic	JJ	O
investigations	NNS	O
have	VBP	O
identified	VBN	O
several	JJ	O
gene	NN	O
variants	NNS	B-Var
which	WDT	O
cause	VBP	B-Reg
RA	NNP	B-Disease
,	,	O
including	VBG	O
EYA1	NNP	O
,	,	O
LHX1	NNP	O
,	,	O
and	CC	O
WT1	NNP	O
However	RB	O
,	,	O
whereas	VBP	O
compound	NN	O
null	JJ	O
mutations	NNS	O
of	IN	O
genes	NNS	O
encoding	VBG	O
and	CC	O
retinoic	JJ	O
acid	NN	O
receptors	NNS	O
(	(	O
RARs	NNP	O
)	)	O
cause	NN	O
RA	NNP	O
in	IN	O
mice	NN	O
,	,	O
to	TO	O
date	NN	O
there	RB	O
have	VBP	O
been	VBN	O
no	DT	O
reports	NNS	O
of	IN	O
variants	NNS	O
in	IN	O
RAR	NNP	O
genes	NNS	O
causing	VBG	O
RA	NNP	O
in	IN	O
humans	NNS	O
.	.	O
In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
carried	VBD	O
out	RP	O
whole	JJ	O
exome	NN	O
sequence	NN	O
analysis	NN	O
of	IN	O
two	CD	O
families	NNS	O
showing	VBG	O
inheritance	NN	O
of	IN	O
an	DT	O
RA	NNP	O
phenotype	NN	O
,	,	O
and	CC	O
in	IN	O
both	DT	O
identified	VBN	O
a	DT	O
single	JJ	O
candidate	NN	O
gene	NN	O
,	,	O
GREB1L	NNP	O
Analysis	NNP	O
of	IN	O
a	DT	O
zebrafish	JJ	O
greb1l	NN	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutant	NN	B-Var
revealed	VBD	O
defects	NNS	O
in	IN	O
the	DT	O
pronephric	JJ	B-MPA
kidney	NN	I-MPA
just	RB	I-MPA
prior	RB	I-MPA
to	TO	I-MPA
death	NN	I-MPA
,	,	O
and	CC	O
F0	NNP	O
CRISPR	NNP	O
Cas9	NNP	O
mutagenesis	NN	B-Var
of	IN	O
Greb1l	NNP	O
in	IN	O
the	DT	O
mouse	NN	O
revealed	VBD	B-Reg
kidney	NN	B-MPA
agenesis	NN	I-MPA
phenotypes	NNS	I-MPA
,	,	O
implicating	VBG	O
Greb1l	NNP	O
in	IN	O
this	DT	O
disorder	NN	O
.	.	O
GREB1L	NNP	O
resides	NNS	O
in	IN	O
a	DT	O
chromatin	NN	O
complex	NN	O
with	IN	O
RAR	NNP	O
members	NNS	O
,	,	O
and	CC	O
our	PRP$	O
data	NNS	O
implicate	NN	O
GREB1L	NNP	O
as	IN	O
a	DT	O
coactivator	NN	O
for	IN	O
RARs	NNP	O
.	.	O

This	DT	O
study	NN	O
is	VBZ	O
the	DT	O
first	JJ	O
to	TO	O
associate	VB	O
a	DT	O
component	NN	O
of	IN	O
the	DT	O
RAR	NNP	O
pathway	NN	O
with	IN	O
renal	JJ	O
agenesis	NN	O
in	IN	O
humans	NNS	O


Pitt	NNP	B-Disease
-	:	I-Disease
Hopkins	VBZ	I-Disease
syndrome	JJ	I-Disease
caused	VBN	B-Reg
by	IN	I-Reg
haploinsufficiency	NN	B-Var
TCF4	NNP	B-Gene

Several	JJ	O
alternatively	RB	O
spliced	VBD	O
TCF4	NNP	O
variants	NNS	O
have	VBP	O
been	VBN	O
described	VBN	O
,	,	O
allowing	VBG	O
for	IN	O
translation	NN	O
of	IN	O
variable	JJ	O
protein	NN	O
isoforms	NNS	O
.	.	O

Typical	JJ	O
PTHS	NNP	O
patients	NNS	O
have	VBP	O
impairment	NN	O
of	IN	O
at	IN	O
least	JJS	O
the	DT	O
bHLH	NN	O
domain	NN	O
.	.	O

To	TO	O
which	WDT	O
extent	JJ	O
impairment	NN	O
of	IN	O
the	DT	O
remaining	VBG	O
domains	NNS	O
contributes	NNS	O
to	TO	O
the	DT	O
final	JJ	O
phenotype	NN	O
is	VBZ	O
not	RB	O
clear	JJ	O
.	.	O

There	EX	O
is	VBZ	O
recent	JJ	O
evidence	NN	O
that	IN	O
certain	JJ	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
variants	NNS	B-Var
disrupting	VBG	B-NegReg
TCF4	NNP	B-Gene
are	VBP	O
associated	VBN	O
with	IN	O
mild	JJ	B-Disease
ID	NNP	I-Disease
,	,	O
but	CC	O
not	RB	O
with	IN	O
typical	JJ	O
PTHS	NNP	O
.	.	O
We	PRP	O
describe	VBP	O
a	DT	O
frameshift	NN	B-Var
-	:	O
causing	VBG	B-Reg
partial	JJ	B-Var
gene	NN	I-Var
deletion	NN	I-Var
encompassing	VBG	O
exons	NNS	O
4	CD	O
-	:	O
6	CD	O
of	IN	O
TCF4	NNP	B-Gene
in	IN	O
an	DT	O
adult	NN	O
patient	NN	O
with	IN	B-Reg
mild	JJ	B-Disease
ID	NNP	I-Disease
and	CC	O
nonspecific	JJ	O
facial	JJ	O
dysmorphisms	NNS	O
but	CC	O
without	IN	O
the	DT	O
typical	JJ	O
features	NNS	O
of	IN	O
PTHS	NNP	O
,	,	O
and	CC	O
a	DT	O
c	NN	B-Var
.	.	I-Var
520	CD	I-Var
C	NNP	I-Var
T	NNP	I-Var
nonsense	NN	O
variant	NN	O
within	IN	O
exon	$	O
8	CD	O
in	IN	O
a	DT	O
child	NN	O
presenting	VBG	O
with	IN	B-Reg
a	DT	O
severe	JJ	O
phenotype	NN	O
largely	RB	O
mimicking	JJ	O
PTHS	NNP	B-Disease
,	,	O
but	CC	O
lacking	VBG	O
the	DT	O
typical	JJ	O
facial	JJ	O
dysmorphism	NN	O
.	.	O
Investigation	NN	O
on	IN	O
mRNA	NN	O
,	,	O
along	IN	O
with	IN	O
literature	NN	O
review	NN	O
,	,	O
led	VBD	O
us	PRP	O
to	TO	O
suggest	VB	O
a	DT	O
preliminary	JJ	O
phenotypic	NN	O
map	NN	O
of	IN	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
variants	NNS	O
affecting	VBG	O
TCF4	NNP	O
.	.	O

An	DT	O
intragenic	JJ	O
phenotypic	NN	O
map	NN	O
of	IN	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
variants	NNS	O
in	IN	O
TCF4	NNP	O
is	VBZ	O
suggested	VBN	O
here	RB	O
for	IN	O
the	DT	O
first	JJ	O
time	NN	O
:	:	O
variants	NNS	O
within	IN	O
exons	NNS	O
1	CD	O
-	:	O
4	CD	O
and	CC	O
exons	NNS	O
4	CD	O
-	:	O
6	CD	O
give	JJ	O
rise	NN	O
to	TO	O
a	DT	O
recurrent	NN	O
phenotype	NN	O
with	IN	O
mild	JJ	O
ID	NNP	O
not	RB	O
in	IN	O
the	DT	O
spectrum	NN	O
of	IN	O
Pitt	NNP	O
-	:	O
Hopkins	VBZ	O
syndrome	JJ	O
(	(	O
biallelic	JJ	O
preservation	NN	O
of	IN	O
both	CC	O
the	DT	O
NLS	NNP	O
and	CC	O
bHLH	VB	O
domains	NNS	O
)	)	O
;	:	O
variants	NNS	O
within	IN	O
exons	NNS	O
7	CD	O
-	:	O
8	CD	O
cause	NN	O
a	DT	O
severe	JJ	O
phenotype	NN	O
resembling	VBG	O
PTHS	NNP	O
but	CC	O
in	IN	O
absence	NN	O
of	IN	O
the	DT	O
typical	JJ	O
facial	JJ	O
dysmorphism	NN	O
(	(	O
impairment	JJ	O
limited	VBN	O
to	TO	O
the	DT	O
NLS	NNP	O
domain	NN	O
)	)	O
;	:	O
variants	NNS	O
within	IN	O
exons	NNS	O
9	CD	O
-	:	O
19	CD	O
cause	NN	O
typical	JJ	O
Pitt	NNP	O
-	:	O
Hopkins	VBZ	O
syndrome	JJ	O
(	(	O
impairment	NN	O
of	IN	O
at	IN	O
least	JJS	O
the	DT	O
bHLH	NN	O
domain	NN	O
)	)	O
.	.	O

Understanding	VBG	O
the	DT	O
TCF4	NNP	O
molecular	JJ	O
syndromology	NN	O
can	MD	O
allow	VB	O
for	IN	O
proper	JJ	O
nosology	NN	O
in	IN	O
the	DT	O
current	JJ	O
era	NN	O
of	IN	O
whole	JJ	O
genomic	JJ	O
investigations	NNS	O



The	DT	O
homeostasis	NN	O
between	IN	O
collagens	NNS	O
and	CC	O
matrix	NN	O
metalloproteases	NNS	O
(	(	O
MMPs	NNP	O
)	)	O
tissue	NN	O
inhibitors	NNS	O
of	IN	O
MMPs	NNP	O
(	(	O
TIMPs	NNP	O
)	)	O
system	NN	O
in	IN	O
the	DT	O
extracellular	JJ	O
matrix	NN	O
plays	VBZ	O
an	DT	O
important	JJ	O
role	NN	O
for	IN	O
structure	NN	O
and	CC	O
functions	NNS	O
of	IN	O
aorta	NN	O
.	.	O

However	RB	O
,	,	O
our	PRP$	O
knowledge	NN	O
on	IN	O
association	NN	O
between	IN	O
variants	NNS	O
of	IN	O
genes	NNS	O
in	IN	O
this	DT	O
system	NN	O
and	CC	O
pathogenesis	NN	O
of	IN	O
AD	NNP	O
is	VBZ	O
very	RB	O
limited	JJ	O
.	.	O

We	PRP	O
analyzed	VBD	O
all	DT	O
yet	RB	O
known	VBN	O
coding	VBG	O
human	JJ	O
genes	NNS	O
of	IN	O
collagens	NNS	O
(	(	O
45	CD	O
genes	NNS	O
)	)	O
,	,	O
MMPs	NNP	O
TIMPs	NNP	O
(	(	O
27	CD	O
genes	NNS	O
)	)	O
in	IN	O
702	CD	O
sporadic	JJ	O
AD	NNP	O
patients	NNS	O
and	CC	O
in	IN	O
163	CD	O
matched	VBD	O
healthy	JJ	O
controls	NNS	O
,	,	O
by	IN	O
using	VBG	O
massively	RB	O
targeted	VBN	O
next	JJ	O
-	:	O
generation	NN	O
and	CC	O
Sanger	NNP	O
sequencing	NN	O
.	.	O

To	TO	O
define	VB	O
the	DT	O
pathogenesis	NN	O
of	IN	O
potential	JJ	O
disease	NN	O
-	:	O
causing	VBG	O
candidate	NN	O
genes	NNS	O
,	,	O
we	PRP	O
performed	VBD	O
transcriptome	JJ	O
sequencing	NN	O
and	CC	O
pedigree	VB	O
co	JJR	O
-	:	O
segregation	NN	O
analysis	NN	O
in	IN	O
some	DT	O
genes	NNS	O
and	CC	O
generated	VBD	O
Col5a2	NNP	O
knockout	NN	O
rats	NNS	O
.	.	O

We	PRP	O
identified	VBD	O
257	CD	O
pathogenic	NN	O
or	CC	O
likely	JJ	O
pathogenic	JJ	O
variants	NNS	O
which	WDT	O
involved	VBD	O
88.89%	CD	O
(	(	O
64	CD	O
72	CD	O
)	)	O
genes	NNS	O
in	IN	O
collagens	NNS	O
-	:	O
MMPs	NNP	O
TIMPs	NNP	O
system	NN	O
and	CC	O
accounted	VBD	O
for	IN	O
31.05%	CD	O
(	(	O
218	CD	O
702	CD	O
)	)	O
sporadic	JJ	O
AD	NNP	O
patients	NNS	O
.	.	O

In	IN	O
them	PRP	O
,	,	O
84.86%	CD	O
patients	NNS	O
(	(	O
185	CD	O
218	CD	O
)	)	O
carried	VBD	O
one	CD	O
variant	NN	O
,	,	O
12.84%	CD	O
two	CD	O
variants	NNS	O
and	CC	O
2.30%	CD	O
more	JJR	O
than	IN	O
two	CD	O
variants	NNS	O
.	.	O

Importantly	RB	O
,	,	O
we	PRP	O
identified	VBD	O
52	CD	O
novel	NN	O
probably	RB	O
pathogenic	JJ	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
(	(	O
LOF	NNP	O
)	)	O
variants	NNS	O
(	(	O
20	CD	O
nonsense	NN	O
,	,	O
16	CD	O
frameshift	NN	O
,	,	O
14	CD	O
splice	NN	O
sites	NNS	O
,	,	O
one	CD	O
stop	SYM	O
-	:	O
loss	NN	O
,	,	O
one	CD	O
initiation	NN	O
codon	NN	O
)	)	O
in	IN	O
11.06%	CD	O
(	(	O
50	CD	O
452	CD	O
)	)	O
AD	NN	O
patients	NNS	O
,	,	O
which	WDT	O
were	VBD	O
absent	NN	O
in	IN	O
163	CD	O
controls	NNS	O
(	(	O
P	NNP	O
2.5	CD	O
10	CD	O
(-	JJ	O
5	CD	O
))	NN	O
.	.	O

Transcriptome	NNP	O
sequencing	NN	O
revealed	VBD	O
that	IN	O
identified	JJ	O
variants	NNS	B-Var
induced	JJ	O
dyshomeostasis	NN	B-Reg
in	IN	O
expression	NN	B-CPA
of	IN	I-CPA
collagens	NNS	I-CPA
-	:	I-CPA
TIMPs	NNP	I-CPA
MMPs	NNP	I-CPA
systems	NNS	I-CPA
.	.	O
The	DT	O
Col5a2	NNP	B-Gene
(-	JJ	O
-)	NNP	O
rats	NNS	O
manifested	VBD	O
growth	NN	B-CPA
retardation	NN	I-CPA
and	CC	O
aortic	JJ	B-CPA
dysplasia	NN	I-CPA
.	.	O
Our	PRP$	O
study	NN	O
provides	VBZ	O
a	DT	O
first	JJ	O
comprehensive	JJ	O
map	NN	O
of	IN	O
genetic	JJ	O
alterations	NNS	O
in	IN	O
collagens	NNS	O
-	:	O
MMPs	NNP	O
TIMPs	NNP	O
system	NN	O
in	IN	O
sporadic	JJ	O
AD	NNP	O
patients	NNS	O
and	CC	O
suggests	VBZ	O
that	IN	O
variants	NNS	O
of	IN	O
these	DT	O
genes	NNS	O
contribute	VBP	O
largely	RB	O
to	TO	O
AD	NNP	O
pathogenesis	NN	O


KEY	JJ	O
MESSAGE	NN	O
:	:	O
Shuhui498	NNP	O
(	(	O
R498	NNP	O
)	)	O
is	VBZ	O
an	DT	O
elite	JJ	O
parent	NN	O
of	IN	O
heavy	JJ	O
panicle	NN	O
hybrid	JJ	O
rice	NN	O
by	IN	O
pyramiding	VBG	O
the	DT	O
rare	JJ	O
gn1a	NN	O
and	CC	O
null	JJ	O
gs3	NN	O
alleles	NNS	O
.	.	O

This	DT	O
finding	NN	O
reveals	VBZ	O
the	DT	O
genetic	JJ	O
basis	NN	O
and	CC	O
great	JJ	O
potential	JJ	O
application	NN	O
in	IN	O
future	JJ	O
breeding	NN	O
of	IN	O
R498	NNP	O
.	.	O

The	DT	O
heavy	JJ	O
panicle	NN	O
trait	NN	O
,	,	O
defined	VBD	O
as	IN	O
5	CD	O
g	NN	O
or	CC	O
more	JJR	O
of	IN	O
grain	NN	O
weight	NN	O
per	IN	O
panicle	NN	O
,	,	O
is	VBZ	O
one	CD	O
of	IN	O
the	DT	O
target	NN	O
traits	NNS	O
in	IN	O
super	JJ	O
-	:	O
high	JJ	O
-	:	O
yield	NN	O
rice	NN	O
breeding	NN	O
programs	NNS	O
.	.	O

The	DT	O
use	NN	O
of	IN	O
heavy	JJ	O
panicle	NN	O
-	:	O
type	NN	O
hybrid	JJ	O
rice	NN	O
has	VBZ	O
been	VBN	O
shown	VBN	O
to	TO	O
be	VB	O
a	DT	O
successful	JJ	O
strategy	NN	O
for	IN	O
super	JJR	O
-	:	O
high	JJ	O
-	:	O
yield	NN	O
breeding	NN	O
programs	NNS	O
,	,	O
particularly	RB	O
under	IN	O
the	DT	O
environmental	JJ	O
conditions	NNS	O
of	IN	O
high	JJ	O
humidity	NN	O
and	CC	O
deficient	NN	O
solar	JJ	O
radiation	NN	O
in	IN	O
southwestern	JJ	O
China	NNP	O
.	.	O

However	RB	O
,	,	O
the	DT	O
genetic	JJ	O
components	NNS	O
of	IN	O
the	DT	O
heavy	JJ	O
panicle	NN	O
trait	NN	O
in	IN	O
hybrid	JJ	O
rice	NN	O
remain	VBP	O
elusive	JJ	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
report	VBP	O
that	IN	O
the	DT	O
combination	NN	O
of	IN	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
in	IN	O
Grain	NNP	O
number	NN	O
1	CD	O
a	DT	O
(	(	O
Gn1a	NNP	B-Gene
)	)	O
and	CC	O
Grain	NNP	O
Size	NNP	O
3	CD	O
(	(	O
GS3	NNP	B-Gene
)	)	O
is	VBZ	O
responsible	JJ	B-Reg
for	IN	O
the	DT	O
heavy	JJ	B-MPA
panicle	NN	I-MPA
phenotype	NN	I-MPA
of	IN	O
the	DT	O
elite	JJ	O
hybrid	JJ	O
rice	NN	O
restorer	NN	O
line	NN	O
Shuhui498	NNP	O
(	(	O
R498	NNP	O
)	)	O
.	.	O
The	DT	O
null	JJ	O
gn1a	NN	O
allele	NN	O
is	VBZ	O
the	DT	O
determinant	JJ	O
factor	NN	O
for	IN	O
heavy	JJ	O
panicles	NNS	O
through	IN	O
increased	VBN	O
grain	NN	O
number	NN	O
,	,	O
while	IN	O
gs3	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
grain	NN	O
size	NN	O
and	CC	O
weight	NN	O
.	.	O

R498	NNP	O
pyramided	VBD	O
the	DT	O
two	CD	O
major	JJ	O
null	NN	O
alleles	NNS	O
,	,	O
resulting	VBG	O
in	IN	O
heavy	JJ	O
panicles	NNS	O
with	IN	O
a	DT	O
high	JJ	O
grain	NN	O
number	NN	O
and	CC	O
large	JJ	O
grains	NNS	O
.	.	O

Clustering	VBG	O
analysis	NN	O
revealed	VBD	O
that	IN	O
the	DT	O
null	JJ	O
gn1aR498	NN	O
allele	NN	O
is	VBZ	O
a	DT	O
rare	JJ	O
haplotype	NN	O
which	WDT	O
has	VBZ	O
been	VBN	O
innovatively	RB	O
utilized	JJ	O
in	IN	O
R498	NNP	O
,	,	O
underscoring	VBG	O
the	DT	O
great	JJ	O
potential	NN	O
of	IN	O
R498	NNP	O
for	IN	O
breeding	VBG	O
purposes	NNS	O
.	.	O

Our	PRP$	O
research	NN	O
thus	RB	O
sheds	VBZ	O
light	NN	O
on	IN	O
the	DT	O
distinct	JJ	O
genetic	JJ	O
compositions	NNS	O
of	IN	O
heavy	JJ	O
panicle	NN	O
-	:	O
type	NN	O
rice	NN	O
and	CC	O
may	MD	O
potentially	RB	O
facilitate	VB	O
super	JJR	O
-	:	O
high	JJ	O
-	:	O
yield	NN	O
rice	NN	O
breeding	NN	O

mutations	NNS	B-Var
KCNJ10	NNP	B-Gene
KCNT1	NNP	B-Gene
associated	VBN	B-Reg
seizures	NNS	B-Disease
neurodevelopmental	JJ	B-Disease
delay	NN	I-Disease



The	DT	O
mutant	NN	O
and	CC	O
wild	JJ	O
-	:	O
type	NN	O
KCNJ10	NNP	O
constructs	NNS	O
were	VBD	O
generated	VBN	O
and	CC	O
heterologously	RB	O
expressed	VBN	O
in	IN	O
Xenopus	NNP	O
laevis	NN	O
oocytes	NNS	O
,	,	O
and	CC	O
whole	JJ	O
-	:	O
cell	NN	O
K	NNP	O
(	(	O
)	)	O
currents	NNS	O
were	VBD	O
measured	VBN	O
using	VBG	O
the	DT	O
two	CD	O
-	:	O
electrode	NN	O
voltage	NN	O
-	:	O
clamp	NN	O
technique	NN	O
.	.	O

The	DT	O
KCNJ10	NNP	B-Gene
mutation	NN	B-Var
c	NN	O
.	.	O
652	CD	O
C	NNP	O
T	NNP	O
resulted	VBD	B-Reg
in	IN	I-Reg
a	DT	O
p	NN	O
.	.	O
L218F	NNP	O
substitution	NN	B-Var
at	IN	O
a	DT	O
highly	RB	O
conserved	VBN	O
residue	JJ	O
site	NN	O
.	.	O
Wild	NNP	O
-	:	O
type	NN	O
KCNJ10	NNP	O
expression	NN	O
yielded	VBD	O
robust	JJ	O
Kir	NNP	O
currents	NNS	O
,	,	O
while	IN	O
currents	NNS	O
from	IN	O
oocytes	NNS	O
expressing	VBG	O
the	DT	O
mutation	NN	O
were	VBD	O
reduced	VBN	O
.	.	O

Western	JJ	O
Blot	NNP	O
analysis	NN	O
revealed	VBD	O
reduced	JJ	B-NegReg
protein	NN	B-MPA
expression	NN	I-MPA
by	IN	O
the	DT	O
mutation	NN	B-Var
.	.	O
Kir5	NNP	O
.	.	O
1	CD	O
subunits	NNS	O
display	VBP	O
selective	JJ	O
heteromultimerization	NN	O
with	IN	O
Kir4	NNP	O
.	.	O
1	CD	O
constituting	VBG	O
channels	NNS	O
with	IN	O
unique	JJ	O
kinetics	NNS	O
.	.	O

The	DT	O
effect	NN	O
of	IN	O
the	DT	O
mutation	NN	O
on	IN	O
Kir4	NNP	O
.	.	O
1	CD	O
5.1	CD	O
channel	NN	O
activity	NN	O
was	VBD	O
twofold	VBN	O
:	:	O
a	DT	O
reduction	NN	O
in	IN	O
current	JJ	O
amplitudes	NNS	O
and	CC	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
pH	NN	O
-	:	O
dependent	JJ	O
inhibition	NN	O
.	.	O

We	PRP	O
thus	RB	O
report	VB	O
a	DT	O
novel	JJ	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutation	NN	B-Var
in	IN	O
Kir4	NNP	O
.	.	O
1	CD	O
found	VBN	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
a	DT	O
co	NN	O
-	:	O
exiting	VBG	O
mutation	NN	B-Var
in	IN	O
SLACK	NNP	O
channels	NNS	O
that	WDT	O
results	NNS	B-Reg
in	IN	I-Reg
a	DT	O
fatal	JJ	B-Disease
disease	NN	I-Disease


Dyslipidemia	NNP	O
,	,	O
characterized	VBN	O
by	IN	O
elevation	NN	O
of	IN	O
plasma	NN	O
low	JJ	O
density	NN	O
lipoprotein	NN	O
cholesterol	NN	O
(	(	O
LDL	NNP	O
-	:	O
C	NNP	O
)	)	O
,	,	O
triglyceride	RB	O
(	(	O
TG	NNP	O
)	)	O
and	CC	O
reduction	NN	O
of	IN	O
plasma	NN	O
high	JJ	O
density	NN	O
lipoprotein	VBP	O
cholesterol	NN	O
(	(	O
HDL	NNP	O
-	:	O
C	NNP	O
)	)	O
,	,	O
has	VBZ	O
been	VBN	O
verified	VBN	O
as	IN	O
a	DT	O
causal	NN	O
risk	NN	O
factor	NN	O
for	IN	O
cardiovascular	JJ	O
diseases	NNS	O
(	(	O
CVD	NNP	O
)	)	O
,	,	O
leading	VBG	O
to	TO	O
a	DT	O
high	JJ	O
mortality	NN	O
rate	NN	O
in	IN	O
general	JJ	O
population	NN	O
.	.	O

It	PRP	O
is	VBZ	O
important	JJ	O
to	TO	O
understand	VB	O
the	DT	O
molecular	JJ	O
metabolism	NN	O
underlying	VBG	O
dyslipidemia	NN	O
in	IN	O
order	NN	O
to	TO	O
reduce	VB	O
the	DT	O
risk	NN	O
and	CC	O
to	TO	O
develop	VB	O
effective	JJ	O
therapeutic	JJ	O
approaches	NNS	O
against	IN	O
CVD	NNP	O
.	.	O

ANGPTL3	NNP	O
(	(	O
human	JJ	O
)	)	O
or	CC	O
Angptl3	NNP	O
(	(	O
mouse	NN	O
)	)	O
,	,	O
one	CD	O
member	NN	O
of	IN	O
the	DT	O
angiopoietin	JJ	O
-	:	O
like	IN	O
protein	NN	O
(	(	O
ANGPTL	NNP	O
)	)	O
family	NN	O
,	,	O
has	VBZ	O
been	VBN	O
identified	VBN	O
as	IN	O
an	DT	O
important	JJ	O
regulator	NN	O
of	IN	O
lipid	JJ	O
metabolism	NN	O
by	IN	O
inhibiting	VBG	O
LPL	NNP	O
and	CC	O
EL	NNP	O
activity	NN	O
.	.	O

Results	NNS	O
have	VBP	O
demonstrated	VBN	O
that	IN	O
inactivation	NN	O
of	IN	O
Angptl3	NNP	O
in	IN	O
mice	NN	O
could	MD	O
obviously	RB	O
reduce	VB	O
the	DT	O
level	NN	O
of	IN	O
TG	NNP	O
,	,	O
LDL	NNP	O
-	:	O
C	NNP	O
and	CC	O
the	DT	O
atherosclerotic	JJ	O
lesion	NN	O
size	NN	O
,	,	O
leading	VBG	O
to	TO	O
a	DT	O
lower	JJR	O
risk	NN	O
for	IN	O
dyslipidemia	NN	O
and	CC	O
CVD	NNP	O
.	.	O

Additionally	RB	O
,	,	O
in	IN	O
humans	NNS	O
,	,	O
carriers	NNS	O
with	IN	O
homozygous	JJ	O
LOF	NNP	B-NegReg
mutations	NNS	B-Var
in	IN	O
ANGPTL3	NNP	B-Gene
have	VBP	O
lower	JJR	B-NegReg
plasma	NN	B-MPA
LDL	NNP	I-MPA
-	:	I-MPA
C	NNP	I-MPA
,	,	O
TG	NNP	B-MPA
levels	NNS	I-MPA
and	CC	O
lower	JJR	O
risk	NN	O
of	IN	O
atherosclerosis	NN	O
compared	VBN	O
to	TO	O
the	DT	O
non	JJ	O
-	:	O
carriers	NNS	O
.	.	O
Here	RB	O
,	,	O
we	PRP	O
collect	VBP	O
the	DT	O
latest	JJS	O
data	NNS	O
and	CC	O
results	NNS	O
,	,	O
giving	VBG	O
a	DT	O
new	JJ	O
insight	NN	O
into	IN	O
the	DT	O
important	JJ	O
role	NN	O
of	IN	O
ANGPTL3	NNP	O
in	IN	O
controlling	VBG	O
lipoprotein	JJ	O
metabolism	NN	O
.	.	O

Finally	RB	O
,	,	O
we	PRP	O
introduce	VBP	O
two	CD	O
update	JJ	O
reports	NNS	O
on	IN	O
the	DT	O
antisense	NN	O
oligonucleotide	NN	O
and	CC	O
monoclonal	JJ	O
antibody	NN	O
-	:	O
based	VBN	O
inactivation	NN	O
of	IN	O
ANGPTL3	NNP	O
in	IN	O
human	JJ	O
clinical	JJ	O
trials	NNS	O
,	,	O
to	TO	O
identify	VB	O
that	DT	O
ANGPTL3	NNP	O
could	MD	O
be	VB	O
a	DT	O
novel	JJ	O
and	CC	O
effective	JJ	O
target	NN	O
for	IN	O
the	DT	O
treatment	NN	O
of	IN	O
dyslipidemia	NN	O
and	CC	O
CVD	NNP	O


variants	NNS	B-Var
CDH1	NNP	B-Gene
associated	VBN	B-Reg
with	IN	I-Reg
hereditary	JJ	B-Disease
diffuse	NN	I-Disease
gastric	JJ	I-Disease
cancer	NN	I-Disease
There	EX	O
is	VBZ	O
a	DT	O
paucity	NN	O
of	IN	O
data	NNS	O
to	TO	O
guide	VB	O
risk	NN	O
assessment	NN	O
and	CC	O
management	NN	O
of	IN	O
families	NNS	O
with	IN	O
hereditary	JJ	O
diffuse	NN	O
gastric	JJ	O
cancer	NN	O
that	WDT	O
do	VBP	O
not	RB	O
carry	VB	O
a	DT	O
CDH1	NNP	O
pathogenic	NN	O
variant	NN	O
,	,	O
making	VBG	O
it	PRP	O
difficult	JJ	O
to	TO	O
make	VB	O
informed	JJ	O
decisions	NNS	O
about	IN	O
surveillance	NN	O
and	CC	O
risk	NN	O
-	:	O
reducing	NN	O
surgery	NN	O
.	.	O

We	PRP	O
aimed	VBD	O
to	TO	O
identify	VB	O
new	JJ	O
candidate	NN	O
genes	NNS	O
associated	VBN	O
with	IN	O
predisposition	NN	O
to	TO	O
hereditary	JJ	O
diffuse	NN	O
gastric	JJ	O
cancer	NN	O
in	IN	O
affected	JJ	O
families	NNS	O
without	IN	O
pathogenic	JJ	O
CDH1	NNP	O
variants	NNS	O
.	.	O

METHODS	NNS	O
:	:	O
We	PRP	O
did	VBD	O
whole	JJ	O
-	:	O
exome	NN	O
sequencing	NN	O
on	IN	O
DNA	NN	O
extracted	VBN	O
from	IN	O
the	DT	O
blood	NN	O
of	IN	O
39	CD	O
individuals	NNS	O
(	(	O
28	CD	O
individuals	NNS	O
diagnosed	VBN	O
with	IN	O
hereditary	JJ	O
diffuse	NN	O
gastric	JJ	O
cancer	NN	O
and	CC	O
11	CD	O
unaffected	VBD	O
first	JJ	O
-	:	O
degree	NN	O
relatives	NNS	O
)	)	O
in	IN	O
22	CD	O
families	NNS	O
without	IN	O
pathogenic	JJ	O
CDH1	NNP	O
variants	NNS	O
.	.	O

Genes	NNS	O
with	IN	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
variants	NNS	O
were	VBD	O
prioritised	VBN	O
using	VBG	O
gene	NN	O
-	:	O
interaction	NN	O
analysis	NN	O
to	TO	O
identify	VB	O
clusters	NNS	O
of	IN	O
genes	NNS	O
that	WDT	O
could	MD	O
be	VB	O
involved	VBN	O
in	IN	O
predisposition	NN	O
to	TO	O
hereditary	JJ	O
diffuse	NN	O
gastric	JJ	O
cancer	NN	O
.	.	O

FINDINGS	NNS	O
:	:	O
Protein	NNP	O
-	:	O
affecting	VBG	O
germline	JJ	O
variants	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
probands	NNS	O
from	IN	O
six	CD	O
families	NNS	O
with	IN	O
hereditary	JJ	O
diffuse	NN	O
gastric	JJ	O
cancer	NN	O
;	:	O
variants	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
genes	NNS	O
known	VBN	O
to	TO	O
predispose	VB	O
to	TO	O
cancer	NN	O
and	CC	O
in	IN	O
lesser	JJR	O
-	:	O
studied	VBN	O
DNA	NNP	O
repair	NN	O
genes	NNS	O
.	.	O

A	DT	O
frameshift	JJ	B-Var
deletion	NN	I-Var
in	IN	O
PALB2	NNP	B-Gene
was	VBD	O
found	VBN	B-Reg
in	IN	O
one	CD	O
member	NN	O
of	IN	O
a	DT	O
family	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
gastric	NN	B-Disease
and	CC	O
breast	NN	B-Disease
cancer	NN	I-Disease
.	.	O
Two	CD	O
different	JJ	O
MSH2	NNP	O
variants	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
two	CD	O
unrelated	JJ	O
affected	JJ	O
individuals	NNS	O
,	,	O
including	VBG	O
one	CD	O
frameshift	NN	O
insertion	NN	O
and	CC	O
one	CD	O
previously	RB	O
described	VBN	O
start	JJ	O
-	:	O
codon	NN	O
loss	NN	O
.	.	O

One	CD	O
family	NN	O
had	VBD	O
a	DT	O
unique	JJ	O
combination	NN	O
of	IN	O
variants	NNS	O
in	IN	O
the	DT	O
DNA	NNP	O
repair	NN	O
genes	NNS	O
ATR	NNP	O
and	CC	O
NBN	NNP	O
.	.	O

Two	CD	O
variants	NNS	O
in	IN	O
the	DT	O
DNA	NNP	O
repair	NN	O
gene	NN	O
RECQL5	NNP	O
were	VBD	O
identified	VBN	O
in	IN	O
two	CD	O
unrelated	JJ	O
families	NNS	O
:	:	O
one	CD	O
missense	NN	O
variant	NN	O
and	CC	O
a	DT	O
splice	NN	O
-	:	O
acceptor	NN	O
variant	NN	O
.	.	O

INTERPRETATION	NN	O
:	:	O
The	DT	O
results	NNS	O
of	IN	O
this	DT	O
study	NN	O
suggest	VBP	O
a	DT	O
role	NN	O
for	IN	O
the	DT	O
known	JJ	O
cancer	NN	O
predisposition	NN	O
gene	NN	O
PALB2	NNP	O
in	IN	O
families	NNS	O
with	IN	O
hereditary	JJ	O
diffuse	NN	O
gastric	JJ	O
cancer	NN	O
and	CC	O
no	DT	O
detected	JJ	O
pathogenic	JJ	O
CDH1	NNP	O
variants	NNS	O
.	.	O

We	PRP	O
also	RB	O
identified	VBD	O
new	JJ	O
candidate	NN	O
genes	NNS	O
associated	VBN	O
with	IN	O
disease	NN	O
risk	NN	O
in	IN	O
these	DT	O
families	NNS	O
.	.	O

FUNDING	NN	O
:	:	O
UK	NNP	O
Medical	NNP	O
Research	NNP	O
Council	NNP	O
(	(	O
Sackler	NNP	O
programme	NN	O
)	)	O
,	,	O
European	JJ	O
Research	NNP	O
Council	NNP	O
under	IN	O
the	DT	O
European	NNP	O
Union	NNP	O
's	POS	O
Seventh	NNP	O
Framework	NNP	O
Programme	NNP	O
(	(	O
2007	CD	O
-	:	O
13	CD	O
)	)	O
,	,	O
National	NNP	O
Institute	NNP	O
for	IN	O
Health	NNP	O
Research	NNP	O
Cambridge	NNP	O
Biomedical	NNP	O
Research	NNP	O
Centre	NNP	O
,	,	O
Experimental	NNP	O
Cancer	NNP	O
Medicine	NNP	O
Centres	NNP	O
,	,	O
and	CC	O
Cancer	NNP	O
Research	NNP	O
UK	NNP	O

aromatase	NN	I-Protein
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutant	JJ	B-Var
undergo	JJ	B-Reg
ovary	JJ	B-CPA
degeneration	NN	I-CPA
partial	JJ	B-CPA
female	NN	I-CPA
-	:	I-CPA
to	TO	I-CPA
-	:	I-CPA
male	NN	I-CPA
sex	NN	I-CPA
reversal	NN	I-CPA

We	PRP	O
isolated	VBD	O
two	CD	O
mutants	NNS	O
with	IN	O
premature	JJ	O
stops	NNS	O
in	IN	O
the	DT	O
ovarian	JJ	O
aromatase	NN	O
(	(	O
cyp19a1	NN	B-Gene
)	)	O
gene	NN	O
from	IN	O
an	DT	O
N	NNP	O
-	:	O
ethyl	NN	O
-	:	O
N	NNP	O
-	:	O
nitrosourea	SYM	O
-	:	O
based	VBN	O
gene	NN	O
-	:	O
driven	VBN	O
mutagenesis	NN	O
library	NN	O
of	IN	O
the	DT	O
medaka	NN	O
,	,	O
Oryzias	NNP	O
latipes	VBZ	O
.	.	O
In	IN	O
XX	NNP	O
mutants	NNS	O
,	,	O
gonads	NNS	O
first	RB	O
differentiated	VBD	O
into	IN	O
normal	JJ	O
ovaries	NNS	O
containing	VBG	O
many	JJ	O
ovarian	JJ	O
follicles	NNS	O
that	WDT	O
failed	VBD	O
to	TO	O
accumulate	VB	O
yolk	NN	O
.	.	O

Subsequently	RB	O
,	,	O
ovarian	JJ	O
tissues	NNS	O
underwent	JJ	O
extensive	JJ	O
degeneration	NN	O
,	,	O
followed	VBN	O
by	IN	O
the	DT	O
appearance	NN	O
of	IN	O
testicular	JJ	O
tissues	NNS	O
on	IN	O
the	DT	O
dorsal	JJ	O
side	NN	O
of	IN	O
ovaries	NNS	O
.	.	O

In	IN	O
the	DT	O
newly	RB	O
formed	VBN	O
testicular	JJ	O
tissue	NN	O
,	,	O
strong	JJ	O
expression	NN	O
of	IN	O
gsdf	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
sox9a2	JJ	O
-	:	O
positive	JJ	O
somatic	JJ	O
cells	NNS	O
surrounding	VBG	O
germline	JJ	O
stem	NN	O
cells	NNS	O
suggesting	VBG	O
that	IN	O
gsdf	NN	O
plays	VBZ	O
an	DT	O
important	JJ	O
role	NN	O
in	IN	O
testicular	JJ	O
differentiation	NN	O
during	IN	O
estrogen	NN	O
-	:	O
depleted	VBN	O
female	JJ	O
-	:	O
to	TO	O
-	:	O
male	NN	O
sex	NN	O
reversal	NN	O
.	.	O

We	PRP	O
conclude	VBP	O
that	DT	O
endogenous	JJ	O
estrogens	NNS	O
synthesized	VBN	O
after	IN	O
fertilization	NN	O
are	VBP	O
not	RB	O
essential	JJ	O
for	IN	O
early	JJ	O
ovarian	JJ	O
differentiation	NN	O
but	CC	O
are	VBP	O
critical	JJ	O
for	IN	O
the	DT	O
maintenance	NN	O
of	IN	O
adult	NN	O
ovaries	NNS	O




p53	NN	B-Gene
Unexpectedly	RB	O
,	,	O
only	RB	O
mutations	NNS	B-Var
on	IN	I-Var
the	DT	I-Var
Arg248	NNP	I-Var
and	CC	I-Var
Arg282	NNP	I-Var
positions	NNS	O
displayed	VBD	O
significant	JJ	O
association	NN	O
with	IN	O
shorter	JJ	B-NegReg
patient	NN	B-CPA
survival	NN	I-CPA
,	,	O
but	CC	O
such	JJ	O
association	NN	O
was	VBD	O
not	RB	O
evident	JJ	O
for	IN	O
other	JJ	O
hotspot	NN	O
GOF	NNP	O
mutations	NNS	O
.	.	O
Gene	NNP	O
set	VBD	O
enrichment	JJ	O
analysis	NN	O
on	IN	O
these	DT	O
mutations	NNS	B-Var
revealed	VBD	O
higher	JJR	B-PosReg
activity	NN	B-MPA
of	IN	O
drug	NN	B-Enzyme
-	:	I-Enzyme
metabolizing	NN	I-Enzyme
enzymes	NNS	I-Enzyme
,	,	O
including	VBG	O
the	DT	O
CYP3A4	NNP	B-Enzyme
cytochrome	NN	I-Enzyme
P450	NNP	I-Enzyme
.	.	O
Ectopic	NNP	B-MPA
expression	NN	I-MPA
of	IN	O
p53	NN	B-Gene
mutant	JJ	B-Var
R282W	NNP	I-Var
in	IN	O
H1299	NNP	O
and	CC	O
SaOS2	NNP	O
cells	NNS	O
significantly	RB	O
upregulated	JJ	B-PosReg
CYP3A4	NNP	B-MPA
mRNA	NN	I-MPA
and	CC	I-MPA
protein	NN	I-MPA
levels	NNS	I-MPA
,	,	O
and	CC	O
cancer	NN	O
cell	NN	O
lines	NNS	O
bearing	VBG	O
mortality	NN	O
-	:	O
associated	VBN	O
p53	NN	B-Gene
mutations	NNS	B-Var
display	VBP	O
higher	JJR	B-PosReg
CYP3A4	NNP	B-Enzyme
expression	NN	B-MPA
and	CC	O
resistance	NN	B-CPA
to	TO	I-CPA
several	JJ	I-CPA
CYP3A4	NNP	I-CPA
-	:	I-CPA
metabolized	VBN	I-CPA
chemotherapeutic	JJ	I-CPA
drugs	NNS	I-CPA
.	.	O
Our	PRP$	O
results	NNS	O
suggest	VBP	O
that	IN	O
p53	NN	O
mutations	NNS	O
have	VBP	O
unequal	JJ	O
GOF	NNP	O
activities	NNS	O
in	IN	O
human	JJ	O
cancers	NNS	O
,	,	O
and	CC	O
future	JJ	O
evaluation	NN	O
of	IN	O
p53	NN	O
as	IN	O
a	DT	O
cancer	NN	O
biomarker	NN	O
should	MD	O
consider	VB	O
which	WDT	O
mutation	NN	O
is	VBZ	O
present	JJ	O
in	IN	O
the	DT	O
tumor	NN	O
,	,	O
rather	RB	O
than	IN	O
having	VBG	O
comparison	NN	O
between	IN	O
wild	JJ	O
-	:	O
type	NN	O
and	CC	O
mutant	JJ	O
genotypes	NNS	O



In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
isolated	VBD	O
the	DT	O
ZEP	NNP	O
gene	NN	O
from	IN	O
both	DT	O
wild	JJ	O
-	:	O
type	NN	O
D.	NNP	O
tertiolecta	NN	O
and	CC	O
the	DT	O
mutant	NN	O
.	.	O

We	PRP	O
found	VBD	O
that	IN	O
the	DT	O
zea1	NN	O
mutant	NN	O
has	VBZ	O
a	DT	O
point	NN	B-Var
mutation	NN	I-Var
of	IN	O
the	DT	O
1337	CD	O
th	NN	O
nucleotide	NN	O
of	IN	O
the	DT	O
ZEP	NNP	B-Gene
sequence	NN	O
(	(	O
a	DT	O
change	NN	O
from	IN	O
guanine	NN	O
to	TO	O
adenine	VB	O
)	)	O
,	,	O
resulting	VBG	O
in	IN	O
a	DT	O
change	NN	B-Reg
of	IN	O
glycine	NN	B-MPA
to	TO	I-MPA
aspartate	VB	I-MPA
in	IN	I-MPA
a	DT	I-MPA
highly	RB	I-MPA
conserved	JJ	I-MPA
region	NN	I-MPA
in	IN	I-MPA
the	DT	I-MPA
catalytic	JJ	I-MPA
domain	NN	I-MPA
.	.	O
Similar	JJ	O
expression	NN	O
levels	NNS	O
of	IN	O
ZEP	NNP	O
mRNA	NN	O
and	CC	O
protein	NN	O
in	IN	O
both	DT	O
wild	JJ	O
-	:	O
type	NN	O
and	CC	O
zea1	NN	O
were	VBD	O
confirmed	VBN	O
by	IN	O
using	VBG	O
qRT	JJ	O
-	:	O
PCR	NN	O
and	CC	O
western	JJ	O
blot	NN	O
analysis	NN	O
,	,	O
respectively	RB	O
.	.	O

Additionally	RB	O
,	,	O
the	DT	O
enzyme	NN	O
activity	NN	O
analysis	NN	O
of	IN	O
ZEPs	NNP	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
cofactors	NNS	O
showed	VBD	O
that	IN	O
the	DT	O
inactivation	NN	O
of	IN	O
ZEP	NNP	O
in	IN	O
zea1	NN	O
was	VBD	O
not	RB	O
caused	VBN	O
by	IN	O
deficiency	NN	O
in	IN	O
the	DT	O
levels	NNS	O
of	IN	O
cofactors	NNS	O
.	.	O

From	IN	O
the	DT	O
predicted	VBN	O
three	CD	O
-	:	O
dimensional	JJ	O
ZEP	NNP	O
structure	NN	O
of	IN	O
zea1	NN	O
,	,	O
we	PRP	O
observed	VBD	O
a	DT	O
conformational	JJ	O
change	NN	O
on	IN	O
the	DT	O
substrate	NN	O
-	:	O
binding	NN	O
site	NN	O
in	IN	O
the	DT	O
ZEP	NNP	O
.	.	O

A	DT	O
comparative	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
ZEP	NNP	B-Enzyme
structures	NNS	O
suggested	VBD	O
that	IN	O
the	DT	O
conformational	JJ	B-MPA
change	NN	I-MPA
induced	VBN	O
by	IN	O
a	DT	O
single	JJ	B-Var
amino	NN	I-Var
acid	JJ	I-Var
mutation	NN	I-Var
might	MD	O
impact	VB	B-NegReg
the	DT	O
interaction	NN	B-Interaction
between	IN	I-Interaction
the	DT	I-Interaction
substrate	NN	I-Interaction
and	CC	I-Interaction
substrate	VB	I-Interaction
-	:	I-Interaction
binding	NN	I-Interaction
site	NN	I-Interaction
,	,	O
resulting	VBG	O
in	IN	O
loss	NN	B-NegReg
of	IN	O
zeaxanthin	JJ	B-Enzyme
epoxidase	NN	I-Enzyme
function	NN	B-MPA


Oesophageal	NNP	B-Disease
squamous	JJ	I-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
We	PRP	O
analysed	VBD	O
1048	CD	O
oesophageal	IN	O
tumour	JJ	O
-	:	O
germline	NN	O
pairs	NN	O
from	IN	O
both	DT	O
subtypes	NNS	O
,	,	O
to	TO	O
characterise	VB	O
their	PRP$	O
genomic	JJ	O
features	NNS	O
,	,	O
and	CC	O
biological	JJ	O
and	CC	O
clinical	JJ	O
significance	NN	O
.	.	O

DESIGN	NN	O
:	:	O
Previously	RB	O
exome	SYM	O
-	:	O
sequenced	VBN	O
samples	NNS	O
were	VBD	O
re	JJ	O
-	:	O
analysed	VBN	O
to	TO	O
identify	VB	O
significantly	RB	O
mutated	VBN	O
genes	NNS	O
(	(	O
SMGs	NNP	O
)	)	O
and	CC	O
mutational	JJ	O
signatures	NNS	O
.	.	O

The	DT	O
biological	JJ	O
functions	NNS	O
of	IN	O
novel	JJ	O
SMGs	NNP	O
were	VBD	O
investigated	VBN	O
using	VBG	O
cell	NN	O
line	NN	O
and	CC	O
xenograft	NN	O
models	NNS	O
.	.	O

We	PRP	O
further	RB	O
performed	VBD	O
whole	JJ	O
-	:	O
genome	NN	O
bisulfite	NN	O
sequencing	NN	O
and	CC	O
chromatin	NN	O
immunoprecipitation	NN	O
(	(	O
ChIP	NNP	O
)-	JJ	O
seq	NN	O
to	TO	O
characterise	VB	O
epigenetic	JJ	O
alterations	NNS	O
.	.	O

RESULTS	NN	O
:	:	O
OSCC	NNP	O
and	CC	O
OAC	NNP	O
displayed	VBD	O
nearly	RB	O
mutually	RB	O
exclusive	JJ	O
sets	NNS	O
of	IN	O
driver	NN	O
genes	NNS	O
,	,	O
indicating	VBG	O
that	IN	O
they	PRP	O
follow	VBP	O
independent	JJ	O
developmental	JJ	O
paths	NNS	O
.	.	O

The	DT	O
combined	JJ	O
sample	NN	O
size	NN	O
allowed	VBD	O
the	DT	O
statistical	JJ	O
identification	NN	O
of	IN	O
a	DT	O
number	NN	O
of	IN	O
novel	JJ	O
subtype	NN	O
-	:	O
specific	JJ	O
SMGs	NNP	O
,	,	O
mutational	JJ	O
signatures	NNS	O
and	CC	O
prognostic	JJ	O
biomarkers	NNS	O
.	.	O

Particularly	RB	O
,	,	O
we	PRP	O
identified	VBD	O
a	DT	O
novel	JJ	O
mutational	JJ	O
signature	NN	O
similar	JJ	O
to	TO	O
Catalogue	NNP	O
Of	IN	O
Somatic	NNP	O
Mutations	NNP	O
In	IN	O
Cancer	NNP	O
(	(	O
COSMIC	NNP	O
)	)	O
signature	NN	O
16	CD	O
,	,	O
which	WDT	O
has	VBZ	O
prognostic	JJ	O
value	NN	O
in	IN	O
OSCC	NNP	O
.	.	O

Two	CD	O
newly	RB	O
discovered	VBN	O
SMGs	NNP	O
,	,	O
CUL3	NNP	O
and	CC	O
ZFP36L2	NNP	O
,	,	O
were	VBD	O
validated	VBN	O
as	IN	O
important	JJ	O
tumour	NN	O
-	:	O
suppressors	NNS	O
specific	VBP	O
to	TO	O
the	DT	O
OSCC	NNP	O
subtype	NN	O
.	.	O

We	PRP	O
further	RB	O
identified	VBD	O
their	PRP$	O
additional	JJ	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
mechanisms	NNS	O
.	.	O

CUL3	NNP	B-Gene
was	VBD	O
homozygously	RB	O
deleted	VBN	B-Var
specifically	RB	O
in	IN	B-Reg
OSCC	NNP	B-Disease
and	CC	O
other	JJ	O
squamous	JJ	B-Disease
cell	NN	I-Disease
cancers	NNS	I-Disease
(	(	O
SCCs	NNP	O
)	)	O
.	.	O
Notably	RB	O
,	,	O
ZFP36L2	NNP	O
is	VBZ	O
associated	VBN	O
with	IN	O
super	JJ	O
-	:	O
enhancer	NN	O
in	IN	O
healthy	JJ	O
oesophageal	NN	O
mucosa	NN	O
;	:	O
DNA	NNP	O
hypermethylation	NN	O
in	IN	O
its	PRP$	O
super	JJ	O
-	:	O
enhancer	NN	O
reduced	VBD	O
active	JJ	O
histone	NN	O
markers	NNS	O
in	IN	O
squamous	JJ	O
cancer	NN	O
cells	NNS	O
,	,	O
suggesting	VBG	O
an	DT	O
epigenetic	JJ	O
inactivation	NN	O
of	IN	O
a	DT	O
super	JJ	O
-	:	O
enhancer	NN	O
-	:	O
associated	VBN	O
SCC	NNP	O
suppressor	NN	O
.	.	O

CONCLUSIONS	NN	O
:	:	O
These	DT	O
data	NNS	O
comprehensively	RB	O
contrast	JJ	O
differences	NNS	O
between	IN	O
OSCC	NNP	O
and	CC	O
OAC	NNP	O
at	IN	O
both	DT	O
genomic	JJ	O
and	CC	O
epigenomic	JJ	O
levels	NNS	O
,	,	O
and	CC	O
reveal	VB	O
novel	JJ	O
molecular	JJ	O
features	NNS	O
for	IN	O
further	JJ	O
delineating	VBG	O
the	DT	O
pathophysiological	JJ	O
mechanisms	NN	O
and	CC	O
treatment	NN	O
strategies	NNS	O
for	IN	O
these	DT	O
cancers	NNS	O



A	DT	O
single	JJ	O
strain	NN	O
of	IN	O
L.	NNP	O
pneumophila	NNP	O
encodes	VBZ	O
a	DT	O
repertoire	NN	O
of	IN	O
over	IN	O
300	CD	O
different	JJ	O
effector	NN	O
proteins	NNS	O
that	WDT	O
are	VBP	O
delivered	VBN	O
into	IN	O
host	NN	O
cells	NNS	O
by	IN	O
the	DT	O
Dot	NNP	O
Icm	NNP	O
type	NN	O
IV	NNP	O
secretion	NN	O
system	NN	O
during	IN	O
infection	NN	O
.	.	O

The	DT	O
large	JJ	O
number	NN	O
of	IN	O
L.	NNP	O
pneumophila	NN	O
effectors	NNS	O
has	VBZ	O
been	VBN	O
a	DT	O
limiting	VBG	O
factor	NN	O
in	IN	O
assessing	VBG	O
the	DT	O
importance	NN	O
of	IN	O
individual	JJ	O
effectors	NNS	O
for	IN	O
virulence	NN	O
.	.	O

Here	RB	O
,	,	O
a	DT	O
transposon	NN	O
insertion	NN	O
sequencing	VBG	O
technology	NN	O
called	VBN	O
INSeq	NNP	O
was	VBD	O
used	VBN	O
to	TO	O
analyze	VB	O
replication	NN	O
of	IN	O
a	DT	O
pool	NN	O
of	IN	O
effector	NN	O
mutants	NNS	O
in	IN	O
parallel	JJ	O
both	DT	O
in	IN	O
a	DT	O
mouse	NN	O
model	NN	O
of	IN	O
infection	NN	O
and	CC	O
in	IN	O
cultured	JJ	O
host	NN	O
cells	NNS	O
.	.	O

Loss	NNP	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
in	IN	O
genes	NNS	O
encoding	VBG	O
effector	NN	O
proteins	NNS	O
resulted	VBD	O
in	IN	O
host	NN	B-MPA
-	:	I-MPA
specific	NN	I-MPA
or	CC	O
broad	JJ	B-MPA
virulence	NN	I-MPA
phenotypes	NNS	I-MPA
.	.	O
Screen	JJ	O
results	NNS	O
were	VBD	O
validated	VBN	O
for	IN	O
several	JJ	O
effector	NN	O
mutants	NNS	O
displaying	VBG	O
different	JJ	O
virulence	NN	O
phenotypes	NNS	O
using	VBG	O
genetic	JJ	O
complementation	NN	O
studies	NNS	O
and	CC	O
infection	NN	O
assays	NNS	O
.	.	O

Specifically	RB	O
,	,	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
in	IN	O
the	DT	O
gene	NN	O
encoding	VBG	O
LegC4	NNP	B-Gene
resulted	VBD	O
in	IN	O
enhanced	JJ	B-PosReg
L.	NNP	B-CPA
pneumophila	NN	I-CPA
in	IN	O
the	DT	O
lungs	NNS	O
of	IN	O
infected	JJ	O
mice	NNS	O
but	CC	O
not	RB	O
within	IN	O
cultured	VBN	O
host	NN	O
cells	NNS	O
,	,	O
which	WDT	O
indicates	VBZ	O
LegC4	NNP	B-Var
augments	NNS	B-PosReg
bacterial	JJ	B-CPA
clearance	NN	I-CPA
by	IN	O
the	DT	O
host	NN	O
immune	NN	O
system	NN	O
.	.	O
The	DT	O
effector	NN	O
proteins	VBZ	O
RavY	NNP	O
and	CC	O
Lpg2505	NNP	O
were	VBD	O
important	JJ	O
for	IN	O
efficient	JJ	O
replication	NN	O
within	IN	O
both	DT	O
mammalian	JJ	O
and	CC	O
protozoan	JJ	O
hosts	NNS	O
.	.	O

Further	JJ	O
analysis	NN	O
of	IN	O
Lpg2505	NNP	O
revealed	VBD	O
that	IN	O
this	DT	O
protein	NN	O
functions	VBZ	O
as	IN	O
a	DT	O
metaeffector	NN	O
that	WDT	O
counteracts	VBZ	O
host	NN	O
cytotoxicity	NN	O
displayed	VBN	O
by	IN	O
the	DT	O
effector	NN	O
protein	NN	O
SidI	NNP	O
.	.	O

Thus	RB	O
,	,	O
this	DT	O
study	NN	O
identified	VBD	O
a	DT	O
large	JJ	O
cohort	NN	O
of	IN	O
effectors	NNS	O
that	WDT	O
contribute	VBP	O
to	TO	O
L.	NNP	O
pneumophila	NN	O
virulence	NN	O
positively	RB	O
or	CC	O
negatively	RB	O
and	CC	O
has	VBZ	O
demonstrated	VBN	O
regulation	NN	O
of	IN	O
effector	NN	O
protein	NN	O
activities	NNS	O
by	IN	O
cognate	NN	O
metaeffectors	NNS	O
as	IN	O
being	VBG	O
critical	JJ	O
for	IN	O
host	NN	O
pathogenesis	NN	O

mutation	NN	B-Var
confers	NNS	B-PosReg
gain	SYM	I-Gene
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
tumor	NN	B-CPA
cell	NN	I-CPA
survival	NN	I-CPA
TNFAIP8	NNP	B-Gene

Mutations	NNS	B-Var
p53	NN	B-Gene
result	NN	B-Reg
in	IN	I-Reg
single	JJ	B-Var
amino	NN	I-Var
acid	NN	I-Var
substitutions	NNS	I-Var
(	(	I-Var
missense	JJ	I-Var
mutations	NNS	I-Var
)	)	I-Var
in	IN	I-Var
the	DT	I-Var
DNA	NN	I-Var
binding	VBG	I-Var
domain	NN	I-Var
blocking	VBG	B-NegReg
tumor	NN	B-CPA
suppressive	JJ	I-CPA
functions	NNS	I-CPA
missense	NN	B-Var
mutations	NNS	I-Var
p53	NN	B-Gene
gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
activities	NNS	B-CPA
to	TO	I-CPA
tumor	VB	I-CPA
cells	NNS	I-CPA

We	PRP	O
report	VBP	O
here	RB	O
that	IN	O
mutations	NNS	B-Var
at	IN	I-Var
K120	NNP	I-Var
,	,	O
a	DT	O
non	JJ	O
-	:	O
hotspot	NN	O
DNA	NNP	O
contact	NN	O
residue	NN	O
,	,	O
confer	VBP	B-PosReg
p53	NN	B-Gene
with	IN	O
the	DT	O
previously	RB	O
unrecognized	JJ	O
ability	NN	B-MPA
to	TO	O
bind	VB	B-Interaction
and	CC	O
activate	VB	B-PosReg
the	DT	O
transcription	NN	B-MPA
of	IN	O
the	DT	O
pro	JJ	O
-	:	O
survival	NN	O
TNFAIP8	NNP	B-Gene
gene	NN	O
.	.	O
Mutant	NNP	O
K120	NNP	O
p53	NN	O
binds	VBZ	O
the	DT	O
TNFAIP8	NNP	O
locus	NN	O
at	IN	O
a	DT	O
cryptic	JJ	O
p53	NN	O
response	NN	O
element	NN	O
that	WDT	O
is	VBZ	O
not	RB	O
occupied	VBN	O
by	IN	O
wild	JJ	O
-	:	O
type	NN	O
p53	NN	O
.	.	O

Furthermore	RB	O
,	,	O
induction	NN	O
of	IN	O
TNFAIP8	NNP	O
is	VBZ	O
critical	JJ	O
for	IN	O
the	DT	O
evasion	NN	O
of	IN	O
apoptosis	NN	O
by	IN	O
tumor	NN	O
cells	NNS	O
expressing	VBG	O
the	DT	O
K120R	NNP	O
variant	NN	O
of	IN	O
p53	NN	O
.	.	O

These	DT	O
findings	NNS	O
identify	VBP	O
induction	NN	O
of	IN	O
pro	JJ	O
-	:	O
survival	JJ	O
targets	NNS	O
as	IN	O
a	DT	O
mechanism	NN	O
of	IN	O
gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
activity	NN	B-MPA
for	IN	O
mutant	JJ	B-Var
p53	NN	B-Gene
and	CC	O
will	MD	O
likely	RB	O
broaden	VB	O
our	PRP$	O
understanding	NN	O
of	IN	O
this	DT	O
phenomenon	NN	O
beyond	IN	O
the	DT	O
limited	JJ	O
number	NN	O
of	IN	O
GOF	NNP	O
activities	NNS	O
currently	RB	O
reported	VBN	O
for	IN	O
hotspot	NN	O
mutants	NNS	O


Chloroplast	NNP	O
genes	NNS	O
are	VBP	O
transcribed	VBN	O
by	IN	O
the	DT	O
plastid	NN	O
-	:	O
encoded	VBD	O
RNA	NNP	O
polymerase	NN	O
(	(	O
PEP	NNP	O
)	)	O
or	CC	O
nucleus	JJ	O
-	:	O
encoded	VBD	O
RNA	NNP	O
polymerase	NN	O
.	.	O

FRUCTOKINASE	NNP	O
-	:	O
LIKE	JJ	O
PROTEINS	NNP	O
(	(	O
FLNs	NNP	O
)	)	O
are	VBP	O
phosphofructokinase	JJ	O
-	:	O
B	NNP	O
(	(	O
PfkB	NNP	O
)-	NNP	O
type	NN	O
carbohydrate	NN	O
kinases	NNS	O
that	WDT	O
act	VBP	O
as	IN	O
part	NN	O
of	IN	O
the	DT	O
PEP	NNP	O
complex	NN	O
;	:	O
however	RB	O
,	,	O
the	DT	O
molecular	JJ	O
mechanisms	NNS	O
underlying	VBG	O
FLN	NNP	O
activity	NN	O
in	IN	O
rice	NN	O
remain	VBP	O
elusive	JJ	O
.	.	O

Previously	RB	O
,	,	O
we	PRP	O
identified	VBD	O
and	CC	O
characterized	VBD	O
a	DT	O
heat	NN	O
-	:	O
stress	NN	O
sensitive	JJ	O
albino	NN	O
(	(	O
hsa1	NN	O
)	)	O
mutant	NN	O
in	IN	O
rice	NN	O
.	.	O

Map	NNP	O
-	:	O
based	VBN	O
cloning	NN	O
revealed	VBD	O
that	IN	O
HSA1	NNP	O
encodes	VBZ	O
a	DT	O
putative	JJ	O
OsFLN2	NNP	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
further	RB	O
demonstrated	VBD	O
that	IN	O
knockdown	NN	O
or	CC	O
knockout	NN	O
of	IN	O
the	DT	O
OsFLN1	NNP	O
,	,	O
a	DT	O
close	JJ	O
homolog	NN	O
of	IN	O
HSA1	NNP	O
OsFLN2	NNP	O
,	,	O
considerably	RB	O
inhibits	VBZ	O
chloroplast	JJ	O
biogenesis	NN	O
and	CC	O
the	DT	O
fln1	NN	O
knockout	NN	O
mutants	NNS	O
,	,	O
created	VBN	O
by	IN	O
clustered	VBN	O
regularly	RB	O
interspaced	VBN	O
short	JJ	O
palindromic	JJ	O
repeats	NNS	O
(	(	O
CRISPR	NNP	O
)	)	O
and	CC	O
CRISPR	NNP	O
-	:	O
associate	NN	O
protein	NN	O
9	CD	O
,	,	O
exhibit	NN	O
severe	JJ	O
albino	NN	O
phenotype	NN	O
and	CC	O
seedling	VBG	O
lethality	NN	O
.	.	O

Moreover	RB	O
,	,	O
OsFLN1	NNP	O
localizes	VBZ	O
to	TO	O
the	DT	O
chloroplast	NN	O
.	.	O

Yeast	RB	O
two	CD	O
-	:	O
hybrid	NN	O
,	,	O
pull	VB	O
-	:	O
down	RB	O
and	CC	O
bimolecular	JJ	O
fluorescence	NN	O
complementation	NN	O
experiments	NNS	O
revealed	VBD	O
that	IN	O
OsFLN1	NNP	O
and	CC	O
HSA1	NNP	O
OsFLN2	NNP	O
interact	NN	O
with	IN	O
THIOREDOXINZ	NNP	O
(	(	O
OsTRXz	NNP	O
)	)	O
to	TO	O
regulate	VB	O
chloroplast	NN	O
development	NN	O
.	.	O

In	IN	O
agreement	NN	O
with	IN	O
this	DT	O
,	,	O
knockout	NN	O
of	IN	O
OsTRXz	NNP	O
resulted	VBD	O
in	IN	O
a	DT	O
similar	JJ	O
albino	NN	O
and	CC	O
seedling	VBG	O
lethality	NN	O
phenotype	NN	O
to	TO	O
that	DT	O
of	IN	O
the	DT	O
fln1	NN	O
mutants	NNS	O
.	.	O

Quantitative	JJ	O
reverse	NN	O
transcription	NN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
and	CC	O
immunoblot	NN	O
analysis	NN	O
revealed	VBD	O
that	IN	O
the	DT	O
transcription	NN	B-MPA
and	CC	O
translation	NN	B-MPA
of	IN	O
PEP	NNP	B-Gene
-	:	I-Gene
dependent	NN	I-Gene
genes	NNS	I-Gene
were	VBD	O
strongly	RB	O
inhibited	VBN	B-NegReg
in	IN	O
fln1	NN	B-Gene
and	CC	O
trxz	NN	O
mutants	NNS	B-Var
,	,	O
indicating	VBG	O
that	IN	O
loss	NN	O
of	IN	O
OsFLN1	NNP	O
,	,	O
HSA1	NNP	O
OsFLN2	NNP	O
,	,	O
or	CC	O
OsTRXz	NNP	O
function	NN	O
perturbs	VBZ	B-NegReg
the	DT	O
stability	NN	B-CPA
of	IN	I-CPA
the	DT	I-CPA
transcriptionally	RB	I-CPA
active	JJ	I-CPA
chromosome	NN	I-CPA
complex	NN	I-CPA
and	CC	O
PEP	NNP	B-Enzyme
activity	NN	B-MPA
.	.	O
These	DT	O
results	NNS	O
show	VBP	O
that	IN	O
OsFLN1	NNP	O
and	CC	O
HSA1	NNP	O
OsFLN2	NNP	O
contribute	NN	O
to	TO	O
chloroplast	VB	O
biogenesis	NN	O
and	CC	O
plant	NN	O
growth	NN	O



Glutathione	NNP	O
S	NNP	O
-	:	O
transferases	NNS	O
(	(	O
GSTs	NNP	O
)	)	O
protect	NN	O
against	IN	O
oxidative	JJ	O
stress	NN	O
,	,	O
inflammation	NN	O
,	,	O
and	CC	O
genotoxicity	NN	O
.	.	O

Polymorphisms	NNS	B-Var
in	IN	O
the	DT	O
GST	NNP	B-Gene
genes	NNS	O
may	MD	O
lead	VB	B-Reg
to	TO	I-Reg
an	DT	O
imbalance	NN	B-MPA
in	IN	I-MPA
pro	JJ	I-MPA
-	:	I-MPA
and	CC	I-MPA
antioxidant	JJ	I-MPA
systems	NNS	I-MPA
resulting	VBG	O
in	IN	O
the	DT	O
increased	JJ	B-PosReg
production	NN	B-MPA
of	IN	I-MPA
reactive	JJ	I-MPA
oxygen	NN	I-MPA
species	NNS	I-MPA
that	WDT	O
could	MD	O
influence	VB	B-Reg
the	DT	O
pathogenesis	NN	O
of	IN	O
psoriasis	NN	B-Disease
.	.	O
AIM	NN	O
:	:	O
The	DT	O
aim	NN	O
of	IN	O
this	DT	O
study	NN	O
was	VBD	O
to	TO	O
investigate	VB	O
the	DT	O
association	NN	O
between	IN	O
GSTs	NNP	O
(	(	O
GSTM1	NNP	O
and	CC	O
GSTT1	NNP	O
)	)	O
gene	NN	O
polymorphism	NN	O
in	IN	O
patients	NNS	O
with	IN	O
chronic	JJ	O
plaque	NN	O
psoriasis	NN	O
as	IN	O
a	DT	O
factor	NN	O
in	IN	O
the	DT	O
susceptibility	NN	O
and	CC	O
development	NN	O
of	IN	O
psoriasis	NN	O
.	.	O

MATERIALS	NNP	O
AND	CC	O
METHODS	NNP	O
:	:	O
We	PRP	O
assessed	VBD	O
128	CD	O
patients	NNS	O
with	IN	O
psoriasis	NN	O
and	CC	O
250	CD	O
age	NN	O
-	:	O
and	CC	O
sex	NN	O
-	:	O
matched	VBN	O
healthy	JJ	O
controls	NNS	O
.	.	O

Genomic	NNP	O
DNA	NNP	O
was	VBD	O
extracted	VBN	O
from	IN	O
peripheral	JJ	O
blood	NN	O
by	IN	O
the	DT	O
phenol	NN	O
chloroform	NN	O
method	NN	O
.	.	O

The	DT	O
null	JJ	O
GSTT1	NNP	O
and	CC	O
GSTM1	NNP	O
genotypes	NNS	O
were	VBD	O
identified	VBN	O
by	IN	O
multiplex	JJ	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	(	O
PCR	NNP	O
)	)	O
method	NN	O
.	.	O

RESULTS	NN	O
:	:	O
The	DT	O
null	JJ	O
genotype	NN	O
of	IN	O
GSTM1	NNP	O
and	CC	O
GSTT1	NNP	O
was	VBD	O
seen	VBN	O
in	IN	O
45.3%	CD	O
and	CC	O
40.6%	CD	O
in	IN	O
psoriasis	NN	O
patients	NNS	O
whereas	VBP	O
in	IN	O
the	DT	O
controls	NNS	O
it	PRP	O
was	VBD	O
34.4%	CD	O
and	CC	O
20.0%	CD	O
,	,	O
respectively	RB	O
.	.	O

A	DT	O
significant	JJ	O
association	NN	O
was	VBD	O
seen	VBN	O
between	IN	O
the	DT	O
null	JJ	O
alleles	NNS	O
of	IN	O
the	DT	O
GSTT1	NNP	O
(	(	O
OR	NNP	O
2.74	CD	O
)	)	O
and	CC	O
GSTM1	NNP	O
(	(	O
OR	NNP	O
1.58	CD	O
)	)	O
alone	RB	O
or	CC	O
in	IN	O
combination	NN	O
with	IN	O
tobacco	NN	O
use	NN	O
(	(	O
P	NNP	O
0.001	CD	O
)	)	O
and	CC	O
psoriasis	NN	O
risk	NN	O
.	.	O

The	DT	O
presence	NN	B-Var
of	IN	O
both	DT	O
null	JJ	O
genotypes	NNS	O
of	IN	O
GSTM1	NNP	B-Gene
and	CC	O
GSTT1	NNP	B-Gene
further	RB	O
increased	VBD	B-PosReg
the	DT	O
risk	NN	O
of	IN	O
psoriasis	NN	B-Disease
(	(	O
OR	NNP	O
3.52	CD	O
)	)	O
when	WRB	O
compared	VBN	O
with	IN	O
the	DT	O
positive	JJ	O
genotypes	NNS	O
of	IN	O
GSTM1	NNP	O
and	CC	O
GSTT1	NNP	O
.	.	O
LIMITATIONS	NNS	O
:	:	O
A	DT	O
major	JJ	O
limitation	NN	O
of	IN	O
this	DT	O
study	NN	O
was	VBD	O
the	DT	O
small	JJ	O
sample	NN	O
size	NN	O
.	.	O

A	DT	O
large	JJ	O
epidemiological	JJ	O
study	NN	O
is	VBZ	O
necessary	JJ	O
to	TO	O
confirm	VB	O
these	DT	O
findings	NNS	O
.	.	O

CONCLUSIONS	NN	O
:	:	O
The	DT	O
null	JJ	O
genotype	NN	O
of	IN	O
GSTT1	NNP	O
is	VBZ	O
a	DT	O
strong	JJ	O
predisposing	NN	O
factor	NN	O
for	IN	O
psoriasis	NN	O
in	IN	O
North	NNP	O
India	NNP	O

MAP1B	NNP	I-Var
in	IN	I-Gene
periventricular	JJ	B-Disease
nodular	JJ	I-Disease
heterotopia	NN	I-Disease


We	PRP	O
first	RB	O
performed	VBD	O
a	DT	O
trio	NN	O
-	:	O
based	VBN	O
analysis	NN	O
and	CC	O
identified	VBD	O
219	CD	O
de	FW	O
novo	FW	O
variants	NNS	O
.	.	O

Although	IN	O
no	DT	O
novel	JJ	O
genes	NNS	O
were	VBD	O
implicated	VBN	O
in	IN	O
this	DT	O
initial	JJ	O
analysis	NN	O
,	,	O
PVNH	NNP	O
cases	NNS	O
were	VBD	O
found	VBN	O
overall	RB	O
to	TO	O
have	VB	O
a	DT	O
significant	JJ	O
excess	NN	O
of	IN	O
nonsynonymous	JJ	O
de	FW	O
novo	FW	O
variants	NNS	O
in	IN	O
intolerant	JJ	O
genes	NNS	O
(	(	O
p	JJ	O
3.27	CD	O
x10	SYM	O
-	:	O
7	CD	O
)	)	O
,	,	O
suggesting	VBG	O
a	DT	O
role	NN	O
for	IN	O
rare	JJ	O
new	JJ	O
alleles	NNS	O
in	IN	O
genes	NNS	O
yet	RB	O
to	TO	O
be	VB	O
associated	VBN	O
with	IN	O
the	DT	O
condition	NN	O
.	.	O

Using	VBG	O
a	DT	O
gene	NN	O
-	:	O
level	NN	O
collapsing	VBG	O
analysis	NN	O
comparing	NN	O
cases	NNS	O
and	CC	O
controls	NNS	O
,	,	O
we	PRP	O
identified	VBD	O
a	DT	O
genome	JJ	O
-	:	O
wide	JJ	O
significant	JJ	O
signal	JJ	O
driven	VBN	O
by	IN	O
four	CD	O
ultra	JJ	O
-	:	O
rare	JJ	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
heterozygous	JJ	O
variants	NNS	B-Var
in	IN	O
MAP1B	NNP	B-Gene
,	,	O
including	VBG	O
one	CD	O
de	FW	O
novo	FW	O
variant	NN	O
.	.	O
In	IN	O
at	IN	O
least	JJS	O
one	CD	O
instance	NN	O
,	,	O
the	DT	O
MAP1B	NNP	B-Gene
variant	NN	B-Var
was	VBD	O
inherited	VBN	B-Reg
from	IN	I-Reg
a	DT	O
parent	NN	O
with	IN	O
previously	RB	O
undiagnosed	VBN	O
PVNH	NNP	B-Disease
.	.	O
The	DT	O
PVNH	NNP	O
was	VBD	O
frontally	RB	O
predominant	JJ	O
and	CC	O
associated	VBN	O
with	IN	O
perisylvian	JJ	O
polymicrogyria	NN	O
.	.	O

These	DT	O
results	NNS	O
implicate	VBP	O
MAP1B	NNP	O
in	IN	O
PVNH	NNP	O
.	.	O

More	RBR	O
broadly	RB	O
,	,	O
our	PRP$	O
findings	NNS	O
suggest	VBP	O
that	IN	O
detrimental	JJ	O
mutations	NNS	O
likely	JJ	O
arising	VBG	O
in	IN	O
immediately	RB	O
preceding	VBG	O
generations	NNS	O
with	IN	O
incomplete	JJ	O
penetrance	NN	O
may	MD	O
also	RB	O
be	VB	O
responsible	JJ	O
for	IN	O
some	DT	O
apparently	RB	O
sporadic	JJ	O
diseases	NNS	O

variants	NNS	I-Var
intellectual	JJ	I-Gene
disability	NN	I-Reg
with	IN	I-Disease
microcephaly	NN	B-Disease


In	IN	O
the	DT	O
affected	JJ	O
individuals	NNS	O
of	IN	O
each	DT	O
family	NN	O
,	,	O
homozygosity	NN	O
for	IN	O
likely	JJ	O
pathogenic	JJ	B-CPA
variants	NNS	O
in	IN	O
KIF14	NNP	B-Gene
were	VBD	O
detected	VBN	O
;	:	O
two	CD	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
(	(	O
p	NN	B-Var
.	.	I-Var
Asn83Ilefs	CC	I-Var
3	CD	I-Var
and	CC	O
p	NN	B-Var
.	.	I-Var
Ser1478fs	NNP	I-Var
)	)	O
,	,	O
and	CC	O
two	CD	O
missense	NN	B-Reg
substitutions	NNS	I-Reg
(	(	O
p	NN	B-Var
.	.	I-Var
Ser841Phe	NNP	I-Var
and	CC	O
p	NN	B-Var
.	.	I-Var
Gly459Arg	NNP	I-Var
)	)	I-Var
.	.	O
KIF14	NNP	O
is	VBZ	O
a	DT	O
mitotic	JJ	O
motor	NN	O
protein	NN	O
that	WDT	O
is	VBZ	O
required	VBN	O
for	IN	O
spindle	JJ	O
localization	NN	O
of	IN	O
the	DT	O
mitotic	JJ	O
citron	NN	O
rho	NN	O
-	:	O
interacting	NN	O
kinase	NN	O
,	,	O
CIT	NNP	B-Gene
,	,	O
also	RB	O
mutated	VBN	B-Var
in	IN	B-Reg
microcephaly	NN	B-Disease
.	.	O
Our	PRP$	O
results	NNS	O
demonstrate	VBP	O
the	DT	O
involvement	NN	O
of	IN	O
KIF14	NNP	O
in	IN	O
development	NN	O
and	CC	O
reveal	VB	O
a	DT	O
wide	JJ	O
phenotypic	NN	O
variability	NN	O
ranging	VBG	O
from	IN	O
fetal	JJ	O
lethality	NN	O
to	TO	O
moderate	VB	O
developmental	JJ	O
delay	NN	O
and	CC	O
microcephaly	NN	O

loss	NN	I-Gene
-	:	I-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
variants	NNS	B-Var
Pierre	NNP	B-Disease
Robin	NNP	I-Disease
sequence	NN	I-Disease

Whole	JJ	O
exome	NN	O
sequencing	NN	O
was	VBD	O
performed	VBN	O
for	IN	O
both	DT	O
patients	NNS	O
.	.	O

No	DT	O
single	JJ	O
gene	NN	O
containing	VBG	O
likely	JJ	O
pathogenic	JJ	O
point	NN	O
mutations	NNS	O
in	IN	O
both	DT	O
patients	NNS	O
could	MD	O
be	VB	O
identified	VBN	O
,	,	O
but	CC	O
the	DT	O
finding	NN	O
of	IN	O
an	DT	O
essential	JJ	O
splice	NN	O
site	NN	O
mutation	NN	O
in	IN	O
mediator	NN	O
complex	JJ	O
subunit	NN	O
13	CD	O
like	IN	O
(	(	O
MED13L	NNP	O
)	)	O
in	IN	O
one	CD	O
patient	NN	O
prompted	VBD	O
the	DT	O
investigation	NN	O
of	IN	O
copy	NN	O
number	NN	O
variants	NNS	O
in	IN	O
MED13L	NNP	O
in	IN	O
the	DT	O
other	JJ	O
,	,	O
leading	VBG	O
to	TO	O
the	DT	O
identification	NN	O
of	IN	O
an	DT	O
intragenic	JJ	O
deletion	NN	O
.	.	O

Disruption	NN	B-Var
of	IN	O
MED13L	NNP	B-Gene
,	,	O
encoding	VBG	O
a	DT	O
component	NN	O
of	IN	O
the	DT	O
Mediator	NNP	O
complex	NN	O
,	,	O
is	VBZ	O
increasingly	RB	O
recognized	VBN	O
as	IN	O
the	DT	O
cause	NN	B-Reg
of	IN	O
an	DT	O
intellectual	JJ	B-Disease
disability	NN	I-Disease
syndrome	NN	I-Disease
with	IN	O
associated	JJ	O
facial	JJ	B-Disease
dysmorphism	NN	I-Disease
.	.	O
Our	PRP$	O
findings	NNS	O
suggest	VBP	O
that	IN	O
MED13L	NNP	O
-	:	O
related	JJ	O
disorders	NNS	O
are	VBP	O
a	DT	O
possible	JJ	O
differential	JJ	O
diagnosis	NN	O
for	IN	O
syndromic	JJ	O
PRS	NNP	O


Brain	NNP	O
-	:	O
derived	VBD	O
neurotrophic	JJ	O
factor	NN	O
(	(	O
BDNF	NNP	O
)	)	O
is	VBZ	O
a	DT	O
member	NN	O
of	IN	O
the	DT	O
neurotrophin	JJ	O
growth	NN	O
factors	NNS	O
family	NN	O
.	.	O

Recent	JJ	O
studies	NNS	O
indicated	VBD	O
that	IN	O
the	DT	O
level	NN	O
of	IN	O
BDNF	NNP	O
in	IN	O
follicular	JJ	O
fluid	NN	O
is	VBZ	O
a	DT	O
marker	NN	O
for	IN	O
oocyte	JJ	O
quality	NN	O
and	CC	O
infertility	NN	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
intend	VBP	O
to	TO	O
further	RBR	O
investigate	VB	O
the	DT	O
function	NN	O
of	IN	O
BDNF	NNP	O
and	CC	O
its	PRP$	O
signaling	VBG	O
pathway	NN	O
in	IN	O
the	DT	O
regulation	NN	O
of	IN	O
endometrial	JJ	O
cells	NNS	O
proliferation	NN	O
.	.	O

We	PRP	O
found	VBD	O
that	IN	O
BDNF	NNP	O
is	VBZ	O
a	DT	O
critical	JJ	O
growth	NN	O
factor	NN	O
in	IN	O
endometrial	JJ	O
cells	NNS	O
.	.	O

Activation	NN	O
of	IN	O
signal	JJ	O
transducer	NN	O
and	CC	O
activator	NN	O
of	IN	O
transcription	NN	O
3	CD	O
signaling	VBG	O
pathway	NN	O
is	VBZ	O
required	VBN	O
for	IN	O
BNDF	NNP	O
-	:	O
regulated	VBD	O
endometrial	JJ	O
cell	NN	O
proliferation	NN	O
.	.	O

Furthermore	RB	O
,	,	O
BDNF	NNP	O
is	VBZ	O
an	DT	O
effector	NN	O
of	IN	O
estrogen	NN	O
in	IN	O
endometrial	JJ	O
cells	NNS	O
.	.	O

Finally	RB	O
,	,	O
we	PRP	O
investigated	VBD	O
the	DT	O
different	JJ	O
role	NN	O
of	IN	O
Val66Met	NNP	O
,	,	O
a	DT	O
single	JJ	O
-	:	O
nucleotide	JJ	O
polymorphism	NN	O
of	IN	O
the	DT	O
BDNF	NNP	O
gene	NN	O
,	,	O
in	IN	O
regulating	VBG	O
endometrial	JJ	O
cells	NNS	O
proliferation	NN	O
.	.	O

The	DT	O
results	NNS	O
showed	VBD	O
that	IN	O
BDNF	NNP	B-Gene
(	(	O
V66M	NNP	O
)	)	O
polymorphism	NN	B-Var
is	VBZ	O
a	DT	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
polymorphism	NN	B-Var
in	IN	O
the	DT	O
regulation	NN	B-MPA
of	IN	I-MPA
endometrial	JJ	I-MPA
cells	NNS	I-MPA
growth	NN	I-MPA
.	.	O
Given	VBN	O
the	DT	O
correlation	NN	O
between	IN	O
endometriosis	NN	O
and	CC	O
infertility	NN	O
,	,	O
it	PRP	O
is	VBZ	O
important	JJ	O
to	TO	O
understand	VB	O
the	DT	O
role	NN	O
of	IN	O
BDNF	NNP	O
in	IN	O
regulating	VBG	O
endometrial	JJ	O
cells	NNS	O
proliferation	NN	O
and	CC	O
to	TO	O
develop	VB	O
new	JJ	O
therapeutic	JJ	O
strategies	NNS	O
for	IN	O
the	DT	O
treatment	NN	O
of	IN	O
endometriosis	NN	O
-	:	O
related	JJ	O
infertility	NN	O

apolipoprotein	NN	B-Protein
C	NNP	I-Protein
-	:	I-Protein
III	NNP	I-Protein
)	)	I-Var
human	JJ	B-Disease
hypertriglyceridemia	NN	I-Disease
gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg



To	TO	O
test	VB	O
this	DT	O
hypothesis	NN	O
,	,	O
we	PRP	O
expressed	VBD	O
C3QK	NNP	O
in	IN	O
McA	NNP	O
-	:	O
RH7777	NNP	O
cells	NNS	O
and	CC	O
apoc3	SYM	O
-	:	O
null	JJ	O
mice	NN	O
to	TO	O
contrast	VB	O
its	PRP$	O
effect	NN	O
with	IN	O
WT	NNP	O
apoC	SYM	O
-	:	O
III	NNP	O
(	(	O
C3WT	NNP	O
)	)	O
.	.	O

In	IN	O
both	DT	O
model	FW	O
systems	NNS	O
,	,	O
C3QK	NNP	O
expression	NN	O
increased	VBD	O
the	DT	O
secretion	NN	O
of	IN	O
VLDL1	NNP	O
-	:	O
TAG	NN	O
(	(	O
by	IN	O
230%	CD	O
)	)	O
under	IN	O
lipid	JJ	O
-	:	O
rich	JJ	O
conditions	NNS	O
.	.	O

Metabolic	NNP	O
labeling	VBG	O
experiments	NNS	O
with	IN	O
C3QK	NNP	O
cells	NNS	O
showed	VBD	O
an	DT	O
increase	NN	O
in	IN	O
de	FW	B-MPA
novo	FW	I-MPA
lipogenesis	NN	I-MPA
(	(	O
DNL	NNP	O
)	)	O
.	.	O
Fasting	VBG	O
plasma	JJ	O
concentration	NN	O
of	IN	O
TAG	NNP	O
,	,	O
cholesterol	NN	O
,	,	O
cholesteryl	NN	O
ester	NN	O
,	,	O
and	CC	O
FA	NNP	O
were	VBD	O
increased	VBN	O
in	IN	O
C3QK	NNP	O
mice	NN	O
as	IN	O
compared	VBN	O
with	IN	O
C3WT	NNP	O
mice	NN	O
.	.	O

Liver	NNP	O
of	IN	O
C3QK	NNP	B-Var
mice	NNP	O
also	RB	O
displayed	VBD	O
an	DT	O
increase	NN	B-PosReg
in	IN	O
DNL	NNP	B-MPA
and	CC	O
expression	NN	B-MPA
of	IN	O
lipogenic	JJ	B-Gene
genes	NNS	I-Gene
as	IN	O
compared	VBN	O
with	IN	O
that	DT	O
in	IN	O
C3WT	NNP	O
mice	NN	O
.	.	O
These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
C3QK	NNP	B-Var
variant	NN	O
is	VBZ	O
a	DT	O
gain	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
mutation	NN	O
that	WDT	O
can	MD	O
stimulate	VB	B-PosReg
VLDL1	NNP	B-MPA
production	NN	I-MPA
,	,	O
through	IN	O
enhanced	VBN	B-PosReg
DNL	NNP	B-MPA




mutant	JJ	B-Var
p53	NN	B-Gene
proteins	VBZ	B-Protein
lose	VB	B-NegReg
tumor	NN	B-CPA
suppressor	NN	I-CPA
activity	NN	I-CPA
actively	RB	B-PosReg
promote	VB	I-PosReg
tumor	NN	B-CPA
development	NN	I-CPA
Two	CD	O
main	JJ	O
mechanisms	NNS	O
accounting	VBG	O
for	IN	O
mutp53	NN	B-Var
proto	NN	O
-	:	O
oncogenic	JJ	O
activity	NN	O
are	VBP	O
inhibition	NN	O
of	IN	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
p53	NN	O
in	IN	O
a	DT	O
dominant	JJ	O
-	:	O
negative	JJ	O
fashion	NN	O
and	CC	O
gain	NN	B-PosReg
of	IN	O
additional	JJ	B-CPA
oncogenic	JJ	I-CPA
activities	NNS	I-CPA
known	VBN	O
as	IN	O
gain	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
(	(	O
GOF	NNP	O
)	)	O
.	.	O
Here	RB	O
,	,	O
we	PRP	O
discuss	VBP	O
a	DT	O
novel	JJ	O
mechanism	NN	O
of	IN	O
mutp53	NN	B-Var
GOF	NNP	O
,	,	O
which	WDT	O
relies	VBZ	O
on	IN	O
its	PRP$	O
oncogenic	JJ	O
cooperation	NN	O
with	IN	O
the	DT	O
heat	NN	O
shock	NN	O
machinery	NN	O
.	.	O
This	DT	O
coordinated	VBD	O
adaptive	JJ	O
mechanism	NN	O
renders	NNS	O
cancer	NN	O
cells	NNS	O
more	RBR	B-PosReg
resistant	JJ	B-CPA
to	TO	I-CPA
proteotoxic	VB	I-CPA
stress	NN	I-CPA
and	CC	O
provides	VBZ	O
both	DT	O
,	,	O
a	DT	O
strong	JJ	O
survival	NN	B-CPA
advantage	NN	I-CPA
to	TO	O
cancer	NN	O
cells	NNS	O
and	CC	O
a	DT	O
promising	NN	O
means	VBZ	O
for	IN	O
therapeutic	JJ	O
intervention	NN	O


KCNT1	NNP	B-Gene
mutations	NNS	B-Var
are	VBP	O
gain	JJ	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutations	NNS	O
in	IN	O
potassium	NN	O
channels	NNS	O
resulting	VBG	O
in	IN	O
severe	JJ	O
infantile	JJ	B-Disease
epilepsy	NN	I-Disease
.	.	O
Herein	NNP	O
we	PRP	O
describe	VBP	O
3	CD	O
infants	NNS	O
with	IN	O
malignant	JJ	O
migrating	VBG	O
partial	JJ	O
seizures	NNS	O
with	IN	O
KCNT1	NNP	O
mutations	NNS	O
accompanied	VBN	O
by	IN	O
massive	JJ	O
systemic	NN	O
to	TO	O
pulmonary	JJ	O
collateral	NN	O
arteries	NNS	O
with	IN	O
life	NN	O
-	:	O
threatening	JJ	O
hemoptysis	NN	O
and	CC	O
heart	NN	O
failure	NN	O


mutations	NNS	B-Var
PDGFRB	NNP	B-Gene
cause	NN	B-Reg
Kosaki	NNP	B-Disease
and	CC	I-Disease
Penttinen	NNP	I-Disease
syndromes	NNS	I-Disease
myofibromatosis	NN	B-Disease
We	PRP	O
describe	VBP	O
a	DT	O
10	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
child	NN	O
with	IN	O
a	DT	O
germ	JJ	O
-	:	O
line	NN	O
PDGFRB	NNP	B-Gene
p	NN	B-Var
.	.	I-Var
N666H	NNP	I-Var
mutation	NN	O
who	WP	O
responded	VBD	B-MPA
to	TO	I-MPA
the	DT	I-MPA
tyrosine	NN	I-MPA
kinase	NN	I-MPA
inhibitor	NN	I-MPA
imatinib	NN	I-MPA
by	IN	O
inhibition	NN	B-NegReg
of	IN	O
PDGFRB	NNP	B-Gene
.	.	O
MethodsThe	NNP	O
impact	NN	O
of	IN	O
p	NN	O
.	.	O
N666H	NNP	O
on	IN	O
PDGFRB	NNP	O
function	NN	O
and	CC	O
sensitivity	NN	O
to	TO	O
imatinib	VB	O
was	VBD	O
studied	VBN	O
in	IN	O
cell	NN	O
culture	NN	O
.	.	O
ResultsCells	NNP	O
expressing	VBG	O
the	DT	O
p	NN	O
.	.	O
N666H	NNP	O
mutation	NN	O
showed	VBD	O
constitutive	JJ	O
PDGFRB	NNP	O
tyrosine	NN	O
phosphorylation	NN	O
.	.	O
PDGF	NNP	O
-	:	O
independent	JJ	O
proliferation	NN	O
was	VBD	O
abolished	VBN	O
by	IN	O
imatinib	NN	O
at	IN	O
1	CD	O
M	NNP	O
concentration	NN	O
.	.	O

Patient	NN	O
fibroblasts	NNS	O
showed	VBD	O
constitutive	JJ	O
receptor	NN	O
tyrosine	NN	O
phosphorylation	NN	O
that	WDT	O
was	VBD	O
also	RB	O
abrogated	VBN	O
by	IN	O
imatinib	NN	O
with	IN	O
reduced	JJ	O
proliferation	NN	O
of	IN	O
treated	JJ	O
cells	NNS	O
.	.	O
This	DT	O
led	VBD	O
to	TO	O
patient	VB	O
treatment	NN	O
with	IN	O
imatinib	NN	O
at	IN	O
400	CD	O
mg	JJ	O
daily	JJ	O
(	(	O
340	CD	O
mg	NN	O
m	NN	O
(	(	O
2	CD	O
))	NN	O
for	IN	O
a	DT	O
year	NN	O
with	IN	O
objective	JJ	O
improvement	NN	O
of	IN	O
debilitating	VBG	O
hand	NN	O
and	CC	O
foot	NN	O
contractures	NNS	O
,	,	O
reduced	VBN	O
facial	JJ	O
coarseness	NN	O
,	,	O
and	CC	O
significant	JJ	O
improvement	NN	O
in	IN	O
quality	NN	O
of	IN	O
life	NN	O
.	.	O

New	NNP	O
small	JJ	O
subcutaneous	JJ	O
nodules	NNS	O
developed	VBN	O
,	,	O
but	CC	O
remained	VBD	O
stable	JJ	O
.	.	O

Transient	NNP	O
leukopenia	NN	O
,	,	O
neutropenia	NN	O
,	,	O
and	CC	O
fatigue	NN	O
resolved	VBN	O
without	IN	O
intervention	NN	O
;	:	O
however	RB	O
,	,	O
mildly	RB	O
decreased	VBD	O
growth	NN	O
velocity	NN	O
resulted	VBD	O
in	IN	O
reducing	VBG	O
imatinib	NN	O
dose	NN	O
to	TO	O
200	CD	O
mg	NNS	O
daily	RB	O
(	(	O
170	CD	O
mg	NN	O
m	NN	O
(	(	O
2	CD	O
))	NN	O
.	.	O

The	DT	O
patient	NN	O
continues	VBZ	O
treatment	NN	O
with	IN	O
ongoing	VBG	O
clinical	JJ	O
response	NN	O
.	.	O
ConclusionTo	NNP	O
our	PRP$	O
knowledge	NN	O
,	,	O
this	DT	O
is	VBZ	O
one	CD	O
of	IN	O
the	DT	O
first	JJ	O
personalized	JJ	O
treatments	NNS	O
of	IN	O
a	DT	O
congenital	JJ	O
disorder	NN	O
caused	VBN	O
by	IN	O
a	DT	O
germ	JJ	O
-	:	O
line	NN	O
PDGF	NNP	O
receptor	NN	O
mutation	NN	O
with	IN	O
a	DT	O
PDGFRB	NNP	O
inhibitor	NN	O
.	.	O
GENETICS	NNP	O
in	IN	O
MEDICINE	NNP	O
advance	NN	O
online	NN	O
publication	NN	O
,	,	O
20	CD	O
July	NNP	O
2017	CD	O
;	:	O
doi	NN	O
:	:	O
10.1038	CD	O
gim	NN	O
.	.	O
2017.104	CD	O


KEY	JJ	O
POINTS	NNS	O
:	:	O
SCN5a	NNP	B-Gene
mutations	NNS	B-Var
may	MD	O
express	VB	O
gain	VB	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
(	(	O
Long	NNP	B-Disease
QT	NNP	I-Disease
Syndrome	NNP	I-Disease
-	:	I-Disease
3	CD	I-Disease
)	)	O
,	,	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
(	(	O
Brugada	NNP	B-Disease
Syndrome	NNP	I-Disease
1	CD	I-Disease
)	)	O
or	CC	O
both	DT	O
(	(	O
mixed	JJ	O
syndromes	NNS	O
)	)	O
,	,	O
depending	VBG	O
on	IN	O
the	DT	O
mutation	NN	O
and	CC	O
environmental	JJ	O
triggers	NNS	O
.	.	O
One	CD	O
such	JJ	O
trigger	NN	O
may	MD	O
be	VB	O
an	DT	O
increase	NN	O
in	IN	O
cytosolic	JJ	O
calcium	NN	O
,	,	O
accompanying	VBG	O
exercise	NN	O
.	.	O

Many	JJ	O
mixed	JJ	O
syndromes	NNS	O
mutants	NNS	O
,	,	O
including	VBG	O
KPQ	NNP	O
,	,	O
E1784K	NNP	O
,	,	O
1795	CD	O
insD	NN	O
and	CC	O
Q1909R	NNP	O
,	,	O
are	VBP	O
found	VBN	O
in	IN	O
calcium	NN	O
-	:	O
sensitive	JJ	O
regions	NNS	O
.	.	O

Elevated	VBN	O
cytosolic	JJ	O
calcium	NN	O
attenuates	VBZ	O
gain	VBP	O
-	:	O
of	IN	O
-	:	O
function	NN	O
properties	NNS	O
in	IN	O
KPQ	NNP	O
,	,	O
1795	CD	O
insD	NN	O
and	CC	O
Q1909R	NNP	O
,	,	O
but	CC	O
not	RB	O
in	IN	O
E1784K	NNP	O
.	.	O

By	IN	O
contrast	NN	O
,	,	O
elevated	VBN	O
cytosolic	JJ	O
calcium	NN	O
further	RBR	O
exacerbates	VBZ	O
gain	VBP	O
-	:	O
of	IN	O
-	:	O
function	NN	O
in	IN	O
E1784K	NNP	O
by	IN	O
destabilizing	VBG	O
slow	JJ	O
inactivation	NN	O
.	.	O

Action	NNP	O
potential	JJ	O
modelling	NN	O
,	,	O
using	VBG	O
a	DT	O
modified	JJ	O
O	NNP	O
Hara	NNP	O
Rudy	NNP	O
model	NN	O
,	,	O
suggests	VBZ	O
that	IN	O
elevated	JJ	O
heart	NN	O
rate	NN	O
rescues	NNS	O
action	NN	O
potential	JJ	O
duration	NN	O
in	IN	O
KPQ	NNP	O
,	,	O
1795	CD	O
insD	NN	O
and	CC	O
Q1909R	NNP	O
,	,	O
but	CC	O
not	RB	O
in	IN	O
E1784K	NNP	O
.	.	O

Action	NNP	O
potential	JJ	O
simulations	NNS	O
suggest	VBP	O
that	IN	O
E1784K	NNP	O
carriers	NNS	O
have	VBP	O
an	DT	O
increased	VBN	O
intracellular	NN	O
sodium	NN	O
-	:	O
to	TO	O
-	:	O
calcium	NN	O
ratio	NN	O
under	IN	O
bradycardia	NN	O
and	CC	O
tachycardia	JJ	O
conditions	NNS	O
.	.	O

Elevated	VBN	O
cytosolic	JJ	O
calcium	NN	O
,	,	O
which	WDT	O
is	VBZ	O
common	JJ	O
during	IN	O
high	JJ	O
heart	NN	O
rates	NNS	O
,	,	O
ameliorates	VBZ	O
or	CC	O
exacerbates	VBZ	O
the	DT	O
mixed	JJ	O
syndrome	NN	O
phenotype	NN	O
depending	VBG	O
on	IN	O
the	DT	O
genetic	JJ	O
signature	NN	O
.	.	O

ABSTRACT	NN	O
:	:	O
Inherited	VBN	O
arrhythmias	NN	O
may	MD	O
arise	VB	O
from	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
gene	NN	O
for	IN	O
SCN5a	NNP	O
,	,	O
which	WDT	O
encodes	VBZ	O
the	DT	O
cardiac	JJ	O
voltage	NN	O
-	:	O
gated	JJ	O
sodium	NN	O
channel	NN	O
,	,	O
NaV	NNP	O
1.5	CD	O
.	.	O

Mutants	NNS	O
in	IN	O
NaV	NNP	O
1.5	CD	O
result	NN	O
in	IN	O
Brugada	NNP	O
Syndrome	NNP	O
(	(	O
BrS1	NNP	O
)	)	O
,	,	O
Long	NNP	O
-	:	O
QT	NNP	O
Syndrome	NNP	O
(	(	O
LQT3	NNP	O
)	)	O
or	CC	O
mixed	JJ	O
syndromes	NNS	O
(	(	O
an	DT	O
overlap	NN	O
of	IN	O
BrS1	NNP	O
LQT3	NNP	O
)	)	O
.	.	O

Exercise	NN	O
is	VBZ	O
a	DT	O
potential	JJ	O
arrhythmogenic	JJ	O
trigger	NN	O
in	IN	O
mixed	JJ	O
syndromes	NNS	O
.	.	O

We	PRP	O
aimed	VBD	O
to	TO	O
determine	VB	O
the	DT	O
effects	NNS	O
of	IN	O
elevated	JJ	O
cytosolic	JJ	O
calcium	NN	O
,	,	O
which	WDT	O
is	VBZ	O
common	JJ	O
during	IN	O
exercise	NN	O
,	,	O
in	IN	O
mixed	JJ	O
syndrome	JJ	O
NaV	NNP	O
1.5	CD	O
mutants	NNS	O
.	.	O

We	PRP	O
used	VBD	O
whole	JJ	O
-	:	O
cell	NN	O
patch	NN	O
clamp	NN	O
to	TO	O
assess	VB	O
the	DT	O
biophysical	JJ	O
properties	NNS	O
of	IN	O
NaV	NNP	O
1.5	CD	O
wild	JJ	O
-	:	O
type	NN	O
(	(	O
WT	NNP	O
)	)	O
,	,	O
KPQ	NNP	O
,	,	O
E1784K	NNP	O
,	,	O
1795	CD	O
insD	NN	O
and	CC	O
Q1909R	NNP	O
mutants	NNS	O
in	IN	O
human	JJ	O
embryonic	JJ	O
kidney	NN	O
293	CD	O
cells	NNS	O
transiently	RB	O
transfected	VBN	O
with	IN	O
the	DT	O
NaV	NNP	O
1.5	CD	O
subunit	NN	O
(	(	O
WT	NNP	O
or	CC	O
mutants	NNS	O
)	)	O
,	,	O
1	CD	O
subunit	NN	O
and	CC	O
enhanced	VBD	O
green	JJ	O
fluorescent	NN	O
protein	NN	O
.	.	O

Voltage	NNP	O
-	:	O
dependence	NN	O
and	CC	O
kinetics	NNS	O
were	VBD	O
measured	VBN	O
at	IN	O
cytosolic	JJ	O
calcium	NN	O
levels	NNS	O
of	IN	O
approximately	RB	O
0	CD	O
,	,	O
500	CD	O
and	CC	O
2500	CD	O
nm	NN	O
.	.	O

In	IN	O
silico	NN	O
,	,	O
action	NN	O
potential	NN	O
(	(	O
AP	NNP	O
)	)	O
model	NN	O
simulations	NNS	O
were	VBD	O
performed	VBN	O
using	VBG	O
a	DT	O
modified	JJ	O
O	NNP	O
Hara	NNP	O
Rudy	NNP	O
model	NN	O
.	.	O

Elevated	VBN	O
cytosolic	JJ	O
calcium	NN	O
attenuates	VBZ	O
the	DT	O
late	JJ	O
sodium	NN	O
current	JJ	O
in	IN	O
KPQ	NNP	O
,	,	O
1795	CD	O
insD	NN	O
and	CC	O
Q1909R	NNP	O
,	,	O
but	CC	O
not	RB	O
in	IN	O
E1784K	NNP	O
.	.	O

Elevated	VBN	O
cytosolic	JJ	O
calcium	NN	O
restores	NNS	O
steady	JJ	O
-	:	O
state	NN	O
slow	JJ	O
inactivation	NN	O
(	(	O
SSSI	NNP	O
)	)	O
to	TO	O
the	DT	O
WT	NNP	O
-	:	O
form	NN	O
in	IN	O
Q1909R	NNP	O
,	,	O
but	CC	O
depolarized	VBD	O
SSSI	NNP	O
in	IN	O
E1784K	NNP	O
.	.	O

Our	PRP$	O
AP	NNP	O
simulations	NNS	O
showed	VBD	O
a	DT	O
frequency	NN	O
-	:	O
dependent	JJ	O
reduction	NN	O
of	IN	O
AP	NNP	O
duration	NN	O
in	IN	O
KPQ	NNP	O
,	,	O
1795	CD	O
insD	NN	O
and	CC	O
Q1909R	NNP	O
carriers	NNS	O
.	.	O

In	IN	O
E1784K	NNP	O
,	,	O
AP	NNP	O
duration	NN	O
is	VBZ	O
relatively	RB	O
prolonged	VBN	O
at	IN	O
both	DT	O
low	JJ	O
and	CC	O
high	JJ	O
heart	NN	O
rates	NNS	O
,	,	O
resulting	VBG	O
in	IN	O
a	DT	O
sodium	NN	O
overload	NN	O
.	.	O

Cellular	JJ	O
perturbations	NNS	O
during	IN	O
exercise	NN	O
may	MD	O
affect	VB	O
BrS1	NNP	O
LQT3	NNP	O
patients	NNS	O
differently	RB	O
depending	VBG	O
on	IN	O
their	PRP$	O
individual	JJ	O
genetic	JJ	O
signature	NN	O
.	.	O

Thus	RB	O
,	,	O
exercise	NN	O
may	MD	O
be	VB	O
therapeutic	JJ	O
or	CC	O
may	MD	O
be	VB	O
an	DT	O
arrhythmogenic	JJ	O
trigger	NN	O
in	IN	O
some	DT	O
SCN5a	NNP	O
patients	NNS	O


Heterozygous	JJ	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
(	(	O
LOF	NNP	O
)	)	O
mutations	NNS	B-Var
in	IN	O
the	DT	O
human	JJ	B-Gene
progranulin	NN	I-Gene
gene	NN	I-Gene
(	(	O
GRN	NNP	B-Gene
)	)	O
cause	VBP	B-Reg
frontotemporal	JJ	B-Disease
lobar	NN	I-Disease
degeneration	NN	I-Disease
(	(	O
FTLD	NNP	O
)	)	O
by	IN	O
a	DT	O
mechanism	NN	O
of	IN	O
haploinsufficiency	NN	B-MPA
.	.	O
Patients	NNS	O
present	JJ	O
most	RBS	O
frequently	RB	O
with	IN	O
frontotemporal	JJ	O
dementia	NN	O
,	,	O
which	WDT	O
is	VBZ	O
the	DT	O
second	JJ	O
most	RBS	O
common	JJ	O
neurodegenerative	JJ	O
dementia	NN	O
at	IN	O
young	JJ	O
age	NN	O
.	.	O

Currently	RB	O
,	,	O
no	DT	O
disease	NN	O
-	:	O
modifying	NN	O
therapies	NNS	O
are	VBP	O
available	JJ	O
for	IN	O
these	DT	O
patients	NNS	O
.	.	O

Stimulating	VBG	O
GRN	NNP	O
protein	NN	O
expression	NN	O
or	CC	O
inhibiting	VBG	O
its	PRP$	O
breakdown	NN	O
is	VBZ	O
an	DT	O
obvious	JJ	O
therapeutic	JJ	O
strategy	NN	O
,	,	O
and	CC	O
is	VBZ	O
indeed	RB	O
the	DT	O
focus	NN	O
of	IN	O
current	JJ	O
preclinical	JJ	O
research	NN	O
and	CC	O
clinical	JJ	O
trials	NNS	O
.	.	O

Multiple	JJ	O
studies	NNS	O
have	VBP	O
demonstrated	VBN	O
the	DT	O
heterogeneity	NN	O
in	IN	O
clinical	JJ	O
presentation	NN	O
and	CC	O
wide	JJ	O
variability	NN	O
in	IN	O
age	NN	O
of	IN	O
onset	NN	O
in	IN	O
patients	NNS	O
carrying	VBG	O
a	DT	O
GRN	NNP	O
LOF	NNP	O
mutation	NN	O
.	.	O

Recently	RB	O
,	,	O
this	DT	O
heterogeneity	NN	O
became	VBD	O
an	DT	O
opportunity	NN	O
to	TO	O
identify	VB	O
disease	NN	O
modifiers	NNS	O
,	,	O
considering	VBG	O
that	IN	O
these	DT	O
might	MD	O
constitute	VB	O
suitable	JJ	O
targets	NNS	O
for	IN	O
developing	VBG	O
disease	JJ	O
-	:	O
modifying	NN	O
or	CC	O
disease	VB	O
-	:	O
delaying	VBG	O
therapies	NNS	O

ABCC9	NNP	B-Gene
mutations	NNS	B-Var
KATP	NNP	B-MPA
channel	NN	I-MPA
gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
Cantu	NNP	B-Disease
syndrome	NN	I-Disease
gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutations	NNS	B-Var
KCNJ8	NNP	B-Gene
ABCC9	NNP	B-Gene
mutations	NNS	B-Var
increase	VB	B-PosReg
channel	NN	B-MPA
activity	NN	I-MPA
KATP	NNP	B-MPA
function	NN	I-MPA
altered	VBN	B-Reg
SUR2	NNP	B-Gene
D207E	NN	B-Var
Y985S	NNP	B-Var
G989E	NNP	B-Var
M1060I	NNP	B-Var
R1154Q	NNP	B-Var
R1154W	NNP	B-Var

Our	PRP$	O
results	NNS	O
indicate	VBP	O
that	IN	O
D207E	NNP	B-Var
increases	VBZ	B-PosReg
KATP	NNP	B-MPA
channel	NN	I-MPA
activity	NN	I-MPA
by	IN	O
increasing	VBG	B-PosReg
intrinsic	JJ	B-MPA
stability	NN	I-MPA
of	IN	I-MPA
the	DT	I-MPA
open	JJ	I-MPA
state	NN	I-MPA
,	,	O
whereas	IN	O
the	DT	O
cluster	NN	O
of	IN	O
Y981S	NNP	B-Var
G985E	NNP	B-Var
M1056I	NNP	B-Var
substitutions	NNS	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
R1150Q	NNP	B-Var
R1150W	NNP	B-Var
,	,	O
augmented	VBD	B-PosReg
Mg	NNP	B-MPA
-	:	I-MPA
nucleotide	JJ	I-MPA
activation	NN	I-MPA
.	.	O
We	PRP	O
also	RB	O
tested	VBD	O
the	DT	O
responses	NNS	O
of	IN	O
these	DT	O
channel	NNS	O
variants	NNS	O
to	TO	O
inhibition	NN	O
by	IN	O
the	DT	O
sulfonylurea	JJ	O
drug	NN	O
glibenclamide	NN	O
,	,	O
a	DT	O
potential	JJ	O
pharmacotherapy	NN	O
for	IN	O
CS	NNP	O
.	.	O

None	NN	O
of	IN	O
the	DT	O
D207E	NNP	O
,	,	O
Y981S	NNP	O
,	,	O
G985E	NNP	O
,	,	O
or	CC	O
M1056I	NNP	O
substitutions	NNS	O
had	VBD	O
a	DT	O
significant	JJ	O
effect	NN	O
on	IN	O
glibenclamide	NN	O
sensitivity	NN	O
.	.	O

However	RB	O
,	,	O
Gln	NNP	O
and	CC	O
Trp	NNP	O
substitution	NN	O
at	IN	O
Arg	NNP	O
-	:	O
1150	CD	O
significantly	RB	O
decreased	VBN	O
glibenclamide	JJ	O
potency	NN	O
.	.	O

In	IN	O
summary	JJ	O
,	,	O
these	DT	O
results	NNS	O
provide	VBP	O
additional	JJ	O
confirmation	NN	O
that	IN	O
mutations	NNS	O
in	IN	O
CS	NNP	O
-	:	O
associated	VBN	O
SUR2	NNP	O
mutations	NNS	O
result	VBP	O
in	IN	O
KATP	NNP	O
gain	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
.	.	O

They	PRP	O
help	VBP	O
link	VB	O
CS	NNP	O
genotypes	NNS	O
to	TO	O
phenotypes	NNS	O
and	CC	O
shed	VBD	O
light	NN	O
on	IN	O
the	DT	O
underlying	VBG	O
molecular	JJ	O
mechanisms	NNS	O
,	,	O
including	VBG	O
consequences	NNS	O
for	IN	O
inhibitory	JJ	O
drug	NN	O
sensitivity	NN	O
,	,	O
insights	NNS	O
that	WDT	O
may	MD	O
inform	VB	O
the	DT	O
development	NN	O
of	IN	O
therapeutic	JJ	O
approaches	NNS	O
to	TO	O
manage	VB	O
CS	NNP	O


Hereditary	NNP	B-Disease
hemorrhagic	NN	I-Disease
telangiectasia	NN	I-Disease
Because	IN	O
HHT	NNP	B-Disease
is	VBZ	O
caused	VBN	O
by	IN	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
in	IN	O
bone	NN	O
morphogenetic	JJ	O
protein	NN	O
9	CD	O
(	(	B-MPA
BMP9	NNP	I-MPA
)-	NNP	I-MPA
ALK1	NNP	I-MPA
-	:	I-MPA
Smad1	VBD	I-MPA
5	CD	I-MPA
8	CD	I-MPA
signaling	NN	I-MPA
,	,	O
interventions	NNS	O
aimed	VBN	O
at	IN	O
activating	VBG	O
this	DT	O
pathway	NN	O
are	VBP	O
of	IN	O
therapeutic	JJ	O
value	NN	O
.	.	O
We	PRP	O
interrogated	VBD	O
the	DT	O
whole	JJ	O
-	:	O
transcriptome	NN	O
in	IN	O
human	JJ	O
umbilical	JJ	O
vein	NN	O
ECs	NNP	O
(	(	O
HUVECs	NNP	O
)	)	O
and	CC	O
found	VBD	O
that	IN	O
ALK1	NNP	O
signaling	VBG	O
inhibition	NN	O
was	VBD	O
associated	VBN	O
with	IN	O
a	DT	O
specific	JJ	O
pro	JJ	O
-	:	O
angiogenic	JJ	O
gene	NN	O
expression	NN	O
signature	NN	O
,	,	O
which	WDT	O
included	VBD	O
a	DT	O
significant	JJ	O
elevation	NN	O
of	IN	O
DLL4	NNP	O
expression	NN	O
.	.	O

By	IN	O
screening	VBG	O
the	DT	O
NIH	NNP	O
clinical	JJ	O
collections	NNS	O
of	IN	O
FDA	NNP	O
-	:	O
approved	VBD	O
drugs	NNS	O
,	,	O
we	PRP	O
identified	VBD	O
tacrolimus	NN	O
(	(	O
FK	NNP	O
-	:	O
506	CD	O
)	)	O
as	IN	O
the	DT	O
most	RBS	O
potent	JJ	O
activator	NN	O
of	IN	O
ALK1	NNP	O
signaling	VBG	O
in	IN	O
BMP9	NNP	O
-	:	O
challenged	VBD	O
C2C12	NNP	O
reporter	NN	O
cells	NNS	O
.	.	O

In	IN	O
HUVECs	NNP	O
,	,	O
tacrolimus	RB	O
activated	VBD	O
Smad1	NNP	O
5	CD	O
8	CD	O
and	CC	O
opposed	VBD	O
the	DT	O
pro	JJ	O
-	:	O
angiogenic	JJ	O
gene	NN	O
expression	NN	O
signature	NN	O
associated	VBN	O
with	IN	O
ALK1	NNP	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
,	,	O
by	IN	O
notably	RB	O
reducing	VBG	O
Dll4	NNP	O
expression	NN	O
.	.	O

In	IN	O
these	DT	O
cells	NNS	O
,	,	O
tacrolimus	NN	O
also	RB	O
inhibited	VBD	O
Akt	NNP	O
and	CC	O
p38	JJ	O
stimulation	NN	O
by	IN	O
vascular	JJ	O
endothelial	JJ	O
growth	NN	O
factor	NN	O
,	,	O
a	DT	O
major	JJ	O
driver	NN	O
of	IN	O
angiogenesis	NN	O
.	.	O

In	IN	O
the	DT	O
BMP9	NNP	O
10	CD	O
-	:	O
immunodepleted	VBN	O
postnatal	JJ	O
retina	NN	O
-	:	O
a	DT	O
mouse	NN	O
model	NN	O
of	IN	O
HHT	NNP	O
vascular	JJ	O
pathology	NN	O
-	:	O
tacrolimus	NN	O
activated	VBD	O
endothelial	JJ	O
Smad1	NNP	O
5	CD	O
8	CD	O
and	CC	O
prevented	VBD	O
the	DT	O
Dll4	NNP	O
overexpression	NN	O
and	CC	O
hypervascularization	NN	O
associated	VBN	O
with	IN	O
this	DT	O
model	NN	O
.	.	O

Finally	RB	O
,	,	O
tacrolimus	NN	O
stimulated	VBD	O
Smad1	NNP	O
5	CD	O
8	CD	O
signaling	NN	O
in	IN	O
C2C12	NNP	O
cells	NNS	O
expressing	VBG	O
BMP9	NNP	O
-	:	O
unresponsive	JJ	O
ALK1	NNP	O
HHT	NNP	O
mutants	NNS	O
and	CC	O
in	IN	O
HHT	NNP	O
patient	NN	O
blood	NN	O
outgrowth	NN	O
ECs	NNP	O
.	.	O

Tacrolimus	NNP	O
repurposing	NN	O
has	VBZ	O
therefore	RB	O
therapeutic	JJ	O
potential	NN	O
in	IN	O
HHT	NNP	O

,	,	I-Gene
deletion	NN	B-Var


Inheritance	NN	O
is	VBZ	O
presumed	VBN	O
autosomal	JJ	O
recessive	NN	O
.	.	O

Although	IN	O
no	DT	O
major	JJ	O
genetic	JJ	O
cause	NN	O
has	VBZ	O
been	VBN	O
identified	VBN	O
for	IN	O
FS	NNP	O
,	,	O
biallelic	JJ	B-Var
truncating	VBG	I-Var
variants	NNS	I-Var
in	IN	O
PIGN	NNP	B-Gene
,	,	O
encoding	VBG	O
a	DT	O
component	NN	O
of	IN	O
the	DT	O
glycosylphosphatidylinositol	NN	O
(	(	O
GPI	NNP	O
)-	NNP	O
anchor	NN	O
biosynthesis	NN	O
pathway	NN	O
,	,	O
have	VBP	O
been	VBN	O
identified	VBN	B-Reg
in	IN	O
a	DT	O
limited	JJ	O
number	NN	O
of	IN	O
cases	NNS	O
with	IN	O
a	DT	O
phenotype	NN	O
compatible	NN	O
with	IN	O
FS	NNP	B-Disease
.	.	O
Biallelic	JJ	O
variants	NNS	O
in	IN	O
PIGN	NNP	B-Gene
,	,	O
typically	RB	O
missense	JJ	B-Var
or	CC	O
compound	JJ	B-Var
missense	NN	I-Var
with	IN	O
truncating	NN	B-MPA
,	,	O
also	RB	O
cause	VBP	B-Reg
multiple	JJ	B-Disease
congenital	JJ	I-Disease
anomalies	NNS	I-Disease
-	:	I-Disease
hypotonia	NN	I-Disease
-	:	I-Disease
seizures	VBZ	I-Disease
syndrome	JJ	I-Disease
1	CD	I-Disease
(	(	O
MCAHS1	NNP	O
)	)	O
.	.	O
Here	RB	O
we	PRP	O
report	VBP	O
six	CD	O
further	JJ	O
patients	NNS	O
with	IN	O
FS	NNP	O
with	IN	O
or	CC	O
without	IN	O
congenital	JJ	O
diaphragmatic	JJ	O
hernia	NN	O
and	CC	O
recessive	JJ	O
loss	NN	O
of	IN	O
function	NN	O
PIGN	NNP	O
alleles	NNS	O
,	,	O
including	VBG	O
an	DT	O
intragenic	JJ	O
deletion	NN	O
with	IN	O
a	DT	O
likely	JJ	O
founder	NN	O
effect	NN	O
in	IN	O
La	NNP	O
R	NNP	O
union	NN	O
and	CC	O
other	JJ	O
Indian	JJ	O
Ocean	NNP	O
islands	NNS	O
.	.	O

Our	PRP$	O
results	NNS	O
support	VB	O
the	DT	O
hypothesis	NN	O
that	IN	O
a	DT	O
spectrum	NN	O
of	IN	O
phenotypic	NN	O
severity	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
recessive	JJ	O
PIGN	NNP	O
variants	NNS	O
,	,	O
ranging	VBG	O
from	IN	O
FS	NNP	O
at	IN	O
the	DT	O
extreme	JJ	O
end	NN	O
,	,	O
caused	VBN	O
by	IN	O
complete	JJ	O
loss	NN	O
of	IN	O
function	NN	O
,	,	O
to	TO	O
MCAHS1	NNP	O
,	,	O
in	IN	O
which	WDT	O
some	DT	O
residual	JJ	O
PIGN	NNP	O
function	NN	O
may	MD	O
remain	VB	O
.	.	O

Our	PRP$	O
data	NNS	O
add	VBP	O
FS	NNP	O
resulting	VBG	O
from	IN	O
PIGN	NNP	O
variants	NNS	O
to	TO	O
the	DT	O
catalog	NN	O
of	IN	O
inherited	JJ	O
GPI	NNP	O
deficiencies	NNS	O
caused	VBN	O
by	IN	O
the	DT	O
disruption	NN	O
of	IN	O
the	DT	O
GPI	NNP	O
-	:	O
anchor	NN	O
biosynthesis	NN	O
pathway	NN	O




The	DT	O
JAK	NNP	O
family	NN	O
of	IN	O
kinases	NNS	O
is	VBZ	O
required	VBN	O
for	IN	O
the	DT	O
signaling	NN	O
of	IN	O
a	DT	O
host	NN	O
of	IN	O
immune	JJ	O
modulators	NNS	O
in	IN	O
tumor	NN	O
,	,	O
stromal	JJ	O
,	,	O
and	CC	O
immune	JJ	O
cells	NNS	O
.	.	O

Therefore	RB	O
,	,	O
we	PRP	O
analyzed	VBD	O
alterations	NNS	O
in	IN	O
this	DT	O
family	NN	O
for	IN	O
the	DT	O
hypothesized	JJ	O
signature	NN	O
of	IN	O
an	DT	O
immune	JJ	O
evasion	NN	O
mutation	NN	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
searched	VBD	O
a	DT	O
database	NN	O
of	IN	O
61	CD	O
,	,	O
704	CD	O
unique	JJ	O
solid	JJ	O
tumors	NNS	O
for	IN	O
alterations	NNS	O
in	IN	O
the	DT	O
JAK	NNP	O
family	NN	O
kinases	NNS	O
(	(	O
JAK1	NNP	O
2	CD	O
3	CD	O
,	,	O
TYK2	NNP	O
)	)	O
.	.	O

We	PRP	O
used	VBD	O
The	DT	O
Cancer	NNP	O
Genome	NNP	O
Atlas	NNP	O
and	CC	O
Cancer	NNP	O
Cell	NNP	O
Line	NNP	O
Encyclopedia	NNP	O
data	NNS	O
to	TO	O
confirm	VB	O
and	CC	O
extend	VB	O
our	PRP$	O
findings	NNS	O
by	IN	O
analyzing	VBG	O
gene	NN	O
expression	NN	O
patterns	NNS	O
.	.	O

Recurrent	JJ	O
frameshift	NN	B-Var
mutations	NNS	I-Var
in	IN	O
JAK1	NNP	B-Gene
were	VBD	O
associated	VBN	B-Reg
with	IN	O
high	JJ	B-MPA
mutation	NN	I-MPA
burden	NN	I-MPA
and	CC	O
microsatellite	JJ	B-MPA
instability	NN	I-MPA
.	.	O
These	DT	O
mutations	NNS	B-Var
occurred	VBD	B-Reg
in	IN	O
multiple	JJ	O
tumor	NN	O
types	NNS	O
including	VBG	O
endometrial	NN	B-Disease
,	,	O
colorectal	NN	B-Disease
,	,	O
stomach	NN	B-Disease
,	,	O
and	CC	O
prostate	NN	B-Disease
carcinomas	NN	B-Disease
.	.	O
Analyzing	VBG	O
gene	NN	O
expression	NN	O
signatures	NNS	O
in	IN	O
endometrial	JJ	O
and	CC	O
stomach	JJ	O
adenocarcinomas	NN	O
revealed	VBD	O
that	IN	O
tumors	NNS	O
with	IN	O
a	DT	O
JAK1	NNP	O
frameshift	NN	O
exhibited	VBD	O
reduced	JJ	O
expression	NN	O
of	IN	O
interferon	NN	O
response	NN	O
signatures	NNS	O
and	CC	O
multiple	JJ	O
anti	NN	O
-	:	O
tumor	NN	O
immune	JJ	O
signatures	NNS	O
.	.	O

Importantly	RB	O
,	,	O
endometrial	JJ	O
cancer	NN	O
cell	NN	O
lines	NNS	O
exhibited	VBD	O
similar	JJ	O
gene	NN	O
expression	NN	O
changes	NNS	O
that	WDT	O
were	VBD	O
expected	VBN	O
to	TO	O
be	VB	O
tumor	NN	O
cell	NN	O
intrinsic	JJ	O
(	(	O
e	NN	O
.	.	O
g	NN	O
.	.	O

interferon	NN	O
response	NN	O
)	)	O
but	CC	O
not	RB	O
those	DT	O
expected	VBN	O
to	TO	O
be	VB	O
tumor	NN	O
cell	NN	O
extrinsic	FW	O
(	(	O
e	NN	O
.	.	O
g	NN	O
.	.	O

NK	NNP	O
cells	NNS	O
)	)	O
.	.	O

From	IN	O
these	DT	O
data	NNS	O
,	,	O
we	PRP	O
derive	VBP	O
two	CD	O
primary	JJ	O
conclusions	NNS	O
:	:	O
1	CD	O
)	)	O
JAK1	NNP	O
frameshifts	NNS	O
are	VBP	O
loss	NN	O
of	IN	O
function	NN	O
alterations	NNS	O
that	WDT	O
represent	VBP	O
a	DT	O
potential	JJ	O
pan	NN	O
-	:	O
cancer	NN	O
adaptation	NN	O
to	TO	O
immune	VB	O
responses	NNS	O
against	IN	O
tumors	NNS	O
with	IN	O
microsatellite	JJ	O
instability	NN	O
;	:	O
2	CD	O
)	)	O
The	DT	O
mechanism	NN	O
by	IN	O
which	WDT	O
JAK1	NNP	B-Var
loss	NN	B-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
contributes	NNS	O
to	TO	O
tumor	VB	B-MPA
immune	JJ	I-MPA
evasion	NN	I-MPA
is	VBZ	O
likely	JJ	O
associated	VBN	O
with	IN	O
loss	NN	O
of	IN	O
the	DT	O
JAK1	NNP	O
-	:	O
mediated	VBD	O
interferon	JJ	O
response	NN	O

-	:	I-MPA
adipogenic	JJ	I-MPA
effect	NN	I-MPA
absent	JJ	B-NegReg
PCSK9	NNP	B-Gene
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
variants	NNS	B-Var
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
variant	NN	B-Var
inhibit	VB	B-NegReg
human	JJ	B-MPA
adipogenesis	NN	I-MPA



PBMC	NNP	O
-	:	O
CM	NNP	O
-	:	O
PP	NN	O
from	IN	O
non	JJ	O
-	:	O
variant	NN	O
controls	NNS	O
inhibited	JJ	O
adipogenesis	NN	O
of	IN	O
human	JJ	O
preadipocytes	NNS	O
more	RBR	O
than	IN	O
did	VBD	O
PBMC	NNP	O
-	:	O
CM	NNP	O
-	:	O
F.	NNP	O

In	IN	O
contrast	NN	O
,	,	O
PBMC	NNP	O
-	:	O
CM	NNP	O
-	:	O
F	NN	O
or	CC	O
-	:	O
PP	NN	O
from	IN	O
PCSK9	NNP	B-Gene
LOF	NNP	B-NegReg
variant	JJ	B-Var
subjects	NNS	O
had	VBD	O
no	DT	O
effect	NN	O
on	IN	O
adipogenesis	NN	B-MPA
.	.	O
After	IN	O
the	DT	O
oral	JJ	O
fat	NN	O
load	NN	O
,	,	O
PBMC	NNP	O
from	IN	O
PCSK9	NNP	B-Gene
LOF	NNP	B-NegReg
variant	JJ	B-Var
subjects	NNS	O
showed	VBD	O
significant	JJ	O
increases	NNS	B-PosReg
in	IN	O
mRNA	NN	B-MPA
levels	NNS	I-MPA
of	IN	I-MPA
interleukin	JJ	I-MPA
-	:	I-MPA
1	CD	I-MPA
,	,	I-MPA
tumor	NN	B-MPA
necrosis	NN	I-MPA
factor	NN	I-MPA
-	:	I-MPA
,	,	I-MPA
sterol	VB	B-MPA
regulatory	JJ	I-MPA
element	NN	I-MPA
binding	VBG	I-MPA
protein	SYM	I-MPA
-	:	I-MPA
1	CD	I-MPA
c	NN	I-MPA
,	,	O
CD36	NNP	B-MPA
,	,	O
and	CC	O
monocyte	NN	O
chemoattractant	NN	O
protein	VBD	O
-	:	O
1	CD	O
(	(	O
MCP	NNP	O
-	:	O
1	CD	O
)	)	O
,	,	O
only	RB	O
MCP	NNP	O
-	:	O
1	CD	O
mRNA	NN	O
levels	NNS	O
increased	VBN	O
in	IN	O
PBMC	NNP	O
from	IN	O
non	JJ	O
-	:	O
variant	NN	O
controls	NNS	O
.	.	O
CONCLUSIONS	NN	O
:	:	O
The	DT	O
absence	NN	B-NegReg
of	IN	O
anti	JJ	B-MPA
-	:	I-MPA
adipogenic	JJ	I-MPA
action	NN	I-MPA
of	IN	O
PBMC	NNP	O
from	IN	O
PCSK9	NNP	B-Gene
LOF	NNP	O
variant	JJ	B-Var
subjects	NNS	O
points	NNS	O
to	TO	O
a	DT	O
novel	JJ	B-PosReg
role	NN	I-PosReg
for	IN	O
PCSK9	NNP	O
in	IN	O
PBMC	NNP	O
-	:	O
adipose	NN	O
cell	NN	O
interactions	NNS	B-Interaction




gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutations	NNS	B-Var
CgPDR1	NNP	B-Gene
lead	VB	B-PosReg
azole	VB	B-MPA
resistance	NN	I-MPA
enhanced	VB	B-PosReg
virulence	NN	B-MPA
implicates	VBZ	B-Reg
CgPDR1	NNP	B-Gene
regulation	NN	B-MPA
interaction	NN	B-Interaction
To	TO	O
identify	VB	O
specific	JJ	O
CgPDR1	NNP	O
-	:	O
regulated	VBD	O
steps	NNS	O
of	IN	O
the	DT	O
host	NN	O
-	:	O
pathogen	NN	O
interaction	NN	O
,	,	O
we	PRP	O
investigated	VBD	O
in	IN	O
this	DT	O
work	NN	O
the	DT	O
interaction	NN	O
of	IN	O
selected	VBN	O
CgPDR1	NNP	O
GOF	NNP	O
mutants	NNS	O
with	IN	O
murine	NN	O
bone	NN	O
marrow	SYM	O
-	:	O
derived	VBN	O
macrophages	NNS	O
and	CC	O
human	JJ	O
acute	NN	O
monocytic	JJ	O
leukemia	NN	O
cell	NN	O
line	NN	O
(	(	O
THP	NNP	O
-	:	O
1	CD	O
)-	JJ	O
derived	VBN	O
macrophages	NNS	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
different	JJ	O
epithelial	NN	O
cell	NN	O
lines	NNS	O
.	.	O

GOF	NNP	O
mutations	NNS	B-Var
in	IN	O
CgPDR1	NNP	B-Gene
did	VBD	O
not	RB	O
influence	VB	O
survival	NN	O
and	CC	O
replication	NN	O
within	IN	O
macrophages	NNS	O
following	VBG	O
phagocytosis	NN	O
but	CC	O
led	VBD	O
to	TO	O
decreased	VBN	B-NegReg
adherence	NN	B-CPA
to	TO	I-CPA
and	CC	I-CPA
uptake	VB	I-CPA
by	IN	I-CPA
macrophages	NNS	I-CPA
.	.	O
This	DT	O
may	MD	O
allow	VB	O
evasion	NN	O
from	IN	O
the	DT	O
host	NN	O
's	POS	O
innate	NN	O
cellular	JJ	O
immune	JJ	O
response	NN	O
.	.	O

The	DT	O
interaction	NN	O
with	IN	O
epithelial	JJ	O
cells	NNS	O
revealed	VBD	O
an	DT	O
opposite	JJ	O
trend	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
GOF	NNP	O
mutations	NNS	B-Var
in	IN	O
CgPDR1	NNP	B-Gene
may	MD	O
favor	VB	B-PosReg
epithelial	JJ	B-CPA
colonization	NN	I-CPA
of	IN	O
the	DT	O
host	NN	O
by	IN	O
C.	NNP	O
glabrata	NNS	O
through	IN	O
increased	VBN	B-PosReg
adherence	NN	B-CPA
to	TO	O
epithelial	JJ	O
cell	NN	O
layers	NNS	O
.	.	O
These	DT	O
data	NNS	O
reveal	VBP	O
that	IN	O
GOF	NNP	O
mutations	NNS	B-Var
in	IN	O
CgPDR1	NNP	B-Gene
modulate	VBP	B-Reg
the	DT	O
interaction	NN	B-Interaction
with	IN	O
host	NN	O
cells	NNS	O
in	IN	O
ways	NNS	O
that	WDT	O
may	MD	O
contribute	VB	O
to	TO	O
increased	VBN	B-PosReg
virulence	NN	B-MPA

polyalanine	JJ	I-Gene
expansion	NN	I-Var
mutations	NNS	I-Var
lead	VBP	B-Reg
to	TO	I-Reg
migration	VB	B-CPA
impediment	NN	I-CPA
in	IN	I-CPA
the	DT	I-CPA
cortex	NN	I-CPA
coupled	VBN	I-CPA
developmental	JJ	B-CPA
deficit	NN	I-CPA
of	IN	I-CPA
calbindin	NN	I-CPA
-	:	I-CPA
positive	JJ	I-CPA
cortical	JJ	I-CPA
GABAergic	NNP	I-CPA
interneurons	NNS	I-CPA

Patients	NNS	O
with	IN	O
ARX	NNP	O
polyalanine	JJ	O
expansion	NN	O
mutations	NNS	O
of	IN	O
the	DT	O
first	JJ	O
two	CD	O
tracts	NNS	O
(	(	O
namely	RB	O
PA1	NNP	O
and	CC	O
PA2	NNP	O
)	)	O
suffer	VBP	O
from	IN	O
intellectual	JJ	O
disability	NN	O
of	IN	O
varying	VBG	O
severity	NN	O
,	,	O
with	IN	O
seizures	NNS	O
a	DT	O
frequent	JJ	O
comorbidity	NN	O
.	.	O

The	DT	O
impact	NN	O
of	IN	O
PA1	NNP	O
and	CC	O
PA2	NNP	O
mutations	NNS	O
on	IN	O
the	DT	O
brain	NN	O
development	NN	O
is	VBZ	O
unknown	JJ	O
,	,	O
hindering	VBG	O
the	DT	O
search	NN	O
for	IN	O
therapeutic	JJ	O
interventions	NNS	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
characterized	VBD	O
the	DT	O
disturbances	NNS	O
to	TO	O
cortical	JJ	O
interneuron	NN	O
development	NN	O
in	IN	O
mice	NN	O
modeling	VBG	O
the	DT	O
two	CD	O
most	JJS	O
common	JJ	O
ARX	NNP	O
polyalanine	NN	O
expansion	NN	O
mutations	NNS	O
in	IN	O
human	NN	O
.	.	O

We	PRP	O
found	VBD	O
a	DT	O
consistent	JJ	O
40	CD	O
-	:	O
50%	CD	O
reduction	NN	O
of	IN	O
calbindin	NN	O
-	:	O
positive	JJ	O
interneurons	NNS	O
,	,	O
but	CC	O
not	RB	O
Stt	NNP	O
or	CC	O
Cr	NNP	O
interneurons	NNS	O
,	,	O
within	IN	O
the	DT	O
cortex	NN	O
of	IN	O
newborn	JJ	O
hemizygous	JJ	O
mice	NN	O
(	(	O
p	JJ	O
0.024	CD	O
)	)	O
for	IN	O
both	DT	O
mutant	JJ	O
strains	NNS	O
compared	VBN	O
to	TO	O
wildtype	VB	O
(	(	O
p	VB	O
0.011	CD	O
)	)	O
.	.	O

We	PRP	O
demonstrate	VBP	O
that	IN	O
this	DT	O
was	VBD	O
a	DT	O
consequence	NN	O
of	IN	O
calbindin	NN	O
precursor	NN	O
cells	NNS	O
being	VBG	O
arrested	VBN	O
or	CC	O
delayed	VBN	O
at	IN	O
the	DT	O
ventral	JJ	O
subpallium	NN	O
en	IN	O
route	NN	O
of	IN	O
tangential	JJ	O
migration	NN	O
.	.	O

Ex	NNP	O
-	:	O
vivo	NN	O
assay	RB	O
validated	VBD	O
this	DT	O
migration	NN	O
deficit	NN	O
in	IN	O
PA1	NNP	O
cells	NNS	O
(	(	O
p	VB	O
0.0002	CD	O
)	)	O
suggesting	NN	O
that	IN	O
the	DT	O
defect	NN	O
is	VBZ	O
contributed	VBN	O
by	IN	O
intrinsic	JJ	O
loss	NN	O
of	IN	O
Arx	NNP	O
function	NN	O
within	IN	O
migrating	VBG	O
cells	NNS	O
.	.	O

Both	DT	O
humans	NNS	O
and	CC	O
mice	NN	O
with	IN	O
PA1	NNP	O
mutations	NNS	O
present	JJ	O
with	IN	O
severe	JJ	O
clinical	JJ	O
features	NNS	O
,	,	O
including	VBG	O
intellectual	JJ	O
disability	NN	O
and	CC	O
infantile	JJ	O
spasms	NNS	O
.	.	O

Our	PRP$	O
data	NNS	O
further	RB	O
demonstrated	VBD	O
the	DT	O
pathogenic	JJ	O
mechanism	NN	O
was	VBD	O
robustly	RB	O
shared	VBN	O
between	IN	O
PA1	NNP	O
and	CC	O
PA2	NNP	O
mutations	NNS	O
,	,	O
as	IN	O
previously	RB	O
reported	VBN	O
including	VBG	O
Arx	NNP	O
protein	NN	O
reduction	NN	O
and	CC	O
overlapping	VBG	O
transcriptome	JJ	O
profiles	NNS	O
within	IN	O
the	DT	O
developing	NN	O
mouse	NN	O
brains	NNS	O
.	.	O

Data	NNS	O
from	IN	O
our	PRP$	O
study	NN	O
demonstrated	VBD	O
that	IN	O
cortical	JJ	B-CPA
calbindin	NN	I-CPA
interneuron	NN	I-CPA
development	NN	B-CPA
and	CC	O
migration	NN	B-CPA
is	VBZ	O
negatively	RB	B-NegReg
affected	VBN	O
by	IN	O
ARX	NNP	B-Gene
polyalanine	JJ	B-Var
expansion	NN	I-Var
mutations	NNS	I-Var
.	.	O
Understanding	VBG	O
the	DT	O
cellular	JJ	O
pathogenesis	NN	O
contributing	VBG	O
to	TO	O
disease	VB	O
manifestation	NN	O
is	VBZ	O
necessary	JJ	O
to	TO	O
screen	VB	O
efficacy	NN	O
of	IN	O
potential	JJ	O
therapeutic	JJ	O
interventions	NNS	O


Null	NNP	B-Var
-	:	I-Var
mutations	NNS	I-Var
loss	NN	B-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
FLG	NNP	B-Gene
linked	VBN	B-Reg
atopic	VBZ	B-Disease
eczema	JJ	I-Disease
dermatitis	NN	I-Disease
syndrome	NN	I-Disease

Up	IN	O
to	TO	O
now	RB	O
,	,	O
around	IN	O
40	CD	O
variants	NNS	O
of	IN	O
FLG	NNP	O
null	FW	O
-	:	O
mutations	NNS	O
have	VBP	O
been	VBN	O
genotyped	VBN	O
among	IN	O
different	JJ	O
world	NN	O
populations	NNS	O
.	.	O

FLG	NNP	O
null	SYM	O
-	:	O
mutations	NNS	O
are	VBP	O
present	JJ	O
in	IN	O
up	IN	O
to	TO	O
10%	CD	O
of	IN	O
the	DT	O
Caucasian	JJ	O
population	NN	O
in	IN	O
Western	NNP	O
Europe	NNP	O
and	CC	O
North	NNP	O
America	NNP	O
,	,	O
with	IN	O
R05X	NNP	O
and	CC	O
2282	CD	O
del4	NN	O
as	IN	O
the	DT	O
most	RBS	O
common	JJ	O
null	JJ	O
-	:	O
mutations	NNS	O
.	.	O

Epidemiological	JJ	O
studies	NNS	O
conducted	VBN	O
in	IN	O
Europe	NNP	O
indicate	VBP	O
a	DT	O
latitude	NN	O
dependent	JJ	O
distribution	NN	O
of	IN	O
common	JJ	O
FLG	NNP	O
null	SYM	O
-	:	O
mutations	NNS	O
with	IN	O
a	DT	O
decreasing	VBG	O
north	JJ	O
-	:	O
south	JJ	O
gradient	NN	O
of	IN	O
R501X	NNP	O
and	CC	O
2282	CD	O
del4	NN	O
mutation	NN	O
frequencies	NNS	O
.	.	O

FLG	NNP	B-Gene
null	SYM	B-Var
-	:	I-Var
mutation	NN	I-Var
carriers	NNS	O
are	VBP	O
prone	NN	O
to	TO	O
develop	VB	B-PosReg
unspecific	JJ	B-Disease
skin	NN	I-Disease
symptoms	NNS	I-Disease
related	VBN	O
to	TO	O
atopic	NNS	O
and	CC	O
non	JJ	O
-	:	O
atopic	NN	O
skin	NN	O
disorders	NNS	O
due	JJ	O
to	TO	O
their	PRP$	O
defect	NN	O
of	IN	O
epidermal	JJ	O
barrier	NN	O
function	NN	O
,	,	O
which	WDT	O
allows	VBZ	O
greater	JJR	O
skin	JJ	O
penetration	NN	O
of	IN	O
various	JJ	O
hazards	NNS	O
.	.	O
Epidemiological	JJ	O
studies	NNS	O
indicate	VBP	O
an	DT	O
association	NN	B-Interaction
of	IN	O
FLG	NNP	B-Gene
null	FW	B-Var
-	:	I-Var
mutations	NNS	I-Var
with	IN	O
AEDS	NNP	B-Disease
,	,	O
whereas	JJ	O
results	NNS	O
regarding	VBG	O
an	DT	O
association	NN	O
of	IN	O
FLG	NNP	O
null	FW	O
-	:	O
mutations	NNS	O
with	IN	O
sensitization	NN	O
to	TO	O
common	JJ	O
inhalant	JJ	O
allergens	NNS	O
and	CC	O
development	NN	O
of	IN	O
rhinitis	NN	O
and	CC	O
asthma	NN	O
are	VBP	O
incoherent	JJ	O
.	.	O
A	DT	O
study	NN	O
conducted	VBN	O
in	IN	O
Croatia	NNP	O
found	VBD	O
a	DT	O
low	JJ	O
frequency	NN	O
of	IN	O
FLG	NNP	O
null	FW	O
-	:	O
mutations	NNS	O
in	IN	O
general	JJ	O
population	NN	O
(	(	O
2.6%	CD	O
)	)	O
and	CC	O
did	VBD	O
not	RB	O
confirm	VB	O
FLG	NNP	O
null	JJ	O
-	:	O
mutations	NNS	O
as	IN	O
an	DT	O
etiological	JJ	O
factor	NN	O
for	IN	O
atopy	NN	O
and	CC	O
atopic	JJ	O
disease	NN	O
in	IN	O
the	DT	O
studied	JJ	O
population	NN	O

gain	NN	I-Gene
-	:	I-PosReg
of	IN	I-PosReg
mutation	NN	I-PosReg
impairs	NNS	I-Var
itch	NN	I-NegReg
sensations	NNS	I-CPA
in	IN	I-CPA
mice	NN	I-CPA



G564S	NNP	B-Var
mutation	NN	I-Var
TRPV1	NNP	B-Gene
increased	VBN	B-PosReg
basal	NN	B-CPA
current	JJ	I-CPA
leftward	JJ	B-CPA
shift	NN	I-CPA
of	IN	I-CPA
voltage	NN	I-CPA
dependence	NN	I-CPA
Intriguingly	RB	O
,	,	O
using	VBG	O
behavioral	JJ	O
analysis	NN	O
,	,	O
we	PRP	O
found	VBD	O
that	IN	O
knock	SYM	O
-	:	O
in	IN	O
mice	NN	O
showed	VBD	O
a	DT	O
thermosensory	NN	B-CPA
defect	NN	B-NegReg
,	,	O
impaired	JJ	B-NegReg
inflammatory	NN	B-MPA
thermal	JJ	I-MPA
pain	NN	I-MPA
,	,	O
and	CC	O
capsaicin	JJ	B-CPA
sensitivity	NN	I-CPA
.	.	O
We	PRP	O
also	RB	O
demonstrated	VBD	O
an	DT	O
attenuated	JJ	O
behavioral	JJ	O
response	NN	O
to	TO	O
the	DT	O
pruritic	JJ	O
agent	NN	O
histamine	NN	O
in	IN	O
the	DT	O
knock	NN	O
-	:	O
in	IN	O
mice	NN	O
.	.	O

Indeed	RB	O
,	,	O
calcium	NN	O
imaging	VBG	O
together	RB	O
with	IN	O
electrophysiology	NN	O
showed	VBD	O
that	IN	O
the	DT	O
overactive	JJ	O
mutant	NN	O
had	VBD	O
decreased	VBN	O
capsaicin	JJ	O
sensitivity	NN	O
.	.	O

Western	JJ	O
blot	NN	O
analysis	NN	O
revealed	VBD	O
that	IN	O
the	DT	O
G564S	NNP	B-Var
mutant	NN	I-Var
reduced	VBD	B-NegReg
TRPV1	NNP	B-Protein
phosphorylation	NN	B-MPA
and	CC	O
cell	NN	B-CPA
membrane	NN	I-CPA
trafficking	NN	I-CPA
.	.	O
Together	RB	O
,	,	O
we	PRP	O
have	VBP	O
generated	VBN	O
a	DT	O
mouse	NN	O
model	NN	O
with	IN	O
a	DT	O
gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutation	NN	B-Var
in	IN	O
Trpv1	NNP	B-Gene
gene	NN	O
and	CC	O
demonstrated	VBD	O
that	IN	O
the	DT	O
pain	NN	B-CPA
and	CC	I-CPA
histamine	NN	I-CPA
-	:	I-CPA
dependent	JJ	I-CPA
itch	NN	I-CPA
sensations	NNS	I-CPA
in	IN	O
these	DT	O
mice	NNS	O
are	VBP	O
impaired	JJ	B-NegReg
due	JJ	O
to	TO	O
a	DT	O
decreased	JJ	B-NegReg
phosphorylation	NN	B-MPA
level	NN	I-MPA
and	CC	O
reduced	JJ	B-NegReg
membrane	NN	B-MPA
localization	NN	I-MPA
of	IN	O
TRPV1	NNP	B-Protein



mutations	NNS	B-Var
CSF3R	NNP	B-Gene
hematologic	JJ	B-Disease
malignancies	NNS	I-Disease
To	TO	O
find	VB	O
additional	JJ	O
CSF3R	NNP	O
mutations	NNS	O
that	WDT	O
give	VBP	O
rise	NN	O
to	TO	O
cell	VB	O
transformation	NN	O
,	,	O
we	PRP	O
performed	VBD	O
a	DT	O
cellular	JJ	O
transformation	NN	O
assay	NN	O
in	IN	O
which	WDT	O
murine	NN	O
interleukin	NN	O
3	CD	O
(	(	O
IL	NNP	O
-	:	O
3	CD	O
)-	JJ	O
dependent	JJ	O
Ba	NNP	O
F3	NNP	O
cells	NNS	O
were	VBD	O
transduced	VBN	O
with	IN	O
WT	NNP	O
CSF3R	NNP	O
plasmid	NN	O
and	CC	O
screened	VBD	O
for	IN	O
spontaneous	JJ	O
growth	NN	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
IL	NNP	O
-	:	O
3	CD	O
.	.	O

Any	DT	O
outgrowth	NN	O
clones	NNS	O
were	VBD	O
sequenced	VBN	O
to	TO	O
identify	VB	O
CSF3R	NNP	O
mutations	NNS	O
with	IN	O
transformation	NN	O
capacity	NN	O
.	.	O

We	PRP	O
identified	VBD	O
several	JJ	O
novel	JJ	O
mutations	NNS	B-Var
and	CC	O
determined	VBD	O
that	IN	O
they	PRP	O
transform	VBP	B-Reg
cells	NNS	B-CPA
via	IN	O
four	CD	O
distinct	JJ	O
mechanisms	NNS	O
:	:	O
1	CD	O
)	)	O
cysteine	NN	B-MPA
-	:	I-MPA
and	CC	I-MPA
disulfide	VB	I-MPA
bond	NN	I-MPA
-	:	I-MPA
mediated	VBN	I-MPA
dimerization	NN	I-MPA
(	(	O
S581C	NNP	O
)	)	O
;	:	O
2	CD	O
)	)	O
polar	NN	B-Var
,	,	I-Var
noncharged	VBD	I-Var
amino	NN	I-Var
acid	NN	I-Var
substitution	NN	I-Var
at	IN	O
the	DT	O
transmembrane	NN	O
helix	NN	O
dimer	NN	O
interface	NN	O
at	IN	O
residue	JJ	O
Thr	NNP	O
-	:	O
640	CD	O
;	:	O
3	CD	O
)	)	O
increased	VBN	B-PosReg
internalization	NN	B-MPA
by	IN	O
a	DT	O
Glu	NNP	O
-	:	O
524	CD	O
substitution	NN	O
that	IN	O
mimics	VBZ	O
a	DT	O
low	JJ	O
G	NNP	O
-	:	O
CSF	NNP	O
dose	NN	O
;	:	O
and	CC	O
4	CD	O
)	)	O
hydrophobic	NN	B-Var
amino	NN	I-Var
acid	JJ	I-Var
substitutions	NNS	I-Var
in	IN	O
the	DT	O
membrane	NN	O
-	:	O
proximal	NN	O
residues	NNS	O
Thr	NNP	O
-	:	O
612	CD	O
,	,	O
Thr	NNP	O
-	:	O
615	CD	O
,	,	O
and	CC	O
Thr	NNP	O
-	:	O
618	CD	O
.	.	O
Furthermore	RB	O
,	,	O
the	DT	O
change	NN	O
in	IN	O
signaling	VBG	O
activation	NN	O
was	VBD	O
related	VBN	O
to	TO	O
an	DT	O
altered	JJ	O
CSF3R	NNP	O
localization	NN	O
.	.	O

We	PRP	O
also	RB	O
found	VBD	O
that	IN	O
CSF3R	NNP	O
-	:	O
induced	VBD	O
STAT3	NNP	O
and	CC	O
ERK	NNP	O
activations	NNS	O
require	VBP	O
CSF3R	NNP	O
internalization	NN	O
,	,	O
whereas	WP	O
STAT5	NNP	O
activation	NN	O
occurred	VBD	O
at	IN	O
the	DT	O
cell	NN	O
surface	NN	O
.	.	O

Cumulatively	RB	O
,	,	O
we	PRP	O
have	VBP	O
expanded	VBN	O
the	DT	O
regions	NNS	O
of	IN	O
the	DT	O
CSF3R	NNP	O
extracellular	NN	O
and	CC	O
transmembrane	NN	O
domains	NNS	O
in	IN	O
which	WDT	O
missense	JJ	B-Var
mutations	NNS	I-Var
exhibit	VBP	B-PosReg
leukemogenic	JJ	B-Disease
capacity	NN	O
and	CC	O
have	VBP	O
further	VBN	O
elucidated	VBN	O
the	DT	O
mechanistic	JJ	O
underpinnings	NNS	O
that	WDT	O
underlie	VBP	O
altered	VBN	O
CSF3R	NNP	O
expression	NN	O
,	,	O
dimerization	NN	O
,	,	O
and	CC	O
signaling	VBG	O
activation	NN	O


inactivation	NN	B-Var
leucine	JJ	B-Gene
zipper	SYM	I-Gene
-	:	I-Gene
like	IN	I-Gene
transcription	NN	I-Gene
regulator	NN	I-Gene
1	CD	I-Gene
(	(	I-Gene
LZTR1	NNP	I-Gene
)	)	I-Gene
enhanced	VB	B-PosReg
mitogen	NN	B-Pathway
-	:	I-Pathway
activated	VBN	I-Pathway
protein	JJ	I-Pathway
kinase	NN	I-Pathway
(	(	I-Pathway
MAPK	NNP	I-Pathway
)	)	I-Pathway
pathway	NN	I-Pathway
activity	NN	B-MPA
reduced	JJ	B-NegReg
sensitivity	NN	B-MPA
to	TO	I-MPA
tyrosine	VB	I-MPA
kinase	NN	I-MPA
inhibitors	NNS	I-MPA
Knockdown	NNP	O
of	IN	O
the	DT	O
Drosophila	NNP	O
LZTR1	NNP	O
ortholog	NN	O
CG3711	NNP	O
resulted	VBD	O
in	IN	O
a	DT	O
Ras	NNP	O
-	:	O
dependent	NN	O
gain	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
phenotype	NN	O
.	.	O

Endogenous	JJ	O
human	JJ	O
LZTR1	NNP	O
associates	NNS	O
with	IN	O
the	DT	O
main	JJ	O
RAS	NNP	O
isoforms	NNS	O
.	.	O

Inactivation	NN	B-Var
of	IN	O
LZTR1	NNP	B-Gene
led	VBD	O
to	TO	O
decreased	VBN	B-NegReg
ubiquitination	NN	B-MPA
and	CC	O
enhanced	VBD	B-PosReg
plasma	NNS	B-MPA
membrane	JJ	I-MPA
localization	NN	I-MPA
of	IN	I-MPA
endogenous	JJ	I-MPA
KRAS	NNP	I-MPA
(	(	O
V	NNP	O
-	:	O
Ki	NNP	O
-	:	O
ras2	NN	O
Kirsten	NNP	O
rat	VBZ	O
sarcoma	JJ	O
viral	JJ	O
oncogene	NN	O
homolog	NN	O
)	)	O
.	.	O
We	PRP	O
propose	VBP	O
that	IN	O
LZTR1	NNP	O
acts	VBZ	O
as	IN	O
a	DT	O
conserved	JJ	O
regulator	NN	O
of	IN	O
RAS	NNP	O
ubiquitination	NN	O
and	CC	O
MAPK	NNP	O
pathway	NN	O
activation	NN	O
.	.	O

Because	IN	O
LZTR1	NNP	O
disease	NN	O
mutations	NNS	O
failed	VBD	O
to	TO	O
revert	VB	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
phenotypes	NNS	O
,	,	O
our	PRP$	O
findings	NNS	O
provide	VBP	O
a	DT	O
molecular	JJ	O
rationale	NN	O
for	IN	O
LZTR1	NNP	O
involvement	NN	O
in	IN	O
a	DT	O
variety	NN	O
of	IN	O
inherited	JJ	O
and	CC	O
acquired	VBD	O
human	JJ	O
disorders	NNS	O



p53	NN	B-Gene
mutations	NNS	B-Var
grow	VB	B-CPA
aggressively	RB	B-PosReg
mutant	JJ	B-Var
p53	NN	B-Gene
up	RP	B-PosReg
-	:	I-PosReg
regulated	VBN	I-PosReg
expression	NN	B-MPA
of	IN	I-MPA
genes	NNS	I-MPA
affect	VB	B-Reg
cell	NN	B-CPA
growth	NN	I-CPA
oncogenesis	NN	B-CPA
tyrosine	JJ	B-Enzyme
kinase	NN	I-Enzyme
Axl	NNP	I-Enzyme
up	RP	B-PosReg
-	:	I-PosReg
regulated	VBN	I-PosReg
p53	NN	B-Gene
mutants	NNS	B-Var
Knockdown	NNP	O
of	IN	O
endogenous	JJ	O
mutant	JJ	O
p53	NN	O
levels	NNS	O
in	IN	O
human	JJ	O
lung	NN	O
cancer	NN	O
cells	NNS	O
H1048	NNP	O
(	(	O
p53	SYM	O
-	:	O
R273C	NN	O
)	)	O
and	CC	O
H1437	NNP	O
(	(	O
p53	SYM	O
-	:	O
R267P	NN	O
)	)	O
led	VBD	O
to	TO	O
a	DT	O
reduction	NN	O
in	IN	O
the	DT	O
level	NN	O
of	IN	O
Axl	NNP	O
as	IN	O
well	RB	O
.	.	O

This	DT	O
effect	NN	O
on	IN	O
Axl	NNP	O
expression	NN	O
is	VBZ	O
refractory	JJ	O
to	TO	O
the	DT	O
mutations	NNS	O
at	IN	O
positions	NNS	O
22	CD	O
and	CC	O
23	CD	O
of	IN	O
p53	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
p53	NN	O
's	POS	O
transactivation	NN	O
domain	NN	O
may	MD	O
not	RB	O
play	VB	O
a	DT	O
critical	JJ	O
role	NN	O
in	IN	O
the	DT	O
up	RP	O
-	:	O
regulation	NN	O
of	IN	O
Axl	NNP	O
gene	NN	O
expression	NN	O
.	.	O

Chromatin	NNP	O
immunoprecipitation	NN	O
(	(	O
ChIP	NNP	O
)	)	O
assays	NNS	O
carried	VBD	O
out	RP	O
with	IN	O
acetylated	JJ	O
histone	NN	O
antibodies	NNS	O
demonstrated	VBD	O
induced	JJ	O
histone	NN	B-Reg
acetylation	NN	B-MPA
on	IN	I-MPA
the	DT	I-MPA
Axl	NNP	I-MPA
promoter	NN	I-MPA
region	NN	I-MPA
by	IN	O
mutant	JJ	B-Var
p53	NN	B-Gene
.	.	O
Direct	JJ	O
mutant	NN	O
p53	NN	O
nucleation	NN	O
on	IN	O
the	DT	O
Axl	NNP	O
promoter	NN	O
was	VBD	O
demonstrated	VBN	O
by	IN	O
ChIP	NNP	O
assays	NNS	O
using	VBG	O
antibodies	NNS	O
against	IN	O
p53	NN	O
.	.	O

The	DT	O
Axl	NNP	O
promoter	NN	O
has	VBZ	O
a	DT	O
p53	NN	O
p63	NN	O
binding	VBG	O
site	NN	O
,	,	O
which	WDT	O
however	RB	O
is	VBZ	O
not	RB	O
required	VBN	O
for	IN	O
mutant	JJ	O
p53	NN	O
-	:	O
mediated	VBN	O
transactivation	NN	O
.	.	O

Knockdown	NNP	O
of	IN	O
Axl	NNP	O
by	IN	O
Axl	NNP	O
-	:	O
specific	JJ	O
RNAi	NNP	O
caused	VBD	O
a	DT	O
reduction	NN	O
of	IN	O
gain	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
(	(	O
GOF	NNP	O
)	)	O
activities	NNS	O
,	,	O
reducing	VBG	O
the	DT	O
cell	NN	O
growth	NN	O
rate	NN	O
and	CC	O
motility	NN	O
rate	NN	O
in	IN	O
lung	NN	O
cancer	NN	O
cells	NNS	O
expressing	VBG	O
mutant	JJ	O
p53	NN	O
.	.	O

This	DT	O
indicates	VBZ	O
that	IN	O
for	IN	O
lung	NN	O
cancer	NN	O
cell	NN	O
lines	NNS	O
with	IN	O
mutant	JJ	B-Var
p53	NN	B-Gene
,	,	O
GOF	NNP	O
activities	NNS	B-MPA
are	VBP	O
mediated	VBN	B-Reg
in	IN	O
part	NN	O
through	IN	O
Axl	NNP	B-Protein

gain	NN	B-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutations	NNS	B-Var
LRP5	NNP	B-Gene
glucose	NN	B-MPA
and	CC	I-MPA
lipid	JJ	I-MPA
homeostasis	NN	I-MPA
LRP5	NNP	B-Gene
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
profound	JJ	B-MPA
osteoporosis	NN	I-MPA
impaired	JJ	B-MPA
insulin	NN	I-MPA
sensitivity	NN	I-MPA
dysregulated	VBD	B-MPA
lipid	JJ	I-MPA
metabolism	NN	I-MPA

LRP5	NNP	B-Gene
gain	VBP	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutations	NNS	B-Var
reduction	NN	B-NegReg
serum	NN	B-MPA
LDL	NNP	I-MPA
INTRODUCTION	NN	O
:	:	O
Wnt	JJ	O
signaling	VBG	O
through	IN	O
LRP5	NNP	O
represents	VBZ	O
a	DT	O
newly	RB	O
appreciated	VBN	O
metabolic	JJ	O
pathway	NN	O
,	,	O
which	WDT	O
potentially	RB	O
represents	VBZ	O
a	DT	O
target	NN	O
for	IN	O
drug	NN	O
discovery	NN	O
in	IN	O
type	NN	O
2	CD	O
diabetes	NNS	O
and	CC	O
hyperlipidemia	NN	O
.	.	O

Studies	NNS	O
in	IN	O
animal	JJ	O
models	NNS	O
suggest	VBP	O
a	DT	O
physiologic	JJ	O
link	NN	O
between	IN	O
LRP5	NNP	O
and	CC	O
glucose	JJ	O
and	CC	O
lipid	JJ	O
homeostasis	NN	O
;	:	O
however	RB	O
,	,	O
whether	IN	O
it	PRP	O
plays	VBZ	O
a	DT	O
similar	JJ	O
role	NN	O
in	IN	O
humans	NNS	O
is	VBZ	O
unclear	JJ	O
.	.	O

As	IN	O
current	JJ	O
literature	NN	O
links	NNS	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
LRP5	NNP	O
to	TO	O
impaired	VB	O
glucose	JJ	O
and	CC	O
lipid	JJ	O
metabolism	NN	O
,	,	O
we	PRP	O
hypothesized	VBD	O
that	IN	O
individuals	NNS	O
with	IN	O
an	DT	O
HBM	NNP	O
-	:	O
causing	VBG	O
mutation	NN	O
in	IN	O
LRP5	NNP	O
would	MD	O
exhibit	VB	O
improved	JJ	O
glucose	NN	O
and	CC	O
lipid	JJ	O
homeostasis	NN	O
.	.	O

Since	IN	O
studies	NNS	O
in	IN	O
animal	NN	O
models	NNS	O
have	VBP	O
suggested	VBN	O
that	IN	O
Wnt	NNP	O
signaling	VBG	O
augments	NNS	O
insulin	JJ	O
secretion	NN	O
,	,	O
we	PRP	O
also	RB	O
examined	VBD	O
the	DT	O
effect	NN	O
of	IN	O
Wnt	NNP	O
signaling	VBG	O
on	IN	O
glucose	JJ	O
-	:	O
stimulated	VBN	O
insulin	JJ	O
secretion	NN	O
on	IN	O
human	JJ	O
pancreatic	JJ	O
islets	NNS	O
.	.	O

METHODS	NN	O
:	:	O
This	DT	O
was	VBD	O
a	DT	O
matched	JJ	O
case	NN	O
-	:	O
control	NN	O
study	NN	O
.	.	O

We	PRP	O
used	VBD	O
several	JJ	O
methods	NNS	O
to	TO	O
assess	VB	O
glucose	JJ	O
and	CC	O
lipid	JJ	O
metabolism	NN	O
in	IN	O
11	CD	O
individuals	NNS	O
with	IN	O
HBM	NNP	O
-	:	O
causing	VBG	O
mutations	NNS	O
in	IN	O
LRP5	NNP	O
.	.	O

Affected	NNP	O
study	NN	O
participants	NNS	O
were	VBD	O
recruited	VBN	O
from	IN	O
previously	RB	O
identified	VBN	O
kindreds	NNS	O
with	IN	O
HBM	NNP	O
-	:	O
causing	VBG	O
LRP5	NNP	O
mutations	NNS	O
and	CC	O
included	VBD	O
9	CD	O
males	NNS	O
and	CC	O
2	CD	O
females	NNS	O
.	.	O

Two	CD	O
subjects	NNS	O
that	WDT	O
were	VBD	O
being	VBG	O
treated	VBN	O
with	IN	O
insulin	NN	O
for	IN	O
type	NN	O
2	CD	O
diabetes	NNS	O
were	VBD	O
excluded	VBN	O
from	IN	O
our	PRP$	O
analysis	NN	O
,	,	O
as	IN	O
this	DT	O
would	MD	O
have	VB	O
obscured	VBN	O
our	PRP$	O
ability	NN	O
to	TO	O
determine	VB	O
the	DT	O
impact	NN	O
of	IN	O
gain	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
LRP5	NNP	O
mutations	NNS	O
on	IN	O
glucose	JJ	O
metabolism	NN	O
.	.	O

The	DT	O
mean	JJ	O
age	NN	O
of	IN	O
the	DT	O
evaluated	VBN	O
study	NN	O
subjects	NNS	O
was	VBD	O
55	CD	O
7	CD	O
with	IN	O
a	DT	O
mean	JJ	O
BMI	NNP	O
of	IN	O
27.2	CD	O
2.0	CD	O
.	.	O

Control	NNP	O
subjects	NNS	O
were	VBD	O
matched	VBN	O
and	CC	O
recruited	VBN	O
from	IN	O
the	DT	O
general	JJ	O
community	NN	O
at	IN	O
an	DT	O
equivalent	JJ	O
ratio	NN	O
,	,	O
with	IN	O
18	CD	O
males	NNS	O
and	CC	O
4	CD	O
females	NNS	O
(	(	O
mean	JJ	O
age	NN	O
56	CD	O
4	CD	O
;	:	O
mean	JJ	O
BMI	NNP	O
27.2	CD	O
1.0	CD	O
)	)	O
.	.	O

Study	NNP	O
testing	NN	O
was	VBD	O
conducted	VBN	O
at	IN	O
an	DT	O
academic	JJ	O
medical	JJ	O
center	NN	O
.	.	O

RESULTS	NN	O
:	:	O
There	EX	O
were	VBD	O
no	DT	O
statistically	RB	O
significant	JJ	O
differences	NNS	O
between	IN	O
affected	VBN	O
and	CC	O
matched	VBN	O
control	NN	O
populations	NNS	O
for	IN	O
HbA1c	NNP	O
(	(	O
p	VB	O
0.06	CD	O
)	)	O
,	,	O
eAG	FW	O
(	(	O
p	VB	O
0.06	CD	O
)	)	O
,	,	O
insulin	NN	O
(	(	O
p	JJ	O
0.82	CD	O
)	)	O
,	,	O
HOMA	NNP	O
-	:	O
B	NNP	O
(	(	O
p	VB	O
0.34	CD	O
)	)	O
,	,	O
or	CC	O
HOMA	NNP	O
-	:	O
IR	NNP	O
(	(	O
p	VB	O
0.66	CD	O
)	)	O
.	.	O

The	DT	O
mean	JJ	O
Insulin	NNP	O
Sensitivity	NNP	O
Index	NNP	O
(	(	O
ISI	NNP	O
)	)	O
was	VBD	O
also	RB	O
similar	JJ	O
between	IN	O
control	NN	O
and	CC	O
affected	JJ	O
individuals	NNS	O
.	.	O

Total	JJ	O
cholesterol	NN	O
(	(	O
p	JJ	O
0.43	CD	O
)	)	O
,	,	O
triglycerides	NNS	O
(	(	O
TG	NNP	O
)	)	O
(	(	O
p	$	O
0.56	CD	O
)	)	O
,	,	O
and	CC	O
HDL	NNP	O
(	(	O
p	VB	O
0.32	CD	O
)	)	O
were	VBD	O
not	RB	O
different	JJ	O
between	IN	O
the	DT	O
same	JJ	O
two	CD	O
groups	NNS	O
.	.	O

In	IN	O
a	DT	O
small	JJ	O
subset	NN	O
of	IN	O
studied	JJ	O
subjects	NNS	O
,	,	O
intramyocellular	JJ	O
and	CC	O
hepatic	JJ	O
lipid	JJ	O
content	NN	O
were	VBD	O
similar	JJ	O
in	IN	O
the	DT	O
affected	JJ	O
individuals	NNS	O
and	CC	O
controls	NNS	O
when	WRB	O
quantified	VBN	O
by	IN	O
proton	NN	O
magnetic	JJ	O
resonance	NN	O
spectroscopy	NN	O
(	(	O
MRS	NNP	O
)	)	O
.	.	O

However	RB	O
,	,	O
the	DT	O
mean	JJ	O
value	NN	O
for	IN	O
serum	NN	O
LDL	NNP	O
was	VBD	O
significantly	RB	O
lower	JJR	O
(	(	O
p	JJ	O
0.04	CD	O
)	)	O
in	IN	O
affected	JJ	O
individuals	NNS	O
.	.	O

In	IN	O
primary	JJ	O
human	JJ	O
islets	NNS	O
,	,	O
there	EX	O
were	VBD	O
no	DT	O
differences	NNS	O
between	IN	O
control	NN	O
and	CC	O
Wnt	NNP	O
treatment	NN	O
groups	NNS	O
for	IN	O
insulin	JJ	O
secretion	NN	O
measured	VBD	O
as	IN	O
area	NN	O
under	IN	O
the	DT	O
curve	NN	O
(	(	O
AUC	NNP	O
)	)	O
for	IN	O
first	JJ	O
phase	NN	O
(	(	O
p	JJ	O
0.17	CD	O
)	)	O
or	CC	O
second	JJ	O
phase	NN	O
(	(	O
p	JJ	O
0.33	CD	O
)	)	O
insulin	NN	O
secretion	NN	O
.	.	O

CONCLUSIONS	NN	O
:	:	O
Although	IN	O
our	PRP$	O
sample	JJ	O
size	NN	O
was	VBD	O
small	JJ	O
,	,	O
our	PRP$	O
data	NNS	O
do	VBP	O
not	RB	O
support	VB	O
the	DT	O
hypothesis	NN	O
that	WDT	O
HBM	NNP	O
-	:	O
causing	VBG	O
LRP5	NNP	O
mutations	NNS	O
,	,	O
associated	VBN	O
with	IN	O
increased	JJ	O
Wnt	NNP	O
signaling	NN	O
,	,	O
improve	VB	O
glucose	JJ	O
metabolism	NN	O
in	IN	O
humans	NNS	O
.	.	O

However	RB	O
,	,	O
it	PRP	O
does	VBZ	O
appear	VB	O
that	IN	O
LRP5	NNP	B-Gene
variants	NNS	B-Var
may	MD	O
affect	VB	B-Reg
LDL	NNP	B-MPA
metabolism	NN	I-MPA
,	,	O
a	DT	O
major	JJ	O
risk	NN	O
factor	NN	O
for	IN	O
coronary	JJ	O
artery	NN	O
disease	NN	O
.	.	O
The	DT	O
molecular	JJ	O
mechanisms	NN	O
underpinning	VBG	O
this	DT	O
effect	NN	O
warrant	NN	O
further	RBR	O
study	NN	O

mutation	NN	I-Gene
and	CC	I-Var
MEFV	NNP	B-Gene
single	JJ	B-Var
nucleotide	NN	I-Var
variant	NN	I-Var
tumor	NN	B-Disease
reduction	NN	B-NegReg
chronic	JJ	B-Disease
myelomonocytic	JJ	I-Disease
leukemia	NN	I-Disease

A	DT	O
mutation	NN	O
analysis	NN	O
of	IN	O
24	CD	O
patients	NNS	O
with	IN	O
CMML	NNP	O
revealed	VBD	O
the	DT	O
relationship	NN	O
of	IN	O
GC	NNP	O
effectiveness	NN	O
,	,	O
defined	VBD	O
as	IN	O
a	DT	O
monocyte	JJ	O
reduction	NN	O
of	IN	O
50%	CD	O
within	IN	O
3	CD	O
days	NNS	O
of	IN	O
methylprednisolone	NN	O
administration	NN	O
,	,	O
with	IN	O
the	DT	O
MEFV	NNP	O
single	JJ	O
-	:	O
nucleotide	NN	O
variant	NN	O
(	(	O
SNV	NNP	O
)	)	O
and	CC	O
CBL	NNP	O
mutation	NN	O
.	.	O

Lipopolysaccharide	NNP	O
-	:	O
stimulated	VBD	O
monocytes	NNS	O
harboring	VBG	O
MEFV	NNP	O
E148Q	NNP	O
produced	VBD	O
greater	JJR	O
amounts	NNS	O
of	IN	O
IL	NNP	O
-	:	O
1	CD	O
and	CC	O
TNF	NNP	O
-	:	O
than	IN	O
did	VBD	O
wild	VB	O
-	:	O
type	NN	O
monocytes	VBZ	O
;	:	O
this	DT	O
was	VBD	O
effectively	RB	O
suppressed	VBN	O
by	IN	O
GC	NNP	O
.	.	O

Primary	JJ	O
CMML	NNP	O
cells	NNS	O
harboring	VBG	O
the	DT	O
MEFV	NNP	O
SNV	NNP	O
and	CC	O
CBL	NNP	O
mutation	NN	O
,	,	O
and	CC	O
the	DT	O
myelomonocytic	JJ	O
leukemia	NN	O
cell	NN	O
line	NN	O
GDM	NNP	O
-	:	O
1	CD	O
,	,	O
harboring	VBG	O
the	DT	O
CBL	NNP	O
mutation	NN	O
,	,	O
were	VBD	O
both	DT	O
more	RBR	O
significantly	RB	O
suppressed	VBN	O
than	IN	O
non	JJ	O
-	:	O
mutated	VBN	O
cells	NNS	O
following	VBG	O
GC	NNP	O
treatment	NN	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
GM	NNP	O
-	:	O
CSF	NN	O
.	.	O

A	DT	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
CBL	NNP	B-Gene
mutation	NN	B-Var
prolonged	VBD	B-PosReg
STAT5	NNP	B-MPA
phosphorylation	NN	I-MPA
after	IN	O
GM	NNP	O
-	:	O
CSF	NNP	O
stimulation	NN	O
,	,	O
which	WDT	O
was	VBD	O
rapidly	RB	O
terminated	VBN	O
in	IN	O
both	DT	O
patient	JJ	O
samples	NNS	O
and	CC	O
GDM	NNP	O
-	:	O
1	CD	O
cells	NNS	O
.	.	O
In	IN	O
conclusion	NN	O
,	,	O
GC	NNP	O
therapy	NN	O
effectively	RB	O
treats	VBZ	O
CMML	NNP	O
cells	NNS	O
harboring	VBG	O
the	DT	O
MEFV	NNP	O
SNV	NNP	O
and	CC	O
CBL	NNP	O
mutation	NN	O
by	IN	O
reducing	VBG	O
inflammatory	JJ	O
cytokine	NN	O
production	NN	O
and	CC	O
terminating	VBG	O
prolonged	JJ	O
STAT5	NNP	O
phosphorylation	NN	O
in	IN	O
the	DT	O
GM	NNP	O
-	:	O
CSF	NNP	O
signaling	VBG	O
pathway	RB	O

of	IN	I-Var
function	NN	I-Var
ROBO1	NNP	B-Gene
associated	VBN	B-Reg
tetralogy	NN	B-Disease
of	IN	I-Disease
Fallot	NNP	I-Disease
septal	JJ	B-Disease
defects	NNS	I-Disease
BACKGROUND	NN	O
:	:	O
Congenital	JJ	O
heart	NN	O
disease	NN	O
(	(	O
CHD	NNP	O
)	)	O
is	VBZ	O
a	DT	O
common	JJ	O
birth	NN	O
defect	JJ	O
affecting	VBG	O
approximately	RB	O
1%	CD	O
of	IN	O
newborns	NNS	O
.	.	O

Great	NNP	O
progress	NN	O
has	VBZ	O
been	VBN	O
made	VBN	O
in	IN	O
elucidating	VBG	O
the	DT	O
genetic	JJ	O
aetiology	NN	O
of	IN	O
CHD	NNP	O
with	IN	O
advances	NNS	O
in	IN	O
genomic	JJ	O
technology	NN	O
,	,	O
which	WDT	O
we	PRP	O
leveraged	VBD	O
in	IN	O
recovering	VBG	O
a	DT	O
new	JJ	O
pathway	NN	O
affecting	VBG	O
heart	NN	O
development	NN	O
in	IN	O
humans	NNS	O
previously	RB	O
known	VBN	O
to	TO	O
affect	VB	O
heart	NN	O
development	NN	O
in	IN	O
an	DT	O
animal	JJ	O
model	NN	O
.	.	O

METHODS	NNS	O
:	:	O
Four	CD	O
hundred	CD	O
and	CC	O
sixteen	JJ	O
individuals	NNS	O
from	IN	O
Thailand	NNP	O
and	CC	O
the	DT	O
USA	NNP	O
diagnosed	VBD	O
with	IN	O
CHD	NNP	O
and	CC	O
or	CC	O
congenital	JJ	O
diaphragmatic	JJ	O
hernia	NN	O
were	VBD	O
evaluated	VBN	O
with	IN	O
chromosomal	JJ	O
microarray	NN	O
and	CC	O
whole	JJ	O
exome	NN	O
sequencing	NN	O
.	.	O

The	DT	O
DECIPHER	NNP	O
Consortium	NNP	O
and	CC	O
medical	JJ	O
literature	NN	O
were	VBD	O
searched	VBN	O
for	IN	O
additional	JJ	O
patients	NNS	O
.	.	O

Murine	NNP	O
hearts	NNS	O
from	IN	O
ENU	NNP	O
-	:	O
induced	JJ	O
mouse	NN	O
mutants	NNS	O
and	CC	O
transgenic	JJ	O
mice	NNS	O
were	VBD	O
evaluated	VBN	O
using	VBG	O
both	DT	O
episcopic	JJ	O
confocal	JJ	O
histopathology	NN	O
and	CC	O
troponin	NN	O
I	PRP	O
stained	VBD	O
sections	NNS	O
.	.	O

RESULTS	NNS	O
:	:	O
Loss	NNP	O
of	IN	O
function	NN	O
ROBO1	NNP	O
variants	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
three	CD	O
families	NNS	O
;	:	O
each	DT	O
proband	NN	O
had	VBD	O
a	DT	O
ventricular	JJ	O
septal	NN	O
defect	NN	O
,	,	O
and	CC	O
one	CD	O
proband	NN	O
had	VBD	O
tetralogy	NN	O
of	IN	O
Fallot	NNP	O
.	.	O

Additionally	RB	O
,	,	O
a	DT	O
microdeletion	NN	O
in	IN	O
an	DT	O
individual	NN	O
with	IN	O
CHD	NNP	O
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
medical	JJ	O
literature	NN	O
.	.	O

Mouse	NNP	O
models	NNS	O
showed	VBD	O
perturbation	NN	O
of	IN	O
the	DT	O
Slit	NNP	O
-	:	O
Robo	NNP	O
signalling	VBG	O
pathway	RB	O
,	,	O
causing	VBG	O
septation	NN	O
and	CC	O
outflow	JJ	O
tract	NN	O
defects	NNS	O
and	CC	O
craniofacial	JJ	O
anomalies	NNS	O
.	.	O

Two	CD	O
probands	NNS	O
had	VBD	O
variable	JJ	O
facial	JJ	O
features	NNS	O
consistent	JJ	O
with	IN	O
the	DT	O
mouse	NN	O
model	NN	O
.	.	O

CONCLUSION	NN	O
:	:	O
Our	PRP$	O
findings	NNS	O
identify	VB	O
Slit	NNP	O
-	:	O
Robo	NNP	O
as	IN	O
a	DT	O
significant	JJ	O
pathway	NN	O
in	IN	O
human	JJ	O
heart	NN	O
development	NN	O
and	CC	O
CHD	NNP	O




The	DT	O
retention	NN	O
and	CC	O
splicing	NN	O
(	(	O
RES	NNP	O
)	)	O
complex	NN	O
is	VBZ	O
formed	VBN	O
by	IN	O
three	CD	O
different	JJ	O
proteins	NNS	O
(	(	O
Bud13p	NNP	O
,	,	O
Pml1p	NNP	O
and	CC	O
Snu17p	NNP	O
)	)	O
and	CC	O
is	VBZ	O
involved	VBN	O
in	IN	O
splicing	VBG	O
in	IN	O
yeast	NN	O
.	.	O

However	RB	O
,	,	O
the	DT	O
importance	NN	O
of	IN	O
the	DT	O
RES	NNP	O
complex	NN	O
for	IN	O
vertebrate	NN	O
splicing	NN	O
,	,	O
the	DT	O
intronic	JJ	O
features	NNS	O
associated	VBN	O
with	IN	O
its	PRP$	O
activity	NN	O
,	,	O
and	CC	O
its	PRP$	O
role	NN	O
in	IN	O
development	NN	O
are	VBP	O
unknown	JJ	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
have	VBP	O
generated	VBN	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutants	NNS	B-Var
for	IN	O
the	DT	O
three	CD	O
components	NNS	O
of	IN	O
the	DT	O
RES	NNP	O
complex	NN	O
in	IN	O
zebrafish	NN	O
and	CC	O
showed	VBD	O
that	IN	O
they	PRP	O
are	VBP	O
required	VBN	O
during	IN	O
early	JJ	O
development	NN	O
.	.	O
The	DT	O
mutants	NNS	O
showed	VBD	O
a	DT	O
marked	JJ	O
neural	JJ	O
phenotype	NN	O
with	IN	O
increased	VBN	B-PosReg
cell	NN	B-CPA
death	NN	I-CPA
in	IN	I-CPA
the	DT	I-CPA
brain	NN	I-CPA
and	CC	O
a	DT	O
decrease	NN	B-NegReg
in	IN	O
differentiated	JJ	B-CPA
neurons	NNS	I-CPA
.	.	O
Transcriptomic	JJ	O
analysis	NN	O
of	IN	O
bud13	NN	B-Gene
,	,	O
snip1	NN	B-Gene
(	(	I-Gene
pml1	NN	I-Gene
)	)	I-Gene
and	CC	O
rbmx2	NN	B-Gene
(	(	I-Gene
snu17	NN	I-Gene
)	)	I-Gene
mutants	NNS	B-Var
revealed	VBD	O
a	DT	O
global	JJ	O
defect	NN	B-NegReg
in	IN	O
intron	NN	B-MPA
splicing	NN	I-MPA
,	,	O
with	IN	O
strong	JJ	O
mis	NNS	B-MPA
-	:	I-MPA
splicing	NN	I-MPA
of	IN	I-MPA
a	DT	I-MPA
subset	NN	I-MPA
of	IN	I-MPA
introns	NNS	I-MPA
.	.	O
We	PRP	O
found	VBD	O
these	DT	O
RES	NNP	O
-	:	O
dependent	JJ	O
introns	NNS	O
were	VBD	O
short	JJ	O
,	,	O
rich	JJ	O
in	IN	O
GC	NNP	O
and	CC	O
flanked	VBN	O
by	IN	O
GC	NNP	O
depleted	VBD	O
exons	NNS	O
,	,	O
all	DT	O
of	IN	O
which	WDT	O
are	VBP	O
features	NNS	O
associated	VBN	O
with	IN	O
intron	JJ	O
definition	NN	O
.	.	O

Using	VBG	O
these	DT	O
features	NNS	O
,	,	O
we	PRP	O
developed	VBD	O
and	CC	O
validated	VBD	O
a	DT	O
predictive	JJ	O
model	NN	O
that	IN	O
classifies	VBZ	O
RES	NNP	O
dependent	JJ	O
introns	NNS	O
.	.	O

Altogether	RB	O
,	,	O
our	PRP$	O
study	NN	O
uncovers	VBZ	O
the	DT	O
essential	JJ	O
role	NN	O
of	IN	O
the	DT	O
RES	NNP	O
complex	JJ	O
during	IN	O
vertebrate	NN	O
development	NN	O
and	CC	O
provides	VBZ	O
new	JJ	O
insights	NNS	O
into	IN	O
its	PRP$	O
function	NN	O
during	IN	O
splicing	VBG	O







catenin	NN	I-Protein
loss	NN	B-NegReg
gain	VB	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutants	NNS	B-Var
clefts	NNS	B-CPA
in	IN	I-CPA
the	DT	I-CPA
perineal	JJ	I-CPA
region	NN	I-CPA
hypoplastic	JJ	B-CPA
elongation	NN	I-CPA
of	IN	I-CPA
the	DT	I-CPA
URS	NNP	I-CPA
The	DT	O
mutants	NNS	B-Var
also	RB	O
displayed	VBD	O
reduced	VBN	B-NegReg
cell	NN	B-CPA
proliferation	NN	I-CPA
in	IN	I-CPA
the	DT	I-CPA
URS	NNP	I-CPA
mesenchyme	NN	I-CPA
.	.	O
In	IN	O
addition	NN	O
,	,	O
the	DT	O
catenin	NN	I-Protein
GOF	NNP	O
mutants	NNS	B-Var
displayed	VBD	O
reduced	VBN	O
apoptosis	NN	O
and	CC	O
subsequently	RB	O
increased	VBD	O
apoptosis	NN	O
in	IN	O
the	DT	O
URS	NNP	O
epithelium	NN	O
.	.	O
This	DT	O
instability	NN	O
possibly	RB	O
resulted	VBD	O
in	IN	O
reduced	JJ	B-NegReg
expression	NN	B-MPA
levels	NNS	I-MPA
of	IN	O
differentiation	NN	O
markers	NNS	O
,	,	O
such	JJ	O
as	IN	O
keratin	NN	B-Protein
1	CD	I-Protein
and	CC	O
filaggrin	NN	B-Protein
,	,	O
in	IN	O
the	DT	O
perineal	NN	O
epithelia	NN	O
.	.	O
The	DT	O
expression	NN	B-MPA
of	IN	O
bone	NN	B-Gene
morphogenetic	JJ	I-Gene
protein	NN	I-Gene
(	(	I-Gene
Bmp	NNP	I-Gene
)	)	I-Gene
genes	NNS	I-Gene
,	,	O
such	JJ	O
as	IN	O
Bmp4	NNP	B-Gene
and	CC	O
Bmp7	NNP	B-Gene
,	,	O
was	VBD	O
also	RB	O
ectopically	RB	O
induced	VBN	B-PosReg
in	IN	O
the	DT	O
epithelia	NN	O
of	IN	O
the	DT	O
URS	NNP	O
in	IN	O
the	DT	O
catenin	NN	I-Protein
GOF	NNP	O
mutants	NNS	B-Var
.	.	O
The	DT	O
expression	NN	B-MPA
of	IN	O
the	DT	O
Msx2	NNP	B-Gene
gene	NN	I-Gene
and	CC	O
phosphorylated	VBD	O
-	:	O
Smad1	NNP	O
5	CD	O
8	CD	O
,	,	O
possible	JJ	O
readouts	NNS	B-MPA
of	IN	I-MPA
Bmp	NNP	I-MPA
signaling	VBG	I-MPA
,	,	O
was	VBD	O
also	RB	O
increased	VBN	B-PosReg
in	IN	O
the	DT	O
mutants	NNS	B-Var
.	.	O
Moreover	RB	O
,	,	O
we	PRP	O
introduced	VBD	O
an	DT	O
additional	JJ	O
mutation	NN	O
for	IN	O
a	DT	O
Bmp	NNP	O
receptor	NN	O
gene	NN	O
:	:	O
BmprIA	NNP	O
.	.	O

The	DT	O
Shh	NNP	O
(	(	O
CreERT2	NNP	O
)	)	O
;	:	O
-	:	O
catenin	NN	O
(	(	O
flox	JJ	O
(	(	O
ex3	FW	O
)	)	O
)	)	O
;	:	O
BmprIA	NNP	O
(	(	O
flox	JJ	O
-)	NN	O
mutants	NNS	O
displayed	VBD	O
partial	JJ	O
restoration	NN	O
of	IN	O
URS	NNP	O
elongation	NN	O
compared	VBN	O
with	IN	O
the	DT	O
-	:	O
catenin	NN	O
GOF	NNP	O
mutants	NNS	O
.	.	O

These	DT	O
results	NNS	O
indicate	VBP	O
that	IN	O
some	DT	O
ARM	NNP	B-Disease
phenotypes	NNS	O
in	IN	O
the	DT	O
catenin	NN	I-Protein
GOF	NNP	B-PosReg
mutants	NNS	B-Var
were	VBD	O
caused	VBN	B-Reg
by	IN	I-Reg
abnormal	JJ	O
Bmp	NNP	B-MPA
signaling	NN	I-MPA
.	.	O
The	DT	O
current	JJ	O
analysis	NN	O
revealed	VBD	O
the	DT	O
close	JJ	O
relation	NN	O
of	IN	O
endodermal	JJ	O
-	:	O
catenin	NN	O
signaling	VBG	O
to	TO	O
the	DT	O
ARM	NNP	O
phenotypes	NNS	O
.	.	O

These	DT	O
results	NNS	O
are	VBP	O
considered	VBN	O
to	TO	O
shed	VB	O
light	NN	O
on	IN	O
the	DT	O
pathogenic	JJ	O
mechanisms	NN	O
of	IN	O
human	JJ	O
ARMs	NNP	O

deficiency	NN	I-Gene
results	NNS	I-Var
increased	JJ	B-PosReg
ectopic	NN	B-MPA
accumulation	NN	I-MPA


Methods	NNS	O
Subjects	NNS	O
from	IN	O
the	DT	O
PLIC	NNP	O
cohort	NN	O
were	VBD	O
genotyped	VBN	O
for	IN	O
the	DT	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
PCSK9	NNP	O
R46L	NNP	O
variant	NN	O
and	CC	O
characterized	VBN	O
for	IN	O
clinical	JJ	O
and	CC	O
biochemical	JJ	O
parameters	NNS	O
,	,	O
total	JJ	O
and	CC	O
android	JJ	O
fat	JJ	O
mass	NN	O
,	,	O
hepatic	JJ	O
steatosis	NN	O
and	CC	O
epicardial	JJ	O
fat	NN	O
thickness	NN	O
.	.	O

Visceral	NNP	O
adipose	JJ	O
tissue	NN	O
and	CC	O
subcutaneous	JJ	O
adipose	JJ	O
tissue	NN	O
in	IN	O
PCSK9	NNP	O
KO	NNP	O
and	CC	O
wild	JJ	O
type	NN	O
mice	NN	O
were	VBD	O
quantified	VBN	O
by	IN	O
nuclear	JJ	O
magnetic	JJ	O
resonance	NN	O
imaging	NN	O
.	.	O

Results	JJ	O
Carriers	NNS	O
of	IN	O
the	DT	O
R46L	NNP	O
variant	NN	O
(	(	O
n	JJ	O
13	CD	O
)	)	O
had	VBD	O
lower	JJR	O
low	JJ	O
-	:	O
density	NN	O
lipoprotein	VBP	O
cholesterol	NN	O
levels	NNS	O
,	,	O
higher	JJR	O
body	NN	O
mass	NN	O
index	NN	O
and	CC	O
increased	VBD	O
percentage	NN	O
of	IN	O
total	JJ	O
and	CC	O
android	JJ	O
fat	NN	O
masses	NNS	O
compared	VBN	O
with	IN	O
non	JJ	O
-	:	O
carriers	NNS	O
(	(	O
n	RB	O
521	CD	O
)	)	O
.	.	O

R46L	NNP	B-Gene
variant	NN	B-Var
associated	VBN	O
with	IN	O
a	DT	O
two	CD	O
-	:	O
fold	JJ	O
increase	NN	B-PosReg
prevalence	NN	O
of	IN	O
hepatic	JJ	B-MPA
steatosis	NN	I-MPA
and	CC	I-MPA
higher	JJR	I-MPA
epicardial	JJ	I-MPA
fat	NN	I-MPA
thickness	NN	I-MPA
.	.	O
These	DT	O
observations	NNS	O
were	VBD	O
replicated	VBN	O
in	IN	O
PCSK9	NNP	O
KO	NNP	O
mice	NN	O
,	,	O
which	WDT	O
showed	VBD	O
increased	VBD	O
visceral	JJ	O
adipose	JJ	O
tissue	NN	O
(	(	O
but	CC	O
not	RB	O
subcutaneous	JJ	O
adipose	JJ	O
tissue	NN	O
)	)	O
when	WRB	O
fed	VBN	O
chow	NN	O
or	CC	O
high	JJ	O
-	:	O
fat	JJ	O
diet	NN	O
for	IN	O
20	CD	O
weeks	NNS	O
,	,	O
compared	VBN	O
with	IN	O
wild	JJ	O
type	JJ	O
mice	NN	O
.	.	O

Conclusions	NNS	O
These	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
genetically	RB	O
determined	VBN	O
PCSK9	NNP	B-Gene
deficiency	NN	B-Var
might	MD	O
be	VB	O
associated	VBN	B-Reg
with	IN	O
ectopic	NN	B-MPA
fat	JJ	I-MPA
accumulation	NN	I-MPA



Here	RB	O
we	PRP	O
report	VBP	O
that	DT	O
germline	JJ	O
loss	NN	B-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
in	IN	O
TRIM28	NNP	B-Gene
predispose	JJ	O
children	NNS	O
to	TO	O
Wilms	VB	B-Disease
tumour	NN	I-Disease
.	.	O
Loss	NNP	O
of	IN	O
function	NN	O
of	IN	O
this	DT	O
transcriptional	JJ	O
co	NN	O
-	:	O
repressor	NN	O
,	,	O
which	WDT	O
has	VBZ	O
a	DT	O
role	NN	O
in	IN	O
nephrogenesis	NN	O
,	,	O
has	VBZ	O
not	RB	O
previously	RB	O
been	VBN	O
associated	VBN	O
with	IN	O
cancer	NN	O
.	.	O

Inactivation	NN	B-NegReg
of	IN	O
TRIM28	NNP	B-Gene
,	,	O
either	RB	O
germline	NN	O
or	CC	O
somatic	JJ	O
,	,	O
occurred	VBD	O
through	IN	O
inactivating	NN	B-Var
mutations	NNS	I-Var
,	,	O
loss	NN	B-Var
of	IN	I-Var
heterozygosity	NN	I-Var
or	CC	O
epigenetic	JJ	B-Var
silencing	NN	I-Var
.	.	O
TRIM28	NNP	O
-	:	O
mutated	VBD	O
tumours	NNS	O
had	VBD	O
a	DT	O
monomorphic	JJ	O
epithelial	JJ	O
histology	NN	O
that	WDT	O
is	VBZ	O
uncommon	JJ	O
for	IN	O
Wilms	NNP	O
tumour	NN	O
.	.	O

Critically	RB	O
,	,	O
these	DT	O
tumours	NNS	O
were	VBD	O
negative	JJ	O
for	IN	O
TRIM28	NNP	O
immunohistochemical	JJ	O
staining	VBG	O
whereas	IN	O
the	DT	O
epithelial	JJ	O
component	NN	O
in	IN	O
normal	JJ	O
tissue	NN	O
and	CC	O
other	JJ	O
Wilms	NNP	O
tumours	NNS	O
stained	VBD	O
positively	RB	O
.	.	O

These	DT	O
data	NNS	O
,	,	O
together	RB	O
with	IN	O
a	DT	O
characteristic	JJ	O
gene	NN	O
expression	NN	O
profile	NN	O
,	,	O
suggest	VBP	O
that	IN	O
inactivation	NN	O
of	IN	O
TRIM28	NNP	O
provides	VBZ	O
the	DT	O
molecular	JJ	O
basis	NN	O
for	IN	O
defining	VBG	O
a	DT	O
previously	RB	O
described	VBN	O
subtype	NN	O
of	IN	O
Wilms	NNP	O
tumour	NN	O
,	,	O
that	WDT	O
has	VBZ	O
early	JJ	O
age	NN	O
of	IN	O
onset	NN	O
and	CC	O
excellent	JJ	O
prognosis	NN	O


Atopic	NNP	B-Disease
eczema	NN	I-Disease
Null	JJ	B-Var
mutations	NNS	I-Var
FLG	NNP	B-Gene
predispose	VB	B-Reg
AE	NNP	B-Disease

METHODS	NN	O
:	:	O
Differentially	RB	O
expressed	VBD	O
proteins	NNS	O
from	IN	O
paired	VBN	O
control	NN	O
(	(	O
nontargeting	VBG	O
control	NN	O
short	JJ	O
hairpin	NN	O
RNA	NNP	O
[	NNP	O
shNT	NN	O
])	NN	O
and	CC	O
FLG	NNP	O
knockdown	NNP	O
(	(	O
FLG	NNP	O
knockdown	VBN	O
short	JJ	O
hairpin	NN	O
RNA	NNP	O
[	NNP	O
shFLG	VBD	O
])	JJ	O
LSEs	NNP	O
were	VBD	O
identified	VBN	O
by	IN	O
means	NNS	O
of	IN	O
proteomic	JJ	O
analysis	NN	O
(	(	O
liquid	JJ	O
chromatography	NN	O
-	:	O
mass	NN	O
spectrometry	NN	O
)	)	O
and	CC	O
Ingenuity	NNP	O
Pathway	NNP	O
Analysis	NNP	O
.	.	O

Expression	NN	O
of	IN	O
key	JJ	O
targets	NNS	O
was	VBD	O
validated	VBN	O
in	IN	O
independent	JJ	O
LSE	NNP	O
samples	NNS	O
(	(	O
quantitative	JJ	O
RT	NNP	O
-	:	O
PCR	NN	O
and	CC	O
Western	NNP	O
blotting	NN	O
)	)	O
and	CC	O
in	IN	O
normal	JJ	O
and	CC	O
AE	NNP	O
skin	VBP	O
biopsy	NN	O
specimens	NNS	O
(	(	O
immunofluorescence	NN	O
)	)	O
.	.	O

RESULTS	NN	O
:	:	O
Proteomic	JJ	O
analysis	NN	O
identified	VBD	O
17	CD	O
(	(	O
P	NNP	O
.	.	O
05	CD	O
)	)	O
differentially	RB	O
expressed	VBN	O
proteins	NNS	O
after	IN	O
FLG	NNP	O
knockdown	NN	O
,	,	O
including	VBG	O
kallikrein	SYM	O
-	:	O
7	CD	O
(	(	O
KLK7	NNP	O
;	:	O
2.2	CD	O
-	:	O
fold	NN	O
)	)	O
,	,	O
cyclophilin	VBZ	O
A	NNP	O
(	(	O
PPIA	NNP	O
;	:	O
0.9	CD	O
-	:	O
fold	NN	O
)	)	O
,	,	O
and	CC	O
cofilin	SYM	O
-	:	O
1	CD	O
(	(	O
CFL1	NNP	O
,	,	O
1.3	CD	O
-	:	O
fold	NN	O
)	)	O
.	.	O

Differential	NNP	O
protein	NN	O
expression	NN	O
was	VBD	O
confirmed	VBN	O
in	IN	O
shNT	NN	O
shFLG	NN	O
LSEs	NNP	O
;	:	O
however	RB	O
,	,	O
only	RB	O
KLK7	NNP	O
was	VBD	O
transcriptionally	RB	O
dysregulated	VBN	O
.	.	O

Molecular	JJ	B-Pathway
pathways	NNS	I-Pathway
overrepresented	VBN	B-PosReg
after	IN	O
FLG	NNP	B-Gene
knockdown	NN	B-Var
included	VBD	O
inflammation	NN	O
,	,	O
protease	NN	O
activity	NN	O
,	,	O
cell	NN	O
structure	NN	O
,	,	O
and	CC	O
stress	NN	O
.	.	O
Furthermore	RB	O
,	,	O
KLK7	NNP	O
(	(	O
1.8	CD	O
-	:	O
fold	NN	O
)	)	O
and	CC	O
PPIA	NNP	O
(	(	O
0.65	CD	O
-	:	O
fold	NN	O
)	)	O
proteins	NNS	O
were	VBD	O
differentially	RB	O
expressed	VBN	O
in	IN	O
lesional	JJ	O
biopsy	NN	O
specimens	NNS	O
from	IN	O
patients	NNS	O
with	IN	O
AE	NNP	O
relative	VBP	O
to	TO	O
normal	JJ	O
skin	NN	O
.	.	O

CONCLUSIONS	NN	O
:	:	O
For	IN	O
the	DT	O
first	JJ	O
time	NN	O
,	,	O
we	PRP	O
show	VBP	O
that	IN	O
loss	NN	B-Var
of	IN	O
FLG	NNP	B-Gene
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
inflammation	NN	O
is	VBZ	O
sufficient	JJ	O
to	TO	O
alter	VB	B-Reg
the	DT	O
expression	NN	B-MPA
level	NN	I-MPA
of	IN	I-MPA
proteins	NNS	I-MPA
relevant	JJ	O
to	TO	O
the	DT	O
pathogenesis	NN	O
of	IN	O
AE	NNP	O
.	.	O
These	DT	O
include	VBP	O
proteins	NNS	O
regulating	VBG	O
inflammatory	NN	O
,	,	O
proteolytic	JJ	O
,	,	O
and	CC	O
cytoskeletal	JJ	O
functions	NNS	O
.	.	O

We	PRP	O
identify	VBP	O
PPIA	NNP	O
as	IN	O
a	DT	O
novel	JJ	O
protein	NN	O
with	IN	O
levels	NNS	O
that	WDT	O
are	VBP	O
decreased	VBN	O
in	IN	O
clinically	RB	O
active	JJ	O
AE	NNP	O
skin	NN	O
and	CC	O
show	NN	O
that	IN	O
the	DT	O
characteristic	JJ	O
upregulation	NN	O
of	IN	O
KLK7	NNP	O
expression	NN	O
in	IN	O
patients	NNS	O
with	IN	O
AE	NNP	O
occurs	VBZ	O
downstream	NN	O
of	IN	O
FLG	NNP	O
loss	NN	O
.	.	O

Importantly	RB	O
,	,	O
we	PRP	O
highlight	VBD	O
disconnect	NN	O
between	IN	O
the	DT	O
epidermal	JJ	O
proteome	NN	O
and	CC	O
transcriptome	NN	O
,	,	O
emphasizing	VBG	O
the	DT	O
utility	NN	O
of	IN	O
global	JJ	O
proteomic	JJ	O
studies	NNS	O

EGFR	NNP	B-Gene
Mutation	NNP	B-Var
Positive	NNP	B-Reg
Non	NNP	B-Disease
-	:	I-Disease
Small	NN	I-Disease
Cell	NNP	I-Disease
Lung	NNP	I-Disease
Cancer	NNP	I-Disease
BACKGROUND	NN	O
:	:	O
This	DT	O
study	NN	O
aimed	VBD	O
to	TO	O
identify	VB	O
independent	JJ	O
prognostic	JJ	O
factors	NNS	O
for	IN	O
overall	JJ	O
survival	NN	O
(	(	O
OS	NNP	O
)	)	O
of	IN	O
patients	NNS	O
with	IN	O
advanced	JJ	O
non	JJ	O
-	:	O
small	JJ	O
cell	NN	O
lung	NN	O
cancer	NN	O
(	(	O
NSCLC	NNP	O
)	)	O
harboring	VBG	O
an	DT	O
activating	VBG	O
epidermal	JJ	O
growth	NN	O
factor	NN	O
receptor	NN	O
(	(	O
EGFR	NNP	O
)	)	O
mutation	NN	O
and	CC	O
receiving	VBG	O
gefitinib	NN	O
as	IN	O
first	JJ	O
-	:	O
line	NN	O
treatment	NN	O
in	IN	O
real	JJ	O
-	:	O
world	NN	O
practice	NN	O
.	.	O

MATERIALS	NNP	O
AND	CC	O
METHODS	NNP	O
:	:	O
We	PRP	O
enrolled	VBD	O
226	CD	O
patients	NNS	O
from	IN	O
June	NNP	O
2011	CD	O
to	TO	O
May	NNP	O
2013	CD	O
.	.	O

During	IN	O
this	DT	O
period	NN	O
,	,	O
gefitinib	NN	O
was	VBD	O
the	DT	O
only	JJ	O
EGFR	NNP	O
-	:	O
tyrosine	NN	O
kinase	NN	O
inhibitor	NN	O
reimbursed	VBN	O
by	IN	O
the	DT	O
Bureau	NNP	O
of	IN	O
National	NNP	O
Health	NNP	O
Insurance	NNP	O
of	IN	O
Taiwan	NNP	O
.	.	O

RESULTS	NN	O
:	:	O
The	DT	O
median	JJ	O
progression	NN	O
-	:	O
free	JJ	O
survival	NN	O
and	CC	O
median	JJ	O
OS	NNP	O
were	VBD	O
11.9	CD	O
months	NNS	O
(	(	O
95%	CD	O
confidence	NN	O
interval	NN	O
[	NNP	O
CI	NNP	O
]	NN	O
:	:	O
9.7	CD	O
-	:	O
14.2	CD	O
)	)	O
and	CC	O
26.9	CD	O
months	NNS	O
(	(	O
21.2	CD	O
-	:	O
32.5	CD	O
)	)	O
,	,	O
respectively	RB	O
.	.	O

The	DT	O
Cox	NNP	O
proportional	JJ	O
hazards	NNS	O
regression	NN	O
model	NN	O
revealed	VBD	O
that	IN	O
postoperative	JJ	O
recurrence	NN	O
,	,	O
performance	NN	O
status	NN	O
(	(	O
Eastern	NNP	O
Cooperative	NNP	O
Oncology	NNP	O
Grade	NNP	O
[	NNP	O
ECOG	NNP	O
]	NNP	O
2	CD	O
)	)	O
,	,	O
smoking	VBG	O
index	NN	O
(	(	O
20	CD	O
pack	NN	O
-	:	O
years	NNS	O
)	)	O
,	,	O
liver	JJ	O
metastasis	NN	O
at	IN	O
initial	JJ	O
diagnosis	NN	O
,	,	O
and	CC	O
chronic	JJ	O
hepatitis	NN	O
C	NNP	O
virus	NN	O
(	(	O
HCV	NNP	O
)	)	O
infection	NN	O
were	VBD	O
independent	JJ	O
prognostic	JJ	O
factors	NNS	O
for	IN	O
OS	NNP	O
(	(	O
hazard	JJ	O
ratio	NN	O
[	VBD	O
95%	CD	O
CI	NNP	O
]	VBD	O
0.3	CD	O
[	NN	O
0.11	CD	O
-	:	O
0.83	CD	O
]	NN	O
,	,	O
p	NN	O
.	.	O
02	CD	O
;	:	O
2.69	CD	O
[	$	O
1.60	CD	O
-	:	O
4.51	CD	O
]	NN	O
,	,	O
p	NN	O
.	.	O
001	CD	O
;	:	O
1.92	CD	O
[	$	O
1.24	CD	O
-	:	O
2.97	CD	O
]	NN	O
,	,	O
p	NN	O
.	.	O
003	CD	O
;	:	O
2.26	CD	O
[	$	O
1.34	CD	O
-	:	O
3.82	CD	O
]	NN	O
,	,	O
p	NN	O
.	.	O
002	CD	O
;	:	O
3.38	CD	O
[	$	O
1.85	CD	O
-	:	O
7.78	CD	O
]	NN	O
,	,	O
p	NN	O
.	.	O
001	CD	O
,	,	O
respectively	RB	O
)	)	O
.	.	O

However	RB	O
,	,	O
brain	NN	O
metastasis	NN	O
(	(	O
BM	NNP	O
)	)	O
at	IN	O
initial	JJ	O
diagnosis	NN	O
or	CC	O
intracranial	JJ	O
progression	NN	O
during	IN	O
gefitinib	JJ	O
treatment	NN	O
had	VBD	O
no	DT	O
impact	NN	O
on	IN	O
OS	NNP	O
(	(	O
1.266	CD	O
[	RB	O
0.83	CD	O
-	:	O
1.93	CD	O
]	NN	O
,	,	O
p	NN	O
.	.	O
275	CD	O
and	CC	O
0.75	CD	O
[	NN	O
0.48	CD	O
-	:	O
1.19	CD	O
]	NN	O
,	,	O
p	NN	O
.	.	O
211	CD	O
,	,	O
respectively	RB	O
)	)	O
.	.	O

CONCLUSION	NN	O
:	:	O
HCV	NNP	O
infection	NN	O
,	,	O
performance	NN	O
status	NN	O
(	(	O
ECOG	NNP	O
2	CD	O
)	)	O
,	,	O
newly	RB	O
diagnosed	VBN	O
advanced	JJ	O
NSCLC	NNP	O
without	IN	O
prior	JJ	O
operation	NN	O
,	,	O
and	CC	O
liver	RB	O
metastasis	NN	O
predicted	VBD	O
poor	JJ	O
OS	NNP	O
in	IN	O
EGFR	NNP	O
mutation	NN	O
-	:	O
positive	JJ	O
advanced	JJ	O
NSCLC	NNP	O
patients	NNS	O
treated	VBD	O
with	IN	O
first	JJ	O
-	:	O
line	NN	O
gefitinib	NN	O
;	:	O
however	RB	O
,	,	O
neither	CC	O
BM	NNP	O
at	IN	O
initial	JJ	O
diagnosis	NN	O
nor	CC	O
intracranial	JJ	O
progression	NN	O
during	IN	O
gefitinib	JJ	O
treatment	NN	O
had	VBD	O
an	DT	O
impact	NN	O
on	IN	O
OS	NNP	O
.	.	O

The	DT	O
Oncologist	NNP	O
2017	CD	O
;	:	O
22	CD	O
:	:	O
1	CD	O
-	:	O
9	CD	O
IMPLICATIONS	NNP	O
FOR	NNP	O
PRACTICE	NNP	O
:	:	O
The	DT	O
finding	NN	O
that	WDT	O
chronic	JJ	O
hepatitis	NN	O
C	NNP	O
virus	NN	O
(	(	O
HCV	NNP	O
)	)	O
infection	NN	O
might	MD	O
predict	VB	O
poor	JJ	O
overall	JJ	O
survival	NN	O
(	(	O
OS	NNP	O
)	)	O
in	IN	O
epidermal	JJ	O
growth	NN	O
factor	NN	O
receptor	NN	O
mutation	NN	O
-	:	O
positive	JJ	O
advanced	JJ	O
non	SYM	O
-	:	O
small	JJ	O
cell	NN	O
lung	NN	O
cancer	NN	O
(	(	O
NSCLC	NNP	O
)	)	O
patients	NNS	O
treated	VBN	O
with	IN	O
first	JJ	O
-	:	O
line	NN	O
gefitinib	NN	O
may	MD	O
raise	VB	O
awareness	NN	O
of	IN	O
benefit	NN	O
from	IN	O
anti	JJ	O
-	:	O
HCV	NNP	O
treatment	NN	O
in	IN	O
this	DT	O
patient	JJ	O
population	NN	O
.	.	O

Brain	NNP	O
metastasis	NN	O
in	IN	O
the	DT	O
initial	JJ	O
diagnosis	NN	O
or	CC	O
intracranial	JJ	O
progression	NN	O
during	IN	O
gefitinib	JJ	O
treatment	NN	O
is	VBZ	O
not	RB	O
a	DT	O
prognostic	JJ	O
factor	NN	O
for	IN	O
OS	NNP	O
.	.	O

This	DT	O
study	NN	O
,	,	O
which	WDT	O
enrolled	VBD	O
a	DT	O
real	JJ	O
-	:	O
world	NN	O
population	NN	O
of	IN	O
NSCLC	NNP	O
patients	NNS	O
,	,	O
including	VBG	O
sicker	NN	O
patients	NNS	O
who	WP	O
were	VBD	O
not	RB	O
eligible	JJ	O
for	IN	O
a	DT	O
clinical	JJ	O
trial	NN	O
,	,	O
may	MD	O
have	VB	O
impact	NN	O
on	IN	O
guiding	VBG	O
usual	JJ	O
clinical	JJ	O
practice	NN	O



However	RB	O
,	,	O
no	DT	O
valid	JJ	O
predictive	NN	O
markers	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
to	TO	O
guide	VB	O
treatment	NN	O
selection	NN	O
and	CC	O
identify	JJ	O
patients	NNS	O
who	WP	O
are	VBP	O
sensitive	JJ	O
to	TO	O
these	DT	O
drugs	NNS	O
.	.	O

Mutations	NNS	O
activating	VBG	O
the	DT	O
mTOR	NN	O
pathway	NN	O
have	VBP	O
been	VBN	O
suggested	VBN	O
to	TO	O
predict	VB	O
response	NN	O
;	:	O
however	RB	O
,	,	O
their	PRP$	O
predictive	JJ	O
value	NN	O
is	VBZ	O
still	RB	O
unclear	JJ	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
present	VBP	O
the	DT	O
genomic	NN	O
and	CC	O
functional	JJ	O
characterization	NN	O
of	IN	O
a	DT	O
patient	NN	O
with	IN	O
metastatic	JJ	O
clear	JJ	O
cell	NN	O
RCC	NNP	O
(	(	O
ccRCC	NN	O
)	)	O
who	WP	O
experienced	VBD	O
a	DT	O
partial	JJ	O
response	NN	O
to	TO	O
temsirolimus	VB	O
after	IN	O
a	DT	O
poor	JJ	O
response	NN	O
to	TO	O
2	CD	O
previous	JJ	O
lines	NNS	O
of	IN	O
treatment	NN	O
.	.	O

At	IN	O
the	DT	O
time	NN	O
of	IN	O
publication	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
disease	JJ	O
-	:	O
free	JJ	O
8	CD	O
years	NNS	O
after	IN	O
temsirolimus	JJ	O
treatment	NN	O
.	.	O

Multiregion	NNP	O
whole	JJ	O
-	:	O
exome	NN	O
sequencing	NN	O
(	(	O
WES	NNP	O
)	)	O
on	IN	O
3	CD	O
regions	NNS	O
of	IN	O
the	DT	O
primary	JJ	O
tumor	NN	O
,	,	O
1	CD	O
metastasis	NN	O
,	,	O
and	CC	O
blood	NN	O
revealed	VBD	O
tumor	NN	O
mutations	NNS	O
in	IN	O
driver	NN	O
genes	NNS	O
in	IN	O
ccRCC	NN	O
:	:	O
a	DT	O
missense	NN	O
mutation	NN	O
in	IN	O
VHL	NNP	O
(	(	O
p	NN	O
.	.	O
W88L	NNP	O
)	)	O
,	,	O
a	DT	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
mutation	NN	O
in	IN	O
BAP1	NNP	O
(	(	O
p	NN	O
.	.	O
E454Rfs	NNP	O
15	CD	O
)	)	O
,	,	O
and	CC	O
a	DT	O
novel	JJ	O
missense	NN	O
mutation	NN	O
in	IN	O
MTOR	NNP	O
(	(	O
p	NN	O
.	.	O
Y1974H	NNP	O
)	)	O
.	.	O

The	DT	O
MTOR	NNP	O
mutation	NN	O
was	VBD	O
present	JJ	O
in	IN	O
all	DT	O
tumor	NN	O
regions	NNS	O
,	,	O
with	IN	O
similar	JJ	O
allele	JJ	O
frequency	NN	O
as	IN	O
the	DT	O
VHL	NNP	O
mutation	NN	O
,	,	O
and	CC	O
in	IN	O
vitro	JJ	O
functional	JJ	O
assessment	NN	O
of	IN	O
the	DT	O
MTOR	NNP	B-Gene
variant	NN	B-Var
demonstrated	VBD	O
that	IN	O
it	PRP	O
increased	VBD	B-PosReg
mTORC1	JJ	B-MPA
activity	NN	I-MPA
.	.	O
Consistently	RB	O
,	,	O
immunohistochemistry	NN	O
in	IN	O
the	DT	O
tumor	NN	O
samples	NNS	O
demonstrated	VBD	O
increased	JJ	O
levels	NNS	O
of	IN	O
phospho	NN	O
-	:	O
S6	NN	O
.	.	O

In	IN	O
conclusion	NN	O
,	,	O
multiregion	NN	O
WES	NNP	O
identified	VBD	O
a	DT	O
novel	JJ	O
MTOR	NNP	B-Gene
mutation	NN	B-Var
acquired	VBD	O
early	JJ	O
during	IN	O
tumor	NN	O
development	NN	O
as	IN	O
the	DT	O
event	NN	O
leading	VBG	B-Reg
to	TO	I-Reg
a	DT	O
high	JJ	B-MPA
sensitivity	NN	I-MPA
to	TO	I-MPA
temsirolimus	VB	I-MPA
treatment	NN	I-MPA
.	.	O
This	DT	O
study	NN	O
supports	VBZ	O
tumor	NN	O
multiregion	NN	O
sequencing	VBG	O
to	TO	O
detect	VB	O
truncal	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
mTOR	NN	O
pathway	NN	O
to	TO	O
identify	VB	O
patients	NNS	O
sensitive	JJ	O
to	TO	O
mTOR	VB	O
inhibitors	NNS	O

of	IN	I-Reg
Proteins	NNS	I-Var
on	IN	I-Gene
Glycolysis	NNP	I-Protein
and	CC	I-MPA
Mitochondrial	NNP	B-MPA
Metabolism	NNP	I-MPA

TP53	NNP	B-Gene
mutations	NNS	B-Var
missense	JJ	B-Var
substitutions	NNS	I-Var
expression	NN	B-MPA
mutant	JJ	B-Var
proteins	VBZ	B-Protein
accumulate	NN	B-PosReg
gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
activities	NNS	B-MPA
promote	VB	B-PosReg
tumorigenic	JJ	B-CPA
events	NNS	I-CPA
Recently	RB	O
,	,	O
mutant	JJ	B-Var
p53	NN	B-Gene
proteins	NNS	B-Protein
have	VBP	O
been	VBN	O
shown	VBN	O
to	TO	O
mediate	VB	O
metabolic	JJ	B-CPA
changes	NNS	I-CPA
as	IN	O
a	DT	O
novel	JJ	O
GOF	NNP	B-PosReg
to	TO	O
promote	VB	B-PosReg
tumor	NN	B-CPA
development	NN	I-CPA
.	.	O
There	EX	O
is	VBZ	O
a	DT	O
strong	JJ	O
rationale	NN	O
that	IN	O
the	DT	O
GOF	NNP	O
activities	NNS	O
,	,	O
including	VBG	O
alterations	NNS	O
in	IN	O
cellular	JJ	O
metabolism	NN	O
,	,	O
might	MD	O
vary	VB	O
between	IN	O
the	DT	O
different	JJ	O
p53	NN	O
mutants	NNS	O
.	.	O

Accordingly	RB	O
,	,	O
the	DT	O
effect	NN	O
of	IN	O
different	JJ	O
mutant	JJ	O
p53	NN	O
proteins	NNS	O
on	IN	O
cancer	NN	O
cell	NN	O
metabolism	NN	O
is	VBZ	O
largely	RB	O
unknown	JJ	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
have	VBP	O
metabolically	RB	O
profiled	VBN	O
several	JJ	O
individual	JJ	O
frequently	RB	O
occurring	VBG	O
p53	NN	O
mutants	NNS	O
in	IN	O
cancers	NNS	O
,	,	O
focusing	VBG	O
on	IN	O
glycolytic	JJ	O
and	CC	O
mitochondrial	JJ	O
oxidative	JJ	O
phosphorylation	NN	O
pathways	NNS	O
.	.	O

Our	PRP$	O
investigation	NN	O
highlights	VBZ	O
the	DT	O
diversity	NN	O
of	IN	O
different	JJ	O
p53	NN	O
mutants	NNS	O
in	IN	O
terms	NNS	O
of	IN	O
their	PRP$	O
effect	NN	O
on	IN	O
metabolism	NN	O
,	,	O
which	WDT	O
might	MD	O
provide	VB	O
a	DT	O
foundation	NN	O
for	IN	O
the	DT	O
development	NN	O
of	IN	O
more	RBR	O
effective	JJ	O
targeted	JJ	O
pharmacological	JJ	O
approaches	NNS	O
toward	IN	O
variants	NNS	O
of	IN	O
mutant	JJ	O
p53	NN	O

-	:	I-NegReg
Mutations	NNS	I-NegReg
in	IN	I-Var
UNC45A	NNP	B-Gene
Syndrome	NNP	B-Disease
Cholestasis	NNP	B-Disease
Diarrhea	NNP	B-Disease
Impaired	NNP	B-Disease
Hearing	NNP	I-Disease
Bone	NNP	B-Disease
Fragility	NNP	I-Disease

cholestasis	NN	B-Disease
congenital	JJ	B-Disease
diarrhea	NN	I-Disease
impaired	JJ	B-Disease
hearing	NN	I-Disease
bone	NN	B-Disease
fragility	NN	I-Disease
biallelic	JJ	B-Var
mutations	NNS	I-Var
UNC45A	NNP	B-Gene
Subsequent	JJ	O
in	IN	O
vitro	NN	O
and	CC	O
in	IN	O
vivo	JJ	O
functional	JJ	O
studies	NNS	O
of	IN	O
the	DT	O
candidate	NN	O
gene	NN	O
indicated	VBD	O
a	DT	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
paradigm	NN	O
,	,	O
wherein	JJ	O
mutations	NNS	O
attenuated	VBD	B-NegReg
or	CC	O
abolished	VBD	B-NegReg
protein	NN	B-Protein
activity	NN	B-MPA
with	IN	O
concomitant	JJ	O
defects	NNS	B-NegReg
in	IN	O
gut	NN	B-CPA
development	NN	I-CPA
and	CC	O
function	NN	O

hypocholesterolemia	NN	B-Disease
steatosis	NN	B-Disease
PCSK9	NNP	B-Gene
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutation	NN	B-Var
c	NN	B-Var
.	.	I-Var
946	CD	I-Var
G	NNP	I-Var
T	NNP	I-Var
loss	NN	B-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
PCSK9	NNP	B-Gene
low	JJ	B-MPA
-	:	I-MPA
density	NN	I-MPA
lipoprotein	NN	I-MPA
receptor	NN	I-MPA
degradation	NN	I-MPA
This	DT	O
patient	NN	O
exhibited	VBD	O
liver	JJ	O
steatosis	NN	O
;	:	O
he	PRP	O
was	VBD	O
neither	CC	O
diabetic	JJ	O
,	,	O
nor	CC	O
obese	JJ	O
or	CC	O
alcoholic	JJ	O
,	,	O
but	CC	O
is	VBZ	O
a	DT	O
carrier	NN	O
of	IN	O
2	CD	O
polymorphisms	NNS	O
,	,	O
p	NN	O
.	.	O
Ile148Met	NNP	O
(	(	O
rs738409	NN	O
)	)	O
and	CC	O
p	NN	O
.	.	O
Glu167Lys	NNP	O
(	(	O
rs58542926	NN	O
)	)	O
on	IN	O
PNPLA3	NNP	O
and	CC	O
TM6SF2	NNP	O
gene	NN	O
,	,	O
respectively	RB	O
,	,	O
previously	RB	O
shown	VBN	O
to	TO	O
be	VB	O
associated	VBN	O
with	IN	O
nonalcoholic	JJ	O
steatosis	NN	O
and	CC	O
fibrosis	NN	O
evolution	NN	O
.	.	O

These	DT	O
data	NNS	O
suggested	VBD	O
that	IN	O
if	IN	O
a	DT	O
resistance	NN	O
to	TO	O
hepatic	JJ	O
steatosis	NN	O
mediated	VBN	O
by	IN	O
the	DT	O
PCSK9	NNP	O
deficiency	NN	O
exists	NNS	O
,	,	O
as	IN	O
demonstrated	VBN	O
in	IN	O
mice	NN	O
,	,	O
it	PRP	O
is	VBZ	O
not	RB	O
sufficient	JJ	O
to	TO	O
prevent	VB	O
hepatic	JJ	O
fatty	JJ	O
accumulation	NN	O
in	IN	O
the	DT	O
case	NN	O
of	IN	O
genetic	JJ	O
factors	NNS	O
predisposing	VBG	O
to	TO	O
nonalcoholic	JJ	O
fatty	JJ	O
liver	NN	O
disease	NN	O

in	IN	I-Reg
-	:	I-Gene
relapsed	VBN	I-Var
acute	JJ	I-Disease
lymphoblastic	JJ	I-Disease
leukaemia	NN	I-Disease
Relapsed	VBN	B-Disease
acute	JJ	I-Disease
lymphoblastic	JJ	I-Disease
leukaemia	NN	I-Disease
Gain	NNP	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutations	NNS	B-Var
NT5C2	NNP	B-Gene
induce	VBP	B-PosReg
resistance	NN	B-MPA
to	TO	I-MPA
6	CD	I-MPA
-	:	I-MPA
mercaptopurine	NN	I-MPA

R367Q	NNP	B-Var
relapsed	VBD	B-Disease
-	:	I-Disease
ALL	DT	I-Disease
NT5C2	NNP	B-Gene
induces	NNS	B-PosReg
resistance	NN	B-MPA
to	TO	I-MPA
chemotherapy	VB	I-MPA
with	IN	I-MPA
6	CD	I-MPA
-	:	I-MPA
mercaptopurine	NN	I-MPA
The	DT	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
fitness	NN	I-NegReg
phenotype	NN	B-CPA
of	IN	O
NT5C2	NNP	B-Gene
R367Q	NNP	B-Var
mutant	JJ	O
cells	NNS	O
is	VBZ	O
associated	VBN	O
with	IN	O
excess	JJ	B-PosReg
export	NN	B-MPA
of	IN	I-MPA
purines	NNS	I-MPA
to	TO	I-MPA
the	DT	I-MPA
extracellular	JJ	I-MPA
space	NN	I-MPA
and	CC	O
depletion	NN	B-MPA
of	IN	I-MPA
the	DT	I-MPA
intracellular	JJ	I-MPA
purine	NN	I-MPA
-	:	I-MPA
nucleotide	JJ	I-MPA
pool	NN	I-MPA
.	.	O
Consequently	RB	O
,	,	O
blocking	VBG	O
guanosine	JJ	O
synthesis	NN	O
by	IN	O
inhibition	NN	O
of	IN	O
inosine	JJ	O
-	:	O
5	CD	O
-	:	O
monophosphate	NN	O
dehydrogenase	NN	O
(	(	O
IMPDH	NNP	O
)	)	O
induced	VBD	O
increased	JJ	O
cytotoxicity	NN	O
against	IN	O
NT5C2	NNP	O
-	:	O
mutant	NN	O
leukaemia	NN	O
lymphoblasts	NNS	O
.	.	O

These	DT	O
results	NNS	O
identify	VBP	O
the	DT	O
fitness	NN	O
cost	NN	O
of	IN	O
NT5C2	NNP	O
mutation	NN	O
and	CC	O
resistance	NN	O
to	TO	O
chemotherapy	VB	O
as	IN	O
key	JJ	O
evolutionary	JJ	O
drivers	NNS	O
that	WDT	O
shape	VBP	O
clonal	JJ	O
evolution	NN	O
in	IN	O
relapsed	VBN	O
ALL	DT	O
and	CC	O
support	VB	O
a	DT	O
role	NN	O
for	IN	O
IMPDH	NNP	O
inhibition	NN	O
in	IN	O
the	DT	O
treatment	NN	O
of	IN	O
ALL	NNP	O


De	NNP	O
novo	FW	O
gain	NN	B-PosReg
of	IN	I-PosReg
function	NN	I-PosReg
mutations	NNS	B-Var
in	IN	O
GRIN2B	NNP	B-Gene
encoding	VBG	O
the	DT	O
GluN2B	NNP	O
subunit	NN	O
of	IN	O
the	DT	O
N	NNP	O
-	:	O
methyl	NN	O
-	:	O
d	NN	O
-	:	O
aspartate	NN	O
(	(	O
NMDA	NNP	O
)	)	O
receptor	NN	O
have	VBP	O
been	VBN	O
linked	VBN	O
with	IN	O
epileptic	JJ	B-Disease
encephalopathies	NNS	I-Disease
,	,	O
including	VBG	O
infantile	JJ	B-Disease
spasms	NNS	I-Disease
.	.	O
We	PRP	O
investigated	VBD	O
the	DT	O
effects	NNS	O
of	IN	O
radiprodil	NN	O
,	,	O
a	DT	O
selective	JJ	O
GluN2B	NNP	O
negative	JJ	O
allosteric	JJ	O
modulator	NN	O
and	CC	O
other	JJ	O
non	JJ	O
-	:	O
selective	JJ	O
NMDA	NNP	O
receptor	NN	O
inhibitors	NNS	O
on	IN	O
glutamate	NN	O
currents	NNS	O
mediated	VBN	O
by	IN	O
NMDA	NNP	O
receptors	NNS	O
containing	VBG	O
mutated	VBD	O
GluN2B	NNP	O
subunits	NNS	O
.	.	O

The	DT	O
experiments	NNS	O
were	VBD	O
performed	VBN	O
in	IN	O
Xenopus	NNP	O
oocytes	NNS	O
co	VBP	O
-	:	O
injected	VBN	O
with	IN	O
the	DT	O
following	JJ	O
human	JJ	O
mRNAs	NN	O
:	:	O
GRIN1	NNP	O
GRIN2B	NNP	O
,	,	O
GRIN1	NNP	O
GRIN2B	NNP	O
-	:	O
R540H	NNP	O
,	,	O
GRIN1	NNP	O
GRIN2B	NNP	O
-	:	O
N615I	NN	O
and	CC	O
GRIN1	NNP	O
GRIN2B	NNP	O
-	:	O
V618G	NN	O
.	.	O

Glutamate	NNP	O
displayed	VBD	O
slightly	RB	O
increased	VBN	O
potency	NN	O
in	IN	O
the	DT	O
R540H	NNP	O
variant	NN	O
,	,	O
but	CC	O
not	RB	O
in	IN	O
N615I	NNP	O
and	CC	O
V618G	NNP	O
variants	NNS	O
.	.	O

However	RB	O
,	,	O
the	DT	O
inhibition	NN	O
by	IN	O
Mg	NNP	O
(	(	O
2	CD	O
)	)	O
was	VBD	O
completely	RB	O
abolished	VBN	O
in	IN	O
N615I	NNP	O
and	CC	O
V618G	NNP	O
variants	NNS	O
.	.	O

In	IN	O
fact	NN	O
,	,	O
Mg	NNP	O
(	(	O
2	CD	O
)	)	O
enhanced	VBD	O
glutamate	JJ	O
responses	NNS	O
in	IN	O
those	DT	O
variants	NNS	O
.	.	O

The	DT	O
potency	NN	O
of	IN	O
radiprodil	NN	O
to	TO	O
block	VB	O
glutamate	NN	O
-	:	O
evoked	JJ	O
currents	NNS	O
was	VBD	O
not	RB	O
affected	VBN	O
in	IN	O
any	DT	O
of	IN	O
the	DT	O
variants	NNS	O
,	,	O
while	IN	O
the	DT	O
effects	NNS	O
by	IN	O
non	JJ	O
-	:	O
selective	JJ	O
NMDA	NNP	O
inhibitors	NNS	O
were	VBD	O
greatly	RB	O
reduced	VBN	O
in	IN	O
some	DT	O
of	IN	O
the	DT	O
variants	NNS	O
.	.	O

Additionally	RB	O
,	,	O
in	IN	O
the	DT	O
Mg	NNP	O
(	(	O
2	CD	O
)	)	O
insensitive	JJ	O
variants	NNS	O
,	,	O
radiprodil	NN	O
blocked	VBD	O
glutamate	JJ	O
-	:	O
activated	JJ	O
currents	NNS	O
with	IN	O
the	DT	O
same	JJ	O
potency	NN	O
as	IN	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
Mg	NNP	O
(	(	O
2	CD	O
)	)	O
.	.	O

The	DT	O
gain	NN	O
of	IN	O
function	NN	O
observed	VBN	O
in	IN	O
the	DT	O
reported	VBN	O
GRIN2B	NNP	O
variants	NNS	O
could	MD	O
be	VB	O
a	DT	O
key	JJ	O
pathophysiological	JJ	O
factor	NN	O
leading	VBG	O
to	TO	O
neuronal	JJ	O
hyper	NN	O
-	:	O
excitability	NN	O
in	IN	O
epileptic	JJ	O
encephalopathies	NNS	O
.	.	O

The	DT	O
GluN2B	NNP	O
-	:	O
selective	JJ	O
inhibitor	NN	O
radiprodil	NN	O
fully	RB	O
retained	VBD	O
its	PRP$	O
pharmacological	JJ	O
profile	NN	O
under	IN	O
these	DT	O
conditions	NNS	O
,	,	O
while	IN	O
other	JJ	O
non	JJ	O
-	:	O
selective	JJ	O
NMDA	NNP	O
receptor	NN	O
antagonists	NNS	O
lost	VBD	O
their	PRP$	O
potency	NN	O
.	.	O

Consequently	RB	O
,	,	O
our	PRP$	O
data	NNS	O
suggest	VBP	O
that	IN	O
radiprodil	NN	O
may	MD	O
be	VB	O
a	DT	O
valuable	JJ	O
therapeutic	JJ	O
option	NN	O
for	IN	O
treatment	NN	O
of	IN	O
pediatric	JJ	O
epileptic	JJ	O
encephalopathies	NNS	O
associated	VBN	O
with	IN	O
GRIN2B	NNP	O
mutations	NNS	O

missense	NN	B-Var
in	IN	I-Var
FOXP2	NNP	B-Gene
FOXP1	NNP	B-Gene
causes	VBZ	B-Reg
neurodevelopmental	JJ	B-Disease
disorders	NNS	I-Disease

However	RB	O
,	,	O
while	IN	O
mutations	NNS	B-Var
in	IN	O
FOXP2	NNP	B-Gene
lead	NN	B-Reg
to	TO	I-Reg
a	DT	O
speech	NN	O
language	NN	O
disorder	NN	O
characterized	VBN	O
by	IN	O
childhood	NN	B-Disease
apraxia	NN	I-Disease
of	IN	I-Disease
speech	NN	I-Disease
(	(	O
CAS	NNP	O
)	)	O
,	,	O
the	DT	O
clinical	JJ	O
profile	NN	O
of	IN	O
FOXP1	NNP	B-Gene
variants	NNS	B-Var
includes	VBZ	B-Reg
a	DT	O
broader	JJR	O
neurodevelopmental	JJ	O
phenotype	NN	O
with	IN	O
global	JJ	B-Disease
developmental	JJ	I-Disease
delay	NN	I-Disease
,	,	O
intellectual	JJ	B-Disease
disability	NN	I-Disease
,	,	O
and	CC	O
speech	JJ	B-Disease
language	NN	I-Disease
impairment	NN	I-Disease
.	.	O
Using	VBG	O
clinical	JJ	O
whole	JJ	O
-	:	O
exome	NN	O
sequencing	NN	O
,	,	O
we	PRP	O
report	VBP	O
an	DT	O
identical	JJ	O
de	FW	O
novo	FW	O
missense	FW	O
FOXP1	NNP	O
variant	NN	O
identified	VBN	O
in	IN	O
three	CD	O
unrelated	JJ	O
patients	NNS	O
.	.	O

The	DT	O
variant	NN	O
,	,	O
p	NN	O
.	.	O
R514H	NNP	O
,	,	O
is	VBZ	O
located	VBN	O
in	IN	O
the	DT	O
forkhead	JJ	O
-	:	O
box	NN	O
DNA	NNP	O
-	:	O
binding	NN	O
domain	NN	O
and	CC	O
is	VBZ	O
equivalent	JJ	O
to	TO	O
the	DT	O
well	NN	O
-	:	O
studied	VBN	O
p	NN	O
.	.	O
R553H	NNP	O
FOXP2	NNP	O
variant	NN	O
that	WDT	O
cosegregates	VBZ	O
with	IN	O
CAS	NNP	O
in	IN	O
a	DT	O
large	JJ	O
UK	NNP	O
family	NN	O
.	.	O

We	PRP	O
present	VBP	O
here	RB	O
for	IN	O
the	DT	O
first	JJ	O
time	NN	O
a	DT	O
direct	JJ	O
comparison	NN	O
of	IN	O
the	DT	O
molecular	JJ	O
and	CC	O
clinical	JJ	O
consequences	NNS	O
of	IN	O
the	DT	O
same	JJ	O
mutation	NN	O
affecting	VBG	O
the	DT	O
equivalent	JJ	O
residue	NN	O
in	IN	O
FOXP1	NNP	O
and	CC	O
FOXP2	NNP	O
.	.	O

Detailed	VBN	O
functional	JJ	O
characterization	NN	O
of	IN	O
the	DT	O
two	CD	O
variants	NNS	O
in	IN	O
cell	NN	O
model	NN	O
systems	NNS	O
revealed	VBD	O
very	RB	O
similar	JJ	O
molecular	NN	O
consequences	NNS	O
,	,	O
including	VBG	O
aberrant	JJ	O
subcellular	JJ	O
localization	NN	O
,	,	O
disruption	NN	O
of	IN	O
transcription	NN	O
factor	NN	O
activity	NN	O
,	,	O
and	CC	O
deleterious	JJ	O
effects	NNS	O
on	IN	O
protein	NN	O
interactions	NNS	O
.	.	O

Nonetheless	RB	O
,	,	O
clinical	JJ	O
manifestations	NNS	O
were	VBD	O
broader	JJR	O
and	CC	O
more	RBR	O
severe	JJ	O
in	IN	O
the	DT	O
three	CD	O
cases	NNS	O
carrying	VBG	O
the	DT	O
p	NN	O
.	.	O
R514H	NNP	O
FOXP1	NNP	O
variant	NN	O
than	IN	O
in	IN	O
individuals	NNS	O
with	IN	O
the	DT	O
p	NN	O
.	.	O
R553H	NNP	O
variant	NN	O
related	VBN	O
to	TO	O
CAS	NNP	O
,	,	O
highlighting	VBG	O
divergent	JJ	O
roles	NNS	O
of	IN	O
FOXP2	NNP	O
and	CC	O
FOXP1	NNP	O
in	IN	O
neurodevelopment	NN	O


In	IN	O
mammalian	JJ	O
urorectal	JJ	O
development	NN	O
,	,	O
the	DT	O
urorectal	JJ	O
septum	NN	O
(	(	O
urs	JJ	O
)	)	O
descends	VBZ	O
from	IN	O
the	DT	O
ventral	JJ	O
body	NN	O
wall	NN	O
to	TO	O
the	DT	O
cloaca	NN	O
membrane	NN	O
(	(	O
cm	NN	O
)	)	O
to	TO	O
partition	VB	O
the	DT	O
cloaca	NN	O
into	IN	O
urogenital	JJ	O
sinus	NN	O
and	CC	O
rectum	NN	O
.	.	O

Defective	JJ	O
urs	NNS	O
growth	NN	O
results	NNS	O
in	IN	O
human	JJ	O
congenital	JJ	O
anorectal	JJ	O
malformations	NNS	O
(	(	O
ARMs	NNP	O
)	)	O
,	,	O
and	CC	O
their	PRP$	O
pathogenic	JJ	O
mechanisms	NNS	O
are	VBP	O
unclear	JJ	O
.	.	O

Recent	JJ	O
studies	NNS	O
only	RB	O
focused	VBD	O
on	IN	O
the	DT	O
importance	NN	O
of	IN	O
urs	JJ	O
mesenchyme	NN	O
proliferation	NN	O
,	,	O
which	WDT	O
is	VBZ	O
induced	VBN	O
by	IN	O
endoderm	JJ	O
-	:	O
derived	VBN	O
Sonic	JJ	O
Hedgehog	NNP	O
(	(	O
Shh	NNP	O
)	)	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
showed	VBD	O
that	IN	O
the	DT	O
programmed	JJ	O
cell	NN	O
death	NN	O
of	IN	O
the	DT	O
apical	JJ	O
urs	NNS	O
and	CC	O
proximal	JJ	O
cm	NN	O
endoderm	NN	O
is	VBZ	O
particularly	RB	O
crucial	JJ	O
for	IN	O
the	DT	O
growth	NN	O
of	IN	O
urs	NNS	O
during	IN	O
septation	NN	O
.	.	O

The	DT	O
apoptotic	JJ	O
endoderm	NN	O
was	VBD	O
closely	RB	O
associated	VBN	O
with	IN	O
the	DT	O
tempo	NN	O
-	:	O
spatial	JJ	O
expression	NN	O
of	IN	O
Wnt	NNP	O
inhibitory	JJ	O
factor	NN	O
1	CD	O
(	(	O
Wif1	NNP	O
)	)	O
,	,	O
which	WDT	O
is	VBZ	O
an	DT	O
inhibitor	NN	O
of	IN	O
Wnt	NNP	O
-	:	O
-	:	O
catenin	NN	O
signaling	NN	O
.	.	O

In	IN	O
Wif1	NNP	O
(	(	O
lacZ	JJ	O
lacZ	NN	O
)	)	O
mutant	NN	O
mice	NN	O
and	CC	O
cultured	VBD	O
urorectum	NN	O
with	IN	O
exogenous	JJ	O
Wif1	NNP	O
,	,	O
cloaca	NN	O
septation	NN	O
was	VBD	O
defective	JJ	O
with	IN	O
undescended	JJ	O
urs	NNS	O
and	CC	O
hypospadias	SYM	O
-	:	O
like	IN	O
phenotypes	NNS	O
,	,	O
and	CC	O
such	JJ	O
septation	NN	O
defects	NNS	O
were	VBD	O
also	RB	O
observed	VBN	O
in	IN	O
Shh	NNP	O
(-	JJ	O
-)	NN	O
mutants	NNS	O
and	CC	O
in	IN	O
endodermal	JJ	O
-	:	O
catenin	NN	O
gain	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
(	(	O
GOF	NNP	O
)	)	O
mutants	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
Wif1	NNP	O
and	CC	O
Shh	NNP	O
were	VBD	O
expressed	VBN	O
in	IN	O
a	DT	O
complementary	JJ	O
manner	NN	O
in	IN	O
the	DT	O
cloaca	NN	O
endoderm	NN	O
,	,	O
and	CC	O
Wif1	NNP	O
was	VBD	O
ectopically	RB	O
expressed	VBN	O
in	IN	O
the	DT	O
urs	NNS	O
and	CC	O
cm	NN	O
associated	VBN	O
with	IN	O
excessive	JJ	O
endodermal	JJ	O
apoptosis	NN	O
and	CC	O
septation	NN	O
defects	NNS	O
in	IN	O
Shh	NNP	O
(-	JJ	O
-)	NN	O
mutants	NNS	O
.	.	O

Furthermore	RB	O
,	,	O
apoptotic	JJ	B-CPA
cells	NNS	I-CPA
were	VBD	O
markedly	RB	O
reduced	VBN	B-NegReg
in	IN	O
the	DT	O
endodermal	JJ	B-Protein
-	:	I-Protein
catenin	NN	I-Protein
GOF	NNP	B-PosReg
mutant	NN	B-Var
embryos	NN	O
,	,	O
which	WDT	O
counteracted	VBD	O
the	DT	O
inhibitory	JJ	O
effects	NNS	O
of	IN	O
Wif1	NNP	O
.	.	O
Taken	NNP	O
altogether	RB	O
,	,	O
these	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
regulated	JJ	O
expression	NN	O
of	IN	O
Wif1	NNP	O
is	VBZ	O
critical	JJ	O
for	IN	O
the	DT	O
growth	NN	O
of	IN	O
the	DT	O
urs	NNS	O
during	IN	O
cloaca	JJ	O
septation	NN	O
.	.	O

Hence	NNP	O
,	,	O
Wif1	NNP	O
governs	VBZ	O
cell	NN	O
apoptosis	NN	O
of	IN	O
urs	JJ	O
endoderm	NNS	O
by	IN	O
repressing	VBG	O
-	:	O
catenin	NN	O
signal	NN	O
,	,	O
which	WDT	O
may	MD	O
facilitate	VB	O
the	DT	O
protrusion	NN	O
of	IN	O
the	DT	O
underlying	VBG	O
proliferating	NN	O
mesenchymal	JJ	O
cells	NNS	O
towards	IN	O
the	DT	O
cm	NN	O
for	IN	O
cloaca	JJ	O
septation	NN	O
.	.	O

Dysregulation	NN	O
of	IN	O
this	DT	O
endodermal	JJ	O
Shh	NNP	O
-	:	O
Wif1	NNP	O
-	:	O
-	:	O
catenin	NN	O
signaling	VBG	O
axis	JJ	O
contributes	NNS	O
to	TO	O
ARM	NNP	O
pathogenesis	NN	O


Activation	NN	O
of	IN	O
the	DT	O
melanocortin	NN	O
1	CD	O
receptor	NN	O
(	(	O
MC1R	NNP	O
)	)	O
by	IN	O
-	:	O
melanocortin	NN	O
(	(	O
-	:	O
MSH	NN	O
)	)	O
stimulates	VBZ	O
eumelanin	JJ	O
synthesis	NN	O
and	CC	O
enhances	VBZ	O
repair	NN	O
of	IN	O
ultraviolet	JJ	O
radiation	NN	O
(	(	O
UV	NNP	O
)-	NNP	O
induced	VBD	O
DNA	NNP	O
damage	NN	O
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
the	DT	O
DNA	NNP	O
damage	NN	O
response	NN	O
(	(	O
DDR	NNP	O
)	)	O
of	IN	O
human	JJ	O
melanocytes	NNS	O
to	TO	O
UV	NNP	O
and	CC	O
its	PRP$	O
enhancement	NN	O
by	IN	O
-	:	O
MSH	NN	O
.	.	O

-	:	O
MSH	NN	O
up	IN	O
-	:	O
regulated	VBD	O
the	DT	O
levels	NNS	O
of	IN	O
XPC	NNP	O
,	,	O
the	DT	O
enzyme	NN	O
that	WDT	O
recognizes	VBZ	O
DNA	NNP	O
damage	NN	O
sites	NNS	O
,	,	O
enhanced	VBD	O
the	DT	O
UV	NNP	O
-	:	O
induced	JJ	O
phosphorylation	NN	O
of	IN	O
the	DT	O
DNA	NNP	O
damage	NN	O
sensors	NNS	O
ataxia	VBP	O
telangiectasia	NN	O
and	CC	O
Rad3	NNP	O
-	:	O
related	VBN	O
(	(	O
ATR	NNP	O
)	)	O
and	CC	O
ataxia	JJ	O
telangiectasia	NN	O
mutated	VBN	O
(	(	O
ATM	NNP	O
)	)	O
and	CC	O
their	PRP$	O
respect	NN	O
-	:	O
ive	JJ	O
substrates	NNS	O
checkpoint	VBP	O
kinases	NNS	O
1	CD	O
and	CC	O
2	CD	O
,	,	O
and	CC	O
increased	VBD	O
phosphorylated	VBN	O
H2AX	NNP	O
(	(	O
H2AX	NNP	O
)	)	O
formation	NN	O
.	.	O

These	DT	O
effects	NNS	O
required	VBD	O
functional	JJ	O
MC1R	NNP	O
and	CC	O
were	VBD	O
absent	VBN	O
in	IN	O
melanocytes	NNS	O
expressing	VBG	O
loss	NN	O
of	IN	O
function	NN	O
(	(	O
LOF	NNP	O
)	)	O
MC1R	NNP	O
.	.	O

The	DT	O
levels	NNS	O
of	IN	O
wild	JJ	O
-	:	O
type	NN	O
p53	NN	O
-	:	O
induced	JJ	O
phosphatase	NN	O
1	CD	O
(	(	O
Wip1	NNP	O
)	)	O
,	,	O
which	WDT	O
dephosphorylates	VBZ	O
H2AX	NNP	O
,	,	O
correlated	VBD	O
inversely	RB	O
with	IN	O
H2AX	NNP	O
.	.	O

We	PRP	O
propose	VBP	O
that	IN	O
-	:	O
MSH	NN	O
increases	NNS	O
UV	NNP	O
-	:	O
induced	VBD	O
H2AX	NNP	O
to	TO	O
facilitate	VB	O
formation	NN	O
of	IN	O
DNA	NNP	O
repair	NN	O
complexes	NNS	O
and	CC	O
repair	NN	O
of	IN	O
DNA	NNP	O
photoproducts	NNS	O
,	,	O
and	CC	O
LOF	NNP	B-Var
of	IN	O
MC1R	NNP	B-Protein
compromises	VBZ	B-NegReg
the	DT	O
DDR	NNP	B-MPA
and	CC	O
genomic	JJ	B-CPA
stability	NN	I-CPA
of	IN	I-CPA
melanocytes	NNS	I-CPA




Variants	NNS	B-Var
association	NN	B-Interaction
chronic	JJ	B-Disease
liver	NN	I-Disease
disease	NN	I-Disease
splice	NN	B-Var
variant	NN	I-Var
HSD17B13	NNP	B-Gene
reduced	JJ	B-NegReg
ALT	NNP	B-MPA
(	(	I-MPA
P	NNP	I-MPA
4.2	CD	I-MPA
10	CD	I-MPA
-	:	I-MPA
12	CD	I-MPA
)	)	I-MPA
and	CC	I-MPA
AST	NNP	I-MPA
(	(	I-MPA
P	NNP	I-MPA
6.2	CD	I-MPA
10	CD	I-MPA
-	:	I-MPA
10	CD	I-MPA
)	)	I-MPA
variant	NN	B-Var
reduced	JJ	B-NegReg
alcoholic	JJ	B-Disease
liver	NN	I-Disease
disease	NN	I-Disease
nonalcoholic	JJ	B-Disease
liver	NN	I-Disease
disease	NN	I-Disease
alcoholic	JJ	B-Disease
cirrhosis	NN	I-Disease
nonalcoholic	JJ	B-Disease
cirrhosis	NN	I-Disease
Associations	NNS	O
were	VBD	O
confirmed	VBN	O
in	IN	O
two	CD	O
independent	JJ	O
cohorts	NNS	O
.	.	O

The	DT	O
rs72613567	NN	O
:	:	O
TA	NNP	O
variant	NN	B-Var
was	VBD	O
associated	VBN	O
with	IN	O
a	DT	O
reduced	JJ	B-NegReg
risk	NN	O
of	IN	O
nonalcoholic	JJ	B-Disease
steatohepatitis	NN	I-Disease
,	,	O
but	CC	O
not	RB	O
steatosis	NN	O
,	,	O
in	IN	O
human	JJ	O
liver	NN	O
samples	NNS	O
.	.	O
The	DT	O
rs72613567	NN	O
:	:	O
TA	NNP	O
variant	NN	B-Var
mitigated	VBD	B-NegReg
liver	JJ	B-Disease
injury	NN	I-Disease
associated	VBN	O
with	IN	O
the	DT	O
risk	NN	O
-	:	O
increasing	VBG	O
PNPLA3	NNP	O
p	NN	O
.	.	O
I148M	NNP	O
allele	NN	O
and	CC	O
resulted	VBD	O
in	IN	O
an	DT	O
unstable	JJ	O
and	CC	O
truncated	VBD	O
protein	NN	O
with	IN	O
reduced	JJ	O
enzymatic	JJ	O
activity	NN	O
.	.	O
CONCLUSIONS	NN	O
:	:	O
A	DT	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
variant	NN	B-Var
in	IN	O
HSD17B13	NNP	B-Gene
was	VBD	O
associated	VBN	O
with	IN	O
a	DT	O
reduced	JJ	B-NegReg
risk	NN	O
of	IN	O
chronic	JJ	B-Disease
liver	NN	I-Disease
disease	NN	I-Disease
and	CC	O
of	IN	O
progression	NN	O
from	IN	O
steatosis	NN	O
to	TO	O
steatohepatitis	VB	O
.	.	O
(	(	O
Funded	VBN	O
by	IN	O
Regeneron	NNP	O
Pharmaceuticals	NNP	O
and	CC	O
others	NNS	O
.	.	O

)	)	O

Mutations	NNP	B-Var
SON	NNP	B-Gene
Causing	VBG	B-Reg
Intellectual	JJ	B-Disease
-	:	I-Disease
Disability	NN	I-Disease
Syndrome	NNP	I-Disease


Here	RB	O
,	,	O
we	PRP	O
report	VBP	O
on	IN	O
an	DT	O
ID	NNP	B-Disease
syndrome	NN	I-Disease
caused	VBN	O
by	IN	O
de	FW	O
novo	FW	O
heterozygous	JJ	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
(	(	O
LoF	NNP	O
)	)	O
mutations	NNS	B-Var
in	IN	O
SON	NNP	B-Gene
.	.	O
The	DT	O
syndrome	NN	O
is	VBZ	O
characterized	VBN	O
by	IN	O
ID	NNP	O
and	CC	O
or	CC	O
DD	NNP	O
,	,	O
malformations	NNS	O
of	IN	O
the	DT	O
cerebral	JJ	O
cortex	NN	O
,	,	O
epilepsy	NN	O
,	,	O
vision	NN	O
problems	NNS	O
,	,	O
musculoskeletal	JJ	O
abnormalities	NNS	O
,	,	O
and	CC	O
congenital	JJ	O
malformations	NNS	O
.	.	O

Knockdown	NNP	O
of	IN	O
son	NN	O
in	IN	O
zebrafish	NN	O
resulted	VBD	O
in	IN	O
severe	JJ	O
malformation	NN	O
of	IN	O
the	DT	O
spine	NN	O
,	,	O
brain	NN	O
,	,	O
and	CC	O
eyes	NNS	O
.	.	O

Importantly	RB	O
,	,	O
analyses	NNS	O
of	IN	O
RNA	NNP	O
from	IN	O
affected	JJ	O
individuals	NNS	O
revealed	VBD	O
that	IN	O
genes	NNS	O
critical	JJ	O
for	IN	O
neuronal	JJ	B-CPA
migration	NN	I-CPA
and	CC	O
cortex	JJ	B-CPA
organization	NN	I-CPA
(	(	O
TUBG1	NNP	O
,	,	O
FLNA	NNP	O
,	,	O
PNKP	NNP	O
,	,	O
WDR62	NNP	O
,	,	O
PSMD3	NNP	O
,	,	O
and	CC	O
HDAC6	NNP	O
)	)	O
and	CC	O
metabolism	NN	B-CPA
(	(	O
PCK2	NNP	O
,	,	O
PFKL	NNP	O
,	,	O
IDH2	NNP	O
,	,	O
ACY1	NNP	O
,	,	O
and	CC	O
ADA	NNP	O
)	)	O
are	VBP	O
significantly	RB	O
downregulated	VBN	B-NegReg
because	IN	O
of	IN	O
the	DT	O
accumulation	NN	B-PosReg
of	IN	O
mis	JJ	O
-	:	O
spliced	VBN	O
transcripts	NNS	O
resulting	VBG	O
from	IN	O
erroneous	JJ	B-Var
SON	NNP	I-Var
-	:	I-Var
mediated	VBD	I-Var
RNA	NNP	I-Var
splicing	NN	I-Var
.	.	O
Our	PRP$	O
data	NNS	O
highlight	RB	O
SON	NNP	O
as	IN	O
a	DT	O
master	NN	O
regulator	NN	O
governing	VBG	O
neurodevelopment	JJ	O
and	CC	O
demonstrate	VB	O
the	DT	O
importance	NN	O
of	IN	O
SON	NNP	O
-	:	O
mediated	VBD	O
RNA	NNP	O
splicing	VBG	O
in	IN	O
human	JJ	O
development	NN	O


The	DT	O
SOX10	NNP	O
gene	NN	O
plays	VBZ	O
a	DT	O
vital	JJ	O
role	NN	O
in	IN	O
neural	JJ	O
crest	NN	O
cell	NN	O
development	NN	O
and	CC	O
migration	NN	O
.	.	O

Abnormalities	NNS	B-Var
in	IN	O
SOX10	NNP	B-Gene
are	VBP	O
associated	VBN	B-Reg
with	IN	O
Waardenburg	NNP	B-Disease
syndrome	VBP	I-Disease
Types	NNP	B-Disease
II	NNP	I-Disease
and	CC	O
IV	NNP	B-Disease
,	,	O
and	CC	O
these	DT	O
patients	NNS	O
have	VBP	O
recognizable	JJ	O
clinical	JJ	O
features	NNS	O
.	.	O
This	DT	O
case	NN	O
report	NN	O
highlights	VBD	O
the	DT	O
first	JJ	O
ever	RB	O
reported	VBN	O
homozygous	JJ	O
loss	NN	O
of	IN	O
function	NN	O
of	IN	O
the	DT	O
SOX10	NNP	O
gene	NN	O
in	IN	O
a	DT	O
human	JJ	O
.	.	O

This	DT	O
deletion	NN	O
is	VBZ	O
correlated	VBN	O
using	VBG	O
family	NN	O
history	NN	O
,	,	O
prenatal	JJ	O
ultrasound	NN	O
,	,	O
microarray	JJ	O
analysis	NN	O
of	IN	O
amniotic	JJ	O
fluid	NN	O
,	,	O
and	CC	O
ultimately	RB	O
,	,	O
a	DT	O
medical	JJ	O
autopsy	NN	O
examination	NN	O
to	TO	O
further	JJ	O
elucidate	NN	O
phenotypic	NN	O
effects	NNS	O
of	IN	O
this	DT	O
genetic	JJ	O
variation	NN	O
.	.	O

Incorporating	VBG	O
the	DT	O
use	NN	O
of	IN	O
molecular	JJ	O
pathology	NN	O
into	IN	O
the	DT	O
autopsy	JJ	O
examination	NN	O
of	IN	O
fetuses	NNS	O
with	IN	O
suspected	JJ	O
congenital	JJ	O
anomalies	NNS	O
is	VBZ	O
vital	JJ	O
for	IN	O
appropriate	JJ	O
family	NN	O
counseling	NN	O
,	,	O
and	CC	O
with	IN	O
the	DT	O
ability	NN	O
to	TO	O
use	VB	O
formalin	JJ	O
-	:	O
fixed	VBN	O
and	CC	O
paraffin	SYM	O
-	:	O
embedded	JJ	O
tissues	NNS	O
,	,	O
has	VBZ	O
become	VBN	O
a	DT	O
practical	JJ	O
approach	NN	O
in	IN	O
autopsy	JJ	O
pathology	NN	O

TBK1	NNP	B-Gene
variants	NNS	B-Var
in	IN	B-Reg
early	JJ	B-Disease
-	:	I-Disease
onset	NN	I-Disease
Alzheimer	NNP	I-Disease
disease	NN	I-Disease
TBK1	NNP	B-Gene
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
frontotemporal	JJ	B-Disease
dementia	NN	I-Disease
amyotrophic	JJ	B-Disease
lateral	JJ	I-Disease
sclerosis	NN	I-Disease
We	PRP	O
performed	VBD	O
targeted	JJ	O
resequencing	NN	O
of	IN	O
TBK1	NNP	O
in	IN	O
1253	CD	O
early	JJ	O
onset	VBN	O
Alzheimer	NNP	O
's	POS	O
disease	NN	O
(	(	O
EOAD	NNP	O
)	)	O
patients	NNS	O
from	IN	O
8	CD	O
European	JJ	O
countries	NNS	O
to	TO	O
investigate	VB	O
whether	IN	O
pathogenic	JJ	O
TBK1	NNP	O
mutations	NNS	O
are	VBP	O
enriched	VBN	O
among	IN	O
patients	NNS	O
with	IN	O
clinical	JJ	O
diagnosis	NN	O
of	IN	O
EOAD	NNP	O
.	.	O

Variant	JJ	O
frequencies	NNS	O
were	VBD	O
compared	VBN	O
against	IN	O
2117	CD	O
origin	SYM	O
-	:	O
matched	VBN	O
controls	NNS	O
.	.	O

We	PRP	O
identified	VBD	O
only	RB	O
1	CD	O
LoF	NNP	O
mutation	NN	O
(	(	O
p	NN	O
.	.	O
Thr79del	NNP	O
)	)	O
in	IN	O
a	DT	O
patient	NN	O
clinically	RB	O
diagnosed	VBN	O
with	IN	O
Alzheimer	NNP	O
's	POS	O
disease	NN	O
and	CC	O
a	DT	O
positive	JJ	O
family	NN	O
history	NN	O
of	IN	O
ALS	NNP	O
.	.	O

We	PRP	O
did	VBD	O
not	RB	O
observe	VB	O
enrichment	NN	O
of	IN	O
rare	JJ	O
variants	NNS	O
in	IN	O
EOAD	NNP	O
patients	NNS	O
compared	VBN	O
to	TO	O
controls	NNS	O
,	,	O
nor	CC	O
of	IN	O
rare	JJ	O
variants	NNS	O
affecting	VBG	O
NF	NNP	O
B	NNP	O
induction	NN	O
.	.	O

Of	IN	O
3	CD	O
common	JJ	O
coding	VBG	O
variants	NNS	O
,	,	O
rs7486100	NN	O
showed	VBD	O
evidence	NN	O
of	IN	O
association	NN	O
(	(	O
OR	CC	O
1.46	CD	O
[	JJ	O
95%	CD	O
CI	NNP	O
1.13	CD	O
-	:	O
1.9	CD	O
]	NN	O
;	:	O
p	CC	O
-	:	O
value	NN	O
0.01	CD	O
)	)	O
.	.	O

Homozygous	JJ	O
carriers	NNS	O
of	IN	O
the	DT	O
risk	NN	O
allele	NN	O
showed	VBD	O
reduced	JJ	O
expression	NN	O
of	IN	O
TBK1	NNP	O
(	(	O
p	SYM	O
-	:	O
value	NN	O
0.03	CD	O
)	)	O
.	.	O

Our	PRP$	O
findings	NNS	O
are	VBP	O
not	RB	O
indicative	JJ	O
of	IN	O
a	DT	O
significant	JJ	O
role	NN	O
for	IN	O
TBK1	NNP	O
mutations	NNS	O
in	IN	O
EOAD	NNP	O
.	.	O

The	DT	O
association	NN	O
between	IN	O
common	JJ	O
variants	NNS	O
in	IN	O
TBK1	NNP	O
,	,	O
disease	NN	O
risk	NN	O
and	CC	O
reduced	JJ	O
TBK1	NNP	O
expression	NN	O
warrants	NNS	O
follow	VBP	O
-	:	O
up	RB	O
in	IN	O
FTD	NNP	O
ALS	NNP	O
cohorts	NNS	O

SLC40A1	NNP	B-Gene
missense	NN	B-Var
mutations	NNS	I-Var
found	VBN	B-Reg
hemochromatosis	NN	B-Disease
type	NN	I-Disease
4	CD	I-Disease
Genetic	JJ	O
medicine	NN	O
applied	VBN	O
to	TO	O
the	DT	O
study	NN	O
of	IN	O
hemochromatosis	NN	O
has	VBZ	O
identified	VBN	O
the	DT	O
systemic	JJ	O
loop	NN	O
controlling	VBG	O
iron	NN	O
homeostasis	NN	O
,	,	O
centered	VBN	O
on	IN	O
hepcidin	NN	O
-	:	O
ferroportin	NN	O
interaction	NN	O
.	.	O

Current	JJ	O
challenges	NNS	O
are	VBP	O
to	TO	O
dissect	VB	O
the	DT	O
molecular	JJ	O
pathways	NNS	O
underlying	VBG	O
liver	RB	O
hepcidin	JJ	O
synthesis	NN	O
in	IN	O
response	NN	O
to	TO	O
circulatory	NN	O
iron	NN	O
,	,	O
HFE	NNP	O
,	,	O
TFR2	NNP	O
,	,	O
HJV	NNP	O
,	,	O
TMPRSS6	NNP	O
and	CC	O
BMP6	NNP	O
functions	NNS	O
,	,	O
and	CC	O
to	TO	O
define	VB	O
the	DT	O
major	JJ	O
structural	JJ	O
elements	NNS	O
of	IN	O
hepcidin	NN	O
-	:	O
ferroportin	NN	O
interaction	NN	O
.	.	O

We	PRP	O
built	VBD	O
a	DT	O
first	JJ	O
3	CD	O
D	NNP	O
model	NN	O
of	IN	O
human	JJ	O
ferroportin	NN	O
structure	NN	O
,	,	O
using	VBG	O
the	DT	O
crystal	JJ	O
structure	NN	O
of	IN	O
EmrD	NNP	O
,	,	O
a	DT	O
bacterial	JJ	O
drug	NN	O
efflux	NN	O
transporter	NN	O
of	IN	O
the	DT	O
Major	NNP	O
Facilitator	NNP	O
Superfamily	NNP	O
,	,	O
as	IN	O
template	NN	O
.	.	O

The	DT	O
model	NN	O
enabled	VBD	O
study	NN	O
of	IN	O
disease	NN	O
-	:	O
associated	JJ	O
mutations	NNS	O
,	,	O
and	CC	O
guided	VBD	O
mutagenesis	NN	O
experiments	NNS	O
to	TO	O
determine	VB	O
the	DT	O
role	NN	O
of	IN	O
conserved	JJ	O
residues	NNS	O
in	IN	O
protein	NN	O
stability	NN	O
and	CC	O
iron	NN	O
transport	NN	O
.	.	O

Results	NNS	O
revealed	VBD	O
novel	JJ	O
amino	NN	O
acids	NNS	O
that	WDT	O
are	VBP	O
critical	JJ	O
for	IN	O
the	DT	O
iron	NN	O
export	NN	O
function	NN	O
and	CC	O
the	DT	O
hepcidin	NN	O
-	:	O
mediated	VBN	O
inhibition	NN	O
mechanism	NN	O
:	:	O
for	IN	O
example	NN	O
,	,	O
tryptophan	RB	O
42	CD	O
,	,	O
localized	VBN	O
in	IN	O
the	DT	O
extracellular	JJ	O
end	NN	O
of	IN	O
the	DT	O
ferroportin	NN	O
pore	NN	O
and	CC	O
involved	VBN	O
in	IN	O
both	DT	O
biological	JJ	O
functions	NNS	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
propose	VBP	O
a	DT	O
strategy	NN	O
that	WDT	O
is	VBZ	O
not	RB	O
limited	JJ	O
to	TO	O
structure	NN	O
analysis	NN	O
,	,	O
but	CC	O
integrates	VBZ	O
information	NN	O
from	IN	O
different	JJ	O
sources	NNS	O
,	,	O
including	VBG	O
human	JJ	O
disease	NN	O
-	:	O
associated	VBN	O
mutations	NNS	O
and	CC	O
functional	JJ	O
in	IN	O
vitro	JJ	O
assays	NNS	O
.	.	O

The	DT	O
first	JJ	O
major	JJ	O
hypothesis	NN	O
of	IN	O
this	DT	O
PhD	NNP	O
thesis	NN	O
is	VBZ	O
that	IN	O
ferroportin	JJ	O
resistance	NN	O
to	TO	O
hepcidin	VB	O
relies	NNS	O
on	IN	O
different	JJ	O
molecular	JJ	O
mechanisms	NNS	O
that	WDT	O
are	VBP	O
critical	JJ	O
for	IN	O
ferroportin	JJ	O
endocytosis	NN	O
,	,	O
and	CC	O
include	VBP	O
at	IN	O
least	JJS	O
three	CD	O
fundamental	JJ	O
steps	NNS	O
:	:	O
(	(	O
i	NN	O
)	)	O
hepcidin	NN	O
binding	VBG	O
to	TO	O
ferroportin	VB	O
,	,	O
(	(	O
ii	NN	O
)	)	O
structural	JJ	O
reorganization	NN	O
of	IN	O
the	DT	O
N	NNP	O
-	:	O
and	CC	O
C	NNP	O
-	:	O
ter	NN	O
ferroportin	NN	O
lobes	NN	O
,	,	O
and	CC	O
(	(	O
iii	NN	O
)	)	O
ferroportin	NN	O
ubiquitination	NN	O


The	DT	O
tumor	NN	O
suppressor	NN	O
p53	NN	O
is	VBZ	O
frequently	RB	O
mutated	VBN	O
in	IN	O
human	JJ	O
cancer	NN	O
.	.	O

Common	JJ	O
mutant	NN	O
p53	NN	O
(	(	O
mutp53	NN	O
)	)	O
isoforms	NNS	O
can	MD	O
actively	RB	O
promote	VB	O
cancer	NN	O
through	IN	O
gain	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
(	(	O
GOF	NNP	O
)	)	O
mechanisms	NN	O
.	.	O

We	PRP	O
report	VBP	O
that	IN	O
mutp53	JJ	O
prolongs	NNS	O
TNF	NNP	O
-	:	O
-	:	O
induced	JJ	O
NF	NNP	O
-	:	O
B	NNP	O
activation	NN	O
in	IN	O
cultured	JJ	O
cells	NNS	O
and	CC	O
intestinal	JJ	O
organoid	NN	O
cultures	NNS	O
.	.	O

Remarkably	RB	O
,	,	O
when	WRB	O
exposed	VBN	O
to	TO	O
dextran	VB	O
sulfate	JJ	O
sodium	NN	O
,	,	O
mice	NN	O
harboring	VBG	O
a	DT	O
germline	NN	O
p53	NN	O
mutation	NN	O
develop	VB	O
severe	JJ	O
chronic	JJ	O
inflammation	NN	O
and	CC	O
persistent	JJ	O
tissue	NN	O
damage	NN	O
,	,	O
and	CC	O
are	VBP	O
highly	RB	O
prone	JJ	O
to	TO	O
inflammation	VB	O
-	:	O
associated	VBN	O
colon	NN	O
cancer	NN	O
.	.	O

This	DT	O
mutp53	NN	O
GOF	NNP	O
is	VBZ	O
manifested	VBN	O
by	IN	O
rapid	JJ	O
onset	NN	O
of	IN	O
flat	JJ	O
dysplastic	JJ	O
lesions	NNS	O
that	WDT	O
progress	VBP	B-PosReg
to	TO	O
invasive	VB	B-Disease
carcinoma	NN	I-Disease
with	IN	O
mutp53	JJ	B-Var
accumulation	NN	B-PosReg
and	CC	O
augmented	VBD	O
NF	NNP	B-Protein
-	:	I-Protein
B	NNP	I-Protein
activation	NN	B-PosReg
,	,	O
faithfully	RB	O
recapitulating	VBG	O
features	NNS	O
frequently	RB	O
observed	VBN	O
in	IN	O
human	JJ	O
colitis	NN	B-Disease
-	:	I-Disease
associated	VBN	I-Disease
colorectal	JJ	I-Disease
cancer	NN	I-Disease
(	(	O
CAC	NNP	O
)	)	O
.	.	O
These	DT	O
findings	NNS	O
might	MD	O
explain	VB	O
the	DT	O
early	JJ	O
appearance	NN	O
of	IN	O
p53	NN	O
mutations	NNS	O
in	IN	O
human	JJ	O
CAC	NNP	O

of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
QRICH2	NNP	B-Gene
cause	NN	B-Reg
male	NN	B-Disease
infertility	NN	I-Disease
Aberrant	JJ	B-Var
sperm	NN	B-CPA
flagella	NN	I-CPA
impair	NN	B-NegReg
sperm	JJ	B-CPA
motility	NN	I-CPA
cause	VB	B-Reg
male	NN	B-Disease
infertility	NN	I-Disease

Remarkably	RB	O
,	,	O
Qrich2	NNP	O
knock	NNP	O
-	:	O
out	RP	O
(	(	O
KO	NNP	O
)	)	O
male	NN	O
mice	NN	O
constructed	VBN	O
by	IN	O
CRISPR	NNP	O
-	:	O
Cas9	NNP	O
technology	NN	O
present	JJ	O
MMAF	NNP	O
phenotypes	NNS	O
and	CC	O
sterility	NN	O
.	.	O

To	TO	O
elucidate	VB	O
the	DT	O
mechanisms	NN	O
of	IN	O
Qrich2	NNP	O
functioning	VBG	O
in	IN	O
sperm	JJ	O
flagellar	JJ	O
formation	NN	O
,	,	O
we	PRP	O
perform	VBP	O
proteomic	JJ	O
analysis	NN	O
on	IN	O
the	DT	O
testes	NNS	O
of	IN	O
KO	NNP	O
and	CC	O
wild	JJ	O
-	:	O
type	NN	O
mice	NN	O
.	.	O

Furthermore	RB	O
,	,	O
in	IN	O
vitro	JJ	O
experiments	NNS	O
indicate	VBP	O
that	IN	O
QRICH2	NNP	O
is	VBZ	O
involved	VBN	O
in	IN	O
sperm	JJ	O
flagellar	NN	O
development	NN	O
through	IN	O
stabilizing	NN	O
and	CC	O
enhancing	VBG	O
the	DT	O
expression	NN	O
of	IN	O
proteins	NNS	O
related	VBN	O
to	TO	O
flagellar	JJ	O
development	NN	O
.	.	O

Our	PRP$	O
findings	NNS	O
strongly	RB	O
suggest	VBP	O
that	IN	O
the	DT	O
genetic	JJ	O
mutations	NNS	B-Var
of	IN	O
human	JJ	O
QRICH2	NNP	B-Gene
can	MD	O
lead	VB	B-Reg
to	TO	I-Reg
male	JJ	B-Disease
infertility	NN	I-Disease
with	IN	O
MMAF	NNP	B-CPA
and	CC	O
that	IN	O
QRICH2	NNP	O
is	VBZ	O
essential	JJ	O
for	IN	O
sperm	JJ	O
flagellar	JJ	O
formation	NN	O




Bioinformatic	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
NCI	NNP	O
-	:	O
60	CD	O
data	NNS	O
set	NN	O
and	CC	O
subsequent	JJ	O
hub	NN	O
prediction	NN	O
identified	VBD	O
EFNB2	NNP	O
as	IN	O
a	DT	O
possible	JJ	O
GOF	NNP	O
mutant	NN	O
p53	NN	O
target	NN	O
gene	NN	O
,	,	O
responsible	JJ	O
for	IN	O
chemoresistance	NN	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
the	DT	O
mutant	JJ	B-Var
p53	NN	B-Gene
-	:	O
NF	NNP	O
-	:	O
Y	NN	O
complex	JJ	O
transcriptionally	RB	O
upregulates	VBZ	B-PosReg
EFNB2	NNP	B-Gene
expression	NN	B-MPA
in	IN	O
response	NN	B-MPA
to	TO	I-MPA
DNA	NNP	I-MPA
damage	NN	I-MPA
.	.	O
Moreover	RB	O
,	,	O
the	DT	O
acetylated	JJ	O
form	NN	O
of	IN	O
mutant	JJ	B-Var
p53	NN	B-Gene
protein	NN	B-Protein
is	VBZ	O
recruited	VBN	B-PosReg
on	IN	O
the	DT	O
EFNB2	NNP	O
promoter	NN	O
and	CC	O
positively	RB	O
regulates	VBZ	B-Reg
its	PRP$	O
expression	NN	B-MPA
in	IN	O
conjunction	NN	O
with	IN	O
coactivator	NN	O
p300	NN	O
.	.	O
In	IN	O
vitro	NNP	O
cell	NN	O
line	NN	O
and	CC	O
in	IN	O
vivo	JJ	O
nude	JJ	O
mice	NN	O
data	NNS	O
show	VBP	O
that	IN	O
EFNB2	NNP	O
silencing	VBG	O
restores	NNS	O
chemosensitivity	NN	O
in	IN	O
mutant	JJ	O
p53	NN	O
-	:	O
harboring	NN	O
tumors	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
we	PRP	O
observed	VBD	O
high	JJ	O
expression	NN	O
of	IN	O
EFNB2	NNP	O
in	IN	O
patients	NNS	O
having	VBG	O
neoadjuvant	JJ	O
non	JJ	O
-	:	O
responder	NN	O
colorectal	JJ	O
carcinoma	NN	O
compared	VBN	O
with	IN	O
those	DT	O
having	VBG	O
responder	JJR	O
version	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

In	IN	O
the	DT	O
course	NN	O
of	IN	O
deciphering	VBG	O
the	DT	O
drug	NN	O
resistance	NN	O
mechanism	NN	O
,	,	O
we	PRP	O
also	RB	O
show	VBP	O
that	IN	O
ephrin	SYM	O
-	:	O
B2	JJ	O
reverse	NN	O
signaling	VBG	O
induces	NNS	B-PosReg
ABCG2	NNP	B-Gene
expression	NN	B-MPA
after	IN	O
drug	NN	O
treatment	NN	O
that	WDT	O
involves	VBZ	O
JNK	NNP	B-MPA
-	:	I-MPA
c	SYM	I-MPA
-	:	I-MPA
Jun	NN	I-MPA
signaling	VBG	I-MPA
in	IN	O
mutant	JJ	B-Var
p53	NN	B-Gene
cells	NNS	O
.	.	O
Moreover	RB	O
,	,	O
5	CD	O
-	:	O
fluorouracil	NN	O
-	:	O
induced	JJ	O
ephrin	SYM	O
-	:	O
B2	JJ	O
reverse	NN	O
signaling	VBG	O
promotes	NNS	O
tumorigenesis	VBP	O
through	IN	O
the	DT	O
Src	NNP	O
-	:	O
ERK	NNP	O
pathway	NN	O
,	,	O
and	CC	O
drives	VBZ	O
EMT	NNP	O
via	IN	O
the	DT	O
Src	NNP	O
-	:	O
FAK	NNP	O
pathway	NN	O
.	.	O

We	PRP	O
thus	RB	O
conclude	VBP	O
that	IN	O
targeting	VBG	O
ephrin	SYM	O
-	:	O
B2	NN	O
might	MD	O
enhance	VB	O
the	DT	O
therapeutic	JJ	O
potential	NN	O
of	IN	O
DNA	NNP	O
-	:	O
damaging	NN	O
chemotherapeutic	JJ	O
agents	NNS	O
in	IN	O
mutant	JJ	O
p53	NN	O
-	:	O
bearing	NN	O
human	JJ	O
tumors	NNS	O
.	.	O
Cell	NNP	O
Death	NNP	O
and	CC	O
Differentiation	NNP	O
advance	NN	O
online	NN	O
publication	NN	O
,	,	O
23	CD	O
October	NNP	O
2015	CD	O
;	:	O
doi	NN	O
:	:	O
10.1038	CD	O
cdd	NN	O
.	.	O
2015.133	CD	O


Exome	NNP	O
sequencing	VBG	O
studies	NNS	O
have	VBP	O
identified	VBN	O
multiple	JJ	O
genes	NNS	O
harboring	VBG	O
de	IN	O
novo	FW	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
(	(	O
LoF	NNP	O
)	)	O
variants	NNS	B-Var
in	IN	O
individuals	NNS	O
with	IN	O
autism	NN	B-Disease
spectrum	NN	I-Disease
disorders	NNS	I-Disease
(	(	O
ASD	NNP	O
)	)	O
,	,	O
including	VBG	O
TBR1	NNP	B-Gene
,	,	O
a	DT	O
master	NN	O
regulator	NN	O
of	IN	O
cortical	JJ	O
development	NN	O
.	.	O
We	PRP	O
performed	VBD	O
ChIP	NNP	O
-	:	O
seq	NN	O
for	IN	O
TBR1	NNP	O
during	IN	O
mouse	RB	O
cortical	JJ	O
neurogenesis	NN	O
and	CC	O
show	NN	O
that	IN	O
TBR1	NNP	O
-	:	O
bound	NN	O
regions	NNS	O
are	VBP	O
enriched	VBN	O
adjacent	JJ	O
to	TO	O
ASD	NNP	O
genes	NNS	O
.	.	O

ASD	NNP	O
genes	NNS	O
were	VBD	O
also	RB	O
enriched	VBN	O
among	IN	O
genes	NNS	O
that	WDT	O
are	VBP	O
differentially	RB	O
expressed	VBN	O
in	IN	O
Tbr1	NNP	O
knockouts	NNS	O
,	,	O
which	WDT	O
together	RB	O
with	IN	O
the	DT	O
ChIP	NNP	O
-	:	O
seq	NN	O
data	NNS	O
,	,	O
suggests	VBZ	O
direct	JJ	O
transcriptional	JJ	O
regulation	NN	O
.	.	O

Of	IN	O
the	DT	O
nine	CD	O
ASD	NNP	O
genes	NNS	O
examined	VBD	O
,	,	O
seven	CD	O
were	VBD	O
misexpressed	VBN	O
in	IN	O
the	DT	O
cortices	NNS	O
of	IN	O
Tbr1	NNP	O
knockout	NN	O
mice	NN	O
,	,	O
including	VBG	O
six	CD	O
with	IN	O
increased	VBN	O
expression	NN	O
in	IN	O
the	DT	O
deep	JJ	O
cortical	JJ	O
layers	NNS	O
.	.	O

ASD	NNP	O
genes	NNS	O
with	IN	O
adjacent	JJ	O
cortical	JJ	O
TBR1	NNP	O
ChIP	NNP	O
-	:	O
seq	NN	O
peaks	NNS	O
also	RB	O
showed	VBD	O
unusually	RB	O
low	JJ	O
levels	NNS	O
of	IN	O
LoF	NNP	O
mutations	NNS	O
in	IN	O
a	DT	O
reference	NN	O
human	JJ	O
population	NN	O
and	CC	O
among	IN	O
Icelanders	NNS	O
.	.	O

We	PRP	O
then	RB	O
leveraged	VBD	O
TBR1	NNP	O
binding	VBG	O
to	TO	O
identify	VB	O
an	DT	O
appealing	VBG	O
subset	NN	O
of	IN	O
candidate	NN	O
ASD	NNP	O
genes	NNS	O
.	.	O

Our	PRP$	O
findings	NNS	O
highlight	VBD	O
a	DT	O
TBR1	NNP	O
-	:	O
regulated	VBD	O
network	NN	O
of	IN	O
ASD	NNP	O
genes	NNS	O
in	IN	O
the	DT	O
developing	VBG	O
neocortex	NN	O
that	WDT	O
are	VBP	O
relatively	RB	O
intolerant	JJ	O
to	TO	O
LoF	NNP	O
mutations	NNS	O
,	,	O
indicating	VBG	O
that	IN	O
these	DT	O
genes	NNS	O
may	MD	O
play	VB	O
critical	JJ	O
roles	NNS	O
in	IN	O
normal	JJ	O
cortical	JJ	O
development	NN	O

-	:	I-PosReg
KCNJ6	NNP	I-PosReg
Mutation	NNP	I-Gene
a	DT	I-Var
Severe	NNP	B-Disease
Hyperkinetic	NNP	I-Disease
Movement	NNP	I-Disease
Disorder	NNP	I-Disease
KCNJ6	NNP	B-Gene
mutation	NN	B-Var
presented	VBD	B-Reg
severe	JJ	B-Disease
hyperkinetic	JJ	I-Disease
movement	NN	I-Disease
disorder	NN	I-Disease
developmental	JJ	B-CPA
delay	NN	I-CPA
KCNJ6	NNP	B-Gene
c	NN	B-Var
.	.	I-Var
512	CD	I-Var
T	NNP	I-Var
G	NNP	I-Var
p	NN	B-Var
.	.	I-Var
Leu171Arg	NNP	I-Var

mutant	JJ	B-Var
GIRK2	NNP	B-Gene
produced	VBD	B-PosReg
basal	NN	B-MPA
inward	JJ	I-MPA
current	JJ	I-MPA
lacked	VBD	B-NegReg
G	NNP	B-Protein
protein	NN	I-Protein
activation	NN	B-MPA
lost	VBD	B-NegReg
K	NNP	B-MPA
selectivity	NN	I-MPA
gained	VBD	B-PosReg
Ca2	NNP	B-MPA
permeability	NN	I-MPA
Notably	RB	O
,	,	O
the	DT	O
inward	NN	O
current	JJ	O
was	VBD	O
inhibited	VBN	O
by	IN	O
the	DT	O
Na	NNP	O
channel	NN	O
blocker	NN	O
QX	NNP	O
-	:	O
314	CD	O
,	,	O
similar	JJ	O
to	TO	O
the	DT	O
previously	RB	O
reported	VBN	O
weaver	JJ	O
mutation	NN	O
in	IN	O
murine	NN	O
GIRK2	NNP	O
.	.	O

Expression	NN	O
of	IN	O
a	DT	O
tandem	JJ	O
dimer	NN	O
containing	VBG	O
GIRK1	NNP	O
and	CC	O
GIRK2	NNP	O
(	(	O
p	NN	O
.	.	O
Leu171Arg	NNP	O
)	)	O
did	VBD	O
not	RB	O
lead	VB	O
to	TO	O
any	DT	O
currents	NNS	O
,	,	O
suggesting	VBG	O
heterotetramers	NNS	O
are	VBP	O
not	RB	O
functional	JJ	O
.	.	O

In	IN	O
neurons	NNS	O
expressing	VBG	O
p	NN	B-Var
.	.	I-Var
Leu171Arg	NNP	I-Var
GIRK2	NNP	B-Gene
channels	NNS	O
,	,	O
these	DT	O
changes	NNS	O
in	IN	O
channel	NN	O
properties	NNS	O
would	MD	O
be	VB	O
expected	VBN	O
to	TO	O
generate	VB	O
a	DT	O
sustained	JJ	O
depolarization	NN	B-NegReg
,	,	O
instead	RB	O
of	IN	O
the	DT	O
normal	JJ	O
G	NNP	B-MPA
protein	NN	I-MPA
-	:	I-MPA
gated	JJ	I-MPA
inhibitory	NN	I-MPA
response	NN	I-MPA
,	,	O
which	WDT	O
could	MD	O
be	VB	O
mitigated	VBN	O
by	IN	O
expression	NN	O
of	IN	O
other	JJ	O
GIRK	NNP	O
subunits	NNS	O
.	.	O
The	DT	O
identification	NN	O
of	IN	O
the	DT	O
p	NN	O
.	.	O
Leu171Arg	NNP	O
GIRK2	NNP	O
mutation	NN	O
potentially	RB	O
expands	VBZ	O
the	DT	O
Keppen	NNP	O
-	:	O
Lubinsky	NNP	O
syndrome	VBD	O
phenotype	NN	O
to	TO	O
include	VB	O
severe	JJ	O
dystonia	NN	O
and	CC	O
ballismus	NN	O
.	.	O

Our	PRP$	O
study	NN	O
suggests	VBZ	O
screening	VBG	O
for	IN	O
dominant	JJ	O
KCNJ6	NNP	O
mutations	NNS	O
in	IN	O
the	DT	O
evaluation	NN	O
of	IN	O
patients	NNS	O
with	IN	O
severe	JJ	O
movement	NN	O
disorders	NNS	O
,	,	O
which	WDT	O
could	MD	O
provide	VB	O
evidence	NN	O
to	TO	O
support	VB	O
a	DT	O
causal	JJ	O
role	NN	O
of	IN	O
KCNJ6	NNP	O
in	IN	O
neurological	JJ	O
channelopathies	NNS	O

due	JJ	I-Disease
caused	VBN	B-Reg
by	IN	I-Reg
mutations	NNS	B-Var
MPDZ	NNP	B-Gene

Congenital	JJ	O
hydrocephalus	NN	O
is	VBZ	O
either	DT	O
syndromic	JJ	O
or	CC	O
non	JJ	O
-	:	O
syndromic	NN	O
,	,	O
and	CC	O
in	IN	O
the	DT	O
latter	JJ	O
no	DT	O
cause	NN	O
is	VBZ	O
found	VBN	O
in	IN	O
more	JJR	O
than	IN	O
half	NN	O
of	IN	O
the	DT	O
patients	NNS	O
.	.	O

In	IN	O
patients	NNS	O
with	IN	O
isolated	JJ	B-Disease
hydrocephalus	NN	I-Disease
,	,	O
L1CAM	NNP	B-Gene
mutations	NNS	B-Var
represent	VBP	O
the	DT	O
most	RBS	O
common	JJ	B-Reg
aetiology	NN	O
.	.	O
More	RBR	O
recently	RB	O
,	,	O
a	DT	O
founder	NN	O
mutation	NN	O
has	VBZ	O
also	RB	O
been	VBN	O
reported	VBN	O
in	IN	O
the	DT	O
MPDZ	NNP	O
gene	NN	O
in	IN	O
foetuses	NNS	O
presenting	VBG	O
massive	JJ	O
hydrocephalus	NN	O
,	,	O
but	CC	O
the	DT	O
neuropathology	NN	O
remains	VBZ	O
unknown	JJ	O
.	.	O

We	PRP	O
describe	VBP	O
here	RB	O
three	CD	O
novel	JJ	O
homozygous	JJ	O
null	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
MPDZ	NNP	O
gene	NN	O
in	IN	O
foetuses	NNS	O
whose	WP$	O
post	NN	O
-	:	O
mortem	NN	O
examination	NN	O
has	VBZ	O
revealed	VBN	O
a	DT	O
homogeneous	JJ	O
phenotype	NN	O
characterized	VBN	O
by	IN	O
multiple	JJ	O
ependymal	JJ	O
malformations	NNS	O
along	IN	O
the	DT	O
aqueduct	NN	O
of	IN	O
Sylvius	NNP	O
,	,	O
the	DT	O
third	JJ	O
and	CC	O
fourth	JJ	O
ventricles	NNS	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
central	JJ	O
canal	NN	O
of	IN	O
the	DT	O
medulla	NN	O
,	,	O
consisting	VBG	O
in	IN	O
multifocal	JJ	O
rosettes	NNS	O
with	IN	O
immature	NN	O
cell	NN	O
accumulation	NN	O
in	IN	O
the	DT	O
vicinity	NN	O
of	IN	O
ependymal	JJ	O
lining	VBG	O
early	JJ	O
detached	VBN	O
from	IN	O
the	DT	O
ventricular	JJ	O
zone	NN	O
.	.	O

MPDZ	NNP	O
also	RB	O
named	VBD	O
MUPP1	NNP	O
is	VBZ	O
an	DT	O
essential	JJ	O
component	NN	O
of	IN	O
tight	JJ	O
junctions	NNS	O
which	WDT	O
are	VBP	O
expressed	VBN	O
from	IN	O
early	RB	O
brain	NN	O
development	NN	O
in	IN	O
the	DT	O
choroid	NN	O
plexuses	NNS	O
and	CC	O
ependyma	NN	O
.	.	O

Alterations	NNS	O
in	IN	O
the	DT	O
formation	NN	O
of	IN	O
tight	JJ	O
junctions	NNS	O
within	IN	O
the	DT	O
ependyma	NN	O
very	RB	O
likely	JJ	O
account	NN	O
for	IN	O
the	DT	O
lesions	NNS	O
observed	VBD	O
and	CC	O
highlight	NN	O
for	IN	O
the	DT	O
first	JJ	O
time	NN	O
that	WDT	O
primary	JJ	O
multifocal	JJ	O
ependymal	JJ	O
malformations	NNS	O
of	IN	O
the	DT	O
ventricular	JJ	O
system	NN	O
is	VBZ	O
genetically	RB	O
determined	VBN	O
in	IN	O
humans	NNS	O
.	.	O

Therefore	RB	O
,	,	O
MPDZ	NNP	O
sequencing	NN	O
should	MD	O
be	VB	O
performed	VBN	O
when	WRB	O
neuropathological	JJ	O
examination	NN	O
reveals	NNS	O
multifocal	JJ	O
ependymal	JJ	O
rosette	NN	O
formation	NN	O
within	IN	O
the	DT	O
aqueduct	NN	O
of	IN	O
Sylvius	NNP	O
,	,	O
of	IN	O
the	DT	O
third	JJ	O
and	CC	O
fourth	JJ	O
ventricles	NNS	O
and	CC	O
of	IN	O
the	DT	O
central	JJ	O
canal	NN	O
of	IN	O
the	DT	O
medulla	NN	O


Mutations	NNS	B-Var
activating	VBG	B-PosReg
heterotrimeric	JJ	B-Protein
Gs	NNP	I-Protein
protein	NN	I-Protein
McCune	NNP	B-Disease
Albright	NNP	I-Disease
syndrome	NN	I-Disease

MAIN	NNP	O
BODY	NNP	O
:	:	O
A	DT	O
similar	JJ	O
repertoire	NN	O
of	IN	O
neoplasms	NNS	O
can	MD	O
develop	VB	O
whether	IN	O
mutations	NNS	O
occur	VBP	O
spontaneously	RB	O
in	IN	O
somatic	JJ	O
tissues	NNS	O
during	IN	O
fetal	JJ	O
development	NN	O
or	CC	O
after	IN	O
birth	NN	O
.	.	O

Glands	NNS	O
are	VBP	O
the	DT	O
most	RBS	O
"	JJ	O
permissive	JJ	O
"	NN	O
tissues	NNS	O
,	,	O
recently	RB	O
found	VBD	O
to	TO	O
include	VB	O
the	DT	O
entire	JJ	O
gastrointestinal	JJ	O
tract	NN	O
.	.	O

High	JJ	O
frequency	NN	O
of	IN	O
activating	VBG	B-PosReg
G	NNP	B-Gene
s	JJ	I-Gene
mutations	NNS	B-Var
is	VBZ	O
associated	VBN	O
with	IN	O
precise	JJ	O
diagnoses	NNS	O
(	(	O
e	NN	O
.	.	O
g	NN	O
.	.	O
,	,	O
IPMN	NNP	B-Disease
,	,	O
Pyloric	NNP	B-Disease
gland	NN	I-Disease
adenoma	NN	I-Disease
,	,	O
pituitary	JJ	B-Disease
toxic	NN	I-Disease
adenoma	NN	I-Disease
)	)	O
.	.	O
Typically	RB	O
,	,	O
most	JJS	O
neoplastic	JJ	O
lesions	NNS	O
,	,	O
from	IN	O
thyroid	NN	O
to	TO	O
pancreas	VB	O
,	,	O
remain	VBP	O
well	RB	O
differentiated	VBN	O
but	CC	O
may	MD	O
be	VB	O
a	DT	O
precursor	NN	O
to	TO	O
aggressive	JJ	O
cancer	NN	O
.	.	O

CONCLUSIONS	NN	O
:	:	O
Here	RB	O
we	PRP	O
propose	VBP	O
the	DT	O
possibility	NN	O
that	WDT	O
gain	VBP	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutations	NNS	B-Var
of	IN	O
G	NNP	B-Gene
s	NN	I-Gene
interfere	RB	B-NegReg
with	IN	O
signals	NNS	O
in	IN	O
the	DT	O
microenvironment	NN	B-MPA
of	IN	I-MPA
permissive	JJ	I-MPA
tissues	NNS	O
and	CC	O
lead	NN	B-Reg
to	TO	I-Reg
a	DT	O
transversal	NN	B-MPA
neoplastic	JJ	I-MPA
phenotype	NN	I-MPA

mutant	JJ	B-Var
chemokines	NNS	I-Gene
migration	NN	I-PosReg
.	.	I-MPA
The	DT	I-PosReg
role	NN	I-CPA

aberrant	JJ	B-Var
p53	NN	B-Protein
proteins	NNS	I-Protein
enhance	VB	B-PosReg
tumorigenesis	NN	B-CPA
and	CC	I-CPA
metastasis	NN	I-CPA

p53	NN	B-Var
-	:	I-Var
R175H	NNP	I-Var
,	,	I-Var
-	:	I-Var
R273H	NN	I-Var
and	CC	I-Var
-	:	I-Var
D281G	NN	I-Var
enhanced	JJ	B-PosReg
migration	NN	B-CPA

GOF	NNP	B-Var
p53	NN	I-Var
upregulate	JJ	B-PosReg
CXC	NNP	B-MPA
-	:	I-MPA
chemokine	NN	I-MPA
expression	NN	I-MPA
Elevated	JJ	B-PosReg
expression	NN	B-MPA
oncogenic	JJ	B-Var
p53	NN	I-Var
Transcription	NN	B-MPA
elevated	VBN	B-PosReg
CXCL5	NNP	B-MPA
and	CC	I-MPA
CXCL8	NNP	I-MPA
promoter	NN	I-MPA
activity	NN	I-MPA
higher	RBR	B-PosReg
GOF	NNP	B-Var
p53	NN	I-Var
Chromatin	NNP	O
immunoprecipitation	NN	O
assays	NNS	O
revealed	VBD	O
enhanced	JJ	O
presence	NN	O
of	IN	O
acetylated	JJ	O
histone	NN	O
H3	NNP	O
on	IN	O
the	DT	O
CXCL5	NNP	O
promoter	NN	O
in	IN	O
H1299	NNP	O
R273H	NNP	O
cells	NNS	O
,	,	O
in	IN	O
agreement	NN	O
with	IN	O
increased	JJ	O
transcriptional	JJ	O
activity	NN	O
of	IN	O
the	DT	O
promoter	NN	O
,	,	O
whereas	WP	O
RNAi	NNP	O
-	:	O
mediated	VBD	O
repression	NN	O
of	IN	O
CXCL5	NNP	O
inhibited	VBD	O
cell	NN	O
migration	NN	O
.	.	O

Consistent	JJ	O
with	IN	O
this	DT	O
,	,	O
knockdown	NN	O
of	IN	O
the	DT	O
endogenous	JJ	B-Var
mutant	NN	I-Var
p53	NN	B-Gene
in	IN	O
lung	NN	O
cancer	NN	O
or	CC	O
melanoma	NN	O
cells	NNS	O
reduced	VBD	B-NegReg
CXCL5	NNP	B-MPA
expression	NN	I-MPA
and	CC	O
cell	NN	B-CPA
migration	NN	I-CPA
.	.	O
Furthermore	RB	O
,	,	O
short	JJ	O
hairpin	NN	O
RNA	NNP	O
knockdown	NN	O
of	IN	O
mutant	JJ	B-Var
p53	NN	B-Gene
in	IN	O
MDA	NNP	O
-	:	O
MB	NNP	O
-	:	O
231	CD	O
cells	NNS	O
reduced	JJ	B-NegReg
expression	NN	B-MPA
of	IN	I-MPA
a	DT	I-MPA
number	NN	I-MPA
of	IN	I-MPA
key	JJ	I-MPA
targets	NNS	I-MPA
,	,	O
including	VBG	O
several	JJ	O
chemokines	NNS	O
and	CC	O
other	JJ	O
inflammatory	JJ	O
mediators	NNS	O
.	.	O
Finally	RB	O
,	,	O
CXCL5	NNP	B-MPA
expression	NN	I-MPA
was	VBD	O
also	RB	O
elevated	VBN	B-PosReg
in	IN	O
lung	NN	B-Disease
tumor	NN	I-Disease
samples	NNS	O
containing	VBG	O
GOF	NNP	B-Var
p53	NN	I-Var
,	,	O
indicating	VBG	O
relevance	NN	O
to	TO	O
human	JJ	O
cancer	NN	O
.	.	O
The	DT	O
data	NN	O
suggest	VBP	O
a	DT	O
mechanistic	JJ	O
link	NN	O
between	IN	O
GOF	NNP	O
p53	NN	O
proteins	NNS	O
and	CC	O
chemokines	NNS	O
in	IN	O
enhanced	JJ	O
cell	NN	O
motility	NN	O


human	JJ	B-Disease
cancers	NNS	I-Disease
associated	VBN	B-Reg
mutations	NNS	B-Var
TP53	NNP	B-Gene
dominant	JJ	B-Var
-	:	I-Var
negative	JJ	I-Var
(	(	I-Var
DN	NNP	I-Var
)	)	I-Var
mutations	NNS	I-Var
DN	NNP	B-MPA
activity	NN	I-MPA
over	IN	B-PosReg
the	DT	I-PosReg
remaining	VBG	I-PosReg
WT	NNP	I-PosReg
allele	NN	I-PosReg
DN	NNP	B-Var
p53	NN	B-Gene
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
(	(	I-PosReg
GOF	NNP	I-PosReg
)	)	I-PosReg
activity	NN	I-PosReg
In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
investigated	VBD	O
GOF	NNP	O
activity	NN	O
of	IN	O
two	CD	O
DN	NNP	O
p53	NN	O
mutants	NNS	O
which	WDT	O
had	VBD	O
a	DT	O
point	NN	O
mutation	NN	O
at	IN	O
codon	NN	O
248	CD	O
(	(	O
R248Q	NNP	O
and	CC	O
R248W	NNP	O
)	)	O
,	,	O
one	CD	O
of	IN	O
the	DT	O
hot	JJ	O
spots	NNS	O
,	,	O
by	IN	O
transfecting	VBG	O
them	PRP	O
respectively	RB	O
into	IN	O
H1299	NNP	O
cells	NNS	O
which	WDT	O
originally	RB	O
expressed	VBD	O
no	DT	O
p53	NN	O
protein	NN	O
.	.	O

Growth	NNP	O
activity	NN	O
of	IN	O
the	DT	O
transfectants	NNS	O
with	IN	O
the	DT	O
two	CD	O
mutants	NNS	O
was	VBD	O
not	RB	O
different	JJ	O
from	IN	O
that	DT	O
of	IN	O
parent	NN	O
or	CC	O
Mock	NNP	O
transfectants	NNS	O
.	.	O

Meanwhile	RB	O
,	,	O
in	IN	O
vitro	JJ	B-CPA
invasions	NNS	I-CPA
of	IN	I-CPA
Matrigel	NNP	I-CPA
and	CC	I-CPA
type	NN	I-CPA
I	PRP	I-CPA
collagen	VBP	I-CPA
gel	VBN	I-CPA
by	IN	O
R248Q	NNP	B-Var
-	:	I-Var
transfectants	NNS	I-Var
were	VBD	O
significantly	RB	O
higher	JJR	B-PosReg
than	IN	O
those	DT	O
by	IN	O
R248W	NNP	O
-	:	O
transfectants	NNS	O
or	CC	O
the	DT	O
control	NN	O
cells	NNS	O
.	.	O
However	RB	O
,	,	O
there	EX	O
were	VBD	O
no	DT	O
differences	NNS	O
in	IN	O
cell	NN	O
motile	NN	O
activities	NNS	O
,	,	O
expressions	NNS	O
of	IN	O
extracellular	JJ	O
matrix	FW	O
-	:	O
degradative	JJ	O
enzymes	NNS	O
such	JJ	O
as	IN	O
matrix	NN	O
metalloproteinases	NNS	O
,	,	O
urokinase	JJ	O
-	:	O
type	NN	O
plasminogen	NN	O
activator	NN	O
and	CC	O
heparanase	NN	O
,	,	O
and	CC	O
their	PRP$	O
inhibitors	NNS	O
,	,	O
between	IN	O
R248Q	NNP	O
-	:	O
and	CC	O
R248W	NNP	O
-	:	O
transfectants	NNS	O
.	.	O

These	DT	O
findings	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
p53	NN	O
mutants	NNS	O
have	VBP	O
a	DT	O
different	JJ	O
quality	NN	O
in	IN	O
GOF	NNP	O
activities	NNS	O
even	RB	O
if	IN	O
the	DT	O
mutations	NNS	O
occurred	VBD	O
at	IN	O
the	DT	O
same	JJ	O
codon	NN	O
.	.	O

And	CC	O
detailed	JJ	O
information	NN	O
of	IN	O
the	DT	O
status	NN	O
of	IN	O
p53	NN	O
,	,	O
including	VBG	O
transdominancy	NN	O
and	CC	O
GOF	NNP	O
activity	NN	O
,	,	O
is	VBZ	O
expected	VBN	O
to	TO	O
be	VB	O
useful	JJ	O
for	IN	O
diagnosis	NN	O
and	CC	O
therapeutic	JJ	O
strategy	NN	O
fitting	VBG	O
the	DT	O
individual	JJ	O
patients	NNS	O


Immunotherapy	NN	O
with	IN	O
PD	NNP	O
-	:	O
1	CD	O
checkpoint	NN	O
blockade	NN	O
is	VBZ	O
effective	JJ	O
in	IN	O
only	RB	O
a	DT	O
minority	NN	O
of	IN	O
patients	NNS	O
with	IN	O
cancer	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
additional	JJ	O
treatment	NN	O
strategies	NNS	O
are	VBP	O
needed	VBN	O
.	.	O

Here	RB	O
we	PRP	O
use	VBP	O
a	DT	O
pooled	VBN	O
in	IN	O
vivo	JJ	O
genetic	JJ	O
screening	NN	O
approach	NN	O
using	VBG	O
CRISPR	NNP	O
-	:	O
Cas9	NNP	O
genome	VBP	O
editing	VBG	O
in	IN	O
transplantable	JJ	O
tumours	NNS	O
in	IN	O
mice	NN	O
treated	VBN	O
with	IN	O
immunotherapy	NN	O
to	TO	O
discover	VB	O
previously	RB	O
undescribed	JJ	O
immunotherapy	JJ	O
targets	NNS	O
.	.	O

We	PRP	O
tested	VBD	O
2	CD	O
,	,	O
368	CD	O
genes	NNS	O
expressed	VBN	O
by	IN	O
melanoma	NN	O
cells	NNS	O
to	TO	O
identify	VB	O
those	DT	O
that	IN	O
synergize	VBP	O
with	IN	O
or	CC	O
cause	VB	O
resistance	NN	O
to	TO	O
checkpoint	VB	O
blockade	NN	O
.	.	O

We	PRP	O
recovered	VBD	O
the	DT	O
known	VBN	O
immune	NN	O
evasion	NN	O
molecules	NNS	O
PD	NNP	O
-	:	O
L1	NNP	O
and	CC	O
CD47	NNP	O
,	,	O
and	CC	O
confirmed	VBD	O
that	IN	O
defects	NNS	O
in	IN	O
interferon	NN	O
-	:	O
signalling	NN	O
caused	VBD	O
resistance	NN	O
to	TO	O
immunotherapy	VB	O
.	.	O

Tumours	NNS	O
were	VBD	O
sensitized	VBN	O
to	TO	O
immunotherapy	VB	O
by	IN	O
deletion	NN	O
of	IN	O
genes	NNS	O
involved	VBN	O
in	IN	O
several	JJ	O
diverse	JJ	O
pathways	NNS	O
,	,	O
including	VBG	O
NF	NNP	O
-	:	O
B	NNP	O
signalling	NN	O
,	,	O
antigen	NN	O
presentation	NN	O
and	CC	O
the	DT	O
unfolded	JJ	O
protein	NN	O
response	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
deletion	NN	B-Var
of	IN	O
the	DT	O
protein	NN	O
tyrosine	JJ	O
phosphatase	NN	O
PTPN2	NNP	B-Gene
in	IN	O
tumour	JJ	O
cells	NNS	O
increased	VBD	B-PosReg
the	DT	O
efficacy	NN	B-CPA
of	IN	I-CPA
immunotherapy	NN	I-CPA
by	IN	O
enhancing	VBG	B-PosReg
interferon	NN	B-MPA
-	:	I-MPA
-	:	I-MPA
mediated	VBN	I-MPA
effects	NNS	I-MPA
on	IN	I-MPA
antigen	NN	I-MPA
presentation	NN	I-MPA
and	CC	O
growth	NN	B-CPA
suppression	NN	I-CPA
.	.	O
In	IN	O
vivo	JJ	O
genetic	JJ	O
screens	NNS	O
in	IN	O
tumour	JJ	O
models	NNS	O
can	MD	O
identify	VB	O
new	JJ	O
immunotherapy	JJ	O
targets	NNS	O
in	IN	O
unanticipated	JJ	O
pathways	NNS	O






We	PRP	O
report	VBP	O
the	DT	O
functional	JJ	O
characterization	NN	O
of	IN	O
six	CD	O
MC1R	NNP	O
alleles	NNS	O
found	VBN	O
in	IN	O
Spanish	JJ	O
melanoma	NN	B-Disease
patients	NNS	O
.	.	O
Two	CD	O
variants	NNS	O
(	(	O
c	NN	O
.	.	O
152	CD	O
T	NNP	O
C	NNP	O
,	,	O
p	NN	O
.	.	O
Val51Ala	NNP	O
and	CC	O
c	NN	O
.	.	O
865	CD	O
T	NNP	O
C	NNP	O
,	,	O
p	NN	O
.	.	O
Cys289Arg	NNP	O
)	)	O
have	VBP	O
never	RB	O
been	VBN	O
described	VBN	O
,	,	O
and	CC	O
the	DT	O
others	NNS	O
(	(	O
c	VB	O
.	.	O
112	CD	O
G	NNP	O
A	NNP	O
,	,	O
p	NN	O
.	.	O
Val38Met	NNP	O
;	:	O
c	NN	O
.	.	O
122	CD	O
C	NNP	O
T	NNP	O
,	,	O
p	NN	O
.	.	O
Ser41Phe	NNP	O
;	:	O
c	NN	O
.	.	O
383	CD	O
T	NNP	O
C	NNP	O
,	,	O
p	NN	O
.	.	O
Met128Thr	NNP	O
;	:	O
and	CC	O
c	VB	O
.	.	O
842	CD	O
A	NNP	O
G	NNP	O
,	,	O
p	NN	O
.	.	O
Asn281Ser	NNP	O
)	)	O
have	VBP	O
not	RB	O
been	VBN	O
analyzed	VBN	O
for	IN	O
function	NN	O
.	.	O

p	NN	B-Var
.	.	I-Var
Asn281Ser	NNP	I-Var
corresponds	VBZ	O
to	TO	O
a	DT	O
functionally	RB	O
silent	JJ	B-NegReg
polymorphism	NN	B-MPA
.	.	O
The	DT	O
other	JJ	O
mutations	NNS	O
are	VBP	O
associated	VBN	O
with	IN	O
varying	VBG	O
degrees	NNS	O
of	IN	O
loss	NN	O
of	IN	O
function	NN	O
(	(	O
LOF	NNP	O
)	)	O
,	,	O
from	IN	O
moderate	JJ	O
decreases	NNS	B-NegReg
in	IN	O
coupling	VBG	B-MPA
to	TO	O
the	DT	O
cAMP	NN	B-Pathway
pathway	NN	I-Pathway
(	(	O
p	NN	B-Var
.	.	I-Var
Val38Met	NNP	I-Var
and	CC	O
p	NN	B-Var
.	.	I-Var
Val51Ala	NNP	I-Var
)	)	O
to	TO	O
nearly	RB	O
complete	JJ	O
absence	NN	B-NegReg
of	IN	O
functional	JJ	B-MPA
coupling	NN	I-MPA
(	(	O
p	NN	B-Var
.	.	I-Var
Ser41Phe	NNP	I-Var
,	,	O
p	NN	B-Var
.	.	I-Var
Met128Thr	NNP	I-Var
,	,	O
and	CC	O
p	NN	B-Var
.	.	I-Var
Cys289Arg	NNP	I-Var
)	)	O
.	.	O
The	DT	O
LOF	NNP	O
p	NN	B-Var
.	.	I-Var
Met128Thr	NNP	I-Var
and	CC	O
p	NN	B-Var
.	.	I-Var
Cys289Arg	NNP	I-Var
mutants	NNS	O
are	VBP	O
trafficked	VBN	O
to	TO	O
the	DT	O
cell	NN	O
surface	NN	O
,	,	O
but	CC	O
are	VBP	O
unable	JJ	B-NegReg
to	TO	O
bind	VB	B-Interaction
agonists	NNS	O
efficiently	RB	O
.	.	O
Conversely	RB	O
,	,	O
LOF	NNP	O
of	IN	O
p	NN	B-Var
.	.	I-Var
Val38Met	NNP	I-Var
,	,	I-Var
p	NN	I-Var
.	.	I-Var
Ser41Phe	NNP	I-Var
,	,	I-Var
and	CC	I-Var
p	NN	I-Var
.	.	I-Var
Val51Ala	NNP	I-Var
is	VBZ	O
due	JJ	O
to	TO	O
reduced	VB	B-NegReg
cell	NN	B-CPA
surface	NN	I-CPA
expression	NN	I-CPA
as	IN	O
a	DT	O
consequence	NN	O
of	IN	O
retention	NN	O
in	IN	O
the	DT	O
endoplasmic	JJ	O
reticulum	NN	O
(	(	O
ER	NNP	O
)	)	O
.	.	O
Therefore	RB	O
,	,	O
LOF	NNP	O
of	IN	O
MC1R	NNP	O
alleles	NNS	O
is	VBZ	O
frequently	RB	O
associated	VBN	O
with	IN	O
aberrant	JJ	O
forward	NN	O
trafficking	NN	O
and	CC	O
accumulation	NN	O
within	IN	O
the	DT	O
ER	NNP	O
or	CC	O
with	IN	O
inability	NN	O
to	TO	O
bind	VB	O
properly	RB	O
the	DT	O
activatory	NN	O
ligand	NN	O


Proprotein	NNP	O
convertase	NN	O
subtilisin	NN	O
kexin	NN	O
type	NN	O
9	CD	O
(	(	O
PCSK9	NNP	O
)	)	O
is	VBZ	O
a	DT	O
critical	JJ	O
modulator	NN	O
of	IN	O
cholesterol	NN	O
homeostasis	NN	O
.	.	O

Whereas	NNP	O
PCSK9	NNP	B-Gene
gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
(	(	O
GOF	NNP	O
)	)	O
mutations	NNS	B-Var
are	VBP	O
associated	VBN	O
with	IN	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
hypercholesterolemia	NN	I-Disease
(	(	O
ADH	NNP	O
)	)	O
and	CC	O
premature	JJ	B-Disease
atherosclerosis	NN	I-Disease
,	,	O
PCSK9	NNP	B-Gene
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
(	(	O
LOF	NNP	O
)	)	O
mutations	NNS	B-Var
have	VBP	B-PosReg
a	DT	O
cardio	NN	B-CPA
-	:	I-CPA
protective	JJ	I-CPA
effect	NN	I-CPA
and	CC	O
in	IN	O
some	DT	O
cases	NNS	O
can	MD	O
lead	VB	O
to	TO	O
familial	JJ	B-Disease
hypobetalipoproteinemia	NN	I-Disease
(	(	O
FHBL	NNP	O
)	)	O
.	.	O
However	RB	O
,	,	O
limitations	NNS	O
of	IN	O
the	DT	O
currently	RB	O
available	JJ	O
cellular	JJ	O
models	NNS	O
preclude	VBP	O
deciphering	VBG	O
the	DT	O
consequences	NNS	O
of	IN	O
PCSK9	NNP	O
mutation	NN	O
further	RB	O
.	.	O

We	PRP	O
aimed	VBD	O
to	TO	O
validate	VB	O
urine	JJ	O
-	:	O
sample	NN	O
-	:	O
derived	VBN	O
human	JJ	O
induced	JJ	O
pluripotent	NN	O
stem	NN	O
cells	NNS	O
(	(	O
UhiPSCs	NNP	O
)	)	O
as	IN	O
an	DT	O
appropriate	JJ	O
tool	NN	O
to	TO	O
model	VB	O
PCSK9	NNP	O
-	:	O
mediated	VBD	O
ADH	NNP	O
and	CC	O
FHBL	NNP	O
.	.	O

To	TO	O
achieve	VB	O
our	PRP$	O
goal	NN	O
,	,	O
urine	JJ	O
-	:	O
sample	NN	O
-	:	O
derived	VBN	O
somatic	JJ	O
cells	NNS	O
were	VBD	O
reprogrammed	VBN	O
into	IN	O
hiPSCs	NN	O
by	IN	O
using	VBG	O
episomal	JJ	O
vectors	NNS	O
.	.	O

UhiPSC	NNP	O
were	VBD	O
efficiently	RB	O
differentiated	VBN	O
into	IN	O
hepatocyte	JJ	O
-	:	O
like	IN	O
cells	NNS	O
(	(	O
HLCs	NNP	O
)	)	O
.	.	O

Compared	VBN	O
to	TO	O
control	VB	O
cells	NNS	O
,	,	O
cells	NNS	O
originally	RB	O
derived	VBN	O
from	IN	O
an	DT	O
individual	NN	O
with	IN	O
ADH	NNP	O
(	(	O
HLC	NNP	O
-	:	O
S127R	NN	O
)	)	O
secreted	VBD	O
less	JJR	O
PCSK9	NNP	O
in	IN	O
the	DT	O
media	NNS	O
(-	JJ	O
38.5%	CD	O
;	:	O
P	NNP	O
0.038	CD	O
)	)	O
and	CC	O
had	VBD	O
a	DT	O
71%	CD	O
decrease	NN	O
(	(	O
P	NNP	O
0.001	CD	O
)	)	O
of	IN	O
low	JJ	O
-	:	O
density	NN	O
lipoprotein	NN	O
(	(	O
LDL	NNP	O
)	)	O
uptake	NN	O
,	,	O
whereas	JJ	O
cells	NNS	O
originally	RB	O
derived	VBN	O
from	IN	O
an	DT	O
individual	NN	O
with	IN	O
FHBL	NNP	O
(	(	O
HLC	NNP	O
-	:	O
R104C	NNP	O
V114A	NNP	O
)	)	O
displayed	VBD	O
a	DT	O
strong	JJ	O
decrease	NN	O
in	IN	O
PCSK9	NNP	O
secretion	NN	O
(-	JJ	O
89.7%	CD	O
;	:	O
P	NNP	O
0.001	CD	O
)	)	O
and	CC	O
had	VBD	O
a	DT	O
106%	CD	O
increase	NN	O
(	(	O
P	NNP	O
0.0104	CD	O
)	)	O
of	IN	O
LDL	NNP	O
uptake	NN	O
.	.	O

Pravastatin	NNP	O
treatment	NN	O
significantly	RB	O
enhanced	VBD	O
LDL	NNP	O
receptor	NN	O
(	(	O
LDLR	NNP	O
)	)	O
and	CC	O
PCSK9	NNP	O
mRNA	NNP	O
gene	NN	O
expression	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
PCSK9	NNP	O
secretion	NN	O
and	CC	O
LDL	NNP	O
uptake	NN	O
in	IN	O
both	DT	O
control	NN	O
and	CC	O
S127R	NNP	O
HLCs	NNP	O
.	.	O

Pravastatin	NNP	O
treatment	NN	O
of	IN	O
multiple	JJ	O
clones	NNS	O
led	VBD	O
to	TO	O
an	DT	O
average	JJ	O
increase	NN	O
of	IN	O
LDL	NNP	O
uptake	NN	O
of	IN	O
2.19	CD	O
0.77	CD	O
-	:	O
fold	NN	O
in	IN	O
HLC	NNP	O
-	:	O
S127R	NN	O
compared	VBN	O
to	TO	O
1.38	CD	O
0.49	CD	O
fold	NN	O
in	IN	O
control	NN	O
HLCs	NNP	O
(	(	O
P	NNP	O
0.01	CD	O
)	)	O
,	,	O
in	IN	O
line	NN	O
with	IN	O
the	DT	O
good	JJ	O
response	NN	O
to	TO	O
statin	VB	O
treatment	NN	O
of	IN	O
individuals	NNS	O
carrying	VBG	O
the	DT	O
S127R	NNP	O
mutation	NN	O
(	(	O
mean	JJ	O
LDL	NNP	O
cholesterol	NN	O
reduction	NN	O
60.4%	CD	O
,	,	O
n	RB	O
5	CD	O
)	)	O
.	.	O

In	IN	O
conclusion	NN	O
,	,	O
urine	JJ	O
samples	NNS	O
provide	VBP	O
an	DT	O
attractive	JJ	O
and	CC	O
convenient	JJ	O
source	NN	O
of	IN	O
somatic	JJ	O
cells	NNS	O
for	IN	O
reprogramming	VBG	O
and	CC	O
hepatocyte	JJ	O
differentiation	NN	O
,	,	O
but	CC	O
also	RB	O
a	DT	O
powerful	JJ	O
tool	NN	O
to	TO	O
further	VB	O
decipher	RB	O
PCSK9	NNP	O
mutations	NNS	O
and	CC	O
function	NN	O



Mind	NNP	O
Bomb	NNP	O
is	VBZ	O
an	DT	O
essential	JJ	O
E3	NNP	O
ligase	NN	O
during	IN	O
Notch	NNP	O
pathway	NN	O
signaling	VBG	O
in	IN	O
insects	NNS	O
and	CC	O
vertebrates	NNS	O
.	.	O

While	IN	O
Caenorhabditis	NNP	O
elegans	VBZ	O
encodes	VBZ	O
a	DT	O
Mind	NNP	O
Bomb	NNP	O
homolog	NN	O
(	(	O
mib	JJ	O
-	:	O
1	CD	O
)	)	O
,	,	O
it	PRP	O
has	VBZ	O
never	RB	O
been	VBN	O
recovered	VBN	O
in	IN	O
the	DT	O
extensive	JJ	O
Notch	NNP	O
suppressor	NN	O
enhancer	NN	O
screens	NNS	O
that	WDT	O
have	VBP	O
identified	VBN	O
numerous	JJ	O
pathway	NN	O
components	NNS	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
show	VBP	O
that	IN	O
C.	NNP	O
elegans	VBZ	O
mib	SYM	B-Gene
-	:	I-Gene
1	CD	I-Gene
null	JJ	O
mutants	NNS	B-Var
have	VBP	O
a	DT	O
spermatogenesis	NN	B-Disease
-	:	I-Disease
defective	JJ	I-Disease
phenotype	NN	I-Disease
that	WDT	O
results	NNS	B-Reg
in	IN	I-Reg
a	DT	O
heterogeneous	JJ	B-MPA
mixture	NN	I-MPA
of	IN	I-MPA
arrested	JJ	I-MPA
spermatocytes	NNS	I-MPA
,	,	O
defective	JJ	O
spermatids	NNS	O
,	,	O
and	CC	O
motility	NN	O
-	:	O
impaired	JJ	O
spermatozoa	NN	O
.	.	O
mib	SYM	O
-	:	O
1	CD	O
mutants	NNS	O
also	RB	O
have	VBP	O
chromosome	VBN	O
segregation	NN	O
defects	NNS	O
during	IN	O
meiosis	NN	O
,	,	O
molecular	JJ	O
null	NN	O
mutants	NNS	O
are	VBP	O
intrinsically	RB	O
temperature	JJ	O
-	:	O
sensitive	JJ	O
,	,	O
and	CC	O
many	JJ	O
mib	NNS	O
-	:	O
1	CD	O
spermatids	NNS	O
contain	VBP	O
large	JJ	O
amounts	NNS	O
of	IN	O
tubulin	NN	O
.	.	O

These	DT	O
phenotypic	NN	O
features	NNS	O
are	VBP	O
similar	JJ	O
to	TO	O
the	DT	O
endogenous	JJ	O
RNA	NNP	O
intereference	NN	O
(	(	O
RNAi	NNP	O
)	)	O
mutants	NNS	O
,	,	O
but	CC	O
mib	SYM	O
-	:	O
1	CD	O
mutants	NNS	O
do	VBP	O
not	RB	O
affect	VB	O
RNAi	NNP	O
.	.	O

MIB	NNP	O
-	:	O
1	CD	O
protein	NN	O
is	VBZ	O
expressed	VBN	O
throughout	IN	O
the	DT	O
germ	JJ	O
line	NN	O
with	IN	O
peak	JJ	O
expression	NN	O
in	IN	O
spermatocytes	NNS	O
followed	VBN	O
by	IN	O
segregation	NN	O
into	IN	O
the	DT	O
residual	JJ	O
body	NN	O
during	IN	O
spermatid	JJ	O
formation	NN	O
.	.	O

C.	NNP	O
elegans	VBZ	O
mib	SYM	O
-	:	O
1	CD	O
expression	NN	O
,	,	O
while	IN	O
upregulated	JJ	O
during	IN	O
spermatogenesis	NN	O
,	,	O
also	RB	O
occurs	VBZ	O
somatically	RB	O
,	,	O
including	VBG	O
in	IN	O
vulva	NN	O
precursor	NN	O
cells	NNS	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
show	VBP	O
that	IN	O
mib	SYM	B-Gene
-	:	I-Gene
1	CD	I-Gene
mutants	NNS	B-Var
suppress	JJ	B-NegReg
both	DT	O
lin	JJ	B-Gene
-	:	I-Gene
12	CD	I-Gene
and	CC	O
glp	VB	B-Gene
-	:	I-Gene
1	CD	I-Gene
(	(	O
C.	NNP	O
elegans	VBZ	O
Notch	NNP	O
)	)	O
gain	VBP	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutants	NNS	B-Var
,	,	O
restoring	VBG	B-PosReg
anchor	NN	B-MPA
cell	NN	I-MPA
formation	NN	I-MPA
and	CC	O
a	DT	O
functional	JJ	B-MPA
vulva	NN	I-MPA
to	TO	O
the	DT	O
former	JJ	O
and	CC	O
partly	RB	O
restoring	VBG	O
oocyte	JJ	B-MPA
production	NN	I-MPA
to	TO	O
the	DT	O
latter	NN	O
.	.	O
However	RB	O
,	,	O
suppressed	VBN	O
hermaphrodites	NNS	O
are	VBP	O
only	RB	O
observed	JJ	O
when	WRB	O
grown	VBN	O
at	IN	O
25	CD	O
,	,	O
and	CC	O
they	PRP	O
are	VBP	O
self	JJ	O
-	:	O
sterile	NN	O
.	.	O

This	DT	O
probably	RB	O
explains	VBZ	O
why	WRB	O
mib	JJ	O
-	:	O
1	CD	O
was	VBD	O
not	RB	O
previously	RB	O
recovered	VBN	O
as	IN	O
a	DT	O
Notch	NNP	O
pathway	NN	O
component	NN	O
in	IN	O
suppressor	NN	O
enhancer	NN	O
selection	NN	O
experiments	NNS	O

-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
HCN2	NNP	B-Gene
variants	NNS	B-Var
.	.	I-Disease


We	PRP	O
identified	VBD	O
HCN2	NNP	O
missense	NN	O
variants	NNS	O
from	IN	O
a	DT	O
large	JJ	O
cohort	NN	O
of	IN	O
585	CD	O
GGE	NNP	O
patients	NNS	O
,	,	O
recruited	VBN	O
by	IN	O
the	DT	O
Epilepsy	NNP	O
Phenome	NNP	O
-	:	O
Genome	NNP	O
Project	NNP	O
(	(	O
EPGP	NNP	O
)	)	O
,	,	O
and	CC	O
performed	VBD	O
functional	JJ	O
analysis	NN	O
using	VBG	O
two	CD	O
-	:	O
electrode	NN	O
voltage	NN	O
clamp	NN	O
recordings	NNS	O
from	IN	O
Xenopus	NNP	O
oocytes	NNS	O
.	.	O

The	DT	O
p	NN	O
.	.	O
S632W	NNP	O
variant	NN	O
was	VBD	O
identified	VBN	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
idiopathic	JJ	O
photosensitive	JJ	O
occipital	JJ	O
epilepsy	NN	O
and	CC	O
segregated	VBN	O
in	IN	O
the	DT	O
family	NN	O
.	.	O

This	DT	O
variant	NN	O
was	VBD	O
also	RB	O
independently	RB	O
identified	VBN	O
in	IN	O
an	DT	O
unrelated	JJ	O
patient	NN	O
with	IN	O
childhood	NN	O
absence	NN	O
seizures	NNS	O
from	IN	O
a	DT	O
European	JJ	O
cohort	NN	O
of	IN	O
238	CD	O
familial	JJ	O
GGE	NNP	O
cases	NNS	O
.	.	O

The	DT	O
p	NN	O
.	.	O
V246M	NNP	O
variant	NN	O
was	VBD	O
identified	VBN	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
photo	NN	O
-	:	O
sensitive	JJ	O
GGE	NNP	O
and	CC	O
his	PRP$	O
father	NN	O
diagnosed	VBD	O
with	IN	O
juvenile	NN	O
myoclonic	JJ	O
epilepsy	NN	O
.	.	O

Functional	JJ	O
studies	NNS	O
revealed	VBD	O
that	IN	O
both	DT	O
p	NN	B-Var
.	.	I-Var
S632W	NNP	I-Var
and	CC	O
p	NN	B-Var
.	.	I-Var
V246M	NNP	I-Var
had	VBD	O
an	DT	O
identical	JJ	O
functional	JJ	O
impact	NN	O
including	VBG	O
a	DT	O
depolarizing	NN	B-MPA
shift	NN	I-MPA
in	IN	I-MPA
the	DT	I-MPA
voltage	NN	I-MPA
dependence	NN	I-MPA
of	IN	O
activation	NN	B-PosReg
that	WDT	O
is	VBZ	O
consistent	JJ	O
with	IN	O
a	DT	O
gain	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
.	.	O
In	IN	O
contrast	NN	O
,	,	O
no	DT	O
biophysical	JJ	O
changes	NNS	O
resulted	VBD	O
from	IN	O
the	DT	O
introduction	NN	O
of	IN	O
common	JJ	O
population	NN	O
variants	NNS	O
,	,	O
p	NN	O
.	.	O
E280K	NNP	O
and	CC	O
p	NN	O
.	.	O
A705T	NNP	O
,	,	O
and	CC	O
the	DT	O
p	NN	O
.	.	O
R756C	NNP	O
variant	NN	O
from	IN	O
EPGP	NNP	O
that	WDT	O
did	VBD	O
not	RB	O
segregate	VB	O
with	IN	O
disease	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
suggest	VBP	O
that	IN	O
HCN2	NNP	B-Gene
variants	NNS	B-Var
can	MD	O
confer	VB	O
susceptibility	NN	B-MPA
to	TO	O
GGE	NNP	O
via	IN	O
a	DT	O
gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mechanism	NN	O



Increased	VBD	O
or	CC	O
ectopic	JJ	B-Var
PDGF	NNP	B-Protein
activity	NN	B-MPA
may	MD	O
also	RB	O
cause	VB	B-Reg
or	CC	O
contribute	VB	B-Reg
to	TO	O
diseases	NNS	O
such	JJ	O
as	IN	O
cancer	NN	B-Disease
and	CC	O
tissue	NN	B-Disease
fibrosis	NN	I-Disease
.	.	O
Until	IN	O
recently	RB	O
,	,	O
no	DT	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
(	(	O
LOF	NNP	O
)	)	O
mutations	NNS	O
in	IN	O
PDGF	NNP	O
or	CC	O
PDGF	NNP	O
receptor	NN	O
genes	NNS	O
were	VBD	O
reported	VBN	O
as	IN	O
causally	RB	O
linked	VBN	O
to	TO	O
a	DT	O
human	JJ	O
disease	NN	O
.	.	O

This	DT	O
changed	VBN	O
in	IN	O
2013	CD	O
when	WRB	O
reports	NNS	O
appeared	VBD	O
on	IN	O
presumed	JJ	O
LOF	NNP	B-NegReg
mutations	NNS	B-Var
in	IN	O
the	DT	O
genes	NNS	O
encoding	VBG	O
PDGF	NNP	B-Gene
-	:	I-Gene
B	NN	I-Gene
and	CC	O
its	PRP$	O
receptor	NN	O
PDGF	NNP	O
receptor	NN	O
-	:	O
beta	NN	O
(	(	O
PDGF	NNP	B-Gene
-	:	I-Gene
R	NN	I-Gene
)	)	I-Gene
in	IN	O
familial	JJ	B-Disease
idiopathic	JJ	I-Disease
basal	NN	I-Disease
ganglia	JJ	I-Disease
calcification	NN	I-Disease
(	(	O
IBGC	NNP	O
)	)	O
,	,	O
a	DT	O
brain	NN	O
disease	NN	O
characterized	VBN	O
by	IN	O
anatomically	RB	O
localized	VBN	O
calcifications	NNS	O
in	IN	O
or	CC	O
near	IN	O
the	DT	O
blood	NN	O
microvessels	NNS	O
.	.	O
Here	RB	O
,	,	O
we	PRP	O
review	VBP	O
PDGF	NNP	O
-	:	O
B	NN	O
and	CC	O
PDGF	NNP	O
-	:	O
R	NNP	O
biology	NN	O
with	IN	O
special	JJ	O
reference	NN	O
to	TO	O
their	PRP$	O
functions	NNS	O
in	IN	O
brain	NN	O
-	:	O
blood	NN	O
vessel	NN	O
development	NN	O
,	,	O
pericyte	JJ	O
recruitment	NN	O
and	CC	O
the	DT	O
regulation	NN	O
of	IN	O
the	DT	O
blood	NN	O
-	:	O
brain	NN	O
barrier	NN	O
.	.	O

We	PRP	O
also	RB	O
discuss	VBP	O
various	JJ	O
scenarios	NNS	O
for	IN	O
IBGC	NNP	O
pathogenesis	NN	O
suggested	VBN	O
by	IN	O
observations	NNS	O
in	IN	O
patients	NNS	O
and	CC	O
genetically	RB	O
engineered	VBN	O
animal	JJ	O
models	NNS	O
of	IN	O
the	DT	O
disease	NN	O

mutations	NNS	I-Var
a	DT	I-Gene
higher	JJR	B-PosReg
oncogenic	JJ	B-CPA
potential	NN	I-CPA
Acute	NNP	B-Disease
myeloid	NN	I-Disease
leukemia	NN	I-Disease
Mutations	NNS	B-Var
FLT3	NNP	B-Gene
prevalent	JJ	B-Reg


Although	IN	O
the	DT	O
juxtamembrane	NN	O
ITDs	NNP	O
have	VBP	O
been	VBN	O
well	RB	O
characterized	VBN	O
,	,	O
the	DT	O
tyrosine	NN	O
kinase	NN	O
domain	NN	O
ITDs	NNP	O
have	VBP	O
not	RB	O
yet	RB	O
been	VBN	O
thoroughly	RB	O
studied	VBN	O
due	JJ	O
to	TO	O
their	PRP$	O
recent	JJ	O
discovery	NN	O
.	.	O

For	IN	O
this	DT	O
reason	NN	O
,	,	O
we	PRP	O
compared	VBN	O
ITD	NNP	O
mutations	NNS	O
in	IN	O
the	DT	O
juxtamembrane	NN	O
domain	NN	O
with	IN	O
those	DT	O
in	IN	O
the	DT	O
tyrosine	NN	O
kinase	NN	O
domain	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
with	IN	O
the	DT	O
most	RBS	O
common	JJ	O
activating	NN	O
point	NN	O
mutation	NN	O
in	IN	O
the	DT	O
tyrosine	NN	O
kinase	NN	O
domain	NN	O
,	,	O
D835Y	NNP	O
.	.	O

The	DT	O
purpose	NN	O
of	IN	O
this	DT	O
study	NN	O
was	VBD	O
to	TO	O
understand	VB	O
whether	IN	O
it	PRP	O
is	VBZ	O
the	DT	O
nature	NN	O
of	IN	O
the	DT	O
mutation	NN	O
or	CC	O
the	DT	O
location	NN	O
of	IN	O
the	DT	O
mutation	NN	O
that	WDT	O
plays	VBZ	O
the	DT	O
main	JJ	O
role	NN	O
in	IN	O
leukemogenesis	NN	O
.	.	O

The	DT	O
various	JJ	O
FLT3	NNP	O
mutants	NNS	O
were	VBD	O
expressed	VBN	O
in	IN	O
the	DT	O
murine	JJ	O
pro	FW	O
-	:	O
B	NNP	O
cell	NN	O
line	NN	O
Ba	NNP	O
F3	NNP	O
and	CC	O
examined	VBN	O
for	IN	O
their	PRP$	O
capacity	NN	O
to	TO	O
form	VB	O
colonies	NNS	O
in	IN	O
semisolid	JJ	O
medium	NN	O
.	.	O

The	DT	O
size	NN	O
and	CC	O
number	NN	O
of	IN	O
colonies	NNS	O
formed	VBN	O
by	IN	O
Ba	NNP	O
F3	NNP	O
cells	NNS	O
expressing	VBG	O
either	CC	O
the	DT	O
internal	JJ	O
tandem	NN	O
duplication	NN	O
within	IN	O
juxtamembrane	NN	O
domain	NN	O
of	IN	O
the	DT	O
receptor	NN	O
(	(	O
JMD	NNP	O
-	:	O
ITD	NN	O
)	)	O
or	CC	O
the	DT	O
tyrosine	JJ	O
kinase	NN	O
domain	NN	O
(	(	O
TKD	NNP	O
)-	JJ	O
ITD	NNP	O
were	VBD	O
indistinguishable	JJ	O
,	,	O
while	IN	O
Ba	NNP	O
F3	NNP	O
cells	NNS	O
expressing	VBG	O
D835Y	NNP	O
FLT3	NNP	O
failed	VBD	O
to	TO	O
form	VB	O
colonies	NNS	O
.	.	O

Cell	NNP	B-CPA
proliferation	NN	I-CPA
and	CC	O
cell	NN	B-CPA
survival	NN	I-CPA
was	VBD	O
also	RB	O
significantly	RB	O
higher	JJR	B-PosReg
in	IN	O
TKD	NNP	B-Var
-	:	I-Var
ITD	NNP	I-Var
expressing	VBG	O
cells	NNS	O
,	,	O
compared	VBN	O
to	TO	O
cells	NNS	O
expressing	VBG	O
D835Y	NNP	O
FLT3	NNP	O
.	.	O
Furthermore	RB	O
,	,	O
TKD	NNP	B-Var
-	:	I-Var
ITD	NN	I-Var
is	VBZ	O
capable	JJ	O
of	IN	O
inducing	VBG	B-PosReg
phosphorylation	NN	B-MPA
of	IN	O
STAT5	NNP	B-Protein
,	,	O
while	IN	O
D835Y	NNP	O
FLT3	NNP	O
fails	VBZ	O
to	TO	O
induce	VB	O
tyrosine	JJ	O
phosphorylation	NN	O
of	IN	O
STAT5	NNP	O
.	.	O
Other	JJ	O
signal	JJ	O
transduction	NN	O
pathways	NNS	O
such	JJ	O
as	IN	O
the	DT	O
RAS	NNP	O
ERK	NNP	O
and	CC	O
the	DT	O
PI3K	NNP	O
AKT	NNP	O
pathways	NNS	O
were	VBD	O
activated	VBN	O
to	TO	O
the	DT	O
same	JJ	O
level	NN	O
in	IN	O
TKD	NNP	O
-	:	O
ITD	NNP	O
cells	NNS	O
as	IN	O
compared	VBN	O
to	TO	O
D835Y	NNP	O
FLT3	NNP	O
expressing	VBG	O
cells	NNS	O
.	.	O

Taken	VBN	O
together	RB	O
,	,	O
our	PRP$	O
data	NNS	O
suggest	VBP	O
that	IN	O
TKD	NNP	O
-	:	O
ITD	NNP	O
displays	VBZ	O
similar	JJ	O
oncogenic	JJ	O
potential	NN	O
to	TO	O
the	DT	O
JMD	NNP	O
-	:	O
ITD	NN	O
but	CC	O
a	DT	O
higher	JJR	O
oncogenic	JJ	O
potential	NN	O
than	IN	O
the	DT	O
D835Y	NNP	O
point	NN	O
mutation	NN	O

SETD5	NNP	B-Gene
loss	NN	B-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
variant	NN	B-Var
intellectual	JJ	B-Disease
disability	NN	I-Disease

The	DT	O
clinical	JJ	O
phenotype	NN	O
includes	VBZ	O
;	:	O
intellectual	JJ	O
disability	NN	O
(	(	O
ID	NNP	O
)	)	O
,	,	O
growth	NN	O
retardation	NN	O
,	,	O
facial	JJ	O
dysmorphism	NN	O
,	,	O
and	CC	O
cardiac	JJ	O
malformations	NNS	O
.	.	O

Advances	NNS	O
in	IN	O
chromosome	NN	O
microarray	NN	O
(	(	O
CMA	NNP	O
)	)	O
testing	VBG	O
narrowed	VBD	O
the	DT	O
3	CD	O
p25	NN	O
critical	JJ	O
region	NN	O
to	TO	O
a	DT	O
124	CD	O
kb	NN	O
region	NN	O
,	,	O
and	CC	O
recent	JJ	O
Whole	NNP	O
Exome	NNP	O
Sequencing	NNP	O
(	(	O
WES	NNP	O
)	)	O
studies	NNS	O
have	VBP	O
suggested	VBN	O
that	IN	O
the	DT	O
SETD5	NNP	O
gene	NN	O
contributes	VBZ	O
significantly	RB	O
to	TO	O
the	DT	O
3	CD	O
p25	NN	O
phenotype	NN	O
.	.	O

Loss	NNP	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
Function	NN	I-NegReg
(	(	O
LoF	NNP	O
)	)	O
variants	NNS	B-Var
in	IN	O
SETD5	NNP	B-Gene
are	VBP	O
now	RB	O
considered	VBN	O
a	DT	O
likely	JJ	O
cause	NN	O
of	IN	O
ID	NNP	B-Disease
.	.	O
We	PRP	O
report	VBP	O
here	RB	O
a	DT	O
patient	NN	O
with	IN	O
a	DT	O
frameshift	NN	O
LoF	NNP	O
variant	NN	O
in	IN	O
exon	JJ	O
12	CD	O
of	IN	O
SETD5	NNP	O
.	.	O

This	DT	O
patient	NN	O
has	VBZ	O
features	NNS	O
overlapping	VBG	O
with	IN	O
other	JJ	O
patients	NNS	O
described	VBN	O
with	IN	O
LoF	NNP	O
SETD5	NNP	O
variants	NNS	O
to	TO	O
include	VB	O
;	:	O
similar	JJ	O
facial	JJ	O
morphology	NN	O
,	,	O
feeding	VBG	O
difficulties	NNS	O
,	,	O
ID	NNP	O
,	,	O
behavioral	JJ	O
abnormalities	NNS	O
and	CC	O
leg	JJ	O
length	NN	O
discrepancy	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
he	PRP	O
presents	VBZ	O
with	IN	O
an	DT	O
aberrant	JJ	O
blind	NN	O
ending	VBG	O
bronchus	NN	O
.	.	O

This	DT	O
report	NN	O
adds	VBZ	O
to	TO	O
publications	NNS	O
describing	VBG	O
intragenic	JJ	O
mutations	NNS	O
in	IN	O
SETD5	NNP	O
and	CC	O
supports	VBZ	O
the	DT	O
assertion	NN	O
that	IN	O
de	FW	O
novo	FW	O
LoF	NNP	O
mutations	NNS	O
in	IN	O
SETD5	NNP	O
present	NN	O
with	IN	O
an	DT	O
overlapping	VBG	O
but	CC	O
distinct	JJ	O
phenotype	NN	O
in	IN	O
comparison	NN	O
with	IN	O
3	CD	O
p25	JJ	O
microdeletion	NN	O
syndromes	NNS	O

Loss	NNP	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
Function	NN	I-NegReg
in	IN	I-Var
AKT2	NNP	B-Gene
Reduced	NNP	B-NegReg
Insulin	NNP	B-CPA
-	:	I-CPA
Mediated	VBD	I-CPA
Glucose	NNP	I-CPA
Uptake	NNP	I-CPA

Recently	RB	O
,	,	O
a	DT	O
novel	JJ	O
partial	JJ	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
AKT2	NNP	O
coding	NN	O
variant	NN	O
(	(	O
p	NN	O
.	.	O
Pro50Thr	NNP	O
)	)	O
was	VBD	O
identified	VBN	O
that	IN	O
is	VBZ	O
nearly	RB	O
specific	JJ	O
to	TO	O
Finns	NNP	O
(	(	O
frequency	NN	O
1.1%	CD	O
)	)	O
,	,	O
with	IN	O
the	DT	O
low	JJ	O
-	:	O
frequency	NN	O
allele	RB	O
associated	VBN	O
with	IN	O
an	DT	O
increase	NN	O
in	IN	O
fasting	VBG	O
plasma	JJ	O
insulin	NN	O
level	NN	O
and	CC	O
risk	NN	O
of	IN	O
type	NN	O
2	CD	O
diabetes	NNS	O
.	.	O

The	DT	O
effects	NNS	O
of	IN	O
the	DT	O
p	NN	O
.	.	O
Pro50Thr	NNP	O
AKT2	NNP	O
variant	NN	O
(	(	O
p	NN	O
.	.	O
P50T	NNP	O
AKT2	NNP	O
)	)	O
on	IN	O
insulin	NN	O
-	:	O
stimulated	VBN	O
glucose	JJ	O
uptake	NN	O
(	(	O
GU	NNP	O
)	)	O
in	IN	O
the	DT	O
whole	JJ	O
body	NN	O
and	CC	O
in	IN	O
different	JJ	O
tissues	NNS	O
have	VBP	O
not	RB	O
previously	RB	O
been	VBN	O
investigated	VBN	O
.	.	O

We	PRP	O
identified	VBD	O
carriers	NNS	O
(	(	O
N	NNP	O
20	CD	O
)	)	O
and	CC	O
matched	VBN	O
noncarriers	NNS	O
(	(	O
N	NNP	O
25	CD	O
)	)	O
for	IN	O
this	DT	O
allele	NN	O
in	IN	O
the	DT	O
population	NN	O
-	:	O
based	VBN	O
Metabolic	NNP	O
Syndrome	NNP	O
in	IN	O
Men	NNP	O
(	(	O
METSIM	NNP	O
)	)	O
study	NN	O
and	CC	O
invited	VBN	O
these	DT	O
individuals	NNS	O
back	RB	O
for	IN	O
positron	NN	O
emission	NN	O
tomography	NN	O
study	NN	O
with	IN	O
[	$	O
18	CD	O
F	NNP	O
]-	JJ	O
fluorodeoxyglucose	NN	O
during	IN	O
euglycemic	JJ	O
hyperinsulinemia	NN	O
.	.	O

When	WRB	O
we	PRP	O
compared	VBN	O
p	NN	O
.	.	O
P50T	NNP	O
AKT2	NNP	O
carriers	NNS	O
to	TO	O
noncarriers	NNS	O
,	,	O
we	PRP	O
found	VBD	O
a	DT	O
39.4%	CD	O
reduction	NN	O
in	IN	O
whole	JJ	O
-	:	O
body	NN	O
GU	NNP	O
(	(	O
P	NNP	O
0.006	CD	O
)	)	O
and	CC	O
a	DT	O
55.6%	CD	O
increase	NN	O
in	IN	O
the	DT	O
rate	NN	O
of	IN	O
endogenous	JJ	O
glucose	JJ	O
production	NN	O
(	(	O
P	NNP	O
0.038	CD	O
)	)	O
.	.	O

We	PRP	O
found	VBD	O
significant	JJ	O
reductions	NNS	O
in	IN	O
GU	NNP	O
in	IN	O
multiple	JJ	O
tissues	NNS	O
-	:	O
skeletal	JJ	O
muscle	NN	O
(	(	O
36.4%	CD	O
)	)	O
,	,	O
liver	RB	O
(	(	O
16.1%	CD	O
)	)	O
,	,	O
brown	VBN	O
adipose	RB	O
(	(	O
29.7%	CD	O
)	)	O
,	,	O
and	CC	O
bone	NN	O
marrow	NN	O
(	(	O
32.9%	CD	O
)-	NN	O
and	CC	O
increases	NNS	O
of	IN	O
16.8	CD	O
-	:	O
19.1%	CD	O
in	IN	O
seven	CD	O
tested	VBD	O
brain	NN	O
regions	NNS	O
.	.	O

These	DT	O
data	NNS	O
demonstrate	NN	O
that	IN	O
the	DT	O
p	NN	B-Var
.	.	I-Var
P50T	NNP	I-Var
substitution	NN	O
of	IN	O
AKT2	NNP	B-Gene
influences	NNS	B-Reg
insulin	VBP	B-MPA
-	:	I-MPA
mediated	VBN	I-MPA
GU	NNP	I-MPA
in	IN	O
multiple	JJ	O
insulin	NN	O
-	:	O
sensitive	JJ	O
tissues	NNS	O
and	CC	O
may	MD	O
explain	VB	O
,	,	O
at	IN	O
least	JJS	O
in	IN	O
part	NN	O
,	,	O
the	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
type	NN	O
2	CD	O
diabetes	NNS	O
in	IN	O
p	NN	O
.	.	O
P50T	NNP	O
AKT2	NNP	O
carriers	NNS	O


PCSK9	NNP	B-Var
cardiovascular	JJ	B-Disease
disease	NN	I-Disease
degrading	VBG	B-NegReg
hepatic	JJ	B-MPA
low	JJ	I-MPA
-	:	I-MPA
density	NN	I-MPA
lipoprotein	NN	I-MPA
receptor	NN	I-MPA
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
PCSK9	NNP	B-Gene
variants	NNS	B-Var
increase	NN	B-PosReg
hepatic	JJ	B-MPA
LDLR	NNP	I-MPA
levels	NNS	I-MPA
lower	JJR	B-NegReg
risk	NN	B-MPA
of	IN	I-MPA
developing	VBG	I-MPA
CVD	NNP	I-MPA
The	DT	O
retention	NN	O
of	IN	O
misfolded	JJ	O
protein	NN	O
in	IN	O
the	DT	O
ER	NNP	O
can	MD	O
cause	VB	O
ER	NNP	O
stress	NN	O
and	CC	O
activate	VB	O
the	DT	O
unfolded	JJ	O
protein	NN	O
response	NN	O
(	(	O
UPR	NNP	O
)	)	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
investigated	VBD	O
whether	IN	O
a	DT	O
variety	NN	O
of	IN	O
LOF	NNP	O
PCSK9	NNP	O
variants	NNS	O
that	WDT	O
are	VBP	O
retained	VBN	O
in	IN	O
the	DT	O
ER	NNP	O
can	MD	O
cause	VB	O
ER	NNP	O
stress	NN	O
and	CC	O
hepatic	JJ	O
cytotoxicity	NN	O
.	.	O

Although	IN	O
overexpression	NN	B-PosReg
of	IN	O
these	DT	O
PCSK9	NNP	B-Gene
variants	NNS	B-Var
caused	VBD	O
an	DT	O
accumulation	NN	B-PosReg
in	IN	O
the	DT	O
ER	NNP	B-MPA
of	IN	I-MPA
hepatocytes	NNS	I-MPA
,	,	O
UPR	NNP	O
activation	NN	O
or	CC	O
apoptosis	NN	O
was	VBD	O
not	RB	O
observed	VBN	O
.	.	O
Furthermore	RB	O
,	,	O
ER	NNP	O
retention	NN	O
of	IN	O
endogenous	JJ	O
PCSK9	NNP	O
via	IN	O
splice	NN	O
switching	VBG	O
also	RB	O
failed	VBD	O
to	TO	O
induce	VB	O
the	DT	O
UPR	NNP	O
.	.	O

Consistent	JJ	O
with	IN	O
these	DT	O
in	IN	O
vitro	NN	O
studies	NNS	O
,	,	O
overexpression	NN	O
of	IN	O
PCSK9	NNP	O
in	IN	O
the	DT	O
livers	NNS	O
of	IN	O
mice	NNS	O
had	VBD	O
no	DT	O
impact	NN	O
on	IN	O
UPR	NNP	O
activation	NN	O
.	.	O

To	TO	O
elucidate	VB	O
the	DT	O
cellular	JJ	O
mechanism	NN	O
to	TO	O
explain	VB	O
these	DT	O
surprising	JJ	O
findings	NNS	O
,	,	O
we	PRP	O
observed	VBD	O
that	IN	O
the	DT	O
94	CD	O
-	:	O
kDa	NN	O
glucose	JJ	O
-	:	O
regulated	VBN	O
protein	NN	O
(	(	O
GRP94	NNP	O
)	)	O
sequesters	NNS	O
PCSK9	NNP	O
away	RB	O
from	IN	O
the	DT	O
78	CD	O
-	:	O
kDa	NN	O
glucose	JJ	O
-	:	O
regulated	VBN	O
protein	NN	O
(	(	O
GRP78	NNP	O
)	)	O
,	,	O
the	DT	O
major	JJ	O
activator	NN	O
of	IN	O
the	DT	O
UPR	NNP	O
.	.	O

As	IN	O
a	DT	O
result	NN	O
,	,	O
GRP94	NNP	O
knockdown	NN	O
increased	VBD	O
the	DT	O
stability	NN	O
of	IN	O
GRP78	NNP	O
-	:	O
PCSK9	NN	O
complex	NN	O
and	CC	O
resulted	VBD	O
in	IN	O
UPR	NNP	O
activation	NN	O
following	VBG	O
overexpression	NN	O
of	IN	O
ER	NNP	O
-	:	O
retained	VBD	O
PCSK9	NNP	O
variants	NNS	O
relative	VBP	O
to	TO	O
WT	NNP	O
secreted	VBD	O
controls	NNS	O
.	.	O

Given	VBN	O
that	DT	O
overexpression	NN	O
of	IN	O
these	DT	O
LOF	NNP	O
PCSK9	NNP	O
variants	NNS	O
does	VBZ	O
not	RB	O
cause	VB	O
UPR	NNP	O
activation	NN	O
under	IN	O
normal	JJ	O
homeostatic	JJ	O
conditions	NNS	O
,	,	O
therapeutic	JJ	O
strategies	NNS	O
aimed	VBN	O
at	IN	O
blocking	VBG	O
the	DT	O
autocatalytic	JJ	O
cleavage	NN	O
of	IN	O
PCSK9	NNP	O
in	IN	O
the	DT	O
ER	NNP	O
represent	NN	O
a	DT	O
viable	JJ	O
strategy	NN	O
for	IN	O
reducing	VBG	O
circulating	VBG	O
PCSK9	NNP	O





Six	NNP	O
MC1R	NNP	O
mutations	NNS	O
segregated	VBD	O
with	IN	O
the	DT	O
phenotype	NN	O
in	IN	O
seven	CD	O
families	NNS	O
,	,	O
including	VBG	O
a	DT	O
p	NN	O
.	.	O
Val174del	NNP	O
in	IN	O
-	:	O
frame	NN	O
deletion	NN	O
and	CC	O
a	DT	O
p	NN	O
.	.	O
Tyr298	NNP	O
nonsense	JJ	O
mutation	NN	O
,	,	O
that	WDT	O
were	VBD	O
analyzed	VBN	O
for	IN	O
function	NN	O
in	IN	O
heterologous	JJ	O
HEK293	NNP	O
cells	NNS	O
.	.	O

p	NN	B-Var
.	.	I-Var
Tyr298	NNP	I-Var
MC1R	NNP	I-Var
showed	VBD	I-Gene
no	DT	B-NegReg
agonist	JJ	B-MPA
-	:	I-MPA
induced	JJ	I-MPA
signaling	NN	I-MPA
to	TO	O
the	DT	O
cAMP	NN	B-Pathway
or	CC	O
ERK	NNP	B-Pathway
pathways	NNS	I-Pathway
,	,	O
nor	CC	B-NegReg
detectable	JJ	O
agonist	NN	B-Interaction
binding	NN	I-Interaction
.	.	O
Conversely	RB	O
,	,	O
signaling	VBG	O
was	VBD	O
comparable	JJ	O
for	IN	O
p	NN	B-Var
.	.	I-Var
Val174del	NNP	I-Var
and	CC	O
wild	JJ	O
-	:	O
type	NN	O
in	IN	O
HEK	NNP	O
cells	NNS	O
overexpressing	VBG	O
the	DT	O
proteins	NNS	O
,	,	O
but	CC	O
binding	VBG	O
analysis	NN	O
suggested	VBD	O
impaired	JJ	B-NegReg
cell	NN	B-MPA
surface	NN	I-MPA
expression	NN	I-MPA
.	.	O
Flow	NNP	O
cytometry	NN	O
and	CC	O
confocal	JJ	O
imaging	NN	O
studies	NNS	O
revealed	VBD	O
reduced	JJ	B-NegReg
plasma	NN	B-MPA
membrane	NN	I-MPA
expression	NN	I-MPA
of	IN	O
p	NN	B-Var
.	.	I-Var
Val174del	NNP	I-Var
and	CC	O
p	NN	B-Var
.	.	I-Var
Tyr298	NNP	I-Var
.	.	I-Var
Therefore	RB	O
,	,	O
p	NN	B-Var
.	.	I-Var
Tyr298	NNP	I-Var
was	VBD	I-Var
a	DT	O
total	JJ	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
(	(	O
LOF	NNP	O
)	)	O
allele	NN	O
,	,	O
while	IN	O
p	NN	B-Var
.	.	I-Var
Val174del	NNP	I-Var
displayed	VBD	O
a	DT	O
partial	JJ	B-NegReg
LOF	NNP	I-NegReg
attribute	NN	O




Fibroblast	NNP	O
growth	NN	O
factor	NN	O
5	CD	O
(	(	O
FGF5	NNP	O
)	)	O
is	VBZ	O
a	DT	O
secreted	JJ	O
signaling	NN	O
protein	NN	O
that	WDT	O
controls	VBZ	O
hair	JJ	O
growth	NN	O
in	IN	O
humans	NNS	O
and	CC	O
other	JJ	O
mammals	NNS	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
FGF5	NNP	O
gene	NN	O
have	VBP	O
been	VBN	O
associated	VBN	O
with	IN	O
long	JJ	O
-	:	O
hair	NN	O
phenotypes	NNS	O
in	IN	O
several	JJ	O
species	NNS	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
sequenced	VBD	O
the	DT	O
llama	NN	O
FGF5	NNP	O
gene	NN	O
,	,	O
which	WDT	O
consists	VBZ	O
of	IN	O
three	CD	O
exons	NNS	O
encoding	VBG	O
813	CD	O
bp	NN	O
.	.	O

cDNA	NN	O
analysis	NN	O
from	IN	O
hair	NN	O
follicles	NNS	O
revealed	VBD	O
the	DT	O
expression	NN	O
of	IN	O
two	CD	O
FGF5	NNP	O
alternative	NN	O
spliced	VBD	O
transcripts	NNS	O
,	,	O
in	IN	O
one	CD	O
of	IN	O
which	WDT	O
exon	VBP	O
2	CD	O
is	VBZ	O
absent	JJ	O
.	.	O

DNA	NN	O
variation	NN	O
analysis	NN	O
showed	VBD	O
four	CD	O
polymorphisms	NNS	O
in	IN	O
the	DT	O
coding	JJ	O
region	NN	O
:	:	O
a	DT	O
synonymous	JJ	O
SNP	NNP	O
(	(	O
c	NN	O
.	.	O
210	CD	O
A	NNP	O
G	NNP	O
)	)	O
,	,	O
a	DT	O
single	JJ	O
base	NN	O
deletion	NN	O
(	(	O
c	NN	B-Var
.	.	I-Var
348	CD	I-Var
delA	NN	I-Var
)	)	O
,	,	O
a	DT	O
12	CD	O
-	:	O
bp	NN	O
insertion	NN	O
(	(	O
c	NN	O
.	.	O
351	CD	O
_	JJ	O
352	CD	O
insCATATAACATAG	NN	O
)	)	O
and	CC	O
a	DT	O
non	JJ	O
-	:	O
sense	NN	O
mutation	NN	O
(	(	O
c	NN	O
.	.	O
499	CD	O
C	NNP	O
T	NNP	O
)	)	O
.	.	O
The	DT	O
deletion	NN	O
was	VBD	O
always	RB	O
found	VBN	O
together	RB	O
with	IN	O
the	DT	O
insertion	NN	O
forming	VBG	O
a	DT	O
haplotype	NN	O
and	CC	O
producing	VBG	O
a	DT	O
putative	JJ	O
truncated	JJ	O
protein	NN	O
of	IN	O
123	CD	O
amino	JJ	O
acids	NNS	O
.	.	O

The	DT	O
c	NN	B-Var
.	.	I-Var
499	CD	I-Var
C	NNP	I-Var
T	NNP	I-Var
mutation	NN	O
also	RB	O
leads	VBZ	O
to	TO	O
a	DT	O
premature	NN	O
stop	NN	O
codon	NN	O
at	IN	O
position	NN	O
168	CD	O
.	.	O
In	IN	O
both	DT	O
cases	NNS	O
,	,	O
critical	JJ	B-MPA
functional	JJ	I-MPA
domains	NNS	I-MPA
of	IN	O
FGF5	NNP	B-Gene
,	,	O
including	VBG	O
one	CD	O
heparin	NN	B-MPA
binding	VBG	I-MPA
site	NN	I-MPA
,	,	O
are	VBP	O
lost	VBN	B-NegReg
.	.	O
All	DT	O
animals	NNS	O
analyzed	VBN	O
were	VBD	O
homozygous	JJ	O
for	IN	O
one	CD	O
of	IN	O
the	DT	O
deleterious	JJ	O
mutations	NNS	O
or	CC	O
compound	NN	O
heterozygous	JJ	O
for	IN	O
both	DT	O
(	(	O
i	NN	O
.	.	O
e	NN	O
.	.	O

c	NN	O
.	.	O
348	CD	O
delA	NN	O
,	,	O
c	NN	O
.	.	O
351	CD	O
_	JJ	O
352	CD	O
insCATATAACATAG	JJ	O
c	NN	O
.	.	O
499	CD	O
T	NNP	O
)	)	O
.	.	O

Sequencing	VBG	O
of	IN	O
guanaco	NN	O
samples	NNS	O
showed	VBD	O
that	IN	O
the	DT	O
FGF5	NNP	O
gene	NN	O
encodes	VBZ	O
a	DT	O
full	JJ	O
-	:	O
length	NN	O
270	CD	O
-	:	O
amino	NN	O
acid	JJ	O
protein	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
FGF5	NNP	O
is	VBZ	O
likely	JJ	O
functional	JJ	O
in	IN	O
short	JJ	O
-	:	O
haired	JJ	O
wild	JJ	O
species	NNS	O
and	CC	O
non	JJ	O
-	:	O
functional	NN	O
in	IN	O
the	DT	O
domestic	JJ	O
fiber	NN	O
-	:	O
producing	VBG	O
species	NNS	O
,	,	O
the	DT	O
llama	NN	O




AMA1	NNP	O
RON2	NNP	O
4	CD	O
5	CD	O
8	CD	O
is	VBZ	O
an	DT	O
important	JJ	O
MJ	NNP	O
complex	NN	O
,	,	O
but	CC	O
its	PRP$	O
mechanism	NN	O
of	IN	O
assembly	NN	O
remains	VBZ	O
unclear	JJ	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
used	VBD	O
the	DT	O
CRISPR	NNP	O
-	:	O
Cas9	NN	O
system	NN	O
to	TO	O
generate	VB	O
a	DT	O
derivative	NN	O
of	IN	O
T.	NNP	O
gondii	NN	O
strain	NN	O
RH	NNP	O
with	IN	O
a	DT	O
null	JJ	B-Var
mutation	NN	I-Var
in	IN	O
TgRON4	NNP	B-Gene
,	,	O
thought	VBD	O
to	TO	O
be	VB	O
an	DT	O
essential	JJ	O
MJ	NNP	O
component	NN	O
.	.	O
Deficiency	NN	B-NegReg
of	IN	O
TgRON4	NNP	B-Protein
moderately	RB	O
decreased	VBD	B-NegReg
invasion	NN	B-CPA
ability	NN	I-CPA
relative	VBP	O
to	TO	O
that	DT	O
of	IN	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
parasite	NN	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
expression	NN	B-MPA
of	IN	I-MPA
the	DT	I-MPA
endogenous	JJ	I-MPA
N	NNP	I-MPA
-	:	I-MPA
terminal	JJ	I-MPA
fragment	NN	I-MPA
of	IN	O
RON5	NNP	B-Protein
decreased	VBD	B-NegReg
in	IN	O
the	DT	O
mutant	NN	B-Var
.	.	O
Together	RB	O
,	,	O
the	DT	O
results	NNS	O
improve	VB	O
our	PRP$	O
understanding	NN	O
of	IN	O
the	DT	O
assembly	NN	O
mechanism	NN	O
of	IN	O
the	DT	O
MJ	NNP	O
complex	NN	O
of	IN	O
T.	NNP	O
gondii	NN	O
and	CC	O
raise	VB	O
the	DT	O
possibility	NN	O
of	IN	O
developing	VBG	O
new	JJ	O
therapeutic	JJ	O
drugs	NNS	O
that	WDT	O
target	VBP	O
this	DT	O
complex	NN	O




Gain	NNP	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
NLRP1	NNP	B-Gene
variants	NNS	B-Var
rs11651270	NN	B-Var
rs12150220	NN	B-Var
rs2670660	NN	B-Var
asthma	VB	B-Disease
rs11651270	VB	B-Var
rs2670660	VB	B-Var
with	IN	B-Reg
asthma	JJ	B-Disease
IgE	NNP	B-MPA
level	NN	I-MPA
gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
SNPs	NNP	B-Var
NLRP1	NNP	B-Gene
prone	NN	B-PosReg
activating	VBG	B-MPA
inflammasome	NN	I-MPA
ER	NNP	O
stress	NN	O
or	CC	O
ROS	NNP	O
)	)	O
,	,	O
and	CC	O
this	DT	O
activation	NN	O
contribute	NN	O
to	TO	O
exacerbate	VB	B-PosReg
inflammatory	JJ	B-CPA
response	NN	I-CPA
and	CC	O
asthma	NN	B-CPA
development	NN	I-CPA
.	.	O
Gain	NNP	O
-	:	O
of	IN	O
-	:	O
function	NN	O
IL1A	NNP	B-Gene
rs17561	NN	B-Var
resulted	VBD	O
significantly	RB	O
associated	VBN	O
with	IN	O
a	DT	O
reduced	JJ	B-NegReg
pulmonary	JJ	B-CPA
capacity	NN	I-CPA
in	IN	O
asthmatic	JJ	O
children	NNS	O
.	.	O
IL18	NNP	B-Gene
rs5744256	NN	B-Var
which	WDT	O
lead	VBP	O
to	TO	O
lower	JJR	B-NegReg
serum	JJ	B-MPA
level	NN	I-MPA
of	IN	I-MPA
IL	NNP	I-MPA
-	:	I-MPA
18	CD	I-MPA
appeared	VBD	O
to	TO	O
be	VB	O
associated	VBN	O
to	TO	O
a	DT	O
worse	JJR	O
response	NN	O
to	TO	O
bronchodilators	NNS	O
.	.	O
Concluding	VBG	O
,	,	O
this	DT	O
work	NN	O
provides	VBZ	O
evidences	NNS	O
about	IN	O
the	DT	O
contribution	NN	O
of	IN	O
inflammasome	JJ	O
genetics	NNS	O
in	IN	O
the	DT	O
development	NN	O
of	IN	O
paediatric	JJ	O
asthma	NN	O
,	,	O
both	DT	O
considering	VBG	O
its	PRP$	O
inflammatory	JJ	O
role	NN	O
in	IN	O
alveolar	JJ	O
macrophages	NNS	O
(	(	O
i	NN	O
.	.	O
e	NN	O
.	.	O

:	:	O
NLRP1	NN	O
)	)	O
or	CC	O
its	PRP$	O
homeostatic	JJ	O
role	NN	O
in	IN	O
lung	NN	O
epithelial	JJ	O
cells	NNS	O
(	(	O
i	NN	O
.	.	O
e	NN	O
.	.	O

:	:	O
IL1A	NN	O
,	,	O
IL18	NNP	O
)	)	O


Gain	NNP	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutations	NNS	B-Var
human	JJ	B-Gene
signal	JJ	I-Gene
transducer	NN	I-Gene
and	CC	I-Gene
activator	NN	I-Gene
of	IN	I-Gene
transcription	NN	I-Gene
1	CD	I-Gene
impaired	JJ	B-NegReg
TH17	NNP	B-CPA
cell	NN	I-CPA
differentiation	NN	I-CPA
exaggerated	JJ	B-PosReg
responsiveness	NN	B-Interaction
to	TO	I-Interaction
type	VB	I-Interaction
I	PRP	I-Interaction
and	CC	I-Interaction
II	NNP	I-Interaction
interferons	NNS	I-Interaction



RESULTS	NNS	O
:	:	O
We	PRP	O
report	VBP	O
a	DT	O
child	NN	O
with	IN	O
a	DT	O
novel	JJ	O
mutation	NN	B-Var
in	IN	I-Var
the	DT	I-Var
linker	NN	I-Var
domain	NN	I-Var
of	IN	O
STAT1	NNP	B-Gene
who	WP	O
had	VBD	O
life	NN	O
-	:	O
threatening	VBG	O
autoimmune	JJ	O
cytopenias	NNS	O
and	CC	O
chronic	JJ	O
mucocutaneous	JJ	O
candidiasis	NN	O
.	.	O
Naive	JJ	O
lymphocytes	NNS	O
from	IN	O
the	DT	O
affected	JJ	O
patient	NN	O
displayed	VBD	O
increased	VBN	B-PosReg
TH1	NNP	B-CPA
and	CC	I-CPA
follicular	JJ	I-CPA
T	NNP	I-CPA
helper	NN	I-CPA
cell	NN	I-CPA
and	CC	O
suppressed	VBD	B-NegReg
TH17	NNP	B-CPA
cell	NN	I-CPA
responses	NNS	I-CPA
.	.	O
The	DT	O
mutation	NN	B-Var
augmented	VBD	B-PosReg
cytokine	JJ	B-MPA
-	:	I-MPA
induced	JJ	I-MPA
STAT1	NNP	I-MPA
phosphorylation	NN	I-MPA
without	IN	O
affecting	VBG	O
dephosphorylation	NN	O
kinetics	NNS	O
.	.	O
Treatment	NN	O
with	IN	O
the	DT	O
Janus	NNP	O
kinase	VBD	O
1	CD	O
2	CD	O
inhibitor	NN	O
ruxolitinib	NN	O
reduced	VBD	O
hyperresponsiveness	NN	O
to	TO	O
type	VB	O
I	PRP	O
and	CC	O
II	NNP	O
interferons	NNS	O
,	,	O
normalized	VBN	O
TH1	NNP	O
and	CC	O
follicular	JJ	O
T	NNP	O
helper	NN	O
cell	NN	O
responses	NNS	O
,	,	O
improved	VBN	O
TH17	NNP	O
differentiation	NN	O
,	,	O
cured	VBD	O
mucocutaneous	JJ	O
candidiasis	NN	O
,	,	O
and	CC	O
maintained	VBD	O
remission	NN	O
of	IN	O
immune	JJ	O
-	:	O
mediated	VBN	O
cytopenias	NN	O
.	.	O

CONCLUSIONS	NN	O
:	:	O
Autoimmunity	NN	O
and	CC	O
infection	NN	O
caused	VBN	O
by	IN	O
STAT1	NNP	B-Gene
GOF	NNP	B-PosReg
mutations	NNS	B-Var
are	VBP	O
the	DT	O
result	NN	O
of	IN	O
dysregulated	JJ	O
T	NNP	B-CPA
helper	NN	I-CPA
cell	NN	I-CPA
responses	NNS	I-CPA
.	.	O
Janus	NNP	O
kinase	NN	O
inhibitor	NN	O
therapy	NN	O
could	MD	O
represent	VB	O
an	DT	O
effective	JJ	O
targeted	JJ	O
treatment	NN	O
for	IN	O
long	JJ	O
-	:	O
term	NN	O
disease	NN	O
control	NN	O
in	IN	O
severely	RB	O
affected	JJ	O
patients	NNS	O
for	IN	O
whom	WP	O
hematopoietic	JJ	O
stem	NN	O
cell	NN	O
transplantation	NN	O
is	VBZ	O
not	RB	O
available	JJ	O




The	DT	O
glutathione	NN	O
(	(	O
GSH	NNP	O
)-	NNP	O
dependent	NN	O
phytochelatin	NN	O
(	(	O
PC	NN	O
)	)	O
synthesis	NN	O
pathway	NN	O
plays	VBZ	O
key	JJ	O
roles	NNS	O
in	IN	O
Cd	NNP	O
detoxification	NN	O
.	.	O

However	RB	O
,	,	O
its	PRP$	O
regulatory	JJ	O
mechanism	NN	O
remains	VBZ	O
largely	RB	O
unknown	JJ	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
showed	VBD	O
a	DT	O
previously	RB	O
unknown	JJ	O
function	NN	O
of	IN	O
the	DT	O
WRKY	NNP	O
transcription	NN	O
factor	NN	O
WRKY12	NNP	O
in	IN	O
the	DT	O
regulation	NN	O
of	IN	O
Cd	NNP	O
tolerance	NN	O
by	IN	O
repressing	VBG	O
the	DT	O
expression	NN	O
of	IN	O
PC	NN	O
synthesis	NN	O
-	:	O
related	VBN	O
genes	NNS	O
.	.	O

The	DT	O
expression	NN	O
of	IN	O
WRKY12	NNP	O
was	VBD	O
inhibited	VBN	O
by	IN	O
Cd	NNP	O
stress	NN	O
.	.	O

Enhanced	NNP	B-PosReg
Cd	NNP	B-CPA
tolerance	NN	I-CPA
was	VBD	O
observed	VBN	O
in	IN	O
the	DT	O
WRKY12	NNP	B-Gene
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutants	NNS	B-Var
,	,	O
whereas	NNS	O
increased	VBD	O
Cd	NNP	O
sensitivity	NN	O
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
WRKY12	NNP	O
-	:	O
overexpressing	NN	O
plants	NNS	O
.	.	O
Overexpression	NN	O
and	CC	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
of	IN	O
WRKY12	NNP	B-Gene
were	VBD	O
associated	VBN	O
respectively	RB	O
with	IN	O
increased	VBN	O
and	CC	O
decreased	VBN	B-NegReg
Cd	NNP	B-CPA
accumulation	NN	I-CPA
by	IN	O
repressing	VBG	O
or	CC	O
releasing	VBG	B-PosReg
the	DT	O
expression	NN	B-MPA
of	IN	O
the	DT	O
genes	NNS	O
involved	VBN	O
in	IN	O
the	DT	O
PC	NN	O
synthesis	NN	O
pathway	NN	O
.	.	O
Transient	JJ	O
expression	NN	O
assay	NN	O
showed	VBD	O
that	IN	O
WRKY12	NNP	O
repressed	VBD	O
the	DT	O
expression	NN	O
of	IN	O
GSH1	NNP	B-Gene
,	,	O
GSH2	NNP	B-Gene
,	,	O
PCS1	NNP	B-Gene
,	,	O
and	CC	O
PCS2	NNP	B-Gene
.	.	O
Further	JJ	O
analysis	NN	O
indicated	VBD	O
that	IN	O
WRKY12	NNP	O
could	MD	O
directly	RB	O
bind	VB	O
to	TO	O
the	DT	O
W	NNP	O
-	:	O
box	NN	O
of	IN	O
the	DT	O
promoter	NN	O
in	IN	O
GSH1	NNP	O
but	CC	O
not	RB	O
in	IN	O
GSH2	NNP	O
,	,	O
PCS1	NNP	O
,	,	O
and	CC	O
PCS2	NNP	O
in	IN	O
vivo	NN	O
.	.	O

Together	RB	O
,	,	O
our	PRP$	O
results	NNS	O
suggest	VBP	O
that	IN	O
WRKY12	NNP	O
directly	RB	O
targets	VBZ	O
GSH1	NNP	O
and	CC	O
indirectly	RB	O
represses	VBZ	O
PC	NN	O
synthesis	NN	O
-	:	O
related	VBN	O
gene	NN	O
expression	NN	O
to	TO	O
negatively	RB	O
regulate	VB	O
Cd	NNP	O
accumulation	NN	O
and	CC	O
tolerance	NN	O
in	IN	O
Arabidopsis	NNP	O

's	POS	I-Disease
Disease	NNP	I-Disease
LRRK2	NNP	B-Gene
Disrupts	NNP	I-Var
Synaptic	NNP	I-NegReg
in	IN	I-MPA
Ventral	NNP	I-MPA
Midbrain	NNP	I-MPA
Neurons	NNP	I-MPA


LRRK2	NNP	B-Gene
mutants	VBZ	B-Var
contribute	VB	B-Reg
nigral	JJ	B-MPA
vulnerability	NN	I-MPA
mutation	NN	B-Var
LRRK2	NNP	B-Gene
impairs	VBZ	B-NegReg
SV	NNP	B-MPA
endocytosis	NN	I-MPA
in	IN	I-MPA
ventral	JJ	I-MPA
midbrain	NN	I-MPA
(	(	I-MPA
MB	NNP	I-MPA
)	)	I-MPA
neurons	NNS	I-MPA
,	,	I-MPA
including	VBG	I-MPA
DA	NNP	I-MPA
neurons	NNS	I-MPA

impairment	NN	B-NegReg
SV	NNP	B-MPA
endocytosis	NN	I-MPA
in	IN	I-MPA
neurons	NNS	I-MPA
deletion	NN	B-Var
SYNJ1	NNP	B-Gene
SYNJ1	NNP	B-Var
-	:	I-Var
LRRK2	NNP	B-Var
G2019S	NNP	I-Var
impairs	NNS	B-NegReg
sustained	VBD	B-MPA
exocytosis	NN	I-MPA
in	IN	I-MPA
MB	NNP	I-MPA
neurons	NNS	I-MPA
alters	NNS	B-Reg
specific	JJ	B-MPA
motor	NN	I-MPA
functions	NNS	I-MPA
Interestingly	RB	O
,	,	O
we	PRP	O
show	VBP	O
that	IN	O
LRRK2	NNP	B-Var
directly	RB	O
phosphorylates	VBZ	O
synaptojanin1	NN	O
in	IN	O
vitro	NN	O
,	,	O
resulting	VBG	B-Reg
in	IN	I-Reg
the	DT	O
disruption	NN	B-MPA
of	IN	I-MPA
endophilin	JJ	I-MPA
-	:	I-MPA
synaptojanin1	JJ	I-MPA
interaction	NN	I-MPA
required	VBN	I-MPA
for	IN	I-MPA
SV	NNP	I-MPA
endocytosis	NN	I-MPA
.	.	O
Our	PRP$	O
work	NN	O
suggests	VBZ	O
a	DT	O
merge	NN	O
of	IN	O
LRRK2	NNP	O
and	CC	O
SYNJ1	NNP	O
pathogenic	JJ	O
pathways	NNS	O
in	IN	O
deregulating	VBG	O
SV	NNP	O
trafficking	NN	O
in	IN	O
MB	NNP	O
neurons	NNS	O
as	IN	O
an	DT	O
underlying	VBG	O
molecular	JJ	O
mechanism	NN	O
of	IN	O
early	JJ	O
PD	NNP	O
pathogenesis	NN	O
.	.	O
SIGNIFICANCE	NNP	O
STATEMENT	NNP	O
Understanding	NNP	O
midbrain	NN	O
dopaminergic	NN	O
(	(	O
DAergic	NNP	O
)	)	O
neuron	SYM	O
-	:	O
selective	JJ	O
vulnerability	NN	O
in	IN	O
PD	NNP	O
is	VBZ	O
essential	JJ	O
for	IN	O
the	DT	O
development	NN	O
of	IN	O
targeted	JJ	O
therapeutics	NNS	O
.	.	O

We	PRP	O
report	VBP	O
,	,	O
for	IN	O
the	DT	O
first	JJ	O
time	NN	O
,	,	O
a	DT	O
nerve	JJ	O
terminal	JJ	O
impairment	NN	O
in	IN	O
SV	NNP	O
trafficking	VBG	O
selectively	RB	O
in	IN	O
MB	NNP	O
neurons	NNS	O
but	CC	O
not	RB	O
cortical	JJ	O
neurons	NNS	O
caused	VBN	O
by	IN	O
two	CD	O
PARK	NNP	O
genes	NNS	O
:	:	O
LRRK2	NNP	O
(	(	O
PARK8	NNP	O
)	)	O
and	CC	O
SYNJ1	NNP	O
(	(	O
PARK20	NNP	O
)	)	O
.	.	O

We	PRP	O
demonstrate	VBP	O
that	IN	O
the	DT	O
enhanced	JJ	B-PosReg
kinase	NN	B-MPA
activity	NN	I-MPA
resulting	VBG	O
from	IN	O
the	DT	O
most	RBS	O
frequent	JJ	O
G2019S	NNP	B-Var
mutation	NN	O
in	IN	O
LRRK2	NNP	B-Gene
is	VBZ	O
the	DT	O
key	NN	O
to	TO	O
this	DT	O
impairment	NN	O
.	.	O
We	PRP	O
provide	VBP	O
evidence	NN	O
suggesting	VBG	O
that	IN	O
LRRK2	NNP	B-Gene
G2019S	NNP	B-Var
and	CC	O
SYNJ1	NNP	B-Gene
loss	NN	B-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
share	NN	O
a	DT	O
similar	JJ	O
pathogenic	JJ	O
pathway	NN	O
in	IN	O
deregulating	VBG	B-MPA
DAergic	NNP	I-MPA
neuron	NN	I-MPA
SV	NNP	I-MPA
endocytosis	NN	I-MPA
and	CC	O
that	IN	O
they	PRP	O
play	VBP	B-Reg
additive	JJ	I-Reg
roles	NNS	I-Reg
in	IN	O
facilitating	VBG	O
each	DT	O
other	JJ	O
's	POS	O
pathogenic	JJ	O
functions	NNS	O
in	IN	O
PD	NNP	B-Disease

SGCD	NNP	B-Gene
limb	NN	I-Var
girdle	NN	I-Reg
muscular	JJ	I-Disease
dystrophy	NN	I-Disease


The	DT	O
clinical	JJ	O
presentation	NN	O
in	IN	O
dogs	NNS	O
is	VBZ	O
characterized	VBN	O
by	IN	O
marked	JJ	O
muscle	NN	O
weakness	NN	O
and	CC	O
atrophy	NN	O
in	IN	O
the	DT	O
shoulder	NN	O
and	CC	O
hips	NNS	O
during	IN	O
puppyhood	NN	O
.	.	O

METHODS	NNS	O
:	:	O
Following	VBG	O
clinical	JJ	O
evaluation	NN	O
,	,	O
the	DT	O
identification	NN	O
of	IN	O
the	DT	O
dystrophic	JJ	O
histological	JJ	O
phenotype	NN	O
on	IN	O
muscle	NN	O
histology	NN	O
,	,	O
and	CC	O
demonstration	NN	O
of	IN	O
the	DT	O
absence	NN	O
of	IN	O
sarcoglycan	JJ	O
-	:	O
sarcospan	NN	O
complex	NN	O
by	IN	O
immunostaining	VBG	O
,	,	O
whole	JJ	O
exome	NN	O
sequencing	NN	O
was	VBD	O
performed	VBN	O
on	IN	O
five	CD	O
Boston	NNP	O
terriers	NNS	O
:	:	O
one	CD	O
affected	VBD	O
dog	NN	O
and	CC	O
its	PRP$	O
three	CD	O
family	NN	O
members	NNS	O
and	CC	O
one	CD	O
unrelated	JJ	O
affected	VBD	O
dog	NN	O
.	.	O

RESULTS	NN	O
:	:	O
Within	JJ	O
sarcoglycan	JJ	O
-	:	O
(	(	O
SGCD	NNP	B-Gene
)	)	O
,	,	O
a	DT	O
two	CD	O
base	NN	O
pair	NN	O
deletion	NN	O
segregating	VBG	O
with	IN	O
LGMD	NNP	O
in	IN	O
the	DT	O
family	NN	O
was	VBD	O
discovered	VBN	O
,	,	O
and	CC	O
a	DT	O
deletion	NN	O
encompassing	VBG	O
exons	NNS	O
7	CD	O
and	CC	O
8	CD	O
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
unrelated	JJ	O
dog	NN	O
.	.	O
Both	DT	O
mutations	NNS	B-Var
are	VBP	O
predicted	VBN	O
to	TO	O
cause	VB	O
an	DT	O
absence	NN	B-NegReg
of	IN	O
SGCD	NNP	B-Gene
protein	NN	B-Protein
,	,	O
confirmed	VBN	O
by	IN	O
immunohistochemistry	NN	O
.	.	O
The	DT	O
mutations	NNS	O
are	VBP	O
private	JJ	O
to	TO	O
each	DT	O
family	NN	O
.	.	O

CONCLUSIONS	NN	O
:	:	O
Here	RB	O
,	,	O
we	PRP	O
describe	VBP	O
the	DT	O
first	JJ	O
cases	NNS	O
of	IN	O
canine	NN	O
LGMD	NNP	O
characterized	VBD	O
at	IN	O
the	DT	O
molecular	JJ	O
level	NN	O
with	IN	O
the	DT	O
classification	NN	O
of	IN	O
LGMD2F	NNP	O

hypertriglyceridemia	NN	B-Disease
-	:	I-NegReg
function	NN	I-NegReg
lipoprotein	VBZ	B-Enzyme
lipase	JJ	I-Enzyme
C310R	NNP	B-Var
E396V	NNP	B-Var
associated	VBN	B-Reg
with	IN	I-Reg
recurrent	JJ	B-Disease
acute	NN	I-Disease
pancreatitis	NN	I-Disease



Another	DT	O
member	NN	O
of	IN	O
the	DT	O
family	NN	O
was	VBD	O
detected	VBN	O
to	TO	O
be	VB	O
a	DT	O
compound	JJ	O
heterozygote	NN	O
who	WP	O
along	IN	O
with	IN	O
the	DT	O
c	NN	O
.	.	O
T928C	NNP	O
mutation	NN	O
also	RB	O
carried	VBD	O
a	DT	O
novel	JJ	O
missense	NN	O
mutation	NN	O
c	NN	O
.	.	O
A1187T	NNP	O
(	(	O
p	NN	O
.	.	O
E396V	NNP	O
)	)	O
in	IN	O
exon	$	O
8	CD	O
of	IN	O
the	DT	O
LPL	NNP	O
gene	NN	O
.	.	O

Furthermore	RB	O
,	,	O
COS	NNP	O
-	:	O
1	CD	O
cells	NNS	O
were	VBD	O
transfected	VBN	O
with	IN	O
lentiviruses	NNS	O
containing	VBG	O
the	DT	O
mutant	JJ	O
LPL	NNP	O
genes	NNS	O
.	.	O

While	IN	O
C310R	NNP	B-Var
markedly	RB	O
reduced	VBD	B-NegReg
the	DT	O
overall	JJ	O
LPL	NNP	B-MPA
protein	NN	I-MPA
level	NN	I-MPA
,	,	O
COS	NNP	O
-	:	O
1	CD	O
cells	NNS	O
carrying	VBG	O
E396V	NNP	O
or	CC	O
double	JJ	O
mutations	NNS	O
contained	VBD	O
similar	JJ	O
overall	JJ	O
LPL	NNP	O
protein	NN	O
levels	NNS	O
to	TO	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
.	.	O
The	DT	O
specific	JJ	O
activity	NN	O
of	IN	O
the	DT	O
LPL	NNP	O
mutants	NNS	O
remained	VBD	O
at	IN	O
comparable	JJ	O
magnitude	NN	O
to	TO	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
.	.	O

However	RB	O
,	,	O
few	JJ	O
LPL	NNP	O
were	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
culture	NN	O
medium	NN	O
for	IN	O
the	DT	O
mutants	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
both	DT	O
mutations	NNS	B-Var
caused	VBD	B-Reg
aberrant	JJ	O
triglyceride	JJ	B-MPA
catabolism	NN	I-MPA
.	.	O
More	RBR	O
specifically	RB	O
,	,	O
E396V	NNP	B-Var
and	CC	O
double	JJ	B-Var
mutations	NNS	I-Var
dampened	VBD	B-NegReg
the	DT	O
transport	NN	B-MPA
of	IN	I-MPA
LPL	NNP	I-MPA
to	TO	I-MPA
the	DT	I-MPA
cell	NN	I-MPA
surface	NN	I-MPA
,	,	O
while	IN	O
for	IN	O
the	DT	O
C310R	NNP	B-Var
mutation	NN	O
,	,	O
reducing	VBG	B-NegReg
LPL	NNP	B-MPA
protein	NNS	I-MPA
level	NN	I-MPA
might	MD	O
be	VB	O
involved	VBN	O
.	.	O
By	IN	O
characterizing	VBG	O
these	DT	O
two	CD	O
novel	NN	O
LPL	NNP	O
mutations	NNS	O
,	,	O
this	DT	O
study	NN	O
has	VBZ	O
expanded	VBN	O
our	PRP$	O
understanding	VBG	O
on	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
familial	JJ	O
hypertriglyceridemia	NN	O
(	(	O
FHTG	NNP	O
)	)	O

SLC30A8	NNP	B-Gene
-	:	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutation	NN	B-Var
increased	VBN	B-PosReg
insulin	NN	B-MPA
secretory	NN	I-MPA
capacity	NN	I-MPA


Loss	NNP	O
-	:	O
of	IN	O
-	:	O
function	NN	O
(	(	O
LOF	NNP	O
)	)	O
mutations	NNS	O
in	IN	O
SLC30A8	NNP	O
protect	NN	O
against	IN	O
type	JJ	O
2	CD	O
diabetes	NNS	O
in	IN	O
humans	NNS	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
generated	VBD	O
a	DT	O
knockin	JJ	O
mouse	NN	O
model	NN	O
carrying	VBG	O
one	CD	O
of	IN	O
the	DT	O
most	RBS	O
common	JJ	O
human	JJ	O
LOF	NNP	O
mutations	NNS	O
for	IN	O
SLC30A8	NNP	O
,	,	O
R138X	NNP	O
.	.	O

The	DT	O
R138X	NNP	O
mice	NN	O
had	VBD	O
normal	JJ	O
body	NN	O
weight	NN	O
,	,	O
glucose	JJ	O
tolerance	NN	O
,	,	O
and	CC	O
pancreatic	JJ	O
-	:	O
cell	NN	O
mass	NN	O
.	.	O

Interestingly	RB	O
,	,	O
in	IN	O
hyperglycemic	JJ	O
conditions	NNS	O
induced	VBN	O
by	IN	O
the	DT	O
insulin	NN	O
receptor	NN	O
antagonist	NN	O
S961	NNP	O
,	,	O
the	DT	O
R138X	NNP	B-Var
mice	NN	O
showed	VBD	O
a	DT	O
50%	CD	O
increase	NN	B-PosReg
in	IN	O
insulin	JJ	B-MPA
secretion	NN	I-MPA
.	.	O
This	DT	O
effect	NN	O
was	VBD	O
not	RB	O
associated	VBN	O
with	IN	O
enhanced	JJ	O
-	:	O
cell	NN	O
proliferation	NN	O
or	CC	O
mass	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
SLC30A8	NNP	B-Gene
R138X	NNP	O
LOF	NNP	B-NegReg
mutation	NN	B-Var
may	MD	O
exert	VB	O
beneficial	JJ	B-PosReg
effects	NNS	I-PosReg
on	IN	O
glucose	JJ	B-MPA
metabolism	NN	I-MPA
by	IN	O
increasing	VBG	B-PosReg
the	DT	O
capacity	NN	O
of	IN	O
-	:	O
cells	NNS	O
to	TO	O
secrete	VB	B-MPA
insulin	NN	I-MPA
under	IN	O
hyperglycemic	JJ	O
conditions	NNS	O

in	IN	I-Var
C11orf70	NNP	B-Gene
Primary	NNP	I-Reg
Ciliary	NNP	I-Disease
Dyskinesia	NNP	I-Disease
Defects	NNP	B-NegReg
Outer	NNP	B-Protein
and	CC	I-Protein
Inner	NNP	I-Protein
Dynein	NNP	I-Protein
Arms	NNP	I-Protein

We	PRP	O
identified	VBD	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
open	JJ	O
-	:	O
reading	NN	O
frame	NN	O
C11orf70	NNP	O
in	IN	O
PCD	NNP	O
individuals	NNS	O
from	IN	O
five	CD	O
distinct	JJ	O
families	NNS	O
.	.	O

Transmission	NNP	O
electron	NN	O
microscopy	NN	O
analyses	NNS	O
and	CC	O
high	JJ	O
-	:	O
resolution	NN	O
immunofluorescence	NN	O
microscopy	NN	O
demonstrate	NN	O
that	WDT	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
in	IN	O
C11orf70	NNP	B-Gene
cause	NN	O
immotility	NN	B-CPA
of	IN	O
respiratory	NN	B-CPA
cilia	NNS	I-CPA
and	CC	O
sperm	JJ	B-CPA
flagella	NN	I-CPA
,	,	O
respectively	RB	O
,	,	O
as	IN	O
a	DT	O
result	NN	O
of	IN	O
the	DT	O
loss	NN	B-NegReg
of	IN	O
axonemal	JJ	B-Protein
outer	NN	I-Protein
(	(	O
ODAs	NNP	O
)	)	O
and	CC	O
inner	JJ	B-Protein
dynein	NN	I-Protein
arms	NNS	I-Protein
(	(	O
IDAs	NNP	O
)	)	O
,	,	O
indicating	VBG	O
that	IN	O
C11orf70	NNP	O
is	VBZ	O
involved	VBN	O
in	IN	O
cytoplasmic	JJ	O
assembly	NN	O
of	IN	O
dynein	NN	O
arms	NNS	O
.	.	O
Expression	NN	O
analyses	NNS	O
of	IN	O
C11orf70	NNP	O
showed	VBD	O
that	IN	O
C11orf70	NNP	O
is	VBZ	O
expressed	VBN	O
in	IN	O
ciliated	JJ	O
respiratory	NN	O
cells	NNS	O
and	CC	O
that	IN	O
the	DT	O
expression	NN	O
of	IN	O
C11orf70	NNP	O
is	VBZ	O
upregulated	JJ	O
during	IN	O
ciliogenesis	NN	O
,	,	O
similar	JJ	O
to	TO	O
other	JJ	O
previously	RB	O
described	VBN	O
cytoplasmic	JJ	O
dynein	NN	O
-	:	O
arm	NN	O
assembly	NN	O
factors	NNS	O
.	.	O

Furthermore	RB	O
,	,	O
C11orf70	NNP	O
shows	VBZ	O
an	DT	O
interaction	NN	O
with	IN	O
cytoplasmic	JJ	O
ODA	NNP	O
IDA	NNP	O
assembly	RB	O
factor	NN	O
DNAAF2	NNP	O
,	,	O
supporting	VBG	O
our	PRP$	O
hypothesis	NN	O
that	IN	O
C11orf70	NNP	O
is	VBZ	O
a	DT	O
preassembly	RB	O
factor	NN	O
involved	VBN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
PCD	NNP	O
.	.	O

The	DT	O
identification	NN	O
of	IN	O
additional	JJ	O
genetic	JJ	O
defects	NNS	O
that	WDT	O
cause	VBP	O
PCD	NNP	O
and	CC	O
male	JJ	O
infertility	NN	O
is	VBZ	O
of	IN	O
great	JJ	O
importance	NN	O
for	IN	O
the	DT	O
clinic	NN	O
as	RB	O
well	RB	O
as	IN	O
for	IN	O
genetic	JJ	O
counselling	NN	O




Specifically	RB	O
,	,	O
the	DT	O
DOT1L	NNP	B-Gene
gene	NN	O
is	VBZ	O
located	VBN	O
in	IN	O
a	DT	O
frequently	RB	O
deleted	VBN	O
region	NN	O
and	CC	O
undergoes	JJ	O
somatic	JJ	O
mutation	NN	O
in	IN	O
human	JJ	O
melanoma	NN	O
.	.	O
Specific	JJ	O
mutations	NNS	B-Var
functionally	RB	O
compromise	VBP	B-NegReg
DOT1L	NNP	B-Gene
methyltransferase	NN	B-Enzyme
enzyme	NN	I-Enzyme
activity	NN	B-MPA
leading	VBG	O
to	TO	O
reduced	VB	B-NegReg
H3K79	NNP	B-Protein
methylation	NN	B-MPA
.	.	O
Importantly	RB	O
,	,	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
DOT1L	NNP	O
,	,	O
UVR	NNP	O
-	:	O
induced	VBD	O
DNA	NNP	O
damage	NN	O
is	VBZ	O
inefficiently	RB	O
repaired	VBN	O
,	,	O
so	IN	O
that	DT	O
DOT1L	NNP	B-Gene
loss	NN	B-NegReg
promotes	VBZ	B-PosReg
melanoma	RBS	B-CPA
development	NN	I-CPA
in	IN	O
mice	NN	O
after	IN	O
exposure	NN	O
to	TO	O
UVR	NNP	O
.	.	O
Mechanistically	RB	O
,	,	O
DOT1L	NNP	O
facilitates	VBZ	O
DNA	NNP	O
damage	NN	O
repair	NN	O
,	,	O
with	IN	O
DOT1L	NNP	O
-	:	O
methylated	VBD	O
H3K79	NNP	O
involvement	NN	O
in	IN	O
binding	NN	O
and	CC	O
recruiting	VBG	O
XPC	NN	O
to	TO	O
the	DT	O
DNA	NNP	O
damage	NN	O
site	NN	O
for	IN	O
nucleotide	JJ	O
excision	NN	O
repair	NN	O
(	(	O
NER	NNP	O
)	)	O
.	.	O

This	DT	O
study	NN	O
indicates	VBZ	O
that	IN	O
DOT1L	NNP	O
plays	VBZ	O
a	DT	O
protective	JJ	O
role	NN	O
in	IN	O
UVR	NNP	O
-	:	O
induced	JJ	O
melanomagenesis	NN	O

p53	NN	I-Var
gain	NN	I-Gene
of	IN	I-PosReg
function	NN	I-PosReg
induces	NNS	B-Reg
HER2	NNP	B-Protein
expression	NN	I-MPA




METHODS	NN	O
:	:	O
HER2	NNP	O
expression	NN	O
(	(	O
transcription	NN	O
and	CC	O
protein	NN	O
)	)	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
HER2	NNP	O
protein	NN	O
stabilization	NN	O
have	VBP	O
been	VBN	O
evaluated	VBN	O
after	IN	O
inducing	VBG	O
or	CC	O
silencing	VBG	O
of	IN	O
p53	NN	O
mutants	NNS	O
expression	NN	O
in	IN	O
cell	NN	O
lines	NNS	O
.	.	O

Finally	RB	O
,	,	O
we	PRP	O
evaluated	VBD	O
the	DT	O
interaction	NN	O
of	IN	O
the	DT	O
p53	NN	O
mutants	NNS	O
over	IN	O
the	DT	O
HER2	NNP	O
receptor	NN	O
promoter	NN	O
.	.	O

RESULTS	NN	O
:	:	O
Higher	JJR	B-PosReg
HER2	NNP	B-Protein
expression	NN	B-MPA
in	IN	O
cell	NN	O
lines	NNS	O
harboring	VBG	O
endogenous	JJ	O
mtp53	NNS	B-Var
compared	VBN	O
with	IN	O
wt	NN	O
or	CC	O
null	JJ	O
expression	NN	O
of	IN	O
p53	NN	O
cell	NN	O
lines	NNS	O
.	.	O
Transfection	NN	O
of	IN	O
p53	NN	B-Gene
mutants	NNS	O
(	(	O
R248Q	NNP	B-Var
and	CC	O
R273C	NNP	B-Var
)	)	O
in	IN	O
cell	NN	O
lines	NNS	O
increased	VBD	B-PosReg
the	DT	O
expression	NN	B-MPA
of	IN	O
HER2	NNP	B-Protein
.	.	O
Silencing	VBG	O
of	IN	O
p53	NN	O
mutants	NNS	O
,	,	O
decrease	NN	O
HER2	NNP	O
expression	NN	O
.	.	O

The	DT	O
p53	NN	B-Gene
mutants	NNS	O
R248Q	NNP	B-Var
and	CC	O
R273C	NNP	B-Var
significantly	RB	O
increase	VB	B-PosReg
the	DT	O
luciferase	JJ	B-Enzyme
activity	NN	B-MPA
on	IN	O
the	DT	O
HER2	NNP	O
promoter	NN	O
,	,	O
and	CC	O
both	DT	O
mutants	NNS	O
also	RB	O
promote	VBP	B-PosReg
acetylation	NN	B-MPA
of	IN	O
H3	NNP	B-Protein
and	CC	O
H4	NNP	B-Protein
histones	NNS	I-Protein
binding	VBG	B-Interaction
in	IN	O
it	PRP	O
.	.	O
CONCLUSIONS	NN	O
:	:	O
These	DT	O
findings	NNS	O
show	VBP	O
for	IN	O
the	DT	O
first	JJ	O
time	NN	O
that	WDT	O
p53	NN	B-Gene
mutants	NNS	B-Var
induce	VBP	B-Reg
over	IN	B-MPA
-	:	I-MPA
expression	NN	I-MPA
of	IN	O
HER2	NNP	B-Protein
at	IN	O
transcriptional	JJ	O
level	NN	O
of	IN	O
the	DT	O
HER2	NNP	O
protein	NN	O
.	.	O
Our	PRP$	O
results	NNS	O
could	MD	O
have	VB	O
clinical	JJ	O
implications	NNS	O
in	IN	O
breast	NN	O
cancer	NN	O
and	CC	O
other	JJ	O
types	NNS	O
of	IN	O
cancer	NN	O
where	WRB	O
HER2	NNP	O
is	VBZ	O
over	IN	O
-	:	O
expressed	VBN	O
and	CC	O
used	VBN	O
as	IN	O
a	DT	O
therapy	NN	O
target	NN	O


Activated	NNP	B-Disease
PI3K	NNP	I-Disease
Delta	NNP	I-Disease
Syndrome	NNP	I-Disease
caused	VBN	B-Reg
mutations	NNS	B-Var
PIK3CD	NNP	B-Gene
There	EX	O
are	VBP	O
two	CD	O
classes	NNS	O
of	IN	O
APDS	NNP	O
:	:	O
APDS1	NN	O
that	WDT	O
arises	VBZ	O
from	IN	O
p110	NN	O
mutations	NNS	O
that	WDT	O
are	VBP	O
analogous	JJ	O
to	TO	O
oncogenic	JJ	O
mutations	NNS	O
found	VBN	O
in	IN	O
the	DT	O
broadly	RB	O
expressed	VBN	O
p110	NN	O
subunit	NN	O
and	CC	O
APDS2	NNP	O
that	WDT	O
occurs	VBZ	O
from	IN	O
a	DT	O
splice	NN	O
mutation	NN	O
resulting	VBG	O
in	IN	O
p85	NN	O
with	IN	O
a	DT	O
central	JJ	O
deletion	NN	O
(	(	O
434	CD	O
-	:	O
475	CD	O
)	)	O
.	.	O

As	IN	O
p85	JJ	O
regulatory	JJ	O
subunits	NNS	O
associate	VBP	O
with	IN	O
and	CC	O
inhibit	VB	O
all	DT	O
class	NN	O
IA	NNP	O
catalytic	JJ	O
subunits	NNS	O
,	,	O
APDS2	NNP	O
mutations	NNS	O
are	VBP	O
expected	VBN	O
to	TO	O
similarly	VB	O
activate	JJ	O
p110	NN	O
,	,	O
,	,	O
and	CC	O
,	,	O
yet	RB	O
APDS2	NNP	O
largely	RB	O
phenocopies	VBZ	O
APDS1	NNP	O
without	IN	O
dramatic	JJ	O
effects	NNS	O
outside	IN	O
the	DT	O
immune	JJ	O
system	NN	O
.	.	O

We	PRP	O
have	VBP	O
examined	VBN	O
the	DT	O
molecular	JJ	O
mechanism	NN	O
of	IN	O
activation	NN	O
of	IN	O
both	DT	O
classes	NNS	O
of	IN	O
APDS	NNP	O
mutations	NNS	O
using	VBG	O
a	DT	O
combination	NN	O
of	IN	O
biochemical	JJ	O
assays	NNS	O
and	CC	O
hydrogen	NN	O
-	:	O
deuterium	NN	O
exchange	NN	O
mass	NN	O
spectrometry	NN	O
.	.	O

Intriguingly	RB	O
,	,	O
we	PRP	O
find	VBP	O
that	IN	O
an	DT	O
APDS2	NNP	B-Gene
mutation	NN	B-Var
in	IN	O
p85	JJ	O
leads	NNS	O
to	TO	O
substantial	JJ	O
basal	JJ	O
activation	NN	B-PosReg
of	IN	O
p110	NN	B-MPA
(	(	I-MPA
300	CD	I-MPA
-	:	I-MPA
fold	NN	I-MPA
)	)	I-MPA
and	CC	O
disrupts	JJ	B-NegReg
inhibitory	JJ	B-MPA
interactions	NNS	I-MPA
from	IN	O
the	DT	O
nSH2	NN	O
,	,	O
iSH2	NN	O
,	,	O
and	CC	O
cSH2	NN	O
domains	NNS	O
of	IN	O
p85	NN	O
,	,	O
whereas	JJ	O
p110	NN	O
is	VBZ	O
only	RB	O
minimally	RB	O
basally	RB	O
activated	VBN	O
(	(	O
2	CD	O
-	:	O
fold	NN	O
)	)	O
when	WRB	O
associated	VBN	O
with	IN	O
mutated	JJ	O
p85	NN	O
.	.	O
APDS1	NNP	O
mutations	NNS	O
in	IN	O
p110	NN	O
(	(	O
N334K	NNP	O
,	,	O
E525K	NNP	O
,	,	O
E1021K	NNP	O
)	)	O
mimic	VBD	O
the	DT	O
activation	NN	O
mechanisms	VBZ	O
previously	RB	O
discovered	VBN	O
for	IN	O
oncogenic	JJ	O
mutations	NNS	O
in	IN	O
p110	NN	O
.	.	O

All	DT	O
APDS	NNP	O
mutations	NNS	O
were	VBD	O
potently	RB	O
inhibited	VBN	O
by	IN	O
the	DT	O
Food	NNP	O
and	CC	O
Drug	NNP	O
Administration	NNP	O
-	:	O
approved	VBD	O
p110	JJ	O
inhibitor	NN	O
idelalisib	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
define	VB	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
how	WRB	O
PIK3CD	NNP	O
and	CC	O
PIK3R1	NNP	O
mutations	NNS	O
result	VBP	O
in	IN	O
APDS	NNP	O
and	CC	O
reveal	VB	O
a	DT	O
potential	JJ	O
path	NN	O
to	TO	O
treatment	NN	O
for	IN	O
all	DT	O
APDS	NNP	O
patients	NNS	O



A	DT	O
filamentous	JJ	O
ascomycete	JJ	O
Bipolaris	NNP	O
maydis	NN	O
,	,	O
responsible	JJ	O
for	IN	O
southern	JJ	O
corn	NN	O
leaf	NN	O
blight	NN	O
,	,	O
is	VBZ	O
also	RB	O
studied	VBN	O
as	IN	O
a	DT	O
model	NN	O
fungus	NN	O
for	IN	O
sexual	JJ	O
reproduction	NN	O
in	IN	O
filamentous	JJ	O
ascomycetes	NNS	O
that	IN	O
form	NN	O
filiform	NN	O
ascospores	NNS	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
clarify	VB	O
the	DT	O
roles	NNS	O
of	IN	O
autophagy	NN	O
in	IN	O
various	JJ	O
stages	NNS	O
of	IN	O
the	DT	O
life	NN	O
cycle	NN	O
of	IN	O
B.	NNP	O
maydis	NN	O
,	,	O
we	PRP	O
constructed	VBD	O
null	JJ	O
mutants	NNS	O
of	IN	O
BmATG8	NNP	O
,	,	O
an	DT	O
orthologue	NN	O
of	IN	O
the	DT	O
Saccharomyces	NNP	O
cerevisiae	NN	O
autophagy	NN	O
gene	NN	O
ATG8	NNP	O
in	IN	O
B.	NNP	O
maydis	NN	O
.	.	O

Deletion	NN	B-Var
of	IN	O
BmATG8	NNP	B-Gene
impaired	JJ	B-NegReg
localization	NN	B-MPA
of	IN	O
cytosolic	JJ	O
components	NNS	O
to	TO	O
the	DT	O
vacuole	NN	O
under	IN	O
nitrogen	NN	O
starvation	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
autophagy	NN	B-CPA
was	VBD	O
deficient	NN	B-NegReg
in	IN	O
the	DT	O
null	JJ	O
mutants	NNS	O
.	.	O
Additionally	RB	O
,	,	O
fluorescent	JJ	O
microscopic	NN	O
observations	NNS	O
on	IN	O
a	DT	O
eGFP	JJ	O
-	:	O
fused	VBN	O
BmATG8	NNP	O
expressing	VBG	O
strain	NN	O
showed	VBD	O
that	IN	O
BmATG8	NNP	O
is	VBZ	O
associated	VBN	O
with	IN	O
autophagy	JJ	O
-	:	O
related	JJ	O
structures	NNS	O
.	.	O

In	IN	O
vegetative	JJ	O
growth	NN	O
,	,	O
strains	VBZ	I-Gene
showed	VBD	O
a	DT	O
reduction	NN	B-NegReg
in	IN	O
conidiation	NN	B-CPA
and	CC	I-CPA
aerial	JJ	I-CPA
mycelial	JJ	I-CPA
growth	NN	I-CPA
.	.	O
Interestingly	RB	O
,	,	O
the	DT	O
mutant	JJ	O
conidia	NN	O
indicated	VBD	O
loss	NN	O
of	IN	O
the	DT	O
germination	NN	O
rate	NN	O
under	IN	O
starvation	NN	O
conditions	NNS	O
and	CC	O
affected	JJ	O
longevity	NN	O
.	.	O

However	RB	O
,	,	O
germinated	VBD	O
mutant	JJ	O
conidia	NN	O
were	VBD	O
still	RB	O
capable	JJ	O
of	IN	O
infecting	VBG	O
the	DT	O
host	NN	O
plant	NN	O
via	IN	O
appressoria	NNS	O
.	.	O

In	IN	O
sexual	JJ	O
reproduction	NN	O
,	,	O
ascospores	VBZ	O
with	IN	O
BmATG8	NNP	O
genetic	JJ	O
background	NN	O
were	VBD	O
aborted	VBN	O
.	.	O

Our	PRP$	O
results	NNS	O
revealed	VBD	O
that	IN	O
autophagy	NN	O
plays	VBZ	O
a	DT	O
crucial	JJ	O
role	NN	O
in	IN	O
the	DT	O
function	NN	O
of	IN	O
conidia	NN	O
,	,	O
not	RB	O
in	IN	O
host	NN	O
infection	NN	O
via	IN	O
appressoria	NN	O
in	IN	O
B.	NNP	O
maydis	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
conservation	NN	O
of	IN	O
the	DT	O
importance	NN	O
of	IN	O
autophagy	NN	O
in	IN	O
ascospore	NN	O
development	NN	O
is	VBZ	O
suggested	VBN	O
among	IN	O
ascomycetes	NNS	O
including	VBG	O
species	NNS	O
that	WDT	O
form	VBP	O
bitunicate	JJ	O
ascus	NN	O




However	RB	O
,	,	O
the	DT	O
association	NN	O
of	IN	O
certain	JJ	O
genetic	JJ	O
polymorphisms	NNS	O
with	IN	O
prediction	NN	O
of	IN	O
major	JJ	O
adverse	JJ	O
clinical	JJ	O
events	NNS	O
following	VBG	O
stroke	NN	O
still	RB	O
remains	VBZ	O
controversial	JJ	O
,	,	O
especially	RB	O
in	IN	O
Caucasians	NNPS	O
.	.	O

STUDY	NNP	O
QUESTION	NNP	O
:	:	O
The	DT	O
primary	JJ	O
aim	NN	O
was	VBD	O
to	TO	O
evaluate	VB	O
the	DT	O
impact	NN	O
of	IN	O
CYP2C19	NNP	O
allele	VBP	O
2	CD	O
in	IN	O
heterozygote	JJ	O
form	NN	O
on	IN	O
major	JJ	O
adverse	JJ	O
clinical	JJ	O
events	NNS	O
in	IN	O
Caucasian	JJ	O
poststroke	NN	O
survivors	NNS	O
treated	VBD	O
with	IN	O
clopidogrel	NN	O
.	.	O

The	DT	O
secondary	JJ	O
aim	NN	O
was	VBD	O
to	TO	O
analyze	VB	O
the	DT	O
potential	JJ	O
link	NN	O
between	IN	O
CYP2C19	NNP	O
genetic	JJ	O
polymorphism	NN	O
and	CC	O
variable	JJ	O
response	NN	O
after	IN	O
clopidogrel	NN	O
.	.	O

STUDY	NNP	O
DESIGN	NNP	O
:	:	O
One	CD	O
hundred	VBD	O
thirty	NN	O
patients	NNS	O
of	IN	O
Caucasian	JJ	O
origin	NN	O
following	VBG	O
documented	JJ	O
ischemic	JJ	O
stroke	NN	O
were	VBD	O
included	VBN	O
.	.	O

Platelet	NNP	O
reactivity	NN	O
was	VBD	O
assessed	VBN	O
by	IN	O
light	JJ	O
transmittance	NN	O
aggregometry	NN	O
(	(	O
LTA	NNP	O
)	)	O
and	CC	O
matched	VBN	O
with	IN	O
various	JJ	O
CYP2C19	NNP	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
genetic	JJ	O
polymorphisms	NNS	O
and	CC	O
major	JJ	O
adverse	JJ	O
clinical	JJ	O
events	NNS	O
(	(	O
composite	NN	O
of	IN	O
vascular	JJ	O
deaths	NNS	O
,	,	O
stroke	VBD	O
transient	JJ	O
ischemic	JJ	O
attack	NN	O
,	,	O
and	CC	O
myocardial	JJ	O
infarction	NN	O
)	)	O
.	.	O

RESULTS	NN	O
:	:	O
Over	IN	O
the	DT	O
mean	JJ	O
follow	NN	O
-	:	O
up	IN	O
of	IN	O
14.9	CD	O
months	NNS	O
,	,	O
19	CD	O
patients	NNS	O
experienced	JJ	O
major	JJ	O
adverse	JJ	O
clinical	JJ	O
events	NNS	O
.	.	O

The	DT	O
risk	NN	O
of	IN	O
major	JJ	B-MPA
adverse	JJ	I-MPA
clinical	JJ	I-MPA
events	NNS	I-MPA
was	VBD	O
nearly	RB	O
3	CD	O
-	:	O
fold	NN	O
in	IN	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
allele	IN	B-Var
carriers	NNS	O
(	(	O
hazard	NN	O
ratio	VBZ	O
2.904	CD	O
;	:	O
95%	CD	O
confidence	NN	O
interval	NN	O
,	,	O
1.083	CD	O
-	:	O
7.786	CD	O
;	:	O
P	NNP	O
0.013	CD	O
)	)	O
,	,	O
whereas	VBZ	O
the	DT	O
risk	NN	O
of	IN	O
ischemic	JJ	B-MPA
stroke	NN	I-MPA
or	CC	O
transient	JJ	B-MPA
ischemic	JJ	I-MPA
attack	NN	I-MPA
alone	NN	I-MPA
was	VBD	O
also	RB	O
higher	JJR	O
(	(	O
hazard	JJ	O
ratio	NN	O
3.170	CD	O
;	:	O
95%	CD	O
confidence	NN	O
interval	NN	O
,	,	O
1.281	CD	O
-	:	O
7.849	CD	O
;	:	O
P	NNP	O
0.034	CD	O
)	)	O
.	.	O
Platelet	NNP	B-MPA
activity	NN	I-MPA
was	VBD	O
strongly	RB	O
associated	VBN	B-Interaction
with	IN	O
allele	JJ	B-Var
2	CD	I-Var
status	NN	I-Var
(	(	O
rs	VB	O
0.21	CD	O
,	,	O
P	NNP	O
0.016	CD	O
)	)	O
but	CC	O
not	RB	O
with	IN	O
other	JJ	O
genetic	JJ	O
polymorphisms	NNS	O
.	.	O
Carriers	NNS	O
of	IN	O
allele	JJ	O
2	CD	O
exhibited	VBD	O
lower	JJR	O
platelet	NN	O
response	NN	O
to	TO	O
adenosine	VB	O
diphosphate	JJ	O
-	:	O
mean	NN	O
LTA	NNP	O
(	(	O
30.1%	CD	O
vs	NN	O
.	.	O

42.0%	CD	O
;	:	O
P	NNP	O
0.017	CD	O
)	)	O
.	.	O

There	EX	O
were	VBD	O
no	DT	O
significant	JJ	O
differences	NNS	O
in	IN	O
LTA	NNP	O
results	NNS	O
with	IN	O
other	JJ	O
agonists	NNS	O
.	.	O

Strong	JJ	O
association	NN	O
of	IN	O
increase	NN	O
in	IN	O
adenosine	JJ	O
diphosphate	NN	O
-	:	O
induced	JJ	O
aggregation	NN	O
with	IN	O
diabetes	NNS	O
mellitus	NNS	O
(	(	O
rs	VB	O
0.20	CD	O
,	,	O
P	NNP	O
0.023	CD	O
)	)	O
,	,	O
increasing	VBG	O
age	NN	O
(	(	O
rs	JJ	O
0.23	CD	O
,	,	O
P	NNP	O
0.008	CD	O
)	)	O
,	,	O
and	CC	O
conversely	RB	O
diminishing	VBG	O
over	RP	O
increased	JJ	O
weight	NN	O
(	(	O
rs	JJ	O
0.23	CD	O
,	,	O
P	NNP	O
0.009	CD	O
)	)	O
was	VBD	O
also	RB	O
detected	VBN	O
.	.	O

The	DT	O
carriers	NNS	O
of	IN	O
other	JJ	O
gene	NN	O
allele	JJ	O
variants	NNS	O
lack	NN	O
uniformed	JJ	O
impact	NN	O
on	IN	O
variable	JJ	O
response	NN	O
after	IN	O
clopidogrel	NN	O
.	.	O

CONCLUSIONS	NN	O
:	:	O
Even	RB	O
heterozygous	JJ	O
CYP2C19	NNP	B-Gene
2	CD	I-Gene
allele	JJ	B-Var
carriers	NNS	O
among	IN	O
Caucasian	JJ	O
patients	NNS	O
after	IN	O
ischemic	JJ	O
stroke	NN	O
had	VBD	O
a	DT	O
higher	JJR	B-PosReg
risk	NN	O
of	IN	O
major	JJ	B-MPA
adverse	JJ	I-MPA
clinical	JJ	I-MPA
events	NNS	I-MPA
.	.	O
The	DT	O
LTA	NNP	O
,	,	O
however	RB	O
,	,	O
did	VBD	O
not	RB	O
predict	VB	O
major	JJ	O
adverse	JJ	O
clinical	JJ	O
events	NNS	O
.	.	O

The	DT	O
exact	JJ	O
clinical	JJ	O
utility	NN	O
of	IN	O
these	DT	O
findings	NNS	O
is	VBZ	O
still	RB	O
uncertain	JJ	O
and	CC	O
requires	VBZ	O
large	JJ	O
outcome	SYM	O
-	:	O
driven	RB	O
randomized	VBN	O
trial	NN	O
in	IN	O
Caucasians	NNP	O
for	IN	O
proof	NN	O
of	IN	O
concept	NN	O



In	IN	O
Caenorhabditis	NNP	O
elegans	NNS	O
,	,	O
either	DT	O
one	CD	O
of	IN	O
two	CD	O
presenilin	NN	O
genes	NNS	O
(	(	O
sel	SYM	O
-	:	O
12	CD	O
or	CC	O
hop	VB	O
-	:	O
1	CD	O
)	)	O
facilitate	NN	O
Notch	NNP	O
activation	NN	O
,	,	O
providing	VBG	O
the	DT	O
catalytic	JJ	O
subunit	NN	O
for	IN	O
the	DT	O
secretase	NN	O
proteolytic	JJ	O
enzyme	NN	O
complex	NN	O
.	.	O

For	IN	O
all	DT	O
known	VBN	O
Notch	NNP	O
signaling	VBG	O
events	NNS	O
,	,	O
sel	SYM	O
-	:	O
12	CD	O
can	MD	O
mediate	VB	O
Notch	NNP	O
activation	NN	O
,	,	O
so	IN	O
the	DT	O
conservation	NN	O
of	IN	O
hop	NN	O
-	:	O
1	CD	O
remains	VBZ	O
a	DT	O
mystery	NN	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
uncover	VBP	O
a	DT	O
novel	JJ	O
"	NN	O
late	JJ	O
-	:	O
onset	NN	O
"	JJ	O
germline	NN	O
Notch	NNP	O
phenotype	NN	O
in	IN	O
which	WDT	O
HOP	NNP	O
-	:	O
1	CD	O
-	:	O
deficient	NN	O
worms	NNS	O
fail	VBP	O
to	TO	O
maintain	VB	O
proliferating	VBG	O
germline	JJ	O
stem	NN	O
cells	NNS	O
during	IN	O
adulthood	NN	O
.	.	O

Either	DT	O
SEL	NNP	O
-	:	O
12	CD	O
or	CC	O
HOP	NNP	O
-	:	O
1	CD	O
presenilin	NN	O
can	MD	O
impart	VB	O
sufficient	JJ	O
Notch	NNP	O
signaling	NN	O
for	IN	O
the	DT	O
establishment	NN	O
and	CC	O
expansion	NN	O
of	IN	O
the	DT	O
germline	NN	O
,	,	O
but	CC	O
maintenance	NN	O
of	IN	O
an	DT	O
adult	NN	O
stem	NN	O
cell	NN	O
pool	NN	O
relies	VBZ	O
exclusively	RB	O
on	IN	O
HOP	NNP	O
-	:	O
1	CD	O
-	:	O
mediated	VBN	O
Notch	NNP	O
signaling	NN	O
.	.	O

We	PRP	O
also	RB	O
show	VBP	O
that	IN	O
HOP	NNP	O
-	:	O
1	CD	O
is	VBZ	O
necessary	JJ	O
for	IN	O
maximum	JJ	O
fecundity	NN	O
and	CC	O
reproductive	JJ	O
span	NN	O
.	.	O

The	DT	O
low	JJ	B-NegReg
-	:	O
fecundity	NN	B-CPA
phenotype	NN	O
of	IN	O
hop	NN	B-Gene
-	:	I-Gene
1	CD	I-Gene
mutants	NNS	B-Var
can	MD	O
be	VB	O
phenocopied	VBN	O
by	IN	O
switching	VBG	B-NegReg
off	RP	I-NegReg
glp	JJ	B-MPA
-	:	I-MPA
1	CD	I-MPA
Notch	NNP	I-MPA
function	NN	I-MPA
during	IN	O
the	DT	O
last	JJ	O
stage	NN	O
of	IN	O
larval	JJ	O
development	NN	O
.	.	O
We	PRP	O
propose	VBP	O
that	DT	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
larval	NN	O
development	NN	O
,	,	O
dual	JJ	O
presenilin	NN	O
usage	NN	O
switches	VBZ	O
exclusively	RB	O
to	TO	O
HOP	NNP	O
-	:	O
1	CD	O
,	,	O
perhaps	RB	O
offering	VBG	O
opportunities	NNS	O
for	IN	O
differential	JJ	O
regulation	NN	O
of	IN	O
the	DT	O
germline	NN	O
during	IN	O
adulthood	NN	O
.	.	O

Additional	JJ	O
defects	NNS	B-NegReg
in	IN	O
oocyte	JJ	B-CPA
size	NN	I-CPA
and	CC	O
production	NN	B-CPA
rate	NN	O
in	IN	O
hop	NN	B-Gene
-	:	I-Gene
1	CD	I-Gene
and	CC	O
glp	VB	B-Gene
-	:	I-Gene
1	CD	I-Gene
mutants	NNS	B-Var
indicate	VBP	O
that	IN	O
the	DT	O
process	NN	O
of	IN	O
oogenesis	NN	O
is	VBZ	O
compromised	VBN	O
when	WRB	O
germline	JJ	O
Notch	NNP	O
signaling	NN	O
is	VBZ	O
switched	VBN	O
off	RP	O
.	.	O
We	PRP	O
calculate	VBP	O
that	IN	O
in	IN	O
wild	JJ	O
-	:	O
type	NN	O
adults	NNS	O
,	,	O
as	RB	O
much	JJ	O
as	IN	O
86%	CD	O
of	IN	O
cells	NNS	O
derived	VBN	O
from	IN	O
the	DT	O
stem	NN	O
cell	NN	O
pool	NN	O
function	NN	O
to	TO	O
support	VB	O
oogenesis	NN	O
.	.	O

This	DT	O
work	NN	O
suggests	VBZ	O
that	IN	O
an	DT	O
important	JJ	O
role	NN	O
for	IN	O
Notch	NNP	O
signaling	VBG	O
in	IN	O
the	DT	O
adult	NN	O
germline	NN	O
is	VBZ	O
to	TO	O
furnish	VB	O
a	DT	O
large	JJ	O
and	CC	O
continuous	JJ	O
supply	NN	O
of	IN	O
nurse	JJ	O
cells	NNS	O
to	TO	O
support	VB	O
the	DT	O
efficiency	NN	O
of	IN	O
oogenesis	NN	O

of	IN	I-Var
rad51	VBP	B-Gene
leads	VBZ	B-Reg
Fanconi	NNP	B-Disease
anemia	SYM	I-Disease
-	:	I-Disease
like	IN	I-Disease
symptoms	NNS	I-Disease

Fanconi	NNP	B-Disease
anemia	NN	I-Disease
FA	NNP	O
is	VBZ	O
a	DT	O
hereditary	JJ	O
DNA	NNP	O
-	:	O
repair	NN	O
disorder	NN	O
characterized	VBN	O
by	IN	O
various	JJ	O
congenital	JJ	O
abnormalities	NNS	O
,	,	O
progressive	JJ	O
bone	NN	O
marrow	NN	O
failure	NN	O
,	,	O
and	CC	O
cancer	NN	O
predisposition	NN	O
.	.	O

In	IN	O
this	DT	O
report	NN	O
,	,	O
we	PRP	O
describe	VBP	O
a	DT	O
viable	JJ	O
vertebrate	NN	O
model	NN	O
of	IN	O
RAD51	NNP	O
loss	NN	O
.	.	O

Zebrafish	JJ	O
rad51	NN	B-Gene
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutants	NNS	B-Var
developed	VBD	O
key	JJ	O
features	NNS	O
of	IN	O
FA	NNP	B-Disease
,	,	O
including	VBG	O
hypocellular	JJ	O
kidney	NN	O
marrow	NN	O
,	,	O
sensitivity	NN	O
to	TO	O
cross	VB	O
-	:	O
linking	VBG	O
agents	NNS	O
,	,	O
and	CC	O
decreased	VBD	O
size	NN	O
.	.	O
We	PRP	O
show	VBP	O
that	IN	O
some	DT	O
of	IN	O
these	DT	O
symptoms	NNS	O
stem	NN	O
from	IN	O
both	DT	O
decreased	VBN	O
proliferation	NN	O
and	CC	O
increased	VBD	O
apoptosis	NN	O
of	IN	O
embryonic	JJ	O
hematopoietic	JJ	O
stem	NN	O
and	CC	O
progenitor	NN	O
cells	NNS	O
.	.	O

Comutation	NN	O
of	IN	O
p53	NN	O
was	VBD	O
able	JJ	O
to	TO	O
rescue	VB	O
the	DT	O
hematopoietic	JJ	O
defects	NNS	O
seen	VBN	O
in	IN	O
the	DT	O
single	JJ	O
mutants	NNS	O
,	,	O
but	CC	O
led	VBD	O
to	TO	O
tumor	VB	O
development	NN	O
.	.	O

We	PRP	O
further	VBP	O
demonstrate	VB	O
that	IN	O
prolonged	JJ	O
inflammatory	JJ	O
stress	NN	O
can	MD	O
exacerbate	VB	O
the	DT	O
hematological	JJ	O
impairment	NN	O
,	,	O
leading	VBG	O
to	TO	O
an	DT	O
additional	JJ	O
decrease	NN	O
in	IN	O
kidney	NN	O
marrow	NN	O
cell	NN	O
numbers	NNS	O
.	.	O

These	DT	O
findings	NNS	O
strengthen	VBP	O
the	DT	O
assignment	NN	O
of	IN	O
RAD51	NNP	O
as	IN	O
a	DT	O
Fanconi	NNP	O
gene	NN	O
and	CC	O
provide	VB	O
more	JJR	O
evidence	NN	O
for	IN	O
the	DT	O
notion	NN	O
that	WDT	O
aberrant	JJ	O
p53	NN	O
signaling	VBG	O
during	IN	O
embryogenesis	NN	O
leads	VBZ	O
to	TO	O
the	DT	O
hematological	JJ	O
defects	NNS	O
seen	VBN	O
later	RB	O
in	IN	O
life	NN	O
in	IN	O
FA	NNP	O
.	.	O

Further	RB	O
research	NN	O
on	IN	O
this	DT	O
zebrafish	JJ	O
FA	NNP	O
model	NN	O
will	MD	O
lead	VB	O
to	TO	O
a	DT	O
deeper	JJR	O
understanding	NN	O
of	IN	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
bone	NN	O
marrow	NN	O
failure	NN	O
in	IN	O
FA	NNP	O
and	CC	O
the	DT	O
cellular	JJ	O
role	NN	O
of	IN	O
RAD51	NNP	O


TRPV1	NNP	B-Gene
Leu206Stop	NNP	B-Var
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg

Capsaicin	NNP	B-MPA
-	:	I-MPA
induced	VBD	I-MPA
[	JJ	I-MPA
Ca2	NNP	I-MPA
]	NNP	I-MPA
i	NN	I-MPA
changes	NNS	O
in	IN	O
small	JJ	O
diameter	NN	O
DRG	NNP	B-CPA
neurons	NNS	I-CPA
were	VBD	O
significantly	RB	O
diminished	VBN	B-NegReg
in	IN	O
TRPV1	NNP	B-Gene
Leu206Stop	NNP	B-Var
mice	NN	O
and	CC	O
administration	NN	O
of	IN	O
capsaicin	NN	O
induced	VBN	O
neither	CC	O
hypothermia	JJ	O
nor	CC	O
nocifensive	JJ	O
behaviour	NN	O
in	IN	O
vivo	NN	O
.	.	O
TRPV1	NNP	O
Leu206Stop	NNP	O
mice	NN	O
were	VBD	O
tested	VBN	O
in	IN	O
the	DT	O
spinal	JJ	O
nerve	NN	O
ligation	NN	O
of	IN	O
mononeuropathic	JJ	O
pain	NN	O
and	CC	O
developed	VBD	O
mechanical	JJ	O
hypersensitivity	NN	O
two	CD	O
weeks	NNS	O
after	IN	O
nerve	JJ	O
injury	NN	O
.	.	O

In	IN	O
the	DT	O
open	JJ	O
field	NN	O
test	NN	O
,	,	O
a	DT	O
significant	JJ	O
increase	NN	B-PosReg
in	IN	O
spontaneous	JJ	B-CPA
locomotion	NN	I-CPA
was	VBD	O
detected	VBN	O
in	IN	O
TRPV1	NNP	B-Gene
Leu206Stop	NNP	B-Var
mice	NN	O
as	RB	O
compared	VBN	O
to	TO	O
wildtype	VB	O
controls	NNS	O
.	.	O
TRPV1	NNP	O
knockout	NN	O
mice	NNS	O
have	VBP	O
been	VBN	O
reported	VBN	O
to	TO	O
carry	VB	O
a	DT	O
similar	JJ	O
phenotype	NN	O
regarding	VBG	O
capsaicin	SYM	O
-	:	O
evoked	JJ	O
responses	NNS	O
in	IN	O
vitro	NN	O
and	CC	O
in	IN	O
vivo	NN	O
.	.	O

However	RB	O
,	,	O
in	IN	O
contrast	NN	O
to	TO	O
TRPV1	NNP	O
Leu206Stop	NNP	O
mice	NN	O
,	,	O
TRPV1	NNP	O
knockout	IN	O
mice	RB	O
did	VBD	O
not	RB	O
differ	VB	O
in	IN	O
spontaneous	JJ	O
locomotion	NN	O
as	IN	O
compared	VBN	O
to	TO	O
congenic	VB	O
C57BL	NNP	O
6	CD	O
mice	NN	O
,	,	O
suggesting	VBG	O
subtle	JJ	O
ENU	NNP	O
-	:	O
dependent	NN	O
or	CC	O
independent	JJ	O
strain	NN	O
differences	NNS	O
between	IN	O
TRPV1	NNP	O
Leu206Stop	NNP	O
mice	NN	O
and	CC	O
their	PRP$	O
wildtype	NN	O
controls	NNS	O
.	.	O

In	IN	O
summary	JJ	O
,	,	O
these	DT	O
data	NNS	O
revealed	VBD	O
a	DT	O
target	NN	O
-	:	O
related	JJ	O
(	(	O
i	JJ	O
.	.	O
e	NN	O
.	.	O

capsaicin	SYM	O
-	:	O
evoked	VBN	O
)	)	O
phenotype	NN	O
of	IN	O
TRPV1	NNP	O
Leu206Stop	NNP	O
mice	NN	O
closely	RB	O
resembling	VBG	O
that	IN	O
of	IN	O
published	VBN	O
TRPV1	NNP	O
knockout	NN	O
mice	NN	O
.	.	O

However	RB	O
,	,	O
since	IN	O
ENU	NNP	O
-	:	O
mutant	JJ	O
mice	NN	O
are	VBP	O
congenic	JJ	O
with	IN	O
the	DT	O
mouse	NN	O
strain	NN	O
initially	RB	O
used	VBN	O
in	IN	O
random	JJ	O
mutagenesis	NN	O
,	,	O
direct	JJ	O
phenotypic	NN	O
comparison	NN	O
with	IN	O
the	DT	O
respective	JJ	O
wildtype	NN	O
controls	NNS	O
is	VBZ	O
possible	JJ	O
,	,	O
and	CC	O
the	DT	O
time	NN	O
-	:	O
consuming	VBG	O
backcrossing	NN	O
in	IN	O
lines	NNS	O
with	IN	O
targeted	JJ	O
mutations	NNS	O
is	VBZ	O
avoided	VBN	O

mutation	NN	I-Gene
causes	VBZ	I-Var
ectodermal	JJ	I-Reg
dysplasia	NN	I-Disease
impairing	VBG	B-NegReg
progenitor	NN	B-CPA
cell	NN	I-CPA
proliferation	NN	I-CPA
KLF4	NNP	B-CPA
-	:	I-CPA
mediated	VBN	I-CPA
differentiation	NN	I-CPA
Human	NNP	O
WNT10A	NNP	O
mutations	NNS	O
are	VBP	O
associated	VBN	O
with	IN	O
developmental	JJ	O
tooth	NN	O
abnormalities	NNS	O
and	CC	O
adolescent	JJ	O
onset	NN	O
of	IN	O
a	DT	O
broad	JJ	O
range	NN	O
of	IN	O
ectodermal	JJ	O
defects	NNS	O
.	.	O

Here	RB	O
we	PRP	O
show	VBP	O
that	IN	O
-	:	O
catenin	NN	O
pathway	NN	O
activity	NN	O
and	CC	O
adult	NN	O
epithelial	JJ	O
progenitor	NN	O
proliferation	NN	O
are	VBP	O
reduced	VBN	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
WNT10A	NNP	O
,	,	O
and	CC	O
identify	VB	O
Wnt	NNP	O
-	:	O
active	JJ	O
self	NN	O
-	:	O
renewing	VBG	O
stem	NN	O
cells	NNS	O
in	IN	O
affected	JJ	O
tissues	NNS	O
including	VBG	O
hair	NN	O
follicles	NNS	O
,	,	O
sebaceous	JJ	O
glands	NNS	O
,	,	O
taste	NN	O
buds	NNS	O
,	,	O
nails	NNS	O
and	CC	O
sweat	NN	O
ducts	NNS	O
.	.	O

Human	NNP	O
and	CC	O
mouse	VB	O
WNT10A	NNP	O
mutant	JJ	O
palmoplantar	NN	O
and	CC	O
tongue	NN	O
epithelia	NNS	O
also	RB	O
display	VBP	O
specific	JJ	O
differentiation	NN	O
defects	NNS	O
that	WDT	O
are	VBP	O
mimicked	VBN	O
by	IN	O
loss	NN	O
of	IN	O
the	DT	O
transcription	NN	O
factor	NN	O
KLF4	NNP	O
.	.	O

We	PRP	O
find	VBP	O
that	IN	O
-	:	O
catenin	NN	O
interacts	NNS	O
directly	RB	O
with	IN	O
region	NN	O
-	:	O
specific	JJ	O
LEF	NNP	O
TCF	NNP	O
factors	NNS	O
,	,	O
and	CC	O
with	IN	O
KLF4	NNP	O
in	IN	O
differentiating	NN	O
,	,	O
but	CC	O
not	RB	O
proliferating	JJ	O
,	,	O
cells	NNS	O
to	TO	O
promote	VB	O
expression	NN	O
of	IN	O
specialized	JJ	O
keratins	NNS	O
required	VBN	O
for	IN	O
normal	JJ	O
tissue	NN	O
structure	NN	O
and	CC	O
integrity	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
identify	VB	O
WNT10A	NNP	O
as	IN	O
a	DT	O
critical	JJ	O
ligand	NN	O
controlling	VBG	O
adult	NN	O
epithelial	JJ	O
proliferation	NN	O
and	CC	O
region	NN	O
-	:	O
specific	JJ	O
differentiation	NN	O
,	,	O
and	CC	O
suggest	JJS	O
downstream	NN	O
-	:	O
catenin	NN	O
pathway	NN	O
activation	NN	O
as	IN	O
a	DT	O
potential	JJ	O
approach	NN	O
to	TO	O
ameliorate	VB	O
regenerative	JJ	O
defects	NNS	O
in	IN	O
WNT10A	NNP	O
patients	NNS	O


Kabuki	NNP	B-Disease
syndrome	NN	I-Disease
loss	NN	B-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
variants	NNS	B-Var
We	PRP	O
performed	VBD	O
targeted	VBN	O
sequencing	NN	O
in	IN	O
a	DT	O
cohort	NN	O
of	IN	O
27	CD	O
probands	NNS	O
with	IN	O
a	DT	O
clinical	JJ	O
diagnosis	NN	O
of	IN	O
Kabuki	NNP	O
syndrome	NN	O
.	.	O

Of	IN	O
these	DT	O
,	,	O
12	CD	O
had	VBD	O
causative	JJ	O
variants	NNS	O
in	IN	O
the	DT	O
two	CD	O
known	VBN	O
Kabuki	NNP	O
syndrome	JJ	O
genes	NNS	O
.	.	O

In	IN	O
2	CD	O
,	,	O
we	PRP	O
identified	VBD	O
presumptive	JJ	O
loss	NN	O
of	IN	O
function	NN	O
de	IN	O
novo	FW	O
variants	NNS	B-Var
in	IN	O
KMT2A	NNP	B-Gene
(	(	O
missense	NN	O
and	CC	O
splice	NN	O
site	NN	O
variants	NNS	O
)	)	O
,	,	O
a	DT	O
gene	NN	O
that	WDT	O
encodes	VBZ	O
another	DT	O
histone	NN	O
modifying	VBG	O
enzyme	CC	O
previously	RB	O
exclusively	RB	O
associated	VBN	B-Reg
with	IN	O
Wiedermann	NNP	B-Disease
-	:	I-Disease
Steiner	NNP	I-Disease
syndrome	NN	I-Disease
.	.	O
Although	IN	O
Kabuki	NNP	O
syndrome	NN	O
is	VBZ	O
a	DT	O
disorder	NN	O
of	IN	O
histone	NN	O
modification	NN	O
,	,	O
we	PRP	O
also	RB	O
find	VBP	O
alterations	NNS	O
in	IN	O
DNA	NNP	O
methylation	NN	O
among	IN	O
individuals	NNS	O
with	IN	O
a	DT	O
Kabuki	NNP	O
syndrome	JJ	O
diagnosis	NN	O
relative	NN	O
to	TO	O
matched	VB	O
normal	JJ	O
controls	NNS	O
,	,	O
regardless	RB	O
of	IN	O
whether	IN	O
they	PRP	O
carry	VBP	O
a	DT	O
variant	NN	O
in	IN	O
KMT2A	NNP	O
or	CC	O
KMT2D	NNP	O
or	CC	O
not	RB	O
.	.	O

Furthermore	RB	O
,	,	O
we	PRP	O
observed	VBD	O
characteristic	JJ	O
global	JJ	O
abnormalities	NNS	O
of	IN	O
DNA	NNP	O
methylation	NN	O
that	WDT	O
distinguished	VBD	O
patients	NNS	O
with	IN	O
a	DT	O
loss	NN	O
of	IN	O
function	NN	O
variant	NN	O
in	IN	O
KMT2D	NNP	O
or	CC	O
missense	NN	O
or	CC	O
splice	NN	O
site	NN	O
variants	NNS	O
in	IN	O
either	DT	O
KMT2D	NNP	O
or	CC	O
KMT2A	NNP	O
from	IN	O
normal	JJ	O
controls	NNS	O
.	.	O

Our	PRP$	O
results	NNS	O
provide	VBP	O
new	JJ	O
insights	NNS	O
into	IN	O
the	DT	O
relationship	NN	O
of	IN	O
genotype	NN	O
to	TO	O
epigenotype	VB	O
and	CC	O
phenotype	VB	O
and	CC	O
indicate	VB	O
cross	NN	O
-	:	O
talk	NN	O
between	IN	O
histone	NN	O
and	CC	O
DNA	NNP	O
methylation	NN	O
machineries	NNS	O
exposed	VBN	O
by	IN	O
inborn	JJ	O
errors	NNS	O
of	IN	O
the	DT	O
epigenetic	JJ	O
apparatus	NN	O


N	NNP	O
-	:	O
cadherin	NN	O
inhibits	VBZ	O
osteogenic	JJ	O
cell	NN	O
differentiation	NN	O
and	CC	O
canonical	JJ	O
Wnt	NNP	O
-	:	O
catenin	NN	O
signaling	VBG	O
in	IN	O
vitro	NN	O
.	.	O

However	RB	O
,	,	O
in	IN	O
vivo	JJ	O
both	DT	O
conditional	JJ	O
Cdh2	NNP	O
ablation	NN	O
and	CC	O
overexpression	NN	O
in	IN	O
osteoblasts	NNS	O
lead	VBP	O
to	TO	O
low	JJ	O
bone	NN	O
mass	NN	O
.	.	O

We	PRP	O
tested	VBD	O
the	DT	O
hypothesis	NN	O
that	WDT	O
N	NNP	O
-	:	O
cadherin	NN	O
has	VBZ	O
different	JJ	O
effects	NNS	O
on	IN	O
osteolineage	NN	O
cells	NNS	O
depending	VBG	O
upon	IN	O
their	PRP$	O
differentiation	NN	O
stage	NN	O
.	.	O

Embryonic	JJ	O
conditional	JJ	O
osteolineage	NN	O
Cdh2	NNP	B-Gene
deletion	NN	B-Var
in	IN	O
mice	JJ	O
results	NNS	O
in	IN	O
defective	JJ	B-NegReg
growth	NN	B-MPA
,	,	O
low	JJ	B-NegReg
bone	NN	B-MPA
mass	NN	I-MPA
,	,	O
and	CC	O
reduced	JJ	B-NegReg
osteoprogenitor	NN	B-MPA
number	NN	I-MPA
.	.	O
These	DT	O
abnormalities	NNS	O
are	VBP	O
prevented	VBN	O
by	IN	O
delaying	VBG	O
Cdh2	NNP	O
ablation	NN	O
until	IN	O
1	CD	O
month	NN	O
of	IN	O
age	NN	O
,	,	O
thus	RB	O
targeting	VBG	O
only	RB	O
committed	VBN	O
and	CC	O
mature	JJ	O
osteoblasts	NNS	O
,	,	O
suggesting	VBG	O
they	PRP	O
are	VBP	O
the	DT	O
consequence	NN	O
of	IN	O
N	NNP	O
-	:	O
cadherin	NN	O
deficiency	NN	O
in	IN	O
osteoprogenitors	NNS	O
.	.	O

Indeed	RB	O
,	,	O
diaphyseal	JJ	O
trabecularization	NN	O
actually	RB	O
increases	VBZ	O
when	WRB	O
Cdh2	NNP	O
is	VBZ	O
ablated	VBN	O
postnatally	RB	O
.	.	O

The	DT	O
sclerostin	NN	O
-	:	O
insensitive	JJ	O
Lrp5	NNP	O
(	(	O
A214V	NNP	O
)	)	O
mutant	NN	O
,	,	O
associated	VBN	O
with	IN	O
high	JJ	O
bone	NN	O
mass	NN	O
,	,	O
does	VBZ	O
not	RB	O
rescue	VB	O
the	DT	O
growth	NN	O
defect	NN	O
,	,	O
but	CC	O
it	PRP	O
overrides	VBZ	O
the	DT	O
low	JJ	O
bone	NN	O
mass	NN	O
of	IN	O
embryonically	RB	O
Cdh2	NNP	O
-	:	O
deleted	JJ	O
mice	NN	O
,	,	O
suggesting	VBG	O
N	NNP	O
-	:	O
cadherin	NN	O
interacts	NNS	O
with	IN	O
Wnt	NNP	O
signaling	VBG	O
to	TO	O
control	VB	O
bone	JJ	O
mass	NN	O
.	.	O

Finally	RB	O
,	,	O
bone	NN	O
accrual	JJ	O
and	CC	O
-	:	O
catenin	NN	O
accumulation	NN	O
after	IN	O
administration	NN	O
of	IN	O
an	DT	O
anti	JJ	O
-	:	O
Dkk1	NN	O
antibody	NN	O
are	VBP	O
enhanced	VBN	O
in	IN	O
N	NNP	O
-	:	O
cadherin	NN	O
-	:	O
deficient	NN	O
mice	NN	O
.	.	O

Thus	RB	O
,	,	O
although	IN	O
lack	NN	O
of	IN	O
N	NNP	O
-	:	O
cadherin	NN	O
in	IN	O
embryonic	JJ	O
and	CC	O
perinatal	JJ	O
age	NN	O
is	VBZ	O
detrimental	JJ	O
to	TO	O
bone	VB	O
growth	NN	O
and	CC	O
bone	NN	O
accrual	JJ	O
,	,	O
in	IN	O
adult	JJ	O
mice	JJ	O
loss	NN	O
of	IN	O
N	NNP	O
-	:	O
cadherin	NN	O
in	IN	O
osteolineage	NN	O
cells	NNS	O
favors	VBZ	O
bone	CD	O
formation	NN	O
.	.	O

Hence	NNP	O
,	,	O
N	NNP	O
-	:	O
cadherin	NN	O
inhibition	NN	O
may	MD	O
widen	VB	O
the	DT	O
therapeutic	JJ	O
window	NN	O
of	IN	O
osteoanabolic	JJ	O
agents	NNS	O
.	.	O

2017	CD	O
American	JJ	O
Society	NNP	O
for	IN	O
Bone	NNP	O
and	CC	O
Mineral	NNP	O
Research	NNP	O




In	IN	O
the	DT	O
present	JJ	O
study	NN	O
,	,	O
we	PRP	O
comprehensively	RB	O
examined	VBD	O
the	DT	O
functions	NNS	O
of	IN	O
CES1	NNP	O
nonsynonymous	JJ	O
single	JJ	O
nucleotide	NN	O
polymorphisms	NN	O
(	(	O
nsSNPs	JJ	O
)	)	O
and	CC	O
haplotypes	VBZ	O
using	VBG	O
transfected	VBN	O
cell	NN	O
lines	NNS	O
and	CC	O
individual	JJ	O
human	JJ	O
liver	NN	O
tissues	NNS	O
.	.	O

The	DT	O
20	CD	O
candidate	NN	O
variants	NNS	O
include	VBP	O
CES1	NNP	O
nsSNPs	FW	O
with	IN	O
a	DT	O
minor	JJ	O
allele	NN	O
frequency	NN	O
(	(	O
MAF	NNP	O
)	)	O
0.5%	CD	O
in	IN	O
a	DT	O
given	VBN	O
population	NN	O
or	CC	O
located	VBN	O
in	IN	O
close	JJ	O
proximity	NN	O
to	TO	O
the	DT	O
CES1	NNP	O
active	JJ	O
site	NN	O
.	.	O

Five	CD	O
nsSNPs	JJ	O
including	VBG	O
L40Ter	NNP	O
(	(	O
rs151291296	NN	B-Var
)	)	O
,	,	O
G142E	NNP	O
(	(	O
rs121912777	NN	B-Var
)	)	O
,	,	O
G147C	NNP	O
(	(	O
rs146456965	NN	B-Var
)	)	O
,	,	O
Y170D	NNP	O
(	(	O
rs148947808	NN	B-Var
)	)	O
,	,	O
and	CC	O
R171C	NNP	O
(	(	O
rs201065375	NN	B-Var
)	)	O
were	VBD	O
found	VBN	O
to	TO	O
be	VB	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
variants	NNS	O
for	IN	O
metabolizing	VBG	B-MPA
the	DT	O
CES1	NNP	B-Enzyme
substrates	VBZ	O
clopidogrel	NN	O
,	,	O
enalapril	NN	O
,	,	O
and	CC	O
sacubitril	NN	O
.	.	O
Additionally	RB	O
,	,	O
the	DT	O
A158V	NNP	O
(	(	O
rs202121317	NN	B-Var
)	)	O
,	,	O
R199H	NNP	O
(	(	O
rs2307243	NN	B-Var
)	)	O
,	,	O
E220G	NNP	O
(	(	O
rs200707504	NN	B-Var
)	)	O
,	,	O
and	CC	O
T290M	NNP	O
(	(	O
rs202001817	NN	B-Var
)	)	O
decreased	VBD	B-NegReg
CES1	NNP	B-Enzyme
activity	NN	B-MPA
to	TO	O
a	DT	O
lesser	JJR	O
extent	NN	O
in	IN	O
a	DT	O
substrate	JJ	O
-	:	O
dependent	JJ	O
manner	NN	O
.	.	O
Several	JJ	O
nsSNPs	NNS	O
including	VBG	O
the	DT	O
L40Ter	NNP	O
(	(	O
rs151291296	NN	B-Var
)	)	O
,	,	O
G147C	NNP	O
(	(	O
rs146456965	NN	B-Var
)	)	O
,	,	O
Y170D	NNP	O
(	(	O
rs148947808	NN	B-Var
)	)	O
,	,	O
and	CC	O
R171C	NNP	O
(	(	O
rs201065375	NN	B-Var
)	)	O
significantly	RB	O
reduced	VBN	B-NegReg
CES1	NNP	B-Protein
protein	NN	I-Protein
and	CC	O
or	CC	O
mRNA	JJ	B-MPA
expressions	NNS	I-MPA
in	IN	O
the	DT	O
transfected	JJ	O
cells	NNS	O
.	.	O
Functions	NNS	O
of	IN	O
the	DT	O
common	JJ	O
nonsynonymous	JJ	O
haplotypes	NNS	O
D203E	NNP	O
-	:	O
A269S	NNP	O
and	CC	O
S75N	NNP	O
-	:	O
D203E	NNP	O
-	:	O
A269S	NNP	O
were	VBD	O
evaluated	VBN	O
using	VBG	O
cells	NNS	O
stably	RB	O
expressing	VBG	O
the	DT	O
haplotypes	NNS	O
and	CC	O
a	DT	O
large	JJ	O
set	NN	O
of	IN	O
human	JJ	O
livers	NNS	O
.	.	O

Neither	DT	O
CES1	NNP	O
expression	NN	O
nor	CC	O
activity	NN	O
were	VBD	O
affected	VBN	O
by	IN	O
the	DT	O
two	CD	O
haplotypes	NNS	O
.	.	O

In	IN	O
sum	NN	O
,	,	O
the	DT	O
study	NN	O
revealed	VBD	O
several	JJ	O
functional	JJ	O
nsSNPs	NN	O
with	IN	O
impaired	JJ	O
activity	NN	O
on	IN	O
the	DT	O
metabolism	NN	O
of	IN	O
CES1	NNP	O
substrate	NN	O
drugs	NNS	O
.	.	O

Clinical	JJ	O
investigations	NNS	O
are	VBP	O
warranted	VBN	O
to	TO	O
determine	VB	O
whether	IN	O
these	DT	O
nsSNPs	NNS	O
can	MD	O
serve	VB	O
as	IN	O
biomarkers	NNS	O
for	IN	O
the	DT	O
prediction	NN	O
of	IN	O
therapeutic	JJ	O
outcomes	NNS	O
of	IN	O
drugs	NNS	O
metabolized	VBN	O
by	IN	O
CES1	NNP	O


variations	NNS	B-Var
TREM2	NNP	B-Gene
linked	VBN	B-Reg
to	TO	I-Reg
Alzheimer	NNP	B-Disease
's	POS	I-Disease
disease	NN	I-Disease
frontotemporal	JJ	B-Disease
lobar	NN	I-Disease
degeneration	NN	I-Disease

Several	JJ	O
disease	NN	O
-	:	O
associated	VBN	O
TREM2	NNP	B-Gene
variants	NNS	B-Var
result	VBP	O
in	IN	O
a	DT	O
loss	NN	O
of	IN	O
function	NN	O
by	IN	O
reducing	VBG	B-NegReg
microglial	JJ	B-CPA
phagocytosis	NN	I-CPA
,	,	O
impairing	VBG	B-NegReg
lipid	JJ	B-MPA
sensing	NN	I-MPA
,	,	O
preventing	VBG	B-NegReg
binding	NN	B-Interaction
of	IN	O
lipoproteins	NNS	B-Protein
and	CC	O
affecting	VBG	B-Reg
shielding	NN	B-MPA
of	IN	I-MPA
amyloid	JJ	I-MPA
plaques	NNS	I-MPA
.	.	O
We	PRP	O
here	RB	O
investigate	VBP	O
the	DT	O
consequences	NNS	O
of	IN	O
TREM2	NNP	O
loss	NN	O
of	IN	O
function	NN	O
on	IN	O
the	DT	O
microglia	JJ	O
transcriptome	NN	O
.	.	O

Among	IN	O
the	DT	O
differentially	RB	O
expressed	VBN	O
messenger	NN	O
RNAs	NNP	O
in	IN	O
wild	JJ	O
-	:	O
type	NN	O
and	CC	O
Trem2	NNP	O
(-	JJ	O
-)	NNP	O
microglia	NN	O
,	,	O
gene	NN	O
clusters	NNS	O
are	VBP	O
identified	VBN	O
which	WDT	O
represent	VBP	O
gene	NN	O
functions	NNS	O
in	IN	O
chemotaxis	NN	O
,	,	O
migration	NN	O
and	CC	O
mobility	NN	O
.	.	O

Functional	JJ	O
analyses	NNS	O
confirm	VBP	O
that	IN	O
loss	NN	B-Var
of	IN	O
TREM2	NNP	B-Gene
impairs	NNS	B-NegReg
appropriate	VBP	O
microglial	JJ	B-CPA
responses	NNS	I-CPA
to	TO	I-CPA
injury	VB	I-CPA
and	CC	I-CPA
signals	NNS	I-CPA
that	WDT	O
normally	RB	O
evoke	VBP	O
chemotaxis	NNS	O
on	IN	O
multiple	JJ	O
levels	NNS	O
.	.	O
In	IN	O
an	DT	O
ex	NN	O
vivo	NN	O
organotypic	NN	O
brain	NN	O
slice	NN	O
assay	NN	O
,	,	O
absence	NN	O
of	IN	O
TREM2	NNP	O
reduces	VBZ	O
the	DT	O
distance	NN	O
migrated	VBN	O
by	IN	O
microglia	NNS	O
.	.	O

Moreover	RB	O
,	,	O
migration	NN	O
towards	NNS	O
defined	VBD	O
chemo	SYM	O
-	:	O
attractants	NNS	O
is	VBZ	O
reduced	VBN	O
upon	IN	O
ablation	NN	O
of	IN	O
TREM2	NNP	O
and	CC	O
can	MD	O
be	VB	O
rescued	VBN	O
by	IN	O
TREM2	NNP	O
re	SYM	O
-	:	O
expression	NN	O
.	.	O

In	IN	O
vivo	NN	O
,	,	O
microglia	FW	O
lacking	VBG	O
TREM2	NNP	O
migrate	NN	O
less	RBR	O
towards	NNS	O
injected	VBN	O
apoptotic	JJ	O
neurons	NNS	O
,	,	O
and	CC	O
outgrowth	NN	O
of	IN	O
microglial	JJ	O
processes	NNS	O
towards	VBP	O
sites	NNS	O
of	IN	O
laser	NN	O
-	:	O
induced	JJ	O
focal	JJ	O
CNS	NNP	O
damage	NN	O
in	IN	O
the	DT	O
somatosensory	NN	O
cortex	NN	O
is	VBZ	O
slowed	VBN	O
.	.	O

The	DT	O
apparent	JJ	O
lack	NN	O
of	IN	O
chemotactic	JJ	O
stimulation	NN	O
upon	IN	O
depletion	NN	O
of	IN	O
TREM2	NNP	O
is	VBZ	O
consistent	JJ	O
with	IN	O
a	DT	O
stable	JJ	O
expression	NN	O
profile	NN	O
of	IN	O
genes	NNS	O
characterizing	VBG	O
the	DT	O
homoeostatic	JJ	O
signature	NN	O
of	IN	O
microglia	NN	O


The	DT	O
nitrogen	NN	O
-	:	O
fixing	VBG	O
symbiosis	NN	O
of	IN	O
legumes	NNS	O
and	CC	O
Rhizobium	NNP	O
bacteria	NN	O
is	VBZ	O
established	VBN	O
by	IN	O
complex	JJ	O
interactions	NNS	O
between	IN	O
the	DT	O
two	CD	O
symbiotic	JJ	O
partners	NNS	O
.	.	O

Legume	NNP	O
Fix	NNP	O
-	:	O
mutants	NNS	O
form	VBP	O
apparently	RB	O
normal	JJ	O
nodules	NNS	O
with	IN	O
endosymbiotic	JJ	O
rhizobia	NNS	O
but	CC	O
fail	VBP	O
to	TO	O
induce	VB	O
rhizobial	JJ	O
nitrogen	NN	O
fixation	NN	O
.	.	O

These	DT	O
mutants	NNS	O
are	VBP	O
useful	JJ	O
for	IN	O
identifying	VBG	O
the	DT	O
legume	NN	O
genes	NNS	O
involved	VBN	O
in	IN	O
the	DT	O
interactions	NNS	O
essential	JJ	O
for	IN	O
symbiotic	JJ	O
nitrogen	NN	O
fixation	NN	O
.	.	O

We	PRP	O
describe	VBP	O
here	RB	O
a	DT	O
Fix	NNP	O
-	:	O
mutant	NN	O
of	IN	O
Lotus	NNP	O
japonicus	NN	O
,	,	O
apn1	NN	O
,	,	O
which	WDT	O
showed	VBD	O
a	DT	O
very	RB	O
specific	JJ	O
symbiotic	JJ	O
phenotype	NN	O
.	.	O

It	PRP	O
formed	VBD	O
ineffective	JJ	O
nodules	NNS	O
when	WRB	O
inoculated	VBN	O
with	IN	O
the	DT	O
Mesorhizobium	NNP	O
loti	NN	O
strain	NN	O
TONO	NNP	O
.	.	O

In	IN	O
these	DT	O
nodules	NNS	O
,	,	O
infected	JJ	O
cells	NNS	O
disintegrated	VBN	O
and	CC	O
successively	RB	O
became	VBD	O
necrotic	JJ	O
,	,	O
indicating	JJ	B-Reg
premature	NN	B-MPA
senescence	NN	I-MPA
typical	JJ	O
of	IN	O
Fix	NNP	B-Var
-	:	I-Var
mutants	NNS	I-Var
.	.	O
However	RB	O
,	,	O
it	PRP	O
formed	VBD	O
effective	JJ	O
nodules	NNS	O
when	WRB	O
inoculated	VBN	O
with	IN	O
the	DT	O
M.	NNP	O
loti	NN	O
strain	NN	O
MAFF303099	NNP	O
.	.	O

Among	IN	O
nine	CD	O
different	JJ	O
M.	NNP	O
loti	NN	O
strains	NNS	O
tested	VBN	O
,	,	O
four	CD	O
formed	VBD	O
ineffective	JJ	O
nodules	NNS	O
and	CC	O
five	CD	O
formed	VBN	O
effective	JJ	O
nodules	NNS	O
on	IN	O
apn1	JJ	O
roots	NNS	O
.	.	O

The	DT	O
identified	VBN	O
causal	NN	O
gene	NN	O
,	,	O
ASPARTIC	NNP	O
PEPTIDASE	NNP	O
NODULE	NNP	O
-	:	O
INDUCED	VBZ	O
1	CD	O
(	(	O
LjAPN1	NNP	O
)	)	O
,	,	O
encodes	VBZ	O
a	DT	O
nepenthesin	JJ	O
-	:	O
type	NN	O
aspartic	JJ	O
peptidase	NN	O
.	.	O

The	DT	O
well	NN	O
characterized	VBN	O
Arabidopsis	NNP	O
aspartic	JJ	O
peptidase	NN	O
CDR1	NNP	O
could	MD	O
complement	VB	O
the	DT	O
strain	NN	O
-	:	O
specific	JJ	O
Fix	NNP	O
-	:	O
phenotype	NN	O
of	IN	O
apn1	NN	O
.	.	O

LjAPN1	NNP	O
is	VBZ	O
a	DT	O
typical	JJ	O
late	JJ	O
nodulin	NN	O
;	:	O
its	PRP$	O
gene	NN	O
expression	NN	O
was	VBD	O
exclusively	RB	O
induced	JJ	O
during	IN	O
nodule	NN	O
development	NN	O
.	.	O

LjAPN1	NNP	O
was	VBD	O
most	JJS	O
abundantly	RB	O
expressed	VBN	O
in	IN	O
the	DT	O
infected	JJ	O
cells	NNS	O
in	IN	O
the	DT	O
nodules	NNS	O
.	.	O

Our	PRP$	O
findings	NNS	O
indicate	VBP	O
that	IN	O
LjAPN1	NNP	O
is	VBZ	O
required	VBN	O
for	IN	O
the	DT	O
development	NN	O
and	CC	O
persistence	NN	O
of	IN	O
functional	JJ	O
(	(	O
nitrogen	JJ	O
-	:	O
fixing	NN	O
)	)	O
symbiosis	NN	O
in	IN	O
a	DT	O
rhizobial	JJ	O
strain	NN	O
-	:	O
dependent	NN	O
manner	NN	O
,	,	O
and	CC	O
thus	RB	O
determines	NNS	O
compatibility	NN	O
between	IN	O
M.	NNP	O
loti	NN	O
and	CC	O
L.	NNP	O
japonicus	NN	O
at	IN	O
the	DT	O
level	NN	O
of	IN	O
nitrogen	JJ	O
fixation	NN	O




By	IN	O
sequencing	VBG	O
of	IN	O
genomic	JJ	O
GNPTAB	NNP	B-Gene
of	IN	O
the	DT	O
MLII	NNP	O
and	CC	O
MLIII	NNP	O
alpha	VBP	O
beta	NN	O
patients	NNS	O
we	PRP	O
identified	VBD	O
six	CD	O
novel	JJ	O
mutations	NNS	O
:	:	O
p	NN	B-Var
.	.	I-Var
D76G	NNP	I-Var
,	,	O
p	NN	B-Var
.	.	I-Var
S385L	NNP	I-Var
,	,	O
p	NN	B-Var
.	.	I-Var
Q278Kfs	NNP	I-Var
3	CD	I-Var
,	,	O
p	NN	B-Var
.	.	I-Var
H588Qfs	NNP	I-Var
27	CD	I-Var
,	,	O
p	NN	B-Var
.	.	I-Var
N642Lfs	CC	I-Var
10	CD	I-Var
and	CC	O
p	NN	B-Var
.	.	I-Var
Y1111	UH	I-Var
.	.	I-Var
Expression	NN	O
analysis	NN	O
by	IN	O
western	JJ	O
blotting	NN	O
and	CC	O
immunofluorescence	NN	O
microscopy	NN	O
revealed	VBD	O
that	IN	O
the	DT	O
mutant	JJ	O
-	:	O
subunit	NN	O
precursor	NN	O
p	NN	B-Var
.	.	I-Var
D76G	NNP	I-Var
is	VBZ	O
retained	VBN	O
in	IN	O
the	DT	O
endoplasmic	JJ	O
reticulum	NN	O
whereas	IN	O
the	DT	O
mutant	JJ	O
p	NN	B-Var
.	.	I-Var
S385L	NNP	I-Var
is	VBZ	O
correctly	RB	O
transported	VBN	O
to	TO	O
the	DT	O
cis	NN	O
-	:	O
Golgi	NNP	O
apparatus	NN	O
and	CC	O
proteolytically	RB	O
processed	VBN	O
.	.	O
Both	DT	O
mutations	NNS	O
lead	VBP	O
to	TO	O
complete	JJ	O
loss	NN	B-NegReg
of	IN	O
GlcNAc	NNP	B-Enzyme
-	:	I-Enzyme
1	CD	I-Enzyme
-	:	I-Enzyme
phosphotransferase	NN	I-Enzyme
activity	NN	B-MPA
,	,	O
consistent	NN	O
with	IN	O
the	DT	O
severe	JJ	O
clinical	JJ	O
MLII	NNP	O
phenotype	NN	O
of	IN	O
the	DT	O
patients	NNS	O
.	.	O
Our	PRP$	O
study	NN	O
expands	VBZ	O
the	DT	O
genotypic	NN	O
spectrum	NN	O
of	IN	O
MLII	NNP	O
and	CC	O
provides	VBZ	O
novel	JJ	O
insights	NNS	O
into	IN	O
structural	JJ	O
requirements	NNS	O
to	TO	O
ensure	VB	O
GlcNAc	NNP	O
-	:	O
1	CD	O
-	:	O
phosphotransferase	NN	O
activity	NN	O




We	PRP	O
previously	RB	O
demonstrated	VBD	O
that	IN	O
the	DT	O
MS	NNP	O
ion	NN	O
channel	NN	O
MscS	NNP	O
-	:	O
Like	IN	O
8	CD	O
(	(	O
MSL8	NNP	O
)	)	O
is	VBZ	O
required	VBN	O
for	IN	O
pollen	NN	O
to	TO	O
survive	VB	O
multiple	JJ	O
osmotic	JJ	O
challenges	NNS	O
that	WDT	O
occur	VBP	O
during	IN	O
the	DT	O
normal	JJ	O
process	NN	O
of	IN	O
fertilization	NN	O
,	,	O
and	CC	O
that	IN	O
it	PRP	O
can	MD	O
inhibit	VB	O
pollen	JJ	O
germination	NN	O
.	.	O

However	RB	O
,	,	O
it	PRP	O
remained	VBD	O
unclear	JJ	O
whether	IN	O
these	DT	O
physiological	JJ	O
functions	NNS	O
required	VBN	O
ion	NN	O
flux	NN	O
through	IN	O
a	DT	O
mechanically	RB	O
gated	JJ	O
channel	NNS	O
provided	VBN	O
by	IN	O
MSL8	NNP	O
.	.	O

We	PRP	O
introduced	VBD	O
two	CD	O
point	NN	O
mutations	NNS	B-Var
into	IN	O
the	DT	O
predicted	VBN	O
pore	IN	O
-	:	O
lining	VBG	O
domain	NN	O
of	IN	O
MSL8	NNP	B-Gene
that	WDT	O
disrupted	VBD	B-NegReg
normal	JJ	B-Pathway
channel	NN	I-Pathway
function	NN	I-Pathway
in	IN	O
different	JJ	O
ways	NNS	O
.	.	O
The	DT	O
Ile711Ser	NNP	B-Var
mutation	NN	I-Var
increased	VBD	B-PosReg
the	DT	O
tension	NN	B-MPA
threshold	NN	I-MPA
of	IN	O
the	DT	O
MSL8	NNP	B-Gene
channel	NN	O
while	IN	O
leaving	VBG	B-Reg
conductance	NN	B-MPA
unchanged	JJ	I-MPA
,	,	O
and	CC	O
the	DT	O
Phe720Leu	NNP	B-Var
mutation	NN	I-Var
severely	RB	O
disrupted	VBD	B-NegReg
the	DT	O
MSL8	NNP	B-Gene
channel	NN	B-Pathway
.	.	O
Both	DT	O
of	IN	O
these	DT	O
mutations	NNS	B-Var
impaired	VBD	B-NegReg
the	DT	O
ability	NN	B-MPA
of	IN	I-MPA
MSL8	NNP	I-MPA
to	TO	I-MPA
preserve	VB	I-MPA
pollen	JJ	I-MPA
viability	NN	I-MPA
during	IN	I-MPA
hydration	NN	I-MPA
and	CC	O
to	TO	O
maintain	VB	B-Reg
the	DT	O
integrity	NN	B-MPA
of	IN	I-MPA
the	DT	I-MPA
pollen	NN	I-MPA
tube	NN	I-MPA
when	WRB	O
expressed	VBN	O
at	IN	O
endogenous	JJ	O
levels	NNS	O
.	.	O
When	WRB	O
overexpressed	VBN	O
in	IN	O
an	DT	O
msl8	NN	O
-	:	O
4	CD	O
null	NN	O
background	NN	O
,	,	O
MSL8I711S	NNP	O
could	MD	O
partially	RB	O
rescue	VB	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
phenotypes	NNS	O
,	,	O
while	IN	O
MSL8F720L	NNP	O
could	MD	O
not	RB	O
.	.	O

When	WRB	O
overexpressed	VBN	O
in	IN	O
the	DT	O
wild	JJ	O
-	:	O
type	NN	O
Ler	NNP	O
background	NN	O
,	,	O
MSL8I711S	NNP	O
suppressed	VBD	O
pollen	JJ	O
germination	NN	O
,	,	O
similar	JJ	O
to	TO	O
wild	VB	O
-	:	O
type	NN	O
MSL8	NNP	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
MSL8F720L	NNP	O
failed	VBD	O
to	TO	O
suppress	VB	O
pollen	JJ	O
germination	NN	O
and	CC	O
increased	VBD	O
pollen	NN	O
bursting	NN	O
,	,	O
thereby	RB	O
phenocopying	VBG	O
the	DT	O
msl8	NN	O
-	:	O
4	CD	O
mutant	NN	O
.	.	O

Thus	RB	O
,	,	O
an	DT	O
intact	JJ	O
MSL8	NNP	O
channel	NN	O
is	VBZ	O
required	VBN	O
for	IN	O
normal	JJ	O
pollen	JJ	O
function	NN	O
during	IN	O
hydration	NN	O
and	CC	O
germination	NN	O
.	.	O

These	DT	O
data	NNS	O
establish	VB	O
MSL8	NNP	O
as	IN	O
the	DT	O
first	JJ	O
plant	NN	O
MS	NNP	O
channel	NN	O
to	TO	O
fulfill	VB	O
previously	RB	O
established	VBN	O
criteria	NNS	O
for	IN	O
assignment	NN	O
as	IN	O
a	DT	O
mechanotransducer	NN	O


Light	NNP	O
is	VBZ	O
an	DT	O
environmental	JJ	O
signal	NN	O
perceived	VBN	O
by	IN	O
most	JJS	O
eukaryotic	JJ	O
organisms	NNS	O
and	CC	O
that	IN	O
can	MD	O
have	VB	O
major	JJ	O
impacts	NNS	O
on	IN	O
their	PRP$	O
growth	NN	O
and	CC	O
development	NN	O
.	.	O

The	DT	O
MadC	NNP	O
protein	NN	O
in	IN	O
the	DT	O
fungus	NN	O
Phycomyces	NNP	O
blakesleeanus	NN	O
(	(	O
Mucoromycotina	NNP	O
)	)	O
has	VBZ	O
been	VBN	O
postulated	VBN	O
to	TO	O
form	VB	O
part	NN	O
of	IN	O
the	DT	O
photosensory	NN	O
input	NN	O
for	IN	O
phototropism	NN	O
of	IN	O
the	DT	O
fruiting	NN	O
body	NN	O
sporangiophores	NNS	O
,	,	O
but	CC	O
the	DT	O
madC	NN	O
gene	NN	O
has	VBZ	O
remained	VBN	O
unidentified	JJ	O
since	IN	O
the	DT	O
1960	CD	O
s	NN	O
when	WRB	O
madC	NN	O
mutants	NNS	O
were	VBD	O
first	RB	O
isolated	VBN	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
the	DT	O
madC	NN	O
gene	NN	O
was	VBD	O
identified	VBN	O
by	IN	O
positional	JJ	O
cloning	NN	O
.	.	O

All	DT	O
madC	RBS	O
mutant	JJ	O
strains	NNS	O
contain	VBP	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
point	NN	O
mutations	NNS	O
within	IN	O
a	DT	O
gene	NN	O
predicted	VBN	O
to	TO	O
encode	VB	O
a	DT	O
GTPase	NNP	O
activating	VBG	O
protein	NN	O
(	(	O
GAP	NNP	O
)	)	O
for	IN	O
Ras	NNP	O
.	.	O

The	DT	O
madC	NN	O
gene	NN	O
complements	VBZ	O
the	DT	O
Saccharomyces	NNPS	O
cerevisiae	NN	O
Ras	NNP	O
-	:	O
GAP	NNP	O
ira1	NN	O
mutant	NN	O
and	CC	O
the	DT	O
encoded	JJ	O
MadC	NNP	O
protein	NN	O
interacts	VBZ	O
with	IN	O
P.	NNP	O
blakesleeanus	NN	O
Ras	NNP	O
homologs	NNS	O
in	IN	O
yeast	NN	O
two	CD	O
-	:	O
hybrid	NN	O
assays	NNS	O
,	,	O
indicating	VBG	O
that	IN	O
MadC	NNP	O
is	VBZ	O
a	DT	O
regulator	NN	O
of	IN	O
Ras	NNP	O
signaling	VBG	O
.	.	O

Deletion	NN	B-Var
of	IN	O
the	DT	O
homolog	NN	O
in	IN	O
the	DT	O
filamentous	JJ	O
ascomycete	JJ	O
Neurospora	NNP	O
crassa	NN	O
affects	VBZ	B-Reg
the	DT	O
circadian	JJ	B-MPA
clock	NN	I-MPA
output	NN	I-MPA
,	,	O
yielding	VBG	B-Reg
a	DT	O
pattern	NN	O
of	IN	O
asexual	JJ	B-MPA
conidiation	NN	I-MPA
similar	JJ	O
to	TO	O
a	DT	O
ras	JJ	O
-	:	O
1	CD	O
mutant	NN	O
that	WDT	O
is	VBZ	O
used	VBN	O
in	IN	O
circadian	JJ	O
studies	NNS	O
in	IN	O
N.	NNP	O
crassa	NN	O
.	.	O
Thus	RB	O
,	,	O
MadC	NNP	O
is	VBZ	O
unlikely	JJ	O
to	TO	O
be	VB	O
a	DT	O
photosensor	NN	O
,	,	O
yet	RB	O
is	VBZ	O
a	DT	O
fundamental	JJ	O
link	NN	O
in	IN	O
the	DT	O
photoresponses	NNS	O
from	IN	O
blue	JJ	O
light	NN	O
perceived	VBN	O
by	IN	O
the	DT	O
conserved	JJ	O
White	NNP	O
Collar	NNP	O
complex	NN	O
with	IN	O
Ras	NNP	O
signaling	VBG	O
in	IN	O
two	CD	O
distantly	RB	O
-	:	O
related	VBN	O
filamentous	JJ	O
fungal	JJ	O
species	NNS	O

MLK4	NNP	B-Gene
Loss	NNP	B-NegReg
-	:	I-NegReg
-	:	I-NegReg
Function	NN	I-NegReg
Mutations	NNP	B-Var
Suppress	NNP	B-NegReg
Signaling	NNP	I-Pathway
Promote	VB	B-PosReg
Colon	NNP	B-Disease
Tumorigenesis	NNP	I-Disease


In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
assessed	VBD	O
the	DT	O
functional	JJ	O
consequences	NNS	O
of	IN	O
MLK4	NNP	O
mutations	NNS	O
in	IN	O
colon	NN	O
tumorigenesis	NN	O
.	.	O

Biochemical	NNP	O
data	NNS	O
indicated	VBD	O
that	IN	O
a	DT	O
majority	NN	O
of	IN	O
MLK4	NNP	B-Gene
mutations	NNS	B-Var
are	VBP	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
(	(	O
LOF	NNP	O
)	)	O
mutations	NNS	O
that	WDT	O
can	MD	O
exert	VB	O
dominant	JJ	O
-	:	O
negative	JJ	O
effects	NNS	O
.	.	O
In	IN	O
seeking	VBG	O
to	TO	O
understand	VB	O
the	DT	O
abrogated	JJ	O
activity	NN	O
of	IN	O
these	DT	O
mutants	NNS	O
,	,	O
we	PRP	O
elucidated	VBD	O
a	DT	O
new	JJ	O
MLK4	NNP	O
catalytic	JJ	O
domain	NN	O
structure	NN	O
.	.	O

To	TO	O
determine	VB	O
whether	IN	O
MLK4	NNP	O
is	VBZ	O
required	VBN	O
to	TO	O
maintain	VB	O
tumorigenic	JJ	O
phenotypes	NNS	O
,	,	O
we	PRP	O
reconstituted	VBD	O
its	PRP$	O
signaling	VBG	O
axis	NN	O
in	IN	O
colon	NN	O
cancer	NN	O
cells	NNS	O
harboring	VBG	O
MLK4	NNP	O
-	:	O
inactivating	NN	O
mutations	NNS	O
.	.	O

We	PRP	O
found	VBD	O
that	IN	O
restoring	VBG	O
MLK4	NNP	O
activity	NN	O
reduced	VBD	O
cell	NN	O
viability	NN	O
,	,	O
proliferation	NN	O
,	,	O
and	CC	O
colony	NN	O
formation	NN	O
in	IN	O
vitro	NN	O
and	CC	O
delayed	JJ	O
tumor	NN	O
growth	NN	O
in	IN	O
vivo	NN	O
.	.	O

Mechanistic	JJ	O
investigations	NNS	O
established	VBD	O
that	IN	O
restoring	VBG	O
the	DT	O
function	NN	O
of	IN	O
MLK4	NNP	O
selectively	RB	O
induced	VBD	O
the	DT	O
JNK	NNP	O
pathway	NN	O
and	CC	O
its	PRP$	O
downstream	NN	O
targets	NNS	O
,	,	O
cJUN	NN	O
,	,	O
ATF3	NNP	O
,	,	O
and	CC	O
the	DT	O
cyclin	NN	O
-	:	O
dependent	JJ	O
kinase	NN	O
inhibitors	NNS	O
CDKN1A	NNP	O
and	CC	O
CDKN2B	NNP	O
.	.	O

Our	PRP$	O
work	NN	O
indicates	VBZ	O
that	IN	O
MLK4	NNP	B-Gene
is	VBZ	O
a	DT	O
novel	JJ	O
tumor	NN	O
-	:	O
suppressing	VBG	O
kinase	NN	O
harboring	VBG	O
frequent	JJ	O
LOF	NNP	B-NegReg
mutations	NNS	B-Var
that	WDT	O
lead	VBP	O
to	TO	O
diminished	VB	B-NegReg
signaling	VBG	B-MPA
in	IN	O
the	DT	O
JNK	NNP	B-Pathway
pathway	NN	I-Pathway
and	CC	O
enhanced	JJ	B-PosReg
proliferation	NN	B-CPA
in	IN	O
colon	NN	O
cancer	NN	O
.	.	O
Cancer	NNP	O
Res	NNP	O
;	:	O
76	CD	O
(	(	O
3	CD	O
)	)	O
;	:	O
1	CD	O
-	:	O
12	CD	O
.	.	O

2015	CD	O
AACR	NNP	O




In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
reveal	VBP	O
that	IN	O
OsPRI1	NNP	O
interacts	VBZ	O
with	IN	O
OsHRZ1	NNP	O
.	.	O

A	DT	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutation	NN	B-Var
to	TO	O
OsPRI1	NNP	B-Gene
increased	VBD	B-PosReg
the	DT	O
sensitivity	NN	B-MPA
of	IN	I-MPA
plants	NNS	I-MPA
to	TO	I-MPA
Fe	NNP	I-MPA
-	:	I-MPA
deficient	NN	I-MPA
conditions	NNS	I-MPA
and	CC	O
downregulated	VBD	B-NegReg
the	DT	O
expression	NN	B-MPA
of	IN	I-MPA
Fe	NNP	I-MPA
-	:	I-MPA
deficiency	NN	I-MPA
-	:	I-MPA
responsive	JJ	I-MPA
genes	NNS	I-MPA
.	.	O
Yeast	NNP	O
one	CD	O
-	:	O
hybrid	NN	O
and	CC	O
electrophoretic	JJ	O
mobility	NN	O
shift	NN	O
assay	VBP	O
results	NNS	O
suggested	VBD	O
that	IN	O
OsPRI1	NNP	O
binds	VBZ	O
to	TO	O
the	DT	O
OsIRO2	NNP	O
and	CC	O
OsIRO3	NNP	O
promoters	NNS	O
.	.	O

In	IN	O
vitro	JJ	O
ubiquitination	NN	O
experiments	NNS	O
indicated	VBD	O
that	IN	O
OsPRI1	NNP	O
is	VBZ	O
ubiquitinated	VBN	O
by	IN	O
OsHRZ1	NNP	O
.	.	O

Cell	NNP	O
-	:	O
free	JJ	O
degradation	NN	O
assays	NNS	O
revealed	VBD	O
that	IN	O
the	DT	O
stability	NN	B-MPA
of	IN	O
OsPRI1	NNP	O
decreased	VBD	O
in	IN	O
wild	JJ	O
type	JJ	O
roots	NNS	O
,	,	O
but	CC	O
increased	VBD	B-PosReg
in	IN	O
the	DT	O
hrz1	NN	B-Gene
-	:	I-Gene
2	CD	I-Gene
mutant	NN	B-Var
,	,	O
suggesting	VBG	O
OsHRZ1	NNP	O
is	VBZ	O
responsible	JJ	O
for	IN	O
the	DT	O
instability	NN	O
of	IN	O
OsPRI1	NNP	O
.	.	O
The	DT	O
hrz1	NN	O
-	:	O
2	CD	O
seedlings	NNS	O
were	VBD	O
insensitive	JJ	O
to	TO	O
Fe	NNP	O
-	:	O
deficient	NN	O
conditions	NNS	O
.	.	O

When	WRB	O
the	DT	O
pri1	NN	B-Gene
-	:	I-Gene
1	CD	I-Gene
mutation	NN	B-Var
was	VBD	O
introduced	VBN	B-Interaction
into	IN	O
hrz1	JJ	B-Gene
-	:	I-Gene
2	CD	I-Gene
mutants	NNS	B-Var
,	,	O
the	DT	O
pri1hrz1	NN	O
double	JJ	O
mutant	NN	O
was	VBD	O
more	RBR	B-PosReg
sensitive	JJ	B-MPA
to	TO	I-MPA
Fe	NNP	I-MPA
deficiency	NN	I-MPA
than	IN	O
the	DT	O
hrz1	JJ	O
-	:	O
2	CD	O
mutant	NN	O
.	.	O
Additionally	RB	O
,	,	O
the	DT	O
expression	NN	O
levels	NNS	O
of	IN	O
Fe	NNP	O
-	:	O
deficiency	NN	O
-	:	O
responsive	JJ	O
genes	NNS	O
were	VBD	O
lower	JJR	O
in	IN	O
the	DT	O
hrz1pri1	NN	O
double	NN	O
mutant	NN	O
than	IN	O
in	IN	O
the	DT	O
hrz1	NN	O
-	:	O
2	CD	O
mutant	NN	O
.	.	O

Collectively	RB	O
,	,	O
these	DT	O
results	NNS	O
imply	VBP	O
that	IN	O
OsPRI1	NNP	O
,	,	O
which	WDT	O
is	VBZ	O
ubiquitinated	VBN	O
by	IN	O
OsHRZ1	NNP	O
,	,	O
mediates	VBZ	O
rice	NN	O
responses	NNS	O
to	TO	O
Fe	NNP	O
-	:	O
deficiency	NN	O
by	IN	O
positively	RB	O
regulating	VBG	O
OsIRO2	NNP	O
and	CC	O
OsIRO3	NNP	O
expression	NN	O
as	IN	O
part	NN	O
of	IN	O
the	DT	O
OsHRZ1	NNP	O
-	:	O
OsPRI1	NNP	O
-	:	O
OsIRO2	$	O
3	CD	O
signal	JJ	O
transduction	NN	O
cascade	NN	O



Previously	RB	O
we	PRP	O
have	VBP	O
found	VBN	O
that	IN	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
(	(	O
LOF	NNP	O
)	)	O
mutations	NNS	B-Var
in	IN	O
the	DT	O
Drosophila	NNP	B-Gene
gene	NN	I-Gene
blue	JJ	I-Gene
cheese	NN	I-Gene
(	(	O
bchs	NN	O
)	)	O
lead	NN	O
to	TO	O
reduced	VBN	B-NegReg
adult	NN	B-CPA
life	NN	I-CPA
span	NN	I-CPA
,	,	O
increased	VBD	B-PosReg
neuronal	JJ	B-CPA
death	NN	I-CPA
,	,	O
and	CC	O
widespread	JJ	B-CPA
CNS	NNP	I-CPA
degeneration	NN	B-NegReg
that	WDT	O
is	VBZ	O
associated	VBN	O
with	IN	O
the	DT	O
formation	NN	O
of	IN	O
ubiquitinated	JJ	O
-	:	O
protein	NN	O
aggregates	NNS	O
.	.	O
To	TO	O
identify	VB	O
potential	JJ	O
genes	NNS	O
that	WDT	O
participate	VBP	O
in	IN	O
the	DT	O
bchs	JJ	O
functional	JJ	O
pathway	NN	O
,	,	O
we	PRP	O
conducted	VBD	O
a	DT	O
genetic	JJ	O
modifier	NN	O
screen	NN	O
based	VBN	O
on	IN	O
alterations	NNS	O
of	IN	O
an	DT	O
eye	NN	O
phenotype	NN	O
that	WDT	O
arises	VBZ	O
from	IN	O
high	JJ	O
-	:	O
level	NN	O
overexpression	NN	O
of	IN	O
Bchs	NNP	O
.	.	O

We	PRP	O
found	VBD	O
that	IN	O
mutations	NNS	O
in	IN	O
select	JJ	O
autophagic	NN	O
and	CC	O
endocytic	JJ	O
trafficking	NN	O
genes	NNS	O
,	,	O
defects	NNS	O
in	IN	O
cytoskeletal	JJ	O
and	CC	O
motor	NN	O
proteins	NNS	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
SUMO	NNP	O
and	CC	O
ubiquitin	JJ	O
signaling	NN	O
pathways	NNS	O
behave	VBP	O
as	IN	O
modifiers	NNS	O
of	IN	O
the	DT	O
Bchs	NNP	O
gain	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
(	(	O
GOF	NNP	O
)	)	O
eye	NN	O
phenotype	NN	O
.	.	O

Individual	JJ	O
mutant	NN	O
alleles	NNS	O
that	WDT	O
produced	VBD	O
viable	JJ	O
adults	NNS	O
were	VBD	O
further	RB	O
examined	VBN	O
for	IN	O
bchs	SYM	O
-	:	O
like	IN	O
phenotypes	NNS	O
.	.	O

Mutations	NNS	B-Var
in	IN	O
several	JJ	O
lysosomal	JJ	B-Gene
trafficking	VBG	I-Gene
genes	NNS	I-Gene
resulted	VBD	O
in	IN	O
significantly	RB	O
decreased	VBN	B-NegReg
adult	NN	B-CPA
life	NN	I-CPA
spans	NNS	I-CPA
and	CC	O
several	JJ	O
mutants	NNS	O
showed	VBD	O
changes	NNS	B-Reg
in	IN	O
ubiquitinated	JJ	B-MPA
protein	NN	I-MPA
profiles	NNS	I-MPA
as	IN	O
young	JJ	O
adults	NNS	O
.	.	O
This	DT	O
work	NN	O
represents	VBZ	O
a	DT	O
novel	JJ	O
approach	NN	O
to	TO	O
examine	VB	O
the	DT	O
role	NN	O
that	IN	O
lysosomal	JJ	O
transport	NN	O
and	CC	O
function	NN	O
have	VBP	O
on	IN	O
adult	NN	O
viability	NN	O
.	.	O

The	DT	O
genes	NNS	O
characterized	VBN	O
in	IN	O
this	DT	O
study	NN	O
have	VBP	O
direct	JJ	O
human	JJ	O
homologs	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
similar	JJ	O
defects	NNS	O
in	IN	O
lysosomal	JJ	O
transport	NN	O
may	MD	O
play	VB	O
a	DT	O
role	NN	O
in	IN	O
human	JJ	O
health	NN	O
and	CC	O
age	NN	O
-	:	O
related	JJ	O
processes	NNS	O

gain	NN	I-Gene
of	IN	I-PosReg
function	NN	I-PosReg
mutations	NNS	B-Var
rapidly	RB	B-Disease
solid	JJ	I-Disease
tumors	NNS	I-Disease
TP53	NNP	B-Gene
mutations	NNS	B-Var
gain	NN	B-PosReg
of	IN	I-PosReg
function	NN	I-PosReg
tumorigenesis	NN	B-CPA


The	DT	O
correlation	NN	O
with	IN	O
p53	NN	O
expression	NN	O
was	VBD	O
also	RB	O
examined	VBN	O
.	.	O

Genomic	NNP	O
DNA	NNP	O
was	VBD	O
extracted	VBN	O
from	IN	O
formalin	JJ	O
-	:	O
fixed	VBN	O
,	,	O
paraffin	SYM	O
-	:	O
embedded	VBN	O
tissue	NN	O
and	CC	O
mutational	JJ	O
analysis	NN	O
was	VBD	O
performed	VBN	O
using	VBG	O
Ion	NNP	O
AmpliSeq	NNP	O
Cancer	NNP	O
HotSpot	NNP	O
Panel	NNP	O
V2	NNP	O
.	.	O

Biallelic	NNP	O
GOF	NNP	B-PosReg
mutations	NNS	O
(	(	O
p	NN	B-Var
.	.	I-Var
R273H	NNP	I-Var
and	CC	O
p	NN	B-Var
.	.	I-Var
R273C	NNP	I-Var
)	)	O
were	VBD	O
identified	VBN	O
in	IN	O
a	DT	O
19	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
male	NN	O
with	IN	O
glioblastoma	NN	B-Disease
(	(	O
allele	JJ	O
frequencies	NNS	O
94%	CD	O
and	CC	O
48%	CD	O
)	)	O
and	CC	O
a	DT	O
54	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
with	IN	O
pT3	NN	O
penile	NN	O
squamous	JJ	O
cell	NN	O
carcinoma	NN	O
(	(	O
allele	JJ	O
frequencies	NNS	O
19%	CD	O
and	CC	O
27%	CD	O
)	)	O
.	.	O
Immunohistochemistry	NN	O
showed	VBD	O
nuclear	JJ	O
accumulation	NN	O
of	IN	O
p53	NN	O
.	.	O

The	DT	O
third	JJ	O
patient	NN	O
,	,	O
a	DT	O
62	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
female	NN	O
with	IN	O
metastatic	JJ	B-Disease
lung	NN	I-Disease
adenocarcinoma	NN	I-Disease
,	,	O
had	VBD	O
allelic	JJ	O
p	NN	B-Var
.	.	I-Var
P278S	NNP	I-Var
(	(	O
GOF	NNP	B-PosReg
)	)	O
and	CC	O
p	NN	B-Var
.	.	I-Var
R283L	NNP	I-Var
(	(	O
non	SYM	B-Reg
-	:	I-Reg
GOF	NN	I-Reg
)	)	O
variants	NNS	O
at	IN	O
frequencies	NNS	O
of	IN	O
61%	CD	O
but	CC	O
with	IN	O
null	JJ	O
staining	VBG	O
for	IN	O
p53	NN	O
.	.	O
Germline	NNP	O
testing	VBG	O
for	IN	O
Patient	NNP	O
1	CD	O
confirmed	VBD	O
wildtype	JJ	O
TP53	NNP	O
.	.	O

No	DT	O
other	JJ	O
variants	NNS	O
were	VBD	O
discovered	VBN	O
among	IN	O
the	DT	O
genes	NNS	O
tested	VBN	O
in	IN	O
these	DT	O
cases	NNS	O
.	.	O

All	DT	O
patients	NNS	O
succumbed	VBN	O
within	IN	O
two	CD	O
years	NNS	O
of	IN	O
diagnosis	NN	O
despite	IN	O
aggressive	JJ	O
treatment	NN	O
.	.	O

In	IN	O
conclusion	NN	O
,	,	O
implementation	NN	O
of	IN	O
TP53	NNP	O
mutation	NN	O
analysis	NN	O
in	IN	O
clinical	JJ	O
practice	NN	O
may	MD	O
predict	VB	O
patient	JJ	O
outcome	NN	O
,	,	O
and	CC	O
inhibition	NN	O
of	IN	O
GOF	NNP	O
p53	NN	O
could	MD	O
represent	VB	O
an	DT	O
attractive	JJ	O
target	NN	O
for	IN	O
therapy	NN	O



Although	IN	O
rare	JJ	O
,	,	O
it	PRP	O
should	MD	O
be	VB	O
suspected	VBN	O
in	IN	O
patients	NNS	O
who	WP	O
present	VBP	O
with	IN	O
hypogonadotropic	NN	O
hypogonadism	NN	O
,	,	O
diabetes	VBZ	O
mellitus	NN	O
,	,	O
or	CC	O
cardiomyopathy	NN	O
without	IN	O
a	DT	O
clear	JJ	O
cause	NN	O
.	.	O

CASE	JJ	O
PRESENTATION	NNP	O
:	:	O
A	DT	O
young	JJ	O
Serbian	JJ	O
male	NN	O
presenting	VBG	O
with	IN	O
end	NN	O
-	:	O
stage	NN	O
heart	NN	O
failure	NN	O
was	VBD	O
referred	VBN	O
for	IN	O
extracorporeal	JJ	O
membrane	NN	O
oxygenation	NN	O
.	.	O

An	DT	O
endomyocardial	JJ	O
biopsy	NN	O
revealed	VBD	O
cytoplasmic	JJ	O
iron	NN	O
deposits	NNS	O
in	IN	O
myocytes	NNS	O
.	.	O

His	PRP$	O
condition	NN	O
was	VBD	O
stabilized	VBN	O
with	IN	O
biventricular	JJ	O
assist	NN	O
devices	NNS	O
and	CC	O
he	PRP	O
was	VBD	O
listed	VBN	O
for	IN	O
heart	NN	O
transplantation	NN	O
.	.	O

Iron	NNP	O
chelation	NN	O
therapy	NN	O
was	VBD	O
commenced	VBN	O
and	CC	O
resulted	VBN	O
in	IN	O
rapid	JJ	O
removal	NN	O
of	IN	O
iron	NN	O
burden	NN	O
.	.	O

Serial	JJ	O
outpatient	NN	O
echocardiograms	NNS	O
demonstrated	VBD	O
myocardial	JJ	O
recovery	NN	O
such	JJ	O
that	IN	O
a	DT	O
successful	JJ	O
biventricular	JJ	O
assist	NN	O
device	NN	O
explant	NN	O
occurred	VBD	O
131	CD	O
days	NNS	O
after	IN	O
initial	JJ	O
implant	NN	O
.	.	O

Targeted	VBN	O
gene	NN	O
sequencing	VBG	O
revealed	VBD	O
a	DT	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutation	NN	B-Var
within	IN	O
the	DT	O
HJV	NNP	B-Gene
gene	NN	O
,	,	O
which	WDT	O
is	VBZ	O
consistent	JJ	O
with	IN	O
juvenile	JJ	B-Disease
hemochromatosis	NN	I-Disease
.	.	O
CONCLUSIONS	NN	O
:	:	O
This	DT	O
rare	JJ	O
case	NN	O
of	IN	O
a	DT	O
patient	NN	O
with	IN	O
juvenile	JJ	B-Disease
hemochromatosis	NN	I-Disease
associated	VBN	B-Reg
with	IN	O
a	DT	O
HJV	NNP	B-Gene
mutation	NN	B-Var
provides	VBZ	O
histologic	JJ	O
evidence	NN	O
documenting	VBG	O
the	DT	O
reversal	NN	O
of	IN	O
associated	JJ	O
end	NN	O
-	:	O
stage	NN	O
heart	NN	O
failure	NN	O
,	,	O
requiring	VBG	O
emergent	JJ	O
mechanical	JJ	O
circulatory	NN	O
support	NN	O
,	,	O
with	IN	O
iron	NN	O
chelation	NN	O
therapy	NN	O



mutations	NNS	B-Var
KV7	NNP	B-Gene
.	.	I-Gene
1	CD	I-Gene
KCNE1	NNP	B-Gene
cause	NN	B-Reg
Long	NNP	B-Disease
QT	NNP	I-Disease
Syndrome	NNP	I-Disease
D242N	NNP	B-Var
KV7	NNP	B-Gene
.	.	I-Gene
1	CD	I-Gene
associated	VBN	B-Reg
LQTS	NNP	B-Disease
mutation	NN	B-Var
disrupting	VBG	B-NegReg
conserved	JJ	B-MPA
charge	NN	I-MPA
balance	NN	I-MPA
of	IN	I-MPA
this	DT	I-MPA
region	NN	I-MPA
Perforated	VBN	O
patch	NN	O
-	:	O
clamp	NN	O
experiments	NNS	O
show	VBP	O
that	IN	O
,	,	O
unexpectedly	RB	O
,	,	O
the	DT	O
mutation	NN	B-Var
did	VBD	O
not	RB	O
disrupt	VB	O
the	DT	O
voltage	NN	O
-	:	O
dependent	JJ	O
activation	NN	O
but	CC	O
it	PRP	O
removed	VBD	B-NegReg
the	DT	O
inactivation	NN	B-MPA
and	CC	O
slowed	VBD	B-NegReg
the	DT	O
activation	NN	B-MPA
kinetics	NNS	I-MPA
of	IN	O
D242N	NNP	B-MPA
KV7	NNP	I-MPA
.	.	I-MPA
1	CD	I-MPA
channels	NNS	I-MPA
.	.	O
Biotinylation	NN	O
of	IN	O
cell	NN	O
-	:	O
surface	NN	O
protein	NN	O
and	CC	O
co	VB	O
-	:	O
immunoprecipitation	NN	O
experiments	NNS	O
revealed	VBD	O
that	IN	O
neither	CC	O
plasma	VB	O
membrane	NN	O
targeting	VBG	O
nor	CC	O
co	JJ	O
-	:	O
assembly	NN	O
between	IN	O
KV7	NNP	O
.	.	O
1	CD	O
and	CC	O
KCNE1	NNP	O
was	VBD	O
altered	VBN	O
by	IN	O
the	DT	O
mutation	NN	O
.	.	O

However	RB	O
,	,	O
the	DT	O
association	NN	O
of	IN	O
D242N	NNP	O
KV7	NNP	O
.	.	O
1	CD	O
with	IN	O
KCNE1	NNP	O
strongly	RB	O
shifted	VBD	O
the	DT	O
voltage	NN	O
dependence	NN	O
of	IN	O
activation	NN	O
to	TO	O
more	RBR	O
depolarized	JJ	O
potentials	NNS	O
(	(	O
50	CD	O
mV	NN	O
)	)	O
,	,	O
hindering	VBG	O
IKs	NNP	O
current	JJ	O
at	IN	O
physiologically	RB	O
relevant	JJ	O
membrane	NN	O
potentials	NNS	O
.	.	O

Both	DT	O
functional	JJ	O
and	CC	O
computational	JJ	O
analysis	NN	O
suggest	VBP	O
that	IN	O
the	DT	O
clinical	JJ	O
phenotype	NN	O
of	IN	O
the	DT	O
LQTS	NNP	O
patients	NNS	O
carrying	VBG	O
the	DT	O
D242N	NNP	B-Var
mutation	NN	O
is	VBZ	O
due	JJ	O
to	TO	O
impaired	JJ	B-NegReg
action	NN	B-MPA
potential	JJ	I-MPA
adaptation	NN	I-MPA
to	TO	I-MPA
exercise	NN	I-MPA
and	CC	O
,	,	O
in	IN	O
particular	JJ	O
,	,	O
to	TO	O
increase	VB	B-PosReg
in	IN	O
heart	NN	B-MPA
rate	NN	I-MPA
.	.	O
Moreover	RB	O
,	,	O
our	PRP$	O
data	NNS	O
identify	VB	O
D242	NNP	O
aminoacidic	JJ	O
position	NN	O
as	IN	O
a	DT	O
potential	JJ	O
residue	NN	O
involved	VBN	O
in	IN	O
the	DT	O
KCNE1	NNP	O
-	:	O
mediated	VBD	O
regulation	NN	O
of	IN	O
the	DT	O
voltage	NN	O
dependence	NN	O
of	IN	O
activation	NN	O
of	IN	O
the	DT	O
KV7	NNP	O
.	.	O
1	CD	O
channel	NN	O

and	CC	I-Disease
Recurrent	NNP	B-Disease
Respiratory	NNP	I-Disease
with	IN	I-Disease
STAT1	NNP	B-Gene
Gain	NNP	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
Function	NN	I-PosReg
Variant	NN	B-Var



Heterozygotes	NNS	O
for	IN	O
gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
(	(	O
GOF	NNP	O
)	)	O
alleles	NNS	B-Var
of	IN	O
the	DT	O
STAT1	NNP	B-Gene
gene	NN	O
usually	RB	O
display	VBP	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
chronic	JJ	I-Disease
mucocutaneous	JJ	I-Disease
candidiasis	NN	I-Disease
(	(	O
CMC	NNP	O
)	)	O
and	CC	O
a	DT	O
wide	JJ	O
range	NN	O
of	IN	O
clinical	JJ	O
features	NNS	O
,	,	O
such	JJ	O
as	IN	O
bronchiectasis	NN	B-Disease
.	.	O
Here	RB	O
,	,	O
we	PRP	O
report	VBP	O
on	IN	O
a	DT	O
patient	NN	O
with	IN	O
CMC	NNP	O
and	CC	O
bronchiectasis	NN	O
with	IN	O
various	JJ	O
types	NNS	O
of	IN	O
infections	NNS	O
who	WP	O
carried	VBD	O
a	DT	O
pathogenic	JJ	O
variant	NN	O
of	IN	O
the	DT	O
STAT1	NNP	O
gene	NN	O
.	.	O

The	DT	O
24	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
female	NN	O
presented	VBN	O
with	IN	O
recurrent	JJ	O
respiratory	NN	B-Disease
bacterial	NN	I-Disease
and	CC	I-Disease
nontuberculous	JJ	I-Disease
mycobacterial	JJ	I-Disease
infections	NNS	I-Disease
complicated	VBN	O
by	IN	O
severe	JJ	O
bronchiectasis	NN	B-Disease
and	CC	O
CMC	NNP	B-Disease
.	.	O
Whole	JJ	O
-	:	O
exome	NN	O
sequencing	NN	O
revealed	VBD	B-Reg
a	DT	O
c	NN	B-Var
.	.	I-Var
800	CD	I-Var
C	NNP	I-Var
T	NNP	I-Var
(	(	O
p	NN	O
.	.	O
Ala267Val	NNP	O
)	)	O
heterozygous	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
STAT1	NNP	B-Gene
gene	NN	O
.	.	O
Further	JJ	O
analysis	NN	O
by	IN	O
Sanger	NNP	O
sequencing	NN	O
of	IN	O
STAT1	NNP	O
from	IN	O
the	DT	O
patient	NN	O
and	CC	O
her	PRP$	O
parents	NNS	O
revealed	VBD	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	O
de	FW	O
novo	FW	O
occurrence	NN	O
of	IN	O
the	DT	O
variant	NN	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
report	NN	O
of	IN	O
a	DT	O
Korean	JJ	O
patient	NN	O
with	IN	O
a	DT	O
GOF	NNP	O
pathogenic	NN	O
variant	NN	O
in	IN	O
STAT1	NNP	O
.	.	O

Physicians	NNS	O
should	MD	O
be	VB	O
aware	JJ	O
of	IN	O
the	DT	O
existence	NN	O
of	IN	O
this	DT	O
variant	NN	O
as	IN	O
a	DT	O
genetic	JJ	O
factor	NN	O
associated	VBN	O
with	IN	O
CMC	NNP	O
and	CC	O
bronchiectasis	NN	O
complicated	VBN	O
by	IN	O
recurrent	JJ	O
infection	NN	O



The	DT	O
chemokine	NN	O
receptor	NN	O
CCR5	NNP	O
play	VBD	O
an	DT	O
important	JJ	O
role	NN	O
in	IN	O
disease	NN	O
pathogenesis	NN	O
,	,	O
contributing	VBG	O
to	TO	O
pro	VB	O
-	:	O
inflammatory	NN	O
response	NN	O
and	CC	O
osteoclastogenesis	NN	O
.	.	O

CCR5	NNP	O
32	CD	O
(	(	O
rs333	NN	B-Var
)	)	O
is	VBZ	O
a	DT	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutation	NN	O
in	IN	O
the	DT	O
CCR5	NNP	B-Gene
gene	NN	O
,	,	O
which	WDT	O
can	MD	O
potentially	RB	O
modulate	VB	B-Reg
the	DT	O
host	NN	B-CPA
response	NN	I-CPA
and	CC	O
,	,	O
consequently	RB	O
periodontitis	VBZ	O
outcome	NN	O
.	.	O
Thus	RB	O
,	,	O
we	PRP	O
investigated	VBD	O
the	DT	O
effect	NN	O
of	IN	O
the	DT	O
CCR5	NNP	O
32	CD	O
mutation	NN	O
over	IN	O
the	DT	O
risk	NN	O
to	TO	O
suffer	VB	O
periodontitis	NN	O
in	IN	O
a	DT	O
cohort	NN	O
of	IN	O
Brazilian	JJ	O
patients	NNS	O
(	(	O
total	JJ	O
N	NNP	O
699	CD	O
)	)	O
,	,	O
representative	NN	O
of	IN	O
disease	NN	O
susceptibility	NN	O
(	(	O
chronic	JJ	O
periodontitis	NN	O
,	,	O
N	NNP	O
197	CD	O
;	:	O
and	CC	O
aggressive	JJ	O
periodontitis	NN	O
,	,	O
N	NNP	O
91	CD	O
)	)	O
or	CC	O
resistance	NN	O
(	(	O
chronic	JJ	O
gingivitis	NN	O
,	,	O
N	NNP	O
193	CD	O
)	)	O
phenotypes	NNS	O
,	,	O
and	CC	O
healthy	JJ	O
subjects	NNS	O
(	(	O
N	NNP	O
218	CD	O
)	)	O
.	.	O

Additionally	RB	O
,	,	O
we	PRP	O
assayed	VBD	O
the	DT	O
influence	NN	O
of	IN	O
CCR5	NNP	O
32	CD	O
in	IN	O
the	DT	O
expression	NN	O
of	IN	O
the	DT	O
biomarkers	NNS	O
TNF	NNP	O
,	,	O
IL	NNP	O
-	:	O
1	CD	O
,	,	O
IL	NNP	O
-	:	O
10	CD	O
,	,	O
IL	NNP	O
-	:	O
6	CD	O
,	,	O
IFN	NNP	O
-	:	O
and	CC	O
T	NNP	O
-	:	O
bet	NN	O
,	,	O
and	CC	O
key	JJ	O
periodontal	JJ	O
pathogens	NNS	O
P.	NNP	O
gingivalis	NN	O
,	,	O
T.	NNP	O
forsythia	NN	O
,	,	O
and	CC	O
T.	NNP	O
denticola	NN	O
.	.	O

In	IN	O
the	DT	O
association	NN	O
analysis	NN	O
of	IN	O
resistant	JJ	O
versus	NN	O
susceptible	JJ	O
subjects	NNS	O
,	,	O
CCR5	NNP	O
32	CD	O
mutant	NN	O
allele	SYM	O
-	:	O
carriers	NNS	O
proved	VBD	O
significantly	RB	O
protected	VBN	O
against	IN	O
chronic	NN	O
(	(	O
OR	NNP	O
0.49	CD	O
;	:	O
95%	CD	O
CI	NNP	O
0.29	CD	O
-	:	O
0.83	CD	O
;	:	O
p	CC	O
-	:	O
value	NN	O
0.01	CD	O
)	)	O
and	CC	O
aggressive	JJ	O
(	(	O
OR	NNP	O
0.46	CD	O
;	:	O
95%	CD	O
CI	NNP	O
0.22	CD	O
-	:	O
0.94	CD	O
;	:	O
p	CC	O
-	:	O
value	NN	O
0.03	CD	O
)	)	O
periodontitis	NN	O
.	.	O

Further	RB	O
,	,	O
heterozygous	JJ	O
subjects	NNS	O
exhibited	VBN	O
significantly	RB	O
decreased	VBN	B-NegReg
expression	NN	B-MPA
of	IN	O
TNF	NNP	B-Protein
in	IN	I-Protein
periodontal	JJ	O
tissues	NNS	O
,	,	O
pointing	VBG	O
to	TO	O
a	DT	O
functional	JJ	O
effect	NN	O
of	IN	O
the	DT	O
mutation	NN	B-Var
in	IN	O
periodontal	JJ	O
tissues	NNS	O
during	IN	O
the	DT	O
progression	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O
Conversely	RB	O
,	,	O
no	DT	O
significant	JJ	O
changes	NNS	O
were	VBD	O
observed	VBN	O
in	IN	O
the	DT	O
presence	NN	O
or	CC	O
quantity	NN	O
of	IN	O
the	DT	O
periodontal	JJ	O
pathogens	NNS	O
P.	NNP	O
gingivalis	NN	O
,	,	O
T.	NNP	O
forsythia	NN	O
,	,	O
and	CC	O
T.	NNP	O
denticola	NN	O
in	IN	O
the	DT	O
subgingival	NN	O
biofilm	NN	O
that	WDT	O
could	MD	O
be	VB	O
attributable	JJ	O
to	TO	O
the	DT	O
mutant	JJ	O
genotype	NN	O


AIM	NN	O
:	:	O
Pseudomonas	NNP	O
aeruginosa	NN	O
is	VBZ	O
one	CD	O
of	IN	O
the	DT	O
most	RBS	O
clinically	RB	O
important	JJ	O
opportunistic	JJ	O
pathogen	NN	O
in	IN	O
humans	NNS	O
.	.	O

The	DT	O
aim	NN	O
of	IN	O
the	DT	O
project	NN	O
was	VBD	O
to	TO	O
study	VB	O
effects	NNS	O
of	IN	O
HtpG	NNP	O
on	IN	O
the	DT	O
selected	VBN	O
virulence	NN	O
factors	NNS	O
responsible	JJ	O
for	IN	O
pathogenesis	NN	O
and	CC	O
biofilm	JJ	O
formation	NN	O
of	IN	O
P.	NNP	O
aeruginosa	NN	O
.	.	O

METHODOLOGY	NN	O
:	:	O
By	IN	O
characterizing	VBG	O
a	DT	O
htpG	NN	O
null	JJ	O
mutant	NN	O
of	IN	O
P.	NNP	O
aeruginosa	NN	O
,	,	O
we	PRP	O
have	VBP	O
identified	VBN	O
the	DT	O
role	NN	O
of	IN	O
HtpG	NNP	O
in	IN	O
the	DT	O
production	NN	O
of	IN	O
selected	VBN	O
factors	NNS	O
.	.	O

RESULTS	NNS	O
:	:	O
We	PRP	O
showed	VBD	O
that	IN	O
htpG	NN	B-Gene
mutant	JJ	B-Var
affects	VBZ	O
many	JJ	O
physiological	JJ	O
processes	NNS	O
containing	VBG	O
:	:	O
decreased	JJ	B-NegReg
activity	NN	B-MPA
of	IN	O
the	DT	O
LasA	NNP	B-Enzyme
protease	NN	I-Enzyme
,	,	O
reduction	NN	B-NegReg
of	IN	O
biofilm	NN	B-MPA
formation	NN	I-MPA
,	,	O
decreased	VBN	B-NegReg
motility	NN	B-CPA
,	,	O
and	CC	O
diminished	VBD	B-NegReg
amount	NN	B-MPA
of	IN	I-MPA
rhamnolipids	NNS	I-MPA
and	CC	I-MPA
pyoverdine	NN	I-MPA
pyocyanin	NN	I-MPA
.	.	O
These	DT	O
defects	NNS	O
were	VBD	O
most	RBS	O
evident	JJ	O
when	WRB	O
the	DT	O
htpG	NN	O
strain	NN	O
was	VBD	O
cultured	VBN	O
at	IN	O
42	CD	O
C.	NNP	O

CONCLUSION	NN	O
:	:	O
Our	PRP$	O
findings	NNS	O
demonstrate	VBP	O
the	DT	O
unexplored	JJ	O
role	NN	O
of	IN	O
HtpG	NNP	O
in	IN	O
the	DT	O
pathogenicity	NN	O
of	IN	O
P.	NNP	O
aeruginosa	NN	O
,	,	O
and	CC	O
indicate	VBP	O
potential	JJ	O
targets	NNS	O
for	IN	O
antibacterial	JJ	O
therapeutics	NNS	O
.	.	O

[	JJ	O
Formula	NN	O
:	:	O
see	VB	O
text	JJ	O
]	NN	O






Detailed	JJ	O
clinical	JJ	O
evaluation	NN	O
of	IN	O
the	DT	O
six	CD	O
individuals	NNS	O
revealed	VBN	O
clinically	RB	O
unexpected	JJ	O
consequences	NNS	O
of	IN	O
the	DT	O
PPP3CA	NNP	B-Gene
mutations	NNS	O
.	.	O
First	RB	O
,	,	O
the	DT	O
catalytic	JJ	B-Var
domain	NN	I-Var
mutations	NNS	I-Var
and	CC	O
frameshift	JJ	B-Var
mutation	NN	I-Var
were	VBD	O
consistently	RB	O
found	VBN	B-Reg
in	IN	O
patients	NNS	O
with	IN	O
nonsyndromic	JJ	B-Disease
early	JJ	I-Disease
onset	VBN	I-Disease
epileptic	JJ	I-Disease
encephalopathy	NN	I-Disease
.	.	O
In	IN	O
contrast	NN	O
,	,	O
the	DT	O
AI	NNP	B-Var
domain	NN	I-Var
mutations	NNS	I-Var
were	VBD	O
associated	VBN	B-Reg
with	IN	O
multiple	JJ	B-Disease
congenital	JJ	I-Disease
abnormalities	NNS	I-Disease
including	VBG	O
craniofacial	JJ	B-Disease
dysmorphism	NN	I-Disease
,	,	O
arthrogryposis	NN	B-Disease
and	CC	O
short	JJ	B-Disease
stature	NN	I-Disease
.	.	O
In	IN	O
addition	NN	O
,	,	O
one	CD	O
individual	NN	O
showed	VBD	O
severe	JJ	O
skeletal	JJ	O
developmental	NN	O
defects	NNS	O
,	,	O
namely	RB	O
,	,	O
severe	JJ	O
craniosynostosis	NN	O
and	CC	O
gracile	JJ	O
bones	NNS	O
(	(	O
severe	JJ	O
bone	NN	O
slenderness	NN	O
and	CC	O
perinatal	JJ	O
fractures	NNS	O
)	)	O
.	.	O

Using	VBG	O
a	DT	O
yeast	NN	O
model	NN	O
system	NN	O
,	,	O
we	PRP	O
showed	VBD	O
that	IN	O
the	DT	O
catalytic	JJ	O
and	CC	O
AI	NNP	B-Var
domain	VBP	I-Var
mutations	NNS	I-Var
visibly	RB	O
result	VBP	O
in	IN	O
decreased	JJ	O
and	CC	O
increased	VBD	B-PosReg
calcineurin	NN	B-MPA
signaling	NN	I-MPA
,	,	O
respectively	RB	O
.	.	O
These	DT	O
findings	NNS	O
indicate	VBP	O
that	IN	O
different	JJ	O
functional	JJ	O
effects	NNS	O
of	IN	O
PPP3CA	NNP	B-Gene
mutations	NNS	O
are	VBP	O
associated	VBN	O
with	IN	O
two	CD	O
distinct	JJ	O
disorders	NNS	O
and	CC	O
suggest	VBP	O
that	IN	O
functional	JJ	O
approaches	NNS	O
using	VBG	O
a	DT	O
simple	JJ	O
cellular	JJ	O
system	NN	O
provide	VBP	O
a	DT	O
tool	NN	O
for	IN	O
resolving	VBG	O
complex	JJ	O
genotype	NN	O
-	:	O
phenotype	NN	O
correlations	NNS	O


Establishment	NN	O
and	CC	O
maintenance	NN	O
of	IN	O
the	DT	O
polar	JJ	O
site	NN	O
are	VBP	O
important	JJ	O
for	IN	O
root	JJ	O
hair	NN	O
tip	JJ	O
growth	NN	O
.	.	O

We	PRP	O
previously	RB	O
reported	VBD	O
that	IN	O
Arabidopsis	NNP	O
(	(	O
Arabidopsis	NNP	O
thaliana	NN	O
)	)	O
MICROTUBULE	NNP	O
-	:	O
ASSOCIATED	NNP	O
PROTEIN18	NNP	O
(	(	O
MAP18	NNP	O
)	)	O
functions	NNS	O
in	IN	O
controlling	VBG	O
the	DT	O
direction	NN	O
of	IN	O
pollen	NN	O
tube	NN	O
growth	NN	O
and	CC	O
root	NN	O
hair	NN	O
elongation	NN	O
.	.	O

Additionally	RB	O
,	,	O
the	DT	O
Rop	NNP	O
GTPase	NNP	O
ROP2	NNP	O
was	VBD	O
reported	VBN	O
as	IN	O
a	DT	O
positive	JJ	O
regulator	NN	O
of	IN	O
both	DT	O
root	JJ	O
hair	NN	O
initiation	NN	O
and	CC	O
tip	NN	O
growth	NN	O
in	IN	O
Arabidopsis	NNP	O
.	.	O

Both	DT	O
loss	NN	B-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
of	IN	O
ROP2	NNP	B-Gene
and	CC	O
knockdown	VBN	B-Var
of	IN	O
MAP18	NNP	B-Gene
lead	NN	O
to	TO	O
a	DT	O
decrease	NN	B-NegReg
in	IN	O
root	NN	B-MPA
hair	NN	I-MPA
length	NN	I-MPA
,	,	O
whereas	JJ	O
overexpression	NN	O
of	IN	O
either	DT	O
MAP18	NNP	O
or	CC	O
ROP2	NNP	O
causes	VBZ	O
multiple	JJ	O
tips	NNS	O
or	CC	O
a	DT	O
branching	JJ	O
hair	NN	O
phenotype	NN	O
.	.	O
However	RB	O
,	,	O
it	PRP	O
is	VBZ	O
unclear	JJ	O
whether	IN	O
MAP18	NNP	O
and	CC	O
ROP2	NNP	O
coordinately	RB	O
regulate	VBP	O
root	JJ	O
hair	NN	O
growth	NN	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
demonstrate	VBP	O
that	IN	O
MAP18	NNP	O
and	CC	O
ROP2	NNP	O
interact	VB	O
genetically	RB	O
and	CC	O
functionally	RB	O
.	.	O

MAP18	NNP	O
interacts	VBZ	O
physically	RB	O
with	IN	O
ROP2	NNP	O
in	IN	O
vitro	NN	O
and	CC	O
in	IN	O
vivo	NN	O
and	CC	O
preferentially	RB	O
binds	VBZ	O
to	TO	O
the	DT	O
inactive	JJ	O
form	NN	O
of	IN	O
the	DT	O
ROP2	NNP	O
protein	NN	O
.	.	O

MAP18	NNP	O
promotes	VBZ	O
ROP2	NNP	O
activity	NN	O
during	IN	O
root	NN	O
hair	NN	O
tip	JJ	O
growth	NN	O
.	.	O

Further	JJ	O
investigation	NN	O
revealed	VBD	O
that	IN	O
MAP18	NNP	O
competes	VBZ	O
with	IN	O
RhoGTPase	NNP	O
GDP	NNP	O
DISSOCIATION	NNP	O
INHIBITOR1	NNP	O
SUPERCENTIPEDE1	NNP	O
for	IN	O
binding	VBG	O
to	TO	O
ROP2	NNP	O
,	,	O
in	IN	O
turn	NN	O
affecting	VBG	O
the	DT	O
localization	NN	O
of	IN	O
active	JJ	O
ROP2	NNP	O
in	IN	O
the	DT	O
plasma	JJ	O
membrane	NN	O
of	IN	O
the	DT	O
root	NN	O
hair	NN	O
tip	NN	O
.	.	O

These	DT	O
results	NNS	O
reveal	VBP	O
a	DT	O
novel	JJ	O
function	NN	O
of	IN	O
MAP18	NNP	O
in	IN	O
the	DT	O
regulation	NN	O
of	IN	O
ROP2	NNP	O
activation	NN	O
during	IN	O
root	JJ	O
hair	NN	O
growth	NN	O


Mutant	NNP	B-Var
p53	NN	B-Gene
proteins	NNS	B-Protein
contributes	VBZ	B-PosReg
tumor	VB	B-CPA
aggressiveness	NN	I-CPA
downregulation	NN	B-NegReg
mutant	JJ	B-Var
p53	NN	B-Gene
RNA	NNP	B-MPA
interference	NN	I-MPA
reduces	VBZ	B-NegReg
tumorigenicity	NN	B-CPA
of	IN	I-CPA
cancer	NN	I-CPA
cells	NNS	I-CPA
in	IN	I-CPA
an	DT	I-CPA
animal	JJ	I-CPA
model	NN	I-CPA

In	IN	O
vivo	JJ	O
studies	NNS	O
assessed	VBD	O
the	DT	O
efficacy	NN	O
of	IN	O
conditional	JJ	B-MPA
RNA	NNP	I-MPA
interference	NN	I-MPA
in	IN	O
inhibiting	VBG	B-NegReg
gain	NN	O
of	IN	O
function	NN	O
activity	NN	B-MPA
of	IN	O
mutant	JJ	B-Var
p53	NN	B-Gene
proteins	NNS	B-Protein
by	IN	O
reducing	VBG	O
tumor	NN	O
growth	NN	O
ability	NN	O
.	.	O
Moreover	RB	O
by	IN	O
using	VBG	O
this	DT	O
system	NN	O
,	,	O
microarray	NN	O
data	NNS	O
were	VBD	O
validated	VBN	O
in	IN	O
vitro	NN	O
and	CC	O
in	IN	O
vivo	NN	O
and	CC	O
putative	JJ	O
mutant	NN	O
p53	NN	O
target	NN	O
genes	NNS	O
that	WDT	O
may	MD	O
contribute	VB	O
to	TO	O
its	PRP$	O
gain	NN	O
of	IN	O
function	NN	O
effects	NNS	O
in	IN	O
cancer	NN	O
were	VBD	O
identified	VBN	O
.	.	O

Results	NNS	O
are	VBP	O
confirmatory	JJ	O
that	IN	O
depletion	NN	B-MPA
of	IN	O
mutant	JJ	B-Var
p53	NN	B-Gene
protein	NN	B-Protein
impacts	NNS	B-Reg
on	IN	O
tumor	NN	B-CPA
malignancy	NN	I-CPA
and	CC	O
validated	VBD	O
the	DT	O
inducible	JJ	O
lentiviral	JJ	O
-	:	O
based	VBN	O
system	NN	O
as	IN	O
an	DT	O
efficient	JJ	O
tool	NN	O
to	TO	O
study	VB	O
the	DT	O
gain	NN	O
of	IN	O
function	NN	O
activity	NN	O
of	IN	O
human	JJ	O
tumor	NN	O
derived	VBD	O
p53	JJ	O
mutants	NNS	O


We	PRP	O
previously	RB	O
reported	VBD	B-Reg
a	DT	O
granulin	NN	O
(	(	O
GRN	NNP	B-Gene
)	)	O
null	NN	B-Var
mutation	NN	I-Var
,	,	O
originating	VBG	O
from	IN	O
a	DT	O
common	JJ	O
founder	NN	O
,	,	O
in	IN	O
multiple	JJ	O
Belgian	JJ	O
families	NNS	O
with	IN	O
frontotemporal	JJ	B-Disease
dementia	NN	I-Disease
.	.	O
Here	RB	O
,	,	O
we	PRP	O
used	VBD	O
data	NNS	O
of	IN	O
a	DT	O
10	CD	O
-	:	O
year	NN	O
follow	SYM	O
-	:	O
up	RB	O
study	NN	O
to	TO	O
describe	VB	O
in	IN	O
detail	NN	O
the	DT	O
clinical	JJ	O
heterogeneity	NN	O
observed	VBN	O
in	IN	O
this	DT	O
extended	JJ	O
founder	NN	O
pedigree	NN	O
.	.	O

We	PRP	O
identified	VBD	O
85	CD	O
patients	NNS	O
and	CC	O
40	CD	O
unaffected	JJ	O
mutation	NN	O
carriers	NNS	O
,	,	O
belonging	VBG	O
to	TO	O
29	CD	O
branches	NNS	O
of	IN	O
the	DT	O
founder	NN	O
pedigree	NN	O
.	.	O

Most	JJS	O
patients	NNS	O
(	(	O
74.4%	CD	O
)	)	O
were	VBD	O
diagnosed	VBN	O
with	IN	O
frontotemporal	JJ	O
dementia	NN	O
,	,	O
while	IN	O
others	NNS	O
had	VBD	O
a	DT	O
clinical	JJ	O
diagnosis	NN	O
of	IN	O
unspecified	JJ	O
dementia	NN	O
,	,	O
Alzheimer	NNP	O
's	POS	O
dementia	NN	O
or	CC	O
Parkinson	NNP	O
's	POS	O
disease	NN	O
.	.	O

The	DT	O
observed	JJ	O
clinical	JJ	O
heterogeneity	NN	O
can	MD	O
guide	VB	O
clinical	JJ	O
diagnosis	NN	O
,	,	O
genetic	JJ	O
testing	NN	O
,	,	O
and	CC	O
counseling	NN	O
of	IN	O
mutation	NN	O
carriers	NNS	O
.	.	O

Onset	NNP	O
of	IN	O
initial	JJ	O
symptomatology	NN	O
is	VBZ	O
highly	RB	O
variable	JJ	O
,	,	O
ranging	VBG	O
from	IN	O
age	NN	O
45	CD	O
to	TO	O
80	CD	O
years	NNS	O
.	.	O

Analysis	NN	O
of	IN	O
known	JJ	O
modifiers	NNS	O
,	,	O
suggested	VBD	O
effects	NNS	O
of	IN	O
GRN	NNP	O
rs5848	NN	O
,	,	O
microtubule	NN	O
-	:	O
associated	VBN	O
protein	NN	O
tau	NN	O
H1	NNP	O
H2	NNP	O
,	,	O
and	CC	O
chromosome	NN	O
9	CD	O
open	JJ	O
reading	NN	O
frame	NN	O
72	CD	O
G4C2	NNP	O
repeat	NN	O
length	NN	O
on	IN	O
onset	JJ	O
age	NN	O
but	CC	O
explained	VBD	O
only	RB	O
a	DT	O
minor	JJ	O
fraction	NN	O
of	IN	O
the	DT	O
variability	NN	O
.	.	O

Contrary	NNP	O
,	,	O
the	DT	O
extended	JJ	O
GRN	NNP	O
founder	NN	O
family	NN	O
is	VBZ	O
a	DT	O
valuable	JJ	O
source	NN	O
for	IN	O
identifying	VBG	O
other	JJ	O
onset	VBN	O
age	NN	O
modifiers	NNS	O
based	VBN	O
on	IN	O
exome	NN	O
or	CC	O
genome	JJ	O
sequences	NNS	O
.	.	O

These	DT	O
modifiers	NNS	O
might	MD	O
be	VB	O
interesting	JJ	O
targets	NNS	O
for	IN	O
developing	VBG	O
disease	JJ	O
-	:	O
modifying	NN	O
therapies	NNS	O


Context	NN	O
:	:	O
The	DT	O
hypothalamic	JJ	O
melanocortin	NN	O
4	CD	O
receptor	NN	O
(	(	O
MC4R	NNP	O
)	)	O
pathway	VBP	O
serves	VBZ	O
a	DT	O
critical	JJ	O
role	NN	O
in	IN	O
regulating	VBG	O
body	NN	O
weight	NN	O
.	.	O

Loss	NNP	B-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
(	(	O
LoF	NNP	O
)	)	O
mutations	NNS	B-Var
in	IN	O
the	DT	O
MC4R	NNP	B-Pathway
pathway	NN	I-Pathway
,	,	O
including	VBG	O
mutations	NNS	O
in	IN	O
the	DT	O
pro	JJ	O
-	:	O
opiomelanocortin	NN	O
(	(	O
POMC	NNP	B-Gene
)	)	O
,	,	O
prohormone	JJ	O
convertase	NN	O
1	CD	O
(	(	O
PCSK1	NNP	B-Gene
)	)	O
,	,	O
leptin	JJ	O
receptor	NN	O
(	(	O
LEPR	NNP	B-Gene
)	)	O
,	,	O
or	CC	O
MC4R	NNP	B-Gene
genes	NNS	O
,	,	O
have	VBP	O
been	VBN	O
shown	VBN	O
to	TO	O
cause	VB	O
early	JJ	B-Disease
-	:	I-Disease
onset	NN	I-Disease
severe	JJ	I-Disease
obesity	NN	I-Disease
.	.	O
Methods	NNS	O
:	:	O
Through	IN	O
a	DT	O
comprehensive	JJ	O
epidemiological	JJ	O
analysis	NN	O
of	IN	O
known	VBN	O
and	CC	O
predicted	VBN	O
LoF	NNP	O
variants	NNS	O
in	IN	O
the	DT	O
POMC	NNP	O
,	,	O
PCSK1	NNP	O
,	,	O
and	CC	O
LEPR	NNP	O
genes	NNS	O
,	,	O
we	PRP	O
sought	VBD	O
to	TO	O
estimate	VB	O
the	DT	O
number	NN	O
of	IN	O
US	NNP	O
individuals	NNS	O
with	IN	O
biallelic	JJ	O
MC4R	NNP	O
pathway	NN	O
LoF	NNP	O
variants	NNS	O
.	.	O

Results	NNS	O
:	:	O
We	PRP	O
predict	VBP	O
650	CD	O
-	:	O
melanocyte	NN	O
-	:	O
stimulating	VBG	O
hormone	NN	O
(	(	O
MSH	NNP	O
)	)	O
POMC	NNP	O
,	,	O
8500	CD	O
PCSK1	NNP	O
,	,	O
and	CC	O
3600	CD	O
LEPR	NNP	O
homozygous	JJ	O
and	CC	O
compound	NN	O
heterozygous	JJ	O
individuals	NNS	O
in	IN	O
the	DT	O
United	NNP	O
States	NNPS	O
,	,	O
cumulatively	RB	O
enumerating	VBG	O
12	CD	O
,	,	O
800	CD	O
MC4R	NNP	O
pathway	NN	O
-	:	O
deficient	NN	O
obese	JJ	O
patients	NNS	O
.	.	O

Few	JJ	O
of	IN	O
these	DT	O
variants	NNS	O
have	VBP	O
been	VBN	O
genetically	RB	O
diagnosed	VBN	O
to	TO	O
date	NN	O
.	.	O

These	DT	O
estimates	NNS	O
increase	VBP	O
when	WRB	O
we	PRP	O
include	VBP	O
a	DT	O
small	JJ	O
subset	NN	O
of	IN	O
less	JJR	O
rare	JJ	O
variants	NNS	O
:	:	O
-	:	O
MSH	NNP	O
POMC	NNP	O
,	,	O
PCSK1	NNP	O
N221D	NNP	O
,	,	O
and	CC	O
a	DT	O
PCSK1	NNP	O
LoF	NNP	O
variant	NN	O
(	(	O
T640A	NNP	O
)	)	O
.	.	O

To	TO	O
further	RBR	O
define	VB	O
the	DT	O
MC4R	NNP	O
pathway	NN	O
and	CC	O
its	PRP$	O
potential	JJ	O
impact	NN	O
on	IN	O
obesity	NN	O
,	,	O
we	PRP	O
tested	VBD	O
associations	NNS	O
between	IN	O
body	NN	O
mass	NN	O
index	NN	O
(	(	O
BMI	NNP	O
)	)	O
and	CC	O
LoF	NNP	O
mutation	NN	O
burden	NN	O
in	IN	O
the	DT	O
POMC	NNP	O
,	,	O
PCSK1	NNP	O
,	,	O
and	CC	O
LEPR	NNP	O
genes	NNS	O
in	IN	O
various	JJ	O
populations	NNS	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
the	DT	O
cumulative	JJ	O
allele	NN	O
burden	NN	O
in	IN	O
individuals	NNS	O
with	IN	O
two	CD	O
or	CC	O
more	JJR	O
LoF	JJ	O
alleles	NNS	O
in	IN	O
one	CD	O
or	CC	O
more	JJR	O
genes	NNS	O
in	IN	O
the	DT	O
MC4R	NNP	O
pathway	NN	O
are	VBP	O
predisposed	VBN	O
to	TO	O
a	DT	O
higher	JJR	O
BMI	NNP	O
than	IN	O
noncarriers	NNS	O
or	CC	O
heterozygous	JJ	O
LoF	NNP	O
carriers	NNS	O
with	IN	O
a	DT	O
defect	NN	O
in	IN	O
only	RB	O
one	CD	O
gene	NN	O
.	.	O

Conclusions	NNS	O
:	:	O
Our	PRP$	O
analysis	NN	O
represents	VBZ	O
a	DT	O
genetically	RB	O
rationalized	VBN	O
study	NN	O
of	IN	O
the	DT	O
hypothalamic	JJ	O
MC4R	NNP	O
pathway	NN	O
aimed	VBN	O
at	IN	O
genetic	JJ	O
patient	NN	O
stratification	NN	O
to	TO	O
determine	VB	O
which	WDT	O
obese	JJ	O
subpopulations	NNS	O
should	MD	O
be	VB	O
studied	VBN	O
to	TO	O
elucidate	VB	O
MC4R	NNP	O
agonist	NN	O
(	(	O
e	NN	O
.	.	O
g	NN	O
.	.	O
,	,	O
setmelanotide	RB	O
)	)	O
treatment	NN	O
responsiveness	NN	O

accelerates	VBZ	I-Gene
aging	VBG	I-Var
dopaminergic	JJ	I-PosReg
neurons	NNS	I-MPA
Loss	NNP	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
PARK2	NNP	B-Gene
early	JJ	B-Disease
-	:	I-Disease
onset	VBN	I-Disease
familial	JJ	I-Disease
Parkinson	NNP	I-Disease
's	POS	I-Disease
disease	NN	I-Disease

loss	NN	B-Var
parkin	NN	B-Gene
accelerated	VBN	B-PosReg
acetylation	NN	B-MPA
Interestingly	RB	O
,	,	O
in	IN	O
PARK2	NNP	O
knockout	NN	O
mice	NN	O
,	,	O
changes	NNS	O
of	IN	O
MT	NNP	O
stability	NN	O
preceded	VBD	O
the	DT	O
alteration	NN	O
of	IN	O
mitochondria	NN	O
transport	NN	O
.	.	O

Moreover	RB	O
,	,	O
in	IN	O
-	:	O
cell	NN	O
experiments	NNS	O
confirmed	VBD	O
that	IN	O
loss	NN	B-Var
of	IN	O
parkin	JJ	B-Gene
affects	NNS	B-Reg
mitochondria	VBP	B-MPA
mobility	NN	I-MPA
and	CC	O
showed	VBD	O
that	IN	O
this	DT	O
defect	JJ	O
depends	VBZ	O
on	IN	O
MT	NNP	O
system	NN	O
as	IN	O
it	PRP	O
is	VBZ	O
rescued	VBN	O
by	IN	O
paclitaxel	NN	O
,	,	O
a	DT	O
well	RB	O
-	:	O
known	VBN	O
MT	NNP	O
-	:	O
targeted	VBD	O
agent	NN	O
.	.	O
Furthermore	RB	O
,	,	O
both	DT	O
in	IN	O
PC12	NNP	O
neuronal	JJ	O
cells	NNS	O
and	CC	O
in	IN	O
patients	NNS	O
induced	JJ	O
pluripotent	JJ	O
stem	NN	O
cell	NN	O
-	:	O
derived	VBN	O
midbrain	NN	O
neurons	NNS	O
,	,	O
we	PRP	O
observed	VBD	O
that	IN	O
parkin	JJ	O
deficiencies	NNS	O
cause	VBP	O
the	DT	O
fragmentation	NN	O
of	IN	O
stable	JJ	O
MTs	NNP	O
.	.	O

Therefore	RB	O
,	,	O
we	PRP	O
suggest	VBP	O
that	IN	O
parkin	JJ	O
acts	NNS	O
as	IN	O
a	DT	O
regulator	NN	O
of	IN	O
MT	NNP	O
system	NN	O
during	IN	O
neuronal	JJ	O
aging	NN	O
,	,	O
and	CC	O
we	PRP	O
endorse	VBP	O
the	DT	O
hypothesis	NN	O
that	WDT	O
MT	NNP	O
dysfunction	NN	O
may	MD	O
be	VB	O
crucial	JJ	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
Parkinson	NNP	O
's	POS	O
disease	NN	O


variants	NNS	B-Var
PCSK9	NNP	B-Gene
gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
effects	NNS	B-Reg
LDL	NNP	B-Disease
cholesterol	NN	I-Disease
cardiovascular	JJ	B-Disease
disease	NN	I-Disease

RECENT	JJ	O
FINDINGS	NN	O
:	:	O
GOF	JJ	B-PosReg
variants	NNS	B-Var
are	VBP	O
individually	RB	O
ultrarare	JJ	O
,	,	O
affect	VB	B-Reg
all	DT	O
domains	NNS	B-Protein
of	IN	I-Protein
the	DT	I-Protein
protein	NN	I-Protein
,	,	O
act	NN	O
to	TO	O
reduce	VB	B-NegReg
LDL	NNP	B-Protein
receptor	NN	I-Protein
expression	NN	B-MPA
through	IN	O
several	JJ	O
mechanisms	NNS	O
,	,	O
are	VBP	O
a	DT	O
minor	JJ	O
cause	NN	B-Reg
of	IN	O
familial	JJ	B-Disease
hypercholesterolemia	NN	I-Disease
,	,	O
have	VBP	O
been	VBN	O
reported	VBN	O
mainly	RB	O
within	IN	O
families	NNS	O
,	,	O
have	VBP	O
variable	JJ	O
LDL	NNP	O
cholesterol	NN	O
-	:	O
raising	NN	O
effects	NNS	O
,	,	O
and	CC	O
are	VBP	O
associated	VBN	O
with	IN	O
increased	JJ	O
CVD	NNP	O
risk	NN	O
mainly	RB	O
through	IN	O
observational	JJ	O
studies	NNS	O
in	IN	O
families	NNS	O
and	CC	O
small	JJ	O
cohorts	NNS	O
.	.	O
In	IN	O
contrast	NN	O
,	,	O
LOF	NNP	B-NegReg
variants	NNS	B-Var
can	MD	O
be	VB	O
either	CC	O
ultrarare	JJ	O
mutations	NNS	O
or	CC	O
relatively	RB	O
more	RBR	O
common	JJ	O
polymorphisms	NN	O
seen	VBN	O
in	IN	O
populations	NNS	O
,	,	O
affect	VBP	B-Reg
all	DT	O
domains	NNS	B-Protein
of	IN	I-Protein
the	DT	I-Protein
protein	NN	I-Protein
,	,	O
act	NN	O
to	TO	O
increase	VB	B-PosReg
LDL	NNP	B-Protein
receptor	NN	I-Protein
expression	NN	B-MPA
through	IN	O
several	JJ	O
mechanisms	NNS	O
,	,	O
have	VBP	O
variable	JJ	O
LDL	NNP	B-MPA
cholesterol	NN	I-MPA
-	:	O
lowering	NN	B-NegReg
effects	NNS	O
,	,	O
and	CC	O
have	VBP	O
been	VBN	O
associated	VBN	O
with	IN	O
decreased	JJ	B-NegReg
CVD	NNP	B-Disease
risk	NN	O
mainly	RB	O
through	IN	O
Mendelian	JJ	O
randomization	NN	O
studies	NNS	O
in	IN	O
epidemiologic	JJ	O
populations	NNS	O
.	.	O
SUMMARY	NN	O
:	:	O
There	EX	O
is	VBZ	O
considerable	JJ	O
complexity	NN	O
underlying	VBG	O
the	DT	O
clinical	JJ	O
concept	NN	O
of	IN	O
both	DT	O
LOF	NNP	O
and	CC	O
GOF	NNP	O
variants	NNS	O
of	IN	O
PCSK9	NNP	O
.	.	O

But	CC	O
despite	IN	O
the	DT	O
underlying	JJ	O
mechanistic	JJ	O
heterogeneity	NN	O
,	,	O
altered	VBD	O
PCSK9	NNP	O
secretion	NN	O
or	CC	O
function	NN	O
is	VBZ	O
ultimately	RB	O
correlated	VBN	O
with	IN	O
plasma	NN	O
LDL	NNP	O
cholesterol	NN	O
level	NN	O
,	,	O
which	WDT	O
is	VBZ	O
also	RB	O
the	DT	O
driver	NN	O
of	IN	O
CVD	NNP	O
outcomes	NNS	O



hyperprolactinemia	NN	B-Disease
She	PRP	O
is	VBZ	O
a	DT	O
compound	NN	O
heterozygote	NN	O
for	IN	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
variants	NNS	B-Var
of	IN	O
PRLR	NNP	B-Gene
.	.	O
Her	PRP$	O
unaffected	JJ	O
parents	NNS	O
are	VBP	O
heterozygotes	NNS	O
.	.	O

These	DT	O
findings	NNS	O
are	VBP	O
consistent	JJ	O
with	IN	O
previous	JJ	O
work	NN	O
showing	VBG	O
that	IN	O
mice	JJ	O
deficient	NN	O
in	IN	O
functional	JJ	O
Prlr	NNP	O
do	VBP	O
not	RB	B-NegReg
lactate	VB	B-CPA

development	NN	I-CPA
extrarenal	JJ	B-CPA
features	NNS	I-CPA
caused	VBN	B-Reg
by	IN	I-Reg
LAMB2	NNP	B-Gene
mutations	NNS	B-Var
BACKGROUND	NN	O
:	:	O
Congenital	JJ	O
nephrotic	JJ	O
syndrome	NN	O
(	(	O
CNS	NNP	O
)	)	O
is	VBZ	O
a	DT	O
rare	JJ	O
disorder	NN	O
caused	VBN	O
by	IN	O
various	JJ	O
structural	JJ	O
and	CC	O
developmental	JJ	O
defects	NNS	O
of	IN	O
glomeruli	NN	O
.	.	O

It	PRP	O
occurs	VBZ	O
typically	RB	O
as	IN	O
an	DT	O
isolated	JJ	O
kidney	NN	O
disorder	NN	O
but	CC	O
associates	VBZ	O
sometimes	RB	O
with	IN	O
other	JJ	O
systemic	JJ	O
,	,	O
extrarenal	JJ	O
manifestations	NNS	O
.	.	O

CASE	JJ	O
PRESENTATIONS	NNP	O
:	:	O
An	DT	O
infant	NN	O
presented	VBN	O
with	IN	O
severe	JJ	O
CNS	NNP	O
,	,	O
which	WDT	O
progressed	VBD	O
rapidly	RB	O
to	TO	O
renal	VB	O
failure	NN	O
at	IN	O
age	NN	O
of	IN	O
3	CD	O
months	NNS	O
and	CC	O
death	NN	O
at	IN	O
27	CD	O
months	NNS	O
.	.	O

The	DT	O
clinical	JJ	O
phenotypes	NNS	O
and	CC	O
genetic	JJ	O
causes	NNS	O
were	VBD	O
studied	VBN	O
,	,	O
including	VBG	O
the	DT	O
renal	JJ	O
pathology	NN	O
at	IN	O
autopsy	NN	O
.	.	O

Besides	IN	O
the	DT	O
CNS	NNP	O
,	,	O
the	DT	O
affected	JJ	O
child	NN	O
had	VBD	O
remarkable	JJ	O
right	JJ	O
-	:	O
side	NN	O
predominant	NN	O
eye	NN	O
-	:	O
ball	NN	O
hypoplasia	NN	O
with	IN	O
bilateral	JJ	O
anterior	JJ	O
chamber	NN	O
dysgenesis	NN	O
(	(	O
microcoria	NN	O
)	)	O
.	.	O

Brain	NNP	O
MRI	NNP	O
revealed	VBD	O
grossly	RB	O
normal	JJ	O
development	NN	O
in	IN	O
the	DT	O
cerebrum	NN	O
,	,	O
cerebellum	NN	O
,	,	O
and	CC	O
brain	NN	O
stem	NN	O
.	.	O

Auditory	NNP	O
brainstem	NN	O
responses	NNS	O
were	VBD	O
bilaterally	RB	O
blunted	VBN	O
,	,	O
suggesting	VBG	O
a	DT	O
defective	JJ	O
auditory	NN	O
system	NN	O
.	.	O

At	IN	O
autopsy	NN	O
,	,	O
both	DT	O
kidneys	NNS	O
were	VBD	O
mildly	RB	O
atrophied	VBN	O
with	IN	O
persistent	JJ	O
fetal	JJ	O
lobulation	NN	O
.	.	O

Microscopic	NNP	O
examination	NN	O
showed	VBD	O
a	DT	O
diffuse	NN	O
global	JJ	O
sclerosis	NN	O
.	.	O

However	RB	O
,	,	O
despite	IN	O
of	IN	O
the	DT	O
smaller	JJR	O
size	NN	O
of	IN	O
glomeruli	NN	O
,	,	O
the	DT	O
nephron	NN	O
number	NN	O
remained	VBD	O
similar	JJ	O
to	TO	O
that	DT	O
of	IN	O
the	DT	O
age	NN	O
-	:	O
matched	VBN	O
control	NN	O
.	.	O

Whole	JJ	O
-	:	O
exome	NN	O
sequencing	NN	O
revealed	VBD	O
that	IN	O
the	DT	O
affected	JJ	O
child	NN	O
was	VBD	O
compound	RB	O
heterozygous	JJ	O
for	IN	O
novel	JJ	O
truncating	VBG	O
LAMB2	JJ	O
mutations	NNS	O
:	:	O
a	DT	O
4	CD	O
-	:	O
bp	NN	O
insertion	NN	O
(	(	O
p	NN	O
.	.	O
Gly1693Alafs	NNP	O
8	CD	O
)	)	O
and	CC	O
a	DT	O
splicing	VBG	O
donor	NN	O
-	:	O
site	NN	O
substitution	NN	O
(	(	O
c	NN	O
.	.	O
1225	CD	O
1	CD	O
G	NNP	O
A	NNP	O
)	)	O
,	,	O
presumably	RB	O
deleting	VBG	O
the	DT	O
coiled	VBN	O
-	:	O
coil	NN	O
domains	VBZ	O
that	IN	O
form	VB	O
the	DT	O
laminin	NN	O
5	CD	O
-	:	O
2	CD	O
-	:	O
1	CD	O
heterotrimer	NN	O
complex	NN	O
.	.	O

CONCLUSIONS	NN	O
:	:	O
Our	PRP$	O
case	NN	O
represents	VBZ	O
a	DT	O
variation	NN	O
of	IN	O
Pierson	NNP	O
syndrome	NN	O
that	WDT	O
accompanies	VBZ	O
CNS	NNP	O
with	IN	O
unilateral	JJ	O
ocular	JJ	O
hypoplasia	NN	O
.	.	O

The	DT	O
average	JJ	O
number	NN	O
but	CC	O
smaller	JJR	O
glomeruli	NN	O
could	MD	O
reflect	VB	O
either	CC	O
mal	JJ	O
-	:	O
development	NN	O
or	CC	O
glomerulosclerosis	NN	O
.	.	O

Heterogeneous	JJ	O
clinical	JJ	O
expression	NN	O
of	IN	O
LAMB2	NNP	O
defects	NNS	O
may	MD	O
associate	VB	O
with	IN	O
the	DT	O
difference	NN	O
in	IN	O
fetal	JJ	O
1	CD	O
subtype	JJ	O
compensation	NN	O
among	IN	O
affected	JJ	O
tissues	NNS	O
.	.	O

Further	RB	O
study	NN	O
is	VBZ	O
necessary	JJ	O
to	TO	O
evaluate	VB	O
incidence	NN	O
and	CC	O
features	NNS	O
of	IN	O
auditory	JJ	O
defect	NN	O
under	IN	O
LAMB2	NNP	O
deficiency	NN	O

-	:	I-PosReg
function	NN	I-PosReg
activity	NN	B-MPA
p53	NN	B-Gene
mutants	NNS	B-Var
lung	NN	B-Disease
cancer	NN	I-Disease
p53	NN	B-Gene
mutations	NNS	B-Var
resulting	VBG	B-Reg
in	IN	I-Reg
expression	NN	B-MPA
gain	NN	B-PosReg
of	IN	I-PosReg
function	NN	I-PosReg
activity	NN	B-MPA
p53	NN	B-Gene
mutants	NNS	B-Var
loss	NN	B-NegReg
activity	NN	B-MPA
lowering	VBG	B-NegReg
cell	NN	B-CPA
growth	NN	I-CPA
rate	NN	I-CPA
mutants	NNS	B-Var
p53	VBP	I-Var
-	:	I-Var
P278S	NN	I-Var
and	CC	I-Var
-	:	I-Var
R267P	NN	I-Var
reduction	NN	B-NegReg
growth	NN	B-MPA
rate	NN	I-MPA
reduction	NN	B-NegReg
p53	NN	B-Var
loss	NN	B-NegReg
tumorigenicity	NN	B-MPA
escalates	VBZ	B-PosReg
tumorigenicity	NN	B-MPA
We	PRP	O
have	VBP	O
tested	VBN	O
their	PRP$	O
transactivation	NN	O
potential	NN	O
on	IN	O
p53	NN	O
target	NN	O
gene	NN	O
promoters	NNS	O
by	IN	O
performing	VBG	O
transient	JJ	O
transcriptional	JJ	O
assays	NNS	O
in	IN	O
the	DT	O
p53	NN	O
-	:	O
null	NN	O
H1299	NNP	O
lung	NN	O
cancer	NN	O
cell	NN	O
line	NN	O
.	.	O

Interestingly	RB	O
,	,	O
while	IN	O
the	DT	O
mutant	JJ	O
p53	NN	O
target	NN	O
promoter	NN	O
Axl	NNP	O
was	VBD	O
activated	VBN	O
by	IN	O
both	DT	O
the	DT	O
mutants	NNS	O
,	,	O
the	DT	O
p21	NN	O
promoter	NN	O
was	VBD	O
activated	VBN	O
by	IN	O
p53	NN	O
-	:	O
R267P	NN	O
and	CC	O
wild	JJ	O
-	:	O
type	NN	O
p53	NN	O
but	CC	O
not	RB	O
by	IN	O
p53	NN	O
-	:	O
P278S	NN	O
;	:	O
showing	VBG	O
a	DT	O
clear	JJ	O
difference	NN	O
in	IN	O
transcriptional	JJ	O
activity	NN	O
between	IN	O
the	DT	O
two	CD	O
mutants	NNS	O
.	.	O

Our	PRP$	O
results	NNS	O
demonstrate	VB	O
allele	JJ	O
specificity	NN	O
between	IN	O
GOF	NNP	O
p53	NN	O
mutants	NNS	O
and	CC	O
attempt	NN	O
to	TO	O
show	VB	O
that	IN	O
the	DT	O
specificity	NN	O
is	VBZ	O
dependent	JJ	O
on	IN	O
the	DT	O
transactivation	NN	O
property	NN	O
of	IN	O
GOF	NNP	O
p53	NN	O
;	:	O
it	PRP	O
also	RB	O
suggests	VBZ	O
importance	NN	O
of	IN	O
p21	JJ	O
activation	NN	O
in	IN	O
tumor	NN	O
suppression	NN	O
by	IN	O
p53	NN	O


point	NN	B-Var
mutations	NNS	I-Var
ERBB2	NNP	B-Gene
activate	VB	B-PosReg
signaling	VBG	B-Pathway
pathway	NN	I-Pathway
breast	NN	B-Disease
cancer	NN	I-Disease
The	DT	O
prevalence	NN	O
of	IN	O
ERBB2	NNP	O
HER2	NNP	O
mutation	NN	O
in	IN	O
bone	NN	O
metastasis	NN	O
of	IN	O
breast	NN	O
cancer	NN	O
and	CC	O
the	DT	O
associated	VBN	O
phenotype	NN	O
are	VBP	O
not	RB	O
known	VBN	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
bone	NN	O
metastases	NNS	O
from	IN	O
breast	NN	O
cancer	NN	O
patients	NNS	O
(	(	O
n	JJ	O
231	CD	O
)	)	O
were	VBD	O
analyzed	VBN	O
for	IN	O
ERBB2	NNP	O
HER2	NNP	O
mutation	NN	O
.	.	O

In	IN	O
7	CD	O
patients	NNS	O
(	(	O
3%	CD	O
;	:	O
median	JJ	O
age	NN	O
70	CD	O
years	NNS	O
,	,	O
range	VBP	O
50	CD	O
-	:	O
83	CD	O
years	NNS	O
)	)	O
,	,	O
gain	VBP	O
-	:	O
of	IN	O
-	:	O
function	NN	O
mutations	NNS	O
of	IN	O
ERBB2	NNP	O
HER2	NNP	O
were	VBD	O
detected	VBN	O
.	.	O

The	DT	O
most	RBS	O
frequent	JJ	O
mutation	NN	O
was	VBD	O
p	JJ	O
.	.	O
L755S	NNP	O
(	(	O
71%	CD	O
)	)	O
.	.	O

In	IN	O
29%	CD	O
of	IN	O
mutated	VBN	O
cases	NNS	O
,	,	O
p	NN	O
.	.	O
V777L	NNP	O
was	VBD	O
found	VBN	O
.	.	O

Lobular	JJ	O
breast	NN	O
cancer	NN	O
was	VBD	O
present	JJ	O
in	IN	O
71%	CD	O
of	IN	O
mutated	VBN	O
cases	NNS	O
(	(	O
n	JJ	O
5	CD	O
)	)	O
and	CC	O
in	IN	O
49%	CD	O
of	IN	O
all	DT	O
samples	NNS	O
(	(	O
n	JJ	O
231	CD	O
;	:	O
p	CC	O
0.275	CD	O
)	)	O
.	.	O

Mutation	NNP	O
frequency	NN	O
was	VBD	O
4.4%	CD	O
in	IN	O
the	DT	O
lobular	JJ	O
subgroup	NN	O
and	CC	O
17.4%	CD	O
in	IN	O
the	DT	O
pleomorphic	JJ	O
subtype	NN	O
of	IN	O
lobular	JJ	O
cancer	NN	O
(	(	O
n	JJ	O
23	CD	O
)	)	O
,	,	O
respectively	RB	O
.	.	O

All	DT	O
but	CC	O
one	CD	O
mutated	VBD	O
lobular	JJ	O
cancers	NNS	O
were	VBD	O
of	IN	O
the	DT	O
pleomorphic	JJ	O
subtype	NN	O
(	(	O
p	JJ	O
0.006	CD	O
)	)	O
.	.	O

Mutated	VBN	O
cancers	NNS	O
belonged	VBD	O
either	DT	O
to	TO	O
the	DT	O
luminal	JJ	O
(	(	O
n	JJ	O
4	CD	O
)	)	O
or	CC	O
to	TO	O
the	DT	O
triple	JJ	O
-	:	O
negative	JJ	O
types	NNS	O
(	(	O
n	RB	O
3	CD	O
)	)	O
.	.	O

With	IN	O
regard	NN	O
to	TO	O
protein	VB	O
expression	NN	O
and	CC	O
gene	NN	O
amplification	NN	O
,	,	O
HER2	NNP	O
was	VBD	O
negative	JJ	O
in	IN	O
all	DT	O
mutated	JJ	O
cases	NNS	O
.	.	O

Among	IN	O
the	DT	O
14%	CD	O
of	IN	O
metastatic	JJ	O
luminal	JJ	O
cancers	NNS	O
with	IN	O
estrogen	NN	O
receptor	NN	O
gene	NN	O
(	(	O
ESR1	NNP	O
)	)	O
mutation	NN	O
,	,	O
conveying	VBG	O
resistance	NN	O
against	IN	O
aromatase	NN	O
inhibitors	NNS	O
,	,	O
no	DT	O
concomitant	NN	O
ERBB2	NNP	O
HER2	NNP	O
mutation	NN	O
occurred	VBD	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
activating	VBG	B-PosReg
HER2	NNP	B-Gene
mutation	NN	B-Var
is	VBZ	O
present	JJ	O
in	IN	O
about	IN	O
3%	CD	O
of	IN	O
bone	NN	B-CPA
metastases	NNS	I-CPA
from	IN	O
breast	NN	B-Disease
cancers	NNS	I-Disease
,	,	O
with	IN	O
significantly	RB	O
higher	JJR	B-PosReg
rates	NNS	I-PosReg
in	IN	O
the	DT	O
pleomorphic	JJ	O
subtype	NN	O
of	IN	O
lobular	JJ	O
cancer	NN	O
.	.	O
Since	IN	O
mutated	VBN	O
cases	NNS	O
appear	VBP	O
to	TO	O
be	VB	O
HER2	NNP	O
-	:	O
negative	JJ	O
by	IN	O
conventional	JJ	O
testing	NN	O
,	,	O
the	DT	O
opportunity	NN	O
for	IN	O
specific	JJ	O
anti	JJ	O
-	:	O
HER2	NNP	O
therapy	NN	O
may	MD	O
be	VB	O
missed	VBN	O


In	IN	O
a	DT	O
genetic	JJ	O
screen	NN	O
to	TO	O
identify	VB	O
genes	NNS	O
that	WDT	O
promote	VBP	O
GLP	NNP	O
-	:	O
1	CD	O
Notch	NNP	O
signaling	VBG	O
in	IN	O
Caenorhabditis	NNP	O
elegans	NNS	O
germline	VBP	O
stem	NN	O
cells	NNS	O
,	,	O
we	PRP	O
found	VBD	O
a	DT	O
single	JJ	O
mutation	NN	O
,	,	O
om40	NN	O
,	,	O
defining	VBG	O
a	DT	O
gene	NN	O
called	VBN	O
ego	SYM	O
-	:	O
3	CD	O
.	.	O

ego	SYM	B-Gene
-	:	I-Gene
3	CD	I-Gene
(	(	O
om40	NN	B-Var
)	)	O
causes	VBZ	B-Reg
several	JJ	O
defects	NNS	B-MPA
in	IN	O
the	DT	O
soma	NN	O
and	CC	O
the	DT	O
germline	NN	O
,	,	O
including	VBG	O
paralysis	NN	B-Disease
during	IN	O
larval	NN	O
development	NN	O
,	,	O
sterility	NN	B-Disease
,	,	O
delayed	JJ	B-CPA
proliferation	NN	I-CPA
of	IN	O
germline	JJ	O
stem	NN	O
cells	NNS	O
,	,	O
and	CC	O
ectopic	RB	B-CPA
germline	JJ	I-CPA
stem	NN	I-CPA
cell	NN	I-CPA
proliferation	NN	I-CPA
.	.	O
Whole	JJ	O
genome	NN	O
sequencing	VBG	O
identified	VBN	O
om40	NN	O
as	IN	O
an	DT	O
allele	NN	O
of	IN	O
hsp	NN	O
-	:	O
90	CD	O
,	,	O
previously	RB	O
known	VBN	O
as	IN	O
daf	NN	O
-	:	O
21	CD	O
,	,	O
which	WDT	O
encodes	VBZ	O
the	DT	O
C.	NNP	O
elegans	VBZ	O
ortholog	NN	O
of	IN	O
the	DT	O
cytosolic	JJ	O
form	NN	O
of	IN	O
HSP90	NNP	O
.	.	O

This	DT	O
protein	NN	O
is	VBZ	O
a	DT	O
molecular	JJ	O
chaperone	NN	O
with	IN	O
a	DT	O
central	JJ	O
position	NN	O
in	IN	O
the	DT	O
protein	NN	O
homeostasis	NN	O
network	NN	O
,	,	O
which	WDT	O
is	VBZ	O
responsible	JJ	O
for	IN	O
proper	JJ	O
folding	NN	O
,	,	O
structural	JJ	O
maintenance	NN	O
,	,	O
and	CC	O
degradation	NN	O
of	IN	O
proteins	NNS	O
.	.	O

In	IN	O
addition	NN	O
to	TO	O
its	PRP$	O
essential	JJ	O
role	NN	O
in	IN	O
cellular	JJ	O
function	NN	O
,	,	O
HSP90	NNP	O
plays	VBZ	O
an	DT	O
important	JJ	O
role	NN	O
in	IN	O
stem	NN	O
cell	NN	O
maintenance	NN	O
and	CC	O
renewal	NN	O
.	.	O

Complementation	NN	O
analysis	NN	O
using	VBG	O
a	DT	O
deletion	NN	O
allele	NN	O
of	IN	O
hsp	NN	O
-	:	O
90	CD	O
confirmed	VBD	O
that	IN	O
ego	NN	O
-	:	O
3	CD	O
is	VBZ	O
the	DT	O
same	JJ	O
gene	NN	O
.	.	O

hsp	SYM	O
-	:	O
90	CD	O
(	(	O
om40	NN	O
)	)	O
is	VBZ	O
an	DT	O
I	PRP	O
N	NNP	O
conservative	JJ	O
missense	NN	O
mutation	NN	O
of	IN	O
a	DT	O
highly	RB	O
conserved	VBN	O
residue	NN	O
in	IN	O
the	DT	O
middle	JJ	O
domain	NN	O
of	IN	O
HSP	NNP	O
-	:	O
90	CD	O
RNA	NNP	O
interference	NN	O
-	:	O
mediated	VBD	O
knockdown	NN	O
of	IN	O
hsp	NN	O
-	:	O
90	CD	O
expression	NN	O
partially	RB	O
phenocopied	VBD	O
hsp	JJ	O
-	:	O
90	CD	O
(	(	O
om40	NN	O
)	)	O
,	,	O
confirming	VBG	O
the	DT	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
nature	NN	O
of	IN	O
hsp	NN	O
-	:	O
90	CD	O
(	(	O
om40	NN	O
)	)	O
Furthermore	NN	O
,	,	O
reduced	VBD	O
HSP	NNP	O
-	:	O
90	CD	O
activity	NN	O
enhanced	VBD	O
the	DT	O
effect	NN	O
of	IN	O
reduced	JJ	O
function	NN	O
of	IN	O
both	CC	O
the	DT	O
GLP	NNP	O
-	:	O
1	CD	O
receptor	NN	O
and	CC	O
the	DT	O
downstream	NN	O
LAG	NNP	O
-	:	O
1	CD	O
transcription	NN	O
factor	NN	O
.	.	O

Taken	VBN	O
together	RB	O
,	,	O
our	PRP$	O
results	NNS	O
provide	VB	O
the	DT	O
first	JJ	O
experimental	JJ	O
evidence	NN	O
of	IN	O
an	DT	O
essential	JJ	O
role	NN	O
for	IN	O
HSP90	NNP	O
in	IN	O
Notch	NNP	O
signaling	VBG	O
in	IN	O
development	NN	O

loss	NN	I-Gene
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
variants	NNS	B-Var
cerebral	JJ	B-CPA
ventriculomegaly	NNS	I-CPA
limb	NN	B-CPA
contractures	NNS	I-CPA
Heterozygous	JJ	B-Var
mutations	NNS	I-Var
KIDINS220	NNP	B-Gene
cause	NN	B-Reg
spastic	JJ	B-Disease
paraplegia	NN	I-Disease
intellectual	JJ	B-Disease
disability	NN	I-Disease
nystagmus	NN	B-Disease
obesity	NN	B-Disease
All	DT	O
patients	NNS	O
carried	VBD	O
terminal	JJ	O
nonsense	NN	O
de	IN	O
novo	FW	O
mutations	NNS	O
that	WDT	O
seemed	VBD	O
to	TO	O
escape	VB	O
nonsense	JJ	O
-	:	O
mediated	VBN	O
mRNA	JJ	O
decay	NN	O
.	.	O

The	DT	O
mechanism	NN	O
for	IN	O
pathogenicity	NN	O
is	VBZ	O
yet	RB	O
unexplained	JJ	O
,	,	O
as	IN	O
it	PRP	O
seems	VBZ	O
that	IN	O
heterozygous	JJ	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
variants	NNS	O
of	IN	O
KIDINS220	NNP	O
are	VBP	O
generally	RB	O
well	RB	O
tolerated	VBN	O
.	.	O

We	PRP	O
present	VBP	O
a	DT	O
consanguineous	JJ	O
couple	NN	O
who	WP	O
experienced	VBD	O
four	CD	O
pregnancy	NN	O
terminations	NNS	O
due	JJ	O
to	TO	O
repeated	JJ	O
findings	NNS	O
in	IN	O
the	DT	O
fetuses	NNS	O
comprising	VBG	O
enlarged	JJ	O
cerebral	JJ	O
ventricles	NNS	O
and	CC	O
limb	NN	O
contractures	NNS	O
.	.	O

Exome	NNP	O
sequencing	VBG	O
in	IN	O
two	CD	O
of	IN	O
the	DT	O
aborted	JJ	O
fetuses	NNS	O
revealed	VBD	O
a	DT	O
shared	VBN	O
homozygous	JJ	O
frameshift	NN	O
variant	NN	O
in	IN	O
exon	JJ	O
24	CD	O
in	IN	O
KIDINS220	NNP	O
.	.	O

Sanger	NNP	O
sequencing	NN	O
of	IN	O
the	DT	O
variant	NN	O
in	IN	O
available	JJ	O
family	NN	O
members	NNS	O
showed	VBD	O
complete	JJ	O
segregation	NN	O
with	IN	O
the	DT	O
affection	NN	O
status	NN	O
,	,	O
resulting	VBG	O
in	IN	O
a	DT	O
LOD	NNP	O
score	NN	O
of	IN	O
2.5	CD	O
under	IN	O
an	DT	O
autozygous	JJ	O
inheritance	NN	O
model	NN	O
.	.	O

mRNA	NN	O
studies	NNS	O
revealed	VBD	O
destruction	NN	O
of	IN	O
the	DT	O
original	JJ	O
splice	NN	O
site	NN	O
,	,	O
resulting	VBG	O
in	IN	O
an	DT	O
out	IN	O
-	:	O
of	IN	O
-	:	O
frame	NN	O
transcript	NN	O
and	CC	O
introduction	NN	O
of	IN	O
a	DT	O
premature	JJ	O
termination	NN	O
codon	NN	O
in	IN	O
exon	JJ	O
25	CD	O
.	.	O

Premature	JJ	O
termination	NN	O
codons	NNS	O
in	IN	O
this	DT	O
position	NN	O
are	VBP	O
likely	JJ	O
to	TO	O
cause	VB	O
activation	NN	O
of	IN	O
nonsense	JJ	O
-	:	O
mediated	VBN	O
mRNA	NN	O
decay	NN	O
and	CC	O
result	NN	O
in	IN	O
complete	JJ	O
absence	NN	O
of	IN	O
KIDINS220	NNP	O
protein	NN	O
in	IN	O
individuals	NNS	O
homozygous	JJ	O
for	IN	O
the	DT	O
variant	NN	O
.	.	O

The	DT	O
phenotype	NN	O
of	IN	O
the	DT	O
presented	JJ	O
fetuses	NNS	O
overlaps	VBP	O
with	IN	O
findings	NNS	O
in	IN	O
functional	JJ	O
studies	NNS	O
of	IN	O
knockout	NN	O
Kidins220	NNP	O
mice	NN	O
embryos	NN	O
that	WDT	O
are	VBP	O
non	JJ	O
-	:	O
viable	JJ	O
with	IN	O
enlarged	JJ	O
cerebral	JJ	O
ventricles	NNS	O
.	.	O

The	DT	O
human	JJ	O
fetuses	NNS	O
also	RB	O
exhibit	VBP	O
several	JJ	O
similarities	NNS	O
to	TO	O
the	DT	O
milder	NN	O
phenotype	NN	O
described	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
heterozygous	JJ	O
KIDINS220	NNP	O
mutations	NNS	O
.	.	O

We	PRP	O
hence	VBP	O
propose	JJ	O
that	IN	O
the	DT	O
identified	JJ	O
homozygous	JJ	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
variant	NN	O
in	IN	O
KIDINS220	NNP	O
causes	VBZ	O
the	DT	O
phenotype	NN	O
in	IN	O
the	DT	O
presented	JJ	O
fetuses	NNS	O
,	,	O
and	CC	O
that	IN	O
this	DT	O
represents	VBZ	O
a	DT	O
hitherto	NN	O
undescribed	JJ	O
severe	JJ	O
autosomal	JJ	O
recessive	JJ	O
neurodevelopmental	JJ	O
disorder	NN	O

-	:	I-Var
Segregating	VBG	I-Var
Variation	NN	I-Var
Ugt86Dd	NNP	B-Gene
Nicotine	NNP	I-PosReg
Resistance	NNP	I-MPA
in	IN	I-MPA
Drosophila	NNP	I-MPA
melanogaster	NN	I-MPA


Previously	RB	O
we	PRP	O
mapped	VBD	O
a	DT	O
series	NN	O
of	IN	O
QTL	NNP	O
contributing	VBG	O
to	TO	O
resistance	VB	O
to	TO	O
nicotine	VB	O
in	IN	O
a	DT	O
Drosophila	NNP	O
melanogaster	NN	O
multiparental	NN	O
mapping	NN	O
resource	NN	O
,	,	O
and	CC	O
here	RB	O
use	VB	O
a	DT	O
battery	NN	O
of	IN	O
functional	JJ	O
tests	NNS	O
to	TO	O
resolve	VB	O
QTL	NNP	O
to	TO	O
the	DT	O
molecular	JJ	O
level	NN	O
.	.	O

One	CD	O
large	JJ	O
-	:	O
effect	NN	O
QTL	NNP	O
resided	VBD	O
over	RP	O
a	DT	O
cluster	NN	O
of	IN	O
UDP	NNP	O
-	:	O
glucuronosyltransferases	NNS	O
,	,	O
and	CC	O
quantitative	JJ	O
complementation	NN	O
tests	NNS	O
using	VBG	O
deficiencies	NNS	O
eliminating	VBG	O
subsets	NNS	O
of	IN	O
these	DT	O
detoxification	NN	O
genes	NNS	O
revealed	VBD	O
allelic	JJ	O
variation	NN	O
impacting	VBG	O
resistance	NN	O
.	.	O

RNAseq	NN	O
showed	VBD	O
that	IN	O
Ugt86Dd	NNP	O
had	VBD	O
significantly	RB	O
higher	JJR	O
expression	NN	O
in	IN	O
genotypes	NNS	O
that	WDT	O
are	VBP	O
more	RBR	O
resistant	JJ	O
to	TO	O
nicotine	VB	O
,	,	O
and	CC	O
anterior	RB	O
midgut	SYM	O
-	:	O
specific	JJ	O
RNAi	NNP	O
of	IN	O
this	DT	O
gene	NN	O
reduced	VBD	O
resistance	NN	O
.	.	O

We	PRP	O
discovered	VBD	O
a	DT	O
segregating	VBG	O
22	CD	O
-	:	O
bp	NN	O
frameshift	NN	B-Var
deletion	NN	I-Var
in	IN	O
Ugt86Dd	NNP	B-Gene
,	,	O
and	CC	O
accounting	NN	O
for	IN	O
the	DT	O
InDel	NNP	O
during	IN	O
mapping	VBG	O
largely	RB	O
eliminates	VBZ	B-NegReg
the	DT	O
QTL	NNP	B-MPA
,	,	O
implying	VBG	O
the	DT	O
event	NN	O
explains	VBZ	O
the	DT	O
bulk	NN	O
of	IN	O
the	DT	O
effect	NN	O
of	IN	O
the	DT	O
mapped	JJ	O
locus	NN	O
.	.	O
CRISPR	NNP	O
Cas9	NNP	O
editing	VBG	O
a	DT	O
relatively	RB	O
resistant	JJ	O
genotype	NN	O
to	TO	O
generate	VB	O
lesions	NNS	B-Var
in	IN	O
Ugt86Dd	NNP	B-Gene
that	WDT	O
recapitulate	VBP	O
the	DT	O
naturally	RB	O
-	:	O
occurring	VBG	O
putative	JJ	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
allele	VBZ	O
leads	VBZ	O
to	TO	O
a	DT	O
large	JJ	O
reduction	NN	B-NegReg
in	IN	O
resistance	NN	B-MPA
.	.	O
Despite	IN	O
this	DT	O
major	JJ	O
effect	NN	O
of	IN	O
the	DT	O
deletion	NN	O
,	,	O
the	DT	O
allele	NN	O
appears	VBZ	O
to	TO	O
be	VB	O
very	RB	O
rare	JJ	O
in	IN	O
wild	JJ	O
-	:	O
caught	NN	O
populations	NNS	O
,	,	O
and	CC	O
likely	RB	O
explains	VBZ	O
only	RB	O
a	DT	O
small	JJ	O
fraction	NN	O
of	IN	O
the	DT	O
natural	JJ	O
variation	NN	O
for	IN	O
the	DT	O
trait	NN	O
.	.	O

Nonetheless	RB	O
,	,	O
this	DT	O
putatively	RB	O
causative	JJ	O
coding	VBG	O
InDel	NNP	O
can	MD	O
be	VB	O
a	DT	O
launchpad	NN	O
for	IN	O
future	JJ	O
mechanistic	JJ	O
exploration	NN	O
of	IN	O
xenobiotic	JJ	O
detoxification	NN	O

variants	NNS	B-Var
are	VBP	I-Gene
prevalent	JJ	B-Reg
mitral	JJ	B-Disease
valve	NN	I-Disease
prolapse	NN	I-Disease

The	DT	O
goal	NN	O
of	IN	O
this	DT	O
study	NN	O
is	VBZ	O
to	TO	O
investigate	VB	O
the	DT	O
presence	NN	O
and	CC	O
frequency	NN	O
of	IN	O
known	VBN	O
and	CC	O
novel	JJ	O
variants	NNS	O
in	IN	O
this	DT	O
gene	NN	O
in	IN	O
100	CD	O
asymptomatic	JJ	O
patients	NNS	O
with	IN	O
moderate	JJ	O
to	TO	O
severe	VB	O
organic	JJ	O
mitral	JJ	O
regurgitation	NN	O
.	.	O

METHODS	NN	O
:	:	O
DNA	NN	O
sequencing	VBG	O
assays	NNS	O
were	VBD	O
developed	VBN	O
for	IN	O
two	CD	O
previously	RB	O
identified	VBN	O
functional	JJ	O
missense	NN	O
variants	NNS	O
,	,	O
namely	RB	O
p	NN	B-Var
.	.	I-Var
R2330C	NNP	I-Var
and	CC	O
p	NN	B-Var
.	.	I-Var
R2513H	NNP	I-Var
,	,	O
and	CC	O
all	DT	O
21	CD	O
exons	NNS	O
of	IN	O
DCHS1	NNP	B-Gene
.	.	O
Pathogenicity	NN	O
of	IN	O
variants	NNS	O
was	VBD	O
evaluated	VBN	O
in	IN	O
silico	NN	O
.	.	O

RESULTS	NN	O
:	:	O
p	NN	O
.	.	O
R2330C	NNP	O
and	CC	O
p	NN	O
.	.	O
R2513H	NNP	O
were	VBD	O
not	RB	O
identified	VBN	O
in	IN	O
this	DT	O
cohort	NN	O
.	.	O

Sequencing	VBG	O
all	DT	O
coding	VBG	O
regions	NNS	O
revealed	VBD	O
eight	CD	O
missense	NN	O
variants	NNS	O
including	VBG	O
six	CD	O
considered	VBN	O
deleterious	JJ	O
.	.	O

This	DT	O
includes	VBZ	O
one	CD	O
novel	NN	O
variant	NN	O
(	(	O
p	NN	O
.	.	O
A2464P	NNP	O
)	)	O
and	CC	O
two	CD	O
rare	JJ	O
variants	NNS	O
(	(	O
p	NN	O
.	.	O
R2770Q	NNP	O
and	CC	O
p	NN	O
.	.	O
R2462Q	NNP	O
)	)	O
.	.	O

These	DT	O
variants	NNS	O
are	VBP	O
predicted	VBN	O
to	TO	O
be	VB	O
deleterious	JJ	O
with	IN	O
combined	JJ	O
annotation	NN	O
-	:	O
dependent	JJ	O
depletion	NN	O
(	(	O
CADD	NNP	O
)	)	O
scores	VBZ	O
greater	JJR	O
than	IN	O
25	CD	O
,	,	O
which	WDT	O
are	VBP	O
in	IN	O
the	DT	O
same	JJ	O
range	NN	O
as	IN	O
p	NN	O
.	.	O
R2330C	NNP	O
(	(	O
CADD	NNP	O
28.0	CD	O
)	)	O
and	CC	O
p	NN	O
.	.	O
R2513H	NNP	O
(	(	O
CADD	NNP	O
24.3	CD	O
)	)	O
.	.	O

More	RBR	O
globally	RB	O
,	,	O
24	CD	O
of	IN	O
100	CD	O
cases	NNS	O
were	VBD	O
carriers	NNS	O
of	IN	O
at	IN	O
least	JJS	O
one	CD	O
in	IN	O
silico	NN	O
-	:	O
predicted	VBN	O
deleterious	JJ	O
missense	NN	O
variant	NN	O
in	IN	O
DCHS1	NNP	O
,	,	O
suggesting	VBG	O
that	IN	O
this	DT	O
single	JJ	O
gene	NN	O
may	MD	O
account	VB	O
for	IN	O
a	DT	O
substantial	JJ	O
portion	NN	O
of	IN	O
cases	NNS	O
.	.	O

CONCLUSION	NN	O
:	:	O
This	DT	O
study	NN	O
reveals	VBZ	O
an	DT	O
important	JJ	O
contribution	NN	O
of	IN	O
germline	JJ	O
variants	NNS	O
in	IN	O
DCHS1	NNP	O
in	IN	O
unrelated	JJ	O
patients	NNS	O
with	IN	O
mitral	JJ	O
valve	NN	O
prolapse	NN	O
and	CC	O
supports	VBZ	O
genetic	JJ	O
testing	NN	O
of	IN	O
this	DT	O
gene	NN	O
to	TO	O
screen	JJ	O
individuals	NNS	O
at	IN	O
risk	NN	O



mutations	NNS	B-Var
ORC1	NNP	B-Gene
ORC4	NNP	B-Gene
ORC6	NNP	B-Gene
CDT1	NNP	B-Gene
CDC6	NNP	B-Gene
cause	NN	B-Reg
Meier	NNP	B-Disease
-	:	I-Disease
Gorlin	NNP	I-Disease
syndrome	NN	I-Disease


Loss	NNP	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
of	IN	O
cdc6	NN	B-Gene
,	,	O
as	IN	O
manifested	VBN	O
by	IN	O
cdc6tsu4305	NN	O
and	CC	O
cdc6tsu7cd	NN	O
mutants	NNS	O
,	,	O
lead	NN	O
to	TO	O
embryonic	JJ	B-CPA
lethality	NN	I-CPA
due	JJ	O
to	TO	O
cell	VB	B-CPA
cycle	NN	I-CPA
arrest	NN	I-CPA
at	IN	I-CPA
the	DT	I-CPA
S	NNP	I-CPA
phase	NN	I-CPA
and	CC	O
extensive	JJ	O
apoptosis	NN	B-CPA
.	.	O
Embryos	NNP	O
homozygous	JJ	O
for	IN	O
a	DT	O
cdc6	NN	O
hypomorphic	JJ	O
mutation	NN	O
,	,	O
cdc6tsu21cd	NN	O
,	,	O
develop	VB	O
normally	RB	O
during	IN	O
embryogenesis	NN	O
.	.	O

Later	RB	O
on	IN	O
,	,	O
compared	VBN	O
with	IN	O
their	PRP$	O
wild	JJ	O
-	:	O
type	NN	O
(	(	O
WT	NNP	O
)	)	O
siblings	NNS	O
,	,	O
cdc6tsu21cd	NN	B-Var
mutant	JJ	I-Var
fish	NN	O
show	NN	O
growth	NN	O
retardation	NN	O
,	,	O
and	CC	O
their	PRP$	O
body	NN	B-CPA
weight	NN	I-CPA
and	CC	I-CPA
length	NN	I-CPA
in	IN	O
adulthood	NN	O
are	VBP	O
greatly	RB	O
reduced	VBN	B-NegReg
,	,	O
which	WDT	O
resemble	JJ	O
human	JJ	O
MGS	NNP	O
.	.	O
Surprisingly	RB	O
,	,	O
cdc6tsu21cd	NN	B-Var
mutant	JJ	I-Var
fish	JJ	O
become	NN	O
males	NNS	O
with	IN	O
a	DT	O
short	JJ	O
life	NN	O
and	CC	O
fail	VB	O
to	TO	O
mate	VB	O
with	IN	O
WT	NNP	O
females	NNS	O
,	,	O
suggesting	VBG	O
defective	JJ	B-NegReg
reproduction	NN	B-CPA
.	.	O
Overexpression	NN	O
of	IN	O
Cdc6	NNP	O
mutant	NN	O
forms	NNS	O
,	,	O
which	WDT	O
mimic	VBP	O
human	JJ	O
CDC6	NNP	B-Gene
(	(	O
T323R	NNP	O
)	)	O
mutation	NN	B-Var
found	VBN	O
in	IN	O
a	DT	O
MGS	NNP	O
patient	NN	O
,	,	O
in	IN	O
zebrafish	JJ	O
cdc6tsu4305	NN	O
mutant	NN	O
embryos	NN	O
partially	RB	O
represses	VBZ	B-NegReg
cell	NN	B-CPA
death	NN	I-CPA
phenotype	NN	I-CPA
,	,	O
suggesting	VBG	O
that	IN	O
the	DT	O
human	JJ	O
CDC6	NNP	O
(	(	O
T323R	NNP	O
)	)	O
mutation	NN	O
is	VBZ	O
a	DT	O
hypomorph	NN	O
.	.	O
cdc6tsu21cd	NN	O
mutant	JJ	O
fish	NN	O
will	MD	O
be	VB	O
useful	JJ	O
to	TO	O
detect	VB	O
more	JJR	O
tissue	NN	O
defects	NNS	O
and	CC	O
develop	VB	O
medical	JJ	O
treatment	NN	O
strategies	NNS	O
for	IN	O
MGS	NNP	O
patients	NNS	O


Germline	NNP	B-Var
heterozygous	JJ	I-Var
mutations	NNS	I-Var
signal	JJ	B-Gene
transducer	NN	I-Gene
activator	NN	B-Gene
of	IN	I-Gene
transcription	NN	I-Gene
1	CD	I-Gene
loss	NN	B-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
mycobacterial	JJ	B-Disease
diseases	NNS	I-Disease
gain	NN	B-PosReg
of	IN	I-PosReg
function	NN	I-PosReg
chronic	JJ	B-Disease
mucocutaneous	JJ	I-Disease
candidiasis	NN	I-Disease
LOF	NNP	O
and	CC	O
GOF	NNP	O
mutations	NNS	B-Var
are	VBP	O
equally	RB	O
rare	JJ	O
and	CC	O
can	MD	O
affect	VB	B-Reg
the	DT	O
same	JJ	O
domains	NNS	B-MPA
of	IN	O
STAT1	NNP	B-Gene
,	,	O
especially	RB	O
the	DT	O
coiled	JJ	B-MPA
-	:	I-MPA
coil	NN	I-MPA
domain	NN	I-MPA
(	(	O
CCD	NNP	O
)	)	O
and	CC	O
DNA	NNP	B-MPA
-	:	I-MPA
binding	NN	I-MPA
domain	NN	I-MPA
(	(	O
DBD	NNP	O
)	)	O
.	.	O
Moreover	RB	O
,	,	O
6%	CD	O
of	IN	O
patients	NNS	O
with	IN	O
chronic	JJ	O
mucocutaneous	JJ	O
candidiasis	NN	O
with	IN	O
a	DT	O
GOF	NNP	O
STAT1	NNP	O
mutation	NN	O
have	VBP	O
mycobacterial	JJ	O
disease	NN	O
,	,	O
obscuring	VBG	O
the	DT	O
functional	JJ	O
significance	NN	O
of	IN	O
the	DT	O
identified	JJ	O
STAT1	NNP	O
mutations	NNS	O
.	.	O

Current	JJ	O
computational	JJ	O
approaches	NNS	O
,	,	O
such	JJ	O
as	IN	O
combined	JJ	O
annotation	NN	O
-	:	O
dependent	JJ	O
depletion	NN	O
,	,	O
do	VBP	O
not	RB	O
distinguish	VB	O
LOF	NNP	O
and	CC	O
GOF	NNP	O
variants	NNS	O
.	.	O

OBJECTIVE	NN	O
:	:	O
We	PRP	O
estimated	VBD	O
variations	NNS	O
in	IN	O
the	DT	O
CCD	NNP	O
DBD	NNP	O
of	IN	O
STAT1	NNP	O
.	.	O

METHODS	NNS	O
:	:	O
We	PRP	O
mutagenized	VBD	O
342	CD	O
individual	JJ	O
wild	JJ	O
-	:	O
type	NN	O
amino	NN	O
acids	NNS	O
in	IN	O
the	DT	O
CCD	NNP	O
DBD	NNP	O
(	(	O
45.6%	CD	O
of	IN	O
full	JJ	O
-	:	O
length	NN	O
STAT1	NNP	O
)	)	O
to	TO	O
alanine	VB	O
and	CC	O
tested	VBD	O
the	DT	O
mutants	NNS	O
for	IN	O
STAT1	NNP	O
transcriptional	JJ	O
activity	NN	O
.	.	O

RESULTS	NN	O
:	:	O
Of	IN	O
these	DT	O
342	CD	O
mutants	NNS	O
,	,	O
201	CD	O
were	VBD	O
neutral	JJ	O
,	,	O
30	CD	O
were	VBD	O
LOF	NNP	O
,	,	O
and	CC	O
111	CD	O
were	VBD	O
GOF	NNP	O
mutations	NNS	O
in	IN	O
a	DT	O
luciferase	NN	O
assay	NN	O
.	.	O

This	DT	O
assay	NN	O
system	NN	O
correctly	RB	O
estimated	VBN	O
all	DT	O
previously	RB	O
reported	VBN	O
LOF	NNP	O
mutations	NNS	O
(	(	O
100%	CD	O
)	)	O
and	CC	O
slightly	RB	O
fewer	JJR	O
GOF	NNP	O
mutations	NNS	O
(	(	O
78.1%	CD	O
)	)	O
in	IN	O
the	DT	O
CCD	NNP	O
DBD	NNP	O
of	IN	O
STAT1	NNP	O
.	.	O

We	PRP	O
found	VBD	O
that	IN	O
GOF	NNP	O
alanine	NN	O
mutants	NNS	O
occurred	VBD	O
at	IN	O
the	DT	O
interface	NN	O
of	IN	O
the	DT	O
antiparallel	JJ	O
STAT1	NNP	O
dimer	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
they	PRP	O
destabilize	VBP	O
this	DT	O
dimer	NN	O
.	.	O

This	DT	O
assay	NN	O
also	RB	O
precisely	RB	O
predicted	VBD	O
the	DT	O
effect	NN	O
of	IN	O
2	CD	O
hypomorphic	JJ	O
and	CC	O
dominant	JJ	O
negative	JJ	O
mutations	NNS	O
,	,	O
E157K	NNP	O
and	CC	O
G250E	NNP	O
,	,	O
in	IN	O
the	DT	O
CCD	NNP	O
of	IN	O
STAT1	NNP	O
that	IN	O
we	PRP	O
found	VBD	O
in	IN	O
2	CD	O
unrelated	JJ	O
patients	NNS	O
with	IN	O
Mendelian	JJ	O
susceptibility	NN	O
to	TO	O
mycobacterial	JJ	O
diseases	NNS	O
.	.	O

CONCLUSION	NN	O
:	:	O
The	DT	O
systematic	JJ	O
alanine	NN	O
-	:	O
scanning	VBG	O
assay	NN	O
is	VBZ	O
a	DT	O
useful	JJ	O
tool	NN	O
to	TO	O
estimate	VB	O
the	DT	O
GOF	NNP	O
or	CC	O
LOF	NNP	O
status	NN	O
and	CC	O
the	DT	O
effect	NN	O
of	IN	O
heterozygous	JJ	O
missense	NN	O
mutations	NNS	O
in	IN	O
STAT1	NNP	O
identified	VBD	O
in	IN	O
patients	NNS	O
with	IN	O
severe	JJ	O
infectious	JJ	O
diseases	NNS	O
,	,	O
including	VBG	O
mycobacterial	JJ	O
and	CC	O
fungal	JJ	O
diseases	NNS	O


A	DT	O
typical	JJ	O
human	JJ	O
exome	NN	O
harbors	NNS	O
dozens	NNS	O
of	IN	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
(	(	O
LOF	NNP	O
)	)	O
variants	NNS	O
,	,	O
which	WDT	O
can	MD	O
lower	VB	O
disease	NN	O
risk	NN	O
factor	NN	O
levels	NNS	O
and	CC	O
affect	JJ	O
drug	NN	O
efficacy	NN	O
.	.	O

We	PRP	O
hypothesized	VBD	O
that	IN	O
LOF	NNP	O
variants	NNS	O
are	VBP	O
enriched	VBN	O
in	IN	O
genes	NNS	O
influencing	VBG	O
risk	NN	O
factor	NN	O
levels	NNS	O
and	CC	O
the	DT	O
onset	NN	O
of	IN	O
common	JJ	O
chronic	JJ	O
diseases	NNS	O
,	,	O
such	JJ	O
as	IN	O
cardiovascular	JJ	O
disease	NN	O
and	CC	O
diabetes	VBZ	O
.	.	O

To	TO	O
test	VB	O
this	DT	O
hypothesis	NN	O
,	,	O
we	PRP	O
sequenced	VBD	O
the	DT	O
exomes	NNS	O
of	IN	O
8	CD	O
,	,	O
554	CD	O
individuals	NNS	O
and	CC	O
analyzed	VBD	O
the	DT	O
effects	NNS	O
of	IN	O
predicted	JJ	O
LOF	NNP	O
variants	NNS	O
on	IN	O
20	CD	O
chronic	JJ	O
disease	NN	O
risk	NN	O
factor	NN	O
phenotypes	NNS	O
.	.	O

Analysis	NN	O
of	IN	O
this	DT	O
sample	NN	O
as	IN	O
discovery	NN	O
and	CC	O
replication	NN	O
strata	NNS	O
of	IN	O
equal	JJ	O
size	NN	O
verified	VBD	O
two	CD	O
relationships	NNS	O
in	IN	O
well	RB	O
-	:	O
studied	VBN	O
genes	NNS	O
(	(	O
PCSK9	NNP	O
and	CC	O
APOC3	NNP	O
)	)	O
and	CC	O
identified	VBN	O
eight	CD	O
new	JJ	O
loci	NN	O
.	.	O

Previously	RB	O
unknown	JJ	O
relationships	NNS	O
included	VBD	O
elevated	JJ	B-PosReg
fasting	VBG	O
glucose	NN	B-MPA
in	IN	O
carriers	NNS	O
of	IN	O
heterozygous	JJ	O
LOF	NNP	B-NegReg
variation	NN	B-Var
in	IN	O
TXNDC5	NNP	B-Gene
,	,	O
which	WDT	O
encodes	VBZ	O
a	DT	O
biomarker	NN	O
for	IN	O
type	NN	O
1	CD	O
diabetes	NNS	O
progression	NN	O
,	,	O
and	CC	O
apparent	JJ	O
recessive	JJ	B-NegReg
effects	NNS	I-NegReg
of	IN	O
C1QTNF8	NNP	B-Gene
on	IN	O
serum	NN	B-MPA
magnesium	NN	I-MPA
levels	NNS	I-MPA
.	.	O
These	DT	O
data	NNS	O
demonstrate	VBP	O
the	DT	O
utility	NN	O
of	IN	O
functional	JJ	O
-	:	O
variant	JJ	O
annotation	NN	O
within	IN	O
a	DT	O
large	JJ	O
sample	NN	O
of	IN	O
deeply	NN	O
phenotyped	JJ	O
individuals	NNS	O
for	IN	O
gene	NN	O
discovery	NN	O


Plaque	NNP	O
psoriasis	NN	O
and	CC	O
pustular	JJ	O
psoriasis	NN	O
are	VBP	O
overlapping	VBG	O
,	,	O
but	CC	O
distinct	JJ	O
,	,	O
disorders	NNS	O
.	.	O

The	DT	O
therapeutic	JJ	O
response	NN	O
to	TO	O
biologics	NNS	O
supports	VBZ	O
the	DT	O
pivotal	JJ	O
role	NN	O
of	IN	O
the	DT	O
tumour	JJ	O
necrosis	NN	O
alpha	NN	O
(	(	O
TNF	NNP	O
-	:	O
?	.	O

)	)	O
interleukin	NN	O
(	(	O
IL	NNP	O
)-	CD	O
23	CD	O
IL	NNP	O
-	:	O
17	CD	O
IL	NNP	O
-	:	O
22	CD	O
axis	NN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
these	DT	O
disorders	NNS	O
.	.	O

Recently	RB	O
,	,	O
functional	JJ	O
activation	NN	O
of	IN	O
the	DT	O
IL	NNP	O
-	:	O
36	CD	O
receptor	NN	O
(	(	O
IL	NNP	O
-	:	O
36	CD	O
R	NNP	O
)	)	O
was	VBD	O
discovered	VBN	O
to	TO	O
be	VB	O
another	DT	O
driving	VBG	O
force	NN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
psoriasis	NN	O
.	.	O

This	DT	O
was	VBD	O
first	RB	O
highlighted	VBN	O
by	IN	O
the	DT	O
discovery	NN	O
that	IN	O
a	DT	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutation	NN	B-Var
of	IN	O
the	DT	O
IL	NNP	O
-	:	O
36	CD	O
R	NNP	O
antagonist	NN	O
(	(	O
IL	NNP	B-Gene
-	:	I-Gene
36	CD	I-Gene
Ra	NNP	I-Gene
)	)	O
causes	VBZ	O
pustular	JJ	B-Disease
psoriasis	NN	I-Disease
.	.	O
Although	IN	O
the	DT	O
TNF	NNP	O
-	:	O
?	.	O
IL	NNP	O
-	:	O
23	CD	O
IL	NNP	O
-	:	O
17	CD	O
IL	NNP	O
-	:	O
22	CD	O
axis	NN	O
and	CC	O
the	DT	O
functional	JJ	O
activation	NN	O
of	IN	O
IL	NNP	O
-	:	O
36	CD	O
R	NN	O
are	VBP	O
fundamentally	RB	O
involved	VBN	O
in	IN	O
plaque	JJ	O
psoriasis	NN	O
and	CC	O
pustular	JJ	O
psoriasis	NN	O
,	,	O
respectively	RB	O
,	,	O
the	DT	O
2	CD	O
pathways	NNS	O
are	VBP	O
closely	RB	O
related	JJ	O
and	CC	O
mutually	RB	O
reinforced	VBN	O
,	,	O
resulting	VBG	O
in	IN	O
full	JJ	O
-	:	O
blown	JJ	O
clinical	JJ	O
manifestations	NNS	O
.	.	O

This	DT	O
review	NN	O
summarizes	VBZ	O
current	JJ	O
topics	NNS	O
on	IN	O
how	WRB	O
IL	NNP	O
-	:	O
36	CD	O
agonists	NNS	O
(	(	O
IL	NNP	O
-	:	O
36	CD	O
?	.	O
,	,	O
IL	NNP	O
-	:	O
36	CD	O
?	.	O
,	,	O
IL	NNP	O
-	:	O
36	CD	O
?	.	O
)	)	O

signal	JJ	O
IL	NNP	O
-	:	O
36	CD	O
R	NNP	O
,	,	O
the	DT	O
pathological	JJ	O
expression	NN	O
of	IN	O
IL	NNP	O
-	:	O
36	CD	O
agonists	NNS	O
and	CC	O
IL	NNP	O
-	:	O
36	CD	O
Ra	NNP	O
in	IN	O
plaque	NN	O
and	CC	O
pustular	JJ	O
psoriatic	JJ	O
lesions	NNS	O
,	,	O
and	CC	O
the	DT	O
cross	NN	O
-	:	O
talk	NN	O
between	IN	O
the	DT	O
TNF	NNP	O
-	:	O
?	.	O
IL	NNP	O
-	:	O
23	CD	O
IL	NNP	O
-	:	O
17	CD	O
IL	NNP	O
-	:	O
22	CD	O
axis	NN	O
and	CC	O
the	DT	O
functional	JJ	O
activation	NN	O
of	IN	O
IL	NNP	O
-	:	O
36	CD	O
R	NN	O
in	IN	O
the	DT	O
epidermal	JJ	O
milieu	NN	O

gain	NN	I-Gene
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
lead	VBP	I-Var
azole	VB	I-Reg
-	:	I-MPA
and	CC	I-MPA
increased	JJ	B-PosReg
adhesion	NN	B-MPA



The	DT	O
azole	JJ	O
-	:	O
susceptible	JJ	O
strains	NNS	O
acquired	VBD	O
azole	JJ	O
resistance	NN	O
after	IN	O
antifungal	JJ	O
therapy	NN	O
.	.	O

Four	CD	O
gain	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
(	(	O
GOF	NNP	O
)	)	O
mutations	NNS	O
in	IN	O
CgPDR1	NNP	O
were	VBD	O
revealed	VBN	O
by	IN	O
sequence	NN	O
analysis	NN	O
,	,	O
namely	RB	O
G1099D	NNP	O
,	,	O
G346D	NNP	O
,	,	O
L344S	NNP	O
and	CC	O
P927S	NNP	O
,	,	O
the	DT	O
last	JJ	O
being	VBG	O
reported	VBD	O
for	IN	O
the	DT	O
first	JJ	O
time	NN	O
.	.	O

CDR1	NNP	B-MPA
,	,	I-MPA
CDR2	NNP	I-MPA
and	CC	I-MPA
SNQ2	NNP	I-MPA
efflux	VBP	I-MPA
pump	JJ	I-MPA
gene	NN	I-MPA
expression	NN	I-MPA
levels	NNS	I-MPA
were	VBD	O
elevated	VBN	B-PosReg
in	IN	O
strains	NNS	O
harbouring	VBG	O
GOF	NNP	B-PosReg
mutations	NNS	B-Var
in	IN	O
CgPDR1	NNP	B-Gene
,	,	O
resulting	VBG	O
in	IN	O
decreased	JJ	B-NegReg
azole	JJ	B-MPA
susceptibility	NN	I-MPA
.	.	O
CgPDR1	NNP	O
alleles	VBZ	O
with	IN	O
distinct	JJ	O
GOF	NNP	O
mutations	NNS	O
displayed	VBD	O
different	JJ	O
expression	NN	O
profiles	NNS	O
for	IN	O
the	DT	O
drug	NN	O
-	:	O
related	VBN	O
genes	NNS	O
.	.	O

CgPDR1GOF	NNP	B-Gene
mutations	NNS	I-Gene
led	VBD	I-PosReg
to	TO	I-Var
increased	VBN	B-PosReg
efflux	NN	B-MPA
pumps	NNS	I-MPA
expression	NN	I-MPA
levels	NNS	I-MPA
in	IN	O
a	DT	O
strain	NN	O
background	NN	O
independent	JJ	O
way	NN	O
.	.	O
Hyperactive	JJ	O
Pdr1G1099D	NNP	O
and	CC	O
Pdr1P927S	NNP	O
displayed	VBD	O
strain	NN	O
background	IN	O
-	:	O
dependent	NN	O
increased	VBD	O
adherence	NN	O
to	TO	O
host	VB	O
cells	NNS	O
via	IN	O
upregulation	NN	O
of	IN	O
EPA1	NNP	O
transcription	NN	O
.	.	O

Interestingly	RB	O
,	,	O
the	DT	O
drug	NN	O
transporter	NN	O
gene	NN	O
expression	NN	O
levels	NNS	O
did	VBD	O
not	RB	O
always	RB	O
correspond	NN	O
with	IN	O
that	DT	O
of	IN	O
the	DT	O
adhesin	NN	O
EPA1	NNP	O
gene	NN	O
.	.	O

GOF	NNP	B-PosReg
mutations	NNS	B-Var
in	IN	O
CgPDR1	NNP	B-Gene
conferred	VBD	B-Reg
drug	NN	B-MPA
resistance	NN	I-MPA
and	CC	O
increased	VBD	B-PosReg
adherence	NN	B-MPA
in	IN	O
the	DT	O
clinical	JJ	O
strains	NNS	O
,	,	O
possibly	RB	O
endowing	VBG	O
C.	NNP	O
glabrata	NN	O
with	IN	O
increased	JJ	O
viability	NN	O
and	CC	O
pathogenicity	NN	O


Estimates	NNS	O
from	IN	O
large	JJ	O
scale	JJ	O
genome	NN	O
sequencing	VBG	O
studies	NNS	O
indicate	VBP	O
that	IN	O
each	DT	O
human	NN	O
carries	VBZ	O
up	IN	O
to	TO	O
20	CD	O
genetic	JJ	O
variants	NNS	O
that	WDT	O
are	VBP	O
predicted	VBN	O
to	TO	O
results	NNS	O
in	IN	O
loss	NN	O
of	IN	O
function	NN	O
(	(	O
LOF	NNP	O
)	)	O
of	IN	O
protein	NN	O
-	:	O
coding	NN	O
genes	NNS	O
.	.	O

While	IN	O
some	DT	O
are	VBP	O
known	VBN	O
disease	JJ	O
-	:	O
causing	VBG	O
variants	NNS	O
or	CC	O
common	JJ	O
,	,	O
tolerated	JJ	O
,	,	O
LOFs	NNP	O
in	IN	O
non	JJ	O
-	:	O
essential	JJ	O
genes	NNS	O
,	,	O
the	DT	O
majority	NN	O
remain	NN	O
of	IN	O
unknown	JJ	O
consequence	NN	O
.	.	O

We	PRP	O
explore	VBP	O
the	DT	O
possibility	NN	O
of	IN	O
using	VBG	O
imputed	VBN	O
GWAS	NNP	O
data	NNS	O
from	IN	O
large	JJ	O
biorepositories	NNS	O
such	JJ	O
as	IN	O
the	DT	O
electronic	JJ	O
medical	JJ	O
record	NN	O
and	CC	O
genomics	NNS	O
(	(	O
eMERGE	NN	O
)	)	O
consortium	NN	O
to	TO	O
determine	VB	O
the	DT	O
effects	NNS	O
of	IN	O
rare	JJ	O
LOFs	NNP	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
show	VBP	O
that	IN	O
two	CD	O
hypocholesterolemia	SYM	B-Disease
-	:	O
associated	VBN	O
LOF	NNP	B-NegReg
mutations	NNS	B-Var
in	IN	O
the	DT	O
PCSK9	NNP	B-Gene
gene	NN	O
can	MD	O
be	VB	O
accurately	RB	O
imputed	VBN	O
into	IN	O
large	JJ	O
-	:	O
scale	NN	O
GWAS	NNP	O
datasets	NNS	O
which	WDT	O
raises	VBZ	O
the	DT	O
possibility	NN	O
of	IN	O
assessing	VBG	O
LOFs	NNP	O
through	IN	O
genomics	NNS	O
-	:	O
linked	VBN	O
medical	JJ	O
records	NNS	O

exchange	NN	I-Var
R	NNP	B-Gene
converts	NNS	B-Reg
nematode	JJ	B-MPA
resistance	NN	I-MPA

changes	NNS	B-Var
alter	VB	B-Reg
resistance	NN	B-MPA
specificities	NNS	I-MPA
towards	VBP	I-MPA
novel	JJ	I-MPA
strains	NNS	I-MPA
of	IN	I-MPA
a	DT	I-MPA
pathogen	NN	I-MPA

To	TO	O
investigate	VB	O
this	DT	O
,	,	O
we	PRP	O
created	VBD	O
domain	NN	O
swaps	NNS	O
between	IN	O
the	DT	O
close	JJ	O
homologs	NNS	O
Gpa2	NNP	O
and	CC	O
Rx1	NNP	O
,	,	O
which	WDT	O
confer	VBP	O
resistance	NN	O
in	IN	O
potato	NN	O
to	TO	O
the	DT	O
cyst	NN	O
nematode	NN	O
Globodera	NNP	O
pallida	NN	O
and	CC	O
Potato	NNP	O
virus	NN	O
X	NNP	O
(	(	O
PVX	NNP	O
)	)	O
,	,	O
respectively	RB	O
.	.	O

The	DT	O
genetic	JJ	O
fusion	NN	O
of	IN	O
the	DT	O
CC	NNP	O
-	:	O
NB	NNP	O
-	:	O
ARC	NN	O
of	IN	O
Gpa2	NNP	O
with	IN	O
the	DT	O
LRR	NNP	O
of	IN	O
Rx1	NNP	O
(	(	O
Gpa2CN	NNP	O
Rx1L	NNP	O
)	)	O
resulted	VBD	O
in	IN	O
autoactivity	NN	O
,	,	O
but	CC	O
lowering	VBG	O
the	DT	O
protein	NN	O
levels	NNS	O
restored	VBD	O
its	PRP$	O
specific	JJ	O
activation	NN	O
response	NN	O
including	VBG	O
extreme	JJ	O
resistance	NN	O
to	TO	O
PVX	NNP	O
in	IN	O
potato	NN	O
shoots	NNS	O
.	.	O

The	DT	O
reciprocal	JJ	O
construct	NN	O
(	(	O
Rx1CN	NNP	O
Gpa2L	NNP	O
)	)	O
showed	VBD	O
a	DT	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
phenotype	NN	O
,	,	O
but	CC	O
exchange	NN	B-Var
of	IN	O
the	DT	O
first	JJ	O
3	CD	O
LRR	NNP	O
repeats	NNS	O
of	IN	O
Rx1	NNP	B-Gene
was	VBD	O
sufficient	JJ	O
to	TO	O
regain	VB	B-PosReg
a	DT	O
wild	JJ	B-MPA
type	NN	I-MPA
resistance	NN	I-MPA
response	NN	I-MPA
to	TO	I-MPA
G.	NNP	I-MPA
pallida	NN	I-MPA
in	IN	I-MPA
the	DT	I-MPA
roots	NNS	I-MPA
.	.	O
These	DT	O
data	NNS	O
demonstrate	NN	O
that	IN	O
exchanging	VBG	B-Var
the	DT	O
recognition	NN	O
moiety	NN	O
in	IN	O
the	DT	O
LRR	NNP	O
is	VBZ	O
sufficient	JJ	O
to	TO	O
convert	VB	B-Reg
extreme	JJ	O
virus	NN	O
resistance	NN	O
in	IN	O
the	DT	O
leaves	NNS	O
into	IN	O
mild	JJ	B-MPA
nematode	JJ	I-MPA
resistance	NN	I-MPA
in	IN	I-MPA
the	DT	I-MPA
roots	NNS	I-MPA
,	,	O
and	CC	O
vice	NN	O
versa	NN	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
we	PRP	O
show	VBP	O
that	IN	O
the	DT	O
CC	NNP	O
-	:	O
NB	NNP	O
-	:	O
ARC	NN	O
can	MD	O
operate	VB	O
independently	RB	O
of	IN	O
the	DT	O
recognition	NN	O
specificities	NNS	O
defined	VBN	O
by	IN	O
the	DT	O
LRR	NNP	O
domain	NN	O
,	,	O
either	CC	O
above	IN	O
or	CC	O
belowground	NN	O
.	.	O

These	DT	O
data	NNS	O
show	VBP	O
the	DT	O
versatility	NN	O
of	IN	O
NB	NNP	O
-	:	O
LRR	NNP	O
genes	NNS	O
to	TO	O
generate	VB	O
resistances	NNS	O
to	TO	O
unrelated	JJ	O
pathogens	NNS	O
with	IN	O
completely	RB	O
different	JJ	O
lifestyles	NNS	O
and	CC	O
routes	NNS	O
of	IN	O
invasion	NN	O


Loss	NNP	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
in	IN	O
the	DT	O
X	NNP	O
-	:	O
linked	VBN	O
gene	NN	O
FLNA	NNP	B-Gene
can	MD	O
lead	VB	O
to	TO	O
abnormal	JJ	B-CPA
neuronal	JJ	I-CPA
migration	NN	I-CPA
,	,	O
vascular	JJ	B-CPA
and	CC	I-CPA
cardiac	JJ	I-CPA
defects	NNS	I-CPA
,	,	O
and	CC	O
congenital	JJ	B-Disease
intestinal	JJ	I-Disease
pseudo	NN	I-Disease
-	:	I-Disease
obstruction	NN	I-Disease
(	(	O
CIPO	NNP	O
)	)	O
,	,	O
the	DT	O
latter	JJ	O
characterized	VBN	O
by	IN	O
anomalous	JJ	O
intestinal	JJ	O
smooth	JJ	O
muscle	NN	O
layering	NN	O
.	.	O
Survival	NN	O
in	IN	O
male	NN	O
hemizygotes	NNS	O
for	IN	O
such	JJ	O
mutations	NNS	O
is	VBZ	O
dependent	JJ	O
on	IN	O
retention	NN	O
of	IN	O
residual	JJ	O
FLNA	NNP	O
function	NN	O
but	CC	O
it	PRP	O
is	VBZ	O
unclear	JJ	O
why	WRB	O
a	DT	O
subgroup	NN	O
of	IN	O
males	NNS	O
with	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
5	CD	O
end	NN	O
of	IN	O
the	DT	O
gene	NN	O
can	MD	O
present	VB	O
with	IN	O
CIPO	NNP	O
alone	RB	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
demonstrate	VBP	O
evidence	NN	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
two	CD	O
FLNA	NNP	O
isoforms	NNS	O
differing	VBG	O
by	IN	O
28	CD	O
residues	NNS	O
at	IN	O
the	DT	O
N	NNP	O
-	:	O
terminus	NN	O
initiated	VBN	O
at	IN	O
ATG	NNP	O
1	CD	O
and	CC	O
ATG	NNP	O
82	CD	O
.	.	O

A	DT	O
male	NN	O
with	IN	O
CIPO	NNP	O
(	(	O
c	NN	O
.	.	O
18	CD	O
_	JJ	O
19	CD	O
del	NN	O
)	)	O
exclusively	RB	O
expressed	VBN	O
FLNA	NNP	O
ATG	NNP	O
82	CD	O
,	,	O
implicating	VBG	O
the	DT	O
longer	JJR	O
protein	JJ	O
isoform	NN	O
(	(	O
ATG	NNP	O
1	CD	O
)	)	O
in	IN	O
smooth	JJ	O
muscle	NN	O
development	NN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
mutations	NNS	O
leading	VBG	O
to	TO	O
reduction	NN	O
of	IN	O
both	DT	O
isoforms	NNS	O
are	VBP	O
associated	VBN	O
with	IN	O
compound	NN	O
phenotypes	NNS	O
affecting	VBG	O
the	DT	O
brain	NN	O
,	,	O
heart	NN	O
,	,	O
and	CC	O
intestine	NN	O
.	.	O

RNA	NNP	O
-	:	O
seq	NN	O
data	NNS	O
revealed	VBD	O
three	CD	O
distinct	JJ	O
transcription	NN	O
start	NN	O
sites	NNS	O
,	,	O
two	CD	O
of	IN	O
which	WDT	O
produce	VBP	O
a	DT	O
protein	NN	O
isoform	NN	O
utilizing	VBG	O
ATG	NNP	O
1	CD	O
while	IN	O
the	DT	O
third	JJ	O
utilizes	JJ	O
ATG	NNP	O
82	CD	O
.	.	O

Transcripts	NNS	O
sponsoring	VBG	O
translational	JJ	O
initiation	NN	O
at	IN	O
ATG	NNP	O
1	CD	O
predominate	NN	O
in	IN	O
intestinal	JJ	O
smooth	JJ	O
muscle	NN	O
,	,	O
and	CC	O
are	VBP	O
more	RBR	O
abundant	JJ	O
compared	VBN	O
with	IN	O
the	DT	O
level	NN	O
measured	VBN	O
in	IN	O
fibroblasts	NNS	O
.	.	O

Together	RB	O
these	DT	O
observations	NNS	O
describe	VBP	O
a	DT	O
new	JJ	O
mechanism	NN	O
of	IN	O
tissue	NN	O
-	:	O
specific	JJ	O
regulation	NN	O
of	IN	O
FLNA	NNP	O
that	WDT	O
could	MD	O
reflect	VB	O
the	DT	O
differing	VBG	O
mechanical	JJ	O
requirements	NNS	O
of	IN	O
these	DT	O
cell	NN	O
types	NNS	O
during	IN	O
development	NN	O


Phosphoribosylpyrophosphate	NNP	O
synthetase	NN	O
(	(	O
PRPPS	NNP	O
)	)	O
superactivity	NN	O
(	(	O
OMIM	NNP	O
300661	CD	O
)	)	O
is	VBZ	O
a	DT	O
rare	JJ	O
inborn	JJ	O
error	NN	O
of	IN	O
purine	JJ	O
metabolism	NN	O
that	WDT	O
is	VBZ	O
caused	VBN	O
by	IN	O
gain	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
X	NNP	O
-	:	O
chromosomal	JJ	O
gene	NN	O
PRPS1	NNP	O
(	(	O
Xq22	NNP	O
.	.	O
3	CD	O
)	)	O
.	.	O

Clinical	JJ	O
characteristics	NNS	O
include	VBP	O
congenital	JJ	O
hyperuricemia	NN	O
and	CC	O
hyperuricosuria	NN	O
,	,	O
gouty	NN	O
arthritis	NN	O
,	,	O
urolithiasis	NN	O
,	,	O
developmental	JJ	O
delay	NN	O
,	,	O
hypotonia	NN	O
,	,	O
recurrent	JJ	O
infections	NNS	O
,	,	O
short	JJ	O
stature	NN	O
,	,	O
and	CC	O
hearing	JJ	O
loss	NN	O
.	.	O

Only	RB	O
eight	CD	O
families	NNS	O
with	IN	O
PRPPS	NNP	O
superactivity	NN	O
and	CC	O
PRPS1	NNP	O
gain	VBP	O
-	:	O
of	IN	O
-	:	O
function	NN	O
mutations	NNS	O
have	VBP	O
been	VBN	O
reported	VBN	O
to	TO	O
date	NN	O
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
a	DT	O
7	CD	O
-	:	O
year	NN	O
-	:	O
old	JJ	O
boy	NN	O
with	IN	O
congenital	JJ	O
hyperuricemia	NN	O
,	,	O
urolithiasis	NN	O
,	,	O
developmental	JJ	O
delay	NN	O
,	,	O
short	JJ	O
stature	NN	O
,	,	O
hypospadias	NN	O
,	,	O
and	CC	O
facial	JJ	O
dysmorphisms	NN	O
.	.	O

His	PRP$	O
mother	NN	O
also	RB	O
suffered	VBD	O
from	IN	O
hyperuricemia	NN	O
that	WDT	O
was	VBD	O
diagnosed	VBN	O
at	IN	O
age	NN	O
13	CD	O
years	NNS	O
.	.	O

A	DT	O
novel	JJ	O
PRPS1	NNP	O
missense	NN	O
mutation	NN	O
(	(	O
c	NN	O
.	.	O
573	CD	O
G	NNP	O
C	NNP	O
,	,	O
p	NN	O
.	.	O

[	JJ	O
Leu191Phe	NNP	O
])	NNP	O
was	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
proband	NN	O
and	CC	O
his	PRP$	O
mother	NN	O
.	.	O

Enzyme	NNP	O
activity	NN	O
analysis	NN	O
confirmed	VBD	O
superactivity	NN	O
of	IN	O
PRPP	NNP	O
synthetase	NN	O
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
crystal	JJ	O
structure	NN	O
of	IN	O
human	JJ	O
PRPPS	NNP	O
suggests	VBZ	O
that	IN	O
the	DT	O
Leu191Phe	NNP	B-Gene
mutation	NN	B-Var
affects	VBZ	B-Reg
the	DT	O
architecture	NN	B-MPA
of	IN	O
both	DT	O
allosteric	JJ	O
sites	NNS	O
,	,	O
thereby	RB	O
preventing	VBG	B-NegReg
the	DT	O
allosteric	JJ	B-MPA
inhibition	NN	I-MPA
of	IN	O
the	DT	O
enzyme	NN	B-Enzyme
.	.	O
The	DT	O
family	NN	O
reported	VBD	O
here	RB	O
broadens	VBZ	O
the	DT	O
clinical	JJ	O
spectrum	NN	O
of	IN	O
PRPPS	NNP	O
superactivity	NN	O
and	CC	O
indicates	VBZ	O
that	IN	O
this	DT	O
rare	JJ	O
metabolic	JJ	O
disorder	NN	O
might	MD	O
be	VB	O
associated	VBN	O
with	IN	O
a	DT	O
recognizable	JJ	O
facial	JJ	O
gestalt	NN	O


The	DT	O
research	NN	O
domain	NN	O
criteria	NNS	O
(	(	O
RDoC	NNP	O
)	)	O
matrix	NN	O
has	VBZ	O
been	VBN	O
developed	VBN	O
to	TO	O
reorient	VB	O
psychiatric	JJ	O
research	NN	O
towards	NNS	O
measurable	JJ	O
behavioral	JJ	O
dimensions	NNS	O
and	CC	O
underlying	VBG	O
mechanisms	NNS	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
used	VBD	O
a	DT	O
new	JJ	O
genetic	JJ	O
rat	NN	O
model	NN	O
with	IN	O
a	DT	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
point	NN	O
mutation	NN	O
in	IN	O
the	DT	O
dopamine	NN	O
transporter	NN	O
(	(	O
DAT	NNP	O
)	)	O
gene	NN	O
(	(	O
Slc6a3	NNP	O
_	NNP	O
N157K	NNP	O
)	)	O
to	TO	O
systematically	RB	O
study	VB	O
the	DT	O
RDoC	NNP	O
matrix	NN	O
.	.	O

First	RB	O
,	,	O
we	PRP	O
examined	VBD	O
the	DT	O
impact	NN	O
of	IN	O
the	DT	O
Slc6a3	NNP	O
_	NNP	O
N157K	NNP	O
mutation	NN	O
on	IN	O
monoaminergic	JJ	O
signaling	NN	O
.	.	O

We	PRP	O
then	RB	O
performed	VBD	O
behavioral	JJ	O
tests	NNS	O
representing	VBG	O
each	DT	O
of	IN	O
the	DT	O
five	CD	O
RDoC	NNP	O
domains	NNS	O
:	:	O
negative	JJ	O
and	CC	O
positive	JJ	O
valence	NN	O
systems	NNS	O
,	,	O
cognitive	JJ	O
,	,	O
social	JJ	O
and	CC	O
arousal	JJ	O
regulatory	JJ	O
systems	NNS	O
.	.	O

The	DT	O
use	NN	O
of	IN	O
RDoC	NNP	O
may	MD	O
be	VB	O
particularly	RB	O
helpful	JJ	O
for	IN	O
drug	NN	O
development	NN	O
.	.	O

We	PRP	O
studied	VBD	O
the	DT	O
effects	NNS	O
of	IN	O
a	DT	O
novel	JJ	O
pharmacological	JJ	O
approach	NN	O
metabotropic	NN	O
glutamate	NN	O
receptor	NN	O
mGluR2	VBD	O
3	CD	O
antagonism	NN	O
,	,	O
in	IN	O
DAT	NNP	O
mutants	NNS	O
in	IN	O
a	DT	O
comparative	JJ	O
way	NN	O
with	IN	O
standard	JJ	O
medications	NNS	O
.	.	O

Loss	NNP	B-NegReg
of	IN	O
DAT	NNP	B-Gene
functionality	NN	O
in	IN	O
mutant	JJ	B-Var
rats	NNS	O
not	RB	O
only	RB	O
elevated	JJ	B-PosReg
subcortical	JJ	B-MPA
extracellular	JJ	I-MPA
dopamine	NN	I-MPA
concentration	NN	I-MPA
but	CC	O
also	RB	O
altered	VBD	B-Reg
the	DT	O
balance	NN	B-MPA
of	IN	I-MPA
monoaminergic	JJ	I-MPA
transmission	NN	I-MPA
.	.	O
DAT	NNP	O
mutant	NN	O
rats	NN	O
showed	VBD	O
deficits	NNS	O
in	IN	O
all	DT	O
five	CD	O
RDoC	NNP	O
domains	NNS	O
.	.	O

Thus	RB	O
,	,	O
mutant	JJ	O
rats	NNS	O
failed	VBD	O
to	TO	O
show	VB	O
conditioned	JJ	O
fear	NN	O
responses	NNS	O
,	,	O
were	VBD	O
anhedonic	JJ	O
,	,	O
were	VBD	O
unable	JJ	O
to	TO	O
learn	VB	O
stimulus	JJ	O
-	:	O
reward	NN	O
associations	NNS	O
,	,	O
showed	VBD	O
impaired	JJ	O
cognition	NN	O
and	CC	O
social	JJ	O
behavior	NN	O
,	,	O
and	CC	O
were	VBD	O
hyperactive	JJ	O
.	.	O

Hyperactivity	NN	O
in	IN	O
mutant	JJ	O
rats	NN	O
was	VBD	O
reduced	VBN	O
by	IN	O
amphetamine	NN	O
and	CC	O
atomoxetine	NN	O
,	,	O
which	WDT	O
are	VBP	O
well	RB	O
-	:	O
established	VBN	O
medications	NNS	O
to	TO	O
reduce	VB	O
hyperactivity	NN	O
in	IN	O
humans	NNS	O
.	.	O

The	DT	O
mGluR2	NN	O
3	CD	O
antagonist	NN	O
LY341495	NNP	O
also	RB	O
normalized	VBD	O
hyperactivity	NN	O
in	IN	O
DAT	NNP	O
mutant	NN	O
rats	NNS	O
without	IN	O
affecting	VBG	O
extracellular	JJ	O
dopamine	NN	O
levels	NNS	O
.	.	O

We	PRP	O
systematically	RB	O
characterized	VBD	O
an	DT	O
altered	VBN	O
dopamine	NN	O
system	NN	O
within	IN	O
the	DT	O
context	NN	O
of	IN	O
the	DT	O
RDoC	NNP	O
matrix	NN	O
and	CC	O
studied	VBD	O
mGluR2	NNS	O
3	CD	O
antagonism	NN	O
as	IN	O
a	DT	O
new	JJ	O
pharmacological	JJ	O
strategy	NN	O
to	TO	O
treat	VB	O
mental	JJ	O
disorders	NNS	O
with	IN	O
underlying	JJ	O
subcortical	JJ	O
dopaminergic	NN	O
hyperactivity	NN	O


Since	IN	O
the	DT	O
discovery	NN	O
of	IN	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
in	IN	O
filaggrin	NN	O
(	(	O
FLG	NNP	B-Gene
)	)	O
gene	NN	O
in	IN	O
atopic	JJ	B-Disease
dermatitis	NN	I-Disease
(	(	O
AD	NNP	O
)	)	O
individuals	NNS	O
,	,	O
significant	JJ	O
attention	NN	O
has	VBZ	O
been	VBN	O
paid	VBN	O
against	IN	O
the	DT	O
skin	JJ	O
barrier	NN	O
as	IN	O
an	DT	O
initial	JJ	O
starting	VBG	O
point	NN	O
of	IN	O
atopic	JJ	O
march	NN	O
.	.	O
Although	IN	O
FLG	NNP	O
is	VBZ	O
a	DT	O
significant	JJ	O
cornification	NN	O
-	:	O
associated	VBN	O
gene	NN	O
,	,	O
skin	FW	O
barrier	JJR	O
formation	NN	O
is	VBZ	O
a	DT	O
complex	JJ	O
process	NN	O
mediated	VBN	O
by	IN	O
an	DT	O
array	NN	O
of	IN	O
genes	NNS	O
with	IN	O
specific	JJ	O
functions	NNS	O
.	.	O

In	IN	O
this	DT	O
article	NN	O
,	,	O
the	DT	O
mechanism	NN	O
of	IN	O
physical	JJ	O
skin	NN	O
barrier	NN	O
formation	NN	O
is	VBZ	O
reviewed	VBN	O
in	IN	O
detail	NN	O
,	,	O
focusing	VBG	O
on	IN	O
specific	JJ	O
gene	NN	O
functions	NNS	O
and	CC	O
inherited	JJ	O
disorders	NNS	O
caused	VBN	O
by	IN	O
genetic	JJ	O
aberrations	NNS	O
.	.	O

Additionally	RB	O
,	,	O
the	DT	O
mechanism	NN	O
of	IN	O
percutaneous	JJ	O
sensitization	NN	O
with	IN	O
environmental	JJ	O
allergens	NNS	O
in	IN	O
association	NN	O
with	IN	O
FLG	NNP	O
-	:	O
deficiency	NN	O
is	VBZ	O
reviewed	VBN	O
in	IN	O
order	NN	O
to	TO	O
clarify	VB	O
the	DT	O
link	NN	O
between	IN	O
defective	JJ	O
skin	NN	O
barrier	NN	O
and	CC	O
atopic	NN	O
march	NN	O
.	.	O

Finally	RB	O
,	,	O
updated	VBD	O
knowledge	NN	O
of	IN	O
psoriasis	NN	O
pathophysiology	NN	O
in	IN	O
connection	NN	O
with	IN	O
genetic	JJ	O
defect	NN	O
in	IN	O
skin	JJ	O
barrier	NN	O
is	VBZ	O
reviewed	VBN	O
.	.	O

This	DT	O
article	NN	O
would	MD	O
provide	VB	O
a	DT	O
novel	JJ	O
opportunity	NN	O
to	TO	O
understand	VB	O
the	DT	O
allergic	NN	O
autoimmune	NN	O
disorders	NNS	O
from	IN	O
the	DT	O
viewpoint	NN	O
of	IN	O
non	JJ	O
-	:	O
classical	JJ	O
immune	NN	O
cells	NNS	O


Control	NN	O
of	IN	O
phosphate	JJ	O
metabolism	NN	O
is	VBZ	O
crucial	JJ	O
to	TO	O
regulate	VB	O
aging	VBG	O
in	IN	O
mammals	NNS	O
.	.	O

Klotho	NNP	O
is	VBZ	O
a	DT	O
well	RB	O
-	:	O
known	VBN	O
anti	JJ	O
-	:	O
aging	VBG	O
factor	NN	O
that	WDT	O
regulates	VBZ	O
phosphate	JJ	O
metabolism	NN	O
:	:	O
mice	NN	O
mutant	NN	O
or	CC	O
deficient	NN	O
in	IN	O
Klotho	NNP	O
exhibit	NN	O
phenotypes	NNS	O
resembling	VBG	O
human	JJ	O
aging	NN	O
.	.	O

Here	RB	O
we	PRP	O
show	VBP	O
that	IN	O
ectonucleotide	JJ	O
pyrophosphatase	NN	O
phosphodiesterase	NN	O
1	CD	O
(	(	O
Enpp1	NNP	O
)	)	O
is	VBZ	O
required	VBN	O
for	IN	O
Klotho	NNP	O
expression	NN	O
under	IN	O
phosphate	NN	O
overload	NN	O
conditions	NNS	O
.	.	O

Loss	NNP	B-Var
-	:	I-Var
of	IN	I-Var
-	:	I-Var
function	NN	I-Var
Enpp1	NNP	B-Gene
(	(	O
ttw	JJ	O
ttw	NN	O
)	)	O
mice	NN	O
under	IN	O
phosphate	NN	O
overload	NN	O
conditions	NNS	O
exhibited	VBD	B-Reg
phenotypes	NNS	O
resembling	VBG	O
human	JJ	O
aging	VBG	O
and	CC	O
Klotho	NNP	O
mutants	NNS	O
,	,	O
such	JJ	O
as	IN	O
short	JJ	O
life	NN	O
span	NN	O
,	,	O
arteriosclerosis	NN	B-Disease
and	CC	O
osteoporosis	NN	B-Disease
,	,	O
with	IN	O
elevated	VBN	B-PosReg
serum	NN	B-MPA
1	CD	I-MPA
,	,	I-MPA
25	CD	I-MPA
(	(	I-MPA
OH	NNP	I-MPA
)	)	I-MPA
2	CD	I-MPA
D3	NNP	I-MPA
levels	NNS	I-MPA
.	.	O
Enpp1	NNP	O
(	(	O
ttw	JJ	O
ttw	NN	O
)	)	O
mice	NN	O
also	RB	O
exhibited	VBD	O
significantly	RB	O
reduced	VBN	O
renal	JJ	O
Klotho	NNP	O
expression	NN	O
under	IN	O
phosphate	NN	O
overload	NN	O
conditions	NNS	O
,	,	O
and	CC	O
aging	VBG	O
phenotypes	NNS	O
in	IN	O
these	DT	O
mice	NNS	O
were	VBD	O
rescued	VBN	O
by	IN	O
Klotho	NNP	O
overexpression	NN	O
,	,	O
a	DT	O
low	JJ	O
vitamin	NN	O
D	NNP	O
diet	NN	O
or	CC	O
vitamin	NN	O
D	NNP	O
receptor	NN	O
knockout	NN	O
.	.	O

These	DT	O
findings	NNS	O
indicate	VBP	O
that	IN	O
Enpp1	NNP	O
plays	VBZ	O
a	DT	O
crucial	JJ	O
role	NN	O
in	IN	O
regulating	VBG	O
aging	VBG	O
via	IN	O
Klotho	NNP	O
expression	NN	O
under	IN	O
phosphate	NN	O
overload	NN	O
conditions	NNS	O

of	IN	I-NegReg
function	NN	I-NegReg
mutation	NN	B-Var
KRIT1	NNP	B-Gene
progressive	JJ	I-Reg
cerebral	NN	B-Disease
and	CC	I-Disease
spinal	JJ	I-Disease
cavernous	JJ	I-Disease
malformations	NNS	I-Disease
Cerebrospinal	NNP	B-Disease
cavernous	JJ	I-Disease
malformations	NNS	I-Disease



METHODS	NN	O
:	:	O
The	DT	O
patient	NN	O
had	VBD	O
multiple	JJ	O
magnet	NN	O
resonance	NN	O
imaging	NN	O
(	(	O
MRI	NNP	O
)	)	O
examinations	NNS	O
of	IN	O
his	PRP$	O
brain	NN	O
and	CC	O
spine	NN	O
following	VBG	O
radiochemotherapy	NN	O
for	IN	O
a	DT	O
primary	JJ	O
intracranial	JJ	O
germ	NN	O
cell	NN	O
tumor	NN	O
(	(	O
GCT	NNP	O
)	)	O
,	,	O
as	IN	O
part	NN	O
of	IN	O
his	PRP$	O
oncologic	NN	O
follow	SYM	O
-	:	O
up	RB	O
.	.	O

The	DT	O
MRI	NNP	O
sequences	NNS	O
included	VBD	O
susceptibility	NN	O
-	:	O
weighted	JJ	O
imaging	NN	O
(	(	O
SWI	NNP	O
)	)	O
.	.	O

The	DT	O
coding	NN	O
exons	NNS	O
and	CC	O
their	PRP$	O
flanking	NN	O
intronic	JJ	O
regions	NNS	O
of	IN	O
KRIT1	NNP	O
CCM1	NNP	O
gene	NN	O
were	VBD	O
analyzed	VBN	O
for	IN	O
mutations	NNS	O
by	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	(	O
PCR	NNP	O
)	)	O
and	CC	O
direct	JJ	O
sequencing	NN	O
.	.	O

RESULTS	NN	O
:	:	O
MRI	NNP	O
revealed	VBD	O
numerous	JJ	O
cerebral	JJ	O
and	CC	O
spinal	JJ	O
microhemorrhages	NNS	O
and	CC	O
pronounced	VBD	O
cavernous	JJ	O
malformations	NNS	O
that	WDT	O
progressed	VBD	O
with	IN	O
subsequent	JJ	O
follow	NN	O
-	:	O
up	RB	O
imaging	NN	O
.	.	O

Genetic	JJ	O
analysis	NN	O
demonstrated	VBD	O
a	DT	O
novel	JJ	O
heterozygous	JJ	O
KRIT1	NNP	B-Gene
CCM1	NNP	O
two	CD	O
base	NN	O
pair	NN	O
deletion	NN	O
(	(	O
c	NN	B-Var
.	.	I-Var
1535	CD	I-Var
_	JJ	I-Var
1536	CD	I-Var
delTG	NN	I-Var
)	)	O
in	IN	O
exon	$	O
14	CD	O
.	.	O
This	DT	O
deletion	NN	O
leads	VBZ	B-Reg
to	TO	I-Reg
a	DT	O
frameshift	NN	B-Var
with	IN	O
a	DT	O
premature	NN	B-MPA
stop	NN	I-MPA
codon	NN	I-MPA
at	IN	O
nucleotide	JJ	O
position	NN	O
1553	CD	O
and	CC	O
a	DT	O
highly	RB	O
likely	JJ	O
loss	NN	B-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
of	IN	O
the	DT	O
KRIT1	NNP	B-Protein
protein	NN	I-Protein
.	.	O
CONCLUSION	NN	O
:	:	O
We	PRP	O
describe	VBP	O
a	DT	O
patient	NN	O
with	IN	O
a	DT	O
novel	JJ	O
heterozygous	JJ	O
germ	NNS	O
line	NN	O
loss	NN	B-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
mutation	NN	B-Var
in	IN	O
KRIT1	NNP	B-Gene
,	,	O
which	WDT	O
is	VBZ	O
associated	VBN	B-Reg
with	IN	I-Reg
rapid	JJ	O
-	:	O
onset	NN	O
and	CC	O
highly	RB	O
progressive	JJ	O
CCMs	NNP	B-Disease
after	IN	O
radiochemotherapy	NN	O
for	IN	O
a	DT	O
malignant	JJ	O
brain	NN	O
tumor	NN	O


Polymorphism	NN	O
in	IN	O
the	DT	O
gene	NN	O
CACNA1C	NNP	O
,	,	O
encoding	VBG	O
the	DT	O
pore	NN	O
-	:	O
forming	VBG	O
subunit	NN	O
of	IN	O
Cav1	NNP	O
.	.	O
2	CD	O
L	NNP	O
-	:	O
type	NN	O
calcium	NN	O
channels	NNS	O
,	,	O
has	VBZ	O
one	CD	O
of	IN	O
the	DT	O
strongest	JJS	O
genetic	JJ	O
linkages	NNS	O
to	TO	O
schizophrenia	VB	O
,	,	O
bipolar	JJ	O
disorder	NN	O
and	CC	O
major	JJ	O
depressive	JJ	O
disorder	NN	O
:	:	O
psychopathologies	NNS	O
in	IN	O
which	WDT	O
serotonin	NN	O
signaling	NN	O
has	VBZ	O
been	VBN	O
implicated	VBN	O
.	.	O

Additionally	RB	O
,	,	O
a	DT	O
gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutation	NN	B-Var
in	IN	O
CACNA1C	NNP	B-Gene
is	VBZ	O
responsible	JJ	O
for	IN	O
the	DT	O
neurodevelopmental	JJ	O
disorder	NN	O
Timothy	NNP	B-Disease
syndrome	NN	I-Disease
that	WDT	O
presents	VBZ	O
with	IN	O
prominent	JJ	O
behavioral	JJ	O
features	NNS	O
on	IN	O
the	DT	O
autism	NN	O
spectrum	NN	O
.	.	O
Given	VBN	O
an	DT	O
emerging	VBG	O
role	NN	O
for	IN	O
serotonin	NN	O
in	IN	O
the	DT	O
etiology	NN	O
of	IN	O
autism	NN	O
spectrum	NN	O
disorders	NNS	O
(	(	O
ASD	NNP	O
)	)	O
,	,	O
we	PRP	O
investigate	VBP	O
the	DT	O
relationship	NN	O
between	IN	O
Cav1	NNP	O
.	.	O
2	CD	O
and	CC	O
the	DT	O
ascending	VBG	O
serotonin	NN	O
system	NN	O
in	IN	O
the	DT	O
Timothy	NNP	O
syndrome	NN	O
type	NN	O
2	CD	O
(	(	O
TS2	NNP	O
-	:	O
neo	NN	O
)	)	O
mouse	NN	O
,	,	O
which	WDT	O
displays	VBZ	O
behavioral	JJ	O
features	NNS	O
consistent	JJ	O
with	IN	O
the	DT	O
core	NN	O
triad	NN	O
of	IN	O
ASD	NNP	O
.	.	O

We	PRP	O
find	VBP	O
that	IN	O
TS2	NNP	O
-	:	O
neo	JJ	O
mice	NN	O
exhibit	NN	O
enhanced	VBD	O
serotonin	JJ	O
tissue	NN	O
content	NN	O
and	CC	O
axon	JJ	O
innervation	NN	O
of	IN	O
the	DT	O
dorsal	NN	O
striatum	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
decreased	VBN	O
serotonin	NN	O
turnover	NN	O
in	IN	O
the	DT	O
amygdala	NN	O
.	.	O

These	DT	O
regionally	RB	O
specific	JJ	O
alterations	NNS	O
are	VBP	O
accompanied	VBN	O
by	IN	O
an	DT	O
enhanced	JJ	O
active	JJ	O
coping	VBG	O
response	NN	O
during	IN	O
acute	JJ	O
stress	NN	O
(	(	O
forced	VBN	O
swim	NN	O
)	)	O
,	,	O
serotonin	JJ	O
neuron	NN	O
Fos	NNP	O
activity	NN	O
in	IN	O
the	DT	O
caudal	NN	O
dorsal	NN	O
raphe	NN	O
,	,	O
and	CC	O
serotonin	VBD	O
type	NN	O
1	CD	O
A	NNP	O
receptor	NN	O
-	:	O
dependent	JJ	O
feedback	NN	O
inhibition	NN	O
of	IN	O
the	DT	O
rostral	JJ	O
dorsal	NN	O
raphe	NN	O
nuclei	NN	O
.	.	O

Collectively	RB	O
,	,	O
these	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
global	JJ	O
gain	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
Cav1	NNP	O
.	.	O
2	CD	O
mutation	NN	O
associated	VBN	O
with	IN	O
Timothy	NNP	O
syndrome	NN	O
has	VBZ	O
pleiotropic	VBN	O
effects	NNS	O
on	IN	O
the	DT	O
ascending	VBG	O
serotonin	NN	O
system	NN	O
including	VBG	O
neuroanatomical	JJ	O
changes	NNS	O
,	,	O
regional	JJ	O
differences	NNS	O
in	IN	O
forebrain	NN	O
serotonin	NN	O
metabolism	NN	O
and	CC	O
feedback	JJ	O
regulatory	JJ	O
control	NN	O
mechanisms	NN	O
within	IN	O
the	DT	O
dorsal	NN	O
raphe	NN	O
.	.	O

Altered	NNP	O
activity	NN	O
of	IN	O
the	DT	O
ascending	VBG	O
serotonin	NN	O
system	NN	O
continues	VBZ	O
to	TO	O
emerge	VB	O
as	IN	O
a	DT	O
common	JJ	O
neural	JJ	O
signature	NN	O
across	IN	O
several	JJ	O
ASD	NNP	O
mouse	NN	O
models	NNS	O
,	,	O
and	CC	O
the	DT	O
capacity	NN	O
for	IN	O
Cav1	NNP	O
.	.	O
2	CD	O
L	NNP	O
-	:	O
type	NN	O
calcium	NN	O
channels	NNS	O
to	TO	O
impact	VB	O
both	DT	O
serotonin	JJ	O
structure	NN	O
and	CC	O
function	NN	O
has	VBZ	O
important	JJ	O
implications	NNS	O
for	IN	O
several	JJ	O
neuropsychiatric	JJ	O
conditions	NNS	O





METHODS	NNS	O
:	:	O
We	PRP	O
used	VBD	O
a	DT	O
combined	VBN	O
in	IN	O
vitro	JJ	O
-	:	O
in	IN	O
vivo	NN	O
approach	NN	O
to	TO	O
determine	VB	O
the	DT	O
role	NN	O
of	IN	O
these	DT	O
pharmacogenes	NNS	O
in	IN	O
the	DT	O
bioactivation	NN	O
of	IN	O
the	DT	O
prodrug	NN	O
to	TO	O
4	CD	O
-	:	O
hydroxy	NN	O
cyclophosphamide	NN	O
(	(	O
4	CD	O
-	:	O
OHCP	NN	O
)	)	O
.	.	O

Cyclophosphamide	NNP	O
metabolism	NN	O
was	VBD	O
determined	VBN	O
in	IN	O
a	DT	O
human	JJ	O
liver	NN	O
biobank	NN	O
(	(	O
n	JJ	O
14	CD	O
)	)	O
and	CC	O
in	IN	O
patients	NNS	O
receiving	VBG	O
the	DT	O
drug	NN	O
for	IN	O
treatment	NN	O
of	IN	O
lupus	NN	O
nephritis	NN	O
(	(	O
n	JJ	O
16	CD	O
)	)	O
RESULTS	NN	O
:	:	O
In	IN	O
livers	NNS	O
of	IN	O
known	VBN	O
CYP2C19	NNP	O
and	CC	O
CYP2B6	NNP	O
genotype	NN	O
and	CC	O
protein	JJ	O
expression	NN	O
we	PRP	O
observed	VBD	O
that	IN	O
there	EX	O
was	VBD	O
a	DT	O
combined	JJ	B-Interaction
role	NN	O
for	IN	O
both	DT	O
CYP2C19	NNP	B-Var
and	CC	O
CYP2B6	NNP	B-Var
in	IN	O
the	DT	O
bioactivation	NN	B-MPA
of	IN	I-MPA
cyclophosphamide	NN	I-MPA
in	IN	I-MPA
vitro	NN	I-MPA
.	.	O
The	DT	O
presence	NN	O
of	IN	O
at	IN	O
least	JJS	O
one	CD	O
loss	NN	O
of	IN	O
function	NN	O
(	(	O
LoF	NNP	O
)	)	O
allele	NN	O
at	IN	O
either	DT	O
CYP2C19	NNP	B-Var
or	CC	O
CYP2B6	NNP	B-Var
resulted	VBD	O
in	IN	O
a	DT	O
significant	JJ	O
decrease	NN	B-NegReg
in	IN	O
both	DT	O
V	NNP	B-MPA
(	(	I-MPA
max	NN	I-MPA
)	)	I-MPA
(	(	I-MPA
P	NNP	I-MPA
0.028	CD	I-MPA
)	)	I-MPA
and	CC	I-MPA
CL	NNP	I-MPA
(	(	I-MPA
int	NN	I-MPA
)	)	I-MPA
(	(	I-MPA
P	NNP	I-MPA
0.0017	CD	I-MPA
)	)	I-MPA
compared	VBN	O
with	IN	O
livers	NNS	O
with	IN	O
no	DT	O
LoF	NNP	O
alleles	NNS	O
.	.	O
This	DT	O
dual	JJ	O
genotype	NN	O
relationship	NN	O
was	VBD	O
also	RB	O
observed	VBN	O
in	IN	O
a	DT	O
preliminary	JJ	O
clinical	JJ	O
study	NN	O
,	,	O
with	IN	O
patients	NNS	O
who	WP	O
had	VBD	O
1	CD	O
LoF	NNP	O
allele	NN	O
at	IN	O
either	DT	O
CYP2C19	NNP	B-Var
or	CC	O
CYP2B6	NNP	B-Var
also	RB	O
displaying	VBG	O
significantly	RB	O
(	(	O
P	NNP	O
0.0316	CD	O
)	)	O
lower	JJR	B-NegReg
bioactivation	NN	B-MPA
of	IN	I-MPA
cyclophosphamide	NN	I-MPA
.	.	O
The	DT	O
mean	NN	O
4	CD	O
-	:	O
OHCP	NN	O
:	:	O
CP	NNP	O
bioactivation	NN	O
ratio	NN	O
was	VBD	O
0.0014	CD	O
(	(	O
95%	CD	O
CI	NNP	O
0.0007	CD	O
,	,	O
0.002	CD	O
)	)	O
compared	VBN	O
with	IN	O
0.0071	CD	O
(	(	O
95%	CD	O
CI	NNP	O
0.0001	CD	O
,	,	O
0.014	CD	O
)	)	O
in	IN	O
patients	NNS	O
with	IN	O
no	DT	O
LoF	NNP	O
alleles	VBZ	O
at	IN	O
either	DT	O
of	IN	O
these	DT	O
genes	NNS	O
.	.	O

CONCLUSIONS	NN	O
:	:	O
The	DT	O
presence	NN	O
of	IN	O
1	CD	O
LoF	NNP	O
allele	NN	O
(	(	O
s	PRP	O
)	)	O
at	IN	O
either	DT	O
CYP2B6	NNP	B-Var
or	CC	O
CYP2C19	NNP	B-Var
appeared	VBD	O
to	TO	O
result	VB	O
in	IN	O
decreased	JJ	B-NegReg
bioactivation	NN	B-MPA
of	IN	I-MPA
cyclophosphamide	JJ	I-MPA
both	DT	O
in	IN	O
vitro	NN	O
and	CC	O
in	IN	O
patients	NNS	O
.	.	O
Further	RB	O
clinical	JJ	O
studies	NNS	O
to	TO	O
confirm	VB	O
this	DT	O
relationship	NN	O
are	VBP	O
warranted	VBN	O

of	IN	I-Var
Fgfr2	NNP	B-Gene
leads	VBZ	B-Reg
to	TO	I-Reg
cleft	VB	B-Disease
palate	NN	I-Disease

However	RB	O
,	,	O
little	JJ	O
is	VBZ	O
known	VBN	O
about	IN	O
the	DT	O
signaling	VBG	O
factors	NNS	O
regulating	VBG	O
palate	JJ	O
initiation	NN	O
.	.	O

Mouse	NNP	O
fibroblast	VBD	O
growth	NN	O
factor	NN	O
(	(	O
FGF	NNP	O
)	)	O
receptor	NN	O
2	CD	O
gene	NN	O
(	(	O
Fgfr2	NNP	O
)	)	O
is	VBZ	O
expressed	VBN	O
on	IN	O
E11	NNP	O
.	.	O
5	CD	O
in	IN	O
the	DT	O
palate	NN	O
outgrowth	NN	O
within	IN	O
the	DT	O
maxillary	JJ	O
process	NN	O
,	,	O
in	IN	O
a	DT	O
region	NN	O
that	WDT	O
is	VBZ	O
responsible	JJ	O
for	IN	O
palate	NN	O
cell	NN	O
specification	NN	O
and	CC	O
shelf	NN	O
initiation	NN	O
.	.	O

Fgfr2	NNP	O
continues	VBZ	O
to	TO	O
express	VB	O
in	IN	O
palate	NN	O
on	IN	O
E12	NNP	O
.	.	O
5	CD	O
and	CC	O
E13	NNP	O
.	.	O
5	CD	O
in	IN	O
both	DT	O
epithelial	JJ	O
and	CC	O
mesenchymal	JJ	O
cells	NNS	O
,	,	O
and	CC	O
inactivation	NN	B-Var
of	IN	O
Fgfr2	NNP	B-Gene
expression	NN	O
in	IN	O
mesenchymal	JJ	O
cells	NNS	O
using	VBG	O
floxed	JJ	O
Fgfr2	NNP	O
allele	NN	O
and	CC	O
Osr2	NNP	O
-	:	O
Cre	NNP	O
leads	VBZ	B-Reg
to	TO	I-Reg
cleft	VB	B-Disease
palate	NN	I-Disease
at	IN	O
various	JJ	O
stages	NNS	O
including	VBG	O
reorientation	NN	O
,	,	O
horizontal	JJ	O
growth	NN	O
and	CC	O
fusion	NN	O
.	.	O
Notably	RB	O
,	,	O
some	DT	O
mutant	JJ	O
embryos	NN	O
displayed	VBD	O
no	DT	O
sign	NN	O
of	IN	O
palate	NN	O
shelf	NN	O
formation	NN	O
suggesting	VBG	O
that	IN	O
FGF	NNP	O
receptor	NN	O
2	CD	O
mediated	VBD	O
FGF	NNP	O
signaling	NN	O
may	MD	O
play	VB	O
an	DT	O
important	JJ	O
role	NN	O
in	IN	O
palate	JJ	O
initiation	NN	O



SIS	NNP	O
is	VBZ	O
triggered	VBN	O
when	WRB	O
epidermal	JJ	O
growth	NN	O
factor	NN	O
(	(	O
EGF	NNP	O
)	)	O
activates	VBZ	O
the	DT	O
ALA	NNP	O
neuron	NN	O
,	,	O
which	WDT	O
then	RB	O
releases	VBZ	O
neuropeptides	NNS	O
to	TO	O
promote	VB	O
sleep	NN	O
.	.	O

To	TO	O
further	JJ	O
understand	NN	O
this	DT	O
behavior	NN	O
,	,	O
we	PRP	O
established	VBD	O
a	DT	O
new	JJ	O
model	NN	O
of	IN	O
stress	JJ	O
-	:	O
induced	JJ	O
sleep	NN	O
using	VBG	O
irradiation	NN	O
by	IN	O
ultraviolet	JJ	O
C	NNP	O
(	(	O
UVC	NNP	O
)	)	O
light	NN	O
.	.	O

While	IN	O
UVC	NNP	O
irradiation	NN	O
requires	VBZ	O
ALA	NNP	O
signaling	VBG	O
and	CC	O
leads	VBZ	O
to	TO	O
a	DT	O
sleep	JJ	O
state	NN	O
similar	JJ	O
to	TO	O
that	DT	O
induced	VBN	O
by	IN	O
heat	NN	O
and	CC	O
other	JJ	O
stressors	NNS	O
,	,	O
it	PRP	O
does	VBZ	O
not	RB	O
induce	VB	O
the	DT	O
proteostatic	JJ	O
stress	NN	O
seen	VBN	O
with	IN	O
heat	NN	O
exposure	NN	O
.	.	O

Based	VBN	O
on	IN	O
the	DT	O
known	VBN	O
genotoxic	NN	O
effects	NNS	O
of	IN	O
UVC	NNP	O
irradiation	NN	O
,	,	O
we	PRP	O
tested	VBD	O
two	CD	O
genes	NNS	O
-	:	O
atl	NN	O
-	:	O
1	CD	O
and	CC	O
cep	VB	O
-	:	O
1	CD	O
-	:	O
which	WDT	O
encode	VBP	O
proteins	NNS	O
that	WDT	O
act	VBP	O
in	IN	O
the	DT	O
DNA	NNP	O
damage	NN	O
response	NN	O
pathway	NN	O
.	.	O

Loss	NNP	O
of	IN	O
function	NN	O
mutants	NNS	O
of	IN	O
atl	JJ	O
-	:	O
1	CD	O
had	VBD	O
no	DT	O
defect	NN	O
in	IN	O
UVC	NNP	O
induced	JJ	O
SIS	NNP	O
but	CC	O
a	DT	O
partial	JJ	O
loss	NN	B-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
mutant	NN	B-Var
of	IN	O
cep	NN	B-Gene
-	:	I-Gene
1	CD	I-Gene
,	,	O
gk138	NN	O
,	,	O
had	VBD	O
decreased	VBN	B-NegReg
movement	NN	B-MPA
quiescence	NN	I-MPA
following	VBG	O
UVC	NNP	O
irradiation	NN	O
.	.	O
Germline	NNP	O
ablation	NN	O
experiments	NNS	O
and	CC	O
tissue	NN	O
-	:	O
specific	JJ	O
RNA	NNP	O
interference	NN	O
experiments	NNS	O
showed	VBD	O
that	IN	O
cep	SYM	O
-	:	O
1	CD	O
is	VBZ	O
required	VBN	O
somatically	RB	O
in	IN	O
neurons	NNS	O
for	IN	O
its	PRP$	O
effect	NN	O
on	IN	O
SIS	NNP	O
.	.	O

The	DT	O
cep	NN	B-Gene
-	:	I-Gene
1	CD	I-Gene
(	(	O
gk138	NN	O
)	)	O
mutant	NN	B-Var
suppressed	VBD	B-NegReg
body	NN	B-MPA
movement	NN	I-MPA
quiescence	NN	I-MPA
controlled	VBN	I-MPA
by	IN	I-MPA
EGF	NNP	I-MPA
,	,	O
indicating	VBG	O
that	IN	O
CEP	NNP	O
-	:	O
1	CD	O
acts	NNS	O
downstream	NN	O
or	CC	O
in	IN	O
parallel	JJ	O
to	TO	O
ALA	NNP	O
activation	NN	O
to	TO	O
promote	VB	O
quiescence	NN	O
in	IN	O
response	NN	O
to	TO	O
ultraviolet	VB	O
light	NN	O

loss	NN	B-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
N	NNP	B-Protein
-	:	I-Protein
methyl	NN	I-Protein
-	:	I-Protein
-	:	I-Protein
aspartate	NN	I-Protein
glutamate	NN	I-Protein
receptors	NNS	I-Protein
schizophrenia	VB	B-Disease

Previous	JJ	O
studies	NNS	O
have	VBP	O
accumulated	VBN	O
evidence	NN	O
supporting	VBG	O
NMDAR	NNP	O
-	:	O
encoding	VBG	O
genes	NNS	O
role	NN	O
in	IN	O
etiology	NN	O
of	IN	O
SCZ	NNP	O
and	CC	O
ASD	NNP	O
.	.	O

We	PRP	O
performed	VBD	O
a	DT	O
screening	NN	O
study	NN	O
for	IN	O
exonic	JJ	O
regions	NNS	O
of	IN	O
GRIN1	NNP	O
,	,	O
GRIN2A	NNP	O
,	,	O
GRIN2C	NNP	O
,	,	O
GRIN2D	NNP	O
,	,	O
GRIN3A	NNP	O
,	,	O
and	CC	O
GRIN3B	NNP	O
,	,	O
which	WDT	O
encode	VBP	O
NMDAR	NNP	O
subunits	NNS	O
,	,	O
in	IN	O
562	CD	O
participates	NNS	O
(	(	O
370	CD	O
SCZ	NNP	O
and	CC	O
192	CD	O
ASD	NNP	O
)	)	O
.	.	O

Forty	NNP	O
rare	JJ	O
variants	NNS	O
were	VBD	O
identified	VBN	O
including	VBG	O
38	CD	O
missense	NN	O
,	,	O
1	CD	O
frameshift	NN	O
mutation	NN	O
in	IN	O
GRIN2C	NNP	O
and	CC	O
1	CD	O
splice	NN	O
site	NN	O
mutation	NN	O
in	IN	O
GRIN2D	NNP	O
.	.	O

We	PRP	O
conducted	VBD	O
in	IN	O
silico	JJ	O
analysis	NN	O
for	IN	O
all	DT	O
variants	NNS	O
and	CC	O
detected	VBD	O
seven	CD	O
missense	NN	O
variants	NNS	O
with	IN	O
deleterious	JJ	O
prediction	NN	O
.	.	O

De	NNP	O
novo	FW	O
analysis	NN	O
was	VBD	O
conducted	VBN	O
if	IN	O
pedigree	JJ	O
samples	NNS	O
were	VBD	O
available	JJ	O
.	.	O

The	DT	O
splice	NN	O
site	NN	O
mutation	NN	O
in	IN	O
GRIN2D	NNP	O
is	VBZ	O
predicted	VBN	O
to	TO	O
result	VB	O
in	IN	O
intron	NN	O
retention	NN	O
by	IN	O
minigene	NN	O
assay	NN	O
.	.	O

Furthermore	RB	O
,	,	O
the	DT	O
frameshift	NN	O
mutation	NN	O
in	IN	O
GRIN2C	NNP	O
and	CC	O
splice	JJ	O
site	NN	O
mutation	NN	O
in	IN	O
GRIN2D	NNP	O
were	VBD	O
genotyped	VBN	O
in	IN	O
an	DT	O
independent	JJ	O
sample	NN	O
set	VBN	O
comprising	NN	O
1877	CD	O
SCZ	NNP	O
cases	NNS	O
,	,	O
382	CD	O
ASD	NNP	O
cases	NNS	O
,	,	O
and	CC	O
2040	CD	O
controls	NNS	O
.	.	O

Both	DT	O
of	IN	O
them	PRP	O
were	VBD	O
revealed	VBN	O
to	TO	O
be	VB	O
singleton	VBN	O
.	.	O

Our	PRP$	O
study	NN	O
gives	VBZ	O
evidence	NN	O
in	IN	O
support	NN	O
of	IN	O
the	DT	O
view	NN	O
that	IN	O
ultra	JJ	O
-	:	O
rare	JJ	O
variants	NNS	O
with	IN	O
loss	NN	B-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
(	(	O
frameshift	NN	B-Var
,	,	O
nonsense	NN	B-Var
or	CC	I-Var
splice	NN	I-Var
site	NN	I-Var
)	)	O
in	IN	O
NMDARs	NNP	B-Gene
genes	NNS	O
may	MD	O
contribute	VB	O
to	TO	O
possible	JJ	O
risk	NN	O
of	IN	O
SCZ	NNP	B-Disease


Paramyotonia	NNP	B-Disease
congenita	NN	I-Disease
caused	VBN	B-Reg
missense	JJ	B-Var
mutations	NNS	I-Var
SCN4A	NNP	B-Gene


Whole	JJ	O
-	:	O
cell	NN	O
electrophysiological	JJ	O
recordings	NNS	O
of	IN	O
the	DT	O
N1366S	NNP	O
channel	NN	O
reveal	NN	O
a	DT	O
gain	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
change	NN	O
of	IN	O
gating	VBG	O
in	IN	O
response	NN	O
to	TO	O
cold	VB	O
.	.	O

Modelling	VBG	O
and	CC	O
molecular	JJ	O
dynamic	JJ	O
simulation	NN	O
data	NNS	O
suggest	VBP	O
that	IN	O
an	DT	O
arginine	JJ	O
-	:	O
to	TO	O
-	:	O
serine	NN	O
substitution	NN	O
at	IN	O
position	NN	O
1366	CD	O
increases	VBZ	O
the	DT	O
distance	NN	O
from	IN	O
N1366	NNP	O
to	TO	O
R1454	NNP	O
and	CC	O
disrupts	VBZ	O
the	DT	O
hydrogen	NN	O
bond	NN	O
formed	VBD	O
between	IN	O
them	PRP	O
at	IN	O
low	JJ	O
temperature	NN	O
.	.	O

We	PRP	O
demonstrate	VBP	O
that	DT	O
N1366S	NNP	O
is	VBZ	O
a	DT	O
disease	NN	O
-	:	O
causing	NN	O
mutation	NN	O
and	CC	O
that	IN	O
the	DT	O
temperature	NN	O
-	:	O
sensitive	JJ	O
alteration	NN	O
of	IN	O
N1366S	NNP	O
channel	NN	O
activity	NN	O
may	MD	O
be	VB	O
responsible	JJ	O
for	IN	O
the	DT	O
pronounced	JJ	O
paramyotonia	NN	O
congenita	NN	O
symptoms	NNS	O
of	IN	O
these	DT	O
patients	NNS	O
.	.	O

ABSTRACT	NN	O
:	:	O
Paramyotonia	NNP	B-Disease
congenita	NN	I-Disease
is	VBZ	O
an	DT	O
autosomal	JJ	O
dominant	JJ	O
skeletal	JJ	O
muscle	NN	O
channelopathy	NNS	O
caused	VBN	B-Reg
by	IN	O
missense	JJ	B-Var
mutations	NNS	I-Var
in	IN	O
SCN4A	NNP	B-Gene
,	,	O
the	DT	O
gene	NN	O
encoding	VBG	O
the	DT	O
subunit	NN	O
of	IN	O
the	DT	O
human	JJ	O
skeletal	JJ	O
muscle	NN	O
voltage	NN	O
-	:	O
gated	JJ	O
sodium	NN	O
channel	NN	O
NaV1	NNP	O
.	.	O
4	CD	O
.	.	O
We	PRP	O
report	VBP	O
a	DT	O
three	CD	O
-	:	O
generation	NN	O
family	NN	O
in	IN	O
which	WDT	O
six	CD	O
members	NNS	O
present	JJ	O
clinical	JJ	O
symptoms	NNS	O
of	IN	O
paramyotonia	NN	O
congenita	NNS	O
characterized	VBN	O
by	IN	O
a	DT	O
marked	JJ	O
worsening	NN	O
of	IN	O
myotonia	NN	O
by	IN	O
cold	JJ	O
and	CC	O
by	IN	O
the	DT	O
presence	NN	O
of	IN	O
clear	JJ	O
episodes	NNS	O
of	IN	O
paralysis	NN	O
.	.	O

We	PRP	O
identified	VBD	O
a	DT	O
novel	JJ	O
mutation	NN	O
in	IN	O
SCN4A	NNP	O
(	(	O
Asn1366Ser	NNP	O
,	,	O
N1366S	NNP	O
)	)	O
in	IN	O
all	DT	O
patients	NNS	O
in	IN	O
the	DT	O
family	NN	O
but	CC	O
not	RB	O
in	IN	O
healthy	JJ	O
relatives	NNS	O
or	CC	O
in	IN	O
500	CD	O
normal	JJ	O
control	NN	O
subjects	NNS	O
.	.	O

Functional	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
channel	NN	O
protein	NN	O
expressed	VBN	O
in	IN	O
HEK293	NNP	O
cells	NNS	O
by	IN	O
whole	JJ	O
-	:	O
cell	NN	O
patch	NN	O
clamp	NN	O
recording	VBG	O
revealed	VBD	O
that	IN	O
the	DT	O
N1366S	NNP	O
mutation	NN	O
led	VBD	O
to	TO	O
significant	JJ	O
alterations	NNS	O
in	IN	O
the	DT	O
gating	NN	O
process	NN	O
of	IN	O
the	DT	O
NaV1	NNP	O
.	.	O
4	CD	O
channel	NN	O
.	.	O

The	DT	O
N1366S	NNP	B-Var
mutant	NN	O
displayed	VBD	O
a	DT	O
cold	JJ	O
-	:	O
induced	JJ	O
hyperpolarizing	VBG	O
shift	NN	O
in	IN	O
the	DT	O
voltage	NN	O
dependence	NN	O
of	IN	O
activation	NN	O
and	CC	O
a	DT	O
depolarizing	VBG	O
shift	NN	O
in	IN	O
fast	JJ	O
inactivation	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
reduced	JJ	B-NegReg
rate	NN	B-MPA
of	IN	O
fast	JJ	B-MPA
inactivation	NN	I-MPA
and	CC	O
accelerated	JJ	B-PosReg
recovery	NN	B-MPA
from	IN	O
fast	JJ	B-MPA
inactivation	NN	I-MPA
.	.	O
In	IN	O
addition	NN	O
,	,	O
homology	NN	O
modelling	NN	O
and	CC	O
molecular	JJ	O
dynamic	JJ	O
simulation	NN	O
of	IN	O
N1366S	NNP	O
and	CC	O
wild	JJ	O
-	:	O
type	NN	O
NaV1	NNP	O
.	.	O
4	CD	O
channels	NNS	O
indicated	VBD	O
that	IN	O
the	DT	O
arginine	NN	O
-	:	O
to	TO	O
-	:	O
serine	NN	O
substitution	NN	O
disrupted	VBD	O
the	DT	O
hydrogen	NN	O
bond	NN	O
formed	VBD	O
between	IN	O
N1366	NNP	O
and	CC	O
R1454	NNP	O
.	.	O

Together	RB	O
,	,	O
our	PRP$	O
results	NNS	O
suggest	VBP	O
that	IN	O
N1366S	NNP	B-Var
is	VBZ	O
a	DT	O
gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutation	NN	O
of	IN	O
NaV1	NNP	O
.	.	O
4	CD	O
at	IN	O
low	JJ	O
temperature	NN	O
and	CC	O
the	DT	O
mutation	NN	O
may	MD	O
be	VB	O
responsible	JJ	O
for	IN	O
the	DT	O
clinical	JJ	O
symptoms	NNS	O
of	IN	O
paramyotonia	NN	B-Disease
congenita	NN	I-Disease
in	IN	O
the	DT	O
affected	JJ	O
family	NN	O
and	CC	O
constitute	VB	O
a	DT	O
basis	NN	O
for	IN	O
studies	NNS	O
into	IN	O
its	PRP$	O
pathogenesis	NN	O


Fibroblast	NNP	O
growth	NN	O
factors	NNS	O
(	(	O
FGFs	NNP	O
)	)	O
and	CC	O
FGF	NNP	O
receptors	NNS	O
(	(	O
FGFRs	NNP	O
)	)	O
are	VBP	O
known	VBN	O
for	IN	O
their	PRP$	O
potent	JJ	O
effects	NNS	O
on	IN	O
cell	NN	O
proliferation	NN	O
differentiation	NN	O
and	CC	O
cortical	JJ	O
patterning	NN	O
in	IN	O
the	DT	O
developing	NN	O
brain	NN	O
.	.	O

However	RB	O
,	,	O
little	JJ	O
is	VBZ	O
known	VBN	O
regarding	VBG	O
the	DT	O
roles	NNS	O
of	IN	O
FGFs	NNP	O
FGFRs	NNP	O
in	IN	O
cortical	JJ	O
circuit	NN	O
formation	NN	O
.	.	O

Here	RB	O
we	PRP	O
show	VBP	O
that	IN	O
Fgfr1	NNP	O
2	CD	O
3	CD	O
and	CC	O
Fgf7	NNP	O
9	CD	O
10	CD	O
22	CD	O
mRNAs	NNS	O
are	VBP	O
expressed	VBN	O
in	IN	O
the	DT	O
developing	VBG	O
primary	JJ	O
somatosensory	NN	O
(	(	O
S1	NNP	O
)	)	O
barrel	NN	O
cortex	NN	O
.	.	O

Barrel	NNP	O
cortex	NN	O
layer	NN	O
IV	NNP	O
spiny	NN	O
stellate	NN	O
cells	NNS	O
(	(	O
bSCs	NN	O
)	)	O
are	VBP	O
the	DT	O
primary	JJ	O
recipients	NNS	O
of	IN	O
ascending	VBG	O
sensory	JJ	O
information	NN	O
via	IN	O
thalamocortical	JJ	O
axons	NNS	O
(	(	O
TCAs	NNP	O
)	)	O
.	.	O

Detail	NNP	O
quantification	NN	O
revealed	VBD	O
distinctive	JJ	O
phases	NNS	O
for	IN	O
bSC	JJ	O
dendritogenesis	NN	O
:	:	O
orienting	NN	O
dendrites	VBZ	O
toward	IN	O
TCAs	NNP	O
,	,	O
adding	VBG	O
de	IN	O
novo	FW	O
dendritic	JJ	O
segments	NNS	O
,	,	O
and	CC	O
elongating	VBG	O
dendritic	JJ	O
length	NN	O
,	,	O
while	IN	O
maintaining	VBG	O
dendritic	JJ	O
patterns	NNS	O
.	.	O

Deleting	VBG	O
Fgfr1	NNP	O
2	CD	O
3	CD	O
in	IN	O
bSCs	NN	O
had	VBD	O
minimal	JJ	O
impact	NN	O
on	IN	O
dendritic	JJ	O
polarity	NN	O
but	CC	O
transiently	RB	O
increased	VBD	O
the	DT	O
number	NN	O
of	IN	O
dendritic	JJ	O
segments	NNS	O
.	.	O

However	RB	O
,	,	O
6	CD	O
d	NN	O
later	RB	O
,	,	O
FGFR1	NNP	O
2	CD	O
3	CD	O
loss	NN	O
of	IN	O
function	NN	O
reduced	VBN	O
dendritic	JJ	O
branch	NN	O
numbers	NNS	O
.	.	O

These	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
FGFs	NNP	O
FGFRs	NNP	O
have	VBP	O
a	DT	O
role	NN	O
in	IN	O
stabilizing	VBG	O
dendritic	JJ	O
patterning	NN	O
.	.	O

Depolarization	NN	O
of	IN	O
cultured	JJ	O
mouse	NN	O
cortical	JJ	O
neurons	NNS	O
upregulated	VBD	O
the	DT	O
levels	NNS	O
of	IN	O
several	JJ	O
Fgf	NNP	O
Fgfr	NNP	O
mRNAs	NN	O
within	IN	O
2	CD	O
h	NN	O
.	.	O
In	IN	O
vivo	NN	O
,	,	O
within	IN	O
6	CD	O
h	NN	O
of	IN	O
systemic	JJ	O
kainic	JJ	O
acid	NN	O
administration	NN	O
at	IN	O
postnatal	JJ	O
day	NN	O
6	CD	O
,	,	O
mRNA	NN	O
levels	NNS	O
of	IN	O
Fgf9	NNP	O
,	,	O
Fgf10	NNP	O
,	,	O
Fgfr2c	NNP	O
,	,	O
and	CC	O
Fgfr3b	NNP	O
in	IN	O
S1	NNP	O
cortices	NNS	O
were	VBD	O
enhanced	VBN	O
,	,	O
and	CC	O
this	DT	O
was	VBD	O
accompanied	VBN	O
by	IN	O
exuberant	JJ	O
dendritogenesis	NN	O
of	IN	O
bSCs	NN	O
by	IN	O
24	CD	O
h	NN	O
.	.	O
Deleting	VBG	O
Fgfr1	NNP	O
2	CD	O
3	CD	O
abolished	VBD	O
kainic	JJ	O
acid	NN	O
-	:	O
induced	JJ	O
bSC	NN	O
dendritic	JJ	O
overgrowth	NN	O
.	.	O

Finally	RB	O
,	,	O
FGF9	NNP	O
10	CD	O
gain	NN	O
of	IN	O
function	NN	O
also	RB	O
resulted	VBD	O
in	IN	O
extensive	JJ	O
dendritogenesis	NN	O
.	.	O

Together	RB	O
,	,	O
our	PRP$	O
data	NNS	O
suggest	VBP	O
that	IN	O
FGFs	NNP	O
FGFRs	NNP	O
can	MD	O
be	VB	O
regulated	VBN	O
by	IN	O
glutamate	JJ	O
transmission	NN	O
to	TO	O
modulate	VB	O
stabilize	VB	O
bSC	JJ	O
dendritic	JJ	O
complexity	NN	O
.	.	O

Both	DT	O
male	NN	O
and	CC	O
female	JJ	O
mice	NN	O
were	VBD	O
used	VBN	O
for	IN	O
our	PRP$	O
study	NN	O
.	.	O
SIGNIFICANCE	NNP	O
STATEMENT	NNP	O
Glutamatergic	NNP	O
transmission	NN	O
plays	VBZ	O
critical	JJ	O
roles	NNS	O
in	IN	O
cortical	JJ	O
circuit	NN	O
formation	NN	O
.	.	O

Its	PRP$	O
dysregulation	NN	O
has	VBZ	O
been	VBN	O
proposed	VBN	O
as	IN	O
a	DT	O
core	NN	O
factor	NN	O
in	IN	O
the	DT	O
etiology	NN	O
of	IN	O
many	JJ	O
neurological	JJ	O
diseases	NNS	O
.	.	O

We	PRP	O
found	VBD	O
that	IN	O
excessive	JJ	O
glutamate	NN	O
transmission	NN	O
upregulated	VBD	O
mRNA	JJ	O
expression	NN	O
of	IN	O
Fgfrs	NNP	O
and	CC	O
their	PRP$	O
ligands	NNS	O
Fgfs	NNP	O
Deleting	NNP	B-Var
Fgfr1	NNP	B-Gene
2	CD	I-Gene
3	CD	I-Gene
not	RB	O
only	RB	O
impaired	JJ	B-NegReg
bSC	JJ	B-MPA
dendritogenesis	NN	I-MPA
but	CC	O
also	RB	O
abolished	VBD	B-NegReg
glutamate	JJ	B-MPA
transmission	NN	I-MPA
-	:	I-MPA
induced	JJ	I-MPA
dendritic	JJ	I-MPA
overgrowth	NN	I-MPA
.	.	O
Overexpressing	VBG	O
FGF9	NNP	O
or	CC	O
FGF10	NNP	O
in	IN	O
cortical	JJ	O
glutamatergic	JJ	O
neurons	NNS	O
results	NNS	O
in	IN	O
excessive	JJ	O
dendritic	JJ	O
outgrowth	NN	O
within	IN	O
24	CD	O
h	NN	O
,	,	O
resembling	VBG	O
the	DT	O
changes	NNS	O
induced	VBN	O
by	IN	O
excessive	JJ	O
glutamate	NN	O
transmission	NN	O
.	.	O

Our	PRP$	O
findings	NNS	O
provide	VBP	O
strong	JJ	O
evidence	NN	O
for	IN	O
the	DT	O
physiological	JJ	O
role	NN	O
of	IN	O
fibroblast	JJ	O
growth	NN	O
factors	NNS	O
(	(	O
FGFs	NNP	O
)	)	O
and	CC	O
FGF	NNP	O
receptors	NNS	O
(	(	O
FGFRs	NNP	O
)	)	O
in	IN	O
establishing	VBG	O
and	CC	O
maintaining	VBG	O
cortical	JJ	O
circuits	NNS	O
.	.	O

Perturbing	VBG	O
the	DT	O
expression	NN	O
levels	NNS	O
of	IN	O
FGFs	NNP	O
FGFRs	NNP	O
by	IN	O
excessive	JJ	O
glutamatergic	JJ	O
neurotransmission	NN	O
could	MD	O
lead	VB	O
to	TO	O
abnormal	JJ	O
neuronal	JJ	O
circuits	NNS	O
,	,	O
which	WDT	O
may	MD	O
contribute	VB	O
to	TO	O
neurological	JJ	O
and	CC	O
psychiatric	JJ	O
disease	NN	O


gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutations	NNS	B-Var
NFKBIA	NNP	B-Gene
anhidrotic	JJ	B-Disease
ectodermal	JJ	I-Disease
dysplasia	NN	I-Disease
with	IN	I-Disease
immunodeficiency	NN	I-Disease
Fourteen	NNP	O
unrelated	JJ	O
patients	NNS	O
have	VBP	O
been	VBN	O
reported	VBN	O
since	IN	O
the	DT	O
identification	NN	O
of	IN	O
the	DT	O
first	JJ	O
case	NN	O
in	IN	O
2003	CD	O
.	.	O

All	DT	O
mutations	NNS	B-Var
enhanced	VBD	B-PosReg
the	DT	O
inhibitory	NN	B-MPA
activity	NN	I-MPA
of	IN	O
I	PRP	B-Protein
B	NNP	I-Protein
,	,	I-Protein
by	IN	O
preventing	VBG	B-NegReg
its	PRP$	O
phosphorylation	NN	B-MPA
on	IN	I-MPA
serine	JJ	I-MPA
32	CD	I-MPA
or	CC	I-MPA
36	CD	I-MPA
and	CC	O
its	PRP$	O
subsequent	JJ	O
degradation	NN	B-MPA
.	.	O
The	DT	O
mutation	NN	O
certainly	RB	O
or	CC	O
probably	RB	O
occurred	VBD	O
de	FW	O
novo	FW	O
in	IN	O
13	CD	O
patients	NNS	O
,	,	O
whereas	IN	O
it	PRP	O
was	VBD	O
inherited	VBN	O
from	IN	O
a	DT	O
parent	NN	O
with	IN	O
somatic	JJ	O
mosaicism	NN	O
in	IN	O
one	CD	O
patient	NN	O
.	.	O

Eleven	JJ	O
mutations	NNS	O
,	,	O
belonging	VBG	O
to	TO	O
two	CD	O
groups	NNS	O
,	,	O
were	VBD	O
identified	VBN	O
:	:	O
(	(	O
i	NN	O
)	)	O
missense	NN	O
mutations	NNS	O
affecting	VBG	O
S32	NNP	O
,	,	O
S36	NNP	O
,	,	O
or	CC	O
neighboring	VBG	O
residues	NNS	O
(	(	O
8	CD	O
mutations	NNS	O
,	,	O
11	CD	O
patients	NNS	O
)	)	O
and	CC	O
(	(	O
ii	NN	O
)	)	O
nonsense	NN	O
mutations	NNS	O
upstream	VBP	O
from	IN	O
S32	NNP	O
associated	VBN	O
with	IN	O
the	DT	O
reinitiation	NN	O
of	IN	O
translation	NN	O
downstream	NN	O
from	IN	O
S36	NNP	O
(	(	O
3	CD	O
mutations	NNS	O
,	,	O
3	CD	O
patients	NNS	O
)	)	O
.	.	O

Thirteen	JJ	O
patients	NNS	O
had	VBD	O
developmental	JJ	O
features	NNS	O
of	IN	O
EDA	NNP	O
,	,	O
the	DT	O
severity	NN	O
and	CC	O
nature	NN	O
of	IN	O
which	WDT	O
differed	VBD	O
between	IN	O
cases	NNS	O
.	.	O

All	DT	O
patient	JJ	O
cells	NNS	O
tested	VBN	O
displayed	RB	O
impaired	JJ	O
NF	NNP	O
-	:	O
B	NNP	O
-	:	O
mediated	VBD	O
responses	NNS	O
to	TO	O
the	DT	O
stimulation	NN	O
of	IN	O
various	JJ	O
surface	NN	O
receptors	NNS	O
involved	VBN	O
in	IN	O
cell	NN	O
-	:	O
intrinsic	JJ	O
(	(	O
fibroblasts	NNS	O
)	)	O
,	,	O
innate	NN	O
(	(	O
monocytes	NNS	O
)	)	O
,	,	O
and	CC	O
adaptive	JJ	O
(	(	O
B	NNP	O
and	CC	O
T	NNP	O
cells	NNS	O
)	)	O
immunity	NN	O
,	,	O
including	VBG	O
TLRs	NNP	O
,	,	O
IL	NNP	O
-	:	O
1	CD	O
Rs	NNP	O
,	,	O
TNFRs	NNP	O
,	,	O
TCR	NNP	O
,	,	O
and	CC	O
BCR	NNP	O
.	.	O

All	DT	O
patients	NNS	O
had	VBD	O
profound	VBN	O
B	NNP	O
-	:	O
cell	NN	O
deficiency	NN	O
.	.	O

Specific	JJ	O
immunological	JJ	O
features	NNS	O
,	,	O
found	VBN	O
in	IN	O
some	DT	O
,	,	O
but	CC	O
not	RB	O
all	DT	O
patients	NNS	O
,	,	O
included	VBD	O
a	DT	O
lack	NN	O
of	IN	O
peripheral	JJ	O
lymph	NN	O
nodes	NNS	O
,	,	O
lymphocytosis	NN	O
,	,	O
dysfunctional	JJ	O
T	NNP	O
cells	NNS	O
,	,	O
and	CC	O
a	DT	O
lack	NN	O
of	IN	O
circulating	VBG	O
T	NNP	O
cells	NNS	O
.	.	O

The	DT	O
patients	NNS	O
had	VBD	O
various	JJ	O
pyogenic	JJ	O
,	,	O
mycobacterial	JJ	O
,	,	O
fungal	JJ	O
,	,	O
and	CC	O
viral	JJ	O
severe	JJ	O
infections	NNS	O
.	.	O

Patients	NNS	O
with	IN	O
a	DT	O
missense	JJ	O
mutation	NN	O
tended	VBD	O
to	TO	O
display	VB	O
more	RBR	O
severe	JJ	O
phenotypes	NNS	O
,	,	O
probably	RB	O
due	JJ	O
to	TO	O
higher	JJR	O
levels	NNS	O
of	IN	O
GOF	NNP	O
proteins	NNS	O
.	.	O

In	IN	O
the	DT	O
absence	NN	O
of	IN	O
hematopoietic	JJ	O
stem	NN	O
cell	NN	O
transplantation	NN	O
(	(	O
HSCT	NNP	O
)	)	O
,	,	O
this	DT	O
condition	NN	O
cause	NN	O
death	NN	O
before	IN	O
the	DT	O
age	NN	O
of	IN	O
1	CD	O
year	NN	O
(	(	O
one	CD	O
child	NN	O
)	)	O
.	.	O

Two	CD	O
survivors	NNS	O
have	VBP	O
been	VBN	O
on	IN	O
prophylaxis	NN	O
(	(	O
at	IN	O
9	CD	O
and	CC	O
22	CD	O
years	NNS	O
)	)	O
.	.	O

Six	NNP	O
children	NNS	O
died	VBD	O
after	IN	O
HSCT	NNP	O
.	.	O

Five	CD	O
survived	VBN	O
,	,	O
four	CD	O
of	IN	O
whom	WP	O
have	VBP	O
been	VBN	O
on	IN	O
prophylaxis	NN	O
(	(	O
3	CD	O
to	TO	O
21	CD	O
years	NNS	O
post	RB	O
HSCT	NNP	O
)	)	O
,	,	O
whereas	WP	O
one	CD	O
has	VBZ	O
been	VBN	O
well	RB	O
with	IN	O
no	DT	O
prophylaxis	NN	O
.	.	O

Heterozygous	JJ	O
GOF	NNP	O
mutations	NNS	O
in	IN	O
I	PRP	O
B	NNP	O
underlie	VBD	O
a	DT	O
severe	JJ	O
and	CC	O
syndromic	JJ	O
immunodeficiency	NN	O
,	,	O
the	DT	O
interindividual	JJ	O
variability	NN	O
of	IN	O
which	WDT	O
might	MD	O
partly	RB	O
be	VB	O
ascribed	VBN	O
to	TO	O
the	DT	O
dichotomy	NN	O
of	IN	O
missense	NN	O
and	CC	O
nonsense	JJ	O
mutations	NNS	O
,	,	O
and	CC	O
the	DT	O
hematopoietic	JJ	O
component	NN	O
of	IN	O
which	WDT	O
can	MD	O
be	VB	O
rescued	VBN	O
by	IN	O
HSCT	NNP	O

loss	NN	B-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
SlMBP21	NNP	B-Gene
jointless	VB	B-CPA
-	:	I-CPA
2	CD	I-CPA
phenotype	NN	I-CPA
Abscission	NN	O
is	VBZ	O
the	DT	O
mechanism	NN	O
by	IN	O
which	WDT	O
plants	NNS	O
disconnect	VBP	O
unfertilized	JJ	O
flowers	NNS	O
,	,	O
ripe	JJ	O
fruits	NNS	O
,	,	O
senescent	NN	O
or	CC	O
diseased	VBN	O
organs	NNS	O
from	IN	O
the	DT	O
plant	NN	O
.	.	O

In	IN	O
tomato	NN	O
,	,	O
pedicel	JJ	O
abscission	NN	O
is	VBZ	O
an	DT	O
important	JJ	O
agronomic	JJ	O
factor	NN	O
that	WDT	O
controls	VBZ	O
yield	JJR	O
and	CC	O
post	VB	O
-	:	O
harvest	NN	O
fruit	NN	O
quality	NN	O
.	.	O

Two	CD	O
non	SYM	O
-	:	O
allelic	JJ	O
mutations	NNS	O
,	,	O
jointless	NN	O
(	(	O
j	NN	O
)	)	O
and	CC	O
jointless	JJ	O
-	:	O
2	CD	O
(	(	O
j	NN	O
-	:	O
2	CD	O
)	)	O
,	,	O
controlling	VBG	O
pedicel	JJ	O
abscission	NN	O
zone	NN	O
formation	NN	O
have	VBP	O
been	VBN	O
documented	VBN	O
but	CC	O
only	RB	O
j	VBZ	O
-	:	O
2	CD	O
has	VBZ	O
been	VBN	O
extensively	RB	O
used	VBN	O
in	IN	O
breeding	NN	O
.	.	O

J	NNP	O
was	VBD	O
shown	VBN	O
to	TO	O
encode	VB	O
a	DT	O
MADS	NNP	O
-	:	O
box	NN	O
protein	NN	O
.	.	O

Using	VBG	O
a	DT	O
combination	NN	O
of	IN	O
physical	JJ	O
mapping	NN	O
and	CC	O
gene	NN	O
expression	NN	O
analysis	NN	O
we	PRP	O
identified	VBD	O
a	DT	O
positional	JJ	O
candidate	NN	O
,	,	O
Solyc12g038510	NNP	O
,	,	O
associated	VBN	O
with	IN	O
j	NN	O
-	:	O
2	CD	O
phenotype	NN	O
.	.	O

Targeted	VBN	O
knockout	NN	O
of	IN	O
Solyc12g038510	NNP	O
,	,	O
using	VBG	O
CRISPR	NNP	O
Cas9	NNP	O
system	NN	O
,	,	O
validated	VBD	O
our	PRP$	O
hypothesis	NN	O
.	.	O

Solyc12g038510	NNP	O
encodes	VBZ	O
the	DT	O
MADS	NNP	O
-	:	O
box	NN	O
protein	NN	O
SlMBP21	NNP	O
.	.	O

Molecular	JJ	O
analysis	NN	O
of	IN	O
j	NN	O
-	:	O
2	CD	O
natural	JJ	O
variation	NN	O
revealed	VBD	O
two	CD	O
independent	JJ	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
mutants	NNS	O
.	.	O

The	DT	O
first	JJ	O
results	NNS	O
of	IN	O
an	DT	O
insertion	NN	O
of	IN	O
a	DT	O
Rider	NNP	O
retrotransposable	JJ	O
element	NN	O
.	.	O

The	DT	O
second	JJ	O
results	NNS	O
of	IN	O
a	DT	O
stop	JJ	O
codon	NN	O
mutation	NN	O
that	WDT	O
leads	VBZ	O
to	TO	O
a	DT	O
truncated	VBN	O
protein	NN	O
form	NN	O
.	.	O

To	TO	O
bring	VB	O
new	JJ	O
insights	NNS	O
into	IN	O
the	DT	O
role	NN	O
of	IN	O
J	NNP	O
and	CC	O
J	NNP	O
-	:	O
2	CD	O
in	IN	O
abscission	NN	O
zone	NN	O
formation	NN	O
,	,	O
we	PRP	O
phenotyped	VBD	O
the	DT	O
single	JJ	O
and	CC	O
the	DT	O
double	JJ	O
mutants	NNS	O
and	CC	O
the	DT	O
engineered	JJ	O
alleles	NNS	O
.	.	O

We	PRP	O
showed	VBD	O
that	IN	O
J	NNP	O
is	VBZ	O
epistatic	JJ	O
to	TO	O
J	NNP	O
-	:	O
2	CD	O
and	CC	O
that	IN	O
the	DT	O
branched	JJ	O
inflorescences	NNS	O
and	CC	O
the	DT	O
leafy	NN	O
sepals	NNS	O
observed	VBD	O
in	IN	O
accessions	NNS	O
harboring	VBG	O
j	NN	O
-	:	O
2	CD	O
alleles	NNS	O
are	VBP	O
likely	JJ	O
the	DT	O
consequences	NNS	O
of	IN	O
linkage	NN	O
drags	NNS	O

Promote	NNP	I-Gene
Growth	NNP	I-Var
of	IN	I-PosReg
Melanoma	NNP	I-MPA
Tumors	NNP	I-Disease
mutations	NNS	B-Var
generate	VB	B-Reg
neoantigens	NNS	B-MPA
suppress	VB	B-NegReg
immune	JJ	B-MPA
response	NN	I-MPA
to	TO	I-MPA
facilitate	VB	I-MPA
continued	JJ	I-MPA
growth	NN	I-MPA

ATR	NNP	B-Gene
mutant	JJ	B-Var
tumors	NNS	O
exhibit	VBP	O
both	DT	O
the	DT	O
accumulation	NN	O
of	IN	O
multiple	JJ	O
mutations	NNS	O
and	CC	O
the	DT	O
altered	JJ	O
expression	NN	O
of	IN	O
inflammatory	JJ	O
genes	NNS	O
,	,	O
resulting	VBG	O
in	IN	O
decreased	JJ	B-NegReg
T	NNP	B-MPA
cell	NN	I-MPA
recruitment	NN	I-MPA
and	CC	O
increased	VBD	B-PosReg
recruitment	NN	B-MPA
of	IN	I-MPA
macrophages	NNS	I-MPA
known	VBN	O
to	TO	O
spur	VB	O
tumor	NN	O
invasion	NN	O
.	.	O
Taken	VBN	O
together	RB	O
,	,	O
these	DT	O
studies	NNS	O
identify	VBP	O
a	DT	O
mechanism	NN	O
by	IN	O
which	WDT	O
melanoma	NN	O
cells	NNS	O
modulate	VBP	O
the	DT	O
immune	JJ	O
microenvironment	NN	O
to	TO	O
promote	VB	O
continued	JJ	O
growth	NN	O



The	DT	O
adaptive	NN	O
telomere	JJ	O
failure	NN	O
hypothesis	NN	O
suggests	VBZ	O
that	IN	O
certain	JJ	O
environmental	JJ	O
stresses	NNS	O
can	MD	O
induce	VB	O
a	DT	O
low	JJ	O
level	NN	O
of	IN	O
telomere	JJ	O
failure	NN	O
,	,	O
potentially	RB	O
leading	VBG	O
to	TO	O
elevated	VBN	O
subtelomeric	JJ	O
recombination	NN	O
that	WDT	O
could	MD	O
result	VB	O
in	IN	O
adaptive	JJ	O
mutational	JJ	O
changes	NNS	O
within	IN	O
subtelomeric	JJ	O
genes	NNS	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
tested	VBD	O
a	DT	O
key	JJ	O
prediction	NN	O
of	IN	O
the	DT	O
adaptive	NN	O
telomere	JJ	O
failure	NN	O
hypothesis	NN	O
-	:	O
that	WDT	O
telomere	EX	O
dysfunction	NN	O
mild	RB	O
enough	RB	O
to	TO	O
have	VB	O
little	JJ	O
or	CC	O
no	DT	O
overall	JJ	O
effect	NN	O
on	IN	O
cell	NN	O
fitness	NN	O
could	MD	O
still	RB	O
lead	VB	O
to	TO	O
substantial	JJ	O
increases	NNS	O
in	IN	O
the	DT	O
mutation	NN	O
rates	NNS	O
of	IN	O
subtelomeric	JJ	O
genes	NNS	O
.	.	O

Our	PRP$	O
results	NNS	O
show	VBP	O
that	IN	O
a	DT	O
mutant	NN	O
of	IN	O
Kluyveromyces	NNP	O
lactis	NN	O
with	IN	O
stably	RB	O
short	JJ	O
telomeres	NNS	O
produced	VBD	O
a	DT	O
large	JJ	O
increase	NN	O
in	IN	O
the	DT	O
frequency	NN	O
of	IN	O
mutations	NNS	O
affecting	VBG	O
the	DT	O
native	JJ	O
subtelomeric	JJ	O
-	:	O
galactosidase	NN	O
(	(	O
LAC4	NNP	O
)	)	O
gene	NN	O
.	.	O

All	DT	O
lac4	JJ	B-Gene
mutants	NNS	B-Var
examined	VBN	O
from	IN	O
strains	NNS	O
with	IN	O
severe	JJ	O
telomere	JJ	O
dysfunction	NN	O
underwent	JJ	B-Reg
terminal	JJ	B-MPA
deletion	NN	I-MPA
duplication	NN	I-MPA
events	NNS	O
consistent	JJ	O
with	IN	O
being	VBG	O
due	JJ	O
to	TO	O
break	VB	O
-	:	O
induced	JJ	O
replication	NN	O
.	.	O
In	IN	O
contrast	NN	O
,	,	O
although	IN	O
cells	NNS	O
with	IN	O
mild	NN	O
telomere	EX	O
dysfunction	NN	O
also	RB	O
exhibited	VBD	O
similar	JJ	O
terminal	JJ	O
deletion	NN	O
and	CC	O
duplication	NN	O
events	NNS	O
,	,	O
up	RB	O
to	TO	O
50%	CD	O
of	IN	O
lac4	JJ	B-Gene
mutants	NNS	B-Var
from	IN	O
this	DT	O
background	NN	O
unexpectedly	RB	O
contained	VBD	B-Reg
base	NN	B-MPA
changes	NNS	I-MPA
within	IN	O
the	DT	O
LAC4	NNP	O
coding	VBG	O
region	NN	O
.	.	O
This	DT	O
mutational	JJ	O
bias	NN	O
for	IN	O
producing	VBG	O
base	NN	O
changes	NNS	O
demonstrates	VBZ	O
that	IN	O
mild	NN	O
telomere	EX	O
dysfunction	NN	O
can	MD	O
be	VB	O
well	RB	O
suited	VBN	O
as	IN	O
a	DT	O
force	NN	O
for	IN	O
altering	VBG	O
the	DT	O
adaptive	JJ	O
potential	NN	O
of	IN	O
subtelomeric	JJ	O
genes	NNS	O


negative	JJ	B-NegReg
mutations	NNS	B-Var
CLCN7	NNP	B-Gene
Albers	NNP	B-Disease
-	:	I-Disease
Sch	NNP	I-Disease
nberg	JJ	I-Disease
disease	NN	I-Disease

Here	RB	O
we	PRP	O
describe	VBP	O
a	DT	O
mouse	NN	O
with	IN	O
a	DT	O
different	JJ	O
osteopetrosis	NN	O
-	:	O
causing	NN	O
mutation	NN	O
(	(	O
Clcn7F318L	NNP	O
)	)	O
.	.	O

Compared	VBN	O
to	TO	O
Clcn7	NNP	O
mice	NN	O
,	,	O
12	CD	O
-	:	O
week	NN	O
-	:	O
old	JJ	O
Clcn7F318L	NNP	O
mice	NN	O
have	VBP	O
significantly	RB	O
increased	VBN	B-PosReg
trabecular	JJ	B-CPA
bone	NN	I-CPA
volume	NN	I-CPA
,	,	O
consistent	JJ	O
with	IN	O
Clcn7F318L	NNP	B-Gene
acting	VBG	I-Gene
as	IN	I-Var
a	DT	O
dominant	JJ	O
negative	JJ	B-NegReg
mutation	NN	O
.	.	O
Clcn7F318L	NNP	O
F318L	NNP	O
and	CC	O
Clcn7F318L	NNP	O
G213R	NNP	O
mice	NN	O
die	NN	O
by	IN	O
1	CD	O
month	NN	O
of	IN	O
age	NN	O
and	CC	O
resemble	JJ	O
Clcn7	NNP	O
knockout	NN	O
mice	NN	O
,	,	O
which	WDT	O
indicate	VBP	O
that	IN	O
p	NN	B-Var
.	.	I-Var
F318L	NNP	I-Var
mutant	JJ	O
protein	NN	B-Protein
is	VBZ	O
non	JJ	B-NegReg
-	:	O
functional	JJ	B-MPA
and	CC	O
p	NN	O
.	.	O
F318L	NNP	O
and	CC	O
p	NN	O
.	.	O
G213R	NNP	O
mutant	JJ	O
proteins	NNS	O
do	VBP	O
not	RB	O
complement	VB	O
one	CD	O
another	DT	O
.	.	O
Since	IN	O
it	PRP	O
has	VBZ	O
been	VBN	O
reported	VBN	O
that	IN	O
treatment	NN	O
with	IN	O
interferon	NN	O
gamma	NN	O
(	(	O
IFN	NNP	O
-	:	O
G	NNP	O
)	)	O
improves	VBZ	O
bone	NN	O
properties	NNS	O
in	IN	O
Clcn7G213R	NNP	O
mice	NN	O
,	,	O
we	PRP	O
treated	VBD	O
Clcn7F318L	NNP	O
mice	NN	O
with	IN	O
IFN	NNP	O
-	:	O
G	NNP	O
and	CC	O
observed	VBD	O
a	DT	O
decrease	NN	O
in	IN	O
osteoclast	JJ	O
number	NN	O
and	CC	O
mineral	JJ	O
apposition	NN	O
rate	NN	O
,	,	O
but	CC	O
no	DT	O
overall	JJ	O
improvement	NN	O
in	IN	O
bone	NN	O
properties	NNS	O
.	.	O

Our	PRP$	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
benefits	NNS	O
of	IN	O
IFN	NNP	O
-	:	O
G	NNP	O
therapy	NN	O
in	IN	O
patients	NNS	O
with	IN	O
Albers	NNP	O
-	:	O
Sch	NNP	O
nberg	IN	O
disease	NN	O
may	MD	O
be	VB	O
mutation	NN	O
-	:	O
specific	NN	O


The	DT	O
Mediator	NNP	O
complex	NN	O
is	VBZ	O
at	IN	O
the	DT	O
core	NN	O
of	IN	O
transcriptional	JJ	O
regulation	NN	O
and	CC	O
plays	VBZ	O
a	DT	O
central	JJ	O
role	NN	O
in	IN	O
plant	NN	O
immunity	NN	O
.	.	O

The	DT	O
MEDIATOR25	NNP	O
(	(	O
MED25	NNP	O
)	)	O
subunit	NN	O
of	IN	O
Arabidopsis	NNP	O
thaliana	NN	O
regulates	VBZ	O
jasmonate	JJ	O
-	:	O
dependent	JJ	O
resistance	NN	O
to	TO	O
Botrytis	NNP	O
cinerea	NN	O
through	IN	O
interacting	VBG	O
with	IN	O
the	DT	O
basic	JJ	O
helix	NN	O
-	:	O
loop	NN	O
-	:	O
helix	NN	O
(	(	O
bHLH	NN	O
)	)	O
transcription	NN	O
factor	NN	O
of	IN	O
jasmonate	NN	O
signaling	NN	O
,	,	O
MYC2	NNP	O
.	.	O

Another	DT	O
Mediator	NNP	O
subunit	NN	O
,	,	O
MED8	NNP	O
,	,	O
acts	VBZ	O
independently	RB	O
or	CC	O
together	RB	O
with	IN	O
MED25	NNP	O
in	IN	O
plant	NN	O
immunity	NN	O
.	.	O

However	RB	O
,	,	O
unlike	IN	O
MED25	NNP	O
,	,	O
the	DT	O
underlying	VBG	O
action	NN	O
mechanisms	NNS	O
of	IN	O
MED8	NNP	O
in	IN	O
regulating	VBG	O
B.	NNP	O
cinerea	NN	O
resistance	NN	O
are	VBP	O
still	RB	O
unknown	JJ	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
demonstrated	VBD	O
that	IN	O
MED8	NNP	O
regulated	VBD	O
plant	NN	O
immunity	NN	O
to	TO	O
B.	NNP	O
cinerea	NN	O
through	IN	O
interacting	VBG	O
with	IN	O
another	DT	O
bHLH	NN	O
transcription	NN	O
factor	NN	O
,	,	O
FAMA	NNP	O
,	,	O
which	WDT	O
was	VBD	O
previously	RB	O
shown	VBN	O
to	TO	O
control	VB	O
the	DT	O
final	JJ	O
proliferation	NN	O
differentiation	NN	O
switch	NN	O
during	IN	O
stomatal	JJ	O
development	NN	O
.	.	O

Our	PRP$	O
research	NN	O
demonstrates	VBZ	O
that	IN	O
FAMA	NNP	O
is	VBZ	O
also	RB	O
an	DT	O
essential	JJ	O
component	NN	O
of	IN	O
B.	NNP	O
cinerea	NN	O
resistance	NN	O
.	.	O

The	DT	O
fama	NN	B-Gene
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutants	NNS	B-Var
(	(	O
fama	SYM	O
-	:	O
1	CD	O
and	CC	O
fama	VB	O
-	:	O
2	CD	O
)	)	O
increased	VBD	B-PosReg
susceptibility	NN	B-MPA
to	TO	I-MPA
B.	NNP	I-MPA
cinerea	NN	I-MPA
infection	NN	I-MPA
and	CC	O
reduced	JJ	B-NegReg
defense	NN	B-MPA
-	:	I-MPA
gene	NN	I-MPA
expression	NN	I-MPA
.	.	O
On	IN	O
the	DT	O
contrary	JJ	O
,	,	O
transgenic	JJ	O
lines	NNS	O
constitutively	RB	O
overexpressing	VBG	O
FAMA	NNP	O
showed	VBD	O
opposite	JJ	O
B.	NNP	O
cinerea	NN	O
responses	NNS	O
compared	VBN	O
with	IN	O
the	DT	O
fama	NN	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
mutants	NNS	O
.	.	O

FAMA	NNP	O
-	:	O
overexpressed	VBD	O
plants	NNS	O
displayed	VBN	O
enhanced	VBD	O
resistance	NN	O
to	TO	O
B.	NNP	O
cinerea	NN	O
infection	NN	O
and	CC	O
increased	JJ	O
expression	NN	O
levels	NNS	O
of	IN	O
defensin	NN	O
genes	NNS	O
following	VBG	O
B.	NNP	O
cinerea	JJ	O
treatment	NN	O
.	.	O

Genetic	JJ	O
analysis	NN	O
of	IN	O
MED8	NNP	O
and	CC	O
FAMA	NNP	O
suggested	VBD	O
that	IN	O
FAMA	NNP	O
-	:	O
regulated	VBD	O
pathogen	NN	O
resistance	NN	O
was	VBD	O
dependent	JJ	O
on	IN	O
MED8	NNP	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
MED8	NNP	O
and	CC	O
FAMA	NNP	O
were	VBD	O
both	DT	O
associated	VBN	O
with	IN	O
the	DT	O
G	NNP	O
-	:	O
box	NN	O
region	NN	O
in	IN	O
the	DT	O
promoter	NN	O
of	IN	O
ORA59	NNP	O
.	.	O

Our	PRP$	O
findings	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
MED8	NNP	O
subunit	NN	O
of	IN	O
the	DT	O
A.	NNP	O
thaliana	NNP	O
Mediator	NNP	O
regulates	VBZ	O
plant	NN	O
immunity	NN	O
to	TO	O
B.	NNP	O
cinerea	NN	O
through	IN	O
interacting	VBG	O
with	IN	O
the	DT	O
transcription	NN	O
factor	NN	O
FAMA	NNP	O
,	,	O
which	WDT	O
was	VBD	O
discovered	VBN	O
to	TO	O
be	VB	O
a	DT	O
key	JJ	O
component	NN	O
in	IN	O
B.	NNP	O
cinerea	NN	O
resistance	NN	O

-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
variants	NNS	B-Var
NFIA	NNP	B-Gene
1	CD	B-Disease
p32	JJ	I-Disease
-	:	I-Disease
p31	NN	I-Disease
deletion	NN	I-Disease
syndrome	NN	I-Disease
The	DT	O
association	NN	O
between	IN	O
1	CD	O
p32	SYM	O
-	:	O
p31	NN	O
contiguous	JJ	O
gene	NN	O
deletions	NNS	O
and	CC	O
a	DT	O
distinct	JJ	O
phenotype	NN	O
that	WDT	O
includes	VBZ	O
anomalies	NNS	O
of	IN	O
the	DT	O
corpus	NN	O
callosum	NN	O
,	,	O
ventriculomegaly	NN	O
,	,	O
developmental	JJ	O
delay	NN	O
,	,	O
seizures	NNS	O
,	,	O
and	CC	O
dysmorphic	JJ	O
features	NNS	O
has	VBZ	O
been	VBN	O
long	RB	O
recognized	VBN	O
and	CC	O
described	VBN	O
.	.	O

Recently	RB	O
,	,	O
the	DT	O
observation	NN	O
of	IN	O
overlapping	VBG	O
phenotypes	NNS	O
in	IN	O
patients	NNS	O
with	IN	O
chromosome	NN	O
translocations	NNS	O
that	WDT	O
disrupt	VBP	O
NFIA	NNP	O
(	(	O
Nuclear	NNP	O
factor	NN	O
I	PRP	O
A	DT	O
)	)	O
,	,	O
a	DT	O
gene	NN	O
within	IN	O
this	DT	O
deleted	JJ	O
region	NN	O
,	,	O
and	CC	O
NFIA	NNP	O
intragenic	JJ	O
deletions	NNS	O
has	VBZ	O
led	VBN	O
to	TO	O
the	DT	O
hypothesis	NN	O
that	IN	O
NFIA	NNP	O
is	VBZ	O
a	DT	O
critical	JJ	O
gene	NN	O
within	IN	O
this	DT	O
region	NN	O
.	.	O

The	DT	O
wide	JJ	O
application	NN	O
and	CC	O
increasing	VBG	O
accessibility	NN	O
of	IN	O
whole	JJ	O
exome	NN	O
sequencing	NN	O
(	(	O
WES	NNP	O
)	)	O
has	VBZ	O
helped	VBN	O
identify	VB	O
new	JJ	O
cases	NNS	O
to	TO	O
support	VB	O
this	DT	O
hypothesis	NN	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
describe	VBP	O
four	CD	O
patients	NNS	O
with	IN	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
variants	NNS	O
in	IN	O
the	DT	O
NFIA	NNP	O
gene	NN	O
identified	VBD	O
through	IN	O
WES	NNP	O
.	.	O

The	DT	O
clinical	JJ	O
presentation	NN	O
of	IN	O
these	DT	O
patients	NNS	O
significantly	RB	O
overlaps	VBZ	O
with	IN	O
the	DT	O
phenotype	NN	O
described	VBN	O
in	IN	O
previously	RB	O
reported	VBN	O
cases	NNS	O
of	IN	O
1	CD	O
p32	JJ	O
-	:	O
p31	NN	O
deletion	NN	O
syndrome	NN	O
,	,	O
NFIA	NNP	O
gene	NN	O
disruptions	NNS	O
and	CC	O
intragenic	JJ	O
NFIA	NNP	O
deletions	NNS	O
.	.	O

Our	PRP$	O
cohort	NN	O
includes	VBZ	O
a	DT	O
mother	NN	O
and	CC	O
daughter	NN	O
as	RB	O
well	RB	O
as	IN	O
an	DT	O
unrelated	JJ	O
individual	NN	O
who	WP	O
share	NN	O
the	DT	O
same	JJ	O
nonsense	NN	O
variant	NN	O
(	(	O
c	NN	O
.	.	O
205	CD	O
C	NNP	O
T	NNP	O
,	,	O
p	NN	O
.	.	O
Arg69Ter	NNP	O
;	:	O
NM	NNP	O
_	NNP	O
001145512.1	CD	O
)	)	O
.	.	O

We	PRP	O
also	RB	O
report	VBP	O
a	DT	O
patient	NN	O
with	IN	O
a	DT	O
frameshift	NN	O
NFIA	NNP	O
variant	NN	O
(	(	O
c	NN	O
.	.	O
159	CD	O
_	JJ	O
160	CD	O
dupCC	NN	O
,	,	O
p	NN	O
.	.	O
Gln54ProfsTer49	NNP	O
)	)	O
.	.	O

We	PRP	O
have	VBP	O
compared	VBN	O
published	VBN	O
cases	NNS	O
of	IN	O
1	CD	O
p32	JJ	O
-	:	O
p31	NN	O
microdeletion	NN	O
syndrome	NN	O
,	,	O
translocations	NNS	O
resulting	VBG	O
in	IN	O
NFIA	NNP	O
gene	NN	O
disruption	NN	O
,	,	O
intragenic	JJ	O
deletions	NNS	O
,	,	O
and	CC	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
mutations	NNS	O
(	(	O
including	VBG	O
our	PRP$	O
four	CD	O
patients	NNS	O
)	)	O
to	TO	O
reveal	VB	O
that	IN	O
abnormalities	NNS	O
of	IN	O
the	DT	O
corpus	NN	O
callosum	NN	O
,	,	O
ventriculomegaly	JJ	O
hydrocephalus	NN	O
,	,	O
macrocephaly	NN	O
,	,	O
Chiari	NNP	O
I	PRP	O
malformation	NN	O
,	,	O
dysmorphic	JJ	O
features	NNS	O
,	,	O
developmental	JJ	O
delay	NN	O
,	,	O
hypotonia	NN	O
,	,	O
and	CC	O
urinary	JJ	O
tract	NN	O
defects	NNS	O
are	VBP	O
common	JJ	O
findings	NNS	O
.	.	O

The	DT	O
consistent	JJ	O
overlap	NN	O
in	IN	O
clinical	JJ	O
presentation	NN	O
provides	VBZ	O
further	JJ	O
evidence	NN	O
of	IN	O
the	DT	O
critical	JJ	O
role	NN	O
of	IN	O
NFIA	NNP	O
haploinsufficiency	NN	O
in	IN	O
the	DT	O
development	NN	O
of	IN	O
the	DT	O
1	CD	O
p32	NN	O
-	:	O
p31	NN	O
microdeletion	NN	O
syndrome	NN	O
phenotype	NN	O



However	RB	O
,	,	O
our	PRP$	O
knowledge	NN	O
of	IN	O
neuronal	JJ	O
necrosis	NN	O
is	VBZ	O
still	RB	O
inadequate	JJ	O
.	.	O

To	TO	O
study	VB	O
the	DT	O
mechanism	NN	O
of	IN	O
neuronal	JJ	O
necrosis	NN	O
,	,	O
we	PRP	O
previously	RB	O
established	VBD	O
a	DT	O
Drosophila	NNP	O
genetic	JJ	O
model	NN	O
of	IN	O
neuronal	JJ	O
necrosis	NN	O
by	IN	O
calcium	NN	O
overloading	VBG	O
through	IN	O
expression	NN	O
of	IN	O
a	DT	O
constitutively	RB	O
opened	VBN	O
cation	NN	O
channel	NN	O
mutant	NN	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
performed	VBD	O
further	RBR	O
genetic	JJ	O
screens	NNS	O
and	CC	O
identified	VBD	O
a	DT	O
suppressor	NN	O
of	IN	O
neuronal	JJ	O
necrosis	NN	O
,	,	O
CG17259	NNP	O
,	,	O
which	WDT	O
encodes	VBZ	O
a	DT	O
seryl	JJ	O
-	:	O
tRNA	NN	O
synthetase	NN	O
.	.	O

We	PRP	O
found	VBD	O
that	IN	O
loss	NN	B-Var
-	:	I-Var
of	IN	I-Var
-	:	I-Var
function	NN	I-Var
(	(	O
LOF	NNP	O
)	)	O
CG17259	NNP	B-Gene
activated	VBD	B-PosReg
eIF2	JJ	B-Protein
phosphorylation	NN	I-Protein
and	CC	I-CPA
subsequent	VB	O
up	RP	B-PosReg
-	:	I-PosReg
regulation	NN	I-PosReg
of	IN	O
chaperons	NNS	B-CPA
(	(	O
Hsp26	NNP	B-Protein
and	CC	O
Hsp27	NNP	B-Protein
)	)	O
and	CC	O
autophagy	NN	B-CPA
.	.	O
Genetically	RB	O
,	,	O
down	RB	B-NegReg
-	:	I-NegReg
regulation	NN	I-NegReg
of	IN	O
eIF2	JJ	B-Protein
phosphorylation	NN	I-Protein
,	,	I-CPA
Hsp26	NNP	B-Protein
Hsp27	NNP	B-Protein
or	CC	O
autophagy	VB	B-CPA
reduced	VBN	B-NegReg
the	DT	O
protective	JJ	B-CPA
effect	NN	I-CPA
of	IN	O
LOF	NNP	B-Var
CG17259	NNP	B-Gene
,	,	O
indicating	VBG	O
they	PRP	O
function	VBP	O
downstream	NN	O
of	IN	O
CG17259	NNP	O
.	.	O
The	DT	O
protective	JJ	O
effect	NN	O
of	IN	O
these	DT	O
protein	NNS	O
degradation	NN	O
pathways	NNS	O
indicated	VBD	O
activation	NN	O
of	IN	O
a	DT	O
toxic	JJ	O
protein	NN	O
during	IN	O
neuronal	JJ	O
necrosis	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
indicated	VBD	O
that	IN	O
p53	NN	O
was	VBD	O
likely	JJ	O
one	CD	O
such	JJ	O
protein	NN	O
,	,	O
because	IN	O
p53	NN	O
was	VBD	O
accumulated	VBN	O
in	IN	O
the	DT	O
necrotic	JJ	O
neurons	NNS	O
and	CC	O
down	RB	O
-	:	O
regulation	NN	O
of	IN	O
p53	NN	O
rescued	VBN	O
necrosis	NN	O
.	.	O

In	IN	O
the	DT	O
SH	NNP	O
-	:	O
SY5Y	NNP	O
human	JJ	O
cells	NNS	O
,	,	O
tunicamycin	NN	O
(	(	O
TM	NNP	O
)	)	O
,	,	O
a	DT	O
PERK	NNP	O
activator	NN	O
,	,	O
promoted	VBN	O
transcription	NN	O
of	IN	O
hsp27	NN	O
;	:	O
and	CC	O
necrosis	NN	O
induced	VBN	O
by	IN	O
glutamate	NN	O
could	MD	O
be	VB	O
rescued	VBN	O
by	IN	O
TM	NNP	O
,	,	O
associated	VBN	O
with	IN	O
reduced	VBN	O
p53	NN	O
accumulation	NN	O
.	.	O

In	IN	O
an	DT	O
ischemic	JJ	O
stroke	NN	O
model	NN	O
in	IN	O
rats	NNS	O
,	,	O
p53	NN	O
protein	NN	O
was	VBD	O
also	RB	O
increased	VBN	O
,	,	O
and	CC	O
TM	NNP	O
treatment	NN	O
could	MD	O
reduce	VB	O
the	DT	O
p53	NN	O
accumulation	NN	O
and	CC	O
brain	NN	O
damage	NN	O

-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutation	NN	B-Var
CYBC1	NNP	B-Gene
causes	VBZ	B-Reg
chronic	JJ	B-Disease
granulomatous	JJ	I-Disease
disease	NN	I-Disease
Mutations	NNS	B-Var
genes	NNS	B-Gene
encoding	VBG	I-Gene
subunits	NNS	I-Gene
of	IN	I-Gene
the	DT	I-Gene
phagocyte	NN	I-Gene
NADPH	NNP	I-Gene
oxidase	NN	I-Gene
complex	NN	I-Gene
cause	VB	B-Reg
chronic	JJ	B-Disease
granulomatous	JJ	I-Disease
disease	NN	I-Disease
deficiency	NN	B-NegReg
CYBC1	NNP	B-Gene
reduced	VB	B-NegReg
expression	NN	B-MPA
of	IN	I-MPA
NADPH	NNP	I-MPA
oxidase	NN	I-MPA
's	POS	I-MPA
main	JJ	I-MPA
subunit	NN	I-MPA
results	NNS	B-Reg
CGD	NNP	B-Disease
Analyzing	VBG	O
two	CD	O
brothers	NNS	O
diagnosed	VBD	O
with	IN	O
CGD	NNP	O
we	PRP	O
identify	VBP	O
a	DT	O
homozygous	JJ	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
mutation	NN	O
,	,	O
p	NN	O
.	.	O
Tyr2Ter	NNP	O
,	,	O
in	IN	O
CYBC1	NNP	O
.	.	O

Imputation	NN	O
of	IN	O
p	NN	O
.	.	O
Tyr2Ter	NNP	O
into	IN	O
155	CD	O
K	NNP	O
chip	NN	O
-	:	O
genotyped	VBD	O
Icelanders	NNS	O
reveals	NNS	O
six	CD	O
additional	JJ	O
homozygotes	NNS	O
,	,	O
all	DT	O
with	IN	O
signs	NNS	O
of	IN	O
CGD	NNP	O
,	,	O
manifesting	VBG	O
as	IN	O
colitis	NN	O
,	,	O
rare	JJ	O
infections	NNS	O
,	,	O
or	CC	O
a	DT	O
severely	RB	O
impaired	JJ	O
PMA	NNP	O
-	:	O
induced	VBD	O
neutrophil	JJ	O
oxidative	JJ	O
burst	NN	O
.	.	O

Homozygosity	NN	O
for	IN	O
p	NN	O
.	.	O
Tyr2Ter	NNP	O
consequently	RB	O
associates	VBZ	O
with	IN	O
inflammatory	JJ	O
bowel	NN	O
disease	NN	O
(	(	O
IBD	NNP	O
)	)	O
in	IN	O
Iceland	NNP	O
(	(	O
P	NNP	O
8.3	CD	O
10	CD	O
-	:	O
8	CD	O
;	:	O
OR	CC	O
67.6	CD	O
)	)	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
reduced	VBN	O
height	NN	O
(	(	O
P	NNP	O
3.3	CD	O
10	CD	O
-	:	O
4	CD	O
;	:	O
-	:	O
8.5	CD	O
cm	NN	O
)	)	O
.	.	O

Overall	JJ	O
,	,	O
we	PRP	O
find	VBP	O
that	IN	O
CYBC1	NNP	O
deficiency	NN	O
results	NNS	O
in	IN	O
CGD	NNP	O
characterized	VBN	O
by	IN	O
colitis	NN	O
and	CC	O
a	DT	O
distinct	JJ	O
profile	NN	O
of	IN	O
infections	NNS	O
indicative	JJ	O
of	IN	O
macrophage	NN	O
dysfunction	NN	O

-	:	I-Disease
onset	NN	I-Disease
autoimmune	JJ	I-Disease
disease	NN	I-Disease
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutation	NN	B-Var
TNFAIP3	NNP	B-Gene

-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
mutation	NN	B-Var
cardiac	JJ	B-MPA
chloride	NN	I-MPA
-	:	I-MPA
bicarbonate	NN	I-MPA
exchanger	NN	I-MPA
AE3	NNP	I-MPA
short	JJ	B-Disease
QT	NNP	I-Disease
syndrome	NN	I-Disease


Here	RB	O
we	PRP	O
identify	VBP	O
a	DT	O
missense	NN	B-Var
mutation	NN	I-Var
in	IN	O
the	DT	O
anion	NN	O
exchanger	NN	O
(	(	O
AE3	NNP	O
)-	CD	O
encoding	VBG	O
SLC4A3	NNP	B-Gene
gene	NN	O
in	IN	O
two	CD	O
unrelated	JJ	O
families	NNS	O
with	IN	O
SQTS	NNP	O
.	.	O
The	DT	O
mutation	NN	O
causes	VBZ	O
reduced	JJ	B-NegReg
surface	NN	B-MPA
expression	NN	I-MPA
of	IN	I-MPA
AE3	NNP	I-MPA
and	CC	O
reduced	VBN	B-NegReg
membrane	NN	B-MPA
bicarbonate	NN	I-MPA
transport	NN	I-MPA
.	.	O
Slc4a3	NNP	O
knockdown	NN	O
in	IN	O
zebrafish	JJ	O
causes	NNS	O
increased	VBD	O
cardiac	JJ	O
pHi	NN	O
,	,	O
short	JJ	O
QTc	NNP	O
,	,	O
and	CC	O
reduced	VBD	O
systolic	JJ	O
duration	NN	O
,	,	O
which	WDT	O
is	VBZ	O
rescued	VBN	O
by	IN	O
wildtype	NN	O
but	CC	O
not	RB	O
mutated	VBN	O
SLC4A3	NNP	O
.	.	O

Mechanistic	JJ	O
analyses	NNS	O
suggest	VBP	O
that	IN	O
an	DT	O
increase	NN	O
in	IN	O
pHi	NN	O
and	CC	O
decrease	NN	O
in	IN	O
[	NNP	O
Cl	NNP	O
-]	NNP	O
i	NN	O
shortened	VBD	O
the	DT	O
action	NN	O
potential	JJ	O
duration	NN	O
.	.	O

However	RB	O
,	,	O
other	JJ	O
mechanisms	NN	O
may	MD	O
also	RB	O
play	VB	O
a	DT	O
role	NN	O
.	.	O

Altered	NNP	O
anion	NN	O
transport	NN	O
represents	VBZ	O
a	DT	O
mechanism	NN	O
for	IN	O
development	NN	O
of	IN	O
arrhythmia	NN	O
and	CC	O
may	MD	O
provide	VB	O
new	JJ	O
therapeutic	JJ	O
possibilities	NNS	O


KIT	NNP	B-Gene
,	,	O
PDGFRA	NNP	B-Gene
,	,	O
NF1	NNP	B-Gene
and	CC	O
SDH	NNP	B-Gene
mutations	NNS	B-Var
are	VBP	O
alternate	JJ	O
initiating	JJ	O
events	NNS	O
,	,	O
fostering	VBG	B-Reg
hyperplasia	NN	O
in	IN	O
gastrointestinal	JJ	B-MPA
stromal	JJ	I-MPA
tumours	NNS	I-MPA
(	(	O
GISTs	NNP	O
)	)	O
,	,	O
and	CC	O
additional	JJ	O
genetic	JJ	O
alterations	NNS	O
are	VBP	O
required	VBN	O
for	IN	O
progression	NN	O
to	TO	O
malignancy	NN	O
.	.	O
The	DT	O
most	RBS	O
frequent	JJ	O
secondary	JJ	O
alteration	NN	O
,	,	O
demonstrated	VBN	O
in	IN	O
70%	CD	O
of	IN	O
GISTs	NNP	O
,	,	O
is	VBZ	O
chromosome	JJ	O
14	CD	O
q	JJ	O
deletion	NN	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
hemizygous	JJ	O
or	CC	O
homozygous	JJ	O
inactivating	VBG	O
mutations	NNS	O
of	IN	O
the	DT	O
chromosome	NN	O
14	CD	O
q	NN	O
MAX	NNP	O
gene	NN	O
in	IN	O
16	CD	O
of	IN	O
76	CD	O
GISTs	NNP	O
(	(	O
21%	CD	O
)	)	O
.	.	O

We	PRP	O
find	VBP	O
MAX	JJ	O
mutations	NNS	O
in	IN	O
17%	CD	O
and	CC	O
50%	CD	O
of	IN	O
sporadic	JJ	O
and	CC	O
NF1	NNP	O
-	:	O
syndromic	JJ	O
GISTs	NNP	O
,	,	O
respectively	RB	O
,	,	O
and	CC	O
we	PRP	O
find	VBP	O
loss	NN	O
of	IN	O
MAX	NNP	O
protein	NN	O
expression	NN	O
in	IN	O
48%	CD	O
and	CC	O
90%	CD	O
of	IN	O
sporadic	JJ	O
and	CC	O
NF1	NNP	O
-	:	O
syndromic	JJ	O
GISTs	NNP	O
,	,	O
respectively	RB	O
,	,	O
and	CC	O
in	IN	O
three	CD	O
of	IN	O
eight	CD	O
micro	NNS	O
-	:	O
GISTs	NNP	O
,	,	O
which	WDT	O
are	VBP	O
early	JJ	O
GISTs	NNP	O
.	.	O

MAX	NNP	O
genomic	JJ	O
inactivation	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
p16	NN	O
silencing	VBG	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
p16	NN	O
coding	VBG	O
sequence	NN	O
deletion	NN	O
and	CC	O
MAX	NNP	O
induction	NN	O
restores	VBZ	O
p16	JJ	O
expression	NN	O
and	CC	O
inhibits	NNS	O
GIST	NNP	O
proliferation	NN	O
.	.	O

Hence	NNP	O
,	,	O
MAX	NNP	O
inactivation	NN	O
is	VBZ	O
a	DT	O
common	JJ	O
event	NN	O
in	IN	O
GIST	NNP	O
progression	NN	O
,	,	O
fostering	VBG	O
cell	NN	O
cycle	NN	O
activity	NN	O
in	IN	O
early	JJ	O
GISTs	NNP	O



In	IN	O
rare	JJ	O
families	NNS	O
,	,	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
(	(	O
LOF	NNP	O
)	)	O
mutations	NNS	B-Var
in	IN	O
PPARG	NNP	B-Gene
are	VBP	O
known	VBN	O
to	TO	O
cosegregate	VB	O
with	IN	O
lipodystrophy	NN	B-Disease
and	CC	O
insulin	NN	B-Disease
resistance	NN	I-Disease
;	:	O
in	IN	O
the	DT	O
general	JJ	O
population	NN	O
,	,	O
the	DT	O
common	JJ	O
P12A	NNP	B-Var
variant	NN	I-Var
is	VBZ	O
associated	VBN	O
with	IN	O
a	DT	O
decreased	JJ	B-NegReg
risk	NN	O
of	IN	O
type	NN	B-Disease
2	CD	I-Disease
diabetes	NNS	I-Disease
(	(	O
T2D	NNP	O
)	)	O
.	.	O
Whether	NNP	O
and	CC	O
how	WRB	O
rare	JJ	O
variants	NNS	O
in	IN	O
PPARG	NNP	O
and	CC	O
defects	NNS	O
in	IN	O
adipocyte	JJ	O
differentiation	NN	O
influence	NN	O
risk	NN	O
of	IN	O
T2D	NNP	O
in	IN	O
the	DT	O
general	JJ	O
population	NN	O
remains	VBZ	O
undetermined	JJ	O
.	.	O

By	IN	O
sequencing	VBG	O
PPARG	NNP	O
in	IN	O
19	CD	O
,	,	O
752	CD	O
T2D	NNP	O
cases	NNS	O
and	CC	O
controls	NNS	O
drawn	VBN	O
from	IN	O
multiple	JJ	O
studies	NNS	O
and	CC	O
ethnic	JJ	O
groups	NNS	O
,	,	O
we	PRP	O
identified	VBD	O
49	CD	O
previously	RB	O
unidentified	JJ	O
,	,	O
nonsynonymous	JJ	O
PPARG	NNP	O
variants	NNS	O
(	(	O
MAF	NNP	O
0.5%	CD	O
)	)	O
.	.	O

Considered	VBN	O
in	IN	O
aggregate	NN	O
(	(	O
with	IN	O
or	CC	O
without	IN	O
computational	JJ	O
prediction	NN	O
of	IN	O
functional	JJ	O
consequence	NN	O
)	)	O
,	,	O
these	DT	O
rare	JJ	O
variants	NNS	O
showed	VBD	O
no	DT	O
association	NN	O
with	IN	O
T2D	NNP	O
(	(	O
OR	NNP	O
1.35	CD	O
;	:	O
P	NNP	O
0.17	CD	O
)	)	O
.	.	O

The	DT	O
function	NN	O
of	IN	O
the	DT	O
49	CD	O
variants	NNS	O
was	VBD	O
experimentally	RB	O
tested	VBN	O
in	IN	O
a	DT	O
novel	JJ	O
high	JJ	O
-	:	O
throughput	NN	O
human	JJ	O
adipocyte	NN	O
differentiation	NN	O
assay	NN	O
,	,	O
and	CC	O
nine	CD	O
were	VBD	O
found	VBN	O
to	TO	O
have	VB	O
reduced	VBN	O
activity	NN	O
in	IN	O
the	DT	O
assay	NN	O
.	.	O

Carrying	VBG	O
any	DT	O
of	IN	O
these	DT	O
nine	CD	O
LOF	NNP	O
variants	NNS	O
was	VBD	O
associated	VBN	O
with	IN	O
a	DT	O
substantial	JJ	O
increase	NN	O
in	IN	O
risk	NN	O
of	IN	O
T2D	NNP	O
(	(	O
OR	NNP	O
7.22	CD	O
;	:	O
P	NNP	O
0.005	CD	O
)	)	O
.	.	O

The	DT	O
combination	NN	O
of	IN	O
large	JJ	O
-	:	O
scale	NN	O
DNA	NN	O
sequencing	NN	O
and	CC	O
functional	JJ	O
testing	NN	O
in	IN	O
the	DT	O
laboratory	NN	O
reveals	NNS	O
that	WDT	O
approximately	RB	O
1	CD	O
in	IN	O
1	CD	O
,	,	O
000	CD	O
individuals	NNS	O
carries	VBZ	O
a	DT	O
variant	NN	B-Var
in	IN	O
PPARG	NNP	B-Gene
that	IN	O
reduces	VBZ	B-NegReg
function	NN	B-CPA
in	IN	I-CPA
a	DT	I-CPA
human	JJ	I-CPA
adipocyte	NN	I-CPA
differentiation	NN	I-CPA
assay	NN	I-CPA
and	CC	O
is	VBZ	O
associated	VBN	B-Reg
with	IN	O
a	DT	O
substantial	JJ	O
risk	NN	O
of	IN	O
T2D	NNP	B-Disease

-	:	I-Gene
Steiner	NNP	I-Var
syndrome	NN	I-Reg
.	.	I-Disease
Variants	NNS	B-Var
KMT2A	NNP	B-Gene
cause	NN	B-Reg
intellectual	JJ	B-Disease
disability	NN	I-Disease
KMT2A	NNP	B-Gene
variants	NNS	B-Var
non	JJ	B-Var
-	:	I-Var
sense	NN	I-Var
frameshift	NN	B-Var
causing	VBG	B-Reg
Wiedemann	NNP	B-Disease
-	:	I-Disease
Steiner	NNP	I-Disease
syndrome	NN	I-Disease

effects	NNS	B-Reg
variants	NNS	B-Var
KMT2A	NNP	B-Gene
expression	NN	B-MPA
function	NN	B-MPA
c	NN	B-Var
.	.	I-Var
11322	CD	I-Var
-	:	I-Var
1	CD	I-Var
G	NNP	I-Var
A	NNP	I-Var
loss	NN	B-NegReg
C	NNP	B-MPA
-	:	I-MPA
terminal	JJ	I-MPA
part	NN	I-MPA
of	IN	I-MPA
the	DT	I-MPA
protein	NN	I-MPA
KMT2A	NNP	B-Gene
c	NN	B-Var
.	.	I-Var
3460	CD	I-Var
C	NNP	I-Var
T	NNP	I-Var
c	NN	B-Var
.	.	I-Var
8558	CD	I-Var
T	NNP	I-Var
G	NNP	I-Var
altered	VBD	B-Reg
expression	NN	B-MPA
Furthermore	RB	O
,	,	O
we	PRP	O
found	VBD	O
a	DT	O
disturbed	JJ	B-Reg
subcellular	JJ	B-MPA
distribution	NN	I-MPA
of	IN	O
KMT2A	NNP	B-Gene
for	IN	O
the	DT	O
c	NN	B-Var
.	.	I-Var
3460	CD	I-Var
C	NNP	I-Var
T	NNP	I-Var
mutant	NN	O
.	.	O
Taken	VBN	O
together	RB	O
,	,	O
our	PRP$	O
results	NNS	O
demonstrated	VBD	O
the	DT	O
deleterious	JJ	O
impact	NN	O
of	IN	O
the	DT	O
splice	NN	O
variant	NN	O
and	CC	O
of	IN	O
the	DT	O
missense	NN	O
variants	NNS	O
located	VBN	O
at	IN	O
two	CD	O
different	JJ	O
functional	JJ	O
domains	NNS	O
and	CC	O
suggested	VBD	O
reduction	NN	O
of	IN	O
KMT2A	NNP	O
function	NN	O
as	IN	O
the	DT	O
disease	NN	O
-	:	O
causing	NN	O
mechanism	NN	O

Gain	NNP	B-PosReg
-	:	I-PosReg
-	:	I-PosReg
Integrin	NNP	I-PosReg
Variant	NNP	B-Var
Serotonin	NNP	B-MPA
System	NNP	I-MPA


The	DT	O
ITGB3	NNP	B-Gene
coding	VBG	O
polymorphism	NN	O
Leu33Pro	NNP	B-Var
(	(	O
rs5918	NN	O
,	,	O
PlA2	NNP	O
)	)	O
produces	VBZ	O
hyperactive	JJ	B-PosReg
3	CD	I-Protein
receptors	NNS	I-Protein
that	IN	O
influence	NN	B-Reg
whole	JJ	B-MPA
-	:	I-MPA
blood	NN	I-MPA
5	CD	I-MPA
-	:	I-MPA
HT	NN	I-MPA
levels	NNS	I-MPA
and	CC	O
may	MD	O
influence	VB	B-Reg
the	DT	O
risk	NN	O
for	IN	O
autism	NN	B-Disease
spectrum	NN	I-Disease
disorder	NN	I-Disease
(	(	O
ASD	NNP	O
)	)	O
.	.	O
Using	VBG	O
a	DT	O
phenome	JJ	O
-	:	O
wide	JJ	O
scan	NN	O
of	IN	O
psychiatric	JJ	O
diagnoses	NNS	O
,	,	O
we	PRP	O
found	VBD	O
significant	JJ	O
,	,	O
male	JJ	O
-	:	O
specific	JJ	O
associations	NNS	O
between	IN	O
the	DT	O
Pro33	NNP	O
allele	NN	O
and	CC	O
attention	NN	O
-	:	O
deficit	NN	O
hyperactivity	NN	O
disorder	NN	O
and	CC	O
ASDs	NNP	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
used	VBD	O
knock	SYM	O
-	:	O
in	IN	O
(	(	O
KI	NNP	O
)	)	O
mice	NN	O
expressing	VBG	O
an	DT	O
Itgb3	NNP	B-Gene
variant	NN	B-Var
that	WDT	O
phenocopies	VBZ	O
the	DT	O
human	JJ	O
Pro33	NNP	O
variant	NN	O
to	TO	O
elucidate	VB	O
the	DT	O
consequences	NNS	O
of	IN	O
constitutively	RB	O
enhanced	VBN	B-PosReg
3	CD	I-MPA
signaling	VBG	I-MPA
to	TO	I-MPA
the	DT	I-MPA
5	CD	I-MPA
-	:	I-MPA
HT	NN	I-MPA
system	NN	I-MPA
in	IN	O
the	DT	O
brain	NN	O
.	.	O
KI	NNP	O
mice	NN	O
displayed	VBD	O
deficits	NNS	O
in	IN	O
multiple	JJ	O
behaviors	NNS	O
,	,	O
including	VBG	O
anxiety	NN	O
,	,	O
repetitive	JJ	O
,	,	O
and	CC	O
social	JJ	O
behaviors	NNS	O
.	.	O

Anatomical	JJ	O
studies	NNS	O
revealed	VBD	O
a	DT	O
significant	JJ	O
decrease	NN	O
in	IN	O
5	CD	O
-	:	O
HT	NN	O
synapses	NNS	O
in	IN	O
the	DT	O
midbrain	NN	O
,	,	O
accompanied	VBN	O
by	IN	O
decreases	NNS	O
in	IN	O
SERT	NNP	O
activity	NN	O
and	CC	O
reduced	JJ	O
localization	NN	O
of	IN	O
SERTs	NNP	O
to	TO	O
integrin	VB	O
adhesion	NN	O
complexes	NNS	O
in	IN	O
synapses	NNS	O
of	IN	O
KI	NNP	O
mice	NN	O
.	.	O

Inhibition	NN	O
of	IN	O
focal	JJ	O
adhesion	NN	O
kinase	NN	O
(	(	O
FAK	NNP	O
)	)	O
rescued	VBD	O
SERT	NNP	O
function	NN	O
in	IN	O
synapses	NNS	O
of	IN	O
KI	NNP	O
mice	NN	O
,	,	O
demonstrating	VBG	O
that	IN	O
constitutive	JJ	O
active	JJ	O
FAK	NNP	O
signaling	VBG	O
downstream	NN	O
of	IN	O
the	DT	O
Pro32Pro33	NNP	O
integrin	NN	O
v	NN	O
3	CD	O
suppresses	NNS	O
SERT	NNP	O
activity	NN	O
.	.	O

Our	PRP$	O
studies	NNS	O
identify	VBP	O
a	DT	O
complex	JJ	O
regulation	NN	O
of	IN	O
5	CD	O
-	:	O
HT	NNP	O
homeostasis	NN	O
and	CC	O
behaviors	NNS	O
by	IN	O
integrin	JJ	O
v	NN	O
3	CD	O
,	,	O
revealing	VBG	O
an	DT	O
important	JJ	O
role	NN	O
for	IN	O
integrins	NNS	O
in	IN	O
modulating	VBG	O
risk	NN	O
for	IN	O
neuropsychiatric	JJ	O
disorders	NNS	O
.	.	O
SIGNIFICANCE	NNP	O
STATEMENT	NNP	O
The	DT	O
integrin	NN	O
3	CD	O
Leu33Pro	NNP	O
coding	VBG	O
polymorphism	NN	O
has	VBZ	O
been	VBN	O
associated	VBN	O
with	IN	O
autism	NN	O
spectrum	NN	O
disorders	NNS	O
(	(	O
ASDs	NNP	O
)	)	O
within	IN	O
a	DT	O
subgroup	NN	O
of	IN	O
patients	NNS	O
with	IN	O
elevated	JJ	O
blood	NN	O
5	CD	O
-	:	O
HT	NN	O
levels	NNS	O
,	,	O
linking	VBG	O
integrin	JJ	O
3	CD	O
,	,	O
5	CD	O
-	:	O
HT	NN	O
,	,	O
and	CC	O
ASD	NNP	O
risk	NN	O
.	.	O

We	PRP	O
capitalized	VBD	O
on	IN	O
these	DT	O
interactions	NNS	O
to	TO	O
demonstrate	VB	O
that	IN	O
the	DT	O
Pro33	NNP	O
coding	VBG	O
variation	NN	O
in	IN	O
the	DT	O
murine	NN	O
integrin	NN	O
3	CD	O
recapitulates	VBZ	O
the	DT	O
sex	NN	O
-	:	O
dependent	JJ	O
neurochemical	JJ	O
and	CC	O
behavioral	JJ	O
attributes	NNS	O
of	IN	O
ASD	NNP	O
.	.	O

Using	VBG	O
state	NN	O
-	:	O
of	IN	O
-	:	O
the	DT	O
-	:	O
art	NN	O
techniques	NNS	O
,	,	O
we	PRP	O
show	VBP	O
that	IN	O
presynaptic	JJ	O
5	CD	O
-	:	O
HT	NN	O
function	NN	O
is	VBZ	O
altered	VBN	O
in	IN	O
these	DT	O
mice	NNS	O
,	,	O
and	CC	O
that	IN	O
the	DT	O
localization	NN	O
of	IN	O
5	CD	O
-	:	O
HT	NN	O
transporters	NNS	O
to	TO	O
specific	JJ	O
compartments	NNS	O
within	IN	O
the	DT	O
synapse	NN	O
,	,	O
disrupted	VBN	O
by	IN	O
the	DT	O
integrin	NN	O
3	CD	O
Pro33	NNP	O
mutation	NN	O
,	,	O
is	VBZ	O
critical	JJ	O
for	IN	O
appropriate	JJ	O
reuptake	NN	O
of	IN	O
5	CD	O
-	:	O
HT	NN	O
.	.	O

Our	PRP$	O
studies	NNS	O
provide	VBP	O
fundamental	JJ	O
insight	NN	O
into	IN	O
the	DT	O
genetic	JJ	O
network	NN	O
regulating	VBG	O
5	CD	O
-	:	O
HT	NNP	O
neurotransmission	NN	O
in	IN	O
the	DT	O
CNS	NNP	O
that	WDT	O
is	VBZ	O
also	RB	O
associated	VBN	O
with	IN	O
ASD	NNP	O
risk	NN	O



mutations	NNS	B-Var
ARHGAP29	NNP	B-Gene
associated	VBD	B-Reg
NSCL	NNP	B-Disease
P.	NNP	I-Disease

This	DT	O
single	JJ	B-Var
-	:	I-Var
nucleotide	JJ	I-Var
variation	NN	I-Var
of	IN	O
ARHGAP29	NNP	B-Gene
translates	NNS	O
to	TO	O
an	DT	O
early	JJ	O
nonsense	NN	O
mutation	NN	O
(	(	O
K326X	NNP	B-Var
)	)	O
,	,	O
presumably	RB	O
resulting	VBG	O
in	IN	O
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
(	(	O
LoF	NNP	O
)	)	O
.	.	O
Embryos	NN	O
from	IN	O
Arhgap29	NNP	O
(	(	O
K326X	NNP	O
)	)	O
intercrosses	NNS	O
were	VBD	O
harvested	VBN	O
at	IN	O
various	JJ	O
time	NN	O
points	NNS	O
.	.	O

No	DT	O
homozygous	JJ	O
Arhgap29	NNP	O
(	(	O
K326X	NNP	O
)	)	O
animals	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
the	DT	O
45	CD	O
analyzed	JJ	O
litters	NNS	O
,	,	O
assessed	VBD	O
as	RB	O
early	JJ	O
as	IN	O
embryonic	JJ	O
day	NN	O
8.5	CD	O
(	(	O
e8	NN	O
.	.	O
5	CD	O
)	)	O
.	.	O

Coronal	JJ	O
sectioning	NN	O
of	IN	O
e13	NN	O
.	.	O
5	CD	O
and	CC	O
e14	VB	O
.	.	O
5	CD	O
heads	NNS	O
revealed	VBD	O
that	IN	O
59%	CD	O
of	IN	O
Arhgap29	NNP	O
(	(	O
K326X	NNP	O
)	)	O
mice	NN	O
(	(	O
n	JJ	O
37	CD	O
)	)	O
exhibited	VBD	O
improper	JJ	O
epithelial	JJ	O
contact	NN	O
between	IN	O
developing	VBG	O
oral	JJ	O
structures	NNS	O
,	,	O
while	IN	O
none	NN	O
were	VBD	O
observed	VBN	O
in	IN	O
wild	JJ	O
types	NNS	O
(	(	O
n	RB	O
10	CD	O
)	)	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
Arhgap29	NNP	O
(	(	O
K326X	NNP	O
)	)	O
embryos	NN	O
exhibited	VBD	O
a	DT	O
significantly	RB	O
higher	JJR	O
percentage	NN	O
of	IN	O
maxillary	JJ	O
epithelium	NN	O
in	IN	O
contact	NN	O
with	IN	O
mandibular	JJ	O
epithelium	NN	O
.	.	O

Immunofluorescent	JJ	O
analyses	NNS	O
of	IN	O
the	DT	O
periderm	NN	O
and	CC	O
oral	JJ	O
adhesions	NNS	O
revealed	VBD	O
the	DT	O
presence	NN	O
of	IN	O
Arhgap29	NNP	O
in	IN	O
periderm	JJ	O
cells	NNS	O
.	.	O

These	DT	O
cells	NNS	O
were	VBD	O
p63	JJ	O
negative	JJ	O
,	,	O
keratin	VBD	O
17	CD	O
positive	JJ	O
,	,	O
and	CC	O
keratin	VBD	O
6	CD	O
positive	JJ	O
and	CC	O
present	JJ	O
at	IN	O
sites	NNS	O
of	IN	O
adhesion	NN	O
,	,	O
although	IN	O
occasionally	RB	O
disorganized	VBN	O
.	.	O

Oral	JJ	O
adhesions	NNS	O
did	VBD	O
not	RB	O
appear	VB	O
to	TO	O
impair	VB	O
palatogenesis	NN	O
,	,	O
as	IN	O
all	DT	O
analyzed	VBN	O
Arhgap29	NNP	O
(	(	O
K326X	NNP	O
)	)	O
embryos	NN	O
showed	VBD	O
confluent	JJ	O
palatal	JJ	O
mesenchyme	NN	O
and	CC	O
epithelium	NN	O
at	IN	O
e18	NN	O
.	.	O
5	CD	O
(	(	O
n	JJ	O
16	CD	O
)	)	O
,	,	O
and	CC	O
no	DT	O
mice	NN	O
were	VBD	O
found	VBN	O
with	IN	O
a	DT	O
cleft	NN	O
at	IN	O
birth	NN	O
.	.	O

Collectively	RB	O
,	,	O
our	PRP$	O
data	NNS	O
demonstrate	NN	O
that	IN	O
ARHGAP29	NNP	O
is	VBZ	O
required	VBN	O
for	IN	O
embryonic	JJ	O
survival	NN	O
and	CC	O
that	DT	O
heterozygosity	NN	O
for	IN	O
LoF	NNP	B-NegReg
variants	NNS	B-Var
of	IN	O
Arhgap29	NNP	B-Gene
increases	VBZ	B-PosReg
the	DT	O
incidence	NN	B-CPA
and	CC	I-CPA
length	NN	I-CPA
of	IN	I-CPA
oral	JJ	I-CPA
adhesions	NNS	I-CPA
at	IN	I-CPA
a	DT	I-CPA
critical	JJ	I-CPA
time	NN	I-CPA
point	NN	I-CPA
during	IN	I-CPA
orofacial	JJ	I-CPA
development	NN	I-CPA
.	.	O
In	IN	O
conclusion	NN	O
,	,	O
we	PRP	O
validate	VBP	O
the	DT	O
LoF	NNP	B-NegReg
nature	NN	O
of	IN	O
the	DT	O
human	JJ	O
K326X	NNP	B-Var
mutation	NN	I-Var
in	IN	O
vivo	NN	O
and	CC	O
reveal	VB	O
a	DT	O
previously	RB	O
unknown	JJ	O
effect	NN	O
of	IN	O
Arhgap29	NNP	B-Gene
in	IN	O
murine	JJ	O
craniofacial	JJ	B-CPA
development	NN	I-CPA

loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
function	NN	I-NegReg
WNT5A	NNP	B-Gene
mutations	NNS	B-Var
Robinow	NNP	B-Disease
syndrome	NN	I-Disease
.	.	I-Disease

Typical	JJ	O
manifestations	NNS	O
include	VBP	O
short	JJ	O
stature	NN	O
,	,	O
characteristic	JJ	O
facies	NNS	O
,	,	O
and	CC	O
skeletal	JJ	O
anomalies	NNS	O
.	.	O

Recessive	JJ	O
inheritance	NN	O
has	VBZ	O
been	VBN	O
associated	VBN	O
with	IN	O
mutations	NNS	O
in	IN	O
ROR2	NNP	O
while	IN	O
dominant	JJ	O
inheritance	NN	O
has	VBZ	O
been	VBN	O
observed	VBN	O
for	IN	O
mutations	NNS	O
in	IN	O
WNT5A	NNP	O
,	,	O
DVL1	NNP	O
,	,	O
and	CC	O
DVL3	NNP	O
.	.	O

Through	IN	O
trio	NN	O
whole	JJ	O
genome	NN	O
sequencing	NN	O
,	,	O
we	PRP	O
identified	VBD	O
a	DT	O
homozygous	JJ	B-Var
frameshifting	NN	I-Var
single	JJ	I-Var
nucleotide	JJ	I-Var
deletion	NN	I-Var
in	IN	O
WNT5A	NNP	B-Gene
in	IN	O
a	DT	O
previously	RB	O
reported	VBN	O
,	,	O
deceased	VBD	O
infant	NN	O
with	IN	O
a	DT	O
unique	JJ	O
constellation	NN	O
of	IN	O
features	NNS	O
comprising	VBG	O
a	DT	O
46	CD	O
,	,	O
XY	NNP	O
disorder	NN	O
of	IN	O
sex	NN	O
development	NN	O
with	IN	O
multiple	JJ	O
congenital	JJ	O
malformations	NNS	O
including	VBG	O
congenital	JJ	B-Disease
diaphragmatic	JJ	I-Disease
hernia	NN	I-Disease
,	,	O
ambiguous	JJ	B-Disease
genitalia	NN	I-Disease
,	,	O
dysmorphic	JJ	B-Disease
facies	NNS	I-Disease
,	,	O
shortened	VBD	B-Disease
long	JJ	I-Disease
bones	NNS	I-Disease
,	,	O
adactyly	NN	B-Disease
,	,	O
and	CC	O
ventricular	JJ	B-Disease
septal	NN	I-Disease
defect	NN	I-Disease
.	.	O
The	DT	O
parents	NNS	O
,	,	O
who	WP	O
are	VBP	O
both	DT	O
heterozygous	JJ	O
for	IN	O
the	DT	O
deletion	NN	O
,	,	O
appear	VBP	O
clinically	RB	O
unaffected	JJ	O
.	.	O

In	IN	O
conjunction	NN	O
with	IN	O
published	JJ	O
observations	NNS	O
of	IN	O
Wnt5a	NNP	O
double	JJ	O
knockout	NN	O
mice	NN	O
,	,	O
we	PRP	O
provide	VBP	O
evidence	NN	O
for	IN	O
the	DT	O
possibility	NN	O
of	IN	O
autosomal	JJ	O
recessive	JJ	O
inheritance	NN	O
in	IN	O
association	NN	O
with	IN	O
WNT5A	NNP	O
loss	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
mutations	NNS	O
in	IN	O
RS	NNP	O


Apert	NNP	B-Disease
syndrome	NN	I-Disease
gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutations	NNS	B-Var
FGFR2	NNP	B-Gene


To	TO	O
investigate	VB	O
the	DT	O
role	NN	O
of	IN	O
FGFR2	NNP	O
in	IN	O
bone	NN	O
formation	NN	O
,	,	O
we	PRP	O
generated	VBD	O
mice	NN	O
with	IN	O
tamoxifen	JJ	O
-	:	O
inducible	JJ	O
expression	NN	O
of	IN	O
mutant	JJ	O
FGFR2	NNP	O
(	(	O
P253R	NNP	O
)	)	O
at	IN	O
the	DT	O
adult	NN	O
stage	NN	O
.	.	O

Mechanical	NNP	O
bone	NN	O
marrow	NN	O
ablation	NN	O
(	(	O
BMX	NNP	O
)	)	O
was	VBD	O
performed	VBN	O
in	IN	O
both	DT	O
wild	JJ	O
-	:	O
type	NN	O
and	CC	O
Fgfr2	NNP	B-Gene
mutant	NN	B-Var
(	(	O
MT	NNP	O
)	)	O
mice	NN	O
.	.	O
Changes	NNS	O
in	IN	O
newly	RB	O
formed	VBN	O
trabecular	JJ	O
bone	NN	O
were	VBD	O
assessed	VBN	O
by	IN	O
micro	SYM	O
-	:	O
computed	VBN	O
tomography	NN	O
and	CC	O
bone	NN	O
histomorphometry	NN	O
.	.	O

We	PRP	O
found	VBD	O
that	IN	O
MT	NNP	O
mice	RB	O
exhibited	VBD	O
increased	JJ	B-PosReg
trabecular	JJ	B-CPA
bone	NN	I-CPA
formation	NN	I-CPA
and	CC	O
decreased	VBD	B-NegReg
bone	NN	B-CPA
resorption	NN	I-CPA
after	IN	O
BMX	NNP	O
accompanied	VBD	O
with	IN	O
a	DT	O
remarkable	JJ	O
increase	NN	B-PosReg
in	IN	O
bone	NN	B-CPA
marrow	NN	I-CPA
stromal	NN	I-CPA
cell	NN	I-CPA
recruitment	NN	B-CPA
and	CC	O
proliferation	NN	B-CPA
,	,	O
osteoblast	JJ	B-CPA
proliferation	NN	B-CPA
and	CC	O
differentiation	NN	B-CPA
,	,	O
and	CC	O
enhanced	VBD	B-PosReg
Wnt	NNP	B-CPA
?	.	I-CPA
-	:	I-CPA
catenin	NN	I-CPA
activity	NN	I-CPA
.	.	O
Furthermore	RB	O
,	,	O
pharmacologically	RB	O
inhibiting	VBG	O
Wnt	NNP	O
-	:	O
catenin	NN	O
signaling	NN	O
can	MD	O
partially	RB	O
reverse	VB	O
the	DT	O
increased	JJ	O
trabecular	NN	O
bone	NN	O
formation	NN	O
and	CC	O
decreased	VBD	O
bone	NN	O
resorption	NN	O
in	IN	O
MT	NNP	O
mice	NN	O
after	IN	O
BMX	NNP	O
.	.	O

Our	PRP$	O
data	NNS	O
demonstrate	NN	O
that	IN	O
gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutation	NN	B-Var
in	IN	O
FGFR2	NNP	B-Gene
exerts	VBZ	B-MPA
a	DT	I-MPA
Wnt	NNP	I-MPA
-	:	I-MPA
catenin	NN	I-MPA
-	:	I-MPA
dependent	JJ	I-MPA
anabolic	JJ	I-MPA
effect	NN	I-MPA
on	IN	O
trabecular	JJ	O
bone	NN	O
by	IN	O
promoting	VBG	B-PosReg
bone	NN	B-CPA
formation	NN	I-CPA
and	CC	O
inhibiting	VBG	B-NegReg
bone	NN	B-CPA
resorption	NN	I-CPA
at	IN	I-CPA
the	DT	I-CPA
adult	NN	I-CPA
stage	NN	I-CPA
.	.	O
This	DT	O
article	NN	O
is	VBZ	O
protected	VBN	O
by	IN	O
copyright	NN	O
.	.	O

All	DT	O
rights	NNS	O
reserved	VBN	O


mutations	NNS	B-Var
KCNK3	NNP	B-Gene
cause	NN	B-Reg
pulmonary	JJ	B-Disease
arterial	JJ	I-Disease
hypertension	NN	I-Disease
KCNK3	NNP	O
encodes	VBZ	O
an	DT	O
acid	JJ	O
-	:	O
sensitive	JJ	O
potassium	NN	O
channel	NN	O
,	,	O
which	WDT	O
contributes	VBZ	O
to	TO	O
the	DT	O
resting	VBG	O
potential	NN	O
of	IN	O
human	JJ	O
pulmonary	JJ	O
artery	NN	O
smooth	JJ	O
muscle	NN	O
cells	NNS	O
.	.	O

KCNK3	NNP	O
is	VBZ	O
widely	RB	O
expressed	VBN	O
in	IN	O
the	DT	O
body	NN	O
,	,	O
and	CC	O
dimerizes	NNS	O
with	IN	O
other	JJ	O
KCNK3	NNP	O
subunits	NNS	O
,	,	O
or	CC	O
the	DT	O
closely	RB	O
related	JJ	O
,	,	O
acid	JJ	O
-	:	O
sensitive	JJ	O
KCNK9	NNP	O
channel	NN	O
.	.	O

METHODS	NNP	O
AND	CC	O
RESULTS	NNP	O
:	:	O
We	PRP	O
engineered	VBD	O
homomeric	JJ	O
and	CC	O
heterodimeric	JJ	O
mutant	NN	O
and	CC	O
nonmutant	JJ	O
KCNK3	NNP	O
channels	NNS	O
associated	VBN	O
with	IN	O
PAH	NNP	O
.	.	O

Using	VBG	O
whole	JJ	O
-	:	O
cell	NN	O
patch	NN	O
-	:	O
clamp	NN	O
electrophysiology	NN	O
in	IN	O
human	JJ	O
pulmonary	JJ	O
artery	NN	O
smooth	JJ	O
muscle	NN	O
and	CC	O
COS7	NNP	O
cell	NN	O
lines	NNS	O
,	,	O
we	PRP	O
determined	VBD	O
that	IN	O
homomeric	JJ	O
and	CC	O
heterodimeric	JJ	O
mutant	NN	O
channels	NNS	O
in	IN	O
heterozygous	JJ	O
KCNK3	NNP	O
conditions	NNS	O
lead	VBP	O
to	TO	O
mutation	VB	O
-	:	O
specific	JJ	O
severity	NN	O
of	IN	O
channel	NN	O
dysfunction	NN	O
.	.	O

Both	DT	O
wildtype	NN	O
and	CC	O
mutant	JJ	O
KCNK3	NNP	O
channels	NNS	O
were	VBD	O
activated	VBN	O
by	IN	O
ONO	NNP	O
-	:	O
RS	NNP	O
-	:	O
082	CD	O
(	(	O
10	CD	O
mol	RB	O
L	NNP	O
)	)	O
,	,	O
causing	VBG	O
cell	NN	O
hyperpolarization	NN	O
.	.	O

We	PRP	O
observed	VBD	O
robust	JJ	O
gene	NN	O
expression	NN	O
of	IN	O
KCNK3	NNP	O
in	IN	O
healthy	JJ	O
and	CC	O
familial	JJ	O
PAH	NNP	O
patient	NN	O
lungs	NNS	O
,	,	O
but	CC	O
no	DT	O
quantifiable	JJ	O
expression	NN	O
of	IN	O
KCNK9	NNP	O
,	,	O
and	CC	O
demonstrated	VBD	O
in	IN	O
functional	JJ	O
studies	NNS	O
that	WDT	O
KCNK9	NNP	O
minimizes	VBZ	O
the	DT	O
impact	NN	O
of	IN	O
select	JJ	O
KCNK3	NNP	O
mutations	NNS	O
when	WRB	O
the	DT	O
2	CD	O
channel	NN	O
subunits	NNS	O
co	VBP	O
-	:	O
assemble	NN	O
.	.	O

CONCLUSIONS	NN	O
:	:	O
Heterozygous	JJ	O
KCNK3	NNP	B-Gene
mutations	NNS	B-Var
in	IN	O
PAH	NNP	O
lead	NN	O
to	TO	O
variable	JJ	O
loss	NN	B-NegReg
of	IN	O
channel	NN	B-MPA
function	NN	I-MPA
via	IN	O
distinct	JJ	O
mechanisms	NNS	O
.	.	O
Homomeric	NNP	O
and	CC	O
heterodimeric	JJ	O
mutant	NN	O
KCNK3	NNP	O
channels	NNS	O
represent	VBP	O
novel	JJ	O
therapeutic	JJ	O
substrates	NNS	O
in	IN	O
PAH	NNP	O
.	.	O

Pharmacological	NNP	O
and	CC	O
pH	SYM	O
-	:	O
dependent	JJ	O
activation	NN	O
of	IN	O
wildtype	NN	O
and	CC	O
mutant	JJ	O
KCNK3	NNP	O
channels	NNS	O
in	IN	O
pulmonary	JJ	O
artery	NN	O
smooth	JJ	O
muscle	NN	O
cells	NNS	O
leads	VBZ	O
to	TO	O
membrane	VB	O
hyperpolarization	NN	O
.	.	O

Co	NNP	O
-	:	O
assembly	NN	O
of	IN	O
KCNK3	NNP	O
with	IN	O
KCNK9	NNP	O
subunits	NNS	O
may	MD	O
provide	VB	O
protection	NN	O
against	IN	O
KCNK3	NNP	O
loss	NN	O
of	IN	O
function	NN	O
in	IN	O
tissues	NNS	O
where	WRB	O
both	DT	O
KCNK9	NNP	O
and	CC	O
KCNK3	NNP	O
are	VBP	O
expressed	VBN	O
,	,	O
contributing	VBG	O
to	TO	O
the	DT	O
lung	NN	O
-	:	O
specific	JJ	O
phenotype	NN	O
observed	VBD	O
clinically	RB	O
in	IN	O
patients	NNS	O
with	IN	O
PAH	NNP	O
because	IN	O
of	IN	O
KCNK3	NNP	O
mutations	NNS	O

Mutations	NNP	I-Var
ATP5F1D	NNP	B-Gene
Cause	NNP	B-Reg
Metabolic	NNP	B-MPA
Disorder	NNP	I-MPA

missense	NN	B-Var
variants	NNS	I-Var
ATP5F1D	NNP	B-Gene
presented	VBD	B-Reg
episodic	JJ	B-MPA
lethargy	NN	I-MPA
metabolic	JJ	B-MPA
acidosis	NN	I-MPA
3	CD	B-MPA
-	:	I-MPA
methylglutaconic	NN	I-MPA
aciduria	NN	I-MPA
hyperammonemia	NN	B-Disease

Cultured	NNP	O
skin	NN	O
fibroblasts	NNS	O
from	IN	O
these	DT	O
individuals	NNS	O
exhibited	VBD	O
impaired	JJ	O
assembly	NN	O
of	IN	O
F1FO	NNP	O
ATP	NNP	O
synthase	NN	O
and	CC	O
subsequent	JJ	O
reduced	VBN	O
complex	JJ	O
V	NNP	O
activity	NN	O
.	.	O

Cells	NNS	O
from	IN	O
subject	JJ	O
1	CD	O
also	RB	O
exhibited	VBD	O
a	DT	O
significant	JJ	O
decrease	NN	O
in	IN	O
mitochondrial	JJ	O
cristae	NN	O
.	.	O

Knockdown	NNP	O
of	IN	O
Drosophila	NNP	O
ATPsyn	NNP	O
,	,	O
the	DT	O
ATP5F1D	NNP	O
homolog	NN	O
,	,	O
in	IN	O
developing	VBG	O
eyes	NNS	O
and	CC	O
brains	NNS	O
caused	VBD	O
a	DT	O
near	JJ	O
complete	JJ	O
loss	NN	O
of	IN	O
the	DT	O
fly	JJ	O
head	NN	O
,	,	O
a	DT	O
phenotype	NN	O
that	WDT	O
was	VBD	O
fully	RB	O
rescued	VBN	O
by	IN	O
wild	JJ	O
-	:	O
type	NN	O
human	JJ	O
ATP5F1D	NNP	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
expression	NN	O
of	IN	O
the	DT	O
ATP5F1D	NNP	O
c	NN	O
.	.	O
245	CD	O
C	NNP	O
T	NNP	O
and	CC	O
c	NN	O
.	.	O
317	CD	O
T	NNP	O
G	NNP	O
variants	NNS	B-Var
rescued	VBD	B-PosReg
the	DT	O
head	NN	B-MPA
-	:	I-MPA
size	NN	I-MPA
phenotype	NN	I-MPA
but	CC	O
recapitulated	VBD	B-NegReg
the	DT	O
eye	NN	B-MPA
and	CC	O
antennae	NN	B-MPA
defects	NNS	I-MPA
seen	VBN	O
in	IN	O
other	JJ	O
genetic	JJ	O
models	NNS	O
of	IN	O
mitochondrial	JJ	O
oxidative	JJ	O
phosphorylation	NN	O
deficiency	NN	O
.	.	O
Our	PRP$	O
data	NNS	O
establish	VB	O
c	NN	O
.	.	O
245	CD	O
C	NNP	O
T	NNP	O
(	(	O
p	NN	O
.	.	O
Pro82Leu	NNP	O
)	)	O
and	CC	O
c	$	O
.	.	O
317	CD	O
T	NNP	O
G	NNP	O
(	(	O
p	NN	O
.	.	O
Val106Gly	NNP	O
)	)	O
in	IN	O
ATP5F1D	NNP	O
as	IN	O
pathogenic	JJ	O
variants	NNS	B-Var
leading	VBG	B-Reg
to	TO	I-Reg
a	DT	O
Mendelian	JJ	B-Disease
mitochondrial	JJ	I-Disease
disease	NN	I-Disease
featuring	VBG	O
episodic	JJ	O
metabolic	JJ	O
decompensation	NN	O

ARL13B	NNP	B-Gene
variant	NN	B-Var
impairs	VBZ	B-NegReg
nucleotide	IN	I-MPA
exchange	NN	I-MPA
factor	NN	I-MPA
activity	NN	I-MPA


Joubert	NNP	O
syndrome	NN	O
is	VBZ	O
characterized	VBN	O
by	IN	O
a	DT	O
wide	JJ	O
spectrum	NN	O
of	IN	O
symptoms	NNS	O
,	,	O
including	VBG	O
a	DT	O
variable	JJ	O
degree	NN	O
of	IN	O
intellectual	JJ	O
disability	NN	O
,	,	O
ataxia	NN	O
,	,	O
and	CC	O
ocular	JJ	O
abnormalities	NNS	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
a	DT	O
novel	JJ	O
homozygous	JJ	O
missense	NN	O
variant	NN	O
c	NN	O
.	.	O

[	RB	O
223	CD	O
G	NNP	O
A	NNP	O
]	NNP	O
(	(	O
p	NN	O
.	.	O

(	(	O
Gly75Arg	NNP	O
)	)	O
in	IN	O
the	DT	O
ARL13B	NNP	O
gene	NN	O
,	,	O
which	WDT	O
was	VBD	O
identified	VBN	O
by	IN	O
whole	JJ	O
-	:	O
exome	JJ	O
sequencing	NN	O
of	IN	O
a	DT	O
trio	NN	O
from	IN	O
a	DT	O
consanguineous	JJ	O
family	NN	O
with	IN	O
multiple	JJ	O
-	:	O
affected	JJ	O
individuals	NNS	O
suffering	VBG	O
from	IN	O
intellectual	JJ	O
disability	NN	O
,	,	O
ataxia	NN	O
,	,	O
ocular	JJ	O
defects	NNS	O
,	,	O
and	CC	O
epilepsy	NN	O
.	.	O

The	DT	O
same	JJ	O
variant	NN	O
was	VBD	O
also	RB	O
identified	VBN	O
in	IN	O
a	DT	O
second	JJ	O
family	NN	O
.	.	O

We	PRP	O
saw	VBD	O
a	DT	O
striking	JJ	O
difference	NN	O
in	IN	O
the	DT	O
severity	NN	O
of	IN	O
ataxia	NN	O
between	IN	O
affected	VBN	O
male	NN	O
and	CC	O
female	JJ	O
individuals	NNS	O
in	IN	O
both	DT	O
families	NNS	O
.	.	O

Both	DT	O
ARL13B	NNP	O
and	CC	O
ARL13B	NNP	O
-	:	O
c	NN	O
.	.	O

[	RB	O
223	CD	O
G	NNP	O
A	NNP	O
]	NNP	O
(	(	O
p	NN	O
.	.	O

(	(	O
Gly75Arg	NNP	O
)	)	O
expression	NN	O
rescued	VBD	O
the	DT	O
cilia	NN	O
length	NN	O
and	CC	O
Shh	NNP	O
defects	NNS	O
displayed	VBN	O
by	IN	O
Arl13b	NNP	O
hennin	NN	O
(	(	O
null	JJ	O
)	)	O
cells	NNS	O
,	,	O
indicating	VBG	O
that	IN	O
the	DT	O
variant	NN	O
did	VBD	O
not	RB	O
disrupt	VB	O
either	RB	O
ARL13B	NNP	O
function	NN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
ARL13B	NNP	B-Gene
-	:	O
c	NN	B-Var
.	.	I-Var
[	RB	I-Var
223	CD	I-Var
G	NNP	I-Var
A	NNP	I-Var
]	NNP	I-Var
(	(	O
p	NN	O
.	.	O

(	(	O
Gly75Arg	NNP	O
)	)	O
displayed	VBD	O
a	DT	O
marked	JJ	O
loss	NN	B-NegReg
of	IN	O
ARL3	NNP	B-MPA
guanine	NN	I-MPA
nucleotide	IN	I-MPA
-	:	I-MPA
exchange	NN	I-MPA
factor	NN	I-MPA
activity	NN	I-MPA
,	,	O
with	IN	O
retention	NN	O
of	IN	O
its	PRP$	O
GTPase	NNP	O
activities	NNS	O
,	,	O
highlighting	VBG	O
the	DT	O
correlation	NN	O
between	IN	O
its	PRP$	O
loss	NN	O
of	IN	O
function	NN	O
as	IN	O
an	DT	O
ARL3	NNP	O
guanine	NN	O
nucleotide	IN	O
-	:	O
exchange	NN	O
factor	NN	O
and	CC	O
Joubert	NNP	B-Disease
syndrome	NN	I-Disease





We	PRP	O
identified	VBD	O
heterozygous	JJ	O
frameshift	NN	O
mutations	NNS	O
in	IN	O
NR2F2	NNP	B-Gene
,	,	O
encoding	VBG	O
COUP	NNP	O
-	:	O
TF2	NN	O
,	,	O
in	IN	O
three	CD	O
children	NNS	O
.	.	O
One	CD	O
carried	VBD	O
a	DT	O
c	NN	O
.	.	O
103	CD	O
_	JJ	O
109	CD	O
delGGCGCCC	NN	O
(	(	O
p	NN	B-Var
.	.	I-Var
Gly35Argfs	NNP	I-Var
75	CD	I-Var
)	)	O
mutation	NN	O
,	,	O
while	IN	O
two	CD	O
others	NNS	O
carried	VBD	O
a	DT	O
c	NN	O
.	.	O
97	CD	O
_	JJ	O
103	CD	O
delCCGCCCG	NN	O
(	(	O
p	NN	B-Var
.	.	I-Var
Pro33Alafs	NNP	I-Var
77	CD	I-Var
)	)	O
mutation	NN	O
.	.	O
In	IN	O
two	CD	O
of	IN	O
three	CD	O
children	NNS	O
the	DT	O
mutation	NN	O
was	VBD	O
de	JJ	O
novo	FW	O
.	.	O

All	DT	O
three	CD	O
children	NNS	O
presented	VBN	B-Reg
with	IN	I-Reg
congenital	JJ	B-Disease
heart	NN	I-Disease
disease	NN	I-Disease
(	(	O
CHD	NNP	O
)	)	O
,	,	O
one	CD	O
child	NN	O
with	IN	O
congenital	JJ	O
diaphragmatic	JJ	O
hernia	NN	O
(	(	O
CDH	NNP	O
)	)	O
,	,	O
and	CC	O
two	CD	O
children	NNS	O
with	IN	O
blepharophimosis	NN	O
-	:	O
ptosis	NN	O
-	:	O
epicanthus	RB	O
inversus	NN	O
syndrome	NN	O
(	(	O
BPES	NNP	O
)	)	O
.	.	O
The	DT	O
three	CD	O
children	NNS	O
had	VBD	O
androgen	NN	O
production	NN	O
,	,	O
virilization	NN	O
of	IN	O
external	JJ	O
genitalia	NN	O
,	,	O
and	CC	O
biochemical	JJ	O
or	CC	O
histological	JJ	O
evidence	NN	O
of	IN	O
testicular	JJ	O
tissue	NN	O
.	.	O

We	PRP	O
demonstrate	VBP	O
a	DT	O
highly	RB	O
significant	JJ	O
association	NN	O
between	IN	O
the	DT	O
NR2F2	NNP	B-Gene
loss	NN	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
and	CC	O
this	DT	O
syndromic	JJ	B-Disease
form	NN	I-Disease
of	IN	I-Disease
DSD	NNP	I-Disease
(	(	O
p	VBP	O
2.44	CD	O
10	CD	O
-	:	O
8	CD	O
)	)	O
.	.	O
We	PRP	O
show	VBP	O
that	IN	O
COUP	NNP	O
-	:	O
TF2	NNP	O
is	VBZ	O
highly	RB	O
abundant	JJ	O
in	IN	O
a	DT	O
FOXL2	NNP	O
-	:	O
negative	JJ	O
stromal	JJ	O
cell	NN	O
population	NN	O
of	IN	O
the	DT	O
fetal	JJ	O
human	JJ	O
ovary	NN	O
.	.	O

In	IN	O
contrast	NN	O
to	TO	O
the	DT	O
mouse	NN	O
,	,	O
these	DT	O
data	NNS	O
establish	VB	O
COUP	NNP	O
-	:	O
TF2	NN	O
as	IN	O
a	DT	O
human	JJ	O
"	JJ	O
pro	FW	O
-	:	O
ovary	JJ	O
"	NN	O
and	CC	O
"	NNP	O
anti	VBP	O
-	:	O
testis	NN	O
"	NNP	O
sex	NN	O
-	:	O
determining	VBG	O
factor	NN	O
in	IN	O
female	JJ	O
gonads	NNS	O
.	.	O

Furthermore	RB	O
,	,	O
the	DT	O
data	NNS	O
presented	VBN	O
here	RB	O
provide	VBP	O
additional	JJ	O
evidence	NN	O
of	IN	O
the	DT	O
emerging	VBG	O
importance	NN	O
of	IN	O
nuclear	JJ	O
receptors	NNS	O
in	IN	O
establishing	VBG	O
human	JJ	O
ovarian	JJ	O
identity	NN	O
and	CC	O
indicate	VBP	O
that	IN	O
nuclear	JJ	O
receptors	NNS	O
may	MD	O
have	VB	O
divergent	JJ	O
functions	NNS	O
in	IN	O
mouse	NN	O
and	CC	O
human	JJ	O
biology	NN	O



Loss	NNP	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
PIEZO1	NNP	B-Gene
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
congenital	NN	I-Disease
lymphatic	JJ	I-Disease
dysplasia	NN	I-Disease
Gain	NNP	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutations	NNS	B-Var
PIEZO1	NNP	B-Gene
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
hemolytic	JJ	I-Disease
anemia	NN	I-Disease
hereditary	JJ	B-Disease
xerocytosis	NN	I-Disease
dehydrated	JJ	B-Disease
stomatocytosis	NN	I-Disease
Loss	NNP	B-NegReg
-	:	I-NegReg
of	IN	I-NegReg
-	:	I-NegReg
function	NN	I-NegReg
mutations	NNS	B-Var
in	IN	O
the	DT	O
human	JJ	O
PIEZO2	NNP	B-Gene
gene	NN	O
cause	NN	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
syndrome	NN	I-Disease
of	IN	I-Disease
muscular	JJ	I-Disease
atrophy	NN	I-Disease
with	IN	O
perinatal	JJ	O
respiratory	NN	O
distress	NN	O
,	,	O
arthrogryposis	NN	B-Disease
,	,	O
and	CC	O
scoliosis	NN	B-Disease
.	.	O
Gain	NNP	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutations	NNS	B-Var
in	IN	O
the	DT	O
human	JJ	O
PIEZO2	NNP	B-Gene
gene	NN	O
cause	NN	O
three	CD	O
clinical	JJ	O
types	NNS	O
of	IN	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
distal	JJ	I-Disease
arthrogryposis	NN	I-Disease
.	.	O
This	DT	O
chapter	NN	O
will	MD	O
review	VB	O
the	DT	O
hereditary	JJ	O
diseases	NNS	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
PIEZO	NNP	O
genes	NNS	O
and	CC	O
will	MD	O
discuss	VB	O
additional	JJ	O
physiological	JJ	O
systems	NNS	O
in	IN	O
which	WDT	O
PIEZO	NNP	O
channel	NN	O
dysfunction	NN	O
may	MD	O
contribute	VB	O
to	TO	O
human	JJ	O
disease	NN	O
pathophysiology	NN	O

gain	NN	B-PosReg
-	:	I-PosReg
function	NN	I-PosReg
mutation	NN	B-Var
CACNA1D	NNP	B-Gene
autism	NN	B-Disease
spectrum	NN	I-Disease
disorders	NNS	I-Disease
epilepsy	NN	B-Disease


Here	RB	O
we	PRP	O
report	VBP	O
the	DT	O
discovery	NN	O
and	CC	O
characterization	NN	O
of	IN	O
a	DT	O
third	JJ	O
de	FW	O
novo	FW	O
missense	NN	O
mutation	NN	O
in	IN	O
CACNA1D	NNP	O
(	(	O
V401L	NNP	O
)	)	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
ASD	NNP	O
and	CC	O
epilepsy	NN	O
.	.	O
For	IN	O
the	DT	O
functional	JJ	O
characterization	NN	O
we	PRP	O
introduced	VBD	O
mutation	NN	O
V401L	NNP	O
into	IN	O
two	CD	O
major	JJ	O
C	NNP	O
-	:	O
terminal	NN	O
long	JJ	O
and	CC	O
short	JJ	O
Cav1	NNP	O
.	.	O
3	CD	O
splice	NN	O
variants	NNS	O
,	,	O
expressed	VBD	O
wild	JJ	O
-	:	O
type	NN	O
or	CC	O
mutant	JJ	O
channel	NN	O
complexes	NNS	O
in	IN	O
tsA	JJ	O
-	:	O
201	CD	O
cells	NNS	O
and	CC	O
performed	VBD	O
whole	JJ	O
-	:	O
cell	NN	O
patch	NN	O
-	:	O
clamp	NN	O
recordings	NNS	O
.	.	O
Mutation	NNP	O
V401L	NNP	B-Var
,	,	O
localized	VBD	O
within	IN	O
the	DT	O
channel	NN	O
's	POS	O
activation	NN	O
gate	NN	O
,	,	O
significantly	RB	O
enhanced	VBD	B-PosReg
current	JJ	B-MPA
densities	NNS	I-MPA
,	,	O
shifted	VBD	O
voltage	NN	O
dependence	NN	O
of	IN	O
activation	NN	O
and	CC	O
inactivation	NN	O
to	TO	O
more	RBR	O
negative	JJ	O
voltages	NNS	O
and	CC	O
reduced	JJ	O
channel	NN	O
inactivation	NN	O
in	IN	O
both	DT	O
Cav1	NNP	O
.	.	O
3	CD	O
splice	JJ	O
variants	NNS	O
.	.	O
Altogether	RB	O
these	DT	O
gating	NN	O
changes	NNS	B-Var
are	VBP	O
expected	VBN	O
to	TO	O
result	VB	O
in	IN	O
enhanced	JJ	B-PosReg
Ca2	NNP	B-MPA
-	:	I-MPA
influx	NN	I-MPA
through	IN	I-MPA
the	DT	I-MPA
channel	NN	I-MPA
,	,	O
thus	RB	O
representing	VBG	O
a	DT	O
strong	JJ	O
gain	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
phenotype	NN	O
.	.	O
Additionally	RB	O
,	,	O
we	PRP	O
also	RB	O
found	VBD	O
that	IN	O
mutant	JJ	O
channels	NNS	O
retained	VBN	O
full	JJ	O
sensitivity	NN	O
towards	IN	O
the	DT	O
clinically	RB	O
available	JJ	O
Ca2	NNP	O
-	:	O
channel	NN	O
blocker	NN	O
isradipine	NN	O
.	.	O
Our	PRP$	O
findings	NNS	O
strengthen	VBP	O
the	DT	O
evidence	NN	O
for	IN	O
CACNA1D	NNP	O
as	IN	O
a	DT	O
novel	JJ	O
candidate	NN	O
autism	NN	O
risk	NN	O
gene	NN	O
and	CC	O
encourage	VB	O
experimental	JJ	O
therapy	NN	O
with	IN	O
available	JJ	O
channel	NNS	O
-	:	O
blockers	NNS	O
for	IN	O
this	DT	O
mutation	NN	O
.	.	O

The	DT	O
additional	JJ	O
presence	NN	O
of	IN	O
seizures	NNS	O
and	CC	O
neurological	JJ	O
abnormalities	NNS	O
in	IN	O
our	PRP$	O
patient	JJ	O
define	NN	O
a	DT	O
novel	JJ	O
phenotype	NN	O
partially	RB	O
overlapping	VBG	O
with	IN	O
symptoms	NNS	O
in	IN	O
two	CD	O
individuals	NNS	O
with	IN	O
PASNA	NNP	O
(	(	O
congential	JJ	O
primary	NN	O
aldosteronism	NN	O
,	,	O
seizures	NNS	O
and	CC	O
neurological	JJ	O
abnormalities	NNS	O
)	)	O
caused	VBN	O
by	IN	O
similar	JJ	O
Cav1	NNP	O
.	.	O
3	CD	O
gain	NN	O
-	:	O
of	IN	O
-	:	O
function	NN	O
mutations	NNS	O



In	IN	O
the	DT	O
Solanaceae	NNP	O
,	,	O
Plantaginaceae	NNP	O
and	CC	O
Rosaceae	NNP	O
gametophytic	JJ	O
SI	NNP	O
is	VBZ	O
controlled	VBN	O
by	IN	O
the	DT	O
pistil	NN	O
-	:	O
specific	JJ	O
S	NNP	O
-	:	O
RNases	NNS	O
and	CC	O
the	DT	O
pollen	NN	O
S	NNP	O
-	:	O
locus	NN	O
F	NNP	O
-	:	O
box	NN	O
proteins	NNS	O
but	CC	O
non	JJ	O
-	:	O
S	NNP	O
-	:	O
specific	JJ	O
factors	NNS	O
,	,	O
namely	RB	O
modifiers	NNS	O
,	,	O
are	VBP	O
also	RB	O
required	VBN	O
.	.	O

In	IN	O
apricot	NN	O
,	,	O
Prunus	NNP	O
armeniaca	NN	O
(	(	O
Rosaceae	NNP	O
)	)	O
,	,	O
we	PRP	O
previously	RB	O
mapped	VBD	O
two	CD	O
pollen	NN	O
-	:	O
part	NN	O
mutations	NNS	B-Var
that	WDT	O
confer	VBP	B-Reg
self	PRP	B-MPA
-	:	I-MPA
compatibility	NN	I-MPA
in	IN	O
cultivars	NNS	O
Canino	NNP	O
and	CC	O
Katy	NNP	O
at	IN	O
the	DT	O
distal	JJ	O
end	NN	O
of	IN	O
chromosome	NN	O
3	CD	O
(	(	O
M	NNP	O
-	:	O
locus	NN	O
)	)	O
unlinked	VBD	O
to	TO	O
the	DT	O
S	NNP	O
-	:	O
locus	NN	O
.	.	O
Here	RB	O
,	,	O
we	PRP	O
used	VBD	O
high	JJ	O
-	:	O
resolution	NN	O
mapping	NN	O
to	TO	O
identify	VB	O
the	DT	O
M	NNP	O
-	:	O
locus	NN	O
with	IN	O
an	DT	O
134	CD	O
kb	NN	O
segment	NN	O
containing	VBG	O
ParM	NNP	O
-	:	O
1	CD	O
-	:	O
16	CD	O
genes	NNS	O
.	.	O

Gene	NNP	O
expression	NN	O
analysis	NN	O
identified	VBD	O
four	CD	O
genes	NNS	O
preferentially	RB	O
expressed	VBN	O
in	IN	O
anthers	NNS	O
as	IN	O
modifier	JJ	O
gene	NN	O
candidates	NNS	O
,	,	O
ParM	NNP	O
-	:	O
6	CD	O
,	,	O
-	:	O
7	CD	O
,	,	O
-	:	O
9	CD	O
and	CC	O
-	:	O
14	CD	O
.	.	O

Variant	JJ	O
calling	VBG	O
of	IN	O
WGS	NNP	O
Illumina	NNP	O
data	NNS	O
from	IN	O
Canino	NNP	O
,	,	O
Katy	NNP	O
,	,	O
and	CC	O
10	CD	O
self	PRP	O
-	:	O
incompatible	JJ	O
cultivars	NNS	O
detected	VBD	O
a	DT	O
358	CD	O
bp	NN	O
miniature	NN	O
inverted	VBN	O
-	:	O
repeat	NN	O
transposable	JJ	O
element	NN	O
(	(	O
MITE	NNP	O
)	)	O
insertion	NN	O
in	IN	O
ParM	NNP	O
-	:	O
7	CD	O
shared	VBN	O
only	RB	O
by	IN	O
self	PRP	O
-	:	O
compatible	JJ	O
apricots	NNS	O
,	,	O
supporting	VBG	O
ParM	NNP	O
-	:	O
7	CD	O
as	IN	O
strong	JJ	O
candidate	NN	O
gene	NN	O
required	VBN	O
for	IN	O
SI	NNP	O
.	.	O

ParM	NNP	O
-	:	O
7	CD	O
encodes	VBZ	O
a	DT	O
disulfide	JJ	O
bond	NN	O
A	NNP	O
-	:	O
like	IN	O
oxidoreductase	NN	O
protein	NN	O
,	,	O
which	WDT	O
we	PRP	O
named	VBD	O
ParMDO	NNP	O
.	.	O

The	DT	O
MITE	NNP	B-Gene
insertion	NN	B-Var
truncates	VBZ	B-NegReg
the	DT	O
ParMDO	NNP	B-MPA
ORF	NNP	I-MPA
and	CC	O
produces	VBZ	O
a	DT	O
loss	NN	B-NegReg
of	IN	O
SI	NNP	B-MPA
function	NN	I-MPA
,	,	O
suggesting	VBG	O
that	IN	O
pollen	NN	O
rejection	NN	O
in	IN	O
Prunus	NNP	O
is	VBZ	O
dependent	JJ	O
on	IN	O
redox	JJ	O
regulation	NN	O
.	.	O
Based	VBN	O
on	IN	O
phylogentic	JJ	O
analyses	NNS	O
we	PRP	O
also	RB	O
suggest	VBP	O
that	IN	O
ParMDO	NNP	O
may	MD	O
have	VB	O
originated	VBN	O
from	IN	O
a	DT	O
tandem	NN	O
duplication	NN	O
followed	VBN	O
by	IN	O
subfunctionalization	NN	O
and	CC	O
pollen	NN	O
-	:	O
specific	JJ	O
expression	NN	O


Mutations	NNS	B-Var
in	IN	O
Cu	NNP	O
Zn	NNP	O
superoxide	JJ	O
dismutase	NN	O
1	CD	O
(	(	O
SOD1	NNP	B-Gene
)	)	O
lead	NN	B-Reg
to	TO	I-Reg
Amyotrophic	NNP	B-Disease
Lateral	NNP	I-Disease
Sclerosis	NNP	I-Disease
(	(	O
ALS	NNP	O
)	)	O
,	,	O
a	DT	O
neurodegenerative	JJ	O
disease	NN	O
that	WDT	O
disproportionately	RB	O
affects	VBZ	O
glutamatergic	JJ	O
and	CC	O
cholinergic	JJ	O
motor	NN	O
neurons	NNS	O
.	.	O
Previous	JJ	O
work	NN	O
with	IN	O
SOD1	NNP	O
overexpression	NN	O
models	NNS	O
supports	VBZ	O
a	DT	O
role	NN	O
for	IN	O
SOD1	NNP	O
toxic	JJ	O
gain	NN	O
of	IN	O
function	NN	O
in	IN	O
ALS	NNP	O
pathogenesis	NN	O
.	.	O

However	RB	O
,	,	O
the	DT	O
impact	NN	O
of	IN	O
SOD1	NNP	O
loss	NN	O
of	IN	O
function	NN	O
in	IN	O
ALS	NNP	O
cannot	NN	O
be	VB	O
directly	RB	O
examined	VBN	O
in	IN	O
overexpression	NN	O
models	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
overexpression	NN	O
may	MD	O
obscure	VB	O
the	DT	O
contribution	NN	O
of	IN	O
SOD1	NNP	O
loss	NN	O
of	IN	O
function	NN	O
in	IN	O
the	DT	O
degeneration	NN	O
of	IN	O
different	JJ	O
neuronal	JJ	O
populations	NNS	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
report	VBP	O
the	DT	O
first	JJ	O
single	JJ	O
-	:	O
copy	NN	O
,	,	O
ALS	NNP	O
knock	SYM	O
-	:	O
in	IN	O
models	NNS	O
in	IN	O
C.	NNP	O
elegans	NNS	O
generated	VBN	O
by	IN	O
transposon	JJ	O
-	:	O
or	CC	O
CRISPR	NNP	O
Cas9	NNP	O
-	:	O
mediated	VBD	O
genome	JJ	O
editing	NN	O
of	IN	O
the	DT	O
endogenous	JJ	O
sod	NN	O
-	:	O
1	CD	O
gene	NN	O
.	.	O

Introduction	NN	O
of	IN	O
ALS	NNP	O
patient	NN	O
amino	NN	O
acid	NN	O
changes	NNS	O
A4V	NNP	O
,	,	O
H71Y	NNP	O
,	,	O
L84V	NNP	O
,	,	O
G85R	NNP	O
or	CC	O
G93A	NNP	O
into	IN	O
the	DT	O
C.	NNP	O
elegans	VBZ	O
sod	JJ	O
-	:	O
1	CD	O
gene	NN	O
yielded	VBN	O
single	JJ	O
-	:	O
copy	NN	O
knock	SYM	O
-	:	O
in	IN	O
ALS	NNP	O
SOD1	NNP	O
models	NNS	O
.	.	O

These	DT	O
differ	VBP	O
from	IN	O
previously	RB	O
reported	VBN	O
overexpression	NN	O
models	NNS	O
in	IN	O
multiple	JJ	O
assays	NNS	O
.	.	O

In	IN	O
single	JJ	O
-	:	O
copy	NN	O
knock	SYM	O
-	:	O
in	IN	O
models	NNS	O
,	,	O
we	PRP	O
observed	VBD	O
differential	JJ	O
impact	NN	O
of	IN	O
sod	JJ	O
-	:	O
1	CD	O
ALS	NNP	O
alleles	NNS	O
on	IN	O
glutamatergic	NN	O
and	CC	O
cholinergic	JJ	O
neurodegeneration	NN	O
.	.	O

A4V	NNP	O
,	,	O
H71Y	NNP	O
,	,	O
G85R	NNP	O
,	,	O
and	CC	O
G93A	NNP	O
animals	NNS	O
showed	VBD	O
increased	JJ	O
SOD1	NNP	O
protein	NN	O
accumulation	NN	O
and	CC	O
oxidative	JJ	O
stress	NN	O
induced	VBN	O
degeneration	NN	O
,	,	O
consistent	JJ	O
with	IN	O
a	DT	O
toxic	JJ	O
gain	NN	O
of	IN	O
function	NN	O
in	IN	O
cholinergic	JJ	O
motor	NN	O
neurons	NNS	O
.	.	O

By	IN	O
contrast	NN	O
,	,	O
H71Y	NNP	O
,	,	O
L84V	NNP	O
,	,	O
and	CC	O
G85R	NNP	O
lead	VBP	O
to	TO	O
glutamatergic	VB	O
neuron	JJ	O
degeneration	NN	O
due	JJ	O
to	TO	O
sod	VB	O
-	:	O
1	CD	O
loss	NN	O
of	IN	O
function	NN	O
after	IN	O
oxidative	JJ	O
stress	NN	O
.	.	O

However	RB	O
,	,	O
dopaminergic	JJ	O
and	CC	O
serotonergic	JJ	O
neuronal	JJ	O
populations	NNS	O
were	VBD	O
spared	VBN	O
in	IN	O
single	JJ	O
-	:	O
copy	NN	O
ALS	NNP	O
models	NNS	O
,	,	O
suggesting	VBG	O
a	DT	O
neuronal	JJ	O
-	:	O
subtype	NN	O
specificity	NN	O
previously	RB	O
not	RB	O
reported	VBN	O
in	IN	O
invertebrate	NN	O
ALS	NNP	O
SOD1	NNP	O
models	NNS	O
.	.	O

Combined	VBN	O
,	,	O
these	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
knock	SYM	O
-	:	O
in	IN	O
models	NNS	O
may	MD	O
reproduce	VB	O
the	DT	O
neurotransmitter	NN	O
-	:	O
type	NN	O
specificity	NN	O
of	IN	O
ALS	NNP	O
and	CC	O
that	IN	O
both	DT	O
SOD1	NNP	O
loss	NN	O
and	CC	O
gain	NN	O
of	IN	O
toxic	JJ	O
function	NN	O
differentially	RB	O
contribute	VBZ	O
to	TO	O
ALS	NNP	O
pathogenesis	NN	O
in	IN	O
different	JJ	O
neuronal	JJ	O
populations	NNS	O

deposition	NN	I-Protein
in	IN	I-Var
Alzheimer	NNP	I-NegReg
's	POS	I-MPA
model	NN	I-Disease
frontotemporal	JJ	B-Disease
lobar	NN	I-Disease
degeneration	NN	I-Disease
Grn	NNP	B-Protein
haploinsufficiency	NN	B-Var
loss	NN	B-NegReg
of	IN	I-NegReg
functional	JJ	I-NegReg
PGRN	NNP	B-Protein
mutations	NNS	B-Var
involved	VBN	B-Reg
FTLD	NNP	B-Disease
Grn	NNP	B-Protein
mutations	NNS	B-Var
associated	VBN	B-Reg
Alzheimer	NNP	B-Disease
's	POS	I-Disease
disease	NN	I-Disease

Brains	NNS	O
were	VBD	O
collected	VBN	O
from	IN	O
16	CD	O
-	:	O
18	CD	O
-	:	O
month	NN	O
-	:	O
old	JJ	O
APP	NNP	O
and	CC	O
APP	NNP	O
Grn	NNP	O
-	:	O
mice	NN	O
and	CC	O
sequential	JJ	O
extraction	NN	O
of	IN	O
proteins	NNS	O
,	,	O
immunoblotting	VBG	O
and	CC	O
immunohistochemical	JJ	O
analysis	NN	O
were	VBD	O
performed	VBN	O
.	.	O

Immunohistochemical	JJ	O
analysis	NN	O
showed	VBD	O
that	IN	O
the	DT	O
number	NN	O
and	CC	O
area	NN	O
of	IN	O
A	NNP	O
plaque	NN	O
was	VBD	O
significantly	RB	O
decreased	VBN	O
in	IN	O
APP	NNP	O
Grn	NNP	O
-	:	O
mice	NN	O
as	IN	O
compared	VBN	O
to	TO	O
APP	NNP	O
mice	NN	O
.	.	O

Immunoblotting	VBG	O
analysis	NN	O
revealed	VBD	O
that	IN	O
A	NNP	O
was	VBD	O
reduced	VBN	O
in	IN	O
the	DT	O
sarkosyl	NN	O
-	:	O
insoluble	JJ	O
fraction	NN	O
of	IN	O
16	CD	O
-	:	O
18	CD	O
-	:	O
month	NN	O
-	:	O
old	JJ	O
APP	NNP	O
Grn	NNP	O
-	:	O
mice	NN	O
as	IN	O
compared	VBN	O
with	IN	O
that	DT	O
of	IN	O
APP	NNP	O
transgenic	JJ	O
mice	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
suggest	VBP	O
that	IN	O
PGRN	NNP	B-Protein
haploinsufficiency	NN	B-Var
may	MD	O
decrease	VB	B-NegReg
accumulation	NN	B-MPA
of	IN	I-MPA
A	NNP	I-MPA

kinase	VBD	I-Enzyme
C	NNP	I-Enzyme
-	:	I-Enzyme
Alzheimer	NNP	I-PosReg
's	POS	I-Var
disease	NN	I-Disease
enhanced	VBN	B-PosReg
catalysis	NN	B-MPA


gain	NN	B-PosReg
-	:	I-PosReg
of	IN	I-PosReg
-	:	I-PosReg
function	NN	I-PosReg
germline	NN	B-Var
mutation	NN	I-Var
PKC	NNP	B-Enzyme
in	IN	I-Enzyme
Alzheimer	NNP	B-Disease
's	POS	I-Disease
disease	NN	I-Disease
enhances	VBZ	B-PosReg
signaling	VBG	B-MPA
mutation	NN	B-Var
increase	NN	B-PosReg
catalytic	JJ	B-MPA
mutation	NN	B-Var
decreasing	VBG	B-NegReg
dynamics	NNS	B-MPA
of	IN	I-MPA
the	DT	I-MPA
C	NNP	I-MPA
-	:	I-MPA
helix	NN	I-MPA

However	RB	O
,	,	O
the	DT	O
mutant	JJ	B-Var
enzyme	NN	B-Enzyme
in	IN	O
cells	NNS	O
displays	NNS	O
increased	VBD	B-PosReg
sensitivity	NN	B-MPA
to	TO	O
an	DT	O
inhibitor	NN	O
that	WDT	O
is	VBZ	O
ineffective	JJ	O
toward	IN	O
scaffolded	JJ	O
PKC	NNP	O
,	,	O
suggesting	VBG	O
the	DT	O
altered	JJ	O
dynamics	NNS	O
of	IN	O
the	DT	O
kinase	NN	O
domain	NN	O
may	MD	O
influence	VB	B-Reg
protein	NN	B-Protein
interactions	NNS	B-Interaction
.	.	O
Finally	RB	O
,	,	O
we	PRP	O
show	VBP	O
that	DT	O
phosphorylation	NN	B-MPA
of	IN	O
a	DT	O
key	JJ	O
PKC	NNP	O
substrate	NN	O
,	,	O
myristoylated	VBN	B-MPA
alanine	NN	I-MPA
-	:	I-MPA
rich	JJ	I-MPA
C	NNP	I-MPA
-	:	I-MPA
kinase	NN	I-MPA
substrate	NN	I-MPA
,	,	O
is	VBZ	O
increased	VBN	B-PosReg
in	IN	O
brains	NNS	O
of	IN	O
CRISPR	NNP	O
-	:	O
Cas9	NNP	O
genome	SYM	O
-	:	O
edited	VBN	O
mice	NN	O
containing	VBG	O
the	DT	O
PKC	NNP	B-Enzyme
-	:	I-Enzyme
M489V	NNP	B-Var
mutation	NN	I-Var
.	.	O
Our	PRP$	O
results	NNS	O
unveil	VB	O
how	WRB	O
an	DT	O
AD	NNP	B-Disease
-	:	O
associated	VBN	B-Reg
mutation	NN	B-Var
in	IN	O
PKC	NNP	B-Enzyme
permits	NNS	I-Enzyme
enhanced	VBD	B-PosReg
agonist	JJ	B-MPA
-	:	I-MPA
dependent	JJ	I-MPA
signaling	VBG	I-MPA
via	IN	O
a	DT	O
mechanism	NN	O
that	WDT	O
evades	VBZ	B-NegReg
the	DT	O
cell	NN	O
's	POS	O
homeostatic	JJ	B-MPA
down	RP	I-MPA
-	:	I-MPA
regulation	NN	I-MPA
of	IN	O
constitutively	RB	B-Enzyme
active	JJ	I-Enzyme
PKC	NNP	I-Enzyme

